Monday

San Diego | November 1216

Scientific Session Listings 273470

Information at a Glance
Note: The themes have been updated for
Neuroscience 2016

Important Phone Numbers

Annual Meeting Headquarters Office

Exhibit Management

Logistics and Programming

San Diego Convention Center: Lobby D

Logistics

(619) 525-6240

San Diego Convention Center: Sails Pavilion

(619) 525-6200

First Aid, Hospital and Urgent

Care Numbers

Programming

First Aid Station

San Diego Convention Center: Sails Pavilion

San Diego Convention Center:

(619) 525-6205

Box Office G

Volunteer Leadership Lounge

(619) 525-6211

Key to Poster Floor by Themes

Theme
A. Development
B. Neural Excitability, Synapses, and Glia
C. Neurodegenerative Disorders and Injury
D. Sensory Systems
E. Motor Systems
F. Integrative Physiology and Behavior

San Diego Convention Center: Room 14A

Scripps Mercy Hospital

(619) 525-6235

4077 Fifth Avenue

G. Motivation and Emotion

San Diego, CA 92103

H. Cognition

(619) 294-8111

I. Techniques

General Information Booths

San Diego Convention Center

J. History and Education

Front of Box Office A, (619) 525-6224

Sharp Rees Stealy Downtown

Lobby D, (619) 525-6225

San Diego Urgent Care

NOTE: Theme J Posters will be located in Hall

Sails Pavilion, (619) 525-6226

300 Fir Street

B beginning at 1 p.m. on Saturday, November

San Diego, CA 92101

12, and will remain posted until 5 p.m., Sunday,

(858) 499-2600

November 13.

Press Office
Press Room
San Diego Convention Center: Room 15B
(619) 525-6230

Code of Conduct at SfN Events

SfN is committed to supporting discovery and
scientific dialogue, and to fostering a welcoming

positive environment. At the convention center,

designated Human Resources Officer in the

onsite medical and security personnel are available

SfN headquarters office at each meeting

directly or through the SfN headquarters office.

convention center, or sent via email to

[email protected]. The HR Officer will facilitate the

community in which all scientists are able to

If attendees experience unwelcome or unsafe

contribute fully. The Society asserts that sexual

situations anywhere in the city, attendees should

harassment and other harassing behaviors have

swiftly contact local authorities (dial 9-1-1), and

no place in a healthy scientific enterprise. We

additional local social services resources are listed

expect all attendees, media, speakers, volunteers,

in one convenient location at the federal website

For more information, on SfNs policy, please

organizers, venue staff, guests, and exhibitors at

www.notalone.gov. Any official report of sexual

go to: sfn.org/Member-Center/Professional-

SfN-organized events to help us ensure a safe and

harassment should be brought to the

Conduct/Code-of-Conduct-at-SfN-Events

Cover Image: This image of a coronal section of the dorsal telencephalon from an embryonic day 18.5
mouse shows excitatory neurons of different layers (yellow and red). Haploinsufficiency for Rbm8a, a
component of the exon junction complex, causes severe microcephaly and defective neurogenesis.
Hanqian Mao, Louis-Jan Pilaz, John J. McMahon, Christelle Golzio, Danwei Wu, Lei Shi, Nicholas
Katsanis, and Debra L. Silver, 2016, The Journal of Neuroscience, 35(18): 7003-7018.

completion of a report by a complainant. View the

entire Code of Conduct at SfN Events statement
for more information.

Complete Session Listing

Monday AM
LECTURE
San Diego Convention Center

SYMPOSIUM
San Diego Convention Center

273.

275.

Quantal Release and Its RequirementsCME

Mon. 8:30 AM- 9:40 AMBallroom 20

Mon. 8:30 AM- 11:00 AM6B

Quantal release by exocytosis requires the transport of

classical neurotransmitters into secretory vesicles. Vesicular
transport activity thus defines the membranes, as well as
the cells capable of transmitter release. However, the three
families of vesicular transporters differ in ionic coupling.
This lecture will discuss the biophysical properties of the
transporters, the properties of secretory vesicles that
influence their function, and the implications for synaptic
transmission, including quantal size, non-vesicular efflux,
synaptic vesicle pools and transmitter co-release.

Chair: C. L. STUCKY
Co-Chair: X. DONG

Microtubule and Tau-Based Therapy for Alzheimers

Disease and Other Brain DisordersCME
Mon. 8:30 AM- 11:00 AM6A
Chair: I. GOZES
Co-Chair: E. MANDELKOW
The microtubule subunit, tubulin, is a major brain protein.
Microtubule associated proteins like tau are key regulatory
elements of neuronal and glial health. Microtubule
dysfunction leads to blockade of axonal transport, glial
impairment, and synaptic dysfunction/loss, which are
hallmarks of brain diseases. This symposium will focus on
microtubules in different cell types for a better understanding
of brain function in health and disease, and toward improved
diagnostics and therapeutics.

8:30 274.01 Introduction.

8:35 274.02 Common microtubule associated genes regulating

autism, schizophrenia and Alzheimers disease: Toward
new diagnostics and therapies. I. GOZES. Sackler Sch. of
Medicine, Tel Aviv Univ.
9:10 274.03 Mechanisms of microtubule loss during Alzheimers
disease. P. W. BAAS. Drexel Univ. Col. of Med.
9:45 274.04 Inclusion body formation in oligodendrocytes: New
horizons for microtubule based-therapies in multiple system
atrophy. C. RICHTER-LANDSBERG. Univ. Oldenburg.
10:20 274.05 Microtubule-associated protein : Drug design and
frontotemporal dementias. E. M. MANDELKOW. German
Ctr. for Neurodegenerative Diseases(DZNE).
10:55 274.06 Closing Remarks.

Chronic pain is a persistent, debilitating condition stemming

from a variety of etiologies and diseases. Over 1.5 billion
people worldwide suffer from chronic pain that is only
partially alleviated by current therapies and treatments.
Recent studies have elucidated novel molecular and cellular
players that drive chronic pain in animal models and human
conditions. This symposium will review these advances and
discuss their implications for the diagnosis and treatment of
chronic pain patients.
8:30 275.01 Introduction.
8:35 275.02 The contribution of Mrgpr GPCRs to persistent
pain. X. DONG. Johns Hopkins Univ. Sch. of Med.
9:10 275.03 Dissecting chronic pain mechanisms in animal
models of disease. C. L. STUCKY. Med. Col. of Wisconsin.

9:45 275.04 Nav1.7: Closing in on personalized

pharmacotherapy for pain. S. G. WAXMAN. Yale Univ. Sch.
of Med. and VA Connecticut.

10:20 275.05 Exploring pain pathophysiology in patients. C. L.

SOMMER. Univ. of Wuerzburg.
10:55 275.06 Closing Remarks.
SYMPOSIUM
San Diego Convention Center
276.

Fronto-Subthalamic Circuits for Control of Action and

CognitionCME
Mon. 8:30 AM- 11:00 AM6F
Chair: A. R. ARON
This session will report new findings about the cognitive
functions and computational properties of the circuit linking
frontal cortex and subthalamic nucleus (STN) of the basal
ganglia. Diverse and novel technical approaches in humans
are taken to record cortical and STN electrophysiology at
the same time, to record single-unit human STN activity, to
use 7T fMRI, and to stimulate STN optogenetically in mice.
The role of the circuit is highlighted for stopping and pausing
behavior and cognition.

8:30 276.01 Introduction.

8:35 276.02 Electrophysiological correlates of dynamic decision
thresholds in humans. P. BROWN. Univ. of Oxford.
9:10 276.03 Dorsomedial frontal cortex and subthalamic
nucleus during decision-making with multiple alternatives. B.
U. FORSTMANN. Univ. of Amsterdam.
9:45 276.04 A subthalamic-nucleus-mediated interrupt has
broad motor and non-motor effects. A. ARON. UCSD.
10:20 276.05 Single unit activity in human subthalamic nucleus
during decision conflict, adaptation, and memory. K. A.
ZAGHLOUL. NIH.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|1

Mon. AM

Speaker: R. EDWARDS, Univ. of California, San Francisco.

SYMPOSIUM
San Diego Convention Center
274.

Current Topics in Chronic Pain: From Molecules to

MedicineCME

10:55 276.06 Closing Remarks.

8:55 278.03 MicroRNA miR-9 regulates vocal learning and

performance in zebra finches. X. LI. Louisiana State Univ.
Hlth. Sci. Ctr.

MINISYMPOSIUM
San Diego Convention Center

9:15 278.04 Vocal production learning in bats- a perspective

from behavioral ecology. M. KNRNSCHILD. Freie Univ.
Berlin & Smithsonian Tropical Res. Inst.

277. Human Brain Development and Maturation: Animal

Brain Mapping, Human Brain Imaging, and Computer
SimulationCME
Mon. 8:30 AM- 11:00 AM28A
Chair: K. ISHIZUKA
Co-Chair: T. SHIMOGORI
The fundamental goal of neuroscience is to understand
the human brain. With this goal in mind, comprehensive
data collection and analysis have begun in each scientific
area and in countries around the world. However, these
datasets need to be connected to one another beyond
the methodological principles to reach the final goal. This
session will discuss a proposal for a symposium in which
investigators from representative nation-level projects can
meet and discuss how to work together for the future of
neuroscience.
8:30 277.01 Introduction.
8:35 277.02 Conserved molecular mechanism of early life
experience dependent circuit development: Mouse to
marmoset. T. SHIMOGORI. RIKEN.

9:35 278.05 Studying the neurobiology of vocal communication

and learning in bats. M. M. YARTSEV. Univ. of California,
Berkeley.
9:55 278.06 The genetic basis of vocal learning: What can we
learn from bat genomes. S. VERNES. Max Planck Inst. for
Psycholinguistics.
10:15 278.07 Parallels between birds song and human speech
at the genetic and epigenetic level. M. WIRTHLIN. Carnegie
Mellon Univ.
10:35 278.08 Closing Remarks.
MINISYMPOSIUM
San Diego Convention Center
279. Mesoscale Imaging of Cortical Function and Dysfunction
in MiceCME
Mon. 8:30 AM- 11:00 AM29D
Chair: J. WATERS

8:55 277.03 Transcriptomic features of primate brain

development. J. MILLER. Allen Inst. for Brain Sci.

The skulls of mice are relatively transparent, permitting

relatively non-invasive optical access to the neocortex.
This minisymposium presents six recent studies that have
leveraged optical access and activity-dependent indicators
and opsins to probe the function and dysfunction of the
neocortex at the mesoscale recording and modulating the
activities of cortical areas in mice performing behavioral
tasks.

9:15 277.04 Autism-like behaviors and germline transmission

of transgenic monkeys overexpressing MeCP2. Z. QIU.
Shanghai Institutions for Biol. Sci.
9:35 277.05 Molecular signature to brain structure and function
in neurodevelopmental disorders. K. ISHIZUKA. Johns
Hopkins Univ.
9:55 277.06 The UNC early brain development study: New
insights into human postnatal brain development. J. H.
GILMORE. Univ. of North Carolina Sch. of Med.
10:15 277.07 Bridging the gap- from genes to cognition. S.
GRILLNER. Karolinska Inst.
10:35 277.08 Closing Remarks.
MINISYMPOSIUM
San Diego Convention Center
278. Neurogenetic Insights Into Speech and Language From
Birds and BatsCME
Mon. 8:30 AM- 11:00 AM6E
Chair: S. C. VERNES
Co-Chair: M. M. YARTSEV
Language and speech are core human traits.
Comprehension of their neurological and genetic basis is
rapidly advancing by studying relevant traits, such as vocal
learning and acoustic communication in mammalian and
non-mammalian models. This session will highlight these
advances, with emphasis on emerging studies in songbirds
and bats. The session will consider benefits of integrating
findings across species to understand the neurogenetic
mechanisms of vocal learning to ultimately shed light on
human spoken language.

8:30 279.01 Introduction.

8:35 279.02 Mesoscale imaging of cortical visual areas and
visually-guided behaviors. J. WATERS. Allen Inst. For Brain
Sci.
8:55 279.03 Mesoscale flow of cortical activity during vision,
behavior and epilepsy. M. CARANDINI. Univ. Col. London.
9:15 279.04 Widefield calcium imaging across neocortex during
whisker-based tactile discrimination. F. HELMCHEN. Univ. of
Zurich, Brain Res. Inst.
9:35 279.05 The role of cortex in skilled motor actions. A.
HANTMAN. Howard Hughes Med. Inst.

9:55 279.06 Optical mapping of functional connectivity from

mouse to man. J. P. CULVER. Washington Univ. in St Louis.
10:15 279.07 Functional and structural connectivity of the default
mode network in wild type and Alzheimers mice. J.D.
WHITESELL. Allen Inst. for Brain Sci.
10:35 279.08 Closing Remarks.

8:30 278.01 Introduction.

8:35 278.02 Dopaminergic error signals in birdsong support a
general model of trial and error learning. J. H. GOLDBERG.
Cornell Univ.
2 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

LECTURE
San Diego Convention Center
280. DAVID KOPF LECTURE ON NEUROETHICS- Reforming
Forensic Science: Some Insights From Research on
Vision and Memory
Mon. 10:00 AM- 11:10 AMBallroom 20
Speaker: T. D. ALBRIGHT, Salk Inst. For Biol. Studies.
Support contributed by: David Kopf Instruments

LECTURE
San Diego Convention Center
281. Understanding Mammalian Microcircuits: Let Inspiration
Guide the WayCME
Mon. 11:30 AM- 12:40 PMBallroom 20
Speaker: J. L. FELDMAN, UCLA.
More than 25 years since our discovery of the pre-Btzinger
Complex, the core of the circuit for breathing, the underlying
mechanisms governing its dynamics remain elusive and
are much more complex than we first thought. This lecture
will address how novel emergent mechanisms, but not
pacemakers, inhibition, or bursting, are likely to be critical
and describe the roles the pre-BtC plays in regulation of
body function, other movements, and emotion. The neural
circuit controlling breathing is inimitably tractable and
may inspire general strategies for elucidating other neural
microcircuits.

NANOSYMPOSIUM
282. Modeling Neuropsychiatric Disease
Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,23A

9:00 282.05 Idiopathic autism patient-derived neural stem

cells display defects in neurite outgrowth, cell migration,
and cellular signaling pathways. S. PREM*; M. WILLIAMS;
C. MCDERMOTT; X. ZHOU; P. YEUNG; C. LU; Z. PANG;
L. BRZUSTOWICZ; P. MATTESON; J. MILLONIG; E.
DICICCO-BLOOM. Rutgers Robert Wood Johnson Med.
Sch., Rutgers Grad. Sch. of Biomed. Sci., Queens College,
City Univ. of New York, Rutgers Robert Wood Johnson Med.
Sch., Rutgers Univ.

9:15 282.06 MicroRNA dysregulation in an induced pluripotent

stem cell model of bipolar disorder. M. BAME*; M. MCINNIS;
S. OSHEA. Univ. of Michigan, Univ. of Michigan, Univ. of
Michigan.

9:30 282.07 A novel human iPSC-based model of Alzheimers

disease generated by knock-in of early-onset AD mutations
displays disease-relevant, zygosity-dependent phenotypes.
D. PAQUET*; D. KWART; A. CHEN; A. SPROUL; S. JACOB;
S. TEO; K. M. OLSEN; A. GREGG; S. NOGGLE; M.
TESSIER-LAVIGNE. The Rockefeller Univ., Columbia Univ.,
The New York Stem Cell Fndn. Res. Inst.
9:45 282.08 Modeling for genetic risk for schizophrenia in
iPSCs and mice reveals synaptic release deficits. N. KIM*; Z.
WEN; J. LIU; K. YOON; Y. ZHOU; Y. LIN; Z. GUO; X. WANG;
H. YU; K. M. CHRISTIAN; K. HSU; W. LI; X. LU; H. SONG;
G. MING. Johns Hopkins Univ., Johns Hopkins Univ. Sch. of
Med., Univ. of Texas Hlth. Sci. Ctr. at San Antonio, Shanghai
Jiao Tong Univ., Natl. Cheng Kung Univ.
10:00 282.09 Investigation of GRIN2B dosage in developing
neurons. G. MAUSSION*; S. TORRES-PLATAS; C.
VASUTA; H. PENG; C. BOUDREAU-PINSONNEAULT;
A. DIALLO; J. THROUX; C. GIGEK; L. CRAPPER; G.
TURECKI; E. CHEN; K. ADAMS; N. MECHAWAR; T.
WONG; C. ERNST. Douglas Mental Hlth. Univ. Inst.
10:15 282.10 Studying serotonergic neurotransmission using
human pluripotent stem cell derived neurons in vitro. K. C.
VADODARIA*; S. DAVE; C. FREDLENDER; L. FUNG; X. LI;
F. GAGE. Salk Inst. For Biol. Sci.
10:30 282.11 Human FTD iPSC-derived neurons provide
novel insights into imbalance of iron homeostasis and
neurodegeneration. Y. ZHANG*; B. SCHMID; N. K.
NIKOLAISEN; M. A. RASMUSSEN; B. I. ALDANA;
K. CALLOE; T. C. STUMMANN; H. M. LARSEN; T. T.
NIELSEN; J. HUANG; L. YE; F. XU; L. BOLUND; L. K.
BAK; H. S. WAAGEPETERSEN; Y. LUO; J. E. NIELSEN;
B. HOLST; C. CLAUSEN; P. HYTTEL; K. K. FREUDE. Univ.
of Copenhagen, Bioneer A/S, H. Lundbeck A/S, Danish
Dementia Res. Centre, Rigshospitalet, Univ. of Copenhagen,
BGI Res., Aarhus Univ.

8:15 282.02 Differentiation of human neural progenitors to

glutamate-responsive cells in fragile X syndrome, a variant of
autism. M. L. CASTRN*; V. S. ACHUTA. Univ. of Helsinki,
Med. Fac.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|3

NANOSYMPOSIUM

8:00 282.01 Modeling Zika virus exposure with human iPSCderived neural cells. Z. WEN*; H. TANG; C. HAMMACK;
S. C. OGDEN; X. QIAN; Y. LI; B. YAO; M. XU; Y. CHENG;
E. M. LEE; J. SHIN; F. ZHANG; W. HUANG; J. TCW; K. M.
CHRISTIAN; R. A. DIDIER; K. BRENNAND; W. ZHENG; P.
JIN; H. SONG; G. MING. Emory Univ. Sch. of Med., Emory
Univ. Sch. of Med., Emory Univ. Sch. of Med., Florida State
Univ., Johns Hopkins Univ. Sch. of Med., Emory Univ. Sch.
of Med., NIH, Icahn Sch. of Med. at Mount Sinai, Johns
Hopkins Univ. Sch. of Med., Florida State Univ., Johns
Hopkins Univ. Sch. of Med., Johns Hopkins Univ. Sch. of
Med.

8:45 282.04 Modeling network regulators of genetic

predisposition to schizophrenia using stem cells. K.
BRENNAND*; B. HARTLEY; S. ZHU; A. TOPOL; J.
ENGLISH; M. HAUBERG; N. TRAN; C. RITTENHOUSE;
A. SIMONE; D. RUDERFER; H. SHAH; G. CAGNEY; J.
RAPOPORT; F. GAGE; P. SKLAR; M. MATTHEISEN; D.
COTTER; G. FANG. Icahn Sch. of Med. at Mount Sinai,
Royal Col. of Surgeons in Ireland, Aarhus Univ., Salk Inst. for
Biol. Studies, Conway Inst., Natl. Inst. of Mental Hlth.

Mon. AM

In its 2009 report, Strengthening Forensic Science in the

United States: A Path Forward, the National Academy of
Sciences identified a number of significant weaknesses
in forensic science, which have contributed to wrongful
convictions and have threatened public confidence in our
criminal justice system. These problems have prompted
broad calls for reform of the processes by which forensic
evidence is acquired, analyzed, and interpreted. Several
types of forensic analyses involve evaluation of complex
visual patterns or memories of visual experiences. Advances
in understanding of brain systems for visual sensation,
perception, and memory can help shape forensic reform by
illuminating the relevant sensory and cognitive processes,
their limitations, and factors that can improve human
performance in a forensic context.

8:30 282.03 Modeling drug response in autism using pluripotent

stem cells. C. MARCHETTO*; Y. KIM; R. SANTOS; A. D.
MENDES; S. LINKER; F. GAGE. Salk Inst.

10:45 282.12 Differential gene expression patterns and synaptic

functions for each genetic class of Angelman syndrome
patient-derived neurons. M. ISHIKAWA*; H. OKUNO; S.
TANAKA; Y. NAKATAKE; H. KOMANO; W. AKAMATSU; M.
KO; K. KOSAKI; S. SAITOH; H. OKANO. Dept. Physiol.,
Keio Univ. Sch. Med., Dept. Syst. Med., Cent. Genet.
Regenerat. Med., Juntendo Univ., Sch. Med., Cent. Med.
Genet., Keio Univ., Sch. Med., Dept. Pediat. and Neonatol.,
Nagoya City Univ., Grad. Sch. Med. Sci.
11:00 282.13 Altered doses of psychiatric risk factor CYFIP1
lead to dysregulated protein and behavioral abnormalities
in models of psychiatric disorders. K. YOON*; F. R.
RINGELING; Y. ZHOU; H. N. NGUYEN; S. J. TEMME;
N. KIM; Y. LIN; B. XIAO; K. HSU; S. CANZAR; W. LI; P.
WORLEY; K. M. CHRISTIAN; H. SONG; G. MING. Johns
Hopkins Univ., Johns Hopkins Univ., Shanghai Jiao Tong
Univ., Natl. Cheng Kung Univ., Sichuan Univ., Toyota
Technological Inst., Shanghai Jiao Tong Univ., Johns
Hopkins Univ.

11:15 282.14 The controlled formation of human vascularized

neural assemblies using synthetic hydrogel technologies and
the application of the assembled neural tissues in human
neurodevelopmental disease modelling. B. T. DALY*; A.
DIAS; C. SOREF; W. MURPHY. Human Models For Analysis
of Pathways Ctr., Univ. of Wisconsin- Madison, Human
Models for Analysis of Pathways Ctr.

NANOSYMPOSIUM
283. Epilepsy: Mechanisms
Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,25A
8:00 283.01 Translational profiling of the dentate mature
granule cells after pilocarpine-induced status epilepticus. K.
CHO*; S. YUN; S. NAM; A. EISCH; J. HSIEH. The Catholic
Univ. of Korea, UTSW, The Catholic Univ. of Korea.
8:15 283.02 Dentate parvalbumin expressing chandelier cells
show early reduction in excitability in experimental epilepsy.
A. PRODDUTUR*; J. GUEVARRA; V. SANTHAKUMAR.
Rutgers New Jersey Med. Sch.
8:30 283.03 Testing for correlation between dentate gyrus
anatomic pathology and frequency of spontaneous
seizures in a mouse model of temporal lobe epilepsy. P.
BUCKMASTER*; E. ABRAMS. Stanford Univ., Stanford Univ.

NANOSYMPOSIUM

8:45 283.04 Hippocampal corticotropin-releasing hormone

neurons potently modulate hippocampal function, excitability,
and seizure susceptibility. A. HOOPER*; J. MAGUIRE. Tufts
Univ., Tufts Univ. Sch. of Med.
9:00 283.05 Systemic delivery of antagomir-134 produces antiepileptogenic effects. C. R. RESCHKE*; V. R. VANGOOR;
M. ROSSO; G. P. BRENNAN; L. F. A. SILVA; A. SANZRODRIGUES; A. BATOOL; E. JIMENEZ-MATEOS; M.
CAMPBELL; J. PASTERKAMP; D. C. HENSHALL. Royal
Col. of Surgeons in Ireland, UMC Utrecht, Trinity Col. Dublin.
9:15 283.06 Can a spider venom fix Dravet Syndrome?
K. L. RICHARDS*; C. J. MILLIGAN*; V. HERZIG; R. J.
RICHARDSON; M. GRUNNET; C. A. REID; G. F. KING*;
S. PETROU*. Florey Inst. of Neurosci. and Mental Hlth.,
Univ. of Queensland, Neurosci. Drug Discovery, The Univ. of
Melbourne, The Univ. of Melbourne.

9:45 283.08 The role of Kv2 in modulating in virto seizure

activity in mice treated with the ketogenic diet. R. PARENT*;
G. FISHER; H. BURNS; A. SMARSH; G. MURPHY. Univ. of
Michigan.

10:00 283.09 Electrophysiology-based HTS for positive allosteric

modulators of N-Methyl-D-Aspartate receptors. N. B.
FEDOROV; Y. A. KURYSHEV; J. FISHER; A. WRIGHT;
C. WU; L. C. ARMSTRONG; C. MATHES*; M. ACKLEY.
Chantest, A Charles River Co., Sage Therapeut.

NANOSYMPOSIUM
284. Brain Wellness and Aging: From Phenotypes to
Mechanisms
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,33C
8:00 284.01 The oldest-old with preserved cognition and the full
range of Alzheimer pathology. A. REZVANIAN; D. T. OHM; L.
KUKREJA; T. D. GEFEN; S. WEINTRAUB; E. ROGALSKI;
R. KIM; C. AGUIRRE; M. CORRADA; M. MESULAM*; C.
KAWAS; C. GEULA. Cognitive Neurol. and Alzheimers Dis.
Ctr., Univ. of California at Irvine, Sch. of Med.
8:15 284.02 Collateral information connectivity in brain
maximizes around 7th decade in man to cognitively
compensate for neurodegenerative changes during
advanced ageing. P. K. ROY*. Natl. Brain Res. Ctr.
8:30 284.03 Positive effect of aerobic exercise on the cortisol
awakening response in healthy older adults: Results from
the Brain in Motion Study. L. L. DROGOS*; K. L. WYNNEEDWARDS; R. ZHOU; S. HALL; C. DUNCAN; M. J.
POULIN. Univ. of Calgary, Univ. of Calgary, Univ. of Calgary,
Univ. of Calgary, Univ. of Calgary, Univ. of Calgary, Univ. of
Calgary.
8:45 284.04 Physical activity modifies corticospinal excitability
of the lower extremity in young and old adults. A. E. SMITH*;
H. HASSANLOUEI; C. W. SUNDBERG; A. KUPLIC; S. K.
HUNTER. Univ. of South Australia, Marquette Univ.
9:00 284.05 The X-chromosome confers resilience against
Alzheimers disease toxicity. E. MINONES-MOYANO; L.
BROESTL; A. ARNOLD; C. WHITE; D. BENNETT; P. DE
JAGER; D. WANG; D. B. DUBAL*. Univ. of California San
Francisco, UCLA, Brigham and Womens Hospital, Harvard
Med. School, and Broad Inst., Rush Univ.

9:15 284.06 Young human plasma as therapy for agingassociated cognitive disorders. S. MINAMI*; S. REGE; H.
HACKBART; S. P. BRAITHWAITE. Alkahest, Inc.

9:30 284.07 Identifying early mechanisms of Alzheimers

disease synaptic pathology for novel therapeutic strategies.
G. E. STUTZMANN*; S. CHAKROBORTY; S. E. RILEY; A.
LITTLEFIELD; C. A. BRIGGS; W. FROST; J. BUOLAMWINI.
Rosalind Franklin Univ. /Chicago Med. Sch., Rosalind
Franklin Univ. /Chicago Med. Sch., Rosalind Franklin Univ. /
College of Pharm., Rosalind Franklin Univ. /Chicago Med.
Sch.
9:45 284.08 Aged rodents are behaviorally and
neurophysiologically sensitive to combinations of
inflammatory and anticholinergic manipulations related to
delirium. E. Y. KIMCHI*; B. F. COUGHLIN; S. S. CASH.
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.

9:30 283.07 In vivo drug discovery of novel therapeutics

for Dravet Syndrome using zebrafish. A. GRIFFIN*; K.
HAMLING; M. DINDAY; S. BARABAN. UCSF.
4 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 284.09 Age-dependent increase in membrane lipid

deregulation observed in brain regions vulnerable to
age-related pathology. S. CAUGHLIN*; K. YEUNG; D. F.
CECHETTO; S. N. WHITEHEAD. The Univ. of Western
Ontario, The Univ. of Western Ontario.
10:15 284.10 Store-operated calcium channel complex in
postsynaptic spines as a new therapeutic target for
Alzheimers disease treatment. I. BEZPROZVANNY*; H.
ZHANG; S. SUN; E. PCHITSKAYA; E. POPUGAEVA. UT
Southwestern Med. Ctr., St Petersburg State Polytechnical
Univ.
10:30 284.11 Pin1 regulates dendritic spines in A42 treated
neurons. J. S. MALTER*; N. STALLINGS; M. ONEAL; J. HU;
I. BEZPROZVANNY. UT Southwestern, UT Southwestern.
10:45 284.12 Role of Calcium in mediating MPP+ toxicity in SN
and VTA dopaminergic neurons. O. LIEBERMAN*; S. CHOI;
E. KANTER; D. SULZER; E. MOSHAROV. Columbia Univ.

11:15 284.14 Causal relationship between store-operated Ca2+

signaling, autophagy, UPR and viability of DA neurons, and
its role in Parkinsons disease. V. M. BOLOTINA*; A. YEN;
Q. ZHOU. Boston Univ. Sch. of Med.

NANOSYMPOSIUM
285. Development of Novel Therapeutics for Alzheimers
Disease: In Vitro Studies
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,32B
8:00 285.01 Functional brain activation patterns in cognitively
normal older adults are differentially associated with
Alzheimer pathology and white matter hyperintensities. B. T.
GOLD*; C. BROWN; J. HAKUN; Y. JIANG; C. SMITH. Univ.
of Kentucky Chandler Med. Ctr.
8:15 285.02 Environmental enrichment changes hippocampal
network activity and modifies its sensitivity to amyloid-
in vitro. A. GONZALEZ ISLA*; F. VAZQUEZ-CUEVAS; F.
PENA-ORTEGA. Univ. Nacional Autnoma De Mxico, Univ.
Nacional Autnoma de Mexico.
8:30 285.03 A study of brain glutathione levels in anterior
and posterior cingulate in mild cognitive impairment and
Alzheimers disease. S. SAHARAN; S. MORE; S. A. KHAN;
M. TRIPATHI; P. K. MANDAL*. Natl. Brain Res. Ctr., AIIMS,
Radiology, Johns Hopkins Univ.

9:00 285.05 Kamikihito regulates axonal growth via cytosolic

aspartate aminotransferase activation. R. KOBAYASHI*; H.
WATARI; Y. SHIMADA; C. TOHDA. Inst. of Natural Med.,
Univ. of Toyama, Dept. of Japanese Oriental Medicine, Grad.
Sch. of Med. and Pharmaceut. Sciences, Univ. of Toyama.
9:15 285.06 Controlling post translational modifications to
modulate aggregation: A toolbox approach. S. GUPTA*;
G. K. VISWANATHAN; K. RALHAN. Indian Inst. of Technol.
Gandhinagar.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

NANOSYMPOSIUM
286. Structural Changes, Connectivity, and Deep Brain
Stimulation Treatment in Parkinsons Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,30B
8:00 286.01 Structural changes in the Substantia Nigra in
Parkinsons disease. M. C. KEUKEN*; B. R. ISAACS; R.
BALESAR; A. ALKEMADE; B. U. FORSTMANN. UvA.
8:15 286.02 White matter structural changes in Parkinsons
disease. A. RAGOTHAMAN*; E. L. DENNIS; M. DAIANU; J.
GALVIS; Y. JIN; G. PRASAD; P. M. THOMPSON. USC.
8:30 286.03 An exploratory whole-brain cohort study of
structural connectivity of Parkinson disease progression.
A. KAMALIAN*; F. RAHMANI; M. DOLATSHAHI; A.
ANJOMSHOA; N. HOSSEINI; M. AARABI. TEHRAN
UNIVERSITY, Student Scientific Res. Ctr., Tehran Univ. of
Med. Sci., Basir Eye Hlth. Res. Ctr.
8:45 286.04 Whole plasma associates with brain structural
changes in early Parkinson disease: A DTI study. F.
RAHMANI*; A. KAMALIAN; N. HOSSEINI; M. DOLATSHAHI;
A. ANJOMSHOJA; M. AARABI. Tehran Univ. of Med. Sci.,
Students Scientific Res. Ctr.
9:00 286.05 A quantification of normative grey-matter structural
variability, covariance, and heritability in the human
cerebellum. C. J. STEELE*; S. PATEL; G. DEVENYI; J.
KNIGHT; B. MISIC; M. CHAKRAVARTY. Cerebral Imaging
Centre, Douglas Mental Hlth. Uni, Max Planck Inst. for
Human Cognitive and Brain Sciences, Campbell Family
Mental Hlth. Res. Institute, Ctr. for Addiction and Mental
Hlth., Univ. of Toronto, McGill Univ., McGill Univ.
9:15 286.06 Dopamine d2 receptors modulation of the striatal
circuitry. K. BRAMI-CHERRIER*; G. KHARKWAL; J. E.
LIZARDI-ORTIZ; A. B. NELSON; M. RAMOS; D. A. DEL
BARRIO; D. SULZER; A. C. KREITZER; E. BORRELLI. UCI,
Columbia Univ., The Gladstone Inst., Univ. of California, San
Francisco.
9:30 286.07 Intraoperative real-time ecog spectrogram
for movement induced spectral change in patients with
Parkinsons disease (pd). N. TIAN*; S. MIOCINOVIC; C.
CORREA; A. MILLER; R. MOAZZEZI; C. DE HEMPTINNE;
P. A. STARR; K. GOLDBERG. Univ. of California, Berkeley,
Univ. of California, San Francisco.
9:45 286.08 DBS of the STN creates impulse control disorders
and fails to restore Parkinsonian apathy and action selection
deficits. C. ANDERSON*. Univ. of Utah.
10:00 286.09 Dopamine release in the nonhuman primate
caudate and putamen depends upon site of stimulation in
the subthalamic nucleus. P. H. MIN*; E. K. ROSS; H. JO; S.
CHO; M. L. SETTELL; J. JEONG; P. S. DUFFY; S. CHANG;
K. E. BENNET; C. D. BLAHA; K. H. LEE. Mayo Clin.

Neuroscience 2016|Monday AM|5

NANOSYMPOSIUM

8:45 285.04 Lack of neuronal uptake of antibodies impairs

their efficacy in preventing pathology and related toxicity.
E. E. CONGDON*; D. UJLA; D. SHAMIR; H. B. R. SAIT; E.
M. SIGURDSSON. New York Univ. Sch. of Med., New York
Univ. Sch. of Med.

9:45 285.08 A small-molecule peptide inhibitor of Caspase-6

prevents neuronal degeneration in human primary neurons
and reverses Caspase-6-dependent cognitive impairment
in mice. P. PAKAVATHKUMAR*; A. NOL; J. AHLFORS; A.
C. LEBLANC. Jewish Gen. Hosp., McGill Univ., New World
Labs. Inc.

Mon. AM

11:00 284.13 Genetic impairment of the store-operated Ca2+

signaling triggers autophagic dysfunction in iPSC-derived
neurons from PARK14/PLA2g6ex2KO and Orai1KO mouse
models. A. YEN*; G. MOSTOSLAVSKY; V. BOLOTINA.
Boston Univ. Sch. of Med., Boston Univ. Sch. of Med.

9:30 285.07 Tissue-specific ABCA1 agonist in Alzheimers.

M. BEN AISSA*; M. LADU; G. R. J. THATCHER. Col. of
Pharmacy, UIC, Univ. of Illinois at Chicago.

10:15 286.10 Battery longevity of Medtronic Activa PC

neurostimulator: Nonlinear regression of clinical battery
decay curves and supplemental end of service thresholds. E.
L. HARGREAVES*; R. P. PATEL; S. WONG; R. J. DIPAOLA;
S. F. DANISH. Robert Wood Johnson Med. School- Rutgers
Univer, Robert Wood Johnson Med. School- Rutgers Univer,
Robert Wood Johnson Med. School- Rutgers Univer.

NANOSYMPOSIUM
287. Transplants and Other Treatments of Parkinsons
Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,1B

8:00 287.01 Transplantation of neural stem cells for Parkinsons

disease, an update of the first-in-human clinical study. I.
GARITAONANDIA; R. GONZALEZ; M. POUSTOVOITOV; T.
ABRAMIHINA; A. NOSKOV; T. CHRISTIANSEN-WEBER; G.
SHERMAN; A. SEMECHKIN; L. LAURENT; J. ELSWORTH;
E. SNYDER; D. REDMOND; R. A. KERN*. Intl. Stem Cell
Corp, Univ. of California San Diego, Yale Univ. Sch. of Med.,
Sanford-Burnham-Prebys Med. Discovery Inst.
8:15 287.02 Transplants of human fetal dopamine neurons into
putamen of Parkinsons patients survive for at least 27 years
without immunosuppression. C. R. FREED*; R. E. BREEZE;
B. A. SYMMES; S. FAHN; D. EIDELBERG; W. ZHOU. Univ.
of Colorado, Univ. of Colorado, Columbia University/Weill
Cornell Med. Ctr., Feinstein Inst. for Med. Res.

8:30 287.03 Extensive graft derived dopaminergic innervation

in degenerating Parkinsonian brain 24 years after
transplantation. W. LI*; E. ENGLUND; H. WIDNER; B.
MATTSSON; D. VAN WESTEN; J. LTT; S. REHNCRONA;
P. BRUNDIN; A. BJRKLUND; O. LINDVALL; J. LI.
Wallenberg Neurosci. Ctr., Div. of Oncology and Pathology,
Lund Univ. Hosp., Div. of Neurology, Lund Univ. Hosp.,
Neurobio. Unit, Wallenberg Neurosci. Centre, Lund
Univ., Ctr. for Med. Imaging and Physiology, Lund Univ.
Hosp., ivision of Neurosurgery, Lund Univ. Hosp., Ctr. for
Neurodegenerative Science, Van Andel Res. Inst., Neurobio.
Unit, Wallenberg Neurosci. Center, Lund Univ., Lund Stem
Cell Center, Lund Univ. Hospital, Lund, Sweden.

NANOSYMPOSIUM

8:45 287.04 Robust dopamine graft survival and normalized

dopaminergic innervation does not obligate clinical recovery
in a patient with Parkinsons disease. J. H. KORDOWER*; C.
G. GOETZ; Y. CHU; G. M. HALLIDAY; D. J. MARMION; D. A.
NICHOLSON; T. MUSIAL; A. J. STOESSL; V. SOSSI; T. B.
FREEMAN; C. W. OLANOW. Rush Univ. Med. Ctr., The Van
Andel Inst., Univ. South Wales, Univ. of British Columbia,
Univ. of South Florida, Mt. Sinai Sch. of Med.

9:15 287.06 Sargramostim improves regulatory T cell and

motor functions in a Phase 1 randomized clinical trial for
Parkinsons disease. H. E. GENDELMAN; Y. ZHANG; P.
SANTAMARIA; K. E. OLSON; C. R. SCHUTT; D. BHATTI; B.
L. DYAVAR SHETTY; Y. LU; K. A. ESTES; E. HEINRICHSGRAHAM; L. LARSON; J. L. MEZA; M. FOLLETT; E.
FORSBERG; G. SIUZDAK; T. W. WILSON; C. PETERSON;
R. MOSLEY*. Univ. of Nebraska Med. Ctr., Nebraska Med.,
Univ. of Nebraska Med. Ctr., Univ. of Nebraska Med. Ctr.,
Univ. of Nebraska Med. Ctr., Scripps Res. Inst., Scripps Res.
Inst., Univ. of Nebraska Med. Ctr.
9:30 287.07 Parkinsons, oxidative stress and osteopathic
manipulation. N. MIKHAIL; S. M. ZAKHARY; G. TORRES;
A. LEDER; J. DONOGHUE; J. D. MANCINI; S. YAO; J. R.
LEHESTE*. NYIT Col. of Osteo. Med., NYIT Col. of Osteo.
Med.

9:45 287.08 A central role for LRRK2 in idiopathic Parkinsons

disease. R. DI MAIO*; E. K. HOFFMAN; E. ROCHA;
J. MCCOY; E. A. BURTON; T. G. HASTINGS; J. T.
GREENAMYRE. Univ. of Pittsburgh.

10:00 287.09 Interrogative Biology identifies p53-inducible gene

3 (PIG3) as a potential contributor to LRRK2-mediated
neuronal cell death in Parkinsons disease. J. CHAUFTY;
S. PHAT; J. RANJAN; K. HA; S. KIM; S. AKELLA; R.
DEGAONKAR; C. BARLOW; K. THAPA*; M. KIEBISH; S.
GESTA; B. SCHUELE; V. K. VISHNUDAS; N. R. NARAIN; R.
SARANGARAJAN; P. NARAIN; J. LANGSTON. Berg, LLC,
Parkinsons Inst.
10:15 287.10 Combination of curcumin and ellagic acid mitigates
rotenone induced oxidative and mitochondrial deficits
in Parkinsons disease (PD) in mice. A. JUVEKAR*; D.
KHATRI. Inst. of Chem. Technol., Inst. of Chem. Technol.
10:30 287.11 Dance and Parkinsons disease: A communitybased dance program improves performance in functional
daily activities in people with Parkinsons disease. A.
FOROUD*; A. P. FLYNN. The Univ. of Lethbridge, The Univ.
of Calgary.
10:45 287.12 A method to describe relative 3D motion between
the rear and front body segments of rodents: Application
om neurodegenerative diseases. T. KARAKOSTAS*; L.
MIDDAUGH; A. GRANHOLM. Rehabil. Inst. of Chicago,
Med. Univ. of South Carolina.

NANOSYMPOSIUM
288. Neural Coding in the Somatosensory System
Theme D: Sensory Systems
Mon. 8:00 AMSan Diego Convention Center,2

9:00 287.05 Combining deep brain stimulation surgery with

autologous peripheral nerve graft to the nucleus basalis
of Meynert to treat non-motor symptoms in Parkinsons
disease. J. E. QUINTERO; J. T. SLEVIN; A. J. ANDERSONMOONEY; J. A. GURWELL; W. KIMMERER; G. A.
GERHARDT*; C. G. VAN HORNE. Univ. of Kentucky Dept.
of Anat. and Neurobio., Univ. of Kentucky, Univ. of Kentucky,
Univ. of Kentucky.

8:00 288.01 The dynamics of neural signals about contact

pressure- implications for bionic hands. S. J. BENSMAIA*;
T. CALLIER; H. P. SAAL; B. DELHAYE. Univ. of Chicago.

6 | Society for Neuroscience

8:15 288.02 Activity hotspots evoked from peripheral nerves are

asymmetrically organised across the dorsal column nuclei
surface. A. J. LOUTIT*; T. MADDESS; J. R. POTAS. The
Australian Natl. Univ.
8:30 288.03 Peripheral nerves evoke reproducible signals with
machine learnable features in the dorsal column nuclei. J. R.
POTAS*; A. J. LOUTIT; S. J. REDMOND; G. STUART; J. W.
MORLEY; T. MADDESS. The Australian Natl. Univ., Univ. of
New South Wales, Univ. of Western Sydney.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:45 288.04 Perceptual and neural effects of cuneate

nucleus microstimulation in primates. T. H. LUCAS;
S. Y. SRITHARAN; I. M. PLANELL-MENDEZ; A. G.
RICHARDSON*. Univ. of Pennsylvania.

8:45 289.04 A supralaryngeal neuromuscular apparatus for

sonar beam-forming in echolocating bats. S. TRENT*; M.
SMOTHERMAN. Texas A&M Univ., Texas A&M Inst. for
Neurosci.

9:00 288.05 Restoring somatic sensation with thalamic

microstimulation. Z. H. KISS*; L. H. KIM. Univ. of Calgary.

9:00 289.05 Individuals with cerebellar degeneration correct for

within-category variation of vowels even in the absence of
auditory feedback. B. PARRELL*; Z. AGNEW; J. HOUDE;
S. NAGARAJAN; R. IVRY. Univ. of Delaware, Univ. of
California, San Francisco, Univ. of California, Berkeley.

9:15 288.06 Intracortical microstimulation in human

somatosensory cortex. R. A. GAUNT*; S. N. FLESHER;
J. L. COLLINGER; S. T. FOLDES; J. E. DOWNEY; E. C.
TYLER-KABARA; S. J. BENSMAIA; A. B. SCHWARTZ; M. L.
BONINGER. Univ. of Pittsburgh, Univ. of Pittsburgh, Univ. of
Pittsburgh, Univ. of Chicago, Univ. of Pittsburgh.

9:30 288.07 Direct cortical stimulation for sensory feedback.

J. G. OJEMANN*; J. OLSON; J. CRONIN; K. WEAVER; K.
COLLINS; A. GUTERSTAM; H. EHRSSON; D. CALDWELL;
L. JOHNSON; L. SORENSEN. Univ. of Washington, Univ. of
Washington, Karolinska Institutet.

10:00 288.09 Microstimulation of residual nerve fibers with

Utah Slanted Electrode Arrays can restore biologically
realistic cutaneous and proprioceptive percepts after hand
amputation. G. A. CLARK*; D. M. PAGE; D. T. KLUGER;
S. M. WENDLEKEN; T. S. DAVIS; C. DUNCAN; D. T.
HUTCHINSON. Univ. of Utah.
10:15 288.10 On the use of intraneural transversal thin-film
electrodes to develop bidirectional bionic limbs. S. MICERA*.
Ecole Polytechnique Federale De Lausanne, Scuola
Superiore SantAnna.
10:30 288.11 Evolution of human-in-the-loop neuroprosthesistoward an artificial hand. D. J. TYLER*; E. GRACZYK; M.
SCHIEFER; I. CUBEROVIC; K. MALONE; M. KEITH; J.
ANDERSON. Case Western Reserve Univ., Cleveland Dept.
of Veterans Affairs Med. Ctr., Cleveland Dept. of Veterans
Affairs, Univ. Hosp., MetroHealth Med. Ctr.
10:45 288.12 Engineering an optimal afferent interface based
on the brains representation of limb state. L. E. MILLER*;
R. CHOWDHURY; T. TOMLINSON; C. VERSTEEG.
Northwestern Univ., Northwestern Univ.

NANOSYMPOSIUM
289. Voluntary Movements: Oral Motor and Speech
Theme E: Motor Systems
Mon. 8:00 AMSan Diego Convention Center,24A

8:15 289.02 Speech production without vocal tract sensory

feedback. M. THOMPSON*; J. HOUDE; S. NAGARAJAN.
UCSF, Univ. of California, San Francisco.
8:30 289.03 Investigating the role of auditory feedback in the
production of speech and non speech vocal behaviours. Z.
K. AGNEW*; H. KOTHARE; S. NAGARAJAN; J. F. HOUDE.
UCSF Med. Sch., UCSF, UCSF.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:45 289.08 Intracortical microstimulation of primary orofacial

motor cortex and its effect on jaw and tongue muscle
recruitment. Y. V. RAM*; C. F. ROSS; N. HATSOPOULOS.
Univ. of Chicago.

NANOSYMPOSIUM
290. Microbiome Gut Brain Axis
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,4
8:00 290.01 Changes in behavior and gut microbiome induced
by chronic treatment with the dopamine agonist quinpirole.
H. SZECHTMAN*; T. JUNG; P. JUNG; L. RAVEENDRAN; Y.
FARBOD; A. DVORKIN-GHEVA; B. SAKIC; M. SURETTE.
McMaster Univ.

8:15 290.02 Mice colonized with GAD microbiota display

anxiety and depressive-like behaviour and changes in brain
BDNF expression. E. PEREZ GUZMAN*; R. ANGLIN; G.
DE PALMA; R. POTTS; J. LU; M. AMER; M. BAILEY; S.
M. COLLINS; M. SURETTE; P. BERCIK. McMaster Univ.,
Farncombe Family Digestive Hlth. Inst., McMaster Univ., Ctr.
for Microbial Pathogenesis.

8:30 290.03 Prenatal stress alters intrauterine environment

and contributes to adult female microbiome and behavioral
changes. T. L. GUR; L. A. SHAY; A. VADODKAR; S. L.
FISHER; M. T. BAILEY*. The Ohio State Univ., The Ohio
State Univ., The Res. Inst. at Nationwide Childrens Hosp.
8:45 290.04 Gut-brain signalling modulates behavioural
deficits in chronic stress independent of the microbiota.
A. BHARWANI*; F. M. MIAN; M. G. SURETTE; J.
BIENENSTOCK; P. FORSYTHE. McMaster Univ., McMaster
Univ., McMaster Brain-Body Inst., McMaster Univ.,
Farncombe Family Digestive Hlth. Res. Inst.
9:00 290.05 Neonatal colonization of the gastrointestinal tract
with Bifidobacterium species alters CNS expression of
synaptic plasticity-related genes. B. LUK*; M. ENGEVIK; J.
VERSALOVIC. Baylor Col. of Med., Texas Childrens Hosp.

Neuroscience 2016|Monday AM|7

NANOSYMPOSIUM

8:00 289.01 Sensorimotor adaptation to real-time formant

shifts is influenced by the direction and magnitude of shift.
H. KOTHARE*; V. RAMANARAYANAN; B. PARRELL; J.
F. HOUDE; S. S. NAGARAJAN. Univ. of California, San
Francisco, Educational Testing Service R&D, Univ. of
Delaware.

9:30 289.07 Neural population dynamics in the primary

motor, primary somatosensory, and cortical masticatory
areas of the orofacial cortex during bite force generation
at varying gapes. C. F. ROSS*; F. ARCE-MCSHANE; N.
HATSOPOULOS; B. SESSLE; Y. LANKA. Univ. of Chicago,
Univ. of Toronto.

Mon. AM

9:45 288.08 Towards artificial proprioception for brain-machine

interfaces. J. E. ODOHERTY*; P. N. SABES. Univ. of
California San Francisco.

9:15 289.06 Neural correlates of language phenotypes

in Autism Spectrum Disorder. J. A. SEGAWA*; J. A.
TOURVILLE; Q. T. H. NGUYEN; F. I. KARAHANOGLU; P.
WIGHTON; A. VAN DER KOUWE; M. D. TISDALL; R. A.
FOWLER; J. SMALL; D. S. MANOACH; F. H. GUENTHER.
Boston Univ., Massachusetts Gen. Hosp., Salem State Univ.

9:15 290.06 Regulation of microRNAs in the prefrontal cortex

by the microbiota: Implications for brain and behaviour. A.
E. HOBAN*; R. STILLING; F. SHANAHAN; T. G. DINAN; J.
F. CRYAN; G. CLARKE. Alimentary Pharmabiotic Ctr., APC
Microbiome Inst., APC Microbiome Inst., APC Microbiome
Inst.

9:30 290.07 The influence of microbiota on brain structure. J.

A. FOSTER*; S. L. THOMPSON; J. ELLEGOOD; J. LERCH.
McMaster Univ., The Hosp. for Sick Children.

NANOSYMPOSIUM

10:15 291.10 Sustained motivation and its brain mechanisms

in object manipulation by marmosets. Y. YAMAZAKI*; S.
WATANABE; K. HIKISHIMA; E. SASAKI; C. J. PRICE; R.
LEMON; H. OKANO; A. IRIKI. Keio Univ., RIKEN Brain Sci.
Inst., Keio Univ., Keio Univ., Central Inst. for Exptl. Animals,
Univ. Col. London, UCL Inst. of Neurol., RIKEN Brain Sci.
Inst.

NANOSYMPOSIUM
292. Computational Models of Decision Making and
Confidence

291. Marmoset Neurobiology

Theme H: Cognition

Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,7B

8:00 291.01 MRI-based structural and functional mapping of

marmoset brains. H. OKANO*; J. HATA; T. KANEKO. Keio
Univ. Sch. of Med., RIKEN Brain Sci. Inst.
8:15 291.02 Axonal projection map of areas around the superior
temporal sulcus in the common marmoset. H. ABE*; T. TANI;
H. MASHIKO; N. KITAMURA; K. SAKAI; H. MIZUKAMI; A.
WATAKABE; T. YAMAMORI; N. ICHINOHE. RIKEN Brain
Sci. Inst., Natl. Ctr. for Neurol. and Psychiatry, Jichi Med.
Univ.
8:30 291.03 Mapping connectivity of marmoset prefrontal cortex
by serial two-photon tomography. A. WATAKABE*; J. WANG;
M. TAKAJI; H. MIZUKAMI; A. WOODWARD; T. KAWASE; H.
SKIBBE; Y. YAMAGUCHI; S. ISHII; T. YAMAMORI. RIKEN,
Jichi Med. Univ., Kyoto Univ.
8:45 291.04 A high-throughput neurohistological pipeline for
whole-brain mesoscale circuit mapping for Marmoset. P.
P. MITRA*; Y. S. TAKAHASHI; K. WEBER; M. K. LIN; K.
HOSSAIN; B. HUO; A. S. TOLPYGO; D. D. FERRANTE;
J. HATA; J. CHAN; H. MIZUKAMI; A. WATAKABE; T.
YAMAMORI; N. KISHI; A. IRIKI; M. G. P. ROSA; E. SASAKI;
H. OKANO. Cold Spring Harbor Lab., RIKEN, Cold Spring
Harbor Lab., Cold Spring Harbor Lab., Monash Univ., Jichi
Med. Univ.
9:00 291.05 The marmoset brain architecture project: Sharing
data on primate corticocortical connectivity through an
open access web platform. M. G. ROSA*; P. MAJKA; J. M.
CHAN; S. BAI; D. FERRANTE; P. P. MITRA. Monash Univ.,
Australian Res. Council, Ctr. of Excellence for Integrative
Brain Function, Monash Univ., Nencki Inst. of Exptl. Biol.,
Cold Spring Harbor Lab.

NANOSYMPOSIUM

9:15 291.06 Two-photon calcium imaging using geneticallyencoded calcium indicator in awake marmoset. O.
SADAKANE*; M. UEDA; A. WATAKABE; H. MIZUKAMI; T.
YAMAMORI. RIKEN Brain Sci. Inst., Tokyo Med. and Dent.
Univ., Jichi Med. Univ.
9:30 291.07 Subthreshold response properties of the primary
auditory cortex in awake marmosets studied by intracellular
recordings. L. GAO*; X. WANG. Johns Hopkins Univ.
9:45 291.08 Pitch perception in marmosets. X. SONG*; M. S.
OSMANSKI; Y. GUO; X. WANG. Johns Hopkins Univ. Dept.
of Biomed. Engin., Johns Hopkins Univ., Johns Hopkins
Univ.
10:00 291.09 The role of frontal cortex in marmoset
conversations. C. T. MILLER*. UCSD.

8 | Society for Neuroscience

Mon. 8:00 AMSan Diego Convention Center,5B

8:00 292.01 Multitasking capability versus efficiency of

representation in neural network architectures. S.
MUSSLICK*; K. ZCIMDER; B. DEY; M. A. PATWARY; P.
KRIEGER; T. L. WILLKE; J. D. COHEN. Princeton Univ.,
Princeton Univ., Intel Corp., Princeton Univ.
8:15 292.02 Optimal policy for multi-alternative decisionmaking. S. TAJIMA*; J. DRUGOWITSCH; A. POUGET. Univ.
of Geneva, Harvard Med. Sch.
8:30 292.03 Human noise blindness and decision suboptimality.
S. HERCE CASTAN*; D. BANG; J. DING; C.
SUMMERFIELD. Univ. of Oxford.
8:45 292.04 Fast encoding of current and past value
computations in human Orbitofrontal Cortex. I. SAEZ*; J.
LIN; E. CHANG; J. PARVIZI; G. SCHALK; R. T. KNIGHT; M.
HSU. Univ. of California Berkeley, Univ. of California Irvine,
Univ. of California San Francisco, Stanford Univ., Wadsworth
Ctr.
9:00 292.05 Computational and neural underpinnings of
individual differences in human confidence. J. NAVAJAS*;
C. HINDOCHA; P. E. LATHAM; B. BAHRAMI. Univ. Col.
London.
9:15 292.06 Intracranial electrocorticography supports
dissociable representations for perceptual decisions and
confidence judgments. M. A. PETERS*; T. THESEN; Y. D.
KO; B. MANISCALCO; C. CARLSON; M. DAVIDSON; W.
DOYLE; R. KUZNIECKY; O. DEVINSKY; E. HALGREN; H.
LAU. UCLA, New York Univ., Columbia Univ., NIH/NINDS,
UCSD, UCLA.
9:30 292.07 The P300 in sequential perceptual decision
making: From subjective evidence to confidence. J.
HERDING*; S. LUDWIG; B. SPITZER; F. BLANKENBURG.
Freie Univ. Berlin, Universtity of Oxford.

POSTER
293. Microglia Development and Function
Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 A1

293.01 Withdrawn.

9:00 A2
293.02 A comparison of microglial distribution
in embryonic primate and rodent using multiple
immunofluorescence histochemistry. N. BARGER*; C.
WEIDENTHALER; S. C. NOCTOR. Univ. of California,
Davis- MIND Inst., Univ. of California, Davis.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 A3
293.03 Infiltrating monocytes promote brain
inflammation, contribute to breakdown of the blood-brain
barrier, and exacerbate neuronal damage after status
epilepticus. N. H. VARVEL*; J. NEHER; A. BOSCH; W.
WANG; R. RANSOHOFF; R. MILLER; R. DINGLEDINE.
Emory Univ., Hertie Inst. for Clin. Brain Res., Biogen,
Northwestern Univ.
11:00 A4
293.04 Satellite microglia show spontaneous
activity that is uncorrelated with activity of the attached
neuron. E. WOGRAM*; S. WENDT; M. MATYASH; T.
PIVNEVA; A. DRAGUHN; H. KETTENMANN. Univ. of
Heidelberg, Max-Delbrck-Center for Mol. Med., Bogomoletz
Inst. of Physiol.
8:00 A5
293.05 Functional investigation of microglia
involvement in the maturation of synapses during postnatal
development of the somatosensory neocortex. C. M.
MOSSER*. INSERM U1128.

10:00 A7
293.07 Sex differences in microglial and fastspiking interneuron maturation in mice and in human
disease. R. HANAMSAGAR*; M. ALTER; C. BLOCK; H.
SULLIVAN; J. BOLTON; S. BILBO. Duke Univ. Med. Ctr.,
Univ. of Pennsylvania, Duke Univ., Univ. of California, Irvine.
11:00 A8
293.08 Microglia and astroglia phenotype in
a neuron specific- A2A receptor overexpression model
with age-like alterations. J. E. COELHO*; I. MARQUESMORGADO; M. BADER; D. BLUM; L. V. LOPES. Inst. De
Medicina Mol., Max-Delbrck-Center for Mol. Med., Inserm
URM-S1172, Univ. de Lille.
8:00 A9
293.09 The role of microglia and their CX3CR1
signaling in olfactory bulb neurogenesis. R. RESHEF*;
E. KUDRAYAVISTKAYA; H. SHANI; N. RIMMERMAN; A.
MIZRAHI; R. YIRMIYA. Dept. of Psychology, The Hebrew
Univ., Dept. of Neurobiology, The Hebrew Univ.
9:00 A10 293.10 Sex differences in microglia number
and activation in the developing rat brain. A. TURANO*; J.
LAWRENCE; J. SCHWARZ. Univ. of Delaware.
10:00 A11
293.11 The distinct effects of prenatal stress on
microglia morphologies in adult and embryonic brain and
mediation by interleukin 6. S. B. GUMUSOGLU*; R. S. FINE;
S. J. MURRAY; M. E. DAILEY; H. E. STEVENS. Univ. of
Iowa, Yale Univ., Univ. of Iowa, Univ. of Iowa Carver Col. of
Med.
11:00 A12
293.12 Use of multiple sub-threshold glutamate
stimuli to monitor brain cell calcium dynamics in cultures
with decreasing microgial and astrocyte content. K. C. ST
MARTHE*; C. N. POOLE; M. GRAGSTON; N. NGUYEN; T.
PIEHLER; L. PIEHLER; M. A. DECOSTER. Louisiana Tech.
Univ., Univ. of Tennessee, US Army Res. Lab.
8:00 A13 293.13 Role of the complement receptor C3aR
in excitotoxicity-induced neuropathology. H. LIAN*; X. LI.
Zhejiang Univ. Sch. of Med., Zhejiang Univ. Sch. of Med.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

294. Environmental Influences on Adult Neurogenesis

Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 B1
294.01 Role of anti-oxidant supplementation on
developing cerebellum of rats exposed to sodium arsenite
(NaAsO2). P. DHAR*; P. KUMAR; P. KAUSHAL. All India Inst.
of Med. Sci., All India Inst. of Med. Sci.
9:00 B2
294.02 Running enhances structural maturity
of young adult-born dentate granule cells in mouse
hippocampus. S. T. LUBEJKO*; N. SAH; C. VIVAR; H. VAN
PRAAG. Natl. Inst. On Aging, Ctr. for Res. and Advanced
Studies of the Natl. Polytechnic Inst.
10:00 B3
294.03 Developmental influence of stress
and fluoxetine on the oxytocinergic system in the
california mouse (Peromyscus californicus). J. CRUZ*; S.
PETERSON; E. A. BECKER. St. Josephs Univ.
11:00 B4
294.04 Early postnatal lipopolysaccharide
exposure leads to enhanced neurogenesis and impaired
communicative functions in rats. Y. PANG*; X. DAI; A.
ROLLER; K. CARTER; I. PAUL; A. BHATT; R. LIN; L. FAN.
Univ. of Mississippi Dept. of Med., Univ. of Mississippi Med.
Ctr.
8:00 B5
294.05 Regional distribution and cellular
colocalization of KCC2 in ferret neocortex. F. T. DJANKPA*;
M. CHATTERJEE; S. L. JULIANO. Uniformed Services Univ.
of the Hlth. Scienc, USUHS, Uniformed Services Univ. of the
Hlth. Scienc.
9:00 B6
294.06 Role of metabolic and nutritional status
in programming cognition by early-life stress: Potential
for peripheral interventions using fatty acids. K. YAM*; E.
NANINCK; L. SCHIPPER; S. LA FLEUR; A. GREFHORST;
A. OOSTING; E. VAN DER BEEK; P. LUCASSEN; A.
KOROSI. Swammerdam Inst. For Life Sci., Nutricia Res.
Danone Nutricia Early Life Nutr., Dept. of Endrocrinol. and
Metabolism, Academic Med. Ctr., Dept. of Intrnl. Medicine,
Erasmus Univ. Med. Ctr.
10:00 B7
294.07 Maternal melatonin deprivation during
pregnancy and lactation impairs spatial reference and
working memory in adult rats. L. C. TEIXEIRA*; A. V.
MACHADO-NILS; F. G. AMARAL; G. F. XAVIER; J. CIPOLLA
NETO. Univ. of Sao Paulo, Univ. of Sao Paulo.
11:00 B8
294.08 Hippocampal neuronal loss and
impaired neurogenesis following repeated closed-head
concussive impacts. D. A. PETERSON*; S. G. CHIREN; E.
REISENBIGLER; N. JAMNIA; N. KAPECKI; G. DEJOSEPH;
J. H. URBAN; R. A. MARR; G. E. STUTZMANN; D. A.
KOZLOWSKI. Rosalind Franklin Univ. Med. Sci., Rosalind
Franklin Univ. Med. Sci., Rosalind Franklin Univ. Med. Sci.,
Rosalind Franklin Univ. Med. Sci., DePaul Univ.
8:00 B9
294.09 Early-age running enhances activity of
adult-born dentate granule neurons following learning. O.
SHEVTSOVA; Y. TAN; C. M. MERKLEY; G. WINOCUR; M.
WOJTOWICZ*. Univ. Toronto, Baycrest Inst.
9:00 B10 294.10 Adult neurogenesis in the dentate gyrus
is regulated by 7 nAChR activation. S. L. OTTO*; J. L.
YAKEL. Natl. Inst. of Envrn. Hlth. Sci.
10:00 B11
294.11 Reversible developmental stasis in
response to nutrient availability in Xenopus laevis CNS. C. K.
THOMPSON*; C. R. MCKEOWN; H. T. CLINE. The Scripps
Res. Inst.

Neuroscience 2016|Monday AM|9

Mon. AM

9:00 A6
293.06 In utero development of microglia:
Instrinsic programs and impact of microbiota. M. S. THION*;
D. LOW; J. CHEN; P. SQUARZONI; P. GRISEL; A. A.
AMOYO; M. POIDINGER; S. PETTERSSON; S. GAREL;
F. GINHOUX. IBENS, INSERM U1024, CNRS UMR 8197,
Singapore Immunol. Network, Agency for Science, Technol.
and Res., Natl. Cancer Ctr., Lee Kong Chian Sch. of Med.
and Sch. of Biol. Sciences, Nanyang Technological Univ.,
Dept. of Microbiology, Tumor and Cell Biology, Karolinska
Inst.

POSTER

11:00 B12
294.12 Loss of the sulfate transporter Slc13a4
alters behavior and neurogenesis in adult mice. Z. ZHANG*;
M. PIPER; P. DAWSON; D. SIMMONS. SBMS, the Univ. of
Queensland, Mater Res. Inst.
8:00 B13 294.13 Neurons born during reactive
neurogenesis activate to Morris water maze similarly
between binge alcohol exposed and control rats. C. R.
GEIL*; K. NIXON. Univ. of Kentucky.
9:00 B14 294.14 Effect of thyroxine on neurogenesis
following galactic cosmic radiation. L. R. VOSE*; O. MIRY;
K. R. GOPAUL; G. SUBAH; P. K. STANTON. New York Med.
Col.
10:00 B15
294.15 DREADD-mediated activation of adult
hippocampal progenitors: Effects on neurogenesis and
behavior. M. MAHESHWARI*; S. SHAH; S. PATI; A. RAWAT;
J. CHELLIAH; V. A. VAIDYA. Tata Inst. of Fundamental Res.,
Jawaharlal Nehru centre for Advanced Scientific Res.
11:00 B16
294.16 Oxytocin stimulates hippocampal
neurogenesis via oxytocin receptor expressed in CA3
pyramidal neurons in adult mice. Y. LIN*; C. CHEN; K. HSU.
Inst. of Basic Med., Dept. of pharmacology.
8:00 B17 294.17 Adult neurogenesis in a crustacean
brain: Serotonin levels influence the integration of adoptively
transferred immune cells into a neurogenic niche. J. L.
BENTON; B. S. BELTZ*. Wellesley Col.
9:00 B18 294.18 Transient inhibition of neural stem cell
proliferation during early life decreases adult dentate gyrus
neurogenesis. M. YOUSSEF*; G. KIRSHENBAUM; V.
KRISH; T. BRINER; E. D. LEONARDO; A. DRANOVSKY.
Columbia Univ. Med. Ctr.
10:00 B19
294.19 Effect of voluntary exercise on adult
hippocampal neurogenesis in maternally separated rats. V.
A. RUSSELL*; N. HARDCASTLE; L. MARAIS; D. LANG.
Univ. Cape Town, Univ. Cape Town.
11:00 B20
294.20 Retinoic acid regulates neural stem &
progenitor cell proliferation in the adult hippocampus. S.
MISHRA*; J. SIEGENTHALER. Univ. of Colorado ,Anschutz
Med. Campus.

9:00 B25 295.02 CNTNAP2 paracrine signaling by

ectodomain shedding. M. D. MARTIN-DE-SAAVEDRA*;
O. VAREA; R. GAO; B. P. SPIELMAN; K. J. KOPEIKINA;
K. MYCZEK; E. A. HALL; J. N. SAVAS; P. PENZES.
Northwestern Univ., Northwestern Univ.
10:00 B26
295.03 Regulation of cortical gabaergic
interneuron function by the mental disorder susceptibility
molecule cntnap2. R. GAO*; A. MELENDEZ; S. YOON; M.
D. SAAVEDRA; M. FORREST; P. PENZES. Northwestern
Univ. Dept. of Physiol.
11:00 C1
295.04 A synaptic role of FKBP5, a genetic risk
factor for stress-related psychiatric disorders. K. MYCZEK*;
I. OZSAN; H. YAMAZAKI; M. MARTIN-DE-SAAVEDRA; P.
PENZES. Northwestern Univ., Gunma Univ.
8:00 C2
295.05 Kalirin proteins display differential
localization in dendritic spines and regulate spine
morphology and trafficking of NR2B-containing glutamate
receptors. T. A. RUSSELL; K. R. SMITH; K. J. KOPEIKINA;
P. PENZES*. Nothwestern Univ. Feinberg Sch. Med.
9:00 C3
295.06 Role of 190 kDa Ankyrin-G palmitoylation
in spine and dendrite maintenance. N. H. PIGUEL*; K. R.
SMITH; P. PENZES. Northwestern Univ., Univ. of Bristol.
10:00 C4
295.07 The epilepsy and intellectual disabilityrelated gene tbc1d24 encodes a novel synaptic protein that
regulates dendritic spine morphogenesis in neuron. L. LIN;
Q. LYU; E. FEI; N. Y. IP; K. LAI*. The Univ. of Hong Kong,
Hong Kong Univ. of Sci. and Technol.
11:00 C5
295.08 A potential role of NMDA receptordependent expression of Striatin-4 in dendritic spine
maturation. L. LO*; L. LIN; Q. LYU; K. LAI. The Univ. of Hong
Kong.
8:00 C6
295.09 Role of IQSEC3 in inhibitory synapse
formation. H. KANG; D. PARK; S. JEON; J. KO; J. UM*.
Yonsei Univ. Col. of Med., Yonsei Univ. Col. of Med., Yonsei
Univ.
9:00 C7
295.10 Spines require normal DISC1 function
during development of their parent dendritic branch. A. M.
DE HAAN*; N. R. HARDINGHAM; K. FOX. Cardiff Univ.

8:00 B21 294.21 Prenatal diabetes affects the postnatal

hippocampal neurogenesis, learning and memory: Role of
neurotrophic factors. N. A. AL-BAHOUH*; M. S. RAO. Kuwait
Univ.

10:00 C8
295.11 Dissecting the components of excitatory
synapse maturation on hippocampal inhibitory interneurons.
G. AKGUL*; K. A. PELKEY; C. J. MCBAIN. Natl. Inst. of
Hlth., Natl. Inst. of Hlth.

9:00 B22 294.22 Emergence of doublecortin positive

cells from astrocytes in the substantia nigra in response to
transplantation of cells derived from pluripotent stem cells.
D. M. ARZATE; M. GUERRA-CRESPO; L. COVARRUBIAS*.
Inst. de Biotecnologia, UNAM, Inst. de Fisiologa Celular.

11:00 C9
295.12 The pseudokinase CaMKv is required
for the activity dependent maintenance of dendritic spines.
Z. LIANG*; Y. ZHAN; Y. SHEN; C. C. WONG; J. YATES; F.
PLATTNER; K. LAI; N. Y. IP. Hong Kong Univ. of Sci. and
Technol., Hong Kong Univ. of Sci. and Technol., Hong Kong
Univ. of Sci. and Technol., The Scripps Res. Inst., Univ. of
Texas Southwestern Med. Ctr.

10:00 B23
294.23 Age-related changes on hippocampal
neurogenesis and mnemonic discrimination of similar objects
and locations. S. ABDEL MALEK; S. SHARMA; R. DE; Y.
E. WEN; A. N. S. CHOWDHURY; E. SATVAT*. Univ. of
Waterloo.

POSTER
295. Synapse Maturation and Remodeling
Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 B24 295.01 Ankyrin-G interacts with X-linked
intellectual disability-associated deubiquitinase Usp9X to
regulate spine maintenance. S. YOON*; K. MYCZEK; P.
PENZES. Northwestern Univ.
10 | Society for Neuroscience

8:00 C10 295.13 Knockout of RICH2, a SHANK3

interacting protein, leads to enlarged dendritic spines via
RAC1 dependent Actin remodeling and causes neophobia in
mice. T. SAROWAR*; S. GRABRUCKER; T. BOECKERS; A.
GRABRUCKER. Inst. of Anat. & Cell Biol., WG Mol. Analysis
of Synaptopathies, Neurol. Department., Neurocenter of Ulm
Univ., Inst. for Anat. and Cell Biology, Ulm Univ.
9:00 C11 295.14 Axonal input to nearby Purkinje cells
in early postnatal mouse cerebellum analyzed with serial
section electron microscopy. A. M. WILSON*; R. SCHALEK;
A. SUISSA-PELEG; T. JONES; S. KNOWLES-BARLEY; J.
LICHTMAN. Harvard Univ., Google.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 C12
295.15 Serial section super-resolution (STORM)
imaging of the perineuronal net and synaptic maturation
during critical period development. Y. SIGAL*; L. BOGART;
H. BAE; X. ZHUANG; T. K. HENSCH. Harvard Univ., Howard
Hughes Med. Inst., Boston Chirdrens Hosp.
11:00 C13
295.16 Cooperative action of neuroligins and
BDNF mediates presynaptic maturation. A. PETKOVA*; N.
GDECKE; M. KORTE; T. DRESBACH. Univ. Med. Ctr.
Goettingen, Tech. Univ. Braunschweig.
8:00 C14 295.17 Synapse tagging by C1q. J. W.
HAMMOND*; H. A. GELBARD. Univ. of Rochester.
9:00 C15 295.18 An inducing role for the pre-synaptic
cadherin/catenin/p140Cap complex in functional synapse
formation in the neocortex. M. LI; W. MIAO; S. HE; X. YU*.
Inst. of Neurosci.

POSTER
296. Molecular and Cellular Mechanisms in Fragile X
Syndrome
Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 C16 296.01 arrestin 2 couples mGlu5 to fmrpregulated protein synthesis and is a novel target for
the treatment of fragile x syndrome. R. K. SENTER*;
L. J. STOPPEL; B. D. AUERBACH; A. R. PREZA; R. J.
LEFKOWITZ; M. F. BEAR. MIT, The State Univ. of New York
at Buffalo, Duke Univ. Med. Ctr.
9:00 C17 296.02 Neuromodulation of synaptic transmission
by group I mGluRs in MNTB neurons in a mouse model of
fragile X syndrome. Y. LU*. Northeast Ohio Med. Univ.
10:00 C18
296.03 Maturation of fast-spiking neurons in
the cortex is delayed in Fragile X mice. T. NOMURA*; A.
CONTRACTOR. Northwestern Univ., Northwestern Univ.
11:00 C19
296.04 Activation of 5-HT7 receptors for serotonin
rescues hippocampal synaptic plasticity in a mouse model
of Fragile X Syndrome through a cyclic AMP-mediated
mechanism involving Cyclin-dependent Kinase 5 and protein
synthesis. L. CIRANNA*; L. COSTA; L. M. SARDONE;
M. SPATUZZA; C. M. BONACCORSO; S. DANTONI; M.
LEOPOLDO; E. LACIVITA; M. V. CATANIA. Univ. of Catania,
Univ. of Messina, Natl. Res. Council (CNR), IRCCS Oasi
Maria Santissima, Univ. of Bari.
8:00 C20 296.05 Reduced lateral inhibition impairs
olfactory computations and behaviors in a Drosophila model
of Fragile X Syndrome. L. M. FRANCO MNDEZ*; Z.
OKRAY; B. A. HASSAN; E. YAKSI. KU Leuven, KU Leuven,
Hpital Piti-Salptrire, NTNU.
9:00 C21 296.06 PQBP1 mutations promote FMRP
degradation. X. ZHANG*; Y. SHEN; X. LIU; Z. ZHANG. Inst.
of Lifescience, Inst. of life sciences.
10:00 C22
296.07 Synaptic translation of neuroligins
1, 2 and 3 is regulated by FMRP. M. DZIEMBOWSKA*;
J. PODSIADOWSKA; K. JCZYSKA; J. MIEK; B.
KUNIEWSKA. Univ. of Warsaw.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 C24 296.09 Fragile X circuits show differential

developmental delays of spontaneous and evoked network
activity but normal homeostatic plasticity. H. MOTANIS*; D.
BUONOMANO. UCLA.
9:00 C25 296.10 Testing the mGluR5 theory of FXS in the
laboratory rat. S. VEERARAGAVAN; L. YUVA; R. PAYLOR;
R. C. SAMACO*. Baylor Col. of Medicine/Jan and Dan
Duncan Neurolog. Res. Inst.
10:00 C26
296.11 Prefrontal cortex dysfunction in Fragile
X Syndrome: Single-unit responses of excitatory and
inhibitory neurons correlated with behavior. J. J. SIEGEL*;
R. A. CHITWOOD; W. TAYLOR; J. M. DING; R. GRAY; D.
JOHNSTON. Univ. of Texas at Austin.
11:00 C27
296.12 Inhibitory function in the piriform cortex
of the Fragile X Syndrome mouse model. A. WIDMER*; J.
LARSON. Univ. of Illinois at Chicago Dept. of Psychiatry.
8:00 C28 296.13 Calcium-binding protein regulation in a
Drosophila model of fragile x syndrome. C. R. TESSIER*; C.
G. SWINFORD. Indiana Univ. Sch. of Medicine-South Bend,
Univ. of Notre Dame.
9:00 C29 296.14 Fragile X-associated tremor/ataxia
syndrome: Linking calcium dysregulation and DNA damage
responses. G. A. ROBIN*; J. R. LPEZ; S. HULSIZER; P.
J. HAGERMAN; I. N. PESSAH. UC Davis, UC Davis, Med.
Investigations of Neurodevelopmental Disorders (M.I.N.D)
Inst.
10:00 C30
296.15 The actin depolymerizing factor cofilin is
critical to spine abnormalities and autism relevant behaviors
in a mouse model of fragile x syndrome. A. PYRONNEAU*;
M. PORCH; R. ZUKIN. Albert Einstein Col. of Med.
11:00 C31
296.16 Enhancement of NMDA receptor
signalling for the treatment of fragile x syndrome. S.
BARNES*; S. G. N. GRANT; N. KOMIYAMA; E. K.
OSTERWEIL. Univ. of Edinburgh, Univ. of Edinburgh, Univ.
of Edinburgh.
8:00 C32 296.17 Cell type specific analysis of mRNA
translation in fragile X syndrome. S. R. THOMSON*; S. S.
SEO; O. DANDO; S. A. BARNES; P. C. KIND; M. F. BEAR;
E. K. OSTERWEIL. Univ. of Edinburgh, MIT.
9:00 C33 296.18 Altered surface expression of subunitcontaining GABAA receptors in a mouse model of Fragile X
syndrome. N. ZHANG; A. K. LINDEMEYER; Z. PENG; Y.
CETINA; C. S. HUANG; R. W. OLSEN; C. R. HOUSER*.
David Geffen Sch. of Med. at UCLA, David Geffen Sch. of
Med. at UCLA.
10:00 C34
296.19 Insulin signaling misregulation underlies
circadian and cognitive deficits in a Drosophila Fragile X
Model. S. M. MCBRIDE*; R. E. MONYAK; D. EMERSON;
B. SCHOENFELD; X. ZHENG; D. CHAMBERS; C.
ROSENFELT; P. HINCHEY; C. CHOI; T. MCDONALD;
F. BOLDUC; A. SEHGAL; T. A. JONGENS. Univ. of
Pennsylvania, Univ. of Pennsylvania, Univ. of Pennsylvania,
Univ. of Alberta, Albert Einstein Col. of Med., Drexel Univ.
Col. of Med., Univ. of Pennsylvania.
11:00 D1
296.20 Maturation of adult-born dentate granule
cells in fragile x mice. C. REMMERS*; A. CONTRACTOR.
Northwestern Univ. Feinberg Sch. of Med., Northwestern
Univ. Weinberg Col. of Arts and Sci.

Neuroscience 2016|Monday AM|11

Mon. AM

8:00 DP01 295.19 (Dynamic Poster) Caught in the act:

Live imaging of microglia-synapse interactions by lightsheet
microscopy. L. WEINHARD*; G. DI BARTOLOMEI; U.
NENISKYTE; G. BOLASCO; A. VADISIUTE; P. MACHADO;
Y. SCHWAB; C. GROSS. EMBL, EMBL.

11:00 C23
296.08 Astrocyte purinergic signaling significantly
altered in fragile x syndrome model. A. L. SCOTT*; A. CHEN;
L. DOERING. McMaster Univ.

8:00 D2
296.21 Modulation of mitochondrial efficiency
and its potential application in the treatment of fragile x
syndrome. P. LICZNERSKI*; P. MIRANDA; H. PARK; M.
BROWN; L. K. KACZMAREK; R. J. LEVY; E. A. JONAS.
Yale Univ. Sch. of Med., Yale Univ. Sch. of Med., Columbia
Univ.

10:00 D9
297.07 Interaction between Gabrb3
haploinsufficiency and prenatal LPS exposure exacerbates
placental and fetal brain vulnerability in mice. H. MOON*; P.
A. CARPENTIER; V. SARAVANAPANDIAN; U. HADITSCH;
J. SU; M. L. CHIN; K. MUENCH; A. R. MOORE; A.
BORMANN; N. NIMA; G. SUBRAMANYAM; M. RIVERA; T.
D. PALMER. Stanford Univ., Cal State Univ. Fullerton, San
Jose State Univ.

POSTER

11:00 D10
297.08 Mutations in DCC cause agenesis of
the corpus callosum and mirror movements in humans.
T. J. EDWARDS*; A. P. L. MARSH; C. GALEA; K. POPE;
A. PAOLINO; I. GOBIUS; J. BUNT; G. MCGILLIVRAY; R.
J. LEVENTER; S. MANDELSTAM; E. H. SHERR; P. J.
LOCKHART; L. J. RICHARDS. Queensland Brain Inst., The
Univ. of Queensland, Sch. of Med., Bruce Lefroy Ctr. for
Genet. Hlth. Research, Murdoch Childrens Res. Institute,
Royal Childrens Hosp., Univ. of Melbourne, Royal Childrens
Hosp., Medicinal Chem. and Drug Delivery, Disposition and
Dynamics (D4), Monash Inst. of Pharmaceut. Sciences,
Monash Univ., Victorian Clin. Genet. Services, Murdoch
Childrens Res. Inst., Brain Res. Institute, Florey Neurosci.
Inst., Univ. of Melbourne, Royal Childrens Hosp., Univ. of
California, San Francisco.

297. Rare Genetic Developmental Disorders

Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 D3
297.01 Disrupted synaptic transmission and
protein homeostasis in an Angelman Syndrome (AS)
mouse model. G. LI*; M. ANDERSON; M. PIECHOWICZ; L.
ZHANG; X. MA; J. WU; S. QIU. Arizona State Univ., Univ.
of Arizona Col. of Medicine-Phoenix, Barrow Neurolog.
Institute, St. Josephs Hosp. and Med. Ctr.
9:00 D4
297.02 Microcephaly, intellectual disability,
mid-hindbrain malformation a novel phenotype. E.
RAVINDRAN*; H. HU; N. KRAEMER; O. NINNEMANN;
L. MUSANTE; E. BOLTSHAUSER; D. SCHINDLER;
A. HBNER; H. ROPERS; C. HUBNER; A. KAINDL.
Charit- Universittsmedizin Berlin, Guangzhou Women
and Childrens Med. Center, Max Planck Inst. for Mol.
Genet., Dept. of Pediatric Neurology, Univ. Childrens Hosp.
of Zurich, Dept. of Human Genetics, Univ. of Wrzburg,
Pediatrics, Univ. Hospital, Tech. Univ.
10:00 D5
297.03 Anatomical underpinnings of decreased
white matter volume in angelman syndrome model mice.
M. C. JUDSON*; C. L. THAXTON; A. C. BURETTE;
A. L. PRIBISKO; A. M. RUMPLE; B. PANIAGUA; R. J.
WEINBERG; B. D. PHILPOT. UNC-Chapel Hill.
11:00 D6
297.04 Altered EEG spectral power in the NSPten knock-out model of cortical dysplasia with epilepsy.
S. AVILA*; A. REGNIER-GOLANOV; Y. A. DABAGHIAN; L.
NGUYEN; A. BREWSTER; N. SUNNEN; A. E. ANDERSON.
Rice Univ., Baylor Col. of Med., Rice Univ., Baylor Col. of
Med., Baylor Col. of Med.
8:00 D7
297.05 Rare genetic variations in MEPE are
associated with Otosclerosis and a Craniofacial bone
disorder with facial paresis and mixed hearing loss. I.
SCHRAUWEN*; L. TOMAS-ROCA; U. ALTUNOGLU;
M. WESDORP; H. VALGAEREN; M. SOMMEN; M.
RAHMOUNI; E. VAN BEUSEKOM; M. HUENTELMAN;
E. OFFECIERS; I. DHOOGHE; R. ROBERT VINCENT; A.
HUBER; C. GILISSEN; E. DE LEENHEER; C. CREMERS;
B. VERBIST; A. DE BROUWER; G. PADBERG; R.
PENNINGS; H. KAYSERILI; H. KREMER; G. VAN CAMP; H.
VAN BOKHOVEN. Translational Genomics Res. Inst., Univ.
of Antwerp, Radboud university medical center, Istanbul
Univ., St-Augustinus Hosp. Antwerp, Ghent Univ. Hosp.,
Causse Ear Clin., Univ. Hosp. Zurich.
9:00 D8
297.06 A gain-of-function mutation in the human
GRIK2 gene causes neurodevelopmental and intellectual
deficits. Y. F. GUZMAN*; K. RAMSEY; J. R. STOLZ; V.
NARAYANAN; G. T. SWANSON. Northwestern Univ.,
Translational Genomics Res. Inst.

8:00 D11 297.09 Everolimus restores mTOR signaling

disrupted by a novel TSC2 mutation and improves
neuropsychiatric symptoms in a tuberous sclerosis patient.
J. YANG*; S. HWANG; K. LEE; J. LEE; J. LEE; Y. LEE; B.
KAANG; C. LIM. Seoul Natl. Univ., Kyungpook Natl. Univ.
Hosp., Kyungpook Natl. Univ. Grad. Sch. of Med., Kyung
Hee Univ., Hannam Univ., Chung-Ang Univ.
9:00 D12 297.10 Neural correlates of impaired visuospatial
cognition in children with Williams syndrome. T. NASH;
J. CARRASCO; J. P. MIKHAIEL; O. RAVINDRANATH; L.
YANKOWITZ; R. PRABAKARAN; M. SOTTILE; K. ROE;
P. KOHN; J. S. KIPPENHAN; D. EISENBERG; M. D.
GREGORY; C. B. MERVIS; K. F. BERMAN*. Natl. Inst. of
Mental Hlth., Univ. of Louisville.

POSTER
298. Limbic System Development
Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 D13 298.01 Prenatal paracetamol exposure
decreases anxiety-related behaviors and disrupts memory in
mice. T. M. MILEWSKI*; R. A. ANTONAWICH; D. WOOD; P.
T. ORR. Univ. of Scranton, Univ. of Scranton.
9:00 D14 298.02 Prospective associations between
maternal interleukin-6 concentrations during pregnancy and
newborn amygdala volume and connectivity. C. BUSS*; A.
M. GRAHAM; J. RASMUSSEN; M. D. RUDOLPH; C. H.
HEIM; J. H. GILMORE; M. A. STYNER; S. ENTRINGER; P.
D. WADHWA; D. A. FAIR. Charit Univ. Med. Berlin, Univ.
of California Irvine, Oregon Hlth. and Sci. Univ., Penn State
Univ., Univ. of North Carolina.
10:00 D15
298.03 Prevention of an infection-induced
maternal adenosine surge during gestation prevents the
development of schizophrenia symptoms in mice. D. M.
OSBORNE*; U. SANDAU; A. JONES; N. ETESAMI; M.
YAHYA; D. BOISON. Legacy Hlth. Res., Legacy Res. Inst.
11:00 D16
298.04 Roles of thalamocortical interactions in
mouse prefrontal cortex development. Y. NAKAGAWA*; A.
PROUE, 55455; T. NICHOLS-MEADE; M. BENNYWORTH.
Univ. of Minnesota Dept. of Neurosci., Univ. of Minnesota.

12 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 D17 298.05 Prenatal paracetamol exposure disrupts

motor behavior in mice. D. BIGLEY*, JR; T. M. MILEWSKI; P.
T. ORR. Univ. of Scranton, Univ. of Scranton.
9:00 D18 298.06 Ontogeny of Glutamatergic, GABAergic
and Dopaminergic neurons of the embryonic mesencephalic
nuclei A9 and A10. D. A. RAMREZ DE LEN*. Univ.
Autnoma De San Luis Potos.
10:00 D19
298.07 Organization of hippocampal mossy
fiber pathway in the mouse. G. XIONG*; H. METHENY; K.
FOLWEILER; A. S. COHEN. Childrens Hosp Philadelphia,
Childrens Hosp Philadelphia, Perelman Sch. of Medicine,
Univ. of Pennslyvania.
11:00 D20
298.08 Exosome-delivered miRNA-146a
ameliorates peripheral neuropathy in diabetic mice. B. FAN*;
X. LIU; M. CHOPP; A. SZALAD; L. WANG; W. PAN; Z.
ZHANG. Henry Ford Hosp., Oakland Univ., Med. Imaging
Inst. of North Sichuan Med. Univ.

299. Adolescent Development: Animal Models I

Theme A: Development
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 D21 299.01 Myelination of prefrontal axons
is accompanied by increased speed and integrity of
cortical neurotransmission in rats. A. SILVA-GOTAY*; S.
MCDOUGALL; W. M. VARGAS; G. LI; H. N. RICHARDSON.
Univ. of Massachusetts Amherst, Univ. of Massachusetts
Amherst, New York Med. Col., Univ. of Massachusetts
Amherst, Univ. of Massachusetts Amherst.
9:00 D22 299.02 Longitudinal assessment of neuronal 3D
genomes in mouse prefrontal cortex. A. C. MITCHELL*; B.
JAVIDFAR; L. K. BICKS; R. NEVE; K. GARBETT, PhD; S.
S. LANDER; K. MIRNICS; H. MORISHITA; M. WOOD; Y.
JIANG; I. GAISLER-SOLOMON; S. AKBARIAN. Icahn Sch.
of Med. at Mount Sinai, MIT, Vanderbilt Univ., Univ. of Haifa,
Univ. of California, Irvine.
10:00 D23
299.03 Maternal care modulates the febrile
response to lipopolysaccharide through differences in
glucocorticoid receptor sensitivity in the rat. T. ZHANG*; H.
NGUYEN; X. WEN; J. DIORIO; M. J. MEANEY; C. PARENT.
McGill Univ., McGill Univ., Singapore Inst. for Clin. Sci.
11:00 D24
299.04 Adolescent social stress results in
sex-specific transcriptional reprogramming throughout
the reward circuitry in adult mice. D. M. WALKER*; I.
PURUSHOTHAMAN; M. E. CAHILL; C. K. LARDNER; S.
MACHLOVI; E. S. CALIPARI; H. M. CATES; R. C. BAGOT;
C. J. PEA; G. E. HODES; M. A. DOYLE; E. RIBEIRO; S.
J. RUSSO; P. J. KENNEDY; E. J. NESTLER. Icahn Sch. of
Med. At Mount Sinai, The Univ. of California Los Angeles.
8:00 D25 299.05 Storm, stress, and nicotine: Interaction of
stress and nicotine during adolescence on adult learning and
stress response systems. E. HOLLIDAY*; C. OLIVER; R.
COLE; D. BANGASSER; T. GOULD. Univ. of Texas Med. Br.,
Temple Univ.
9:00 D26 299.06 MAGL inhibition decreases aggression
after post-weaning social isolation in male and female rats.
L. DAWUD; E. LOETZ; J. FONTENOT; D. TAUBER; I.
BRALLIER; S. T. BLAND*. Univ. of Colorado, Denver, Univ.
of Colorado, Denver.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 D28
299.08 Periodic enrichment affects the outcome
of two social preference tasks in adolescent female rats.
H. JOHNSON*; H. C. SKINNER; S. L. SANTIAGO; R.
GUCWA; M. N. PAVELKA; K. L. PATTERSON; M. C. ZRULL.
Appalachian State Univ.
8:00 D29 299.09 Animal models of severe traumatic brain
injury and its clinical significanc. S. LU*; Q. YING; X. XU;
Y. TANG; Y. JIAO; Q. WANG; X. WANG; X. ZHANG; N. LU.
411th Navy Hosp, No.411 Naval Hosp., No.411 Naval Hosp.,
Naval Med. Res. Inst., No.411 Naval Hosp., Shanghai Res.
Inst. of Sinopec.
9:00 D30 299.10 Social interaction during critical
developmental periods affects development of the prefrontal
cortex. W. E. MEDENDORP*; A. PAL; E. PETERSEN; U.
HOCHGESCHWENDER; K. JENROW. Central Michigan
Univ., Central Michigan Univ., Central Michigan Univ.
10:00 D31
299.11 Enrichment affects exploration of a field
containing familiarly and newly located objects by adolescent
rats. E. A. ARTZ*; H. L. JOHNSON; H. C. SKINNER; S. J.
SNOUSE; R. C. PIERCE-MESSICK; T. J. ARNOLD; D. E.
COBB; M. C. ZRULL. Appalachian State Univ.
11:00 D32
299.12 Attentional control assessment in LgDel
adolescent mice through a modified five choice serial
reaction time task. M. CIAMPOLI*; M. MEREU; F. PAPALEO.
Inst. Italiano Di Tecnologia, Univ. degli Studi di Padova.
8:00 D33 299.13 Adolescent binge ethanol exposure alters
cholinergic cell populations, but not functional acetylcholine
release. G. M. FERNANDEZ*; J. E. SANDERS; L. M.
SAVAGE. Binghamton Univ.
9:00 D34 299.14 Deprivation of social play behavior
results in decreased inhibition in adult prefrontal cortex
and associated behavioral changes in rats. A. OMRANI;
M. SPOELDER; R. VAN DORLAND; C. CORNELIS; L.
J. VANDERSCHUREN*; C. J. WIERENGA. Univ. Med.
Ctr. Utrecht, Utrecht University, Fac. of Vet. Med., Utrecht
University, Fac. of Sci.
10:00 E1
299.15 Neonatal vincristine administration
evokes delayed mechanical pain hypersensitivity in the
developing rat. K. A. SCHAPPACHER*; M. L. BACCEI. Univ.
of Cincinnati Dept. of Anesthesiol.
11:00 E2
299.16 Effects of estrogen on brain structural
maturation during adolescence: Prefrontal, amygdala and
temporal cortex in female macaques. F. LOMBARDI*; J. R.
GODFREY; B. R. HOWELL; M. STYNER; M. E. WILSON; M.
M. SANCHEZ. Yerkes Natl. Primate Res. Ctr., Emory Univ.,
Univ. of North Carolina.
8:00 E3
299.17 Amygdala growth from youth to adulthood
in the macaque monkey. C. M. SCHUMANN*; J. A. SCOTT;
A. LEE; E. FLETCHER; M. D. BAUMAN; D. G. AMARAL. UC
Davis MIND Inst., UC Davis, UC Davis.
9:00 E4
299.18 Physical activity during adolescence
and neural reserve: A study of the brain levels of brain
derived neurotrophic factor (BDNF), adrenocorticotropic
hormone (ACTH) and corticosterone. A. D. DOMINGUEZ
CARVALHO*; A. B. VICTORINO; A. A. DE ALMEIDA; J. S.
HENRIQUE; F. R. CABRAL; L. B. TORRES; R. M. ARIDA;
S. GOMES DA SILVA. Federal Univ. of Sao Paulo, Federal
Univ. of Sao Paulo, Hosp. Israelita Albert Einstein.

Neuroscience 2016|Monday AM|13

Mon. AM

POSTER

10:00 D27
299.07 The impact of BDNF Val66Met single
nucleotide polymorphism on rodent social interaction across
development. A. LI*; D. JING; R. YANG; F. LEE. Weill Cornell
Med. Col., Weill Cornell Med. Col.

POSTER
300. Postsynaptic Organization and Structure I
Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 E5
300.01 GABAergic/non-GABAergic synaptic
inputs to striatal medium spiny neurons. Y. KUBOTA*; Y.
KAWAGUCHI. Natl. Inst. Physiol Sci. (NIPS), Grad Univ.
Advanced Studies (SOKENDAI).
9:00 E6
300.02 Contacts between the ER and other
membranes in neurons: An inter-organelle connectome. Y.
WU*; S. XU; H. KENNETH; H. HESS; P. DE CAMILLI. Yale
University, Med. Sch., Howard Hughes Med. Inst.
10:00 E7
300.03 Imaging of polarized light signal
changes associated with neuronal activity in mouse
hippocampus. M. KOIKE-TANI*; S. MEHTA; T. TOMINAGA;
R. OLDENBOURG; T. TANI. MBL, Tokushima Bunri Univ.
11:00 E8
300.04 Calsyntenin-3 mediates synapse
development via neurexin/cbln complexes. J. KO*; H. KANG;
J. KO; T. MORI; K. MATSUDA; S. JEON; M. YUZAKI; K.
TABUCHI; J. UM. Yonsei Univ., Yonsei Univ. Sch. of Med.,
Shinshu Univ. Sch. of Med., Keio Univ.
8:00 E9
300.05 Shank modulates postsynaptic Wnt
signaling to regulate synaptic development. K. P. HARRIS*;
Y. AKBERGENOVA; R. W. CHO; M. S. BAAS-THOMAS; J. T.
LITTLETON. MIT.
9:00 E10 300.06 Developmental regulation of
NMDA receptor subunits expression by drebrin. N.
KOGANEZAWA*; T. SHIRAO. Gunma Univ. Grad. Sch. of
Med.
10:00 E11
300.07 Quantitative analysis of synapse
organization at nanoscale by cryo-electron tomography. A.
MARTINEZ-SANCHEZ; Z. KOCHOVSKI; U. LAUGKS; W.
BAUMEISTER; V. LUCIC*. Max Planck Inst. of Biochem.
11:00 E12
300.08 The role of cortactin in AMPAR trafficking.
G. PARKINSON*; S. E. L. CHAMBERLAIN; M. TURVEY; N.
JAAFARI; J. G. HANLEY. Univ. of Bristol, Univ. of Bristol.
8:00 E13 300.09 Identification and characterization of
proteins at the synaptic cleft. A. BURCH; J. TAO-CHENG; A.
DOSEMECI*. NIH, NINDS, NIH.
9:00 E14 300.10 Gephyrin splice variant dependent
aminobutyric type a receptor clustering. Y. MERKLER*; G.
SCHWARZ. Univ. of Cologne, CECAD Cologne Excellence
in Aging Res., Ctr. for Mol. Med. Cologne.
10:00 E15
300.11 An automatic pipeline to optimize
subcellular models of transynaptic signaling at inhibitory
synapses. M. MIGLIORE*; C. A. LUPASCU; A. MORABITO;
E. MERENDA; S. MARINELLI; C. MARCHETTI; R.
MIGLIORE; E. CHERUBINI. Natl. Res. Council, Natl. Res.
Council, European Brain Res. Inst.
300.12 Consequences

11:00 E16
of mGluR5-dependent
regulation of the spinophilin/sapap3 interaction. C. W.
MORRIS*; M. C. EDLER; A. J. BAUCUM, II. Indiana Univ.
Purdue Univ. at Indianapolis, Indiana Univ. Purdue Univ. at
Indianapolis, Stark Neurosciences Res. Inst.
8:00 E17 300.13 Unraveling the inhibitory synapse
proteome in vivo. A. UEZU*; D. J. KANAK; T. W. A.
BRADSHAW; C. M. CATAVERO; A. C. BURETTE; R. J.
WEINBERG; S. H. SODERLING. Duke Univ., Univ. of North
Carolina.

14 | Society for Neuroscience

9:00 E18 300.14 Screening and functional analysis of

neuroligin 1 interacting proteins. R. DANG*; A. LIU; W. XIE;
Z. ZHOU; Z. JIA. Inst. of Life Sciences, Southeast Univ.,
Dept. of Physiology, Fac. of Medicine, Univ. of Toronto.
10:00 E19
300.15 Ketamine-induced antidepressant effects
and psychosis: A role for postsynaptic supercomplexes
revealed using mouse genetic models and synaptome
mapping. S. LEMPRIERE*; J. NITHIANANTHARAJAH; F.
ZHU; Z. QIU; N. H. KOMIYAMA; S. G. N. GRANT. Univ. of
Edinburgh, The Florey Inst. of Neurosci. and Mental Hlth.,
Univ. Col. London.
11:00 E20
300.16 Mechanisms underlying spinophilindependent regulation of the association of PP1 with the
NMDA receptor. A. BEIRAGHI SALEK*; J. MCBRIDE; M. C.
EDLER; A. J. BAUCUM, II. Indiana University-Purdue Univ.
Indianapolis, Northwestern Univ., Stark Neurosciences Res.
Inst.

POSTER
301. Modulation: Pharmacology
Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 E21 301.01 Chemogenetic control of hilar mossy cell
excitability regulates emotional behaviors. K. WANG*; C.
LIEN. Natl. Yang-Ming Univ., Natl. Yang-Ming Univ., Natl.
Yang-Ming Univ.
9:00 E22 301.02 Acute and chronic noradrenergic effects
on cortical excitability in healthy humans. M. KUO*; H. KUO;
W. PAULUS; G. BATSIKADZE; A. JAMIR; M. A. NITSCHE.
Leibniz Res. Ctr. For Working Envrn. An, Georg-AugustUniversity Gttingen, Univ. Med. Hosp. Bergmannsheil
Bochum.
10:00 E23
301.03 Neurosteroid induction of NMDA and
AMPA receptor trafficking. V. KUMARESAN*; K. SUGUNAN;
R. M. BADOLATO; R. SINGH; J. LUEBKE; J. M. ADAMS; D.
H. FARB. Boston Univ. Sch. of Med., Boston Univ. Sch. of
Med.
11:00 E24
301.04 Chronic toluene exposure alters medial
prefrontal cortex synaptic transmission of adolescent rats.
M. I. TORRES-FLORES*; S. L. CRUZ; E. J. GALVN.
CINVESTAV.
8:00 E25 301.05 Effect of Carbenoxolone on gap junction
in the hippocampus of rats with epileptiform activity
induced by 4-aminopyridine. C. VENTURA*; R. BELTRNRAMREZ; S. D. CONTRERAS-DELATORRE; G. ZARATERODRGUEZ; B. VILLANUEVA-AVALOS; N. S. MUOZFILIPPETTI. Ctr. De Enseanza Tcnica Industrial, Univ. de
Guadalajara, Ctr. de Enseanza Tcnica Industrial.
9:00 E26 301.06 Restraint stress differentially alters 1and 2-Adrenergic Receptor modulation of glutamatergic
transmission in the Ventral Bed Nucleus of the Stria
Terminalis. Y. SILBERMAN*. Penn State Col. of Med.
10:00 E27
301.07 Peptidergic modulation of spontaneous
and evoked synaptic activity in ca1 pyramidal cells
of rat hippocampal slices. V. G. SKREBITSKY*; R.
KONDRATENKO; I. POVAROV; S. KOLBAEV. Res. Ctr. of
Neurology., Res. Ctr. of Neurol.
11:00 E28
301.08 L-proline, a metabolite linked to
neuropsychiatric disorders and associated with the
22q11.2 deletion syndrome, specifically disrupts GABAergic transmission in the mPFC. G. W. CRABTREE*; J. A.
GOGOS. Columbia Univ. Med. Ctr., Columbia Univ. Med. Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 E29 301.09 Electrophysiological signatures of

modulation of GABA-A 5 receptor activity by S 44819 in
human cortex. G. DARMANI*; C. ZIPSER; G. M. BHMER;
F. MLLER-MAHLHAUS; P. BELARDINELLI; M. SCHWAB;
K. DESCHET; U. ZIEMANN. Hertie Inst. For Clin. Brain Res.,
Univ. Hosp. Tbingen, Univ. of Tbingen, and Dr. Margarete
Fischer-Bosch Inst. of Clin. Pharmacol., Inst. de Recherches
Internationales Servier.
9:00 E30 301.10 Effects of olanzapine and haloperidol on
mtorc1 signaling, dendritic outgrowth, and synaptic proteins
in rat primary hippocampal neuron under toxic conditions. M.
SEO; H. CHO; C. LEE; Y. KIM; J. LEE; S. PARK*. Inje Univ.,
Inje Univ., Inje Univ., Univ. of Toronto.

11:00 E32
301.12 Effects of the antipsychotic drug
loxapine on synaptic transmission in the superficial lamina
of the dorsal horn. K. EVELY*; S. HAJ-DAHMANE; A.
BHATTACHARJEE. Univ. At Buffalo- Downtown Campus,
Univ. at Buffalo, Univ. at Buffalo, Univ. at Buffalo.
8:00 E33 301.13 Dystrophins in the cerebellum: A first look
at the role of Dp71 role in Purkinje neurons and Bergmann
glia. R. HELLERINGER*; O. JOLY; M. BELMAADICHERKAOUI; H. DANIEL; C. VAILLEND; M. GALANTE.
Paris-South Univ.
9:00 E34 301.14 Synergistic effects on calcium entry and
transmitter release of a potassium channel blocker and a
calcium channel gating modifier at the NMJ. R. LAGHAEI;
M. WU; A. PUGLIONESI; T. TARR; M. DITTRICH; S. D.
MERINEY*. Carnegie Mellon Univ., Univ. Pittsburgh, Univ.
Pittsburgh.
10:00 E35
301.15 Trans-synaptic zinc mobilization improves
social interaction in two mouse models of autism through
NMDAR activation. H. LEE*, V; E. LEE; T. HUANG, 305-701;
C. CHUNG; W. SHIN; K. KIM; J. KOH; Y. HSUEH; E. KIM.
Inst. of Basic Sci. (IBS), Inst. of Basic Sci. (IBS), Inst. of Mol.
Biol., Korea Asan Inst. for Life Sci.
11:00 E36
301.16 Functional endpoint assays to assess
neurotoxicity with human iPSC-derived neurons. S.
DELAURA; E. M. JONES*; K. KIM; C. KANNEMEIER; R.
LEWIS; K. MANGAN; B. SWANSON; C. CARLSON. Cell.
Dynamics Intl., Gist Consulting.
8:00 E37 301.17 Pre- and postsynaptic dopamine
receptors differentially modulate the subicular inputs to layer
V pyramidal neurons in medial and lateral entorhinal cortex.
H. KIM*; J. KWAG. Korea Univ.
9:00 E38 301.18 Corticosterone and neuromodulators
display similar rapid effects on inhibitory cortical networks.
C. A. WOTTON*; E. F. QUON; L. K. BEKAR. Univ. of
Saskatchewan.
10:00 F1
301.19 2-Adrenergic receptor and isoflurane
modulation of presynaptic Ca2+ influx and exocytosis
in hippocampal neurons. Z. ZHOU*; M. HARA; H. C.
HEMMINGS, Jr. Weill Cornell Med. Col., Kurume Univ. Sch.
of Med., Weill Cornell Med. Col.

302. Network Interactions and Signal Propagation

Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 F2
302.01 Modulation of entorhinal cortical input
to hippocampal granule cells through activation of local
inhibitory network in the dentate gyrus. Y. MIRCHEVA*; M.
R. PERALTA, III; K. TOTH. Ctr. De Recherche De LInstitut
Universitaire En.
9:00 F3
302.02 Adenosine provides fine-tuned and
highly localised negative-feedback control of spatiotemporal
activity in the neocortex. M. J. WALL*; A. NEWTON; M. G.
THOMAS; M. J. E. RICHARDSON. Univ. of Warwick, Univ. of
Warwick.
10:00 F4
302.03 Effect of electrode morphology on
the frequency spectrum of local field potentials in the rat
ventral tegmental area. C. DELAIRESSE; G. BECKER; A.
PLENEVAUX; V. M. SEUTIN*; S. KOULCHITSKY. Univ. of
Liege, Univ. Liege.

11:00 F5
302.04 Probing the ventral fronto-temporal
pathway in the language dominant hemisphere- an
intraoperative cortico-cortical evoked potential study. T.
NAKAE*; R. MATSUMOTO; T. KUNIEDA; Y. ARAKAWA;
T. KOBAYASHI; T. INADA; Y. TAKAHASHI; S. NISHIDA;
K. KOBAYASHI; A. SHIMOTAKE; M. MATSUHASHI; R.
INANO; Y. YAMAO; T. KIKUCHI; K. YOSHIDA; A. IKEDA; S.
MIYAMOTO. Kyoto Univ. Hosp., Kyoto Univ. Hosp., Ehime
Univ. Hosp., Kyoto Univ. Hosp., Kyoto Univ., Kouseikai
Takeda Hosp.
8:00 F6
302.05 The capacity of active memory. E. P.
FRADY*; G. ISELY; F. T. SOMMER; P. KANERVA. UC
Berkeley, Redwood Ctr. for Theoretical Neurosci.
9:00 F7
302.06 Sleep in clock mutant mice, clock5-6,
responds to light changes and sleep deprivation very
differently. B. QIN*; A. AKLADIOUS; P. FENG. Case Western
Reserve University/Va Med., Louis Stokes Cleveland DVA
Med. Ctr., Louis Stokes Cleveland DVA Med. Ctr., Case
Western Reserve Univ.
10:00 F8
302.07 Networks critical state and its relation to
the inverted-U profile of dopamine related working memory
performance. G. HU; X. HUANG; T. JIANG; S. YU*. Inst. of
Automation, Chinese Acad. of Sci.
11:00 F9
302.08 Enhanced signal propagation and
nonnormality in a large scale circuit model of the primate
cortex. M. JOGLEKAR*; J. MEJIAS; G. R. YANG; X. WANG.
New York Univ. Ctr. for Neural Sci., NYU Shanghai.
8:00 F10 302.09 Pacap modulates amygdalar-bnst
interactions in control of anxiety. Y. LI; R. ANDERO; K. J.
RESSLER; V. Y. BOLSHAKOV*. McLean Hosp- Harvard
Med. Sch.
9:00 F11 302.10 Hippocampal modulation of sensory
integration in entorhinal cortex. M. ELMALEH*; R. ZEMLA;
M. DUFOUR; A. HAIRSTON; S. SUNDAR; J. BASU. NYU
Langone Med. Ctr., NYU Langone Med. Ctr.
10:00 F12
302.11 Using multielectrode arrays to investigate
the spontaneous firing patterns and functional connectivity
in large neural assemblies. T. FENG*; N. X. KODAMA; R.
FERNANDEZ GALAN. Case Western Reserve Univ.
11:00 F13
302.12 Spherical harmonics reveal standing EEG
waves and long-range neural synchronization in the sleeping
brain. S. S. SIVAKUMAR*; A. G. NAMATH; R. FERNANDEZ
GALAN. Case Western Reserve Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|15

Mon. AM

10:00 E31
301.11 Electrophysiological characterization
of S 47445, a novel positive allosteric modulator of AMPA
type glutamate receptors. L. DANOBER*; T. SCHAER; K.
KAMBARAT; F. MARGER; S. BRETIN; D. BERTRAND. Inst.
De Recherches Servier, PIT-NPS, HiQScreen Sarl, Inst. de
Recherches Internationales Servier.

POSTER

8:00 F14 302.13 Propagation of spike timing and firing rate

across multiple layers in networks of cultured neurons. J.
BARRAL*; A. REYES; X. WANG. New York Univ.
9:00 F15 302.14 Network plasticity facilitating the neural
excitation propagation between the perirhinal and entorhinal
cortices as revealed by voltage-sensitive dye imaging. R.
KAJIWARA*; Y. WAKAYAMA; Y. TOMINAGA; T. TOMINAGA.
Meiji Univ. / Dept. of Electro. & Bioinfo., TokushimaBunri
Univ. / Dept. of Neurophysiol.
10:00 F16
302.15 Propagation of neural activity induced
by single-pulse electrical stimulation during various sleep
stages. K. USAMI*; A. KORZENIEWSKA; R. MATSUMOTO;
T. KUNIEDA; N. MIKUNI; K. KOBAYASHI; T. KIKUCHI; K.
YOSHIDA; S. MIYAMOTO; R. TAKAHASHI; A. IKEDA; N.
E. CRONE. Johns Hopkins Univ., Kyoto Univ., Kyoto Univ.,
Sapporo Med. Univ. Sch. of Med., Kyoto Univ.
11:00 F17
302.16 Hippocampal-Perirhinal oscillatory
coupling switched on and off by light. J. DINE*; A.
GENEWSKY; F. HLADKY; C. T. WOTJAK; J. M. DEUSSING;
W. ZIEGLGNSBERGER; A. CHEN; M. EDER. Max Planck
Inst. of Psychiatry.
8:00 F18 302.17 Patch clamp recordings of cellular and
synaptic properties in adult mouse thoracic paravertebral
ganglia. M. L. MCKINNON*; S. HOCHMAN. Emory Univ.
9:00 F19 302.18 Anatomy of mouse thoracic sympathetic
chain ganglia and electrophysiological assessment of their
multisegmental preganglionic input. M. HALDER*; M. CHOI;
C. MACDOWELL; M. MCKINNON; M. SAWCHUK; S.
HOCHMAN. Emory Univ., Emory Univ.
10:00 F20
302.19 Suppressed GABAergic signaling in
the zona incerta causes neuropathic pain in a thoracic
hemisection spinal cord injury rat model. B. OH*; H. MOON;
Y. LEE; C. CHO; Y. PARK. Chungbuk Natl. Univ. Hosp.,
Chungbuk national university, epartment of Radiology,
Daejoen St. Marys Hospital, The Catholic Univ. Of Korea,
Dept. of Neurosurgery, St. Vincents Hospital, The Catholic
university of Korea, Chungbuk Natl. Univ. Hosp.
11:00 F21
302.20 Exact analysis of spike-timing and
higher-order interactions of neurons at the threshold regime
suggests network architecture underlying sparse population
activity. S. RASHID SHOMALI*; M. NILI AHMADABADI; S.
RASULI; H. SHIMAZAKI. Inst. For Res. In Fundamental Sci.,
Univ. of Tehran, Univ. of Guilan, RIKEN Brain Sci. Inst.
8:00 F22 302.21 5ht3a+ interneurons inhibit pv+
interneurons to enhance signal fidelity in hippocampal area
ca1. B. SUUTARI*; S. M. COHEN; A. SALAH; R. W. TSIEN.
NYU Neurosci. Inst.
9:00 F23 302.22 Propagation patterns in spontaneous
activity are state and frequency-dependent. A. MITRA*; P. W.
WRIGHT; A. Z. SNYDER; G. A. BAXTER; A. Q. BAUER; J. P.
CULVER; M. E. RAICHLE. Washington Univ. Sch. of Med.
10:00 F24
302.23 Closed-loop modulation of hippocampal
reveals a role of recurrent excitation in setting the oscillatory
frequency. E. NICHOLSON*; D. KUZMIN; M. LEITE; T.
AKAM; D. M. KULLMANN. UCL, Inst. of Neuology, UCL,
Champalimaud Neurosci. Programme.

8:00 F26 302.25 Directional propagation of ketamineinduced high-frequency oscillations between the striatum,
hippocampus, and motor cortex. M. B. SCHMIT*; T. YE;
M. J. BARTLETT; T. FALK; S. L. COWEN. Univ. of Arizona,
Univ. of Arizona, Univ. of Arizona, Univ. of Arizona, Univ. of
Arizona, Univ. of Arizona.

POSTER
303. Oscillations and Synchrony: Unit Studies
Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 F27 303.01 Intracellular dynamics during selfgenerated oscillations in the whole hippocampal
preparation. F. FURMANOV*; S. WILLIAMS; J. A. WHITE.
Boston Univ., Univ. of Utah, Douglas Mental Hlth. Univ.
Institute, McGill Univ.
9:00 F28 303.02 Specialized contributions of individual
GABAergic medial septal neurons to hippocampal network
activity. G. UNAL*; M. G. CRUMP; T. J. VINEY; T. ELTES;
T. KLAUSBERGER; P. SOMOGYI. Univ. of Oxford, Inst. of
Exptl. Med. of the Hungarian Acad. of Sci.
10:00 F29
303.03 Cell-type specific participation in sharpwave dynamics in the CA3 region of the hippocampus. N.
P. SPRUSTON*; D. L. HUNT. HHMI Janelia Res. Campus,
HHMI Janelia research campus.
11:00 F30
303.04 Spiking correlates and temporal
variability of oscillatory frequency modulation. R. GAO*; E.
J. PETERSON; B. VOYTEK. Univ. of California San Diego
Dept. of Cognitive Sci., Univ. of California San Diego Dept. of
Cognitive Sci., UCSD Inst. for Neural Computation, UCSD.
8:00 F31 303.05 Bdnf val66met polymorphism impairs
network oscillations in the hippocampus. Y. HUANG*. Tongji
Univ.
9:00 F32 303.06 Volitional control of -band oscillations
by brain machine interface affects sensorimotor behavior of
primates. O. PELES*; U. WERNER-REISS; H. BERGMAN;
Z. ISRAEL; E. VAADIA. Hebrew Univ., Hebrew Univ.,
Hadassah Univ. Hosp.
10:00 F33
303.07 Extracting neural networks formed by
consistent between-cell spike timing from unit recordings. R.
VAN DER MEIJ*; E. MARIS; B. VOYTEK. Univ. of California
San Diego, Radboud Univ.
11:00 F34
303.08 Fast-spiking neurons organize largescale coherent oscillations and are the main generators
of local field potentials in human and monkey cortex. A.
DESTEXHE*; M. LE VAN QUYEN; N. DEHGHANI; E.
HALGREN; S. CASH; N. HATSOPOULOS; B. TELENCZUK.
CNRS, ICM, Wyss Inst., UCSD, Harvard Med. Sch., Univ. of
Chicago.
8:00 DP02 303.09 (Dynamic Poster) Fast Oscillatory activity
in the hippocampus can back-propagate electrotonically to
the dentate gyrus. F. ORTIZ*; R. GUTIRREZ. CINVESTAV,
UNAM.

11:00 F25
302.24 Gain control across cortical layers can be
mediated by balanced oscillatory coupling. E. PETERSON*;
B. VOYTEK. U.C. San Diego.

9:00 F35 303.10 Identified cellular correlates of neocortical

ripple and high oscillations during spindles of natural sleep.
G. TAMAS*; V. SZEMENYEI; S. BORD; R. G. AVERKIN.
Univ. of Szeged.

16 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 F36
303.11 Intrinsic and extrinsic sources of
GABAergic inhibition in the dentate gyrus. G. G. SZABO*;
C. VARGA; I. SOLTESZ. Stanford Univ., Szentgothai Res.
Center, MTA-PTE-NAP A-Entorhinal Microcircuits, Univ. of
Pcs.

8:00 F47 304.09 Antineoplastic activity of cannabidiol

combined with DNA-damaging agents in glioma cells. L.
DENG*; L. NG; T. OZAWA; E. C. HOLLAND; N. STELLA.
Univ. of Washington, Univ. of Washington, Fred Hutchinson
Cancer Res. Ctr.

11:00 F37
303.12 Changes in network dynamics and
prefrontal spiking activity in a mouse genetic model of
schizophrenia: Implications for connectivity. J. L. ZICK*; K.
SCHULTZ; T. I. NETOFF; M. V. CHAFEE. Univ. of Minnesota
Dept. of Neurosci., Univ. of Minnesota, VA Med. Ctr., Univ. of
Minnesota.

9:00 F48 304.10 Synthesis and characterization of a

novel copper-containing nano-biocomposite for potential
drug delivery and imaging in brain. M. A. DECOSTER*; D.
MILAM; A. KARAN; M. DELAHOUSSAYE. Louisiana Tech.
Univ., Louisiana Tech. Univ.

8:00 F38 303.13 Association of ketamine, dopamine D4

receptor activation, and locomotion with range activity
in the prefrontal cortex and mediodorsal thalamus. K. E.
FURTH*; A. J. MCCOY; J. R. WALTERS; A. BUONANNO; C.
DELAVILLE. NINDS, NIH, Boston Univ., NICHD, NIH.

304. Neuro-Oncology: Signaling and Therapeutics

Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 F39 304.01 Mutual influence of ROS, pHi and chloride
current in cell cycle progression of glioblastoma cancer stem
cells. I. VERDUCI; M. PERETTI; F. M. RACITI; R. WURTH;
F. BARBIERI; T. FLORIO; M. MAZZANTI*. Univ. di Milano,
Univ. di Genova, Univ. di Milano.
9:00 F40 304.02 Inhibition of glioma progression by a
novel compound of anthraquinone. K. CHEN*; S. KANG; Y.
CHIANG; J. WU; H. HUANG. Taipei Med. Univ., Taipei Med.
Univ., Taipei Med. Univ., Taipei Med. Univ.
10:00 F41
304.03 Inhibition of sonic hedgehog signaling
suppresses glioma stem-like cells through inducing
autophagic cell death. P. GEAN*; H. HUNG. Natl. ChengKung Univ., Natl. Cheng-Kung Univ.
11:00 F42
304.04 Sevoflurane may increase glioma cell
invasion via CD44. Z. ZUO*; R. LAI; W. SHAN. Unvi of VA.
8:00 F43 304.05 Downregulation of TLX induces TET3
expression and inhibits glioblastoma stem cell self-renewal
and tumorigenesis. Q. CUI*; S. YANG; P. YE; E. TIAN;
G. SUN; J. ZHOU; G. SUN; X. LIU; C. CHEN; K. MURAI;
L. YANG; X. WU; M. DAPUZZO; C. BROWN; B. BADIE;
L. PENG; A. D. RIGGS; J. J. ROSSI; Y. SHI. Beckman
Res. Inst. City of Hope, Beckman Res. Inst. City of Hope,
Beckman Res. Inst. City of Hope, Beckman Res. Inst. City of
Hope, Aix-Marseille Universite, Beckman Res. Inst. City of
Hope, Beckman Res. Inst. City of Hope, Beckman Res. Inst.
City of Hope, Beckman Res. Inst. City of Hope, Beckman
Res. Inst. City of Hope.

9:00 F44 304.06 In vitro antiglioma action of indomethacin

is mediated via AMPK/mTOR signaling pathway. A.
PANTOVIC*; A. PANTOVIC. Military Med. Acad., Military
Med. Acad. and Inst. for microbiology and immunology Sch.
of Med. Univ. of Belgrade.
10:00 F45
304.07 The impact of ionotropic glutamate
receptors on glioblastoma stem-like cells upon ionizing
radiation. H. LUTZ; H. A. BRAUN*; B. LAUBE. TU
Darmstadt, Univ. Marburg.
11:00 F46
304.08 Heterogeneous glioblastoma cell
responses to TNF depend on molecular subtype. M. E.
BARISH*; A. MIZES; B. BREWSTER; N. BAGHDADCHI;
C. E. BROWN. Beckman Res. Inst. City of Hope, Beckman
Res. Inst. City of Hope.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 F50
304.12 CEP5003, a novel compound targeting
glioblastoma cancer stemcells. C. SHARMA; M. JANI; N.
AMEZCUA; M. SHARMA; P. NARAYANAN; M. NAVEL;
D. STANTON; S. SHARMA; D. FOSTER; J. COLLINS; S.
SHARMA; J. JANI; J. SHARMA*. Celprogen, ROSS Med.
Sch. in Domanica, VA Greater Los Angeles Hlth. Care Syst.
and JCCC, UCLA, Biopico Systems.
8:00 F51 304.13 Brain structural changes after
treatment of cerebellar tumors in children. J. TANEDO;
D. SACCHETTO; F. YEPES; J. COLOIGNER; M.
DESCOTEAUX; M. D. NELSON, Jr; N. LEPORE; M. BARON
NELSON*. Childrens Hosp. Los Angeles, USC, Univ. of
Sherbrooke, USC.
9:00 F52 304.14 The impact of surgical stress, immune
stimulation, and native immune cells on brain metasatasis.
A. BENBENISHTY*; L. SHAASHUA; A. GLASNER; S. BENELIYAHU; P. BLINDER. Tel Aviv Univ., The Hebrew Univ.
Hadassah.
10:00 F53
304.15 Examination of FOXJ1 as a modulator
of proliferation in glioblastoma. E. M. PARONETT*; E. P.
MCCORMACK; T. M. MAYNARD; J. H. SHERMAN. George
Washington Univ., George Washington Univ.
11:00 G1
304.16 HIV-associated brain Lymphoma
activates NAMPT/SIRT3/PGC-1 signaling. T. K. MAKAR;
S. RAY*; D. D. PATEL; P. R. GUDA; J. L. BRYANT. Univ. of
Maryland Baltimore, VA Med. Ctr., Inst. of Human Virology.
8:00 G2
304.17 Implication of mRNA binding protein HuR
in PD-L1 up regulation in brain tumor. N. FILIPPOVA*; X.
YANG; L. B. NABORS. Univ. of Alabama At Birmingham.

POSTER
305. Neuro-Oncology: Tumor Characterization and Modeling
Theme B: Neural Excitability, Synapses, and Glia
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 G3
305.01 Modelling human glioma using 3D
bioprinting. C. C. NAUS*; K. HARADA; W. SIN; D. SONG; N.
KITA. Univ. of British Columbia, Cyfuse Biomed. K.K.
9:00 G4
305.02 3D visualisation of Collagen IV
vasculature in human GBM tissue blocks: Morphometric
parameters relate to tumor severity and suggest
mechanisms of angiogenesis. G. P. CRIBARO; E.
SAAVEDRA-LPEZ; P. V. CASANOVA; C. BARCIA*. Univ.
Autonoma De Barcelona.

Neuroscience 2016|Monday AM|17

Mon. AM

POSTER

10:00 F49
304.11 Microglial properties of glioblastoma
as potential therapeutic targets. G. D. MANOCHA*; J. A.
KULAS; T. N. SEYFRIED; C. K. COMBS. Univ. of North
Dakota, Boston Col.

10:00 G5
305.03 Use of in vivo imaging for stem cell
therapy in a model of glioblastoma in rodents. K. IDYLE;
K. COPELY; A. STEWART; L. HUFFMAN; L. KNIGHT; M.
JEAKLE; L. SIEGEL; A. ANTCLIFF; D. DUES; K. FINK;
M. LU; U. HOCHGESCHWENDER; G. DUNBAR; J.
ROSSIGNOL*. Field Neurosciences Inst. Lab., Central
Michigan Univ., Dept. of Psychology at Central Michigan
Univ., Central Michigan Univ., Central Michigan Univ., Univ.
of California, Field Neurosciences Inst.
11:00 G6
305.04 Lipid droplet accumulation in glioblastoma
multiforme. B. TAIB*; R. AHIMA. Perelman Sch. of Med. at
the Univ. of Pennsylvania.
8:00 G7
305.05 Differential gene expression profiles
of adherent and neurosphere-like GL261 cells. J. L. V.
MONTEIRO DE BARROS; R. L. DANIELS*. Col. of Idaho.
9:00 G8
305.06 longitudinal functional alterations
of peritumoral neurons in a murine glioma model. E.
TANTILLO*; C. CERRI; F. OLIMPICO; S. FRANCESCHI;
E. VANNINI; P. ARETINI; M. MENICAGLI; C. MAZZANTI;
M. CALEO. Scuola Normale Superiore, Italian Natl. Res.
Council CNR, Pisa Sci. Foundation-ONLUS.

9:00 G16 305.14 PAD expression and citrullination

profiles in malignant glioma. E. A. SUSWAM; J. JYOTI;
G. Y. GILLESPIE; C. P. LANGFORD; U. MANNE; A. P.
NICHOLAS*. Univ. of Alabama at Birmingham, Univ. of
Alabama at Birmingham, Univ. of Alabama at Birmingham,
Univ. of Alabama at Birmingham.
10:00 G17
305.15 The potential impact of pro-inflammatory
B cells and T cells on the progression of glioblastoma
multiforme (GBM) in a syngeneic mouse model of
GBM. S. MUKHERJEE*; C. PEDDABOINA; L. DAO; S.
HENDERSON; J. KAIN; D. LITTLE; M. NEWELL ROGERS.
Texas A & M, Texas A and M Hlth. Sci. Ctr., Baylor Scott and
White, Baylor Col. of Med.
11:00 G18
305.16 Cellular origin influences glioma
pathogenesis and treatment. D. IRVIN*; R. MCNEILL; M.
VITUCCI; R. BASH; R. SCHMID; C. MILLER. Univ. of North
Carolina, Univ. of North Carolina, Univ. of North Carolina,
Univ. of North Carolina.

POSTER

10:00 G9
305.07 The effects of glioma growth on resting
state networks. I. E. ORUKARI*; A. Q. BAUER; G. A.
BAXTER; J. B. RUBIN; J. P. CULVER. Washington Univ. In
St Louis.

306. Brain Energetics in Health and Disease

11:00 G10
305.08 Brain tumours near the posterior
cingulate cortex have a larger effect on overall cerebral
connectivity. S. GHUMMAN*; D. FORTIN; M. NOEL-LAMY;
S. CUNNANE; K. WHITTINGSTALL. Univ. of Sherbrooke,
Univ. of Sherbrooke, Univ. of Sherbrooke, Univ. of
Sherbrooke.

8:00 G19 306.01 Acute insulin treatment of hippocampal

neurons highlights new mechanisms of action. S. MAIMAITI;
H. N. FRAZIER; K. L. ANDERSON*; L. D. BREWER; N. M.
PORTER; O. THIBAULT. Univ. of Kentucky.

8:00 G11 305.09 Mechanisms of diffuse intrinsic pontine

glioma invasion of the subventricular zone. E. Y. QIN*; D.
COOPER; S. NAGARAJA; A. MACKAY; C. JONES; M.
MONJE. Stanford Univ. Sch. of Med., The Inst. of Cancer
Res.
9:00 G12 305.10 Obesity as a potential attribute for
vincristine induced peripheral neuropathy. F. BOYLE; K.
FORAN; T. J. SAJDYK*; E. SMITH; R. HO; E. WELLS; J.
RENBARGER. Indiana Univ. Sch. of Med., Indiana Univ.
Sch. Med., Univ. of Michigan, Vanderbilt Univ., Childrens
Children Res. Inst.
10:00 G13
305.11 Potential biomarkers for early detection
of neuropathy in pediatric ALL patients. S. E. ROSS*; E.
SMITH; R. HO; E. WELLS; T. SAJDYK; J. THEN; L. LI; J.
RENBARGER. Indiana Univ. Sch. of Med., Univ. of Michigan,
Vanderbilt Univ., Childrens Natl. Med. Ctr.
11:00 G14
305.12 Brain-mimetic hydrogels to study
development of glioblastoma resistance to EGFR inhibition.
W. XIAO*; R. ZHANG; S. SUN; A. EHSNAIPOUR; C.
WALTHERS; J. LIANG; L. TA; D. NATHANSON; S.
SEIDLITS. UCLA, Univ. of California Los Angeles, Univ. of
California Los Angeles, UCLA.
8:00 G15 305.13 Increased phosphorylation of the
mitochondrial fission protein DRP1 in p75 neurotrophin
receptor (p75NTR)-induced glioma. Y. AHN*; N. SALEM; B.
AHN; S. M. ROBBINS; D. SENGER; J. M. RHO. Alberta
ChildrenS Hosp. Res. Inst., Univ. of Calgary, Univ. of
Calgary.

Theme C: Neurodegenerative Disorders and Injury

Mon. 8:00 AMSan Diego Convention Center,Halls B-H

9:00 G20 306.02 Signaling and expression of a

truncated, constitutively active human insulin receptor in
neurons and astrocytes. H. N. FRAZIER*; S. MAIMAITI;
K. L. ANDERSON; K. HAMPTON; L. D. BREWER; S. D.
KRANER; C. M. NORRIS; R. J. CRAVEN; N. M. PORTER;
O. THIBAULT. Univ. of Kentucky, Univ. of Kentucky.
10:00 G21
306.03 Insulin phosphosignaling in the
hippocampus of young and aged animals. K. K. HAMPTON;
H. FRAZIER; K. ANDERSON; O. THIBAULT; R. CRAVEN*.
Univ. of Kentucky.
11:00 G22
306.04 Altered mitochondrial function and
succinate-dependent H2O2 production in the cortex of
type 1 diabetic rodents. S. ROY CHOWDHURY*; J.
DJORDJEVIC; E. THOMSON; D. SMITH; B. C. ALBENSI; P.
FERNYHOUGH. St. Boniface Hosp. Res. Ctr.
8:00 G23 306.05 Respiratory parameters of rat brain,
liver and heart mitochondria during the aging process. H.
BARAN*; K. STANIEK; M. BERTIGNOL-SPRR; M. ATTAM;
B. KEPPLINGER. Karl Landsteiner Res. Inst. Mauer, Univ. of
Vet. Med. Vienna, Univ. of Vet. Med. Vienna.
9:00 G24 306.06 Metabolic syndrome impairs spatial
memory & dendritic morphology of rat hippocampal
neurons. A. D. DIAZ*; P. AGUILAR-ALONSO; A. MORENORODRIGUEZ; U. PEA-ROSAS; G. LPEZ-LPEZ; E.
BRAMBILA; R. A. VAZQUEZ-ROQUE; J. GUEVARA; G.
FLORES; S. TREVIO. Facultad De Ciencias Quimicas,
BUAP, Inst. de Fisiologia, BUAP, Facultad de MedicinaUNAM.
10:00 G25
306.07 Metabolic fuel switch from glucose to
ketones regulatesSIRT3 in the brain. K. MAROSI*; S. KIM;
M. P. MATTSON; R. CUTLER; S. CAMANDOLA. NIH.
11:00 G26
306.08 Nutrition and healthy brain functioning
across the lifespan. J. HEATH MATHISON*; L. M. JAMES; A.
LEUTHOLD; A. GEORGOPOULOS; A. GEORGOPOULOS;
H. HOOVER. Univ. of Minnesota, Minneapolis VA Med. Ctr.

18 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 G27 306.09 Hippocampal damage in the offspring

exposed to perinatal high sucrose diet. I. ZARCO DE
CORONADO*; S. MOSSO-MENDOZA; M. A. HERRERA.
UNAM, UNAM, UNAM.
9:00 G28 306.10 Oxidative stress underlies amyloid-
toxicity and mitochondrial dysfunction in Alzheimers disease.
L. ADLER*; W. REGENOLD; S. DODDI. Univ. of Maryland
Sch. of Med.
10:00 G29
306.11 Neuroprotective effect of blackberry juice
in rats under a hypercaloric diet. B. PREZ GRIJALVA*; R.
MORA ESCOBEDO; R. GUZMAN GERONIMO; A. DIAZ;
S. TREVIO; C. PEREZ CRUZ. CINVESTAV Unidad
Zacatenco, Escuela Nacional de Ciencias Biologicas,
universidad Veracruzana, BENEMERITA UNIVERSIDAD
AUTONOMA DE PUEBLA.

8:00 G31 306.13 Mitochondrial complex-1 assembly

into supercomplexes determines mitochondrial reactive
oxygen species production in neurons and astrocytes.
J. P. BOLANOS*; I. LOPEZ-FABUEL; J. LE DOUCE; G.
BONVENTO; A. M. JAMES; M. P. MURPHY; A. ALMEIDA.
UNIVERSITY OF SALAMANCA, Mol. Imaging Ctr.
(MIRCen), Med. Res. Council Mitochondrial Biol. Unit, Inst.
of Biomed. Res. of Salamanca.
9:00 G32 306.14 Aerobic glycolysis in the frontal cortex
correlates with memory performance in wild-type but not
APP/PS1 mice: Implications for metabolic intervention in
Alzheimers disease. R. A. HARRIS; S. L. MACAULEY; D.
M. HOLTZMAN; R. BARTHA; R. C. CUMMING*. Univ. of
Western Ontario, Washington Univ. Sch. of Med., Univ. of
Western Ontario, Univ. of Western Ontario.
10:00 G33
306.15 Functional food restores SIRT1 levels
and reverses dendritic spine loss in medial prefrontal
cortex of obese rats. L. PREZ JIMNEZ*; T. BEGUM S;
A. RAMIREZ-MIRAFUENTES; M. SANCHZ-TAPIA; N.
TORRES-TORRES; C. PEREZ-CRUZ. CINVESTAV, Natl.
Inst. of Med. Sci. and Nutr. Salvador Zubiran.
11:00 G34
306.16 Neural effects of high-fat diet are
exacerbated by aging and improved by testosterone in
male brown Norway rats. C. J. PIKE*; V. MOSER; A.
CHRISTENSEN. USC, USC, USC.
8:00 G35 306.17 The relationship between metabolic
impairment and proteasome activity the nervous system of
Drosophila. T. SCHMIDT-GLENEWINKEL*; M. JANSEN; S.
BENNETT; A. KLEIN; A. RASHID; J. NETHERCOTT. Hunter
Col. of CUNY.
9:00 G36 306.18 A vascular niche for highly active
neurons. T. MIYAWAKI*; S. YAMAGUCHI; Y. IKEGAYA. The
Univ. of Tokyo, Gifu Univ.
10:00 G37
306.19 Effects of recurrent hypoglycemia on
growth hormone releasing hormone (GHRH) neurons. M.
BAYNE*; A. ALVARSSON; S. A. STANLEY. Icahn Sch. of
Med. at Mount Sinai.
11:00 G38
306.20 Dynamics of lactate and glucose in
the extracellular compartment of the motor cortex during
running: Impact of intraperitoneal glucose, fructose,
and insulin. C. MESSIER*; A. BELAND; P. SHUKLA; J.
LARCHER. Univ. of Ottawa, Univ. of Ottawa.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 G40 306.22 Dorsal raphe nucleus: A locus for

energy homeostasis. B. FIELD*; A. NECTOW; Y. LIANG; J.
FRIEDMAN. Rockefeller Univ.
10:00 G41
306.23 Estradiol in the medial amygdala prevents
ovariectomized induced metabolic responses in female rats.
C. ESTRADA*; V. GHISAYS; E. T. NGUYEN; J. CALDWELL;
J. STREICHER; M. B. SOLOMON. Univ. of Cincinnati, Univ.
of Cincinnati, Univ. of Cincinnati.
11:00 G42
306.24 Genetically dissecting a hypothalamic
neural circuit controlling glucose homeostasis. C. S. LOW*;
X. YI; C. BARTOLOME; J. XU; P. WANG; D. KONG. Tufts
Univ.
8:00 G43 306.25 Physiological characterization of the
hypoxia tolerant heart and brain of the naked mole rat. D.
T. APPLEATE*; J. LARSON; T. PARK. Univ. of Illinois at
Chicago Dept. of Neurosurg., Univ. of Illinois at Chicago.

9:00 G44 306.26 Alternate fuels for the brain: Impact

of intraperitoneal glucose, fructose, galactose, lactate,
pyruvate, -hydroxybutyrate and insulin on glucose and
lactate levels in the brains antechamber. A. BELAND*; J.
COURTEMANCHE; J. LARCHER; T. YUAN; C. MESSIER.
Univ. of Ottawa, Univ. of Ottawa.
10:00 G45
306.27 Low glucose utilization and high lactate
production in the Alzheimers disease brain. R. J. MULLINS*;
D. REITER; D. KAPOGIANNIS. Natl. Inst. On Aging, Natl.
Inst. on Aging.
11:00 G46
306.28 Imaging cytosolic metabolites and pH
in mouse astrocytes. J. W. DEITMER*; J. SCHMLZLE;
T. WEBER; I. RUMINOT; S. M. THEPARAMBIL. Univ.
Kaiserslautern, CECs.
8:00 G47 306.29 Cell specific expression of amylase 1
and 2A in hippocampus of non demented elders and patients
with Alzheimerss disease. E. K. BYMAN*; N. H. SCHULZ; N.
BRAIN BANK; M. WENNSTRM. Lund Univ., Netherlands
Inst. for Neurosci.
9:00 G48 306.30 Role of DMH/DHA LepRb-expressing
neurons in temperature-dependent neuronal circuits.
M. FRANCOIS*; S. YU; E. QUALLS-CREEKMORE;
C. HUESING; C. MORRISON; H. BERTHOUD; H.
MUNZBERG. Pennington Biomed. Res. Ctr.

POSTER
307. Alzheimers Disease: In Vitro and In Vivo Therapeutics
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 G49 307.01 Allopregnanolone promotes neural stem
cell differentiation to neurons and oligodendrocyte precursor
cells. S. CHEN*; J. YAO; K. WONG; R. D. BRINTON. USC,
Univ. of Arizona.
9:00 G50 307.02 Allopregnanolone activates LXR and
PXR gene expression and signaling pathways regulating
neuroinflammation, apoptosis, A trafficking, and cholesterol
clearance: Implications for Alzheimers disease. R. W.
IRWIN*; H. M. SWANSON; R. D. BRINTON. USC, Univ. of
Arizona, Univ. of Arizona.
Neuroscience 2016|Monday AM|19

Mon. AM

11:00 G30
306.12 Weakened neurotrophic support and
aberrant levels of neurometabolites in the brain underlie
reduced lifespan of WNIN/Ob obese rats. J. K. SINHA*; S.
GHOSH; V. TIWARI; A. B. PATEL; M. RAGHUNATH. Natl.
Inst. of Nutr. (NIN), Ctr. for Cell. and Mol. Biol.

8:00 G39 306.21 PTG is a central regulator of glycogen

synthesis in astrocytes. I. ALLAMAN*; E. RUCHTI; P. J.
ROACH; A. A. DEPAOLI-ROACH; P. J. MAGISTRETTI.
EPFL/Brain Mind Inst., Ctr. de Neurosciences Psychiatriques
(CHUV), Indiana Univ. Sch. of Med., King Abdullah Univ. of
Sci. and Technol. (KAUST).

10:00 H1
307.03 Human iPSC-based biomarker strategy to
identify neuro-regenerative responders to allopregnanolone:
Proof of concept. C. M. SOLINSKY*; V. HENNES; J. A.
PARK; H. C. CHUI; M. BLURTON-JONES; J. K. ICHIDA; R.
D. BRINTON. USC, USC, Univ. of California Irvine, USC,
Univ. of Arizona.

11:00 H12
308.04 Progression of oligomer pathology
in cholinergic nucleus basalis neurons in mild cognitive
impairment and Alzheimers disease. C. T. TIERNAN*; E. J.
MUFSON; N. M. KANAAN; S. E. COUNTS. Michigan State
Univ., Barrow Neurolog. Inst., Michigan State Univ., Mercy
Hlth. St. Marys, Michigan State Univ.

11:00 H2
307.04 Increased number of neural stem cells in
the hippocampus correlates with maintenance of cognitive
integrity in non-demented individuals with Alzheimers
disease neuropathology. D. BRILEY*; O. ZOLOCHEVSKA;
R. WOLTJER; M. MICCI; G. TAGLIALATELA. Univ. of Texas
Med. Br. at Galveston, Oregon Hlth. and Sci. Univ.

8:00 H13 308.05 Volumetric assessment of brain areas

involved in executive function deficit in Alzheimers disease.
F. JUNG*; S. KAZEMIFAR; R. BARTHA; R. N. RAJAKUMAR.
Western Univ., Western Univ.

8:00 H3
307.05 D-Serine mediates adult neurogenesis in
mice. R. ROYCHAUDHURI*; S. H. SNYDER. Johns Hopkins
Sch. of Med.
9:00 H4
307.06 ProNGF/p75/sortilin: Potential targets to
recover neurogenesis in Alzheimers disease. C. FLEITAS
PREZ*; C. RAMPON; R. CURI; E. BERNAUS; J. EGEA;
C. ESPINET. Irblleida. Univ. of Lleida, Ctr. de Recherches
sur la Cognition Animale. Univ. Paul Sabatier.
10:00 H5
307.07 Neural stem cell transplantation increases
the neurogenesis in double transgenic mouse model of
Alzheimers disease. B. M. LONGO*; S. A. ROMARIZ; D. S.
PAIVA. UNIFESP, UNIFESP.
11:00 H6
307.08 The epigenetic regulation of h3k9me3
promotes neuronal survival and functions. L. TONG*; S.
SNIGDHA; C. W. COTMAN. UC Irvine, UC Irvine.

8:00 H7
307.09 Discovery of novel,neuroprotective
small molecules for the treatment of ER stress related to
Alzheimers disease. K. KRAJNAK*; F. WANG; R. DAHL.
Purdue Univ. Calumet, Neurodon.
9:00 H8
307.10 A genetically immortalized human stem
cell line: A promising new tool for Alzheimers disease
therapy. N. PUANGMALAI*; W. THANGNIPON; A. SOMANI;
C. BALLARD; M. BROADSTOCK. Mol. Biosci., Kings Col.
London, Wolfson Ctr. for Age-Related Dis.

POSTER
308. Neuropsychological, Biochemical and Imaging
Biomarkers of Alzheimers Disease and Other
Neurodegenerative Diseases
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 H9
308.01 Higher resting motor threshold associated
with better cognitive function in patients with mild Alzheimers
disease. P. J. FRIED*; A. JANNATI; P. DAVILA PEREZ; V.
M. CHEN; D. Z. PRESS; A. PASCUAL-LEONE. Beth Israel
Deaconess Med. Ctr.
9:00 H10 308.02 Blood-based biomarkers for staging of
Alzheimers disease. C. N. WINSTON*; E. J. GOETZL; J.
C. AKERS; B. S. CARTER; E. M. ROCKENSTEIN; D. R.
GALASKO; E. MASLIAH; R. A. RISSMAN. UC San Diego,
Univ. of California, San Francisco, UC San Diego, UC San
Diego.
10:00 H11
308.03 Semantic and episodic memory
impairments for faces in frontotemporal dementia and
Alzheimers disease. J. A. COLLINS*; B. C. DICKERSON.
Massachusetts Gen. Hosp., Dept. of Neurol., Harvard Med.
Sch.

20 | Society for Neuroscience

9:00 H14 308.06 Genome-wide expression and

methylation profiling in Medial Temporal Gyrus reveals
dysregulated genes with specific methylation associated with
Alzheimers disease. I. S. PIRAS*; Y. KONG; W. J. DANIEL;
J. KRATE; E. DELVAUX; J. NOLZ; D. MASTROENI; M.
SWAPNA; A. BLATTER; A. M. PERSICO; W. JEPSEN;
K. D. SIEGMUNG; T. D. BEACH; P. W. LAIRD; M. J.
HUENTELMAN; P. D. COLEMAN. TGEN- Neurogenomic
Div., USC, Univ. of Arizona Col. of Med., Arizona State
University-Banner Neurodegenerative Dis. Res. Ctr., Univ.
of California, Univ. of California, Univ. Campus Bio-Medico,
Banner Sun Hlth. Res. Inst., Van Andel Inst.
10:00 H15
308.07 Predicting Alzheimers disease risk with a
deep neural network model. K. NING*; B. CHEN; F. SUN; Z.
HOBEL; A. Alzheimers disease GENETIC CONSORTIUM;
A. W. TOGA. USC, Caltech, Alzheimers Dis. Genet.
Consortium.
11:00 H16
308.08 The preclinical pathology of Alzheimers
disease and its modulation by ApoE. O. PLETNIKOVA; G.
L. RUDOW; Y. KAGEYAMA; K. LACLAIR; D. R. FOWLER;
L. J. MARTIN; J. C. TRONCOSO*. Johns Hopkins Univ.,
Neuropathology, Office of the Chief Med. Examiner.
8:00 H17 308.09 Neuropsychological assessment of
semantic memory in Alzheimers and primary progressive
aphasia patients. J. FERRER*; V. PATIO-TORREALVA.
UAEM, Ctr. de Investigacin Transdisciplinar en Psicologa.
9:00 H18 308.10 Human brain isoprenoids and
Alzheimers disease. S. PELLEIEUX*; Y. S. TSANTRIZOS;
L. LAMARRE-THROUX; D. DEA; J. POIRIER. Douglas
Mental Hlth. Res. Inst., McGill Univ., Douglas Mental Hlth.
Univ. Institute, McGill, Psychiatry and medecine, McGill Univ.
and Douglas Mental Hlth. Univ. Inst.
10:00 H19
308.11 EEG oscillations during word processing
predict MCI conversion to Alzheimers disease. A.
MAZAHERI*; K. SEGAERT; J. YANG; Y. NIU; J. OLICHNEY;
K. SHAPIRO; H. BOWMAN. Univ. of Birmingham, Ctr. for
Mind and Brain, Univ. of California, Davis, MIND Institute,
UC Davis, Ctr. for Mind and Brain, Univ. of California, Davis.
11:00 H20
308.12 Integrity of the basal forebrain cholinergic
space and its relation to the hippocampus in Alzheimers
disease. J. L. REEP*; B. A. ARDEKANI; C. E. MYERS; L.
ZABORSZKY. Rutgers, The State Univ. of New JerseyNewark, Nathan S. Kline Inst. for Psychiatric Res., VA New
Jersey Hlth. Care Syst., Rutgers, The State Univ. of New
Jersey-Newark.
8:00 H21 308.13 Nia genetics of Alzheimers disease data
storage site (niagads): 2016 update. L. QU*; A. PARTCH;
P. GANGADHARAN; O. VALLADARES; M. CHILDRESS;
R. CWEIBEL; J. MALAMON; H. LIN; Y. ZHAO; E.
GREENFEST-ALLEN; C. J. STOECKERT JR.; A. NAJ; G.
SCHELLENBERG; L. WANG. Univ. of Pennsylvania, Univ. of
Pennsylvania.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 H22 308.14 Gender differences in Alzheimers

disease: Brain atrophy, gender differences in Alzheimers
disease: Brain atrophy, histopathology burden and cognition.
G. E. SERRANO; J. FILON; L. SUE; T. G. BEACH*. Banner
Sun Hlth. Res. Inst.
10:00 H23
308.15 Identifying genetic modifiers of
Alzheimers disease-relevant phenotypes. K. D. ONOS*; K.
J. KEEZER; C. J. ACKLIN; H. M. JACKSON; S. J. SUKOFF
RIZZO; M. SASNER; G. W. CARTER; E. J. CHESLER; B. T.
LAMB; G. R. HOWELL. The Jackson Lab., Tufts Univ., Univ.
of Maine, Indiana Univ. Sch. of Med.

11:00 H24
308.16 Evaluation of cGMP concentrations
in CSF as biomarker for PDE2A inhition in the dog brain.
H. BORGHYS*; P. BUIJNSTERS; D. DHUYVETTER; M.
SOMERS; R. VREEKEN. Janssen Res. & Develop.

POSTER

Theme C: Neurodegenerative Disorders and Injury

Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 H26 309.01 Frontal oscillations time-locked
to corrective sub-movements in Parkinsons disease:
Modulation by L-dopa. A. HAJIHOSSEINI*; C. GONZALEZ;
M. OISHI; M. J. MCKEOWN. Univ. of British Columbia, Univ.
of New Mexico.
9:00 I1
309.02 Movement related subthalamic
oscillatory neurons in patients with Parkinsons disease. P.
ZHUANG*; R. CHEN; M. HALLETT; Q. CUI; Y. ZHANG; J. LI;
Y. LI. Xuanwu Hosp, Capital Med. Uni, Krembil Res. Institute,
Univ. of Toronto, NINDS,NIH.
10:00 I2
309.03 Globus Pallidus internus low phaseamplitude coupling correlates with motor impairment
in Parkinsons disease. M. MALEKMOHAMMADI*; N.
AUYONG; N. POURATIAN. Univ. of California Los Angeles,
UCLA.

11:00 I3
309.04 Neural and motor responses to
temporally non-regular deep brain stimulation in Parkinsons
disease. B. D. SWAN*; D. BROCKER; C. OZA; D. TURNER;
W. GRILL. Duke Univ., Duke Univ. Med. Ctr.
8:00 I4
309.05 High resolution electrocorticography
in prefrontal cortex in Parkinsons disease patients. C.
DE HEMPTINNE*; W. CHEN; A. MILLER; C. RACINE; P.
STARR. Univ. of California San Francisco, UCSF.
9:00 I5
309.06 Sensorimotor coherence with highresolution electrocorticography in Parkinsons disease
patients. W. CHEN*; C. DE HEMPTINNE; N. ROWLAND;
P. A. STARR. Univ. of California San Francisco, Univ. of
Toronto.
10:00 I6
309.07 Resetting and saving of oscillatory
changes during motor practice in healthy subjects and in
Parkinsons disease. J. LIN; P. PANDAY; A. B. NELSON;
M. S. VENANZI; C. MOISELLO; A. DI ROCCO; M. F.
GHILARDI*. CUNY, Univ. of Milan, NYU Langone Med. Sch.
11:00 I7
309.08 Rapid prediction of movement states from
ongoing neural activity in Parkinsons disease. M. AHN*;
S. LEE; J. A. GUERIN; D. J. SEGAR; T. V. SANKHLA; W.
F. ASAAD. Brown Univ., Brown Univ., Brown Univ., Rhode
Island Hosp., Rhode Island Hosp.
Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 I10
309.11 Parkinsons disease outcomes of
implanting deep brain stimulation leads to the globus pallidus
internus while undergoing surgery under general anesthesia.
N. S. TIMONEY; J. E. QUINTERO*; J. H. SMITH; F. N.
MCCARRON; G. A. GERHARDT; C. G. VAN HORNE. Univ.
of Kentucky, Univ. Kentucky, Univ. of Kentucky, Univ. of
Kentucky.

309. Oscillatory Activity in Parkinsons Disease

9:00 I9
309.10 Effects of STN deep brain stimulation
on voice motor control in Parkinsons disease. R.
BEHROOZMAND*; P. HERATH; K. JOHARI; R. KELLEY; E.
KAPNOULA; K. BRYANT; N. NARAYANAN; J. GREENLEE.
Univ. of South Carolina, Univ. of South Carolina, Univ. of
Iowa.

11:00 I11
309.12 Feasibility of 1.5T fMRI BOLD activation
patterns for guiding deep brain stimulation targeting and
parameter selection demonstrated in a large-animal model.
T. A. JERDE; N. REINKING; M. KELLY; T. BILLSTROM; L.
LENTZ; R. S. RAIKE*. New York Unveristy, Medtronic Inc.
8:00 I12
309.13 A novel approach for measuring lightevoked neurotransmitter release. A. K. KONRADSSONGEUKEN*; T. VIERECKEL; G. SERRA; A. WALLNMACKENZIE. Uppsala Univ.
9:00 J1
309.14 Optogenetic stimulation parameter
settings and candidate electrophysiological features for
maximizing behavioral response. T. H. SANDERS*. Emory
Univ. Dept. of Biol.
10:00 J2
309.15 Development and implementation of a
large animal model for investigation of neurochemical activity
during behavior. J. TREVATHAN*; A. D. BATTON; E. N.
NICOLAI; K. H. LEE; J. L. LUJAN. Mayo Clin.
11:00 J3
309.16 Optogenetics stimulation of
entopeduncular input affects thalamic signaling and behavior
in -synuclein-induced hemiparkinson rat model. H. MOON*;
Y. PARK; B. OH; C. CHUL BUM; Y. LEE. Med. Neuroscience,
Col. of Med., Chungbuk Natl. Univ. Hosp., Neurosurgery, St.
Vincents Hosp., Radiology St. Marys Hosp.

POSTER
310. Parkinsons Disease: Cell and Circuit Mechanisms
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 J4
310.01 Evaluating mitochondrial biogenesis in
a cell model of Parkinson disease via mitochondrial DNA
replication in neuron cell bodies, axons, and dendrites.
V. S. VAN LAAR*; L. H. SANDERS; B. ARNOLD; E. H.
HOWLETT; J. T. GREENAMYRE; S. B. BERMAN. Univ. of
Pittsburgh, Univ. of Pittsburgh.
9:00 J5
310.02 Investigating molecular mechanisms
regulating mitochondrial quality control. K. BUSH*; A.
M. BUCKLEY; K. R. BARBER; M. WOODSON; M. B.
SHERMAN; Y. WAIRKAR. Univ. of Texas Med. Br., UTMB.

Neuroscience 2016|Monday AM|21

Mon. AM

8:00 H25 308.17 Eeg markers of leukoaraiosis in older

adults. N. B. LAM*; A. RAJAN; N. SCHWAB; R. LIU; M.
DING. Univ. of Florida.

8:00 I8
309.09 Differential effect of bicycling and walking
on subthalamic high-frequency oscillations in Parkinsons
disease. L. STORZER*; M. BUTZ; J. HIRSCHMANN; O.
ABBASI; M. GRATKOWSKI; D. SAUPE; J. VESPER;
A. SCHNITZLER; S. S. DALAL. Heinrich Heine Univ.
Duesseldorf, Radboud Univ., Ruhr-University Bochum,
Univ. of Konstanz, Univ. Hosp. Duesseldorf, Univ. Hosp.
Duesseldorf, Aarhus Univ., Univ. of Konstanz.

10:00 J6
310.03 Altered lysosomal stress markers
in idiopathic Parkinsons disease and following
pharmacological-induced lysosomal dysfunction via
glucocerebrosidase inhibition. E. B. MOLONEY; S. LEVY; J.
A. KORECKA; O. ISACSON; P. HALLETT*. Harvard Med.
Sch. / McLean Hos.

10:00 J18
310.15 Alterations of oscillatory activity in the
striatal-cortical circuit following repeated sub-anesthetic
ketamine administration in 6-OHDA-lesioned rats. T. YE*;
M. J. BARTLETT; M. B. SCHMIT; S. J. SHERMAN; T. FALK;
S. L. COWEN. Univ. of Arizona, Univ. of Arizona, Univ. of
Arizona, Univ. of Arizona, Univ. of Arizona, Univ. of Arizona.

11:00 J7
310.04 Prolyl Oligopeptidase (PREP), a novel
modulator of PI3K class III regulated autophagy pathway.
R. SVARCBAHS*; J. JAKOLA; T. MYHNEN. Univ. of
Helsinki.

11:00 K1
310.16 Initiation and propagation of action
potentials in the hyperdirect pathway during subthalamic
deep brain stimulation. R. W. ANDERSON*; B. HOWELL; K.
GUNALAN; C. C. MCINTYRE. Case Western Reserve Univ.

8:00 J8
310.05 Blockade of SK channels with the
scorpion venom peptide scyllatoxin protects midbrain
dopamine neurons from degeneration. P. P. MICHEL*; S.
HAMADAT; D. SERVENT; G. MOURIER; E. C. HIRSCH.
Brain and Spinal Cord Inst. (ICM), CEA, iBiTecS, Service
dIngnierie Molculaire des Protines.

8:00 K2
310.17 The relevant nuclei of Parkinsons
disease were elucidated by the quantitative activationinduced manganese-enhanced MRI in MPTP mouse model.
S. KIKUTA; Y. NAKAMURA; Y. YAMAMURA; Y. YANAGAWA;
N. HOMMA; H. TAMURA; J. KASAHARA; M. OSANAI*.
Tohoku Univ. Grad Sch. Med., JSPS Res. Fellow, Grad Sch.
Fac Pharmaceut. Sciences, Tokushima Univ., Gunma Univ.
Grad Sch. Med., Grad Sch. Biomed. Engineering, Tohoku
Univ.

9:00 J9
310.06 Receptor-mediated endocytosis 8 is
a new component of the protein homeostasis network
in mammalian cells. A. M. CLEMENT*; A. BESEMER; J.
MAUS; K. NALBACH; C. FREESE; C. VON HILCHEN; A.
KERN; C. BEHL. Univ. Med. Ctr. Mainz.
10:00 J10
310.07 The involvement of ASC in Parkinsons
disease: Beyond an adaptor protein. E. ALBORNOZ
BALMACEDA*; R. GORDON; A. B. ROBERTSON; K.
SCHRODER; M. A. COOPER; T. M. WOODRUFF. Univ. of
Queensland, The Univ. of Queensland.

11:00 J11
310.08 PKD1 activation positively regulates
PGC-1 transcriptional activity and protects against
dopaminergic neurodegeneration. M. AY; A. ASAITHAMBI;
D. HARISCHANDRA; A. KANTHASAMY; H. JIN; V.
ANANTHARAM; A. G. KANTHASAMY*. IOWA STATE
UNIVERSITY, Iowa State Univ.
8:00 J12 310.09 LRRK2-G2019S alters developing
synapse structure and function in dorsal striatum. B. A.
MATIKAINEN-ANKNEY*; N. KEZUNOVIC; G. W. HUNTLEY;
D. L. BENSON. Icahn Sch. of Med. At Mount Sinai, Icahn
Sch. of Med. At Mount Sinai.
9:00 J13 310.10 Implication of 8-oxodG-mediated
Transcriptional Mutagenesis in sporadic Parkinsons
disease. S. BASU*; S. GUHATHAKURTA; G. GOLDBLATT;
S. TATULIAN; S. DAS; E. BOK; G. JE; A. C. CRISTOVAO; Y.
KIM. Univ. of Central Florida, Univ. of Beira Interior.
10:00 J14
310.11 Alteration of cholinergic neuron activity in
the l-dopa induced dyskinesia mouse model. S. CHOI*; T. C.
MA; T. CHEUNG; Y. DING; D. SULZER; E. MOSHAROV; U.
J. KANG. Columbia Univ.
11:00 J15
310.12 Munc18-1 controls a-synuclein
self-replicating aggregation in early infantile epileptic
encephalopathy. Y. CHAI*; E. SIERECKI; V. M. TOMATIS;
R. S. GORMAL; N. ARIOTTI; N. GILES; D. XIA; R.
PARTON; B. M. COLLINS; Y. GAMBIN; F. A. MEUNIER.
The Univ. of Queensland, Clem Jones Ctr. for Ageing
Dementia Research, Queensland Brain Institute,The Univ.
of Queensland, Inst. for Mol. Bioscience, The Univ. of
Queensland, Single Molecule Sci. Centre, EMBL Australia,
The Univ. of New South Wales.
8:00 J16 310.13 Characterization of -synuclein-enriched
periglomerular cells in the olfactory bulb. K. TAGUCHI*; Y.
WATANABE; A. TSUJIMURA; M. TANAKA. Kyoto Prefectural
Univ. of Med., Kyoto Prefectural Univ. of Med.
9:00 J17 310.14 Transmission of -synucleinopathy from
olfactory structures deep into the temporal lobe. D. MASON*;
N. NOURAEI; J. HAN; D. PANT; K. MINER; K. LUK; J.
STOLZ; R. LEAK. Duquesne Univ., Duquesne Univ., Univ. of
Pennsylvania, Duquesne Univ.
22 | Society for Neuroscience

9:00 K3
310.18 Systems-level neurophysiological state
characteristics for drug evaluation in an animal model of
levodopa-induced dyskinesia. P. HALJE*; M. TAMTE; U.
RICHTER; I. BRYS; P. PETERSSON. Lund Univ.
10:00 K4
310.19 A computational model for the
progression of Parkinsons disease in the basal ganglia. M.
CAIOLA*; M. HOLMES. Rensselaer Polytechnic Inst.
11:00 K5
310.20 Development of an in vivo model of
basal ganglia pathway isolation for study of information
transmission. K. M. LAMBERT*; J. A. WHITE; A. D.
DORVAL. Univ. of Utah, Boston Univ.
8:00 K6
310.21 Neural basis for bradykinesia/akinesia in
Parkinsons disease: Causality of frequency oscillations.
C. BEHREND*; D. T. BROCKER; W. M. GRILL. Duke Univ.,
Duke Univ. Sch. of Med., Duke Univ. Med. Ctr.
9:00 K7
310.22 Evaluation of cardiovascular risk factors
in a rat model of Parkinsons disease. A. A. HAIDAR*;
L. F. OLIVEIRA; L. D. RODRIGUES; M. B. NEJM; P. P.
GHAZALE; H. B. FERRAZ; C. SCORZA; E. CAVALHEIRO;
L. R. BRITTO; F. SCORZA. Sao Paulo Federal Univ., Gois
Federal Univ., Sao Paulo Univ.
10:00 K8
310.23 Experimental reduction of nigrostriatal
dopamine similar to aging in substantia nigra, but not
striatum, reduces open-field locomotor activity. M. F.
SALVATORE*; T. MCINNIS; B. S. PRUETT; C. OWENS.
Univ. of North Texas Hlth. Sci. Ctr., Brown Univ., LSU Hlth.
Sci. Ctr.
11:00 K9
310.24 Functional connectivity in the corticobasal ganglia-thalamic circuit in rodent and primate models
of Parkinsons disease. P. PETERSSON*; U. RICHTER; M.
TAMTE; I. BRYS. Lund Univ.
8:00 K10 310.25 White matter and functional connectivity
changes in MPTP nonhuman primates (Cercopithecus
aethiops) model using fMRI and DTI. G. RAMREZ
GARCA*; C. CASTILLO-HERNNDEZ; J. FERNNDEZ
RUZ; A. LPEZ ORNELAS; I. ESCOBEDO AVILA; A.
CAMPOS ROMO. Univ. Nacional Autnoma de Mxico,
Consejo Nacional de Ciencia y Tecnologa, Inst. de
Neuroetologa, Lab. de Neuropsicologa, Dept. de Fisiologa,
Facultad de Medicina, Univ. Nacional Autnoma de Mxico,
Inst. de Fisiologa Celular, Univ. Nacional Autnoma de
Mxico, Univ. Nacional Autnoma de Mxico.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 K11 310.26 Limbic system and olfactory dysfunction

in drug naive patients with Parkinsons disease : A
connectometry study. N. HOSSEINI*; B. POURMENNATI;
F. RAHMANI; A. KAMALIAN; A. ANJOMSHOA; M.
DOLATSHAHI; M. AARABI. Students Scientific Res. Ctr.,
Tehran Univ. of Med. Sci., Basir Eye Hlth. Res. Ctr.

10:00 K12
310.27 Physical activity and resting state fMRI in
Parkinsons disease patients with mild cognitive impairment.
B. JARRAHI; G. PETZINGER*; L. HAWTHORNE; M.
GOMEZ; A. PETKUS; B. FISHER; V. FILOTEO; S.
MCEWEN. UCLA, USC, USC, USC, UCSD.
11:00 K13
310.28 Does impaired reaction time cause
rest tremor in Parkinsons disease? V. V. SHAH*; T.
HOMAYOUNI; S. GOYAL; H. PALANTHANDALAMMADAPUSI. Indian Inst. of Technol. Gandhinagar, Univ. of
California, Merced, Univ. of California Merced.

POSTER
311.

Movement Disorders
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 K15 311.01 Region-specific transcriptomics of SCA1

mouse models highlight biological pathways underlying
tissue vulnerability. T. DRIESSEN*; J. LIM. Yale Univ.
9:00 K16 311.02 Generation of a marmoset model of
spinocerebellar ataxia type 3 via AAV9 vector-mediated gene
transfer. A. KONNO*; Y. MATSUZAKI; H. HIRAI. Gunma
Univ.
10:00 K17
311.03 Analysis of glucose metabolism during
the pathogenesis of Spinocerebellar Ataxia Type 1. J.
DIAZ*; A. PEREZ; M. GALLEGO; Y. WAN; T. INOUE; A.
CHAI; M. MALETIC-SAVATIC; H. ORR; M. GABER; Z. LIU;
R. SAMACO; J. BOTAS. Baylor Col. of Med., Kings Col.
London, Univ. of Minnesota.
11:00 L1
311.04 Pathogenic polyglutamine expansion
length correlates with polarity of the flanking sequences. M.
KIM; I. BEZPROZVANNY. UT southwestern Med. Ctr.
8:00 L2
311.05 Upregulation of glial GLT1 glutamate
transporter corrects Purkinje cell dysfunction and
cerebellum-dependent motor incoordination in a mouse
model of myotonic dystrophy. M. GOMES-PEREIRA*; D.
M. DINCA; G. SICOT; S. O. BRAZ; A. LEROY; F. MEDJA;
A. HUGUET; A. NICOLE; N. GUERIBA; C. CHHUON; C.
PRIGOGINE; C. GUERRERA; G. CHERON; L. SERVAIS;
G. GOURDON. Imagine Inst., Universite Libre de Bruxelles,
Paris Descartes Univ., I-Motion Inst.
9:00 L3
311.06 Deficient nuclear export of polyglutamineexpanded androgen receptor contributes to toxicity in a cell
model of spinal and bulbar muscular atrophy. F. ARNOLD*;
D. MERRY. Thomas Jefferson Univ.
10:00 L4
311.07 TFEB and Hikeshi influence the
degradation of the disease-causative proteins in cellular
models of neurodegenerative diseases. H. ADACHI*; Z.
HUANG; K. OKADA; K. OHNARI; T. HASHIMOTO; T.
TOYOTA; Y. IWANAKA; R. KATSUMATA; G. SOBUE. Univ.
of Occup. and Envrn. Hlth., Nagoya Univ. Grad. Sch. of Med.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 L6
311.09 Expression of the novel polyglutamine
protein FAM171B in the developing and adult mouse brain.
A. K. SUDASINGHE; D. S. SHARLIN; G. M. GOELLNER*.
Minnesota State Univ- Mankato.
9:00 L7
311.10 Protein interaction networks in the
pathogenicity of spinal and bulbar muscular atrophy. A.
PLUCIENNIK*; T. BERGER; S. FINKBEINER; D. MERRY.
Thomas Jefferson Univ., Gladstone Inst. of Neurolog. Dis.
and the Univ. of California.
10:00 L8
311.11 Behavioral characterization of Zip14
knockout mice; a potential model of manganism. C. G.
JANUS*; S. JENKITKASEMWONG; H. KHAN; B. GIASSON;
M. KNUTSON. Univ. of Florida, Univ. of Florida, Univ. of
Florida.
11:00 L9
311.12 Cas9 lipid nanoparticles as an efficient
delivery tool for primary neural cultures. E. RAMSAY*; J.
SINGH; G. THARMARAJAH; R. DESOUZA; E. OUELLET;
A. THOMAS; S. GARG; T. LEAVER; A. WILD; A. WHITE; C.
HANSEN; J. TAYLOR. Precision Nanosystems Inc., Univ. of
British Columbia.
8:00 L10 311.13 Micro-RNA351 alleviates denervationinduced skeletal muscle astrophy by targeting tumor
necrosis factor receptor-associated factor 6. F. DING*; M.
SHEN; J. QIU; Q. CHENG; Q. HE. Nantong University,
China.
9:00 L11 311.14 Prominent phase-amplitude crossfrequency coupling between and oscillations underlies
motor-tic encoding in cerebro-basal ganglia-cerebellar
networks. T. NINOMIYA*; Y. NAGAI; T. SUHARA; T.
MINAMIMOTO; M. TAKADA; M. MATSUMOTO; M. ISODA;
K. W. MCCAIRN. Primate Res. Institute, Kyoto Univ., Natl.
Inst. of Radiological Sci., Univ. of Tsukuba, Kansai Med.
Univ.
10:00 L12
311.15 Combined malonic and methylmalonic
aciduria (CMAMMA) presenting as myelopathy in eighth
decade. D. NARENDRA*; N. ATASSI; K. LINDGREN; F.
EICHLER. MGH, NINDS Intramural Program.
11:00 L13
311.16 Dexmedetomidine decreased the spinal
motoneurons death in roots avulsion injury of the brachial
plexus via AC-cAMP-PKA pathway. X. XU*; G. YU; X.
CHEN; X. CHEN; J. LI; M. CAO; Y. TANG; L. LIU; R. AN; Z.
QIU; L. ZHOU. Zhongshan Sch. of Medicine, Sun Yat-Sen
Universi, the first affiliate hospital of Sun Yat-sen Univ., Sun
Yat-sen memorial hospital of Sun Yat-sen Univ., Sun Yat-sen
memorial hospital of Sun Yat-sen Univ., Zhongshan Sch.
of Medicine, Sun Yat-sen University, Zhongshan Sch. of
Medicine, Sun Yat-sen Univ., Guangdong Province Key Lab.
of Brain Function and Dis.

8:00 L14 311.17 Altered resting-state functional

connectivity in patients with essential tremor. A. E.
MORRIS*; S. A. NORRIS; A. Z. SNYDER; J. M. KOLLER; J.
W. MINK; J. S. PERLMUTTER. Univ. of Rochester Med. Ctr.,
Washington Univ. in St. Louis, Washington Univ. in St. Louis.
9:00 M1
311.18 Lack of ABCD1 primes microglia
for phagocytosis and axonal degeneration. Y. GONG*;
N. SASIDHARAN; P. MUSOLINO; J. EL KHOURY; F.
EICHLER. Massachusetts Gen. Hosp. Ctr. For Comparat,
Massachusettes Gen. hospital, Massachusetts Gen.
hospital, Massachusetts Gen. hispital.
Neuroscience 2016|Monday AM|23

Mon. AM

8:00 K14 310.29 Multivariate pattern analysis of fMRI

data reveals the discrete neural signature of target-specific
deep brain stimulation in the pigs. S. CHO*; P. TESTINI; M.
SETTELL; H. JO; H. MIN; K. H. LEE. Mayo Clin.

11:00 L5
311.08 Generation of transgenic marmoset line
with polyglutamine disease and behavioral phenotyping.
K. OWARI; N. NOGAMI; T. NAKATANI; M. KOIZUMI; H.
ISHIBASHI; Y. NAGAI; I. TOMIOKA; K. SEKI*. Natl.inst.
Neurosci., Tokyo Med. Univ., Osaka Univ. Grad. Sch. of
Med., Shinshu Univ.

10:00 M2
311.19 Extraction of motor spatial patterns in
children with movement disorders via joint decomposition of
brain and muscle activity. A. BARACHANT*; J. B. CARMEL;
K. M. FRIEL; A. M. GORDON; D. GUPTA. Burke Med. Res.
Inst., Weill cornell medical college, Cornell Univ., Blythedale
Childrens Hosp., Teachers College, Columbia Univ.
11:00 M3
311.20 Closing the loop in essential tremor
treatment: An adaptive approach to deep brain stimulation.
E. OPRI*; J. SHUTE; R. MOLINA; K. FOOTE; M. OKUN; A.
GUNDUZ. Univ. of Florida, Univ. of Florida, Univ. of Florida,
Univ. of Florida.
8:00 M4
311.21 Functional correlates of the therapeutic
and adverse effects evoked by thalamic stimulation for
essential tremor. H. JO*; W. S. GIBSON; P. TESTINI; S.
CHO; K. R. GORNY; J. P. FELMLEE; K. M. WELKER; B. T.
KLASSEN; H. MIN; K. H. LEE. Mayo Clin., Mayo Clin., Mayo
Clin.
9:00 M5
311.22 Evaluation of a wearable tremor
modulation device for patients with essential tremor based
on electrical peripheral nerve stimulation. J. KIM*; C. K.
PARNELL; T. WICHMANN; S. P. DEWEERTH. Georgia Inst.
of Technol., Georgia Inst. of Technol., Emory Univ.
10:00 M6
311.23 Modeling Progressive Supranuclear Palsy
by viral-mediated seeding in the cholinergic neurons of the
pedunculopontine. D. A. MACLAREN*; M. E. GRIFFIN; S. D.
CLARK. Univ. At Buffalo, State Univ. of New York, Univ. at
Buffalo, State Univ. of New York, Univ. at Buffalo, SUNY.
11:00 M7
311.24 Ligand for cell adhesion molecule
PTPRD: Illudalic acid derivatives inhibit recombinant PTPRD
phosphatase and are tolerated in vivo. G. R. UHL*; P. PAIK;
M. MARTINEZ; A. SULIMA; K. RICE. NMVAHCS, BRINM
and NIH/NIDA, NIDA-IRP NIH, NMVAHCS/BRINM, NIDAIRP, NIH, NIDA-IRP NIH.
8:00 M8
311.25 The role of ABCD1 in dorsal root ganglia
in adrenomyeloneuropathy. F. EICHLER*; R. KOK; Y. GONG;
N. SASIDHARAN. Massachusetts Gen. Hosptial | Harvard
Med. Sch.
9:00 M9
311.26 Harmaline-induced tremor in large
animals. J. LEE*; I. KIM; L. CHENG; S. CHANG. Mayo Clin.,
The affiliated hospital of Gingdao Univ.
10:00 M10
311.27 Psychoactive compounds induce
distinctive fine motor deficits and gait disturbance in mice.
T. HEIKKINEN*; T. BRAGGE; T. TURKIA; A. NURMI; R.
HODGSON. Charles River Discovery.
11:00 M11
311.28 Identifying cannabis strains for treatment
of epilepsy. G. M. LEWITUS*; P. BERMAN; K. FUTORAN; D.
MEIRI. Technion, Technion, Technion.
8:00 M12 311.29 Neural connectivity and cortical activation
in chronic tic disorders. K. TUNG*; M. MIYAKOSHI; S.
MAKEIG; S. CHANG; J. PIACENTINI; S. LOO. UCLA Semel
Inst., SCCN UCSD, UCLA Semel Inst.

POSTER
312. ALS
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 M13 312.01 Detailed genetic analysis of healthy
and diseased CSMN reveals molecular determinants
of vulnerability and progressive degeneration. L.
LABOISSONNIERE*; B. GENC; J. TRIMARCHI; P.
OZDINLER. Iowa State Univ., Northwestern Univ.
24 | Society for Neuroscience

9:00 M14 312.02 Altered ceramide generation in Charcot

Marie Tooth 2f. N. SCHWARTZ*; C. E. SENKAL; L. M.
OBEID. Stony Brook Univ., Northport VA Med. Ctr.

10:00 M15
312.03 ALS and artificial intelligence: IBM watson
suggests additional RNA binding proteins linked to ALS. R.
P. BOWSER*; E. ARGENTINIS; R. SATTLER; M. COLLINS;
A. BOEHRINGER; I. LORENZINI; P. FERRANTE; A.
LACOSTE; S. SPANGLER; N. BAKKAR. Barrow Neurolog.
Inst., IBM Watson Hlth., IBM Res.- Almaden.
11:00 M16
312.04 Abnormalities of the neuregulin and
ErbB4 receptor pathway in Amyotrophic Lateral Sclerosis.
M. HERRANDO-GRABULOSA*; B. GARCIA-LAREU;
R. MANCUSO; A. MARTINEZ-MURIANA; G. MODOLCABALLERO; A. BOSCH; X. NAVARRO. Univ. Autonoma
De Barcelona, Ctr. de Investigacin Biomdica en Red sobre
Enfermedades Neurodegenerativas (CIBERNED), Ctr. of
Animal Biotech. and Gene Therapy, Univ. Autonoma de
Barcelona, Ctr. for Biol. Sciences, Univ. of Southampton.
8:00 M17 312.05 MAPK signaling mediates
neurodegeneration in Spinal muscular atrophy. S. AHMAD*;
N. GENABAI; X. JIANG; K. BHATIA; L. GANGWANI. Texas
Tech. Univ. Hlth. Sci. Ctr.
9:00 M18 312.06 A novel Optineurin truncation mutation
identified in an adult onset consanguineous Palestinian
family with amyotrophic lateral sclerosis. M. DE MAJO*; M.
GOTKINE; C. WONG; S. TOPP; R. MICHAELSON-COHEN;
S. EPSZTEJN-LITMAN; R. EIGESS; A. NISHIMURA; B.
SMITH; C. SHAW. Kings Col. London Inst. of Psychiatry,
Psy, Hebrew Univeristy-Hadassah Med. Ctr., Med. Genet.
Inst. Shaare Zedek Med. Ctr., Med. Genet. Institute, Shaare
Zedek Med. Ctr.
10:00 N1
312.07 Disease specific changes in sirtuin 3
levels in a mouse model of amyotrophic lateral sclerosis
and Huntingtons disease. E. BARTH; H. BAYER; J.
HANSELMANN; P. WEYDT; K. LINDENBERG; A. WITTING*.
Ulm Univ., Univ. Ulm.
11:00 N2
312.08 Apical dendrite degeneration of Betz
cells, a new cellular pathology in ALS. P. OZDINLER*; B.
GENC; J. H. JARA; P. PAYTEL; R. ROOS; M. MESULAM;
C. GEULA; E. BIGIO. Northwestern Univ. Feinberg Sch. of
Med., Northwestern Univ., Univ. of Chicago Med. Ctr.
8:00 N3
312.09 SMN functions as a chaperone for the
assembly of mRNP transport complexes. P. G. DONLINASP*; C. FALLINI; M. E. MERRITT; H. C. PHAN; G. J.
BASSELL; W. ROSSOLL. Emory Univ. Sch. of Med., Emory
Univ. Sch. of Med., Emory Univ. Sch. of Med., Emory Univ.
Sch. of Med., Emory Univ. Sch. of Med.
9:00 N4
312.10 Adenovirus-induced TDP-43 and FUS
aggregates in cultured neuronal and glial cells demonstrated
by time-lapse imaging. K. WATABE*; T. ISHII; H. MISAWA.
Kyorin Univ. Fac. of Hlth. Sci., Keio Univ. Fac. of Pharm.
10:00 N5
312.11 Methylmercury exposure alters fluo-4
fluorescence in spinal cord slices of mice expressing the
human Cu2+/Zn2+ superoxide dismutase 1 (hSOD1) gene
mutation. J. M. BAILEY*; Y. YUAN; W. ATCHISON. Michigan
State Univ.
11:00 N6
312.12 Long-term systemic adipose-derived
stem cell-conditioned medium therapy in a mouse model
of amyotrophic lateral sclerosis. C. L. WALKER*; F. M.
KENNEDY; C. M. E. FRY; A. K. IYER; Y. DU; K. MARCH; K.
J. JONES. Indiana Univ. Sch. of Med., Indiana Univ. Sch. of
Med., Indiana Univ. Sch. of Med., Roudebush VA Med. Ctr.
8:00 N7
312.13 The functional role of AMPK activation in
amyotrophic lateral sclerosis. Y. CHERN*; Y. LIU; C. LEE; H.
PEI. Inst. Biomed Sci.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 N8
312.14 Bioenergetic characterization of
human iPSC-derived ALS astrocytes. C. KONRAD; K.
MCAVOY; D. TROTTI; A. ALMAD; N. MARAGAKIS; J.
PHAM; J. ROTHSTEIN; R. SATTLER; G. MANFREDI; H.
KAWAMATA*. Weill Cornell Med., Thomas Jefferson Univ.,
Johns Hopkins Univ., Johns Hopkins Univ., Barrow Neurolog.
Inst.
10:00 N9
312.15 Hud regulation of sod1 and fus mrnas
in sporadic ALS. M. DELLORCO; A. S. GARDINER; C.
CEREDA; N. PERRONE-BIZZOZERO*. Univ. of New Mexico
HSC, C. Mondino Natl. Inst. of Neurol. Foundation, IRCCS.
11:00 N10
312.16 Arginine-rich DPRs perturb
nucleocytoplasmic transport and RNA metabolism in the
pathogenesis of C9orf72 ALS and FTLD. S. BOEYNAEMS;
E. BOGAERT; P. VAN DAMME; W. ROBBERECHT; L. M.
VAN DEN BOSCH*. Lab. of Neurobiology, Vesalius Res.
Center, VIB, Leuven, Belgium.

9:00 N12 312.18 Pathology and functional implications of

the C9orf72 repeat expansion in ALS/FTD iPS astrocytes. J.
T. PHAM*; J. C. GRIMA; L. HAYES; X. TANG; W. ZHOU; S.
VIDENSKY; T. GENDRON; J. D. ROTHSTEIN. The Johns
Hopkins Sch. of Med., The Johns Hopkins Sch. of Med.,
Mayo Clin., Brain Sci. Inst.
10:00 N13
312.19 Elucidation of ALS mouse (sod1g93a)
locomotor transformation relative to a wt cohort: A lifetime,
longitudinal, speed-controlled analysis. R. J. BATKA*; M.
M. HAULCOMB; S. L. DICKINSON; V. M. SANDERS; K. J.
JONES. Indiana Univ. Sch. of Med., Richard L Roudebush
VAMC, Indiana Univ. Sch. of Publ. Hlth., The Ohio State
Univ. Col. of Med.

11:00 N14
312.20 Early and androgen-dependent loss
of neuromuscular transmission in two SBMA mouse
models. Y. XU*; M. KATSUNO; H. ADACHI; G. SOBUE; M.
BREEDLOVE; C. L. JORDAN. Michigan State Univ., Nagoya
Univ. Grad. Sch. of Med., Univ. of Occup. and Envrn. Hlth.
Sch. of Med.

POSTER
313. Neuromuscular Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 N15 313.01 Novel principle component analysis
(PCA) to assess gait in chronically exercised vs unexercised
mice shows both exacerbation and amelioration of the
underlying phenotype the MDX mouse model for Duchennes
muscular dystrophy (DMD). P. J. SWEENEY*; T. BRAGGE;
A. NURMI; T. HEIKKINEN; T. AHTONIEMI; J. PUOLIVLI; D.
J. WELLS. Charles River Dicovery Services, Royal Vet. Col.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 N17
313.03 Genetic rescue of spinal muscular
atrophy by zinc finger protein ZPR1. X. N. JIANG; S.
AHMAD; L. D. GANGWANI*. Texas Tech. Univ. Hlth. Sci. Ctr.
11:00 N18
313.04 Acetylcholine receptor fragmentation
is correlated with the extent of muscle fiber damage in a
mouse model of muscular dystrophy. R. MASSOPUST*; W.
J. THOMPSON. Texas A&M Univ.
8:00 O1
313.05 Postsynaptic participation in synapse
elimination at the developing neuromuscular junction. I. W.
SMITH*; W. J. THOMPSON. Inst. For Neurosci., Texas A&M
Univ.
9:00 O2
313.06 Interaction of age and myostatin in
neuromuscular function. D. TAVOIAN; W. D. ARNOLD; S.
DE LACALLE*. Ohio Univ., Ohio State Univ., Heritage Col. of
Osteo. Med.
10:00 O3
313.07 Mechanically patterned extracellular
matrix improves neuromuscular junction formation in vitro. C.
L. WEAVER*; A. VU; L. FIJANY; G. YEO; A. ENGLER. Univ.
of California San Diego.
11:00 O4
313.08 Assessment of TrkB receptor expression
and function at the neuromuscular junction and sciatic nerve
retrograde transport complexes in mice missing musclesynthesized BDNF. L. A. VANOSDOL; R. L. DANGREMOND;
A. M. VANDERPLOW; B. WILMOT; A. L. JUDKINS; E. N.
OTTEM*. Northern Michigan Univ., Northern Michigan Univ.
8:00 O5
313.09 Increased BDNF expression in muscle
slows disease in a mouse model of spinal bulbar muscular
atrophy. K. HALIEVSKI*; M. KATSUNO; H. ADACHI; G.
SOBUE; S. M. BREEDLOVE; C. L. JORDAN. Michigan State
Univ., Nagoya Univ. Grad. Sch. of Med., Univ. of Occup. and
Envrn. Hlth.
9:00 O6
313.10 Vital imaging of aging neuromuscular
junctions. R. HASTINGS*; W. J. THOMPSON. Texas A&M
Univ.
10:00 O7
313.11 Neuromuscular acetylcholine
receptor dynamics in dystrophic mice. S. HADDIX*; W. J.
THOMPSON. Texas A&M Univ., Texas A&M Univ.
11:00 O8
313.12 Androgen receptor p160 co-activators
in spinal and bulbar muscular atrophy. J. ZENCHAK*; J.
JOHANSEN. Central Michigan Univ., Central Michigan Univ.
8:00 O9
313.13 Deletion of pre-B-cell colony-enhancing
factor in neurons results in motor dysfunction and paralysis
of adult mice. X. WANG*; Q. ZHANG; R. BAO; N. ZHANG;
S. DING. Univ. of Missouri Columbia Dalton Cardiovasc.
Res. Ctr., Dalton Cardiovasc. Res. Ctr.
9:00 O10 313.14 Activation of Schwann cells in a rat model
of Critical Illness Myopathy. Y. LEE*; L. LARSSON; W. J.
THOMPSON. Texas A&M Univ., Karolinksa Institutet.

Neuroscience 2016|Monday AM|25

Mon. AM

8:00 N11 312.17 Analysis and comparison of WT and

mSOD1G93A immune-mediated neuroprotection mechanisms
in immunodeficient mice after facial nerve axotomy. D. O.
SETTER*; E. M. RUNGE; N. A. MESNARD-HOAGLIN;
M. M. HAULCOMB; R. J. BATKA; N. D. SCHARTZ; V.
M. SANDERS; K. J. JONES. Indiana Univ. Sch. of Med.,
Richard L. Roudebush VAMC, Loyola Univ. Med. Ctr.,
Edward Hines, Jr. VA Hosp., The Ohio State Univ. Col. of
Med.

9:00 N16 313.02 High field (11.7) MRI reflects cyclic

changes in muscle damage in chronically exercised vs
unexercised MDX model of Duchennes muscular dystrophy
and can be confirmed by novel fine motor kinematic
analysis in vivo. P. J. SWEENEY; A. SHATILLO; A. NURMI;
A. HARTIKAINEN; T. D. WOLINSKY*; K. LEHTIMKI;
T. AHTONIEMI; O. KONTKANEN; M. V. KOPANITSA;
J. PUOLIVLI; D. J. WELLS. Charles River Discovery
Services, Discovery from Charles River, Royal Vet. Col.

10:00 O11
313.15 Reduced corpus callosum and
somatosensory pathway function in a CCUG mouse model
of myotonic dystrophy type 2: An autofluorescence optical
imaging and electrophysiological study. G. CHEN*; R. E.
CARTER; J. D. CLEARY; J. M. MARGOLIS; Y. KANG; C.
M. CHAMBERLAIN; L. P. W. RANUM; T. J. EBNER. Univ.
of Minnesota, Univ. of Minnesota, Univ. of Florida, Univ. of
Minnesota.
11:00 O12
313.16 Zebrafish models to validate mutations
in CAPN1 causing hereditary spastic paraplegia. A.
LISSOUBA*; M. LIAO; P. DRAPEAU. CRCHUM, Univ. de
Montreal, Univ. de Montreal.

8:00 O13 313.17 Improved motor performance in spastic

cerebral palsy children after repetitive transcranial magnetic
stimulation. D. BHATIA*; B. L. RAJAK; M. GUPTA; S. PAUL;
A. MUKHERJEE; T. K. SINHA. North- Eastern Hill Univ.,
UDAAN-for the differently abled, Lajpat Nagar.
9:00 O14 313.18 Establishment of TDP-43 cryptic exon as
a new ante-mortem functional biomarker for Inclusion Body
Myositis. K. E. BRAUNSTEIN*; J. P. LING; T. E. LLOYD; P.
C. WONG. Johns Hopkins Sch. of Med., Johns Hopkins Sch.
of Med.
8:00 DP03 313.19 (Dynamic Poster) High-throughput
automated time-lapse imaging of neuron degeneration
within a live animal using robotic microscopy. J. LINSLEY*;
S. FINKBEINER. Gladstone Inst., Univ. of California, San
Francisco.
11:00 O15
313.20 Clinical investigation of manihot
esculentas cyanogenic glycosides induced neurological
conditions,treatments and the effect of Netfussion innovated
device on reducing chemical tuber food poisoning in Nigeria
and third world countries. A. EKWERIKE*; C. A. DIKEUKWU;
K. MUFORO; H. IGBONAGWAM; V. C. OSUOHA; R.
OKEA. Sci. Med. Res. Institute., Inst.Of Neurosci. and
BiomedicalResearch, American Acad. Of Primary Care Res.,
Calvary Life Care Hosp. / Tropical Pharmedic Clin. Res.
Center, Blessings Of The Lords Hosp., Calvary Life Care
Hosp. / Tropical Pharmedic Clin. Res. Center, Owerri, Imo,
Nigeria., Blessings Of The Lords Hospital, Dept.Of Human
Kinetics & Hlth. Education,Ebonyi State,University.
8:00 O16 313.21 Aggregation of the disease-causing
mutants of cysteine string protein- via Fe-S cluster binding.
N. NASERI*; B. ERGEL; Q. HUANG; R. HUANG; G. A.
PETSKO; M. SHARMA. Weill Cornell Med. Col., Cornell
Univ.
9:00 O17 313.22 Screening of dysferlinopathies by
whole blood flow cytometry. L. SANCHEZ-CHAPUL*;
M. DEL ANGEL MUOZ; L. RUANO-CALDERN; A. B.
LUNA-ANGULO; R. M; J. MAGAA; O. HERNNDEZHERNNDEZ; R. E. ESCOBAR-CEDILLO; A. LPEZMACAY; S. VARGAS. Inst. Nacional De Rehabilitacion,
Inst. Nacional de Rehabilitacion, Secretara de Salud del
Estado de Durango, Inst. Politecnico Nacional, Inst. Nacional
de Rehabilitacion, Inst. Nacional de Rehabilitacion, Inst.
Nacional de Neurologa y Neurociruga.
10:00 O18
313.23 Translational profiling of motor neurons in
two mouse models of Charcot-Marie-Tooth disease Type 2D.
E. L. SPAULDING*; R. W. BURGESS. The Jackson Lab.,
Grad. Sch. of Biomed. Sci. and Engineering, Univ. of Maine.
11:00 P1
313.24 Progranulin overexpression attenuates
TDP-43A315T mediated neurodegeneration. S. BEEL; S.
HERDEWYN; L. VAN DEN BOSCH; W. ROBBERECHT;
P. VAN DAMME*. Vesalius Res. Center, VIB, Neurol.
Department, UZ Leuven.

26 | Society for Neuroscience

8:00 P2
313.25 Decrease of rate dependent depression
of H-reflex in newborns with muscle hypertonia after
antenatal hypoxia-ischemia in rabbit cerebral palsy model.
A. DROBYSHEVSKY*; K. QUINLAN. Northshore Univ. Hlth.
Syst. Res. Inst., Northwestern Univ.
9:00 P3
313.26 Serotonin sensitivity of spinal motor
neurons from hypoxia-ischemia rabbit model of cerebral
palsy. K. A. QUINLAN*; A. DROBYSHEVSKY. Northwestern
Univ. Feinberg Sch. of Med., Northshore Univ. Hlth. Syst.

POSTER
314. Oxidative Stress and Cell Death
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 P4
314.01 Inositol polyphosphate multikinase is
a regulator of transsulfuration pathway. R. TYAGI*; S. H.
SNYDER; B. D. PAUL. Johns Hopkins Univ. Sch. of Med.
9:00 P5
314.02 Investigating the function of
TLDc proteins in the oxidative stress response and
neurodegeneration. P. L. OLIVER*; M. J. FINELLI; K. X. LIU;
Y. WU; K. E. DAVIES. Univ. of Oxford.
10:00 P6
314.03 N-Acetyl-L-Cysteine attenuates
Porphyromonas gingivalis-induced inflammatory response
and cell death in murine brain endothelial cells. V.
CHAROENSAENSUK*; K. OU; L. YANG. Taipei Med. Univ.,
Taipei Med. Univ., Taipei Med. Univ., China Med. Univ.
11:00 P7
314.04 Sevoflurane-induced changes in gene
expression in developing monkey brain. F. LIU*; T. A.
PATTERSON; M. G. PAULE; W. SLIKKER, Jr.; C. WANG.
Natl. Ctr. For Toxicological Research/FDA.
8:00 P8
314.05 Participation of MAPK signaling pathway
in a model of neuronal degeneration in rat striatal. R.
A. SANTANA MARTINEZ*; D. BARRERA OVIEDO; P.
D. MALDONADO JIMNEZ. Natl. Inst. of Neurol. and
Neurosurg., Facultad de Medicina.
9:00 P9
314.06 NADPH oxidase-2 and inflammasomes
after traumatic brain injury. M. W. MA*; J. WANG; K. M.
DHANDAPANI; D. W. BRANN. Med. Col. of GeorgiaAugusta Univ., Charlie Norwood VA Med. Ctr., Med. Col. of
Georgia- Augusta Univ.
10:00 P10
314.07 Effect of diferuloylmethane on egg-laying
behaviour in hydrogen peroxide-exposed Caenorhabditis
elegans. M. MENDOZA-MAGAA; M. MALDONADORUBIO; M. GALLEGOS-SAUCEDO; S. NERY-FLORES;
A. CASTILLO-ROMERO; M. RAMIREZ-HERRERA; G.
CAMARGO; L. HERNANDEZ*. CUCS-Universidad de
Guadalajara.
11:00 P11
314.08 Crispr/Cas9 knockout demonstrates a
key role for Bid as a molecular link between paradigms of
ferroptosis and mitochondrial death pathways in neuronal
cells. A. JELINEK*; S. NEITEMEIER; L. HOFFMANN; G.
GANJAM; C. CULMSEE. Philipps-University of Marburg.
8:00 P12 314.09 The pro-survival pathway of -1 receptorzinc finger protein 179 guards against hydrogen peroxideinduced cellular damage. T. SU*; P. LEE; S. YEH; T. HSIEH;
S. CHOU; J. HUNG; W. CHANG; Y. LEE; J. CHUANG. Natl.
Inst. On Drug Abuse, Natl. Hlth. Res. Inst., Taipei Med. Univ.,
Taipei Med. Univ., Natl. Cheng Kung Univ., Taipei Med. Univ.,
Taipei Med. Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 Q1
314.10 Evaluation of the Nrf2 activation in a
no canonical pathway. Participation of DPP3 protein. C.
A. SILVA*; P. D. MALDONADO. Natl. Inst. of Neurol. and
Neurosurg., Inst. Nacional de Neurologa y Neurociruga.
10:00 Q2
314.11 Manganese induced toxicity can
be attenuated by VIP in NE 4C cell line. T. DAGCI*; G.
ARMAGAN; S. BORA; A. ERDOGAN. Ege Univ. Sch. of
Med. Physiol. Dept., Ege Univ., Ege Univ.
11:00 Q3
314.12 Genetic loss of CYLD exerts
neuroprotective effects against RIP-1 mediated necroptosis
in vitro and after experimental traumatic brain injury. N. A.
TERPOLILLI*; G. K. GANJAM; S. DIEMERT; I. EISENBACH;
L. HOFFMANN; C. REUTHER; N. PLESNILA; C. CULMSEE.
Univ. of Munich, Dept. of Neurosurg., Univ. of Munich,
Philipps-Universitaet.
314.13 Effect

9:00 Q5
314.14 Pro-inflammatory and oxidative stress
mechanisms elicited by A in astrocytic/glial cells: Their
impact for the integrity of the neurovascular unit. A. A.
ROSTAGNO*; S. COCKLIN; J. GHISO. New York Univ. Sch.
of Med.

8:00 Q12 314.21 Regulation of mitochondrial oxidative

stress and protein aggregation in dopaminergic neuron
degeneration in Parkinsons disease. H. SHI*; K. PARK;
N. MILLER; J. R. MAZZULLI; Y. MA. Northwestern Univ.
Feinberg Sch. of Med., Northwestern Univ. Feinberg Sch. of
Med.
9:00 Q13 314.22 Neuron releases -synuclein during
hypoxia causes neuroinflammation and exacerbate
neurodegeneration through Mac1/NOX2 pathway. V. JAIN*;
S. B. SINGH. Defence Inst. of Physiol. and Allied Sci.,
Defence Inst. of Physiol. and Allied Sci.
10:00 Q14
314.23 Inhibition of palmitic acid-induced cell
death by blocking apoptosis, necroptosis and inducing
autophagy. M. L. MONTERO*; J. LIU; M. DE LEON. Loma
Linda Univ., Loma Linda Univ., Loma Linda Univ.
11:00 R1
314.24 Multiple sources contribute to
extracellular H2O2 dynamics in the striatum. S. PANDA*;
L. R. WILSON; A. C. SCHMIDT; L. A. SOMBERS. North
Carolina State Univ.

10:00 Q6
314.15 Anti-oxidant effects of Curcumin following
spinal cord injury in rats. Y. A. ABDULLAH; S. A. EL SAYED;
S. W. AZIZ; A. A. ABDELLATIF*. American Univ. in Cairo.

8:00 R2
314.25 Structure and function analysis of
epidermal fatty acid binding protein in nerve growth factordifferentiated PC12 cells. A. DURAN*; J. LIU; M. DELEON.
Loma Linda Univ., Loma Linda Univ.

11:00 Q7
314.16 An expanded palette of redox-sensitive
fluorescent proteins with enhanced sensitivity and
brightness. B. CAMPBELL*; C. LIU; G. PETSKO. Weill
Cornell Med. Col.

9:00 R3
314.26 Anti-inflammatory actions of heme
oxygenase mediated by binding and down- regulating nitric
oxide synthase. S. CHOWDHURY*; S. SNYDER. Johns
Hopkins Med. Inst., JHMI.

8:00 Q8
314.17 Effect of pyrophosphate thiamine
on the nerve conduction speed in patients with diabetic
polyneuropathy. I. IBARRA VALDOVINOS*; R. G.
RESENDIZ GUTIERREZ; B. UGALDE VILLANUEVA; J. C.
SOLIS SAINZ; P. GARCIA SOLIS; M. RAMOS GOMEZ; L.
S. GALLARDO VIDAL; H. L. HERNANDEZ-MONTIEL. Univ.
Autonoma De Queretaro, Univ. Autonoma De Queretaro,
Inst. Mexicano del Seguro Social.
9:00 Q9
314.18 Effect of an endogenous interferon
inducer and a promoter of energetic metabolism on the
viability of a islets of langerhans hepatic portal graft in a
murine model of type 1 diabetes mellitus: A new approach to
neurodegeneration? B. UGALDE VILLANUEVA*; I. IBARRA
VALDOVINOS; R. G. RESNDIZ GUTIRREZ; E. A.
LPEZ ARVIZU; M. D. ABURTO FERNNDEZ; M. RAMOS
GMEZ; H. L. HERNNDEZ MONTIEL. Univ. Autnoma De
Quertaro, Univ. Autnoma De Quertaro, Univ. Autnoma
De Quertaro.
10:00 Q10
314.19 Inflammation and oxidative stress risk
factors for neurodegenerative diseases in a population of
patients with metabolic syndrome from Queretaro, Mexico.
R. G. RESENDIZ GUTIERREZ*; B. UGALDE VILLANUEVA;
I. IBARRA VALDOVINOS; P. GARCA SOLS; M. RAMOS
GMEZ; L. S. GALLARDO VIDAL; H. L. HERNNDEZ
MONTIEL. Univ. Autonoma De Queretaro, Univ. Autnoma
De Quertaro, Univ. Autnoma De Quertaro, Inst. Mexicano
del Seguro Social, Univ. Autonoma De Quertaro.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
315. Neuroprotective Mechanisms: Alzheimers Disease and
Multiple Sclerosis
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 R4
315.01 Sleep deprivation aggravates brain
pathology in Alzheimers disease. Enhanced neuroprotection
with co-administration of nanowired 5-HT6 receptor
antagonist SB-399885 and cerebrolysin. A. SHARMA*; D. F.
MURESANU; J. V. LAFUENTE; A. NOZARI; A. OZKIZILCIK;
R. TIAN; R. PATNAIK; H. MOESSLER; H. S. SHARMA.
Uppsala Univ., Univ. of Med. & Pharm., Univ. of Basque
Countries, Massachusetts Gen. Hospital, Harvard Med.
Sch., Univ. of Arkansas, Univ. of Arkansas, Indian Inst. of
Technology, Banaras Hindu Univ., Ever Neuro Pharma,
Uppsala Univ. Hosp.
9:00 R5
315.02 Nanowired cerebrolysin potentiates
neuroprotective effects of histamine H3 receptor inverse
agonist and antagonist with partial H4 agonist in Alzheimers
disease. R. PATNAIK*; A. SHARMA; D. F. MURESANU;
S. D. SKAPER; R. J. CASTELLANI; A. NOZARI; A.
OZKIZILCIK; R. TIAN; J. V. LAFUENTE; H. MOESSLER;
H. S. SHARMA. Indian Inst. of Technology,Banaras Hindu
Univ., Uppsala Univ. Hosp., Univ. of Med. & Pharm., Univ.
of Padova, Univ. of Maryland Hosp., Massachusetts Gen.
Hospital, Harvard Med. Sch., Univ. of Arkansas, Univ. of
Arkansas, Univ. of Basque Country, Ever Neuro Pharma.
Neuroscience 2016|Monday AM|27

Mon. AM

8:00 Q4
of copper on the activity of
kynurenine pathway enzymes in rat cortex slices. D.
RAMREZ ORTEGA*; I. I. LUNA PRIETO; D. F. GONZALEZ
ESQUIVEL; B. PINEDA; C. RIOS; V. PEREZ DE LA CRUZ.
Inst. Nacional De Neurologa y Neurociruga Manuel
Velasco, Inst. Nacional De Neurologa y Neurociruga
Manuel Velasco, Inst. Nacional De Neurologa y
Neurociruga Manuel Velasco.

11:00 Q11
314.20 Quinolinic acid toxicity involves
mitochondrial dysfunction as an independent manner of
NMDA receptor activation in astrocytes primary cultures.
J. G. REYES OCAMPO*; A. SALAZAR-RAMIRO; D.
GONZLEZ-ESQUIVEL; B. PINEDA; C. RIOS; V. PREZDE LA CRUZ. Inst. Nacional de Neurologa y Neurociruga,
Inst. Nacional de Neurologa y Neurociruga, Inst. Nacional
de Neurologa y Neurociruga.

10:00 R6
315.03 Impact of cellular stress produced
by acidic pH and growth factor withdrawal on neuronal
differentiation of human hippocampal neural precursor
cells (hHippNPCs): Implications in neurodegenerative
diseases. M. CARDENAS-AGUAYO*; L. GOMEZVIRGILIO; G. LOPEZ-TOLEDO; U. GARCIA. UNAM, Sch.
of Medicine, Natl. Autonomous Univ. of Mexico, Ctr. for
Res. and Advanced Studies of the Natl. Polytechnic Inst.
(CINVESTAV-IPN), Ctr. for Res. and Advanced Studies of
the Natl. Polytechnic Inst. (CINVESTAV-IPN).
11:00 R7
315.04 Prion protein suppresses seizure-induced
c-fos expression, a marker for neural activity in zebrafish.
R. KANYO*; P. L. A. LEIGHTON; W. T. ALLISON. Univ. of
Alberta.
8:00 R8
315.05 Neuroprotection against Alzheimers
disease-related amyloid- toxicity: -1 receptor modulation
of VDAC-1 channels. C. FERNNDEZ ECHEVARRA*; T.
MEDIAVILLA; D. MARCELLINO. Ume Univ.
9:00 R9
315.06 Neuroprotection by a N-terminal fragment
and hexapeptide core sequence of amyloid. N. ALFULAIJ*.
Univ. of Hawaii at Manoa Dept. of Biol.
10:00 R10
315.07 Extensive axonal damage is observed in
Gas6-/-Axl-/- double-knockout (DKO) mice following exposure
to cuprizone. B. SHAFIT-ZAGARDO*; A. RAY; R. C.
GRUBER; J. WILLIAMSON; J. DUBOIS. Albert Einstein Col.
Med., Albert Einstein Col. Med.
11:00 R11
315.08 In vivo tracking confirms dendritic
cell exosomes enter the brain and may travel along CSF
pathways. A. D. PUSIC*; D. DUKALA; R. P. KRAIG. Univ. of
Chicago.
8:00 R12 315.09 Delayed treatment of 7,
8-Dihydroxyflavone protects axonal injury and demyelination
in an animal model of Multiple Sclerosis. T. K. MAKAR; V.
NIMMAGADDA; P. R. GUDA; D. TRISLER*; C. T. BEVER,
Jr. Univ. Maryland Sch. Med., VA Med. Ctr., VA Multiple
Sclerosis Ctr. of Excellence East.
9:00 R13 315.10 Neuronal hemoglobin expression and
its relevance to multiple sclerosis neuropathology. K.
ALKHAYER*; N. K. SINGHAL; J. MCDONOUGH. Kent State
Univ.
10:00 R14
315.11 Estriol preserves axonal integrity
and cortical volume in experimental autoimmune
encephalomyelitis. C. E. MEYER*; H. JOHNSONBAUGH; S.
LEPORE; N. ITO; R. VOSKUHL; A. MACKENZIE-GRAHAM.
UCLA, UCLA.

11:00 R15
315.12 Sensitivity of mri measures to axonal
and/or myelin repair in the presence of inflammation: A
quantitative assessment of in vivo mtr, dti, and post-mortem
immunohistochemistry in a rodent model of spontaneous
remyelination. B. A. HOOKER*; R. RAJAGOVINDAN; M. J.
VOORBACH; C. H. SCHROEDER; J. D. BEAVER. AbbVie.

POSTER
316. Neuroprotective Mechanisms: Brain or Spinal Cord
Injury
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 R17 316.01 Concussive head injury at simulated
high altitude exacerbates blood-brain barrier breakdown,
edema formation and cellular injury. Neuroprotection by
nanowired delivery of cerebrolysin with mesenchymal stem
cells. H. S. SHARMA*; D. F. MURESANU; J. V. LAFUENTE;
A. OZKIZILCIK; Z. R. TIAN; A. NOZARI; R. PATNAIK; H.
MOESSLER; A. SHARMA. Uppsala Univ., Univ. of Med.
& Pharm., Univ. of Basque Country, Univ. of Arkansas
Fayetteville, Univ. of Arkansas Fayetteville, Massachusetts
Gen. Hosp., Indian Inst. of Technology, Banaras Hindu Univ.,
Ever Neuro Pharma, Uppsala Univ. Hosp.
9:00 S1
316.02 Nicotine exacerbates closed head injury
induced brain pathology at hot environment. S. SHARMA*;
D. F. MURESANU; J. V. LAFUENTE; A. NOZARI; Z. TIAN;
R. PATNAIK; H. S. SHARMA; A. SHARMA. Uppsala Univ.,
Univ. Hosp. Med. & Pharm., Univ. of Basque Countries,
Massachusetts Gen. Hospital, Harvard Med. Sch., Univ. of
Arkansas, Indian Inst. of Technology, Banaras Hindu Univ.,
Uppsala Univ. Hosp.
10:00 S2
316.03 Focal blast brain injury induces rapid
edema formation, blood-brain barrier breakdown and
intensive cellular damage. Neuroprotective effects of a
multimodal drug cerebrolysin. D. F. MURESANU*; A.
SHARMA; L. FENG; J. V. LAFUENTE; A. NOZARI; A.
OZKIZILCIK; R. TIAN; R. PATNAIK; H. MOESSLER; H. S.
SHARMA. THE FOUNDATION OF THE SOCIETY FOR
THE STUDY OF NEU, RoNeuro Inst. for Neurolog. Res.
and Diagnostic, Uppsala Univ. Hosp., Bethune Intl. Peace
Army Hosp., Univ. of Basque Country, Massachusetts Gen.
Hospital, Harvard Med. Sch., Univ. of Arkansas, Univ. of
Arkansas, Indian Inst. of Technology, Banaras Hindu Univ.,
Ever Neuro Pharma.
11:00 S3
316.04 Concussive head injury induced brain
ischemia and oxidative stress are thwarted by nanodelivery
of Chinese traditional medicine DL-3-n-butylphthalide
(DL-NBP). L. FENG*; A. SHARMA; A. NOZARI; D. F.
MURESANU; J. V. LAFUENTE; A. OZKIZILCIK; R. TIAN;
H. S. SHARMA. Bethune Intl. Peace Hosp., Uppsala Univ.
Hosp., Massachusetts Gen. Hospital, Harvard Med. Sch.,
Univ. of Med. & Pharm., Univ. of Basque Country, Univ. of
Arkansas, Univ. of Arkansas.
8:00 S4
316.05 Treatment with Nrf2 and p53 transcription
factor modulators in an in vitro mild TBI model. W. A.
RATLIFF*; J. N. CHANG; N. H. GREIG; B. A. CITRON. Bay
Pines VA Healthcare Syst., Univ. of South Florida Morsani
Col. of Med., Natl. Inst. on Aging, NIH.

8:00 R16 315.13 Delayed treatment of experimental

autoimmune encephalomyelitis with glibenclamide
promotes M2 polarization of macrophages and reduces
neuroinflammation. T. K. MAKAR*; V. GERZANICH; V.
NIMMAGADDA; P. R. GUDA; A. B. MORRIS; D. TRISLER;
C. T. BEVER, Jr; M. SIMARD. Univ. of Maryland Baltimore,
VA Med. Ctr., VA Multiple Sclerosis Ctr. of Excellence East,
Univ. of Maryland Sch. of Med.

9:00 S5
316.06 Co-administration of nanowired
mesenchymal stem cells with antioxidant H-290/51
ameliorates exacerbation of spinal cord pathology following
trauma in hypertensive rats. A. NOZARI*; A. SHARMA; L.
FENG; P. SJOQUIST; D. F. MURESANU; J. V. LAFUENTE;
R. PATNAIK; A. OZKIZILCIK; R. TIAN; H. S. SHARMA.
Massachusetts Gen. Hosp., Uppsala Univ. Hosp., Bethune
Intl. Peace Army Hosp., Karolinska Institute, Karolinska Univ.
Hosp., Univ. of Med. & Pharm., Univ. of Basque Country,
Indian Inst. of Technology, Banaras Hindu Univ., Univ. of
Arkansas, Univ. of Arkansas.

28 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 S6
316.07 Differential changes of protein expression
on heat shock proteins in a rat model of contusive spinal
cord injury. K. YANG; K. LEE; Y. KIM; S. HAHM; Y. YOON; J.
KIM*. Korea Univ. Grad. Sch., Korea Univ. Grad. Sch., Korea
Univ. Col. Med., Korea Univ. Col. Hlth. Sci.
11:00 S7
316.08 The neuroprotective role of peroxisome
proliferator activated receptor- (PPAR-) after spinal cord
injury in rats. Y. KIM; J. OH; J. KIM; Y. W. YOON*. Korea
Univ. Col. Med., Korea Univ. Grad. Sch., Korea Univ. Grad.
Sch., Korea Univ. Col. Hlth. Sci.
8:00 S8
316.09 Role of miR 711 in neuronal cell death
after spinal cord injury. J. WU*; B. SABIRZHANOV; B. A.
STOICA; J. MATYAS; M. COLL-MIRO; L. YU; A. I. FADEN.
Univ. of Maryland, Sch. of Med.

10:00 S10
316.11 Neuroprotective properties of BK
channel modulators in an acute spinal cord injury model. M.
JACOBSEN; J. BARDEN; K. LETT; M. KARNITSKY; J. A.
BUTTIGIEG*. Univ. of Regina.
11:00 S11
316.12 Omega three fatty acids and cooling
mitigate altered structural properties of cortical neurons
following mechanical injury. P. CINTORA*; Y. J. LEE; C.
BEST-POPESCU. Univ. of Illinois At Urbana Champaign,
Univ. of Illinois At Urbana Champaign.
8:00 S12 316.13 Repeated topical application of Acure
compound AP-173 enhances neuroprotective efficacy and
early functional recovery following spinal cord trauma. A
comparative study using systemic dexamethasone treatment
in the rat. A. K. PANDEY*; A. SHARMA; T. LUNDSTEDT; E.
SEIFERT; A. NOZARI; D. F. MURESANU; J. V. LAFUENTE;
R. PATNAIK; H. S. SHARMA. Senior Res. Fellow, IIT-BHU,
Uppsala Univ. Hosp., Acure Pharma, Massachusetts Gen.
Hospital, Harvard Med. Sch., Univ. of Med. & Pharm., Univ.
of Basque Country, Indian Inst. of Technology, Banaras
Hindu Univ.

POSTER
317. Neuroprotective Mechanisms: Signaling and Gene
Expression
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 S13 317.01 Protective effect of the L-type calcium
channel on the survival of rat cortical cells. T. TAKADERA*;
N. OKUMURA. Hokuriku Univ., Fukui Univ.
9:00 S14 317.02 Antidepressants protect mouse HT22
hippocampal cells from apoptosis through activation of the
lysophosphatidic acid receptor LPA1. M. C. OLIANAS*; S.
DEDONI; P. ONALI. Univ. of Cagliari.
10:00 T1
317.03 Arundic acid increases the expression
and function of human excitatory amino acid transporter 1
(EAAT1) via ERK, Akt and NF-B pathways. P. KARKI; E. Y.
LEE*. Meharry Med. Col.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 T3
317.05 Androgen receptor-independent
mechanisms for dihydrotestosterone protection in rodent
astrocytes. N. K. KUBELKA*; N. RYBALCHENKO; M.
SINGH. Univ. of North Texas Hlth. Sci. Ctr.

9:00 T4
317.06 Knock-down of targets in the rat CNS
using Antisense Oligonucleotides: Kinetics of distribution and
pharmacodynamics in the CNS after an intrathecal dose.
F. KAMME*; B. POWERS; C. MAZUR; D. A. WOLF; J. M.
SULLIVAN; D. A. NORRIS; A. VERMA; E. SWAYZE. Ionis
Pharmaceuticals Inc, Ionis Pharmaceuticals, Biogen Inc.,
inviCRO LLC.
10:00 T5
317.07 The dysfunction of glutamate transporters
on the endothelial cells induced by A2AR decreases
intracranial glutamate efflux across the blood brain barrier.
W. BAI*; N. YANG; X. CHEN; Y. NING; P. LI; Y. PENG;
R. XIONG; Y. ZHAO; Y. ZHOU. Res. Inst. of Surgery and
Daping Hosp.
11:00 T6
317.08 N-docosahexaenoylethanolamine
enables robust optic nerve regeneration after injury. H.
KWON*; H. KIM. NIAAA/National Instiutes of Hlth.

8:00 T7
317.09 Efficient protein-based genome
editing by local delivery in the brain. B. T. STAAHL*; M.
BENEKAREDDY; C. COULON-BAINIER; A. GHOSH; J.
A. DOUDNA. Univ. of California, Berkeley, F. HoffmannLa Roche Pharma Res. and Early Develop., E-Scape Bio,
Univ. of California, Berkeley, Howard Hughes Med. Inst.,
Innovative Genomics Initiative, Physical Biosci. Division,
Lawrence Berkeley Natl. Lab., Univ. of California, Berkeley.
9:00 T8
317.10 Inhibition of Cdc42 signaling enhances
the sensitivity of cerebellar granule neurons to intrinsic
apoptosis. N. PUNESSEN*; A. NGUYEN; D. A. LINSEMAN.
Univ. of Denver.
10:00 T9
317.11 Identification of proteins that bind to
LDL Receptor-related Protein-1 (LRP1) in Schwann cells
and activate c-Jun in vitro and in vivo. A. FLTSCH*; A.
GILDER; K. HENRY; E. MANTUANO; S. L. GONIAS; W. M.
CAMPANA. UCSD, UCSD.
11:00 T10
317.12 Immunohistochemistry of selected gene
candidates following early life exposure of NMDA and
glutamate to hippocampal neurons reveals diversity. L. K.
FRIEDMAN*; A. SLOMKO. New York Med. Col., New York
Med. Col.
8:00 T11 317.13 The importance of expression of nur
family genes on neurite outgrowth through the effect of p300
and histone modification. K. SHIMOKE*; R. YAMAZOE; Y.
NISHIHATA; H. MARUOKA. Kanasai Univ., KURABO.
9:00 T12 317.14 Investigation of intracellular signaling
and non-coding RNA underlying microglial polarity Induced
by neuronal damage. S. YACKLEY; C. MEYER; E.
WHITEFORD; M. TAPPATA; A. SHIBATA*. Creighton Univ.,
Creighton Univ.
10:00 T13
317.15 Drugs that affect dna methylation
modulate neuritogenesis in sh-sy5y cells. R. A.
CANTELMO*; A. C. SANTOS; N. A. G. SANTOS; S. R. L.
JOCA. Sch. of Pharmaceut. Sci. of Ribeiro Pret, Sch. of
Pharmaceut. Sci. of Ribeiro Preto, Sch. of Pharmaceut. Sci.
of Ribeiro Preto.

Neuroscience 2016|Monday AM|29

Mon. AM

9:00 S9
316.10 The kruppel like factor gene target dusp
14 regulates axon growth and regeneration. J. GALVAO*;
K. IWAO; A. APARA; Y. WANG; M. ASHOURI; T. N. SHAH;
D. L. MOORE; M. BLACKMORE; N. J. KUNZEVITZKY; J. L.
GOLDBERG. Stanford Univ., Kumamoto Univ., Shiley Eye
Ctr., Bascom Palmer Eye Inst., Marquette Univ., Byers Eye
Inst.

11:00 T2
317.04 Paraoxon effects in hippocampal explants
and adult rats: Synaptotoxicity and protection through an
endocannabinoid enhancement avenue. S. MCEWAN; K. L.
G. FARIZATTO; H. W. ROMINE; M. F. ALMEIDA; C. LONG;
C. MUNDELL; A. BYRD; V. NAIDOO; V. SHUKLA; S. NIKAS;
A. MAKRIYANNIS; B. A. BAHR*. Biotech Ctr. / William C.
Friday Lab., Univ. of Cape Town, Northeastern Univ.

11:00 T14
317.16 Pathological stimuli-induced HDAC1
nuclear export is dependent on calcineurin-mediated
dephosporylation. Y. ZHU*; O. G. VIDAURRE; K. P. ADULA;
N. KEZUNOVIC; G. HUNTLEY; P. CASACCIA. Icahn school
of Med. at Mount Sinai.

POSTER
318. Neuroinflammation
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 T15 318.01 A time course analysis of focused
ultrasound mediated glial activation and neuronal stress
responses. J. SILBURT*; K. MARKHAM-COULTES; M.
A. OREILLY; K. HYNYNEN; I. AUBERT. Univ. of Toronto,
Sunnybrook Res. Inst., Sunnybrook Res. Inst., Univ. of
Toronto.
9:00 T16 318.02 Proteomic analysis of focused
ultrasound-induced blood-brain barrier permeability. M.
LYNCH*; M. KAWAJA; J. SILBURT; S. HEINEN; I. AUBERT;
M. OREILLY; K. HYNYNEN. Sunnybrook Res. Inst., Univ.
of Toronto, Queens Univ., Sunnybrook Res. Inst., Univ. of
Toronto.
10:00 T17
318.03 Induction of osteopontin expression in
3-nitropropionic acid-induced neurotoxicity in rats: Potential
involvement in striatal neuronal death. T. RIEW*; Y. SHIN; X.
JIN; J. CHOI; M. LEE. Dept. of Anatomy, Col. of Medicine,
The Catholic Univ. of Korea, Catholic Neurosci. Institute, The
Catholic Univ. of Korea, Dept. of Anatomy, Catholic Neurosci.
Institute, Col. of Medicine, The Catholic Univ. of Korea.
11:00 T18
318.04 Preventing oxidative neurodegeneration
after traumatic brain injury followed by secondary smoke
exposure. B. A. CITRON*; W. A. RATLIFF; K. L. KEELEY;
C. G. PICK; M. OKUKA; J. C. M. TSIBRIS; R. F. MERVIS; J.
N. CHANG. Bay Pines VA Healthcare Syst., Univ. of South
Florida Morsani Col. of Med., Sackler Sch. of Medicine,
Tel Aviv Univ., Univ. of South Florida Morsani Col. of Med.,
4NeuroStructural Res. Laboratories, Inc., Univ. of South
Florida Morsani Col. of Med.
8:00 U1
318.05 Endothelial cell responses in the
hippocampus and cerebellum after irradiation to the young
mouse brain. M. BOSTRM*; M. KALM; C. BULL; N.
HELLSTRM ERKENSTAM; K. BLOMGREN. Univ. of
Gothenburg, Univ. of Gothenburg, Univ. of Gothenburg,
Karolinska Institutet.
8:00 DP04 318.06 (Dynamic Poster) Imaging
neurodegenerative and glial pathology at single-cell
resolution using AAV mediated conditional genetics: A proof
of principle in focal cerebral ischemia. M. EL-SAADI*; X.
TIAN; L. RIVERS; H. SUN; X. LU. Lsuhsc-Shreveport,
Lsuhsc-Shreveport.
10:00 U2
318.07 The role of ER stress in Neuropathy
Target Esterase-associated disorders. E. SUNDERHAUS*;
D. KRETZSCHMAR. Oregon Hlth. and Sci. Univ., Oregon
Hlth. and Sci. Univ.
11:00 U3
318.08 Mutation of histidine 547 of human
dopamine transporter increases dopamine uptake and
attenuates HIV-1 Tat-induced inhibition of dopamine
transport. J. ZHU*; P. QUIZON; W. SUN; Y. YUAN; N. M.
MIDDE; C. ZHAN. South Carolina Col. of Pharmacy, Univ.
of South Carolina, Univ. of South Carolina, Univ. o South
Carolina, Univ. of Kentucky.

30 | Society for Neuroscience

8:00 U4
318.09 Genetic ablation of Trpm2 accelerates
protein and lipid aggregation in the brain by impaired
autophagic clearance. B. LEE*; J. JUNG; J. LEE; H. KIM; G.
HONG; J. WEE; H. LU; U. OH. Seoul Natl. Univ.
9:00 U5
318.10 Modulating the lysosomal gene
network to identify new therapeutic opportunities for
neurodegenerative disorders. V. BOUCHE*; A. PEREZ
ESPINOSA; D. MEDINA; L. LEONE; M. SARDIELLO; A.
BALLABIO; J. BOTAS. Baylor Col. of Med.- Neurolog.
Res., Telethon Inst. of Genet. and Med. (TIGEM), Inst. of
Bimolecular Chemistry, Consiglio Nazionale delle Ricerche.
10:00 U6
318.11 Effect of nitric oxide synthase inhibitors
on methamphetamine-induced hyperthermia and
dopaminergic neurotoxicity in mice. A. S. DARVESH*; W. J.
GELDENHUYS; M. M. HOSSAIN; P. SADANA; A. J. PRUS;
S. P. BERGER; J. R. RICHARDSON. Northeast Ohio Med.
Univ. (NEOMED), West Virginia Univ., Northern Michigan
Univ., Portland Veterans Affairs Med. Ctr.
11:00 U7
318.12 Impact of stressors on lambda-cyhalothrin
induced brain cholinergic dysfunction in rats: Role of
mitochondrial bioenergetics. R. K. SHUKLA*; R. GUPTA; M.
H. SIDDIQUI; A. KUMAR; A. B. PANT; V. K. KHANNA. CSIR
Indian Inst. of Toxicology Res., Integral Univ., Integral Univ.

8:00 U8
318.13 Lipidomic analyses identify mitochondrial
lipids and omega-3/omega-6 phospholipid decreases in a
mouse model of Gulf War Illness. U. JOSHI*. Roskamp Inst.

POSTER
319. Opto-Chemogenetics and Microvascular Imaging of
Stroke and Injury
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 U9
319.01 Probing the contractility of capillary
pericytes in vivo with optogenetics. D. A. HARTMANN*; R. I.
GRANT; A. Y. SHIH. Med. Univ. of South Carolina.
9:00 U10 319.02 The cerebrovascular mural cell
continuum: A structural and biochemical characterization of
smooth muscle cells, pericytes and intermediary hybrids.
R. I. GRANT*; D. A. HARTMANN; R. G. UNDERLY; A. N.
WATSON; A. Y. SHIH. Med. Univ. of South Carolina.
10:00 U11
319.03 Chemogenetic modulation of disinhibitory
VIP interneuron circuits to enhance recovery from stroke. C.
E. BROWN*; E. WHITE; N. LIANG; K. GERROW. Univ. of
Victoria, Univ. of Victoria.
11:00 U12
319.04 Whole brain activation dynamics after
stroke. S. LEVY*; M. ASWENDT; B. HSUEH; G. SUN; S.
ISHIZAKA; D. SMERIN; M. CHENG; K. DEISSEROTH; G.
STEINBERG. Stanford Univ., Stanford Univ.

8:00 U13 319.05 Investigating neural and molecular

mechanisms of spontaneous recovery in experimental
stroke. M. ITO*; M. ASWENDT; M. CHENG; S. ISHIZAKA; A.
LEE; S. LEVY; D. SMERIN; E. WANG; G. K. STEINBERG.
Stanford Univ., Max Planck Inst. for Metabolism Res., Natl.
Hosp. Organization Nagasaki Kawatana Med. Ctr., Stanford
Univ., Univ. of San Diego.

9:00 U14 319.06 The dramatic alterations of microvascular

complexity and oligovascular unit in mice with metabolic
syndrome. G. XIAO*; S. NUNEZ; J. HINMAN. UCLA.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 U15
319.07 Vasoconstriction induced by cortical
inhibition reduces cerebral blood flow and hemoglobin
oxygenation. M. DESJARDINS*; K. KILI; C. MATEO;
P. SAISAN; C. L. G. FERRI; Q. CHENG; K. WELDY; D.
KLEINFELD; A. DALE; A. DEVOR. UCSD, UCSD, UCSD,
UCSD, UCSD, UCSD, Massachusetts Gen. Hosp. / Harvard
Med. Sch.

8:00 U17 319.09 Optical control of blood flow in naive

animals. R. L. RUNGTA*; B. OSMANSKI; D. BOIDO; M.
TANTER; S. CHARPAK. INSERM U1128 and Univ. Paris
Descartes, INSERM U979.
9:00 U18 319.10 Repetitive model of mild traumatic brain
injury produces cortical abnormalities detectable by magnetic
resonance diffusion imaging (DTI/DKI), histopathology,
and behavior. K. L. RADOMSKI; F. YU*; D. SHUKLA;
R. C. ARMSTRONG; C. M. MARION; R. SELWYN; B.
J. DARDZINSKI. Uniformed Services Univ., Uniformed
Services Univ., Uniformed Services Univ., Univ. of Maryland
Sch. of Med., Uniformed Services Univ., Univ. of New
Mexico, Uniformed Services Univ.
10:00 V1
319.11 Neovascularization and functional
recovery after intracerebral hemorrhage is conditioned by
the Tp53 Arg72Pro single nucleotide polymorphism. A.
ALMEIDA*; C. RODRGUEZ; T. SOBRINO; M. RAMOSARAQUE; J. CASTILLO; J. P. BOLAOS. Inst. of Biomed.
Res. of Salamanca, Univ. of Salamanca, Univ. Clin. HospitalUniversity of Santiago de Compostela.

POSTER
320. Injury Responses after Spinal Cord Injury
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 V2
320.01 Lysophosphatidic acid receptor 2
contributes to secondary damage after spinal cord injury. C.
LPEZ SERRANO*; E. SANTOS-NOGUEIRA; I. FRANCOSQUIJORNA; M. COLL-MIR; J. CHUN; R. LOPEZ-VALES.
Univ. Autonoma De Barcelona, Mol. and Cell. Neurosci.
Department, Dorris Neurosci. Center. The Scripps Res.
Institute, La Jolla.
9:00 V3
320.02 Activity of dorsal raphe serotonergic
neurons in a spinal cord injury model of depression. K.
FARRELL*; M. R. DETLOFF; J. D. HOULE. Drexel Univ. Col.
of Med., Drexel Univ. Col. of Med.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 V5
320.04 Dissecting trauma-reactive astrogliosis
in vivo by cell-type specific analysis of actively translating
mRNA. J. E. BURDA*; Y. AO; R. KAWAGUCHI; S.
DEVERASETTY; G. COPPOLA; M. V. SOFRONIEW. UCLA,
UCLA, UCLA, UCLA, UCLA.
8:00 V6
320.05 The Aqp4-Trpm4 macromolecular
complex mediates astrocyte migration after spinal cord
contusion. J. A. STOKUM*; V. GERZANICH; J. SIMARD.
Univ. of Maryland, Baltimore, Univ. of Maryland, Baltimore.
9:00 V7
320.06 The effects of distinct spared nerve injury
models on spinal synaptic plasticity following spinal cord
injury. J. HUIE*; K. MORIOKA; C. OMONDI; J. HAEFELI;
J. SACRAMENTO; A. FERGUSON. UCSF, San Francisco
Veterans Affairs Med. Ctr.
10:00 V8
320.07 Nano-based drug delivery systems:
Targeting to corticospinal tract neurons for controlled release
of therapeutics. C. MENGJIE*; R. VEETTIL; D. HYNDS; S.
GHOSH; T. MCALLISTER. TEXAS WOMANS UNIVERSITY,
Southeast Missouri State Univ.
11:00 V9
320.08 Age-associated exacerbation of myelin
injury is associated with decreases cholesterol synthesis. N.
MICHAELS*; S. K. JENSEN; K. S. RAWJI; M. B. KEOUGH;
J. R. PLEMEL; V. W. YONG. Univ. of Calgary.
8:00 V10 320.09 Behavioral and histochemical evaluation
of phantom limb pain model in rats. S. JERGOVA*; A.
LANJEWAR; A. R. NIEDECKEN; C. MARCH; J. SAGEN.
Univ. of Miami Sch. of Med.
9:00 V11 320.10 Experimental cervical spinal cord
injury induces an autoantibody response in the sub-acute
phase of the disease. A. ULNDREAJ*; A. TZEKOU; E. E.
TORLAKOVIC; M. G. FEHLINGS. Univ. of Toronto, Univ.
Hlth. Network, Dept. of Lab. Hematology, Univ. of Toronto,
Inst. of Med. Science, Univ. of Toronto.
10:00 V12
320.11 Promoting targeted reinnervation of
phrenic motor neurons and restoration of respiratory function
using BDNF after spinal cord injury. B. CHARSAR*; M.
URBAN; B. GHOSH; G. M. SMITH; A. C. LEPORE. Thomas
Jefferson Univ., Temple Univ.

11:00 V13
320.12 Pharmacological inhibition of CSPGs
receptors LAR and PTP positively modulates the
inflammatory response and promotes oligodendrocyte
replacement following spinal cord injury. S. M. DYCK*; H.
KATARIA; S. THOMAS; B. LANG; J. SILVER; S. KARIMIABDOLREZAEE. Univ. of Manitoba, Case Western Reserve
Univ. Sch. of Med.
8:00 V14 320.13 Induction of immune tolerance by shortcourse immunosuppresion after spinal grafting of allogeneic
neural precursors in pigs with previous chronic spinal cord
traumatic injury. M. MARSALA*; J. D. CIACCI; E. I. CURTIS;
S. MARSALA; M. R. NAVARRO; P. CHEN; S. JUHAS; J.
JUHASOVA; K. YAMADA; K. JOHE. Univ. of California San
Diego, Univ. of California San Diego, Inst. of Animal Physiol.
and Genet., Columbia Univ. Med. Ctr., Neuralstem.

Neuroscience 2016|Monday AM|31

Mon. AM

11:00 U16
319.08 The selective role of cortical inhibitory
interneurons in functional hyperemia. K. KILI*; H.
UHLIROVA; P. TIAN; M. THUNEMANN; M. DESJARDINS; P.
SAISAN; S. SAKADI; T. V. NESS; C. MATO; Q. CHENG;
K. L. WELDY; F. RAZOUX; M. VANDENBERGHE; J. A.
CREMONESI; C. G. L. FERRI; K. NIZAR; V. B. SRIDHAR;
T. C. STEED; M. ABASHIN; Y. FAINMAN; E. MASLIAH; S.
DJUROVIC; O. A. ANDREASSEN; G. A. SILVA; D. A. BOAS;
D. KLEINFELD; R. B. BUXTON; G. T. EINEVOLL; A. M.
DALE; A. DEVOR. UCSD, UCSD, Brno Univ. of Technol.,
Brno Univ. of Technol., John Carroll Univ., Harvard Med.
Sch., Norwegian Univ. of Life Sci., UCSD, Univ. of Oslo,
UCSD, UCSD, UCSD, UCSD, Oslo Univ. Hosp., Univ. of
Bergen, UCSD, UCSD, Univ. of Oslo.

10:00 V4
320.03 Assessment of the contribution of
endogenous oligodendrocytic remyelination to locomotor
recovery after spinal cord contusion injury in adult mouse. W.
TETZLAFF*; S. B. MANESH; G. J. DUNCAN; B. J. HILTON;
P. ASSINCK; J. LIU; S. NADERI-AZAD; P. CHAU; D. E.
BERGLES; J. R. PLEMEL. Univ. of British Columbia, Univ. of
British Columbia, Johns Hopkins Univ. Sch. of Med., Univ. of
Calgary.

9:00 V15 320.14 Astrocytic morphology altered by

glycogen synthase kinase 3 (GSK3) and chondroitinase
ABC in the optic nerve and the spinal cord. A. KALAM*; A. D.
RIVERA; E. J. BRADBURY; A. DIDANGELOS; A. M. BUTT.
Univ. of Portsmouth, Kings Col. London.
10:00 V16
320.15 The combined therapy of estradiol and
tamoxifen confers neuroprotection after spinal cord injury. J.
M. SANTIAGO SANTANA*; W. I. MALDONADO GEORGE;
D. N. MILLN; L. A. RODRGUEZ; S. M. RIVERA; L. M.
GARCA; J. COLN; A. PREZ; S. AYUSO; J. M. COLN;
A. I. TORRADO; I. K. SALGADO; Y. ARROYO; J. D.
MIRANDA. Univ. of Puerto Rico At Carolina, Univ. of Puerto
Rico, Rio Piedras Campus, Univ. of Puerto Rico, Carolina
Campus, Univ. of Puerto Rico, Med. Sci. Campus.
8:00 DP05 320.16 (Dynamic Poster) Imaging neural
activity in the primary somatosensory cortex using GCaMP
transgenic mice. X. LIN; W. XIONG; W. WU; M. WALKER; X.
JIN; X. M. XU*. Indiana Univ.
8:00 V17 320.17 miR-21 correlates with progression
of degenerative cervical myelopathy and is a marker of
hypoxia-induced inflammation. A. M. LALIBERTE*; S.
KARADIMAS; K. SATKUNENDRARAJAH; P. VIDAL; M. G.
FEHLINGS. Univ. of Toronto, Univ. Hlth. Network.

9:00 V18 320.18 Immune modifying microparticles

modulate hematogenous monocytes and promote recovery
after spinal cord injury. J. G. COOPER*; S. JEONG; I.
IFERGAN; S. B. SHARMA; D. XU; T. MCGUIRE; J. A.
KESSLER; S. D. MILLER. Northwestern Univ., Northwestern
Univ.
10:00 W1
320.19 Riluzole prevents functional deficits
during mild distraction spinal cord injury. E. N. SHIMIZU*; K.
J. JOHNSON; M. I. ROMERO-ORTEGA. Univ. of Texas At
Dallas.

11:00 W2
320.20 Neuroplasticity in the injured spinal
cord following Sox9 ablation three weeks post injury. N.
M. OSSOWSKI*; N. M. GEREMIA; T. HRYCIW; K. XU; A.
BROWN. Univ. of Western Ontario.
8:00 W3
320.21 IL-13 administration favors microglia and
macrophages to adopt an M2-like phenotype after spinal
cord injury. J. AMO-APARICIO*; R. LOPEZ-VALES. Univ.
Autonoma De Barcelona.
9:00 W4
320.22 A potent anti-spastic effect after
intrathecal NK1 antisense oligonucleotide or subpial AAV9NK1-ShRNA delivery in rats with chronic spinal transectioninduced muscle spasticity. M. BRAVO HERNANDEZ*;
T. YOSHIOZUMI; M. R. NAVARRO; K. KAMIZATO; T.
TADOKORO; O. PLATOSHYN; S. MARSALA; J. D. CIACCI;
C. MAZUR; M. MARSALA. Univ. of California San Diego,
Univ. of California San Diego, Ionis Pharmaceuticals.
10:00 W5
320.23 The effects of 10ms pulsed
radiofrequency (PRF) treatment on behavioral measures
of chronic pain and gene expression changes along the
nociceptive pathway. J. M. WILLIAMS*; D. M. TILLEY; C.
KELLEY; D. L. CEDENO; R. VALLEJO. Illinois Wesleyan
Univ. Dept. of Psychology, Millennium Pain Ctr.
11:00 W6
320.24 Treatment of postraumatic intraspinal
pressure may limit secondary damage in acute rodent spinal
cord injury. Z. Z. KHAING*; L. N. CATES; D. M. DEWEES; Z.
BIRJANDIAN; C. P. HOFSTETTER. Univ. of Washington.

32 | Society for Neuroscience

8:00 W7
320.25 Potent & long-lasting suppression of
muscle spasticity by spinal subpial AAV9-mediated VGAT
and GAD65 gene delivery in a rat thoracic 9 transection
model of chronic spasticity. T. YOSHIZUMI*; K. KAMIZATO;
A. PLATOSHYN; M. R. NAVARRO; S. MARSALA; J. D.
CIACCI; M. MARSALA. UNIVERSITY OF CALIFORNIA SAN
DIEGO MARASALA LAB, UNIVERSITY OF CALIFORNIA
SAN DIEGO.
9:00 W8
320.26 Activation of RhoA is contributed to
apoptosis of reticulospinal neurons in lamprey brain after
spinal cord injury. K. G. ZHANG*; J. HU; W. RODEMER;
M. E. SELZER. Lewis Katz Sch. of Medicine, Temple Univ.,
Lewis Katz Sch. of Medicine, Temple Univ.
10:00 W9
320.27 Surgical decompression for degenerative
cervical myelopathy induces activation of the immune
system. P. VIDAL VERA*; S. K. KARADIMAS; A.
ULNDREAJ; A. M. LALIBERTE; J. WANG; M. FEHLINGS.
UHN, Univ. of Toronto, UHN, UHN.
11:00 W10 320.28 Assessment of suspensions of the
polypyrrole doped with iodine synthesized by plama
(PPPy/I) and rat serum albumin (RSA) microinjected as
treatment of traumatic injury of the spinal cord (TSCI). O.
FABELA*; S. SNCHEZ-TORRES; L. ALVAREZ-MEJIA;
R. MONDRAGN-LOZANO; G. J. CRUZ; M.-. OLAYO;
J. MORALES; A. DAZ-RUZ; C. ROS; L. MEDINATORRES; H. SALGADO-CEBALLOS; R. OLAYO. Univ.
Autnoma Metropolitana, Proyecto Camina A.C., Ctr. Mdico
Nacional Siglo XXI, Univ. Autnoma Metropolitana, Ctr.
Mdico Nacional Siglo XXI, CONACyT, Inst. Nacional de
Investigaciones Nucleares, Univ. Autnoma Metropolitana,
Inst. Nacional de Neurologa y Neurociruga, Univ. Autnoma
de Mexico.
9:00 W11 320.29 Neuroprotective strategy at acute
phase reduces microglia activation and improves survival
of motoneuron after cervical nerve root transection. M.
HUANG*; C. LIN; Y. LIN; C. HONG; K. CHANG; H. CHENG.
Taipei Veterans Gen. Hosp, Taipei Med. Univ., Taipei
Veterans Gen. Hosp., Natl. Chung Hsin Univ., Natl. YangMing Univ., Taipei Veterans Gen. Hosp.
8:00 W12 320.30 In vivo three-photon excited fluorescence
imaging of neural activity in the spinal cord of awake,
locomoting mouse. Y. CHENG*; S. L. NESS; S. H. HU; J.
RAIKIN; L. D. PAN; D. G. OUZOUNOV; T. WANG; X. LI; J.
C. CRUZ HERNANDEZ; I. M. BASTILLE; N. NISHIMURA; J.
R. FETCHO; C. XU; C. B. SCHAFFER. Cornell Univ., Cornell
Univ., Cornell Univ., Cornell Univ.

POSTER
321. Trauma and Blast-Induced Neurochemical and Cellular
Mechanisms
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 X1
321.01 Single versus repeated mild blast
exposure; the galanin, serotonin and noradrenalin systems.
L. KAWA; U. P. ARBORELIUS; A. KAMNAKSH; T. HOKFELT;
D. V. AGOSTON; M. G. RISLING*. Karolinska institutet,
Uniformed Services Univ., Karolinska Inst.
9:00 X2
321.02 Astrocyte reactivity following blast
exposure involves aberrant histone acetylation. Z. S.
BAILEY*; M. B. GRINTER; P. J. VANDEVORD. Virginia
Tech., Salem Veterans Affairs Med. Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 X3
321.03 Network Trauma: Electrophysiological
and subcellular damage after tangential 300-600g impacts in
vitro. E. A. ROGERS; G. W. GROSS*. Univ. North Texas.
11:00 X4
321.04 Conjugated linoleic acid administration
in male rats induces amnesia and exacerbates recovery
from functional deficits induced by a penetrating controlled
cortical contusion injury. C. S. ATWOOD*; I. M. ANDERSON;
Q. BONGERS; A. JANSEN; C. NIER; M. WEHBER; A.
KAPOOR; T. E. ZIEGLER; K. HAYASHI; S. VADAKKADATH
MEETHAL; R. I. GEDDES. Univ. of Wisconsin-Madison,
Univ. of Wisconsin-Madison.

9:00 X6
321.06 Defective methionine metabolism in the
brain after repeated blast exposures might contribute to
increased oxidative stress. P. ARUN*; W. B. RITTASE; D.
M. WILDER; Y. WANG; I. D. GIST; J. B. LONG. Walter Reed
Army Inst. of Res.
10:00 X7
321.07 A proteomics study of the temporal
and spatial changes following blast induced traumatic
brain injury. A. KAMNAKSH; R. BEKDASH; I. LIN; G.
MUELLER; G. LING; A. SCRIMGEOUR; L. TONG; J.
LONG; T. WESTMORLAND; W. TAYLOR; S. PARKS; D. V.
AGOSTON*. USUHS, USAMRA, WRAIR, ACI-AMT, ORA,
USU.

11:00 X8
321.08 Durable engraftment, neuronal
differentiation of human fetal neural stem cell transplants
in penetrating ballistic-like brain injury accompanied by
amelioration of cognitive deficits. S. GAJAVELLI*; M. S.
SPURLOCK; K. N. RIVERA; A. I. AHMED; S. YOKOBORI;
S. W. LEE; M. P. HEFFERAN; K. JOHE; T. G. HAZEL; F. C.
TORTELLA; D. A. SHEAR; R. M. BULLOCK. Univ. Miami,
Univ. of Miami, Neuralstem Inc, Neuralstem Inc, Walter Reed
Army Inst. of Res.
8:00 X9
321.09 Inhibition of caspase-3 protects a broad
range of developing neurons andneural stem cells from
chemotherapeutic-induced cell damage. A. J. ELIA*; J.
HENDERSON. Univ. Hlth. Network, Fac. of Pharmacy, Univ.
of Toronto.

9:00 X10 321.10 Effects on the 2 adrenoreceptor

antagonist efaroxan on sensorimotor responses and
the norepinephrine levels in the dentate gyrus after
cortical damage. L. RAMOS-LANGUREN*; S. MONTES;
G. GARCA-DAZ; N. CHVEZ-GARCA; C. ROS;
R. GONZLEZ-PIA. Univ. Autnoma Metropolitana,
Xochimilco, Dept. de Neuroqumica. Inst. Nacional de
Neurologa y Neurociruga, Torre de Investigacin. Inst.
Nacional de Rehabilitacin.
10:00 X11
321.11 Immunohistochemical study of nrf2antioxidant response element as indicator of oxidative stress
in the rat brain following by kainic acid and petylenetetrazol
treatment. A. RUIZ-DAZ; J. MANJARREZ; C. NAVA-RUIZ;
A. DAZ-RUIZ; M. MENDEZ-ARMENTA*. Natl. Inst. of
Neurol. and Neurosurg., Natl. Inst. Neurol Neurosurg.
11:00 X12
321.12 Evaluation of acute cell death in
rat organotypic hippocampal slice cultures exposed to
mechanical or blast injury. A. GLAVASKI-JOKSIMOVIC*; A.
S. SHAH; B. V. APERI; S. N. KURPAD; B. D. STEMPER.
Med. Col. of Wisconsin, Med. Col. of Wisconsin, Clement J.
Zablocki Veterans Affairs Med. Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 X14 321.14 Polarized aquaporin-4 (AQP4) expression

in the cerebellum is disturbed by blast-induced traumatic
brain injury (TBI). K. D. MEEKER*; J. ILIFF; M. SIMON; J.
S. MEABON; E. R. PESKIND; D. G. COOK. SIBCR, Univ. of
Washington, Oregon Hlth. & Sci. Univ., Oregon Hlth. & Sci.
Univ., VA Puget Sound Hlth. Care Syst., VA Puget Sound
Hlth. Care Syst., Univ. of Washington, Univ. of Washington.
10:00 X15
321.15 Mitigation of neuropathology and
behavioral deficits in a rat model of brain injury to occupants
of vehicles targeted by land mines by an advanced shock
absorbing hull design. F. TCHANTCHOU*; W. FOURNEY; U.
LEISTE; A. PUCHE; G. FISKUM. Univ. of Maryland Sch. of
Med., Univ. of Maryland Col. Park, Univ. of Maryland Sch. of
Med.
11:00 X16
321.16 Assessing glycomics and neuroproteomic
changes in experimental TBI: Comparative analysis of
aspirin and clopidogrel. F. H. KOBEISSY*; H. BAHMAD;
N. RAMADAN; R. ZHU; Y. MECHREF. Univ. of Florida,
American Univ. of Beirut, Texas Tech. University.
8:00 X17 321.17 Role of glia in the pathophysiology of
Gulf War Illness. D. J. DUTTA*; D. H. WOO; M. ROBNETT;
W. HUFFMAN; P. LEE; K. SULLIVAN; R. KILLIANY; J.
OCALLAGHAN; R. D. FIELDS. NIH, Natl. Institites of Hlth.,
Boston Univ. Sch. of Publ. Hlth., Boston Univ. Sch. of Med.,
Centers for Dis. Control and Prevention.
9:00 X18 321.18 Phenelzine induces restoration of function
following a medial frontal cortex contusion in adult male rats
housed in standard environments, but not in adult male rats
reared in enriched environments. M. A. SEARLES*. Saginaw
Valley State Univ.
10:00 Y1
321.19 The role of pontine -2 receptors in the
reinstatement of the motor deficit after cortical damage. G.
GARCA-DAZ; L. E. RAMOS-LANGUREN; J. LOMELGONZLEZ; F. AYALA-GUERRERO; N. CHVEZ-GARCA;
R. GONZLEZ-PIA; S. MONTES*. Escuela Superior de
Medicina. Inst. Politcnico Nacional, Natl. Inst. Neurol.
Neurosurg, Facultad de Psicologa. Univ. Nacional
Autnoma de Mxico, Torre de Investigacin. Inst. Nacional
de Rehabilitacin.

POSTER
322. Traumatic Brain Injury: Models, Mechanisms, and
Treatments
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 Y2
322.01 Effects of P2 receptor blocker MRS2179
against experimental cerebral contusion injury in rat. T.
KUMAGAWA*; K. SHIJO; N. MORO; M. FUKUSHIMA; T.
MAEDA; A. YOSHINO. Nihon Univ. Sch. of Med.
9:00 Y3
322.02 Traumatic brain injury during adolescence
enhances rewarding effects of a subthreshold dose of
cocaine in mice. L. CANNELLA*; S. F. MERKEL; R.
RAZMPOUR; M. SEASOCK; S. M. RAWLS; S. H. RAMIREZ.
Temple Univ. Lewis Katz Sch. of Med., Temple Univ. Lewis
Katz Sch. of Med.

Neuroscience 2016|Monday AM|33

Mon. AM

8:00 X5
321.05 Repetitive blast exposure in mice and
combat Veterans promotes a persistent profile of behavioral
and dopaminergic dysfunction. A. G. SCHINDLER*; J. S.
MEABON; K. D. MEEKER; G. LI; C. W. WILKINSON; E.
PESKIND; D. G. COOK; J. J. CLARK. Univ. of Washington,
Veterans Affairs Puget Sound Mental Illness Res.
Educational and Clin. Ctr., Veterans Affairs Puget Sound
Geriatric Res. Educ. and Clin. Ctr.

8:00 X13 321.13 Is docosahexaenoic acid neuroprotective

after traumatic brain injury in rats? L. S. BELAYEV*; L.
KHOUTOROVA; A. OBENAUS; N. G. BAZAN. LSUHSC,
Loma Linda Univ.

10:00 Y4
322.03 Histological evaluation of biomarkers in a
longitudinal traumatic brain injury study. S. C. SCHWERIN*;
E. HUTCHINSON; K. RADOMSKI; A. IMAM-FULANI; M.
CHATTERJEE; C. PIERPAOLI; S. L. JULIANO. Uniformed
Services Univ., NIH.

11:00 Y17
322.16 Transcranial direct current stimulation
(tDCS) improves neurological outcomes in a mice model
of traumatic brain injury. O. BRAGIN*; E. NEMOTO; C.
SHUTTLEWORTH; D. BRAGIN. Univ. of New Mexico Sch. of
Med., Univ. of New Mexico Sch. of Med.

11:00 Y5
322.04 A new model for un-anaesthetised repeat
closed head injury produces acute neurological deficits in
the juvenile rat. A. L. MECONI*; R. C. WORTMAN; B. R.
CHRISTIE. Univ. of Victoria, Univ. of Victoria.

8:00 Y18 322.17 Systemic administration of cell-free

exosomes generated by human marrow mesenchymal
stem cells cultured under 2D and 3D conditions improves
functional recovery in rats after traumatic brain injury. Y.
ZHANG; M. CHOPP; Z. G. ZHANG; M. KATAKOWSKI; H.
XIN; C. QU; E. PIKULA; M. ALI; A. MAHMOOD; Y. XIONG*.
Henry Ford Hlth. Syst., Henry Ford Hlth. Syst., Oakland Univ.

8:00 Y6
322.05 The effects of mild traumatic brain injury
on hippocampal neuroinflammation in female juvenile rats.
M. A. CLARKSON*; B. R. CHRISTIE; P. C. NAHIRNEY; A.
L. MECONI; A. COLLINS; E. TRUESDELL. Univ. of Victoria,
Univ. of Victoria.
9:00 Y7
322.06 Repetitive Closed-Head Impact Model
of Engineered Rotational Acceleration (rCHIMERA) induced
long-term cognitive impairment and persistent astrogliosis
and microgliosis in mouse. H. CHEN*. NIAAA/NIH.
10:00 Y8
322.07 Acute pathophysiologies associated with
mild, head on concussion injury in the Sprague-Dawley.
S. M. VITA*; K. R. CLARK; R. J. GRILL. Univ. of Mississippi
Med. Ctr.
11:00 Y9
322.08 Increased ethanol intake and progressive
reductions in striatal cannabinoid receptor 1 protein levels
following mild traumatic brain injury. B. L. SCHNEIDER; L.
L. SUSICK; A. C. CONTI*. John D. Dingell VA Med. Ctr.,
Wayne State Univ.
8:00 Y10 322.09 Pyridoxamine deficiency induces carbonyl
stress and schizophrenia-like phenotypes in Drosophila. K.
KORI*. Tokyo Metorolitan Inst. of Med. Sci.
9:00 Y11 322.10 Regrowth of serotonin axons in the
neocortex following a stab injury. S. E. DOUGHERTY*; Y.
JIN; D. J. LINDEN. Johns Hopkins Univ.

10:00 Y12
322.11 Diffusion Tensor Imaging detects
alterations in the corpus callosum after mild TBI in the
mouse. P. N. VENKATASUBRAMANIAN*; M. SMITH; D.
R. SCHUBERT; J. C. PINA-CRESPO; K. MATHEWS; P.
RIGBY; A. MANN; E. RUOSLAHTI; A. M. WYRWICZ; J.
SPIESS. Northshore Univ. Healthsystem, The Salk Inst.,
Sanford Burnham Prebys Med. Discovery Inst., L3 Applied
Technologies, Inc., Cortrop Inc.
11:00 Y13
322.12 Impact of chronic traumatic brain injury on
noradrenergic innervation to the major anxiety-related neural
pathways in rats. S. TSUDA*; J. HOU; R. NELSON; G.
MUSTAFA; J. WATTS; F. J. THOMPSON; P. BOSE. Malcom
Randal VA Med. Ctr., Univ. of Florida, Univ. of Florida, Univ.
of Florida.
8:00 Y14 322.13 Graded Mild traumatic brain injury
(mTBI)-induces different trajectories reaching enduring
multiple comorbidities. F. J. THOMPSON*; J. HOU; R.
NELSON; G. MUSTAFA; J. JOSEPH; Z. WILKIE; P. BOSE.
North Florida/South Georgia Veterans Hlth. Syst., Univ. of
Florida, Univ. of Florida, Univ. of Florida.
9:00 Y15 322.14 Chronic cerebrovascular abnormalities
in a mouse model of repetitive mild traumatic brain injury. C.
E. LYNCH*; G. CRYNEN; S. FERGUSON; B. MOUZON; D.
PARIS; J. OJO; P. LEARY; F. CRAWFORD; C. BACHMEIER.
The Roskamp Inst., The Open Univ., James A. Haley
Veterans Admin. Ctr., Bay Pines VA Healthcare Syst.
10:00 Y16
322.15 An adapted model of mTBI in adult
zebrafish. R. SPENCE*; B. DIX; A. YOUNG; V. GILL;
L. STANISLAW; J. ELLIS; A. MAHERAS; B. FORTINI.
Claremont McKenna Col., Scripps Col., Pitzer Col.
34 | Society for Neuroscience

9:00 Z1
322.18 Enduring effects of environmental
enrichment on functional network reorganization after
experimental TBI in rats. A. PAYDAR*; D. ROBIO; S.
SRINIVAS; Y. CAI; A. E. KLINE; N. G. HARRIS. UCLA, Dept.
of Neurosurgery, BIRC, Univ. of Pittsburgh.
10:00 Z2
322.19 The impact of MIF binding and CD74
on the activation and expansion of pro inflammatory
B cells and T cells in a fluid percussion model of
traumatic brain injury. L. A. SHAPIRO*; S. K. ROGERS; D.
NIZAMUTDINOV; R. BUCALA; M. K. NEWELL0ROGERS.
Texas A&M Hlth. Sci. Ctr., Yale Univ.
11:00 Z3
322.20 Alteration of cardiac performance after
traumatic brain injury through acute signaling mechanisms.
D. NIZAMUTDINOV*; J. KAIN; L. A. SHAPIRO. Texas A&M
Univ., Texas A&M HSC, Texas A&M HSC.
8:00 Z4
322.21 Role of oxidation of kcnb1 potassium
channels in mouse model of traumatic brain injury. W. YU;
R. PARAKRAMA; S. TENG; M. GOWDA; Y. SHARAD; S.
THAKKER-VARIA; J. ALDER; F. SESTI*. Rutgers, Rutgers,
Rutgers.
9:00 Z5
322.22 Sensor-based quantitation of a closedskull weight drop model for traumatic brain injury. J.
ALLENDE LABASTIDA*; S. ALI; J. GAO; T. J. DUNN; Y. YU;
D. S. DEWITT; D. S. PROUGH; P. WU. Univ. of Texas Med.
Br., Univ. of Texas Med. Br., Univ. of Texas Med. Br., Univ. of
Texas Med. Br.
10:00 Z6
322.23 Administration of miR-155 antagomir
following experimental traumatic brain injury (TBI) attenuates
post-traumatic neuroinflammatory responses and improves
neurological recovery. R. J. HENRY*; D. J. LOANE; B.
E. SABIRZHANOV; B. A. STOICA; A. I. FADEN. Univ. of
Maryland, Baltimore, Univ. of Maryland, Baltimore.
11:00 Z7
322.24 Corticospinal tract pathology with impact
acceleration: Modeling diffuse axonal injury in the mouse. N.
ZIOGAS; J. RYU; L. XU; P. TSOULFAS; V. E. KOLIATSOS*.
Johns Hopkins Univ., The Miami Project to Cure Paralysis,
Johns Hopkins Univ.
8:00 Z8
322.25 Chronic retinal injury in a mouse
model of blast-induced trauma. N. MAMMADOVA*; D.
S. SAKAGUCHI; S. GHAISAS; G. D. ZENITSKY; A. G.
KANTHASAMY; J. J. GREENLEE; M. H. W. GREENLEE.
Iowa State Univ., Iowa State Univ., Natl. Animal Dis. Center,
USDA, Agr. Res. Service.
9:00 Z9
322.26 Experimental traumatic brain injury
induces changes resembling motor neuron disease that are
exacerbated by pathological TDP-43. S. R. SHULTZ*; D.
WRIGHT; X. TAN; T. OBRIEN. Univ. of Melbourne, The Univ.
of Melbourne.
10:00 Z10
322.27 Pomegranate treatment for repetitive mild
brain insults. A. M. BRISENO*; N. M. BAJWA; A. OBENAUS;
R. E. HARTMAN. Loma Linda Univ., Loma Linda Univ., Loma
Linda Univ., Univ. of California Riverside.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
323. Spinal Cord Injury Models and Mechanisms
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 Z11 323.01 Acute vasopressor administration
after traumatic SCI: The impact on metabolism, blood
flow, oxygenation, pressure and long-term behavioural
recovery using a porcine model of SCI. A. GHEORGHE*; F.
STREIJGER; K. SO; E. B. OKON; N. MANOUCHEHRI; K.
SHORTT; D. E. GRIESDALE; M. S. SEKHON; B. K. KWON.
Univ. of British Columbia, Dept. of Anesthesiology, UBC,
Dept. of Medicine, UBC, Dept. of Orthopaedics, UBC.

10:00 Z13
323.03 Duraplasty in acute traumatic SCI: The
impact on metabolism, blood flow, oxygenation and pressure
using a porcine model of SCI. N. MANOUCHEHRI*; F.
STREIJGER; K. SHORTT; K. SO; E. B. OKON; B. K. KWON.
UBC, Dept. of Orthopaedics, UBC.
11:00 Z14
323.04 New neurotrauma marker panel of
astroglial heterogeneity predicts severity and outcome after
recoverable swine spinal cord injury. I. B. WANNER*; J.
HALFORD; S. SHEN; J. A. LOO; R. KINSLER; P. CRIPTON;
B. KWON; A. MAYER. UCLA, UCLA, U.S. Army Aeromedical
Res. Lab., ICORD, Univ. of British Columbia, ICORD, Univ.
of British Columbia, Lovelace Resp. Res. Inst.
8:00 AA1 323.05 Relationship between injury severity and
miRNA expression in CSF and serum from human spinal
cord injury patients. S. S. TIGCHELAAR*; F. STREIJGER;
S. SINHA; S. FLIBOTTE; N. MANOUCHEHRI; K. SO; K.
SHORTT; I. MALENICA; A. COURTRIGHT; J. STREET; S.
PAQUETTE; M. BOYD; T. AILON; C. FISHER; M. DVORAK;
J. MAC-THIONG; S. PARENT; C. BAILEY; S. CHRISTIE;
K. VAN KEUREN-JENSEN; C. NISLOW; B. K. KWON.
ICORD, Fac. of Pharmaceut. Sci.- Univ. of British Columbia,
Translational Genomics, Vancouver Spine Surgery Inst.,
Vancouver Spine Surgery Inst., Hpital du Sacr-Coeur
de Montral, Chu Sainte-Justine- Univ. de Montral,
Schulich Med. & Dentistry, Victoria Hosp., Halifax InfirmaryDalhousie Univ.
9:00 AA2 323.06 Overexpression of KLF6 in corticospinal
tract neurons promotes axon growth after spinal injury. Z.
WANG*; I. VENKATESH; N. KRUEGER; D. NOWAK; B.
CALLIF; B. MAUNZE; M. G. BLACKMORE. Marquette Univ.
10:00 AA3
323.07 Combined rehabilitation and genetic
enhancement of intrinsic regenerative growth ability
to improve behavioral outcomes after spinal injury. A.
A. KRAMER*; Z. WANG; E. BALLE; L. K. HOLAN; N.
KRUEGER; J. A. EVANS; M. G. BLACKMORE. Marquette
Univ.
11:00 AA4
323.08 Combined expression of pro-regenerative
transcription factors and transplanted stem cells to promote
corticospinal tract regeneration. N. JAYAPRAKASH*; Z.
WANG; N. KRUEGER; A. KRAMER; M. BLACKMORE.
Marquette Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 AA6 323.10 Gene therapy using a stealth gene switch

for GDNF expression promotes long distance regeneration
of motor axons following a spinal ventral root avulsion. R.
EGGERS*; F. DE WINTER; S. A. HOYNG; R. C. HOEBEN;
M. J. A. MALESSY; M. R. TANNEMAAT; J. VERHAAGEN.
Neth Inst. Neurosci, Leiden Univ. Med. Ctr., Leiden Univ.
Med. Ctr., Leiden Univ. Med. Ctr.
10:00 AA7
323.11 Regulateable Chondroitinase ABC
gene therapy as a treatment for spinal cord injury. E. R.
BURNSIDE*; F. DE WINTER; A. DIDANGELOS; N. D.
JAMES; K. BARTUS; E. M. MUIR; J. VERHAAGEN; E.
J. BRADBURY. Kings Col. London, Netherlands Inst. for
Neurosci., Univ. of Cambridge.
11:00 AA8
323.12 Rhoa knockdown by pgp/rhoa sirna
nanoparticle increases axon growth after spinal cord
injury. S. GWAK; C. MACKS; K. WEBB; M. LYNN; J. LEE*.
Clemson Univ., Greenville Hlth. Syst.
8:00 AA9 323.13 Stretching distrupts locomotor function
in rats with spinal cord injury: Static stretch and hold
vs dynamic range of motion patterns. A. KELLER*; K.
NORD; C. HAINLINE; D. PRINCE; A. SHUM-SIU; D. S. K.
MAGNUSON. Univ. of Louisville, Univ. of Louisville, Univ. of
Louisville, Univ. of Louisville.
9:00 AA10 323.14 Stretching disrupts locomotor function
in rats with spinal cord injury: Role of nociceptive afferents.
D. S. MAGNUSON*; A. KELLER; S. KRUPP; K. NORD; C.
HAINLINE; D. PRINCE; A. SHUM-SIU; J. C. PETRUSKA.
Univ. of Louisville, Univ. of Louisville, Univ. of Louisville, Univ.
of Louisville.
10:00 AA11 323.15 Grafts of multipotent neural progenitor
cells in models of cervical contusive SCI: Engraftment,
axonal outgrowth and functional effects. J. H. BROCK*; L.
GRAHAM; S. IM; N. ARMSTRONG; M. TUSZYNSKI. UCSD,
VA, UC San Diego.
11:00 AA12 323.16 Human neural stem cell grafts into nonhuman primate spinal cord contusion or hemisection lesions.
E. S. ROSENZWEIG*; J. H. BROCK; P. LU; J. L. WEBER;
R. MOSEANKO; S. HAWBECKER; E. A. SALEGIO; Y. S.
NOUT; L. A. HAVTON; A. R. FERGUSON; M. S. BEATTIE;
J. C. BRESNAHAN; M. H. TUSZYNSKI. Univ. of California
San Diego Dept. of Neurosciences, VAMC, California Natl.
Primate Res. Center, Univ. Calif. Davis, Col. of Vet. Med.
and Biomed. Sciences, Colorado State Univ., David Geffen
Sch. of Medicine, Univ. of California, Los Angeles, Univ. of
California San Francisco.
8:00 AA13 323.17 Distal BDNF delivery to promote axonal
regeneration through Schwann cell-seeded alginate
hydrogels after spinal cord injury. S. LIU*; S. BEATRICE; R.
MLLER; R. PUTTAGUNTA; N. WEIDNER; A. BLESCH.
Heidelberg Univ. Hosp., Tongji Hospital, Tongji Med.
College, Huazhong Univ. of Sci. and Technology, Univ. of
Regensburg, Stark Neurosciences Res. Inst.

Neuroscience 2016|Monday AM|35

Mon. AM

9:00 Z12 323.02 Trauma-induced alterations of cerebral

excitability and cortical reorganization in a porcine model
of SCI. K. SHORTT*; C. R. JUTZELER; F. STREIJGER; N.
MANOUCHEHRI; K. SO; J. KRAMER; B. K. KWON. Univ. of
British Columbia, Univ. of Zurich, Univ. of British Columbia,
Univ. of British Columbia.

8:00 AA5 323.09 Developing an immune-evading

doxycycline-inducible viral vector for gene therapy in the
spinal cord. F. DE WINTER*; B. HOBO; R. EGGERS; S.
A. HOYNG; R. C. HOEBEN; R. J. YEZ-MUOZ; E. J.
BRADBURY; E. M. MUIR; J. VERHAAGEN. Netherlands
Inst. for Neurosci., Leiden Univ. Med. Ctr., Leiden Univ.
Med. Ctr., Univ. of London, Kings Col. London, Univ. of
Cambridge.

9:00 AA14 323.18 Surface modification and cell seeding into

capillary alginate hydrogels promote axonal regrowth in the
acutely injured spinal cord. T. SCHACKEL*; M. GNTHER;
S. LIU; B. SANDNER; M. MOTSCH; R. MLLER; R.
PUTTAGUNTA; N. WEIDNER; A. BLESCH. Spinal Cord
Injury Center, Univ. Hosp. Hei, Spinal Cord Injury Center,
Univ. Hosp. Heidelberg, Univ. of Regensburg, Univ. of
Indianapolis, Sch. of Med.
10:00 AA15 323.19 Vasopressin and polyuria after acute
spinal cord injury. L. R. MONTGOMERY*; C. HUBSCHER.
Univ. of Louisville.
11:00 AA16 323.20 Cardiovascular regulation post-epidural
stimulation in cervical spinal cord injury. B. DITTERLINE*; S.
WANG; S. ASLAN; S. HARKEMA. Univ. of Louisville, Univ. of
Louisville.
8:00 AA17 323.21 Activity-based training with spinal cord
epidural stimulation promoted the recovery of lower limb
motor function independent from spinal stimulation in a
chronic motor complete paraplegic. E. REJC*; C. ANGELI;
D. ATKINSON; S. HARKEMA. Univ. of Louisville, Frazier
Rehab Institute, Kentucky One Hlth.
9:00 AA18 323.22 Targeting improvements in bladder
function with epidural stimulation after human spinal cord
injury. C. HUBSCHER*; A. HERRITY; L. MONTGOMERY; A.
WILLHITE; C. ANGELI; S. HARKEMA. Univ. Louisville Sch.
Med., Frazier Rehab Inst.
10:00 BB1
323.23 Lumbosacral spinal cord epidural
stimulation enables step like patterns during BWST
stepping in motor complete paraplegics. C. A. ANGELI*; S.
HARKEMA. Frazier Rehab Inst., Univ. of Louisville.
11:00 BB2
323.24 Acute pain after SCI exacerbates
progressive hemorrhagic necrosis. M. K. BRUMLEY*; J. D.
TURTLE; J. M. FORSBERG; J. W. GRAU. Texas A&M Univ.
8:00 BB3 323.25 Spared fibers promote the development
of secondary spinal injury in response to acute pain. J. A.
REYNOLDS*; J. D. TURTLE; Y. HUANG; M. M. STRAIN; J.
W. GRAU. Texas A&M Univ.
9:00 BB4 323.26 Spinal block with lidocaine: An effective
treatment for reducing secondary injury after SCI and
noxious stimulation. J. TURTLE*; M. M. STRAIN; Y. HUANG;
J. A. REYNOLDS; M. K. BRUMLEY; J. W. GRAU. Texas
A&M Univ.
10:00 BB5
323.27 CX3CR1-deficient microglia and
macrophages enhance endogenous repair, axon sprouting
and synaptogenesis after spinal cord injury in mice. C.
M. FRERIA*; J. C. HALL; P. WEI; D. M. MCTIGUE; P. G.
POPOVICH. The Ohio State Univ.
11:00 BB6
323.28 Proliferating NG2+ cells are required for
glial and fibrotic scar formation and maintenance of tissue
integrity after spinal cord injury in mice. Z. C. HESP*; R.
SUZUKI; A. NISHIYAMA; D. M. MCTIGUE. The Ohio State
Univ., Univ. of Connecticut.

POSTER
324. Peripheral Nerve Injury
Theme C: Neurodegenerative Disorders and Injury
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 BB9 324.01 Anti allodynic effects of medicinal herbs in
a rat model of oxaliplatin induced neuropathic pain through
the suppression of spinal glial activation. J. LEE*; W. KIM;
H. YOON; H. BAE; S. KIM. Kyung Hee Univ., Grad. School,
Kyung Hee Univ., Kyung Hee Univ.
9:00 BB10 324.02 Vagus nerve stimulation paired with
rehabilitation improves functional recovery following
peripheral nerve injury. E. MEYERS*; R. GRANJA;
R. SOLORZANO; G. BENDALE; P. GANZER; N.
ROBERTSON; K. ADCOCK; M. ROMERO-ORTEGA; M.
KILGARD; R. RENNAKER; S. HAYS. Univ. of Texas At
Dallas.
10:00 BB11 324.03 The removal of proprioceptive IA afferent
synapses from motoneurons after nerve injury occurs
through a mechanism dependent on chemokine receptor
CCR2. T. M. ROTTERMAN*; F. J. ALVAREZ. Emory Univ.
11:00 BB12 324.04 Enhancing peripheral nerve regeneration
through combined tissue engineering and gene therapy.
F. BUSUTTIL*; M. P. HUGHES; K. S. BHANGRA; P. J.
KINGHAM; J. B. PHILLIPS; A. A. RAHIM. Sch. of Pharmacy,
Univ. Col. London, Eastman Dent. Institute, Univ. Col.
London, Ume Univ.
8:00 BB13 324.05 Analgesic effects of bee venom and
bee venom derived phospholipase A2 in a mouse model
of oxaliplatin-induced neuropathic pain. W. KIM*; D. LI; J.
LEE; H. BAE; S. KIM. Dept. of Physiology, Kyung Hee Univ.,
Kyung Hee Univ.
9:00 BB14 324.06 MCT1 in Schwann cells expedites
regeneration of injured peripheral nerves and is necessary
for maintenance of aging sensory axons. M. K. JHA*; K.
RUSSELL; A. SINGH; Y. LEE; J. D. ROTHSTEIN; B. M.
MORRISON. Johns Hopkins Univ.
10:00 BB15 324.07 Excitability changes in aged regenerating
axons. M. MOLDOVAN; S. ALVAREZ; D. CINTEZA; C.
KRARUP*. Univ. of Copenhagen, Rigshospitalet, Carol
Davila Univ. of Med. and Pharm.

11:00 BB16 324.08 Multifunctional nerve conduit for

peripheral nerve regeneration. H. AHN*; M. KIM; J. KIM; J.
HYUN. Dankook Univ., Dankook Univ., Dankook Univ. Col. of
Med.
8:00 BB17 324.09 Benefits of combinatorial therapies for
improving functional recovery in a rat model of facial nerve
injury. E. M. RUNGE*; T. J. ASANTE; H. R. WELCH; C.
L. WALKER; A. R. BEST; J. L. MULDOON; K. J. JONES.
Indiana Univ. Sch. of Med., Richard L Roudebush VAMC,
Indiana Univ. Sch. of Med.

9:00 BB8 323.30 Spinal cord injury-induced pain and motor

deficits in rats. T. NDAM*; J. CUI; Z. QU; M. BEKEMEIER;
D. K. MILLER; A. SIMONYI; W. R. FOLK; G. Y. SUN; Z. GU.
Univ. of Missouri Sch. of Med., Univ. of Missouri Sch. of
Med., Univ. of Missouri, Univ. of Missouri Sch. of Med.

9:00 BB18 324.10 Distinct expression profiles of LncRNAs

between ipsilateral and contralateral in adult rats following
unilateral brachial plexus root avulsion. Y. GUANGYIN*; X.
XU; Y. TANG; L. LIU; X. CHEN; Z. QIU; Q. YAN; Q. ZHU;
Z. WU; L. ZHOU. Zhongshan Sch. of Medicine, Sun YatSen Universi, Zhongshan Sch. of Medicine, Sun Yat-Sen
Universi, Dept. of Anesthesiology, The First Affiliated Hosp.
of Sun Yat-Sen Univ., Zhongshan Sch. of Medicine, Sun Yatsen Univ., Guangdong Province Key Lab. of Brain Function
and Dis.

36 | Society for Neuroscience

8:00 BB7 323.29 Gut dysbiosis impairs recovery after

spinal cord injury. K. A. KIGERL*; L. WANG; J. C. E. HALL;
X. MO; Z. YU; P. G. POPOVICH. The Ohio State Univ., The
Ohio State Univ., The Ohio State Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER

POSTER

325. Primary Olfactory Signal Transduction

326. Auditory Processing: Subcortical

Theme D: Sensory Systems

Theme D: Sensory Systems

Mon. 8:00 AMSan Diego Convention Center,Halls B-H

Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 CC1 325.01 Detection of pup odors by non-canonical

adult vomeronasal neurons expressing an odorant receptor
gene is influenced by sex and parenting status. T. S.
NAKAHARA*; P. G. RIBEIRO; P. H. M. MAGALHAES; P. H.
M. NETTO; X. IBARRA-SORIA; D. W. LOGAN; F. PAPES.
Univ. of Campinas (UNICAMP), Wellcome Trust Sanger Inst.
9:00 CC2 325.02 Native olfactory sensory neuron imaging
with swept confocally-aligned planar excitation (SCAPE)
microscopy. L. XU*; W. LI; V. VOLETI; E. M. C. HILLMAN; S.
J. FIRESTEIN. Columbia Univ., Columbia Univ.

11:00 CC4 325.04 Effects of glycosylation in activity

dependent cAMP mediated olfactory signaling. S. RYU*;
T. SHIM; S. Y. KIM; J. GOLEBIOWSKI; C. MOON. DGIST,
Univ. of Nice Sophia Antipolis.

8:00 CC5 325.05 What makes pineapple smell like a

pineapple? Heres how medicinal chemistry would slice it. N.
TAHIROVA*; E. POIVET; L. XU; S. FIRESTEIN. Columbia
Univ., New York Univ.
9:00 CC6 325.06 Motile cilia in sensory organs: More than
just generating flow? N. JURISCH-YAKSI*; I. REITEN; S.
FORE; R. PELGRIMS; M. HOFFMANN; E. YAKSI. Kavli Inst.
For Systems Neuroscience, NTNU.
10:00 CC7
325.07 Hormonal modulation of pheromone
detection enhances male courtship sucess. H. LIN*; J. W.
WANG. UCSD.
11:00 CC8 325.08 Inhibition of olfactory behavior in
Drosophila melanogaster larvae through antagonism of the
odorant receptor co-receptor (Orco) subunit. D. KEPCHIA; S.
MOLIVER; K. CHOHAN; C. PHILLIPS; C. W. LUETJE*. Univ.
of Miami Miller Sch. of Med.
8:00 CC9 325.09 The locally distinctive cGMP response
in an olfactory sensory neuron of Caenorhabditis elegans.
H. SHIDARA*; K. ASHIDA; K. HOTTA; K. OKA. Lab. of
Biophysics and Neuroinformatics, Keio Univ.
9:00 CC10 325.10 Identifying and characterizing odor
receptors in Caenorhabditis elegans. S. MAHER; M.
HARWOOD; L. RESCH; C. DALTON; S. NATHAN; A. COXHARRIS; R. MORTON; B. MOSQUEDA; E. JEROME; B.
MEADOWS; V. THAKKER; W. MANKINS; L. ROST; H.
RAGHUNATHAN; Y. HSUEH; N. LETOILE; J. J. YOUNG*.
Mills Col., Academia Sinica, Univ. of California San
Francisco.
10:00 CC11 325.11 Biological sex modulates chemosensory
function to bring about sex differences in C. elegans
behavioral prioritization. D. S. PORTMAN*; K. A. FAGAN; E.
WEXLER. Univ. of Rochester.
11:00 DD1 325.12 Characterization of odorant receptor
expression and its glycosylated form in the olfactory and
non-olfactory system. T. SHIM*; S. RYU; S. KIM; G. V.
RONNETT; C. MOON. DGIST.
8:00 DD2 325.13 Cyclophosphamide induced loss in
olfactory cell populations. N. AWADALLAH*; K. B. JOSEPH;
K. PROCTOR; R. DELAY; E. DELAY. Univ. of Vermont, Univ.
of Vermont.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 DD4 326.02 Chronic Ca2+ imaging reveals strong

suppressive effects of anaesthesia on spontaneous and
sound-evoked responses in dorsal inferior colliculus. A. B.
WONG*; J. G. G. BORST. Erasmus MC.
10:00 DD5
326.03 Cell type specific connectivity and
function in auditory midbrain. C. CHEN*; M. CHENG; T.
ITO; M. ONO; S. SONG. Tsinghua Univ., Univ. of Fukui,
Kanazawa Med. Univ.
11:00 DD6 326.04 Nonstationary correlation statistics allow
robust sound category identification. M. SADEGHI; I. H.
STEVENSON; M. A. ESCABI*. Univ. of Connecticut.
8:00 DD7 326.05 Learning and performance variability in
a rodent model of multi-channel cochlear implant use. J.
KING*; I. SHEHU; M. A. SVIRSKY; R. C. FROEMKE. New
York Univ. Sch. of Med., Hunter Col.
9:00 DD8 326.06 The intrinsic physiology of inhibitory
brainstem neurons changes during auditory development. B.
J. CARROLL*; R. BERTRAM; R. L. HYSON, 32301. Florida
State Univ., The Florida State Univ., The Florida State Univ.
10:00 DD9
326.07 Resistance to spike depression of a rat
central axon terminal during in vivo high-frequency firing. M.
C. SIERKSMA*; J. G. G. BORST. Erasmus MC, Erasmus
MC.
11:00 DD10 326.08 The role of nitric oxide in modulating
neuronal activity in the ventral cochlear nucleus. A.
HOCKLEY*; J. I. BERGER; P. A. SMITH; M. N. WALLACE;
A. R. PALMER. MRC IHR, Univ. of Nottingham.
8:00 DD11 326.09 Nitrergic Signalling in the bullfrog IC. A.
W. STAFFORD*. Univ. of Tennessee.
9:00 DD12 326.10 Sensory and motor activity in the
superior colliculus of the actively orienting bat. M. J.
WOHLGEMUTH*, III; C. F. MOSS. Johns Hopkins Univ.,
Johns Hopkins Univ.

POSTER
327. Auditory Processing: Coding and Theory
Theme D: Sensory Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 DD13 327.01 Neuronal activity packets as basic units
of neuronal code. A. LUCZAK*; B. L. MCNAUGHTON; K. D.
HARRIS. Univ. of Lethbridge, Univ. Col. London.
9:00 DD14 327.02 Multi-channel open-loop thalamo-reticular
architectures support thalamocortical wave propagation.
J. W. BROWN*; D. A. LLANO. Univ. of Illinois at UrbanaChampaign, Univ. of Illinois at Urbana-Champaign.
10:00 DD15 327.03 Nominally non-responisve sensory and
frontal cortical cells encode task-relevant variables. M.
INSANALLY*; I. CARCEA; B. ALBANNA; R. FROEMKE.
New York Univ., Fordham Univ.

Neuroscience 2016|Monday AM|37

Mon. AM

10:00 CC3
325.03 A mathematical model for the response of
olfactory sensory neurons to odor mixtures. A. MARASCO*;
A. DE PARIS; M. MIGLIORE. Univ. of Naples Federico II,
Natl. Res. Council, Yale Univ.

8:00 DD3 326.01 Neural coding and discrimination of highorder sound statistics in the inferior colliculus. F. KHATAMI*;
M. SADEGHI; H. L. READ; I. H. STEVENSON; M. A.
ESCABI. Univ. of Connecticut.

11:00 DD16 327.04 Top-down and bottom-up control through

distinct phase-amplitude couplings in macaque auditory
cortex. C. D. MRTON*; M. FUKUSHIMA; S. SCHULTZ; B.
B. AVERBECK. Neural Coding Lab, Imperial Col. London,
NIH/NIMH, RIKEN Brain Sci. Inst.

POSTER
328. Motion Processing
Theme D: Sensory Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 DD17 327.05 Coding sound loudness by pulse

amplitude or pulse duration in cochlear implants: Does
it matter for cortical neurons? V. ADENIS*; P. STAHL;
D. GNASIA; B. GOURVITCH; J. EDELINE. Neuro-Psi,
Neurelec / Oticon Med.
9:00 EE1 327.06 Distinct timescales for neural
discrimination of sound envelope shape in three auditory
cortical fields. A. OSMAN*; C. LEE; M. ESCABI; H.
READ. Univ. of Connecticut, Univ. of Connecticut, Univ. of
Connecticut, Univ. of Connecticut.
10:00 EE2
327.07 Interactions of simultaneous sound
representations in the primate inferior colliculus. S. M.
WILLETT*; V. C. CARUSO; S. T. TOKDAR; J. M. GROH.
Duke Univ.
11:00 EE3
327.08 Persistent activity in auditory cortex
during passive listening. J. LEE; J. E. COOKE*; X. WANG;
D. BENDOR. UCL, Johns Hopkins Univ.
8:00 EE4 327.09 Predominance of dormant sensory
neurons and learning-induced recruitment in auditory cortex.
X. CHOU*; F. LIANG; H. LI; M. ZHOU; Q. FANG; H. W. TAO;
L. I. ZHANG. Zilkha Neurogenetic Inst., USC, USC, Southern
Med. Univ., USC.
9:00 EE5 327.10 Neurofilament heavy chain expression
and neuroplasticity in rat auditory cortex after unilateral and
bilateral deafness. M. PARK*; H. LEE; S. OH. SMG-SNU
Boramae Med. Ctr., Seoul Natl. University, Col. of Med.
10:00 EE6
327.11 Neuronal adaptation to background
sound level statistics in the inferior colliculus of macaques. F.
ROCCHI; R. RAMACHANDRAN*. Vanderbilt Univ. Med. Ctr.
11:00 EE7
327.12 A novel method for analyzing cortical
steady state responses. P. KRAUSS*; A. SCHILLING; C.
METZNER; K. TZIRIDIS; H. SCHULZE. Univ. of ErlangenNurnberg.
8:00 EE8 327.13 The impact of hearing loss on the neural
representation of speech in noise in the gerbil auditory
midbrain. J. A. GARCIA-LAZARO*; D. MCALPINE; R.
SCHAETTE. Ear Inst., Macquarie Univ.
9:00 EE9 327.14 Simultaneous estimation of receptive
fields and intrinsic dynamics of auditory neurons using
affine-invarient MCMC. T. D. ROBBINS; C. MELIZA*. Univ.
of Virginia, Univ. of Virginia, Univ. of Virginia.
10:00 EE10 327.15 Combining multi-unit recording and
flavoprotein fluorescence imaging reveals field- and layerspecific sound-evoked neural responses in the rodent
auditory cortex. J. NISHIKAWA*; T. HAGA; Y. TACHIBANA;
Y. OHTAKA; Y. YANAGAWA; H. OSANAI; T. TATENO.
Hokkaido Univ.

8:00 EE11 328.01 How grit can overcome oculomotor

insufficiencies and change GPA. T. GORJI*; D.
LARRANAGA; A. S. HOCHMAN; J. R. MIER; S. A. DREW.
California State University, Northridge, California State
University, Northridge, California State University, Northridge,
California State University, Northridge, California State Univ.
Northridge.
9:00 EE12 328.02 Apparent motion extrapolates size, shape
and brightness. C. CHUNHARAS*; V. RAMACHANDRAN.
UCSD, Chulalongkorn University, KCMH.
10:00 EE13 328.03 Neural representation of multiple moving
stimuli with competing features in cortical area MT is
drastically altered by spatial arrangement of visual stimuli. S.
WIESNER*; X. HUANG. Univ. of Wisconsin Madison.
11:00 EE14 328.04 The Spatial temporal filter for motion
integration for smooth pursuit eye movements. T.
MUKHERJEE*; C. SIMONCINI; L. C. OSBORNE. Univ. of
Chicago.
8:00 EE15 328.05 Human motion-responsive regions in
intracerebral recordings. P. CARDELLICCHIO*; P. AVANZINI;
F. CARUANA; V. PELLICCIA; G. CASACELI; G. LO RUSSO;
G. RIZZOLATTI; G. A. ORBAN. Univ. of Parma, Niguarda
Hosp.
9:00 EE16 328.06 A 9.4T human fMRI study reveals
differential laminar responses for visual motion in eye- and
world-centered reference frames in area V3A. F. MOLAEIVANEGHI*; K. SCHEFFLER; A. BARTELS. Max-Planck
Inst. for Biol. Cybernetics, Vision and Cognition Lab, Ctr.
for Integrative Neuroscience, Univ. of Tbingen, Dept. of
Psychology, Univ. of Tbingen.
10:00 EE17 328.07 Resolving the apparent motion paradox
by rTMS. J. CSATLOS*; S. SHIMOJO; R. J. BUCHANAN;
Z. NADASDY. Etvs Lrnd Univ., Wigner Res. Ctr. for
Physics, Hungarian Acad. of Sciences, Budapest, Hungary,
CALTECH, Seton Brain and Spine Inst. and UT Austin, Univ.
of Texas at Austin Dell Med. Sch., St. Davids Neurosci. and
Spine Inst.
11:00 EE18 328.08 Selective computation of path-dependent
and-independent rotations in macaque parietal cortex. Z.
CHENG*; B. LIU; Y. GU. Inst. of Neuroscience, CAS.
8:00 FF1 328.09 Hierarchical effects of contrast and
motion coherence in human visual cortex. D. BIRMAN*; J.
GARDNER. Stanford Univ.
9:00 FF2 328.10 Synergistic encoding of multiple visual
features in MT neurons and implications for natural vision. M.
V. MACELLAIO*; B. LIU; L. C. OSBORNE. Univ. of Chicago.
10:00 FF3
328.11 Neural response to object motion-indepth independent of vergence eye movements. A. WADA*;
Y. SAKANO; H. MIZUSHINA; H. ANDO. Natl. Inst. of Info.
and Communications Technol., Osaka Univ., Tokushima
Univ.
11:00 FF4
328.12 Synchronous human motion is processed
by two distinct mechanisms in the brain. N. ALP*; A.
NIKOLAEV; N. KOGO; J. WAGEMANS. KU Leuven, KU
Leuven.

38 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 FF5 328.13 GABA and visual context processing

in autism spectrum disorders. M. SCHALLMO*; A. V.
FLEVARIS; A. M. KALE; R. A. BERNIER; S. O. MURRAY.
Univ. of Washington.
9:00 FF6 328.14 Effects of stimulus size and contrast on
motion perception: Comparing psychophysics and fMRI. A.
V. FLEVARIS*; M. SCHALLMO; A. KALE; S. O. MURRAY.
Univ. of Washington Dept. of Psychology.
10:00 FF7
328.15 Response properties of global motion
sensitive neurons in the zebra finch vestibulocerebellum. A.
H. GAEDE*; D. L. ALTSHULER. Univ. of British Columbia.
11:00 FF8
328.16 Voluntarily tracking moving clouds
Effects of spatial frequency bandwidth on human smooth
pursuit. K. MANSOUR POUR*; L. PERRINET; G. MASSON;
A. MONTAGNINI. CNRS, Inst. De Neurosciences De La
Timone, Inst. de Neurosciences de la Timone, UMR7289,
CNRS & Aix-Marseille Univ.

11:00 GG2 328.28 Ferret visual area PSS: A model system

for studying functional development of higher order motion
cortex. A. A. LEMPEL*; A. DANIELS; J. M. LAW; K. J.
NIELSEN. Johns Hopkins Univ., Zanvyl Krieger Mind/Brain
Inst., Johns Hopkins Univ.
8:00 GG3 328.29 Binocular contrast summation for visual
motion processing in humans. C. QUAIA*; B. M. SHELIGA;
L. M. OPTICAN; B. G. CUMMING. Natl. Eye Inst.
9:00 GG4 328.30 Human white-matter pathway
communicating parietal and posterior-insular cortex.
H. TAKEMURA*; M. UESAKI; H. ASHIDA. Natl. Inst. of
Information and Communicatio, Japan Society for the
Promotion of Sci., Osaka Univ., Kyoto Univ., Ritsumeikan
Univ.

POSTER
329. Visual Motion

9:00 FF10 328.18 The neural mechanisms in MST

underlying Pinna- Brelstaff rotational visual illusions. J.
LUO*; X. LI; K. HE; J. YIN; I. ANDOLINA; Y. GU; W. WANG.
Inst. of Neurosci.

8:00 GG5 329.01 Integration of visual and extra-retinal

self-motion during voluntary head movements in the
human brain. A. SCHINDLER*; A. BARTELS. Vision and
Cognition Lab., Univ. of Tbingen, Max Planck Inst. for Biol.
Cybernetics.

10:00 FF11 328.19 Optic flow parsing in macaque monkeys.

N. E. PELTIER*; D. E. ANGELAKI; G. C. DEANGELIS. Univ.
of Rochester, Baylor Col. of Med., Univ. of Rochester.
11:00 FF12 328.20 Training alters the causal contribution of
area MT to visual motion perception. L. D. LIU*; C. C. PACK.
McGill Univ., McGill Univ.
8:00 FF13 328.21 Localization and functional
characterization of human area prostriata using fMRI.
H. YAMAMOTO*; Z. LIN; K. OKAMOTO; S. OHNO; S.
KANAZAWA; J. WU. Kyoto Univ., Okayama Univ., Dept.
of Radiology, Okayama Univ. Hospital, Okayama Univ.,
Okayama Univ.
9:00 FF14 328.22 Pupillary response to objects and
perceived motion. S. BEUKEMA*; B. JENNINGS; J. OLSON;
F. KINGDOM. McGill Univ., McGill Univ., McGill Univ.
10:00 FF15 328.23 A biologically-based computational model
to deliver unambiguous motion information and overcome
the X-junction illusion. P. ZAREI ESKIKAND; T. KAMENEVA;
M. R. IBBOTSON*; A. BURKITT; D. GRAYDEN. Univ. of
Melbourne, Natl. Vision Res. Inst.
11:00 FF16 328.24 Retinal stabilization reveals limits of
efference copy influence on heading tuning in the medial
superior temporal area (MST). T. MANNING*; K. BRITTEN.
Univ. of California, Davis.
8:00 FF17 328.25 Functional analysis of visual responses
with an ultra high filed MRI in awake marmorets. T.
KANEKO*; J. HATA; N. KISHI; H. OKANO. RIKEN Brain Sci.
Inst., Keio Univ. Sch. of Med.
9:00 FF18 328.26 Neurons in macaque area MT signal
depth from motion parallax by combining extra-retinal signals
regarding both eye and body rotation. V. KOGAN*; D. E.
ANGELAKI; G. C. DEANGELIS. Univ. of Rochester, Baylor
Col. of Med.
10:00 GG1 328.27 Visual processing of motion-selective
information in the larval zebrafish brain. C. RIEGLER*; D.
GUGGIANA-NILO; F. ENGERT. Harvard Univ., Univ. of
Vienna.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Theme D: Sensory Systems

Mon. 8:00 AMSan Diego Convention Center,Halls B-H

9:00 GG6 329.02 Dopamine preserves visual motion

perception despite noise interference of human V5/MT. B.
M. SEEMUNGAL*; N. YOUSIF; R. Z. FU; B. ABOU-EL-ELABOURQUIN; V. BHRUGUBANDA; S. R. SCHULTZ. Imperial
Col. London, Imperial Col. London, Imperial Col. London.
10:00 GG7 329.03 Frequency of visual oscillations
in adults with ASD: A pilot study. E. OREKHOVA*; J.
SCHNEIDERMAN; S. LUNDSTRM; B. RIAZ; S. RAJAEI;
N. HADJIKHANI; O. SYSOEVA; T. STROGANOVA; C.
GILLBERG. Univ. of Gothenburg, Moscow State Univ. of
Psychology and Educ., MedTech West, Sahlgrenska Acad.
and Univ. of Gothenburg, Univ. of Gothenburg, Harvard Med.
School, MGH/MIT/HST.
11:00 GG8 329.04 Selective cortical responses to relative
object/background motion. M. I. SERENO*; C. OZOLINS;
M. SOOD; C. GALLETTI; P. FATTORI. Univ. of California
San Diego Dept. of Cognitive Sci., Birkbeck Univ. of London,
Univ. di Bologna, Univ. di Bologna.
8:00 GG9 329.05 (Mis-)perception of motion in depth
originates from underestimation of binocular extraretinal
signals. T. MURDISON*; G. LECLERCQ; P. LEFVRE; G.
BLOHM. Queens Univ., Canadian Action and Perception
Network (CAPNet), Assn. for Canadian Neuroinformatics and
Computat. Neurosci. (CNCN), Univ. catholique de Louvain,
Univ. catholique de Louvain.
9:00 GG10 329.06 Representation of egomotion in
non-human primate. B. R. COTTEREAU*; S. RIMA; Y.
TROTTER; A. T. SMITH; J. DURAND. Ctr. de recherche
Cerveau & Cognition, Royal Holloway.
10:00 GG11 329.07 Fewer neurons in MT are direction
selective to random dot stimuli after chronic V1 lesions in
adult marmoset monkeys. M. A. HAGAN*; T. CHAPLIN; K. R.
HUXLIN; M. G. P. ROSA; L. L. LUI. Monash Univ., Univ. of
Rochester.

Neuroscience 2016|Monday AM|39

Mon. AM

8:00 FF9 328.17 High spatial frequency components

of white noise stimuli suppress initial disparity-vergence
responses in humans. B. M. SHELIGA*; C. QUAIA; E. J.
FITZGIBBON; B. G. CUMMING. Natl. Eye Inst.

11:00 GG12 329.08 The effect of a transient congenital visual

deprivation on the neural systems for visual and sound
motion processing. D. BOTTARI*; R. KEKUNNAYA; M.
HENSE; S. SOURAV; R. BALACHANDAR; N. F. TROJE;
B. RDER. Univ. of Hamburg, Biol. Psychology and
Neuropsychology, Univ. of Hamburg, LV Prasad Eye Inst.,
Queens Univ.
8:00 GG13 329.09 Gain adaptation with and without rate
adaptation in cortical area MT. B. LIU*; M. MACELLAIO; L.
OSBORNE. Univ. of Chicago.
9:00 GG14 329.10 Efficient coding of optic flow can account
for MSTd visual response properties. M. BEYELER*; N.
DUTT; J. L. KRICHMAR. Univ. of California Irvine Dept. of
Computer Sci., Univ. of California, Irvine, Univ. of California,
Irvine.
10:00 HH1
329.11 Task- and time-dependence of population
codes for motion in marmoset MT. E. ZAVITZ*; H. YU; M. G.
P. ROSA; N. S. C. PRICE. Monash Univ.
11:00 HH2 329.12 Dynamics of population codes of
stimulus features in primate area MT. E. GODDARD*; S. G.
SOLOMON; T. A. CARLSON. Macquarie Univ., ARC Ctr. of
Excellence in Cognition and its Disorders (CCD), Univ. of
Sydney, Univ. Col. London.
8:00 HH3 329.13 A neural model of how direction and
disparity signals interact in MT and MSTd to extract object
motion during self-motion. O. W. LAYTON*; B. R. FAJEN.
Rensselaer Polytechnic Inst., Rensselaer Polytechnic Inst.
9:00 HH4 329.14 Causal evidence of directional signals
in macaque middle temporal area pooled for heading
computation based on optic flow. Y. GU*; X. YU. Inst. of
Neurosci., Inst. of Neurosci.
10:00 HH5
329.15 Rats can process high level motion: A
behavioral study using a discrimination task. R. BELLACOSA
MAROTTI*; S. E. ROSSI; D. F. ZOCCOLAN. SISSA- Intl.
Sch. For Advanced Studied.
11:00 HH6 329.16 MT neurons have different tuning
properties at contrast threshold and above. A. PAWAR*; S.
GEPSHTEIN; T. D. ALBRIGHT. Salk Inst. VCL-A.
8:00 HH7 329.17 The appearance and disappearance of
visual forms defined by differential motion evokes distinctive
EEG responses in school-age children. R. O. GILMORE*;
D. A. FOUAD, 16802; M. G. DEXHEIMER, 16802; A. R.
SEISLER. Penn State Univ.
9:00 HH8 329.18 Visual projection neurons link feature
detection to distinct behavioral programs in Drosophila.
M. WU*; A. NERN; W. WILLIAMSON; M. MORIMOTO; M.
REISER; G. CARD; G. RUBIN. HHMI/Janelia Res. Campus,
HHMI/Janelia Res. Campus.
10:00 HH9
329.19 Dynamic motion-tuning of macaque MST
neurons before impending saccades. J. DUIJNHOUWER*;
B. KREKELBERG. Rutgers University-Newark.
11:00 HH10 329.20 Freeze or flight: Vision guides choice
of defence strategies in mice. G. DE FRANCESCHI; T.
VIVATTANASARN; A. B. SALEEM; S. G. SOLOMON*. Univ.
Col. London.
8:00 HH11 329.21 Sharper, stronger, faster upper visual field
representation in primate superior colliculus: Implications for
afferent and efferent collicular topography. Z. M. HAFED*; C.
CHEN. Werner Reichardt Ctr. For Integrative Neurosci.
9:00 HH12 329.22 Visual receptive fields and cortical
oscillations during saccadic suppression in area V4. T.
P. ZANOS*; P. J. MINEAULT; D. GUITTON; C. C. PACK.
Feinstein Inst. For Med. Res., Montreal Neurolog. Inst.
40 | Society for Neuroscience

POSTER
330. Visual Cognition: Decision Making
Theme D: Sensory Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 HH13 330.01 Monitoring cortical state to explain
variability in visual detection behavior and evoked responses
in primary visual cortex. G. T. NESKE*; D. A. MCCORMICK.
Yale Univ.
9:00 HH14 330.02 Voltage imaging in mouse primary visual
cortex reveals late correlates of perceptual decisions.
D. SHIMAOKA*; N. A. STEINMETZ; K. D. HARRIS; M.
CARANDINI. Univ. Col. London.
10:00 HH15 330.03 The effects of uncertainty on change
detection in the marmoset. M. AVERY*; J. REYNOLDS. Salk
Inst.

11:00 HH16 330.04 Dissociation of confidence from

performance in the monkey. S. CHO*; P. GRIMALDI; H. LAU;
M. A. BASSO. UCLA.
8:00 HH17 330.05 Effects of optogenetic inactivation in
macaque areas MT and MST on choice and confidence
during a direction discrimination task. C. R. FETSCH*; Y.
EL-SHAMAYLEH; N. N. ODEAN; G. D. HORWITZ; M. N.
SHADLEN. HHMI & Columbia Univ., Univ. of Washington.
9:00 II1
330.06 Monkeys use different strategies to
achieve near-optimal performance on a visual motion
discrimination task with unequal rewards. Y. FAN*;
J. I. GOLD; L. DING. Univ. of Pennsylvania, Univ. of
Pennsylvania.
10:00 II2
330.07 Inactivation of the lateral prefrontal cortex
increases neuronal activity in the ipsilateral area MT during
memory-guided comparisons of visual motion. C. CHU; P. M.
SPINELLI; T. PASTERNAK*. Univ. of Rochester.
11:00 II3
330.08 Noise correlations of macaque MT
neurons for bistable stimuli are task-dependent. I. KANG; B.
G. CUMMING*. Natl. Eye Institute, NIH, Natl. Eye Institute,
NIH.
8:00 II4
330.09 Perception of object motion during
self-motion: Neural computations for flexible reference
frame transformations in macaque areas VIP and MSTl. R.
SASAKI*; D. E. ANGELAKI; G. C. DEANGELIS. Univ. of
Rochester, Dept. of Neurosci., Baylor Col. of Med., Dept. of
Brain and Cognitive Sciences, Univ. of Rochester.
9:00 II5
330.10 Choice-driven and stimulus-related
activity is confounded in parietal neurons: Implications for
choice probabilities. A. ZAIDEL*; G. C. DEANGELIS; D.
E. ANGELAKI. Bar Ilan Univ., Baylor Col. of Med., Univ. of
Rochester.
10:00 II6
330.11 Modality-dependent evidence
accumulation in multisensory decision-making. H. HOU*; Y.
ZHAO; Q. K. ZHENG; Y. GU. Inst. of Neuroscience, CAS.
11:00 II7
330.12 Topographical organization, local
cortical connectivity, and feature encoding in frontoparietal
cortices. N. Y. MASSE*; A. SARMA; J. M. HODNEFIELD; S.
SWAMINATHAN; D. J. FREEDMAN. Univ. of Chicago.
8:00 II8
330.13 Contributions of parietal and prefrontal
cortices to categorical match vs. non-match decisions. Y.
ZHOU*; S. SWAMINATHAN; D. FREEDMAN. The Univ. of
Chicago.
9:00 II9
330.14 Interaction between spatial and feature
attention in posterior parietal cortex. G. IBOS*; D. J.
FREEDMAN. The Univ. of Chicago.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 II10
330.15 Looking where we want to look: Relating
neuronal and behavioral correlates of image familiarity. W.
J. JOHNSTON*; K. MOHAN; D. J. FREEDMAN. Univ. of
Chicago.

11:00 JJ5
331.04 Characteristic of visual feedback delay
detection in apraxia following stroke. S. MORIOKA*; S.
NOBUSAKO; R. ISHIBASHI; M. OSUMI; T. ZAMA; S.
SHIMADA. Kio Univ., Murata Hosp., Meiji Univ.

11:00 II11
330.16 Task-specific vs. generalized category
encoding in parietal cortex during task switching.
K. MOHAN*; O. ZHU; S. K. SWAMINATHAN; D. J.
FREEDMAN. The Univ. of Chicago.

8:00 JJ6 331.05 Attractive and repulsive multisensory

interactions in time perception. L. LAI*; J. M. YAU. Rice
Univ., Baylor Col. of Med.

8:00 II12 330.17 NMDAR antagonist ketamine affects

sensitivity to irrelevant information and onset of build-up
activity in the parietal cortex. Y. SUDA*; T. UKA. Tamagawa
Univ., Grad. Sch. of Medicine, Juntendo Univ.
9:00 II13 330.18 Choice certainty reveals equivalence of
POMDP and drift-diffusion model. K. KHALVATI; R. KIANI; R.
P. RAO*. Univ. of Washington, New York Univ.

11:00 II15
330.20 Evidence for a predictive coding account
of bistable perception. K. SCHMACK*; V. WEILNHAMMER;
H. STUKE; G. HESSELMANN; P. STERZER. Charit
Universittsmedizin Berlin.
8:00 II16 330.21 Cortical dynamics of surprise and
entropy during stochastic perceptual transition. J. LEE*; S.
LEE. Seoul Natl. Univ.
9:00 II17 330.22 Sparse neural coding at the limits of
visual performance. B. SRIRAM*; L. LI; A. CRUZ-MARTN;
A. GHOSH. UCSD Div. of Biol., Boston Univ., F. HoffmannLa Roche.
10:00 JJ1
330.23 Impaired use of priors in patients with
Parkinsons disease is independent of dopaminergic
medications. A. PERUGINI*; M. A. BASSO. UCLA, Fuster
Lab. of Cognitive Neuroscience, Departments of Psychiatry
and Biobehavioral Sci. and Neurobiology, The Semel Inst. for
Neurosci. and Human Behavior, The David Geffen Sch. of
Medicine, UCLA.

POSTER
331. Temporal Factors of Crossmodal Integration
Theme D: Sensory Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 JJ2 331.01 Multisensory convergence in brainstem
structures: Transfer of taste and odor information between
the NTS and the PbN in awake, freely licking rats. O. D.
ESCANILLA*; P. M. DI LORENZO. Binghamton Univ.
9:00 JJ3 331.02 Temporal ensemble coding in subsecond
sensory events: An MEG study. L. CHEN*; H. XU. Dept. of
Psychology, Peking Univ., Key Lab. of Machine Perception
(Ministry of Education), Peking Univ., Acad. of Psychology
and Behavior, Tianjin Normal Univ.
10:00 JJ4
331.03 Sensorimotor delays and the vestibular
control of standing balance. B. G. RASMAN*; R. M.
PETERS; R. CHUA; J. T. INGLIS; J. BLOUIN. Univ. of
British Columbia, Djavad Mowafaghian Ctr. for Brain Health,
Univ. of British Columbia, Intl. Collaboration on Repair
Discoveries, Univ. of British Columbia, Inst. for Computing,
Information and Cognitive Systems, Univ. of British
Columbia.

10:00 JJ8
331.07 Investigating audiovisual temporal
processing in rats using electrophysiology and novel operant
conditioning-based behavioral tasks. A. L. SCHORMANS*;
K. SCOTT; D. STOLZBERG; B. L. ALLMAN. Western Univ.,
Western Univ.
11:00 JJ9
331.08 Perceived timing of a postural
perturbation with and without visual feedback. R. E.
MCILROY*; M. BARNETT-COWAN. Univ. of Waterloo.
8:00 JJ10 331.09 Using visual-haptic synchrony to facilitate
and manipulate cross-modal integration. J. HEGDE*.
Augusta Univ., Augusta Univ.
9:00 JJ11 331.10 The magnitude of the size-weight
illusion depends on when size information is provided. I. A.
KULING*; M. A. PLAISIER; E. BRENNER; J. B. J. SMEETS.
VU Univ. Amsterdam.
10:00 JJ12 331.11 Audiovisual simultaneity and temporal
order in the young and elderly: An ERP study. A.
BASHARAT*; G. BEDARD; A. WISE; M. ADAMS; W. R.
STAINES; M. BARNETT-COWAN. Univ. of Waterloo.
11:00 JJ13 331.12 A common parieto-frontal network
for impact prediction to the face and peripersonal space
encoding: An non-human primate fMRI study. J. CLRY*; O.
GUIPPONI; S. ODOUARD; C. WARDAK; S. BEN HAMED.
Ctr. De Neurosci. Cognitive.

8:00 JJ14 331.13 Respiration modulates neuronal activity in

visual cortex. S. S. MCAFEE*; Y. LIU; D. H. HECK. Univ. of
Tennessee Hlth. Sci. Ctr.
9:00 JJ15 331.14 oscillations reflect supramodal
information during perceptual judgment. S. HAEGENS*; J.
VERGARA; L. LEMUS; R. ROMO. Donders Inst. For Brain,
Cognition & Behaviour, Columbia Univ. Med. Ctr., Univ.
Nacional Autnoma de Mxico, El Colegio Nacional.
10:00 JJ16 331.15 Perceived timing of active head
movement with and without visual feedback. W. CHUNG*; M.
BARNETT-COWAN. Univ. of Waterloo, Univ. of Waterloo.
11:00 JJ17 331.16 Inference of multimodal duration
information from unimodal subjective durations. K. YUASA*;
Y. YOTSUMOTO. NICT, JSPS, The Univ. of Tokyo.
8:00 KK1 331.17 Multisensory interactions in frequency
sweep perception. L. E. CROMMETT*; D. MADALA; J. M.
YAU. Baylor Col. of Med., Rice Univ.
9:00 KK2 331.18 Genetic determinants of multisensory
integration. A. WISE*; M. BARNETT-COWAN; R. DUNCAN.
Univ. of Waterloo, Univ. of Waterloo.
10:00 KK3
331.19 Utilizing multisensory integration to
improve auditory alarm design in the intensive care unit. J.
SCHLESINGER*; M. WALLACE. Vanderbilt Univ. Med. Ctr.,
Vanderbilt Univ.
11:00 KK4
331.20 Neural correlates of rapid audiovisual
temporal recalibration. J. NOEL*; D. M. SIMON; M. M.
WALLACE. Vanderbilt Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|41

Mon. AM

10:00 II14
330.19 Face discrimination under uncertainty
depends on linear integration of visual features over space
and time. G. OKAZAWA*; L. SHA; R. KIANI. New York Univ.

9:00 JJ7 331.06 Using a novel prepulse inhibition

paradigm and electrophysiology to assess audiovisual
temporal integration. K. SCOTT; A. SCHORMANS; S.
SCHMID; B. L. ALLMAN*. Univ. of Western Ontario.

8:00 KK5 331.21 Weighting perception of ambiguous

motion stimuli: The curious case of audition trumping
vision. A. THELEN*; M. CHADHA; A. R. NIDIFFER; R.
RAMACHANDRAN; M. T. WALLACE. Vanderbilt Brain Inst.,
Vanderbilt Univ.
9:00 KK6 331.22 Integration of ambiguous auditory-visual
motion stimuli to form perceptual judgements. M. CHADHA*;
A. THELEN; A. R. NIDIFFER; R. RAMACHANDRAN; M. T.
WALLACE. Vanderbilt Univ. Med. Ctr., Vanderbilt Univ. Med.
Ctr.
10:00 KK7
331.23 Cortical multisensory circuits: Implications
for autism spectrum disorder. G. E. DICARLO*; M. T.
WALLACE. Vanderbilt Univ.
11:00 KK8
331.24 Magnetic fields modulate horizontal
movements of the fruit fly, Drosophila melanogaster. K.
CHAE*; S. LEE; I. OH. Kyungpook Natl. Univ.

8:00 KK9 331.25 Audiovisual integration in cochlear

implant users. I. M. BUTERA*; R. A. STEVENSON; R.
H. GIFFORD; M. T. WALLACE. Vanderbilt Univ., Univ. of
Western Ontario, Vanderbilt Univ.
9:00 KK10 331.26 Neurophysiological substrates and
developmental sequelae of sensory seeking in infants at high
risk for autism spectrum disorder. T. G. WOYNAROSKI*;
C. DAMIANO; D. SIMON; L. IBANEZ; M. MURIAS; M.
WALLACE; W. L. STONE; C. CASCIO. Vanderbilt Univ. Med.
Ctr., Duke Univ., Vanderbilt Univ., Univ. of Washington, Duke
Univ., Vanderbilt Univ. Med. Ctr.
10:00 KK11 331.27 Neural basis of the expanded temporal
binding window in autism spectrum disorder: An MEG
study. J. CHAN*; M. NAUMER; A. LANGER; C. FREITAG;
J. KAISER. Univ. Col. Cork, Goethe-University, GoetheUniversity.
11:00 KK12 331.28 Neuromodulation of primary
somatosensory cortex alters auditory perception. S.
CONVENTO*; M. RAHMAN; J. M. YAU. Baylor Col. of Med.

POSTER
332. Reaching: Human Motor-Learning and Adaptation
Theme E: Motor Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 KK13 332.01 The influence of visual feedback on
perturbed reaches. F. ZAHED*; M. BERNIKER. Univ. of
Illinois at Chicago, Univ. of Illinois at Chicago.
9:00 KK14 332.02 Separate motor memories are
engaged when controlling different points on the same
tool. J. HEALD*; J. N. INGRAM; J. R. FLANAGAN; D. M.
WOLPERT. The Univ. of Cambridge, Queens Univ.
10:00 KK15 332.03 Proprioceptive and predicted
consequences of action disentangled. B. M. T HART*; A. A.
MOSTAFA; D. Y. P. HENRIQUES. York Univ.

9:00 KK18 332.06 Multisensory effects of force field

adaptation. B. M. SEXTON*; Y. LIU; A. K. LYNCH; D. J.
OSTRY; H. J. BLOCK. Indiana Universtiy, Indiana Univ.,
McGill Univ., Yale Univ.
10:00 LL1
332.07 Estimating properties of the fast and
slow adaptive processes during sensorimotor learning. S. T.
ALBERT*; R. SHADMEHR. Johns Hopkins Sch. of Med.
11:00 LL2
332.08 Using a real-world chopping task to study
interference in a motor learning task. A. H. NEPOTIUK*; L.
E. BROWN. Trent Univ.
8:00 LL3 332.09 Structure of solution space in a redundant
motor task determines learning. Z. ZHANG*; M. HUBER; S.
PARK; D. STERNAD. Northeastern Univ.
9:00 LL4 332.10 Use-dependent learning reduces
movement initiation latency. F. MAWASE*; A. HAITH; P.
CELNIK. Johns Hopkins Univ., Johns Hopkins Univ.
10:00 LL5
332.11 Augmenting motor generalization by
inducing instance-reliant plasticity. S. BAO*; Y. LEI; J.
WANG. Univ. of Wisconsin Milwaukee, Univ. of Miami, Univ.
of Wisconsin Milwaukee.
11:00 LL6
332.12 Retrieval of a motor memory triggered
by a previously unseen error. N. J. POPP*; M. HARPER; A.
M. HAITH. Univ. of Western Ontario, Johns Hopkins Univ.,
Johns Hopkins Univ.
8:00 LL7 332.13 Selective retroactive interference
between two different functional motor tasks: Effect of
training order. T. K. LUMBRERAS*; C. S. WALTER; S. Y.
SCHAEFER. Utah State Univ., Univ. of Utah, Arizona State
Univ.

9:00 LL8 332.14 Motor skill transfer of functional tasks: Is

task similarity important? C. WALTER*; G. N. OLIVIER; L.
G. RICHARDS; S. Y. SCHAEFER. Univ. of Utah, Utah State
Univ.
10:00 MM1 332.15 Motor adaptation in head-mounted
virtual reality versus conventional training. J. M. ANGLIN*; T.
SUGIYAMA; S. LIEW. USC.
11:00 MM2 332.16 Motor adaptation during a planar
reaching using robotic device. J. SHIN*; G. PARK; H. KIM.
Natl. Rehabil. Ctr., Natl. Rehabil. Ctr.
8:00 MM3 332.17 Dissociating the role of sensory prediction
error from performance errors in strategy based motor
adaptation. K. LEE*; Y. OH; J. IZAWA; N. SCHWEIGHOFER.
USC, Univ. of Tsukuba.
9:00 MM4 332.18 Learning mechanism of nondominant
single-joint elbow extension movements. J. SONG*; K. LEE;
S. Y. SCHAEFER; N. SCHWEIGHOFER. USC, Utah State
Univ., USC.
10:00 MM5 332.19 The effect of signal-dependent noise
on error- and reward-based learning of an isometric force
visuomotor transformation task. V. BARRADAS PATINO*; N.
SCHWEIGHOFER. USC, USC.

11:00 KK16 332.04 Time course of reach adaptation and

proprioceptive recalibration: During volitional and exposure
training with a rotated cursor. J. E. RUTTLE*; D. Y. P.
HENRIQUES. York Univ., York Univ.

11:00 MM6 332.20 Neural Substrates of reinforcement

learning in a continuous visuo-motor task. N.
SCHWEIGHOFER*; S. KIM; T. HORIKAWA; S. SCHAAL; Y.
KAMITANI; D. CALLAN. USC, Northwestern U., ATR, Univ.
of Southern California and Max Planck Inst., Kyoto Univ.

8:00 KK17 332.05 Dual adaptation to opposing visuomotor

rotations by skewing movement trajectories. M. N. AYALA*;
D. Y. P. HENRIQUES. York Univ., York Univ.

8:00 MM7 332.21 Eye-hand coordination during visuomotor

learning: Effects of terminal visual feedback. M. K. RAND*;
S. RENTSCH. IfADo-Leibniz Res. Ctr.

42 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 MM8 332.22 Sensorimotor adaptation to small

visual errors: Error size-dependent effects on rate but not
magnitude. H. E. KIM*; J. R. MOREHEAD; M. J. BOGGESS;
W. SHWE; T. C. DIXON; D. PARVIN; R. B. IVRY. Univ.
of California, Berkeley, Harvard Univ., Univ. of California,
Berkeley.
10:00 MM9 332.23 Sequence specific motor learning in an
immersive virtual environment. J. BAER*; J. C. STEWART.
Univ. of South Carolina.
11:00 MM10 332.24 Effect of perturbation uncertainty on the
retention of a new visuomotor relationship. C. CANAVERAL*;
F. BERRIGAN; P. BERNIER. Univ. De Sherbrooke.
8:00 MM11 332.25 Spatiotemporal properties of motor
adaptation generalization. W. ZHOU*; J. FITZGERALD; K.
COLUCCI-CHANG; K. MURTHY; W. M. JOINER. George
Mason Univ.

11:00 NN8 333.04 Neural decoding of attentional selection

in multi-speaker environments without access to separated
sources. Z. CHEN*; J. OSULLIVAN; S. SHETH; G.
MCKANN; A. D. MEHTA; N. MESGARANI. Columbia Univ.
Counseling and Psychological S, The Neurolog. Inst.,
Hofstra North Shore LIJ Sch. of Med., Feinstein Inst. for
Med. Res.
8:00 NN9 333.05 Brain Computer Interface human
platform to control a 4-limb exoskeleton based on the
ECoG-recording implant WIMAGINE: Toward clinical trials.
C. MESTAIS*; G. CHARVET; F. SAUTER; N. ABROUG;
S. COKGUNGOR; T. COSTECALDE; M. FOERSTER;
E. LABYT; B. MORINIERE; D. RATEL; M. SCHAEFFER;
N. TORRES-MARTINEZ; A. VERNEY; I. VERGARA; A.
YELISYEYEV; T. AKSENOVA; A. BENABID. CEA-LETICLINATEC, CEA-LIST.
9:00 NN10 333.06 Adaptive identification of highdimensional brain network dynamics to track non-stationarity
and plasticity. Y. YANG*; E. F. CHANG; M. M. SHANECHI.
USC, Univ. of California, San Francisco.

10:00 NN1
332.27 Rotation of preferred direction of
motor primitive explains the dependence of visuomotor
adaptation rate on shape of visuomotor map. T. HAYASHI*;
K. TAKIYAMA; D. NOZAKI. The Univ. of Tokyo, Grad Sch.
Educ, Tokyo Univ. of Agr. and Technol.

10:00 NN11 333.07 Cortical activity during object grasp

represents movement and force differently. R. D. FLINT*,
III; M. C. TATE; M. W. SLUTZKY. Northwestern Univ.,
Northwestern Univ., Northwestern Univ., Northwestern Univ.,
Rehabil. Inst. of Chicago.

11:00 NN2 332.28 Opposite effects of reward probability on

learning and motivation in a 3D visuomotor adaptation task.
K. VAN DER KOOIJ*; K. E. OVERVLIET; L. OOSTWOUDWIJDENES; J. B. J. SMEETS. Vrije Univ. Amsterdam, The
Netherlands, Univ. Hamburg, Radboud Univ.

11:00 NN12 333.08 Using deep learning techniques to

decode electrocorticographic signals. T. PAILLA*; K. J.
MILLER; V. GILJA. Univ. of California San Diego, Stanford
Univ. Sch. of Med.

8:00 NN3 332.29 Planning different follow-throughs, rather

than their execution, activates separate motor memories. H.
R. SHEAHAN*; D. W. FRANKLIN; D. M. WOLPERT. Univ. of
Cambridge, Tech. Univ. of Munich.
9:00 NN4 332.30 The effects of cognitive aging on
attentional context in visuomotor learning. E. K. FESTA*; T.
WANG; W. C. HEINDEL; J. SONG. Brown Univ.

POSTER
333. Neuroprosthetics: eCoG
Theme E: Motor Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 NN5 333.01 Unravelling temporal dynamics of
sensorimotor cortex activity during speech for BCI decoding.
E. SALARI*; Z. V. FREUDENBURG; M. J. VANSTEENSEL;
N. F. RAMSEY. Univ. Med. Ctr. Utrecht.
9:00 NN6 333.02 Preclinical chronical implantation of
the wimagine ECOG recording implant: A sheep study. C.
CRETALLAZ*; M. FOERSTER; F. SAUTER-STARACE;
T. COSTECALDE; D. RATEL; C. GAUDE; A. LAMBERT;
G. CHARVET; C. MESTAIS; N. TORRES. CEA LETI/
CLINATEC.
10:00 NN7
333.03 WIMAGINE: An ECoG recording implant
validated for clinical trials. G. CHARVET*; C. MESTAIS;
F. SAUTER-STARACE; M. FOERSTER; A. LAMBERT; N.
TORRES-MARTINEZ; T. COSTECALDE; C. CRETALLAZ;
D. RATEL; A. BENABID. CEA/LETI/CLINATEC- MINATEC
Campus.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 NN13 333.09 Online coordinated user-computer based

decoding of electrocorticographic signals for brain-machine
interfaces. A. PATEL*; V. ELANGO; F. BAEK; K. J. MILLER;
V. GILJA. UCSD, Stanford Univ. Sch. of Med.
9:00 NN14 333.10 Decoding naturalistic kinematic states
using electrocorticography in humans. P. G. GABRIEL*; W.
K. DOYLE; O. DEVINSKY; D. FRIEDMAN; T. THESEN; V.
GILJA. UCSD, New York University, Langone Med. Ctr.
10:00 OO1 333.11 Adaptation of neural population activity
in rat cortex connected to ECoG-based BMI system. M.
YOKOTA*; Y. KUNIMURA; T. SUZUKI. Osaka Univ., Natl.
Inst. of Information and Communications Technol.
11:00 OO2 333.12 Behavior classification using multi-site
LFP and ECOG signals. A. O. HEBB*; H. GOLSHAN; M.
MAHOOR; J. NEDRUD; S. HANRAHAN. Colorado Brain and
Spine Inst., Univ. of Denver, Colorado Neurolog. Inst.
8:00 OO3 333.13 Electrocorticographic features of
therapeutic deep brain stimulation in Tourette syndrome. J.
B. SHUTE*; E. OPRI; R. MOLINA; J. ROSSI; K. FOOTE; M.
OKUN; A. GUNDUZ. UF, UF, UF, UF, UF.
9:00 OO4 333.14 Using low frequency components to
predict speed and position of fingers during execution of a
motor task. J. F. DELGADO SAA*. Univ. Del Norte.

POSTER
334. Neuroprosthetics: Network and Motor Processing
Theme E: Motor Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 OO5 334.01 Effects of speed tuning on trajectory
decoding. Y. INOUE*; X. ZHOU; A. B. SCHWARTZ. Osaka
Univ., Systems Neurosci. Institute, Univ. of Pittsburgh,
Biomed. Engineering, Carnegie Mellon Univ.
Neuroscience 2016|Monday AM|43

Mon. AM

9:00 MM12 332.26 Short-term maintenance of motor memory

induced by memory retrieval. A. SASAKI*; D. NOZAKI. Univ.
of Tokyo.

9:00 OO6 334.02 Adaptation of motor planning activity

in monkey motor, premotor and parietal cortices during
BCI control of 3d reaches. E. FERREA*; P. MOREL; M.
BERGER; A. GAIL. German Primate Ctr., Bernstein Ctr. for
Computat. Neurosci., Fac. of Biol. and Psychology, GeorgAugust Univ.
10:00 OO7 334.03 Coordinate frames for encoding reach
movements by single neurons in the human posterior
parietal cortex. M. JAFARI*; T. AFLALO; N. POURATIAN;
E. ROSARIO; D. OUELLETTE; K. PEJSA; R. ANDERSEN.
Caltech, Univ. of California Los Angeles, Casa Colina
Centers for Rehabil.
11:00 OO8 334.04 Decoding objects and grips from
the medial posterior parietal cortex of the macaque. M.
FILIPPINI; R. BREVEGLIERI; E. CHINELLATO; A. BOSCO;
P. FATTORI*. Univ. of Bologna, Middlesex Univ. London.
8:00 OO9 334.05 Decoding for brain-machine interfaces
with a new, unsupervised-learning algorithm. J. G. MAKIN*;
J. E. ODOHERTY; P. N. SABES. Univ. of California, San
Francisco.
9:00 OO10 334.06 Closed-loop pairing of motor cortex
activity and phasic VTA activation reinforces specific
spatiotemporal activity patterns. V. R. ATHALYE*; F. J.
SANTOS; J. M. CARMENA; R. M. COSTA. Champalimaud
Ctr. For the Unknown, UC Berkeley.
10:00 OO11 334.07 Does the brain learns to control robotic
limbs using sparse representations? C. KONNARIS; F.
MEHRABAN POUR BEHBAHANI; A. A. FAISAL*. Imperial
Col. London, Imperial Col. London.
11:00 OO12 334.08 Computational capacity as a function
of network size. C. KERR*; S. DURA-BERNAL; R. J.
MENZIES; C. MCLAUCHLAN; S. J. VAN ALBADA; D.
J. KEDZIORA; S. NEYMOTIN; W. W. LYTTON. Univ. of
Sydney, SUNY Downstate Med. Ctr., Univ. of Sydney, Julich
Res. Ctr.
8:00 OO13 334.09 A new modeling framework for multiscale
neural activity underlying behavior. H. ABBASPOURAZAD*;
M. SHANECHI. USC.
9:00 OO14 334.10 Adaptive multiscale brain machine
interface decoders. H. HSIEH*; M. SHANECHI. USC.
10:00 PP1
334.11 Increasing brain-machine interface
performance by using discrete state selection with hidden
Markov models. J. C. KAO*; P. NUYUJUKIAN; S. I. RYU; K.
V. SHENOY. Stanford Univ., Stanford Univ., Stanford Univ.,
Palo Alto Med. Fndn., Stanford Univ., Howard Hughes Med.
Inst.
11:00 PP2
334.12 Volitional modulation of neuronal
activities among multiple neuron groups via neuronal operant
conditioning. K. SONG*; S. TAKAHASHI; Y. SAKURAI.
Doshisha Univ.
8:00 PP3 334.13 Self-recalibrating brain-computer
interfaces based on population subspace alignment. A. D.
DEGENHART*; W. E. BISHOP; E. R. OBY; E. C. TYLERKABARA; A. P. BATISTA; S. M. CHASE; B. M. YU. Univ.
of Pittsburgh, Univ. of Pittsburgh, Ctr. for the Neural Basis
of Cognition, Carnegie Mellon Univ., Univ. of Pittsburgh,
Univ. of Pittsburgh, McGowan Inst. for Regenerative Med.,
Carnegie Mellon Univ., Carnegie Mellon Univ.
9:00 PP4 334.14 Distinct subspaces emerge in
neuroprosthetic control during different tasks. P. KHANNA*;
V. R. ATHALYE; S. GOWDA; R. M. COSTA; J. M.
CARMENA. UC Berkeley, Champalimaud Ctr. For the
Unknown.
44 | Society for Neuroscience

10:00 PP5
334.15 Effects of vagus nerve stimulation on
cortical activity and excitability in the nonhuman primate. S.
ZANOS*; S. MOORJANI; S. SABESAN; E. E. FETZ. Univ. of
Washington Sch. of Med., Rice Univ.
11:00 PP6
334.16 Quantifying the information rate of
sensory feedback for neuroprosthesis. J. D. RECHENMANN;
J. E. ODOHERTY; P. N. SABES*. EPFL, UCSF.
8:00 PP7 334.17 Decoding the bimanual movements in
non-human primate using hybrid-regression method. H.
CHOI*; J. LEE; S. LEE; I. KIM; K. AHN; K. LEE; D. JANG.
Hanyang Univ., Seoul Natl. Univ. Hosp.
9:00 PP8 334.18 Dorsal premotor area of the macaque
monkey encodes internal grasp movement planning. S.
GUANGHAO*; S. ZHANG; Q. ZHANG; J. ZHU; X. ZHENG.
Zhejiang Univ., Zhejiang Univ., New York Univ., The 2nd
affiliated Hosp.
10:00 PP9
334.19 Predicting decision outcomes from single
realizations of lateral prefrontal cortex neuronal activity.
C. BOULAY*; F. PIEPER; M. LEAVITT; J. MARTINEZTRUJILLO; A. SACHS. Ottawa Hosp. Res. Inst., Univ. of
Ottawa, Inst. for Neuro and Pathophysiology, Univ. Med. Ctr.
Hamburg, McGill Univ., Robarts Res. Inst., Western Univ.
11:00 PP10 334.20 Brain-spinal interface to alleviate gait
deficits in rats: Direct-proportional neuromodulation. M.
BONIZZATO*; G. PIDPRUZHNYKOVA; G. COURTINE;
S. MICERA. cole Polytechnique Fdrale de Lausanne,
Scuola Superiore SantAnna.
8:00 PP11 334.21 A novel rat movement control for rat-robot
using electrical stimulation of basal ganglia. C. KOH*; H.
PARK; J. SHIN; C. KONG; M. YUN; W. CHANG; H. JUNG;
H. SHIN; J. CHANG. Dept. of Neurosurg. Yonsei Univ., Col.
of Medicine, Hallym Univ., Brain Korea 21 PLUS Project for
Med. Sci. and Brain Res. Inst.
9:00 PP12 334.22 Decoding intended gait modifications
from the hindlimb sensorimotor cortex. M. MEYERS*; K. A.
MOXON. Drexel Univ.

POSTER
335. Posture and Gait: Afferent Control
Theme E: Motor Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 PP13 335.01 Training effect of position perceptibility
in forward and backward leaning posture using a balanceboard for the elderly. K. FUJIWARA*; N. KIYOTA; H.
TOYAMA; A. HYODO; F. SATO. Kanazawa Gakuin Univ.,
Japan Hlth. Care Col., Kanazawa Univ.
9:00 PP14 335.02 Viral expression of excitatory DREADDs
in dorsal root ganglia induces reflex hyperexcitability. B. D.
ROBERTSON*; M. A. LEMAY; G. M. SMITH; A. J. SPENCE.
Temple Univ., Temple Univ., Temple Univ.
10:00 PP15 335.03 Correlation of plantar-surface pressure
and lower limb muscle activity during gait. S. D. PERRY*; B.
MCGREGOR. Wilfrid Laurier Univ.
11:00 PP16 335.04 Does ankle proprioception modulate
muscle recruitment during locomotor-related leg movements
in chick embryos? S. SUN*; N. S. BRADLEY. USC.
8:00 QQ1 335.05 Balancing sensory inputs: Sensory
reweighing of vision and ankle proprioception during a
bipedal posture task. C. S. LAYNE*; R. KABBALIGERE; B.
LEE. Univ. Houston.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 QQ2 335.06 The influence of physiological arousal

on human lower limb cutaneous reflexes during treadmill
walking. M. ZABACK*; B. C. HORSLEN; T. W. CLEWORTH;
L. COLLINGS; C. LANGLET; T. INGLIS; M. G. CARPENTER.
Univ. of British Columbia, Univ. de Lorraine, Univ. of British
Columbia, Univ. of British Columbia.
8:00 DP06 335.07 (Dynamic Poster) Walking through
aperture with visual information obtained at a distance. T.
HIGUCHI*; D. MUROI. Tokyo Metropolitan Univ.
11:00 QQ3 335.08 Gait characteristics of children walking
barefoot and with socks. ii. tandem walk. C. W. CHAU*;
B. ALTHAUS; K. DE MARREE; E. PRIMUS; H. ZURITA.
Nazareth Col. of Rochester.

9:00 QQ5 335.10 Visual influence on balance response

during locomotion. T. D. FETTROW*; H. REIMANN; J. JEKA.
Temple Univ.
10:00 QQ6 335.11 Toe flexor reinnervation results in frontal
plane motor deficits during slope walking in the cat. M. A.
LYLE*; E. KAJTAZ; T. R. NICHOLS. Georgia Inst. of Technol.
11:00 QQ7 335.12 The effect of light touch on standing sway
when the touch reference is unreliable. J. E. MISIASZEK*;
J. W. VANDER MEULEN; T. SHIVA. Univ. of Alberta, Univ. of
Alberta, Univ. of Alberta.

8:00 QQ8 335.13 Dorsal root ganglia stimulation elicits

behavioral responses during translational postural
perturbation. L. E. FISHER*; K. KING; W. CUSACK; A.
NANIVADEKAR; R. GAUNT; D. WEBER. Univ. of Pittsburgh,
Univ. of Pittsburgh, St. Jude Med.
9:00 QQ9 335.14 Force sensing and muscle synergies in
insects: Adapting proprioception to motor action in serially
homologous legs. S. N. ZILL*; J. SCHMITZ; A. BSCHGES;
S. CHAUDHRY. J.C. Edwards Sch. Med., Univ. of Bielefeld,
Univ. of Cologne, J.C. Edwards Sch. Med.
10:00 QQ10 335.15 Role of knee joint afferents in rat
locomotion. C. ALESSANDRO*; F. BARROSO; M. TRESCH.
Northwestern Univ.
11:00 QQ11 335.16 Enhancement of ankle position and force
controls contributes to balance improvement. S. YEN*; M.
POLETTI; A. FARJADIAN. Northeastern Univ., MIT.
8:00 QQ12 335.17 Role of muscle spindle feedback in
the swing movement dynamics and foot placement during
walking. W. P. MAYER*; W. G. TOURTELLOTTE; T. AKAY.
Dalhousie University, Brain Repair Ctr.- AMAP, Federal Univ.
of Espirito Santo, Northwestern Univ.
9:00 QQ13 335.18 Modulation of input from paw cutaneous
afferents and quadriceps-sartorius stretch afferents
differentially affects lateral static and dynamic stability
during cat split-belt locomotion. H. PARK*; R. MEHTA; S. P.
DEWEERTH; B. I. PRILUTSKY. Georgia Inst. of Technol.,
Georgia Inst. of Technol., Georgia Inst. of Technol.
10:00 QQ14 335.19 Effects of increased arm swing cued by a
wearable device on gait parameters. E. D. THOMPSON*; H.
REIMANN; T. FETTROW; P. AGADA; S. WEISS; M. LEE; J.
JEKA. Temple Univ., Shriners Hosp. for Children.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 QQ16 335.21 The sensory origin of the perception of

heaviness at the shoulder. D. PHILLIPS*; A. KARDUNA.
Univ. of Oregon.
9:00 QQ17 335.22 A spinal reflex based neuromuscular
model of human locomotion investigated against unexpected
disturbances. S. SONG*; H. GEYER. Carnegie Mellon Univ.
10:00 QQ18 335.23 A novel work loop approach for decoding
sensory information in afferent nerves during cyclic muscle
contractions. G. S. SAWICKI; P. NARDELLI*; T. C. COPE.
NC State Univ. and UNC Chapel Hill, Georgia Inst. of
Technol.
11:00 QQ19 335.24 Human microneurography reveals muscle
spindles encode small/slow ankle movements associated
with standing. J. INGLIS*; R. M. PETERS; B. H. DALTON; J.
BLOUIN. Univ. British Columbia, Univ. of British Columbia,
Univ. of Oregon.

POSTER
336. Neural Control of Respiration II
Theme E: Motor Systems
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 QQ20 336.01 Changes in protein expression and
ventrolateral medulla network properties accompanying
in utero mu-opioid agonist and/or nociceptin receptor
antagonist exposure. N. M. MELLEN*; B. GOURVITCH;
J. M. CAI, 40202; N. TOPORIKOVA. Univ. of Louisville,
NeuroPsi, UMR CNRS 9197, Univ. of Louisville, Washington
and Lee Univ.
9:00 RR1 336.02 Inflammation alters cell expression in
the respiratory regions of neonatal brainstem of rats. C. G.
WILSON*; R. JOHNSON; S. MURRAY. Loma Linda Univ.,
Loma Linda Univ.
10:00 RR2
336.03 Effects of melatonin, 5-hydroxytryptamine
& acetazolamide on hypoxia induced depression of field
excitatory postsynaptic potentials in rat hippocampal CA1
neurons. N. KANG; J. HWANG; Q. NGUYEN; V. SUEN; B.
SASTRY*. Univ. British Columbia Fac Med.
11:00 RR3 336.04 Bicarbonate-dependent inhibition of
chemosensitive neurons of the retrotrapezoid nucleus. C. M.
GONALVES*; F. KUO; E. DANIEL; D. K. MULKEY. Univ. of
Connecticut.
8:00 RR4 336.05 Hypercapnic acidosis induces glutamate,
D-serine, and ATP release from caudal brainstem astrocytes
in culture. M. OLIVARES*; V. DONOSO; R. CONTRERAS;
G. ZUIGA; J. P. HUIDOBRO-TORO; I. LLONA; R. VON
BERNHARDI; J. EUGENN. Univ. de Santiago de Chile,
Pontificia Univ. Catlica de Chile.
9:00 RR5 336.06 Suppression of astrocytic activation by
arundic acid prevents severe hypoxia-induced seizure and
death in mice. I. FUKUSHI*; K. TAKEDA; J. HORIUCHI;
Y. OKADA. Grad. Sch. of Sci. and Engineering, Toyo U,
Murayama Med. Ctr., Fujita Hlth. Univ.
10:00 RR6
336.07 Effect of nicotinic antagonism in the
commissural nucleus of the solitary tract on the respiratory
responses to hypercapnia. W. I. FURUYA*; M. BASSI;
J. V. MENANI; E. COLOMBARI; D. B. ZOCCAL; D. S. A.
COLOMBARI. Dept. Physiol. & Pathol., UNESP.
Neuroscience 2016|Monday AM|45

Mon. AM

8:00 QQ4 335.09 Sensori-motor responses evoked

by continuous, aperiodic Achilles tendon vibration
during standing. R. L. MILDREN*; R. M. PETERS; G. J.
MCKENDRY; M. G. CARPENTER; J. BLOUIN; T. INGLIS.
Univ. of British Columbia, Univ. of British Columbia, Univ. of
British Columbia, Univ. of British Columbia.

11:00 QQ15 335.20 Rorb interneurons act as essential spinal

filters for the refinement of motor movements. S. C. KOCH*;
M. GARCIA DEL BARRIO; A. DALET; G. GATTO; M.
GOULDING. The Salk Inst. For Biol. Studies.

11:00 RR7 336.08 Decrease in central chemosensitivity after

perinatal fluoxetine exposure is associated with changes
in serotonin receptors contributions. K. A. BRAVO*; J.
EUGENN; I. LLONA. Univ. De Santiago De Chile, Univ. de
Santiago de Chile.
8:00 RR8 336.09 Respiratory chemoreceptions
neuroplasticity in a rat model of Parkinsons disease. L. M.
OLIVEIRA; M. TUPPY; T. S. MOREIRA; A. T. TAKAKURA*.
Dept of Pharmacology, Inst. of Biomed. Science, Univ. of
Sao Paulo, Inst. of Biomed. Science, Univ. of Sao Paulo.
9:00 RR9 336.10 The raphe chemosensory amplifier:
A novel amplifier network model for respiratory control.
K. KEPLINGER; S. A. CAMPBELL; B. E. TAYLOR; M. B.
HARRIS*. Univ. of Waterloo, Univ. of Alaska Fairbanks, Univ.
Alaska Fairbanks.
10:00 RR10 336.11 Characterization of acute intermittent
hypoxia (AIH)-induced respiratory activity in spontaneously
breathing 6-OHDA SN-lesioned Parkinsons disease rat
model. I. C. SOLOMON*; W. F. COLLINS, III. Stony Brook
Univ., Stony Brook Univ.
11:00 RR11 336.12 Activation of cholinergic receptors
the pedunculopontine tegmental nucleus suppresses
respiratory activity in urethane-anesthetized and awake
rats. C. R. SOBRINHO*; J. D. LIMA; A. C. T. TAKAKURA;
D. K. MULKEY; T. S. MOREIRA. Univ. of Sao Paulo, Inst.
of Biomed. Sciences- USP, Inst. of Biomed. Sciences-USP,
Univ. of Connecticut, Inst. of Biomed. Sciences-USP.
8:00 RR12 336.13 ATP-mediated specialized control of
vascular tone in the retrotrapezoid nucleus. V. E. HAWKINS*;
A. TRINH; A. C. TAKAKURA; I. C. WENKER; T. DUBREUIL;
M. T. NELSON; T. S. MORRIERA; D. K. MULKEY. Univ. of
Connecticut, Unoversity of Sao Paulo, Univ. of Vermont,
Univ. of Sao Paulo.
9:00 RR13 336.14 Adenosine in the retrotrapezoid nucleus
inhibits breathing in rats. B. FALQUETTO*; L. OLIVEIRA; A.
TAKAKURA; T. MOREIRA. Univ. of Sao Paulo, Univ. of Sao
Paulo.
10:00 RR14 336.15 Differential noradrenegic modulation
of retrotrapezoid nucleus in neonatal rats. F. KUO*; B.
FALQUETTO; D. CHEN; A. C. TAKAKURA; T. S. MOREIRA;
D. K. MULKEY. Univ. of Connecticult, Univ. of Connecticut,
Univ. of Sao Paulo, Univ. of Sao Paulo.
11:00 RR15 336.16 Retrotrapezoid neurons control
breathing during exercise and determine exercise capacity.
R. T. HUCKSTEPP*; A. KORSAK; A. MACHHADA; S.
SHEIKHBAHAEI; A. V. GOURINE. UCL, NIH.
8:00 RR16 336.17 Influence of developmental nicotine
exposure on serotonergic control of breathing-related motor
output. A. A. HILL*; R. F. FREGOSI. Dept. of Physiol., Univ.
of Arizona, Univ. of Arizona.
9:00 RR17 336.18 Genetic mapping of developmental
noradrenergic neuron subpopulations in respiratory
homeostasis. J. SUN*; M. KEY; R. RAY. Baylor Col. of Med.,
Baylor Col. of Med.
10:00 RR18 336.19 Cholinergic modulation of the parafacial
respiratory group. S. PAGLIARDINI*; R. C. T. BOUTIN; Z.
ALSAHAFI. Univ. of Alberta.
11:00 RR19 336.20 Neuronal morphology changes in the
respiratory centers of the developing rat. P. A. WILLIAMS*;
C. G. WILSON. Ctr. For Perinatal Biology, Loma Linda
Universit, Loma Linda Univ.

46 | Society for Neuroscience

8:00 RR20 336.21 Sciatic nerve stimulation activates

presympathetic (C1) neurons and retrotrapezoid nucleus
(RTN) chemoreceptors in anesthetized rats. R. KANBAR*; P.
G. GUYENET. Lebanese American Univ., Univ. of Virginia.
9:00 RR21 336.22 A practical biomarker for obstructive
apnea in potential sudden death in epilepsy (SUDEP)
cases. M. G. STEWART*; R. KOLLMAR; K. NAKASE; J.
SILVERMAN; K. SUNDARAM; R. ORMAN; J. LAZAR.
State Univ. of New York Downstate Med. Ctr., State Univ.
of New York Downstate Med. Ctr., State Univ. of New York
Downstate Med. Ctr., State Univ. of New York Downstate
Med. Ctr.
10:00 RR22 336.23 Anatomical arrangement of neurons and
astrocytes in the phrenic nucleus of the rat. Y. OKADA*; S.
YOKOTA; Y. SHINOZAKI; Y. YASUI. Murayama Med. Ctr.,
Shimane Univ. Sch. of Med., Keio Univ. Sch. of Med.
11:00 SS1
336.24 Voluntary control of breathing engages
multiple supratentorial brain areas and modulates sensory
processing. J. L. HERRERO*; A. ASHESH. Cushing
Neurosci. Inst.

POSTER
337. Neuroethology of Sensory and Motor Systems:
Invertebrates
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 SS2 337.01 Neural correlates of responses to
mechanical loading in Aplysia californica. J. P. GILL*; D. N.
LYTTLE; M. J. CULLINS; P. J. THOMAS; H. J. CHIEL. Case
Western Reserve Univ., Case Western Reserve Univ., Case
Western Reserve Univ.
9:00 SS3 337.02 Grasping by a muscular hydrostat:
Function of the radular surface in Aplysia californica. C. E.
KEHL*; D. M. NEUSTADTER; S. LU; H. J. CHIEL. Case
Western Reserve Univ., Calore Med. LTD, Case Western
Reserve Univ.
10:00 SS4
337.03 Aplysia californica as a source of
actuators, scaffolds, and controllers for the development
of biohybrid robots and living machines. V. WEBSTER*; K.
J. CHAPIN; O. AKKUS; H. J. CHIEL; R. D. QUINN. Case
Western Reserve Univ.
11:00 SS5
337.04 A gravity-sensing cell in Trichoplax
adhaerens, an early branching metazoan. T. D.
MAYOROVA*; C. L. SMITH; N. B. PIVOVAROVA; T. S.
REESE. NINDS, NINDS.
8:00 SS6 337.05 C. elegans ASE sensory neurons
differentially code NaCl information providing greater
environmental resolution for successful navigation. M.
DESROCHERS*; J. LEE; M. HENDRICKS. McGill Univ.
9:00 SS7 337.06 Dissecting the function of acetylcholine
in the Caenorhabditis elegans egg-laying behavior circuit. R.
KOPCHOCK*, III; K. M. COLLINS. Univ. of Miami.
10:00 SS8
337.07 Behavioral characterization
of magnetotaxis in the nematode C. elegans. C.
BAINBRIDGE*; A. AHLERT; L. BARICKMAN; B. BRACHT; A.
VIDAL-GADEA. Illinois State Univ.
11:00 SS9
337.08 Investigations in to the neural deficits
of Duchenne muscular dystrophy using C. elegans. A. M.
RODRIGUEZ*; S. GOEL; A. SCHULER; L. BARICKMAN;
M. CISNEROS; P. DEVRIES; B. RODEMOYER; A. VIDALGADEA. Illinois State Univ., Illinois State Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 SS10 337.09 Understanding how sex modulates

the female nervous system to drive distinct reproductive
behavior states. L. M. NASSAR*; A. BODE; K. M. COLLINS.
Univ. of Miami.
8:00 DP07 337.1 (Dynamic Poster) Pan-neuronal recording
in the leech nervous system using dual-sided voltage
sensitive dye imaging. Y. TOMINA*; D. A. WAGENAAR. Univ.
of Cincinnati.
10:00 SS11 337.11 Visual responses of the S-cell system
of the leech Hirudo verbana suggest complex integration
mechanisms. D. A. WAGENAAR*; A. STOWASSER. Univ. of
Cincinnati.
11:00 SS12 337.12 S-cell responses to visual and
mechanical water waves in the leech Hirudo verbana. A.
MUTHUSAMY*; A. M. LEHMKUHL, II; D. A. WAGENAAR.
Univ. of Cincinnati, Univ. of Cincinnati.

POSTER
338. Parental Behavior
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 SS14 338.01 Maternal aggression is impaired by
prepartum serotonin-specific lesions of the midbrain
dorsal raphe. E. M. VITALE*; M. A. HOLSCHBACH; J. S.
LONSTEIN. Michigan State Univ., Colorado State Univ.
9:00 SS15 338.02 Altered monoamines and associated
metabolites across the postpartum period in the WistarKyoto rat model of postpartum depression. S. B.
WINOKUR*; Y. MOPARTHI; E. ELGUENAOUI; V. LEE; A.
FARRAR; M. PEREIRA. Univ. of Massachusetts, Amherst.
10:00 SS16 338.03 Altered genetic expression in the
maternal circuitry of Wistar-Kyoto rat model of postpartum
depression across the postpartum period. V. LEE*; S.
B. WINOKUR; A. M. FARRAR; M. PEREIRA. Univ. of
Massachusetts Amherst.
11:00 SS17 338.04 Effects of oxytocin receptor knockdown
in the dorsal raphe on maternal and anxiety like behaviors
in postpartum rats. Z. GRIEB*; F. MANFREDSSON; J.
LONSTEIN. Michigan State Univ.
8:00 SS18 338.05 Intensity of exercise and postpartum
exposure to fluoxetine differentially affect behavior and
hippocampal neurogenesis in a rat model of postpartum
stress. A. R. GOBINATH*; R. J. RICHARDSON; C. CHOW;
J. L. WORKMAN; S. E. LIEBLICH; A. M. BARR; L. A. M.
GALEA. Univ. of British Columbia, Univ. of British Columbia,
Univ. of British Columbia.
9:00 SS19 338.06 Gestational stress effects on dopamine
and oxytocin within the postpartum reward circuitry:
Implications for mood and mothering. B. LEUNER*; A.
HAIM; C. ALBIN-BROOKS; D. JULIAN; B. SPRINGER; H.
BROTHERS. Ohio State Univ., Ohio State Univ., Ohio State
Univ.

8:00 SS22 338.09 Activation of CRF receptor type 1 in the

medial preoptic area severely impairs maternal behavior and
increases anxiety-related behavior in lactating rats. O. J.
BOSCH*; B. M. GANER; D. S. BAYERL; S. M. KLAMPFL.
Univ. of Regensburg, Univ. of British Columbia.
9:00 SS23 338.10 Investigating neural circuits governing
parental behavior. A. E. AUTRY*; Z. WU; B. MARINRODRIGUEZ; N. RUBINSTEIN; D. BAMBAH-MUKKU; J.
KOHL; C. DULAC. Harvard Univ., Harvard Univ.
10:00 SS24 338.11 Effects of fatherhood on synaptic,
intrinsic, and morphological characteristics of neurons in the
medial preoptic area of male California mice. N. HORRELL*;
P. HICKMOTT; D. LUU; W. SALTZMAN. Univ. of California
Riverside, Univ. of California Riverside, Univ. of California
Riverside.
11:00 SS25 338.12 Influence of parental interaction
and prolactin treatment diminishing kainic acid-induced
neurodegeneration in the hippocampus of male mice. I.
ANAGNOSTOU; T. MORALES*. Inst. for Neurobio. UNAM,
Intitute for Neurobio. UNAM.
8:00 SS26 338.13 Esr1 expressing neurons in the medial
preoptic area mediate maternal behaviors. Y. FANG*; D. LIN.
NYU Langone Med. Ctr.
9:00 TT1 338.14 Melanin concentrating hormone
modulates maternal behavior. A. ALACHKAR*; L.
ALHASSEN; Z. WANG; O. CIVELLI. Univ. of California
Irvine, Univ. of California irvine.
10:00 TT2
338.15 Experience-dependent alterations in
maternal behavior are associated with gene expression
changes in maternal neural pathways. H. S. MAYER*; D. S.
STOLZENBERG. Univ. of California Davis, Univ. of California
Davis.
11:00 TT3
338.16 Maternal behavior and neuronal
activation differs in lactating rats depending on ratio of own
pups present. K. A. UNROE; T. C. FRUCHTERMAN; M. L.
GRIMES; A. O. RIPLEY; C. L. FRANSSEN; A. FRANSSEN*.
Longwood Univ., Longwood Univ.
8:00 TT4 338.17 Exposure to bisphenol-S during
pregnancy and lactation alters maternal brain and behavior
in CD-1 mice. M. C. CATANESE*; L. N. VANDENBERG.
Univ. of Massachusetts, Amherst, Univ. of Massachusetts,
Amherst.
9:00 TT5 338.18 Perinatal exposure to a commercial
formulation of glyphosate alters maternal behavior and
neurobehavioral development in infant rats. E. L. RICCI*;
M. O. RIBEIRO; M. M. BERNARDI; H. S. SPINOSA.
Presbyterian Mackenzie Univ., Presbyterian Mackenzie
Univ., Paulista Univ., Univ. of So Paulo.
10:00 TT6
338.19 Electroencephalographic correlation
in biological & adoptive mothers while listening to a baby
crying. M. PREZ-HERNNDEZ*; R. M. HIDALGOAGUIRRE; M. HERNNDEZ-GONZLEZ; C. AMEZCUA; M.
A. GUEVARA. Inst. De Neurociencias.

10:00 SS20 338.07 Maternal behavior in virgin forebrain

oxytocin receptor knockout mice. S. K. WITCHEY*; H. K.
CALDWELL. Kent State Univ., Kent State Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|47

Mon. AM

8:00 SS13 337.13 Localization of allatotropin-like

immunoreactivity in the central nervous system of
Biomphalaria glabrata, an intermediate host for intestinal
schistosomiasis. J. MALDONADO-ALERS; A. HERNNDEZVZQUEZ; S. ROLN-MARTNEZ; M. W. MILLER*. Inst.
Neurobio., Univ. of Puerto Rico Med. Sci. Campus.

11:00 SS21 338.08 Arginine vasopressin increases

maternal behavior in the biparental California mouse
(Peromyscus californicus). N. D. NG; M. F. CONLEY; G. E.
MAMMARELLA; J. K. BESTER-MEREDITH*. Seattle Pacific
Univ.

POSTER
339. HPG Axis II
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 TT7 339.01 Role of rostral periventricular area of the
third ventricle (RP3V) GABAergic neurons in generating the
preovulatory luteinizing hormone surge in female mouse. B.
KALIL*; T. MCLENNAN; R. PIET; A. E. HERBISON. Univ. of
Otago.
9:00 TT8 339.02 Defining subpopulations of arcuate
nucleus GABA neurons in male, female and prenatally
androgenized female mice: A role for GABAergic NPY
neurons in regulating fertility? C. J. MARSHALL*; E.
DESROZIERS; R. E. CAMPBELL. Univ. of Otago.
10:00 TT9
339.03 Arcuate kisspeptin neurons connect to
hypothalamic histamine, GABA and oxytocin neurons. G. E.
HOFFMAN*; K. J. MURPHY; A. WOLFE; H. NOVAIRA; M.
KOBAN; S. RADOVICK. Morgan State Univ., Johns Hopkins
Univ., Rutgers Univ.
11:00 TT10 339.04 Effects of selective deletion of tyrosine
hydroxylase from kisspeptin neurons on puberty and
reproduction. S. B. Z. STEPHENS*; M. L. ROUSE; K. P.
TOLSON; R. A. PARRA; N. CHAHAL; A. S. KAUFFMAN.
UCSD.
8:00 TT11 339.05 Stimulatory effect of neuromedin U on
pulsatile LH secretion in ewes is dependent on melanocortin
MC4 receptor signaling. P. GRACHEV*; R. B. MCCOSH;
M. N. BEDENBAUGH; M. VALENT; S. L. HARDY; J. M.
CONNORS; S. M. HILEMAN; R. L. GOODMAN. West
Virginia University, Sch. of Med.
9:00 TT12 339.06 Seasonal gating of chemosensory
processing in the male Syrian hamster. K. J. JENNINGS*; M.
CHASLES; J. CHO; M. KELLER; L. J. KRIEGSFELD. Univ.
of California, Berkeley, UMR 0085 INRA.
10:00 TT13 339.07 Restraint-stress-induced effects or
administration of corticosterone on novel object recognition
in rats. N. L. GARCIA SALDIVAR*; M. R. GONZLEZ
LPEZ; G. CASTILLO ROBERTO; G. A. BARRIOS DE LA
CRUZ; S. E. CRUZ MORALES. UNAM FES-Iztacala, UNAM
FES-Iztacala.
11:00 TT14 339.08 Acute effects of blocking adrenergic
receptors in ovaries on ovulation and steroidogenesis in rats
with polycystic ovary syndrome. B. VENEGAS MENESES*;
L. Y. DE LEN GORDILLO; J. A. ESPINOZA MORENO;
L. MORALES-LEDESMA. Physiol. Laboratory, UIBR, FES
Zaragoza, UNAM.
8:00 UU1 339.09 The effect of PACAP on fertility is relayed
through a subset of hypothalamic leptin receptor expressing
neurons in the female mouse. R. A. ROSS; S. LEN; C.
A. MAGUIRE; J. C. MADARA; A. M. J. VERSTEGEN; U.
KAISER; B. B. LOWELL; V. M. NAVARRO*. Beth Israel
Deaconess Med. Ctr., Massachusetts Gen. Hosp., Harvard
Med. Sch., Brigham and Womens Hosp., Brigham and
Womens Hosp. / Harvard Med. Sch.
9:00 UU2 339.10 Blockade of somatostatin receptor 2
stimulates episodic LH secretion, but not surge LH secretion,
in ewes. R. MCCOSH*; M. N. BEDENBAUGH; J. A.
LOPEZ; S. M. HILEMAN,; M. VALENT; P. GRACHEV; R. L.
GOODMAN. West Virginia Univ.

48 | Society for Neuroscience

10:00 UU3
339.11 Neurokinin B, but not dynorphin, acts in
the arcuate nucleus of prepubertal female sheep to control
LH secretion. M. BEDENBAUGH*; C. A. RAINEY; R. B.
MCCOSH; J. A. LOPEZ; R. L. GOODMAN; S. M. HILEMAN.
West Virginia Univ. HSC, Alderson Broaddus Univ., West
Virginia Univ.
11:00 UU4 339.12 Rapid activation of classical progesterone
receptor in kisspeptin neurons. M. A. MITTELMAN-SMITH*;
A. K. SCOTT; A. M. WONG; P. E. MICEVYCH. UCLA.
8:00 UU5 339.13 Sexually dimorphic Kisspeptin neurons
in the RP3V regulate testosterone synthesis in male mice.
E. SANZ*; A. QUINTANA; A. URPI; G. MCKNIGHT. Univ.
Autonoma de Barcelona, Univ. of Washington.
9:00 UU6 339.14 Chemically-induced periestropause
is associated with changes in kisspeptin/gonadotrophinreleasing hormone/luteinizing hormone cascade of female
rats. C. M. LEITE*; N. P. OLIVEIRA; E. T. UCHOA; J.
ANTUNES-RODRIGUES; L. L. K. ELIAS; J. A. ANSELMOFRANCI. Univ. of Sao Paulo, Univ. of Sao Paulo, Londrina
State Univ., Univ. of Sao Paulo.
10:00 UU7
339.15 Kiss1 expression is modulated by
estrogen and endocrine disruptors in immortalized female
AVPV- and arcuate-specific neuronal kisspeptin cell lines. D.
C. JACOBS; R. E. VEITCH; P. E. CHAPPELL*. Oregon State
Univ., Oregon State Univ., Oregon State Univ.
11:00 UU8 339.16 Effects of unilateral orchidectomy
to immature rats on dendritic arborization of pyramidal
neurons in the hippocampus. N. B. SANTOS TENORIO; N.
P. CORDERO FLORES; F. M. GONZLEZ CARRERA; G.
LEN LPEZ; G. FLORES ALONSO; R. REYES LUNA; U.
QUIRZ LPEZ; C. MORAN*. Univ. Autonoma de Puebla,
Univ. Autonoma de Puebla, Univ. Autonoma de Puebla.
8:00 UU9 339.17 Utility of anti-rabphilin-3A antibodies in
the diagnosis of lymphocytic infundibulo-neurohypophysitis
in pediatric patients. S. IWAMA*; Y. SUGIMURA; N. IWATA;
Y. YASUDA; H. ARIMA. Nagoya Univ., Nagoya Univ. Grad
Schl of Med.
9:00 UU10 339.18 Autoantibodies against corticotrophs as
a biomarker for IgG4-related hypophysitis. N. IWATA*; S.
IWAMA; Y. SUGIMURA; Y. YASUDA; H. ARIMA. Nagoya
Univ., Nagoya Univ.
10:00 UU11 339.19 Viability after permeabilization and
introduction of trehalose in intracytoplasmic sperm porcine
compartment. M. BARRIENTOS*; E. JACOME-SOSA;
M. ORTEGA CASTRO; B. DOMINGUEZ MANCERA; P.
CERVANTES ACOSTA; A. HERNANDEZ BELTRAN; D.
ROMERO SALAS. Univ. Veracruzana.
11:00 UU12 339.20 Emergence of folliculo-stellate cells in
the postnatal pituitary gland development in wistar rats. E.
GMEZ DOMNGUEZ*; C. SOLANO-AGAMA; E. VERAAGUILAR; J. CAMACHO; M. E. MENDOZA-GARRIDO.
CINVESTAV-IPN, CINVESTAV-IPN.
8:00 UU13 339.21 The anatomy and neurohistology of the
minipig pituitary. L. TVILLING; A. GLUD; D. ORLOWSKI;
J. JAKOBSEN; M. PETERSEN; K. ETTRUP; M. WEST; D.
BENDER; C. BJARKAM; J. SORENSEN*. Aarhus Univ.
Hospital, Head-Heart Ctr., Aarhus Univ. Hospital, Head-Heart
Ctr., Aarhus Univ. Hospital, Head-Heart Ctr., Aarhus Univ.
Hospital, Head-Heart Ctr., Aalborg Univ. Hosp., Aarhus Univ.
Hospital, Head-Neuro Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
340. Stress: Hippocampus
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 UU14 340.01 Hippocampal resting-state connectivity:
Longitudinal and concurrent associations with parenting and
cortisol reactivity during childhood. S. L. BLANKENSHIP*;
T. RIGGINS; L. R. DOUGHERTY. Univ. of Maryland, Univ. of
Maryland.
9:00 VV1 340.02 Reliability of SES effects on hippocampal
and frontal brain structure in children and youth: A systematic
review. L. T. WITTMAN; A. J. WINKELMAN; G. M. LAWSON;
M. J. FARAH*. Univ. of Penn, Univ. Pennsylvania.

11:00 VV3
340.04 Effect of chronic stress on gene
expression in the hippocampus of female and male rats.
M. RANDESI; Y. ZHOU; S. MAZID; S. C. ODELL; B. S.
MCEWEN; T. A. MILNER*; M. KREEK. The Rockefeller
Univ., Weill Cornell Med., The Rockefeller Univ.
8:00 VV4 340.05 Functionally distinct ca1 npy
interneurons regulate npy release in schaffer collateral and
temporammonic feedforward pathways. Q. LI*; A. BARTLEY;
L. DOBRUNZ. Univ. of Alabama at Birimgham.
9:00 VV5 340.06 Daily running exercise mitigates the
negative consequences of increased corticosterone due to
stress on hippocampal ltp. R. M. MILLER*; D. MARRIOTT;
T. HAMMOND; D. LYMAN; J. TROTTER; T. CALL; Z.
BADURA; J. G. EDWARDS. Brigham Young Univ.
10:00 VV6
340.07 Repeated restraint stress causes
alteration in neuronal maturation makers in the dentate
gyrus in BALB/c mice. H. SHOJI*; H. HAGIHARA; T.
MIYAKAWA. Inst. for Comprehensive Med. Sci., Natl. Inst.
for Physiological Sci.
11:00 VV7
340.08 Klf9 regulates dendritic spines to protect
against chronic stress induced maladaptive fear responses.
A. SAHAY*; T. LANGBERG; S. LEVINSON; D. CHU; K.
SCOBIE; R. HEN; E. LEONARDO; A. BESNARD. Ctr. For
Regenerative Med., Columbia Univ., Massachusetts Gen.
Hospital, Harvard Stem Cell Institute, Harvard Med. Sch.
8:00 VV8 340.09 Reorganization of hippocampal spatial
maps during adaptive behavior in an aversive situation. S.
OKADA*; H. IGATA; T. SASAKI; Y. IKEGAYA. The Univ. of
Tokyo.
9:00 VV9 340.10 The results of forced swim test in
Wistar rats are negatively correlated with the degree of
neurogenesis in the subventricular zone and dentate gyrus.
K. KIN*; T. YASUHARA; M. KAMEDA; M. UMAKOSHI; I.
KIN; K. KUWAHARA; J. MORIMOTO; M. OKAZAKI; H.
TAKEUCHI; A. TOYOSHIMA; T. SASAKI; T. AGARI; I. DATE.
Okayama Univ. Grad. Sch. of Med.
10:00 VV10 340.11 Social buffering prevents psychosocial
stress-decreased neurogenesis in mouse dentate gyrus. C.
WANG*; L. YU. Natl. Cheng Kung Univ., Inst. of Behavioral
Medicine, Natl. Cheng Kung Univ.
11:00 VV11 340.12 Endogenous CRH enhances excitatory
synaptic transmission and intrinsic hippocampal network
activity. B. G. GUNN*; C. D. COX; Y. CHEN; C. M. GALL; G.
LYNCH; T. Z. BARAM. Univ. of California Irvine.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 VV13 340.14 Folate deficiency-induced depressionlike behavior and abnormal neuronal matulation in adult
hippocampus in mice. S. NISHIDA*; Y. HIRAKI; M. TSUBOI;
Y. NAKAMURA; R. ARAKI; T. YABE. Setsunan Univ., Meiji
Co., Ltd.
10:00 VV14 340.15 CA3 neurons of BDNF-Val66Met mice
exhibit a unique translational profile in response to stress.
J. KOGAN*; J. D. GRAY; T. G. RUBIN; E. F. SCHMIDT; N.
HEINTZ; B. S. MCEWEN. The Rockefeller Univ., Albert
Einstein Col. of Med., The Rockefeller Univ.
11:00 VV15 340.16 In vitro study of chronic stress effect on
the adult neurogenesis. J. WOO*; H. RYU; C. HEO; M. SUH.
CNIR IBS, Sungkyunkwan Univ.
8:00 VV16 340.17 ANA12 prevents hippocampal CA3 apical
dendritic arbors from becoming more complex in the weeks
after chronic stress ends. P. PAODE*; K. NISHIMURA;
J. M. ANGLIN; J. M. JUDD; S. KEMMOU; B. Q. LE; A.
FLEGENHEIMER; J. B. ORTIZ; C. D. CONRAD. Arizona
State Univ.
9:00 VV17 340.18 Hippocampal endocannabinoid signalling
mediates the residual effects of early life stress on fear
memory. P. ATSAK*; M. MORENA; C. SCHOENMAKER;
M. N. HILL; B. ROOZENDAAL. Radboud Univ. Med. Ctr.,
Donders Inst. for Brain, Cognition and Behaviour, Hotchkiss
Brain Institute, Univ. of Calgary.
10:00 VV18 340.19 Early life stress alters the levels of
proteostasis markers in the rat hippocampus. J. A. SIERRA
FONSECA*; J. N. HAMDAN; G. A. LODOZA; S. SAUCEDO,
Jr.; K. L. GOSSELINK. Univ. of Texas At El Paso.
11:00 VV19 340.20 Effects of stress on fibroblast growth
factor receptor 1 expression in the tgFgfr1-EGFP BAC
transgenic mouse line. J. COLLETTE*; H. M. TORRES; K.
M. SMITH. Univ. of Louisiana At Lafayette.

POSTER
341. Autonomic Control: Cardiovascular Regulation I
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 VV20 341.01 Effect of hypo- and hyper-perfusion on
neurovascular coupling. D. KAIN*; P. BLINDER. Tel Aviv
Univ., Tel Aviv Univ.
9:00 VV21 341.02 Effect of endogenous nitric oxide
on adrenergic nerve-mediated vasoconstriction and
CGRPergic nerve-mediated vasodilation in pithed rats. H.
KAWASAKI*; S. TAKATORI; K. YAMAWAKI; Y. ZAMAMI.
Col. of Pharmaceut. Sciences, Matsuyama Univ., Col. of
Pharmaceut. Sciences, Matsuyama Univ., Grad. Sch. of
Medicine, Dent. and Pharmaceut. Sciences, Okayama Univ.,
Inst. of Biomed. Sciences, Tokushima Univ. Grad. Sch.
10:00 VV22 341.03 Female and male obstructive sleep apnea
patients show prior diagnosis of co-morbid hypertension and
mental health conditions. E. AN*; A. AGUILA; K. WATSON;
M. R. IRWIN; R. AYSOLA; L. DOERING; R. M. HARPER;
P. M. MACEY. UCLA, UCLA, UCLA, UCLA, UCLA, UCLA,
UCLA, UCLA.
11:00 VV23 341.04 Cardiorespiratory coupling in individuals
with spinal cord injury. S. C. ASLAN*; S. HARKEMA; A.
OVECHKIN. Univ. Louisville, Univ. Louisville, Univ. Louisville.
Neuroscience 2016|Monday AM|49

Mon. AM

10:00 VV2
340.03 Acute predator odor exposure rapidly
activates the CREB turn-off pathway in the hippocampus of
adult male Wistar rats. D. R. HOMIACK*; E. OCINNEIDE;
S. HAJMURAD; M. STANLEY; B. BARRILEAUX; L.
SCHRADER. Tulane Univ., Broad Insitute, Tulane Univ.

8:00 VV12 340.13 Temporal analysis of hippocampal

glucocorticoid receptor activity in the therapeutic action of
fluoxetine. S. HER*; M. JEONG; J. JUNG. KBSI, KBSI.

8:00 VV24 341.05 Sex differences in insular gyral responses

to an autonomic challenge. N. S. RIEKEN*; J. A. OGREN,
91403; R. KUMAR; R. M. HARPER; P. M. MACEY. Sch. of
Nursing, UCLA, UCLA, UCLA, UCLA.
9:00 VV25 341.06 Central modulation of cardiac
sympathetic nerve activity following acute myocardial
infarction. R. ROY*. Univ. of Otago.
10:00 VV26 341.07 Persistence of post-stress blood pressure
elevation is induced by activated astrocytes. Y. HASEBE*;
S. SUGAMA; K. TAKEDA; K. KOIZUMI; I. FUKUSHI;
M. HOSHIAI; Y. KAKINUMA; J. HORIUCHI; K. SUGITA;
Y. OKADA. Sch. of Medicine,University of Yamanashi,
Murayama Med. Ctr., Nippon Med. Sch., Fujita Hlth. Univ.,
Grad. Sch. of Sci. & Engineering, Toyo Univ.
11:00 WW1 341.08 Vasopressin contributes to the
development of angiotensin II-dependent hypertension.
A. KORPAL*; D. O. SCHWENKE; C. H. BROWN. Univ. of
Otago.
8:00 WW2 341.09 Temporal structure of metabolic
modulation of autonomic nervous system activity. A.
PANARESE; M. CRACCHIOLO; J. CARPANETO; J. F.
SACRAMENTO; S. V. CONDE*; A. MAZZONI; S. MICERA.
The Biorobotics Institute, Scuola Superiore SantAnna,
CEDOC, NOVA Med. School, Faculdade De Cincias,
Bertarelli Fndn. Chair in Translational NeuroEngineering,
Inst. of Bioengineering And Ctr. for Neuroprosthetics, Sch. of
Engineering, Ecole Polytechnique Federale De Lausanne.
9:00 WW3 341.10 Mapping the brainstem circuitry of
transcutaneous vagus nerve stimulation (tVNS) in humans
using ultrahigh-field (7T) fMRI. N. W. KETTNER*; R.
SCLOCCO; J. R. POLIMENI; R. G. GARCIA; I. MAWLA;
N. TOSCHI; L. L. WALD; R. BARBIERI; V. NAPADOW.
Logan Univ., Athinoula A. Martinos Ctr. for Biomed. Imaging,
Massachusetts Gen. Hospital, Harvard Med. Sch., Connors
Ctr. for Womens Hlth. and Gender Biology, Div. of Womens
Health, Brigham and Womens Hosp., Dept. of Biomedicine
and Prevention, Univ. of Rome Tor Vergata, Dept. of
Electronics, Information and Bioengineering, Politecnico di
Milano.
10:00 WW4 341.11 Ascending cholinergic neurons in the
mesopontine tegmentum regulate blood pressure fluctuation
during REM sleep. Y. KOYAMA*; N. TAKAKU; H. SATOU;
K. NISHIMURA; N. HARUYAMA; T. KODAMA. Fukushima
Univ., Tokyo Metropol Inst. Med. Sci.
11:00 WW5 341.12 Cardiovascular regulation in individuals
with chronic motor complete and incomplete spinal cord
injury. S. WANG*; S. ASLAN; D. LORENZ; A. OVECHKIN; G.
HIRSCH; B. DITTERLINE; S. HARKEMA. Univ. of Louisville,
Frazier Rehab Inst., Univ. of Louisville, Univ. of Louisville.
8:00 WW6 341.13 Arterial stiffness predicts white matter
burden in patients with mild cognitive impairment. B. C.
TSENG*; C. GWO. Univ. of Texas At Tyler, Chien Hsin Univ.
of Sci. and Technol.
9:00 WW7 341.14 Non-gaussian diffusion measures show
axonal and myelin changes in patients with heart failure.
B. ROY*; M. WOO; G. FONAROW; R. KUMAR. Univ. of
California at Los Angeles, Univ. of California at Los Angeles,
Univ. of California at Los Angeles, Univ. of California at
Los Angeles, Univ. of California at Los Angeles, Univ. of
California at Los Angeles.
10:00 WW8 341.15 Cholinergic intrinsic cardiac ganglion
neurons may glutamatergic in nature. T. WANG*; K. E.
MILLER. Oklahoma State Univ. Ctr. For Hlth. Scienc,
Oklahoma State Univ. Ctr. For Hlth. Scienc.
50 | Society for Neuroscience

11:00 WW9 341.16 Regional brain changes in patients with

cystic fibrosis. C. TOM*; M. WOO; B. ROY; K. AFSHAR;
A. P. RAO; L. FUKUSHIMA; P. ESHAGHIAN; M. WOO; R.
KUMAR. David Geffen Sch. of Med. At UCLA, David Geffen
Sch. of Med. At UCLA, Sch. of Nursing, UCLA, UC San
Diego, Keck Med. of USC, Keck Sch. of Med. of USC, David
Geffen Sch. of Med. at UCLA, David Geffen Sch. of Med. at
UCLA.
8:00 WW10 341.17 Regulation of epinephrine biosynthesis
by intermittent hypoxia. R. B. MAILLOUX*; S. KHURANA;
T. C. TAI. Laurentian Univ., Northern Ontario Sch. of Med.,
Laurentian Univ., Laurentian Univ.
9:00 WW11 341.18 Quantifying stress through crustacean
EKG: A modified detrended fluctuation analysis (mDFA) of
the nerve-heart dynamics. T. YAZAWA*. Tokyo Metropolitan
Univ.
10:00 WW12 341.19 Dorsal hypothalamic DA neurons
contributes to PVN RVLM circuitry and Ang II mediated
sympatoexcitation. O. M. OGUNDELE*; C. C. LEE; J.
FRANCIS. Louisiana State Univ., Louisiana State Univ.
11:00 WW13 341.20 Reliable and noninvasive protocol for
the induction of acute cardiac response to emotional stress
in intact freely-moving mice. S. SATO*; T. KANBAYASHI; A.
IMANISHI; K. TSUTSUI; T. SHIMIZU. Akita Univ. Grad. Sch.
of Med.
8:00 WW14 341.21 The role of dopamine D2-like receptors
in the inhibition of the cardioaccelerator sympathetic outflow
in diabetic pithed rats. B. VILLANUEVA-CASTILLO*; E.
RIVERA-MANCILLA; A. H. ALTAMIRANO-ESPINOZA; G.
MANRIQUE-MALDONADO; C. M. VILLALN. CINVESTAVIPN.
9:00 WW15 341.22 The role of epigenetic regulators in
the fetal programming of hypertension. J. LAMOTHE*; S.
KHURANA; C. WILLIAMSON; C. J. BYRNE; S. MERCIER;
S. THARMALINGAM; T. TAI. Laurentian Univ., Northern
Ontario Sch. of Med., Laurentian Univ., Laurentian Univ.

POSTER
342. Sleep Behavior and Systems II
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 WW16 342.01 Interhemispheric asymmetry in sleep
depth, arousal and behavioral response associated with the
first-night effect. M. TAMAKI*; J. BANG; T. WATANABE; Y.
SASAKI. Brown Univ.
9:00 WW17 342.02 Genes differentially methylated in young
adults with short sleep duration may regulate sleep across
species. A. C. HART*; H. HUANG; Y. ZHU; V. KNOPIK; J. E.
MCGEARY; M. ELIOT; M. CARSKADON. Brown Univ., Yale
Univ., Rhode Island Hosp., Brown Universty, Providence
Veterans Affairs Med. Ctr., Brown Universty, Bradley Hosp.
10:00 WW18 342.03 Sleep loss induce diabetes in mice
model. S. CHIKAHISA*; S. HARADA; N. SHIMIZU; T.
SHIUCHI; S. NISHINO; H. SI. Tokushima Univ. Grad. Sch.,
Tokushima Univ., Stanford Univ. Sch. of Med.
11:00 WW19 342.04 First evidence of sleep in flight. N. C.
RATTENBORG*; B. VOIRIN; S. M. CRUZ; R. TISDALE; G.
DELLOMO; H. LIPP; M. WIKELSKI; A. L. VYSSOTSKI. Max
Planck Inst. for Ornithology, Max Planck Inst. for Ornithology,
Ornis italica, Univ. of Zurich, Univ. of Zurich.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 WW20 342.05 No benefits of sleep extension on

executive processes during an acute total sleep deprivation.
A. RABAT*; P. J. ARNAL; H. MONNARD; C. BOUGARD; M.
ERBLANG; P. VAN BEERS; C. DROGOU; M. GUILLARD; D.
GOMEZ-MERINO; F. SAUVET; D. LGER; M. CHENNAOUI.
French Armed Forces Biomed. Res. Inst., Htel Dieu Hosp.,
Alertness and Sleep Center, Publ. Assistance of Paris Hosp.
9:00 WW21 342.06 New declarative learning after sleep
is enhanced by pre-sleep D-cycloserine administration.
M. ALIZADEH ASFESTANI*; J. SCHWIDETZKY; E.
BRAGANZA; S. SOEKADAR; J. BORN; G. FELD. Univ.
of Tuebingen, Universtity of Tuebingen, Universtity of
Tuebingen.

11:00 XX1
342.08 Sleep to abstract the gist: A long-term
study on visual perceptual memories. N. D. LUZ*; S.
DIEKELMANN; J. BORN; K. RAUSS. Univ. of Tuebingen,
Univ. of Tuebingen, Univ. of Tuebingen.
8:00 XX2 342.09 Sleep deprivation negatively impacts
reproductive output in Drosophila melanogaster. S.
POTDAR*; D. DANIEL; F. A. THOMAS; S. CHIDAMBARAM;
V. SHEEBA; S. LALL. JNCASR.
9:00 XX3 342.10 Repetitive sleep deprivation dysregulates
the cortico-cortical connectivity of and oscillation in REM
sleep. B. KIM*; B. KOCSIS; E. HWANG; J. CHOI. Korea
Inst. of Sci. and Technol., Univ. of Sci. and Technol., Harvard
Med. Sch.
10:00 XX4
342.11 Differential effect of sleep deprivation and
behavioral sate on excitatory vs inhibitory neurons in CA1. J.
E. HEISS*; A. M. THOMAS; T. S. KILDUFF. SRI Intl.
11:00 XX5
342.12 Prefrontal cortex to accumbens
projections regulate reward seeking after sleep deprivation.
Z. LIU*; Y. WANG; L. CAI; Y. LI; B. CHEN; Y. DONG; Y.
HUANG. Univ. of Pittsburgh, Univ. of Pittsburgh.
8:00 XX6 342.13 Gaba and muscarinic receptors on motor
trigeminal neurons are homeostatically regulated with sleep
deprivation. H. TOOSSI*; E. DEL CID-PELLITERO; B.
JONES. McGill Univ.
9:00 XX7 342.14 The role of nuclear peroxisome
proliferator activated receptor (PPAR) in sleep recovery
after sleep deprivation in rats. A. SARRO-RAMIREZ*; G.
ARANKOWSKY-SANDOVAL; E. MURILLO-RODRGUEZ; K.
GUZMN. Univ. Anahuac Mayab, Univ. Nacional Autnoma
de Mxico, Univ. Anhuac Mayab, Univ. Autonoma de
Yucatan.
10:00 XX8
342.15 Spike timing rigidity is maintained in
bursting neurons under pentobarbital-induced anesthetic
conditions. R. KATO; M. YAMANAKA; M. KOBAYASHI*.
Nihon Univ. Sch. Dent., Col. of Sci. and Technology, Nihon
Univ.
11:00 XX9
342.16 Multi-site intracranial recordings in
rats under propofol and sevoflurane anesthesia. J. A.
GUIDERA*; N. E. TAYLOR; J. T. LEE; K. Y. VLASOV; J.
PEI; E. N. BROWN; K. SOLT. Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., MIT.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 XX11 342.18 oscillations, not slow spindles, precede

down state troughs. C. E. GONZALEZ*; R. A. MAKMCCULLY; S. S. CASH; P. CHAUVEL; H. BASTUJI; M. REY;
E. HALGREN. Univ. of California San Diego, MGH, AixMarseille Univ., LUniversite Lyon.
10:00 XX12 342.19 Hidden subcortical sleep. B. A. GROSS*;
J. J. EMRICK; B. T. RILEY; G. R. POE. Univ. of Michigan,
Univ. of California, San Francisco, Columbia Basin Col.
11:00 XX13 342.20 Chronic immobilization stress modify
sleep pattern and several metabolic parameters in
both stress and recovery period in rats. A. JIMENEZANGUIANO*; A. L. GUZMAN-GUZMAN; A. I. GOMEZMORALES; A. K. LEON-OLGUIN; G. BLANCAS-FLORES; J.
VELAZQUEZ-MOCTEZUMA. Univ. Autonoma MetropolitanaIztapalapa, Univ. Autonoma Metropolitana-Iztapalapa.
8:00 XX14 342.21 Sleep and sleep-related motor activity
in female rats. Y. CHENG; K. HSIEH; L. RAMANATHAM; J.
M. SIEGEL; Y. LAI*. UCLA, VAGLAHS Sepulveda, UCLA/
VAGLAHS Sepulveda, UCLA/VAGLAHS Sepulveda.
9:00 XX15 342.22 Short time running exercise enhances
sleep pressure in mice. N. SHIMIZU*; Y. YOSHIOKA; S.
CHIKAHISA; Y. KITO; T. SHIUCHI; H. SEI. Tokushima Univ.
Grad. Sch., Tokushima Univ. faculty of medicine.
10:00 XX16 342.23 Chronic inflammation of the preoptichypothalamic sleep-regulatory systems contributes to
changes in sleep-wake organization in aging. A. KOSTIN; A.
ALAM; J. GERA; R. SZYMUSIAK; D. MCGINTY; N. ALAM*.
VA Greater Los Angeles Healthcare Syst.

11:00 XX17 342.24 Characterizing sleep, circadian rhythms,

and eye closure in Acomys cahirinus (Cairo spiny mouse)
using EEG, EMG, piezoelectric sensors, and video. L. E.
GUERRIERO*; C. WANG; T. C. BROOKS; A. A. AJWAD;
S. SUNDERAM; A. W. SEIFERT; B. F. OHARA. Univ. of
Kentucky, Univ. of Kentucky.

8:00 XX18 342.25 A comparative study of sleep and

circadian rhythms between the house mouse (Mus
musculus) and African spiny mouse (Acomys cahirinus). C.
WANG*; T. C. BROOKS; L. E. GUERRIERO; A. A. AJWAD;
S. SUNDERAM; A. W. SEIFERT; B. F. OHARA. Univ. of
Kentucky, Univ. of Kentucky.

POSTER
343. Sleep Regulators and Pharmacology
Theme F: Integrative Physiology and Behavior
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 XX19 343.01 mGluR1-PLC4 signal is critical for sleep
architecture. J. HONG*; J. LEE; G. HA; K. SONG; H. SHIN;
E. CHEONG. Yonsei Univ., Inst. for Basic Sci.
9:00 XX20 343.02 Microinjections of carbachol into
dorsomedial pons elicit REM sleep in naturally sleeping rats.
V. B. FENIK*; N. J. CARBALLO; I. RUKHADZE. VA Greater
Los Angeles Healthcare Syst., WebSciences Intl., David
Geffen Sch. of Med. at UCLA.

Neuroscience 2016|Monday AM|51

Mon. AM

10:00 WW22 342.07 Increasing acetylcholine levels does

not affect odor-induced memory reactivation during slow
wave sleep. J. G. KLINZING*; B. RASCH; J. BORN; S.
DIEKELMANN. Univ. Tbingen, Grad. Training Ctr. of
Neurosci. / IMPRS for Cognitive & Systems Neurosci., Univ.
of Fribourg.

8:00 XX10 342.17 Nonlinear spatiotemporal analysis of

sleep spindles. A. L. SAMPSON*; C. LAINSCSEK; S. S.
CASH; E. HALGREN; T. J. SEJNOWSKI. Salk Inst. For Biol.
Studies, UCSD, Massachusetts Gen. Hosp., Harvard Med.
Sch.

10:00 XX21 343.03 Effects of breath-holding on subjective

drowsiness. T. KIKUCHI; M. TAKAYOSE; R. KOSHIZAWA*;
K. ARAI; K. FUJIMOTO; Y. SANO; K. SHIROISHI; N.
GYODA. Nihon Univ. Col. of Industrial Technol., Nihon Univ.
Col. of Commerce, Tokyo Univ. of Marine Sci. and Technol.,
Teikyo Univ. Fac. of Med. Technol., Teikyo Univ. of Sceince
Fac. of Med. Sci.
11:00 XX22 343.04 Forward genetics approach in
identification of novel sleep/wakefulness related gene(s). S.
J. KIM*; T. FUJIYAMA; C. MIYOSHI; N. HOTTA; S. KANNO;
A. IKKYU; M. KAKIZAKI; T. MATSUOKA; S. MIZUNO;
I. MIURA; T. SUZUKI; K. VIVEK; J. S. TAKAHASHI; S.
TAKAHASHI; S. WAKANA; H. FUNATO; M. YANAGISAWA.
Univ. of Tsukuba, Univ. of Tsukuba, Univ. of Tsukuba, RIKEN
Bioresource Ctr., Univ. of Texas Southwestern Med. Ctr.,
Toho Univ., Univ. of Texas Southwestern Med. Ctr.
8:00 YY1 343.05 The unfolded protein response regulates
behavioral state. S. LY*; A. I. PACK; N. NAIDOO. Univ. of
Pennsylvania.
9:00 YY2 343.06 Reductions in local and global sleep
need following pharmacological depotentiation in rat
cerebral cortex. C. CARROLL; H. HSIANG; S. SNYDER; J.
FORSBERG; M. B. DASH*. Middlebury Col., Middlebury Col.

10:00 YY3
343.07 Hypnotic, anxiolytic and anticonvulsant
effect of the methanolic extract of Ricinus communis
(Euphorbiaceae) leaves. O. O. SUNDAY*; L. D. IOR; S.
ADEDOYIN. Univ. of Jos, Univ. of Jos.
11:00 YY4
343.08 Serotonergic dorsal raphe neurons in
hypercapnia-induced arousal from sleep. N. LEIBOLD*;
H. R. SMITH; C. M. GINAPP; D. A. RAPPAPORT; G. F.
BUCHANAN. Univ. of Iowa Carver Col. of Med., Maastricht
University, Sch. for Mental Hlth. and Neuroscience,
European Grad. Sch. of Neurosci., Yale Univ. Sch. of Med.,
Univ. of Iowa Carver Col. of Med.
8:00 YY5 343.09 Identifying genes and gene networks
underlying sleep and psychiatric behaviors in an F2
mouse population. V. GAO*; P. JIANG; J. SCARPA; M.
VITATERNA; A. KASARSKIS; F. TUREK. Northwestern
Univ., Northwestern Univ., Mt. Sinai Sch. of Med.
9:00 YY6 343.10 Effects of subarachnoid infusion of CRF
receptor-1 antagonist on sleep and preoptic neuronal activity
in rats. S. KUMAR*; I. GVILIA; K. HSIEH; S. RAI; K. CHEW;
D. MCGINTY; R. SZYMUSIAK. VA Greater Los Angeles
Healthcare Syst., VA Greater Los Angeles Healthcare Syst.,
Univ. of California, California Hlth. Sci. Univ., Univerversity of
California, Univ. of California, Univ. of California.

10:00 YY11 343.15 T-type calcium channel inhibition in

thalamic reticular nucleus reduces sleep spindles in mice.
C. SHUKLA*; S. THANKACHAN; J. M. MCNALLY; J. T.
MCKENNA; C. YANG; R. E. BROWN; R. W. MCCARLEY;
R. BASHEER. VA Boston Healthcare System-Harvard Med.
Sch., VA Boston Healthcare System-Harvard Med. Sch.
11:00 YY12 343.16 Importance of histamine clearance
for brain functions. T. YOSHIKAWA*; F. NAGANUMA; T.
NAKAMURA; T. IIDA; A. KARPATI; T. MOCHIZUKI; K.
YANAI. Tohoku Univ., Kyushu Univ.

8:00 YY13 343.17 Deletion of trace amine-associated

receptor 1 attenuates behavioral response to caffeine. M.
D. SCHWARTZ*; J. B. PALMERSTON; D. L. LEE; M. C.
HOENER; T. S. KILDUFF. SRI Intl., F. Hoffmann-LaRoche,
Ltd.
9:00 YY14 343.18 Pharmacological characterization of
primidone in the sleep-wake cycle of rats. M. SALASCRISOSTOMO*; K. GUZMN; F. SARLAT-ACUNA; N.
ELLIS-INFANTE; G. ARANKOWSKY-SANDOVAL; E.
MURILLO-RODRGUEZ. Univ. Anahuac Mayab, Dept. de
Neuropatologa Molecular. Inst. de Fisiologa Celular Univ.
Nacional Autnoma de Mxico. Mxico D.F. Mxico, Lab.
de Neurociencias Moleculares e Integrativas Escuela de
Medicina, Divisin Ciencias de la Salud. Univ. Anhuac
Mayab Mrida, Yucatn. Mxico, Ctr. de Investigaciones
Regionales Dr. Hideyo Noguchi Univ. Autnoma de
Yucatn. Mrida, Yucatn. Mxico.
10:00 ZZ1
343.19 Trichostatin A attenuates insomnia
associated with alcohol withdrawal and normalizes sleepwakefulness. R. SHARMA*; A. SHARMA; P. SAHOTA; M.
THAKKAR. Harry S Truman Mem. Veterans Hosp.
11:00 ZZ2
343.20 Flumazenil, a GABA antagonist, delays
return of righting reflex in mice after isoflurane anesthesia
but does not significantly alter dendritic spine density. J.
A. FIDLER; Y. A. JAMAL; L. A. SHAPIRO; P. S. GARCIA*.
Atlanta VA Med. Ctr. / Emory Univ.

POSTER
344. Neurocircuitry of Human Emotion
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

10:00 YY7
343.11 The role of CL thalamic nucleus in the
modulation of cortical slow oscillation in mice. A. OZUR*;
S. CHAUVETTE; I. TIMOFEEV. Univ. Laval, CRIUSMQ,
CRIUSMQ, Univ. Laval.

8:00 ZZ3 344.01 Stress-induced changes in resting

state functional connectivity vary with history of violence
exposure. H. E. DARK*; N. G. HARNETT; A. GOODMAN;
M. WHEELOCK; S. MRUG; M. A. SCHUSTER; M. N.
ELLIOTT; S. TORTOLERO; D. C. KNIGHT. Univ. of Alabama
Birmingham, Boston Childrens Hosp., RAND Corp., The
Univ. of Texas Hlth. Sci. Ctr. at Houston.

11:00 YY8
343.12 Effects of the noisy orexin current
on firing and input-output gain of cholinergic neurons
in the laterodorsal tegmental and pedunculopontine
tegmental nuclei of mice. M. ISHIBASHI*; N. E. MOLINA; I.
GUMENCHUK; C. S. LEONARD. New York Med. Coll.

9:00 ZZ4 344.02 Resting-state functional connectivity in

combat veterans suffering from anger and aggression. T.
VARKEVISSER; T. GLADWIN; L. HEESINK; J. VAN HONK;
E. GEUZE*. UMC Utrecht, Utrecht Univ., Utrecht Univ. Med.
Ctr., Military Mental Healthcare.

8:00 YY9 343.13 Sexually dimorphic increase in kynurenic

acid and impaired contextual memory after acute sleep
deprivation in rats. A. BARATTA*; A. D. BUCHLA; A.
POCIVAVSEK. Maryland Psychiatric Res. Ctr.

10:00 ZZ5
344.03 Amygdala response to emotional pictures
in veterans with anger and aggression. L. HEESINK*; R.
KLEBER; M. VINK; E. GEUZE. UMC Utrecht, Utrecht Univ.,
Res. Ctr. Military Mental Hlth. Care.

9:00 YY10 343.14 Hypothalamic feedforward inhibition of

thalamocortical network controls arousal and consciousness.
C. G. HERRERA*; M. BANDARABADI; M. CARUS
CADAVIECO; K. SCHINDLER; A. PONOMARENKO; T.
KOROTKOVA; A. ADAMANTIDIS. Inselspital Univ. of Bern,
Leibniz Inst. for Mol. Pharmacol. (FMP), Univ. of Bern.

11:00 ZZ6
344.04 Effects of anger induction on human
behavior- an agonistic behavior pattern. R. M. DE
ALMEIDA*; J. C. CABRAL. UFRGS.

52 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 ZZ7 344.05 Developmental perturbation of dopamine

signaling increases adult aggression. D. MAHADEVIA*; C.
M. TEIXEIRA; Q. YU; D. SURI; M. ANSORGE. Columbia
Univ., Columbia Univ. Med. Ctr., Massachusetts Gen. Hosp.

9:00 ZZ8 344.06 The relevance of coordinated brain and

heart interactions to human personality and emotions. E.
SHOKRI-KOJORI*; D. TOMASI; N. VOLKOW. NIH, NIH.
10:00 ZZ9
344.07 Intersubject differences in dynamic
functional connectivity associated with successful use of
cognitive reappraisal and expressive suppression. S. JUN*;
S. HAN. Yonsei Univ.
11:00 ZZ10 344.08 Verbal and nonverbal communications
convey distinct emotional qualities through shared neural
circuitry. R. ROJIANI*; X. ZHANG; A. NOAH; J. HIRSCH.
Yale Univ. Sch. of Med., Yale Univ. Sch. of Med., Yale Univ.
Sch. of Med., Univ. Col. of London.

9:00 ZZ12 344.10 Differentiating neural activity associated

with implied motion and emotion in the cervical spinal cord
using spinal fMRI. T. KOLESAR*; J. KORNELSEN; S. D.
SMITH. The Univ. of Manitoba, The Univ. of Manitoba, St.
Boniface Hosp. Res., Univ. of Winnipeg.
10:00 ZZ13 344.11 Aligning brains to extinguish naturally
occurring fears with multivoxel neurofeedback. V.
TASCHEREAU-DUMOUCHEL*; A. KOIZUMI; A. CORTESE;
M. KAWATO; H. LAU. Univ. of California- Los Angeles,
Advance Telecommunication Res. (ATR) Inst. Intl., Natl. Inst.
of Information and Communication Technol. (NICT), Nara
Inst. of Sci. and Technol., Univ. of California- Los Angeles.
11:00 ZZ14 344.12 Real-time fMRI self-regulation of
functional network connectivity during a visual motion task.
J. ECK*; Q. NOIRHOMME; M. ROSENKE; S. BRUNHEIM;
F. KRAUSE; C. BENJAMINS; M. LUEHRS; R. GOEBEL.
Maastricht Univ., Brain Innovation B.V., Univ. of Lige,
Stanford Univ., Univ. Duisburg-Essen, Inst. of the Royal
Netherlands Acad. of Arts and Sci. (KNAW).
8:00 AAA1 344.13 Effects of a virtual reality (VR)-based
functional near-infrared spectroscopy (fNIRS) neurofeedback
(NF) intervention on highly-impulsive college students.
J. HUDAK*; F. BLUME; T. DRESLER; C. GAWRILOW;
A. EHLIS. LEAD Grad. Sch. and Res. Network, Clin.
for Psychiatry and Psychotherapy, Eberhard Karls Univ.
Tuebingen.
9:00 AAA2 344.14 Embodied learning: How interoceptive
signals from the heart interact with anxiety in fear
conditioning and extinction. S. N. GARFINKEL*; C. D.
GOULD VAN PRAAG; M. ENGELS; D. WATSON; T. DUKA;
H. CRITCHLEY. Clin. Imaging Sci. Ctr., Univ. of Sussex,
Univ. of Duesseldorf, Univ. of Sussex.

POSTER
345. Depression: Human Postmortem Studies
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 AAA3 345.01 Proteomic analysis of postmortem

anterior cingulate cortex reveals persistent disease effects
across MDD states. E. SCIFO*; M. PABBA; F. KAPADIA;
C. MA; D. A. LEWIS; G. C. TSENG; E. SIBILLE. Campbell
Family Mental Hlth. Res. Inst., Univ. of Pittsburgh, Univ. of
Pittsburgh, Univ. of Pittsburgh.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 AAA5 345.03 Exploring the role of long non-coding

RNAs in depression. O. ISSLER*; B. LABONT; I.
PURUSHOTHAMAN; B. J. HARTLEY; D. M. WALKER; C.
J. PEA; Z. LORSCH; K. J. BRENNAND; L. SHEN; E. J.
NESTLER. Icahn Sch. of Med. At Mount Sinai.
11:00 AAA6 345.04 Fibroblast growth factors 2 and 9 may
act as molecular organizers in anterior cingulate cortex
and hippocampus to mediate circuit function in MDD.
E. L. AURBACH*; M. H. HAGENAUER; K. E. PRATER;
W. E. BUNNEY; R. M. MYERS; J. D. BARCHAS; A.
SCHATZBERG; J. Z. LI; F. MENG; S. J. WATSON; H.
AKIL. MBNI, Univ. of Michigan, Univ. of California, Irvine,
HudsonAlpha Inst., Cornell Univ., Stanford Univ.
8:00 AAA7 345.05 Altered levels of polyamine metabolic
genes in various sub-nuclei of the human amygdala in major
depressive disorder. V. SHARMA*; M. HAGENAUER; S.
CHAUDHURY; R. C. THOMPSON; R. M. MYERS; A. F.
SCHATZBERG; J. D. BARCHAS; W. E. BUNNEY; H. AKIL;
S. J. WATSON. Univ. of Michigan, HudsonAlpha Inst. of
Biotech., Stanford Sch. of Med., Weil Cornell Col. of Med.,
Univ. of California, Irvine.
9:00 AAA8 345.06 A comprehensive regional analysis of
genome-wide expression profiles for major depressive
disorder. Y. GONZLEZ*; G. P. GUIO; D. A. FORERO.
Pontificia Univ. Javeriana, Univ. Antonio Nario.
10:00 AAA9 345.07 The Effect of Early Life Adversity on
the Oxytocinergic System: From childhood maltreatment
and suicide to natural variation in rat maternal care. D.
ALMEIDA*; L. FIORI; G. TURECKI. McGill Group For
Suicide Studies.
11:00 AAA10 345.08 Analysis of myelin-associated genes
and proteins in postmortem samples of uncinate fasciculus
from suicides having experienced early life adversity. M.
J. SHAW*; A. TANTI; M. DAVOLI; N. MECHAWAR; G.
TURECKI. McGill Univ., McGill Univ., Mcgill Univ.
8:00 AAA11 345.09 Abnormal gene expression of
proinflammatory cytokines in the postmortem brain of
depressed suicide victims. H. ZHANG*; H. RIZAVI; X. REN;
G. PANDEY. Univ. of Illinois at Chicago.
9:00 AAA12 345.10 Molecular insights of dysregulated
microrna network in locus coeruleus of suicide brain. B.
ROY*; M. PALKOVITS; G. FALUDI; Y. DWIVEDI. Univ. of
Alabama At Birmingham, Univ. of Alabama at Birmingham.
10:00 AAA13 345.11 Poly ADP-ribose polymerase are more
in subjects with major depressive disorder and disintegrate
neural progenitors in dentate gyrus of human hippocampal
formation. M. K. JAISWAL*; A. DWORK; V. ARANGO; G.
ROSOKIJA; J. MANN; R. HEN; M. BOLDRINI. New York
State Psychiatric Inst., Columbia Univ., Columbia Univ., New
York State Psychiatric Inst., Columbia Univ., Columbia Univ.

Neuroscience 2016|Monday AM|53

Mon. AM

8:00 ZZ11 344.09 The rasa in the raga- brain networks

of emotion responses to North Indian Classical ragas. A.
MATHUR*; N. C. SINGH. Natl. Brain Res. Ctr.

9:00 AAA4 345.02 Sex specific transcriptional signatures

in human depression. B. LABONT*; O. ENGMANN;
I. PURUSHOTHAMAN; G. HODES; J. SCARPA; H.
KRONMAN; Z. LORSCH; P. HAMILTON; E. CALIPARI; O.
ISSLER; J. WANG; E. LOH; M. CAHILL; D. WALKER; M.
PFAU; S. RUSSO; A. KAZARSKIS; R. NEVE; Y. DONG; N.
MECHAWAR; C. TAMMINGA; G. TURECKI; B. ZHANG; L.
SHEN; E. NESTLER. Icahn Sch. of Med. At Mount Sinai,
Univ. of Pittsburgh, MIT, McGill Univ., The Univ. of Texas
Southwestern Med. Ctr.

11:00 AAA14 345.12 Epigenetic and transcript aberrations

of the galanin system in major depressive disorder. S. S.
BARDE*; J. RUEGG; T. EKSTRM; M. PALKOVITS; G.
TURECKI; J. PRUDHOMME; N. MECHAWAR; T. HKFELT.
Karolinska Institutet, Karolinska Institutet, Semmelweis Univ.
and the Hungarian Acad. of Sci., McGill Group for Suicide
Studies, Douglas Mental Hlth. Univ. Inst., Douglas Mental
Hlth. Univ. Inst.
8:00 AAA15 345.13 Increased expression of PARP-1 in
granule cells of human hippocampus in major depressive
disorder. C. ZIZOLA*; A. DWORK; V. ARANGO; G.
ROSOKIJA; J. MANN; R. HEN; M. BOLDRINI. NYSPI, Div.
of Mol. Imaging and Neuropathology, NYSPI, NYSPI.

POSTER
346. Eating Disorders
Theme G: Motivation and Emotion

11:00 AAA23 346.08 Hypersensitivity to pleasant touch in

individuals remitted from anorexia nervosa. A. BISCHOFFGRETHE*; C. E. WIERENGA; L. A. BERNER; A. N.
SIMMONS; M. OGASAWARA; L. J. GREATHOUSE; U.
BAILER; M. P. PAULUS; W. H. KAYE. Univ. of California San
Diego Dept. of Psychiatry, VA San Diego Healthcare Syst.,
Laureate Inst. for Brain Res.
8:00 AAA24 346.09 Accumbens firing in a dietary-induced
model of binge eating. J. STAMOS; A. TAYLOR; D.
QUINTIN; K. COFFEY; J. KULIK; A. PAWLAK; N. BELLO;
M. O. WEST*. Rutgers Univ., Rutgers Univ., Rutgers Univ.,
Rutgers Univ., Panasonic Corp of North America.
9:00 AAA25 346.10 Glucose effect on memory is modulated
by stress. C. FOX*; J. DOYLE. Holy Cross Col., Holy Cross
Col.
10:00 AAA26 346.11 Recovery of brain structural abnormalities
in morbidly obese patients after bariatric surgery. Y.
ZHANG*; W. CAI; Q. ZHU; G. LI; Q. MENG; G. WANG.
Xidian Univ., Xidian Univ., NIAAA.

Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 AAA16 346.01 Transcriptional effects on hypothalamic
inflammatory mediators in an animal model of binge
eating. M. V. MICIONI DI BONAVENTURA*; S. ALBONI; C.
BENATTI; M. E. GIUSEPPONI; N. BRUNELLO; C. CIFANI.
Univ. of Camerino, Sch. of Pharmacy, Pharmacol. Unit, Univ.
of Modena and Reggio Emilia.
9:00 AAA17 346.02 Enhanced coupling between salience
network and basal ganglia network predicts distorted
eating attitude in anorexia nervosa. M. ISOBE*; Y. MORI;
J. MIYATA; H. FUKUYAMA; S. NOMA; T. MURAI; H.
TAKAHASHI. Kyoto Univ. Grad. Sch. of Med., Human Brain
Res. Ctr.
10:00 AAA18 346.03 Sex and strain-dependent response to a
stress free animal model of binge eating. H. PAPACOSTAS
QUINTANILLA*; V. M. ORTZ-ORTEGA; C. LPEZRUBALCAVA. CINVESTAV, Inst. Nacional de Ciencias
Mdicas y Nutricin Salvador Zubirn, CINVESTAV.
11:00 AAA19 346.04 Prefrontal cognitive control over
interference by food images in binge eating disorder and
bulimia nervosa. J. LEE*; K. NAMKOONG; Y. JUNG. Dept.
of Psychiatry, Yonsei Univ. Colleg, Inst. of Behavioral Sci. in
Medicine, Yonsei Univ. Col. of Med.
8:00 AAA20 346.05 Reinforcement learning during a
monetary reward task changes with weight restoration
in adolescents with anorexia nervosa. M. DEGUZMAN*;
M. SHOTT; G. FRANK. Univ. of Colorado Anschutz Med.
Campus.
9:00 AAA21 346.06 Reduced serotonin transporter
availability in anorexia nervosa: A [11C]DASB PET study.
M. YOKOKURA*; T. TERADA; T. BUNAI; K. NAKAIZUMI;
K. TAKEBAYASHI; M. FUTATSUBASHI; E. YOSHIKAWA;
Y. OUCHI. Hamamatsu Univ. Sch. of Med., Hamamatsu
Photonics KK.
10:00 AAA22 346.07 Psychiatric disorders among diabetic
patients attending medical outpatient clinics of Abubakar
Tafawa Balewa University Teaching Hospital, Bauchi,
Nigeria. Y. M. MAHMUD*; D. SULYMAN. Abubakar Tafawa
Balewa Univ. Teaching Hospita, Abubakar Tafawa Balewa
Univ. Teaching Hosp.

54 | Society for Neuroscience

POSTER
347. Alcohol: Behavioral Studies I
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 BBB1 347.01 Social defeat stress and escalated
ethanol drinking by C57BL/6J mice: Modulation by CRF-R1
antagonism. J. F. DEBOLD*; P. ANDREW; J. G. AULD; E. L.
NEWMAN; E. Y. ZHANG; K. A. MICZEK. Tufts Univ., Tufts
Univ.
9:00 BBB2 347.02 Paternal chronic variable stress reduces
ethanol drinking behavior selectively in male offspring. G.
ROMPALA*; G. HOMANICS. Univ. of Pittsburgh.
10:00 BBB3 347.03 No maternal separation- or supplierdependent effect on basal corticosterone or alcohol intake
and preference in female Wistar rats. S. LUNDBERG*; I.
NYLANDER; E. ROMAN. Uppsala Univ.
11:00 BBB4 347.04 The effect of stress on ethanol selfadministration in Wistar rats. C. J. HEYSER*; B. HOFF; R. E.
BLASER. Univ. of California San Diego, Univ. of San Diego.
8:00 BBB5 347.05 Stress and chronic ethanol interactions
on drinking and cognitive control. E. M. RODBERG*; C. R.
DEN HARTOG; D. E. MOORMAN; E. M. VAZEY. Univ. of
Massachusetts Amherst, Univ. of Massachusetts Amherst.

9:00 BBB6 347.06 Risk and severity of alcohol dependence

are associated with the fatty acid amide hydrolase C385A
missense variant. M. E. SLOAN*; J. YAN; J. L. GOWIN; M.
L. SCHWANDT; H. SUN; C. HODGKINSON; D. GOLDMAN;
V. A. RAMCHANDANI. NIH, Johns Hopkins, Natl. Inst. on
Alcohol Abuse and Alcoholism.
10:00 BBB7 347.07 Longitudinal analysis of GPR88
knockout mice behavior under ethological conditions. G.
MAROTEAUX*; S. BEN HAMIDA; T. AREFIN; B. KIEFFER;
L. HARSAN. Douglas Res. Ctr., Advanced Mol. Imaging
Ctr. (AMIR), Med. Physics, Univ. Med. Ctr., IGBMC, Inst.
Gntique Biologie Molculaire Cellulaire.
11:00 BBB8 347.08 FABP5/7 deficiency decreases ethanol
consumption in female but not male mice. B. H. CLAVIN*;
J. A. HAMILTON; J. OROURKE; D. DEUTSCH; S. HAJDAHMANE; M. KACZOCHA; P. K. THANOS. Univ. At
Buffalo, Stony Brook Univ., Stony Brook Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 BBB9 347.09 Alcohol consumption in response to

exercise access is modulated by gonadal hormones. C.
E. MCGONIGLE*; L. P. ERCOLANO; Z. J. KOZICK; T. B.
NENTWIG; J. E. GRISEL. Bucknell Univ.
9:00 BBB10 347.10 The AMPA antagonist NBQX reduces
alcohol intake in sham-operated and olfactory bulbectomized
rats. J. RUDA-KUCEROVA; Z. BABINSKA; B. GETACHEW;
Y. TIZABI*. Masaryk Univ., Howard Univ. Col. of Med.
10:00 BBB11 347.11 The 5-HT1A partial agonist Tandospirone
reduces long term binge-like alcohol drinking and
prevents the subsequent deletious effects on anxiety and
neurogenesis. A. BELMER*; O. PATKAR; S. BARTLETT.
QUT-IHBI-TRI.
11:00 BBB12 347.12 Circadian dysregulation exacerbates
alcohol induced tissue injury and mortality. L. C. LYONS*; A.
K. DE NOBREGA; A. P. MELLERS; E. J. NOAKES. Florida
State Univ.

9:00 BBB14 347.14 Preconception alcohol increases offspring

vulnerability to stress. L. G. CHASTAIN*; S. JABBAR; O.
GANGISETTY; M. A. CABRERA; K. SOCHACKI; D. K.
SARKAR. Rutgers The State Univ. of New Jersey.
10:00 BBB15 347.15 Gender differentially responds to
disruption of circadian rhythm in alcohol drinking and mood
behaviors via adenosine transporter 1. Y. JIA*; C. VADNIE;
N. CARNEIRO; H. DAVID; D. CHOI. Mayo Clin. Dept. of Mol.
Pharmacol. A, Univ. Federal de Viosa.
11:00 BBB16 347.16 Longitudinal effects of alcohol on sleep
distribution using a novel murine model of alcohol abuse:
Repeated drinking-in-the-dark alternating with two-bottle
choice paradigm. S. PERREAU-LENZ*; J. VAZQUEZDEROSE; M. D. SCHWARTZ; W. POLGAR. SRI Intl.
8:00 BBB17 347.17 Intermittent two-bottle choice (I-2BC)
chronic alcohol exposure alters REM sleep in a rodent model
of alcoholism. J. VAZQUEZ-DEROSE*; S. PERREAU-LENZ;
A. NGUYEN. SRI Intl.

9:00 BBB18 347.18 Effects of acute, mild sleep deprivation on

alcohol-induced effects in mice: Analysis of strain, sex and
age. K. M. HAMRE*; J. A. BAKER; N. VO; A. AGARWAL;
K. DONOHUE; B. F. OHARA. Univ. of Tennessee Hlth. Sci.
Ctr., Univ. of Tennessee Hlth. Sci. Ctr., Christian Brothers
Univ., Signal Solutions LLC.
10:00 BBB19 347.19 Sazetidine-A reduces alcohol but not
nicotine consumption in a mouse model of alcohol and
nicotine co-addiction. J. C. TOUCHETTE*; K. Y. LEE; E. C.
HARTELL; E. J. BADE; R. PEARSON; A. M. LEE. Univ. of
Minnesota Twin Cities.
11:00 BBB20 347.20 Microarchitecture of self-administration
patterns during concurrent alcohol and nicotine access in
mice: Temporal overlap in drug intakes amplifies bout size
and extends bout duration. M. M. FORD*; S. S. OSWALD; A.
D. MCCRACKEN; N. L. DAVIS. Oregon Hlth. and Sci. Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

348. Amphetamines: Neurocircuitry and Cell Signaling

Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 BBB21 348.01 Increased methamphetamine selfadministration in hnrnph1 heterozygous mice directly
implicates this RNA binding protein in genetic susceptibility
to methamphetamine addiction. K. K. SZUMLINSKI*; J.
SHAHIN; E. K. FULTZ; C. N. BROWN; N. YAZDANI; C. D.
BRYANT. Univ. California-Santa Barbara, Boston Univ. Sch.
of Med.
9:00 BBB22 348.02 Manipulation of extracellular glutamate in
the prelimbic and infralimbic cortices during the incubation
of cocaine craving. C. B. SHIN*; T. J. TEMPLETON; E. S.
GABLE; A. S. CHIU; T. E. KIPPIN; K. K. SZUMLINSKI. Univ.
of California, Santa Barbara.
10:00 BBB23 348.03 Neuroanatomically specific role of
Homer2 expression in NAC regulation of methamphetamine
reward sensitivity. C. N. BROWN*; E. K. FULTZ; T. E.
KIPPIN; K. K. SZUMLINSKI. UCSB Psychological and Brain
Sci.
11:00 BBB24 348.04 Transcriptomic and neuroanatomical
mechanisms of Hnrnph1 in methamphetamine reward.
N. YAZDANI*; Q. T. RUAN; M. CHAU; E. R. REED; F.
MORTAZAVI; D. ROSENE; J. GRANT; W. JOHNSON; C. D.
BRYANT. Boston Univ. Sch. of Med., Boston Univ., Boston
Univ. Sch. of Med., The Univ. of New Orleans, Boston Univ.
Sch. of Med.
8:00 BBB25 348.05 The effects of mGlu5 blockade within
the nucleus accumbens shell on alcohol withdrawal-induced
anxiety in mice. K. M. LEE*; M. A. COELHO; M. A. CLASS;
K. R. SERN; M. D. BOCZ; M. SUZUKI; K. K. SZUMLINSKI.
Univ. of California Santa Barbara.
9:00 BBB26 348.06 Increased expression of AMPA glutamate
receptors in the prefrontal cortex distinguishes abstinent rats
from compulsive methamphetamine takers. J. L. CADET*;
I. KRASNOVA; B. LADENHEIM; M. MCCOY; N. TERRY; D.
WALTHER. NIH/NIDA, NIH/NIDA.
10:00 CCC1 348.07 The dorsomedial striatum is critical for
incubation of methamphetamine craving after voluntary
abstinence. D. CAPRIOLI*; M. VENNIRO; M. ZHANG; A. LI;
B. L. WARREN; Y. SHAHAM. Natl. Inst. on Drug Abuse.
11:00 CCC2 348.08 A critical role of the central amygdala
nucleus in relapse to methamphetamine seeking after
voluntary abstinence. M. VENNIRO*; M. ZHANG; C. CIFANI;
B. L. WARREN; J. M. BOSSERT; N. J. MARCHANT; C.
CHIAMULERA; D. CAPRIOLI; Y. SHAHAM. Natl. Inst. On
Drug Abuse, Univ. of Camerino, Univ. of Verona.
8:00 CCC3 348.09 Incubation of methamphetamine but not
heroin craving after voluntary abstinence in male and female
rats. M. ZHANG*; M. VENNIRO; Y. SHAHAM; D. CAPRIOLI.
NIH.
9:00 CCC4 348.10 Role of afferents into dorsal striatum
in incubation of methamphetamine craving. X. LI*; F.
SURJONO; T. ZERIC; J. BOSSERT; Y. SHAHAM. Natl. Inst.
On Drug Abuse.

Neuroscience 2016|Monday AM|55

Mon. AM

8:00 BBB13 347.13 Differential rearing alters ethanol

preference during adolescence but not operant responding
for ethanol in adulthood. T. J. WUKITSCH*; K. PARKS; M. E.
CAIN. Kansas State Univ., Kansas State Univ.

POSTER

10:00 CCC5 348.11 Diazepam inhibits phasic dopamine

release in the nucleus accumbens and reverses the increase
of phasic dopamine release induced by amphetamine. A.
GOMEZ-A.; A. M. FIORENZA; S. L. BOSCHEN; A. H. SUGI;
D. BECKMAN; S. T. FERREIRA; K. LEE; C. D. BLAHA;
C. DA CUNHA*. Univ. of North Carolina, Univ. Federal do
Parana, Univ. Federal do Parana, Federal Univ. of Rio de
Janeiro, Mayo Clin.
11:00 CCC6 348.12 Methamphetamine induces striatal
dopamine efflux through interactions between VMAT2 and
receptors. D. HEDGES*; E. Y. JANG; J. T. YORGASON;
C. CARR; J. SKIDMORE; V. K. WEERASEKARA; F. P.
BELLINGER; J. D. UYS; S. STEFFENSEN, 84602. Brigham
Young Univ., Daegu Haany Univ., Oregon Hlth. & Sci. Univ.,
Univ. of Hawaii, Med. Univ. of South Carolina.
8:00 CCC7 348.13 Methylphenidate significantly alters
functional connectivity between the prefrontal cortex and
ventral tegmental area dopamine neurons. I. DELA PENA*;
W. SHI. Loma Linda Univ., Loma Linda Univ.
9:00 CCC8 348.14 Effect of amphetamine sensitization
on single unit activity in the rat dorsolateral striatum. R. I.
GATICA*; M. I. AGUILAR-RIVERA; J. A. FUENTEALBA.
Pontificia Univ. Catlica De Chile, Pontificia Univ. Catlica
De Chile, Pontificia Univ. Catlica De Chile, UCSD.
10:00 CCC9 348.15 Roles of nucleus accumbens core and
shell for methamphetamine-induced behavioral sensitization
in rats. C. CHENG*; A. C. W. HUANG. Fo Guang University,
Psychology.
11:00 CCC10 348.16 Effects of TMEM168 overexpression
on methamphetamine-induced hyperlocomotion and place
preference, and anxiety in mice via regulating dopaminergic
and GABAergic neuronal systems in the nucleus accumbens
of mice. K. FU*; Y. MIYAMOTO; E. SAIKA; S. MURAMATSU;
K. UNO; A. NITTA. Univ. of Toyama, Jichi Med. Univ.
8:00 CCC11 348.17 Methamphetamine-induced dysfunction of
NE signaling in the bed nucleus of the stria terminalis of the
rat brain. J. PARK*; R. V. BHIMANI; K. T. WAKABAYASHI.
Univ. At Buffalo.
9:00 CCC12 348.18 Time correlated single photon counting
in vivo reveals enhanced activation of D1-expressing
medium spiny neurons in the dorsal striatum following acute
amphetamine administration in mice. T. H. CHEUNG*; R.
M. MIKOFSKY; T. ZERIC; S. D. CLARK; U. J. KANG; D. L.
SULZER. Columbia Univ.
10:00 CCC13 348.19 Medial prefrontal cortex is not required
for amphetamine to produce acute-withdrawal related
hypoactivity in rats. W. WHITE*; H. L. HOWARD; Z. S.
ABBOTT; K. M. HAGER; K. L. EVERMAN; I. M. WHITE.
Morehead State Univ.
11:00 CCC14 348.20 The medial prefrontal cortex-basolateral
amygdala pathway mediates methamphetamine-induced
conditioned saccharin suppression: Evaluation of the reward
comparison hypothesis. A. C. HUANG*; A. B. H. HE. Fo
Guang Univ, Psychology.
8:00 CCC15 348.21 Chemogenetic inhibition of CaMKII
neurons in the rat dorsal medial prefrontal cortex attenuates
methamphetamine addiction following concurrent sexual
behavior. L. B. KUIPER*; L. M. COOLEN. Univ. of Mississippi
Med. Ctr., Univ. of Mississippi Med. Ctr.
9:00 CCC16 348.22 Glutamatergic output from the medial
prefrontal cortex modulates the daily rhythm in amphetamine
reward. I. C. WEBB*; G. G. WILSON; N. N. NEMATI; L. M.
COOLEN. Univ. of Mississippi Med. Ctr., Univ. of Mississippi
Med. Ctr.
56 | Society for Neuroscience

10:00 CCC17 348.23 Prelimbic 1-adrenergic

receptors modulate extinction of both appetitive and
aversive conditioned memories. E. LATAGLIATA*; G.
CHIACCHIERINI; M. SANCANDI; S. PUGLISI-ALLEGRA.
Fndn. Santa Lucia, Sapienza Univ., Fndn. Santa Lucia.
11:00 CCC18 348.24 Inhibition of withdrawal induced
neurogenesis in the dentate gyrus Inhibition of
withdrawal-induced neurogenesis in the dentate gyrus
blocks methamphetamine relapse. M. H. GALINATO*;
J. LOCKNER; M. C. STAPLES; S. S. SOMKUWAR; J.
SOBIERAJ; S. CHAING; M. FANNON; A. GHOFRANIAN;
A. JOEA; A. I. NAVARRO; B. W. LUIKART; K. JANDA; C.
MANDYAM. UCSD, The Scripps Res. Inst., The Scripps
Res. Inst., Dartmouth Geisel Sch. of Med.
8:00 CCC19 348.25 Contributions of neurotrophic factors to
exercise-induced attenuation of methamphetamine-induced
neurotoxicity. M. F. MURRAY*; A. E. SIMPSON; A. N.
FRICKS-GLEASON. Regis Univ.
9:00 CCC20 348.26 Neural substrates of conditioning and
extinction on methamphetamine-induced conditioned place
preference paradigm: An immunohistochemistry c-Fos and
p-ERK staining. B. H. HE*; A. HUANG. Fo Guang Univ.
10:00 CCC21 348.27 Voluntary exercise attenuates
methamphetamine-induced monoaminergic neurotoxicity.
A. SIMPSON*; M. F. MURRAY; A. N. FRICKS-GLEASON.
Regis Univ., Regis Univ.
11:00 CCC22 348.28 Regulator of G Protein Signaling-12
(RGS12) in the action of amphetamine and related drugs
of abuse. J. D. GROSS*; A. SCHROER; K. WIX; D. P.
SIDEROVSKI; V. SETOLA. West Virginia Univ. Sch. of Med.,
West Virginia Univ.
8:00 CCC23 348.29 Sex differences in neural activation
patterns within HPA axis associated brain regions following
repeated methamphetamine exposure. J. JACOBSKIND*; Z.
J. ROSINGER; D. G. ZULOAGA. SUNY Albany.
9:00 CCC24 348.30 Dopamine transporter-inhibiting
psychostimulants increase exocytotic dopamine release.
P. CHALWADI; S. H. WALTERS; A. C. MICHAEL; P. A.
GARRIS*. Illinois State Univ., Univ. of Pittsburgh.

POSTER
349. Cellular and Circuit Mechanisms of Cocaine Addiction
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 CCC25 349.01 Neural activity in the anterior insula
tracks cocaine-induced devaluation of natural rewards. T. M.
MOSCHAK*; E. A. WEST; R. M. HAAKE; X. WANG; R. M.
CARELLI. Univ. of North Carolina.
9:00 CCC26 349.02 Neuronal correlates of motivational
sensitivity to natural and drug rewards. B. ODONOVAN*;
P. HASHEMI; S. SAMARANAYAKE; R. ROBKE; P. I.
ORTINSKI. Univ. of South Carolina, Univ. of South Carolina.
10:00 DDD1 349.03 Altered encoding of motivational
stimuli in the basolateral and central amygdala in cocaineexperienced rats. K. J. STANSFIELD*; K. L. AGSTER;
K. S. MCCONOMY; C. N. BROWN; M. R. PAYNE; M. P.
SADDORIS. Univ. of Colorado Boulder.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 DDD2 349.04 Reduced dopamine as a substrate of

aversive motivation. M. G. SPRING*; R. C. TWINING; M.
A. ROBBLE; S. M. CONWAY; D. S. WHEELER; M. G.
BLACKMORE; M. F. ROITMAN; R. A. WHEELER. Marquette
Univ., Univ. of Illinois at Chicago.
8:00 DDD3 349.05 Dissecting the role of the ventral pallidum
in cocaine seeking. J. A. HEINSBROEK*; D. N. NEUHOFER;
A. BOBADILLA; P. W. KALIVAS. Med. Univ. of South
Carolina.
9:00 DDD4 349.06 Social defeat stress augments
economic demand for cocaine via CRF in the rat VTA. M. Z.
LEONARD*; D. STEIN; J. F. DEBOLD; K. A. MICZEK. Tufts
Univ.

11:00 DDD6 349.08 Increased limbic connectivity strength

and impaired social interaction, recognition memory, and
ultrasonic vocalizations, 24 hours after single MDPV
exposure. M. FEBO*; M. POMPILUS; J. A. PINO-REYES;
S. E. KAPLITZ; N. T. CHOUDHURY; G. E. TORRES; L. M.
COLON-PEREZ. Univ. of Florida, Univ. of Florida.
8:00 DDD7 349.09 Enhancement of negative affect by
abstinence from cocaine in a preclinical model. R. M.
HAAKE*; E. A. WEST; X. WANG; E. L. THOMAS; R. M.
CARELLI. Univ. of North Carolina.
9:00 DDD8 349.10 Role of anterior dorsal lateral
hypothalamic area perineuronal nets in the acquisition
of cocaine-induced conditioned place preference and
self-administration. J. M. BLACKTOP*; R. P. TODD; L.
CHURCHILL; M. SLAKER; B. A. SORG. Washington State
Univ. Vancouver, Washington State Univ.
10:00 DDD9 349.11 Perineuronal nets protect parvalbumin
neurons from the effects of cocaine-induced oxidative stress
in the rat prefrontal cortex. M. SLAKER*; K. REYES; B. A.
SORG. Washington State Univ. Vancouver.
11:00 DDD10 349.12 Optogenetic manipulation of Parvalbumin
interneurons in the central amygdala (CeA) modulates the
negative affective states and the expression of corticotropinreleasing hormone within morphine withdrawal. L. WANG*;
J. M. SHEN; F. F. WANG; L. MA. The Ninth Peoples Hosp.,
Fudan Univ.
8:00 DDD11 349.13 Optogenetics reveals that dopamine
signaling in the rostral-caudal NAc shell differentially inhibits/
facilitates cocaine-induced natural reward devaluation and
negative affect in a preclinical model. S. W. HURLEY*; E. A.
WEST; R. M. CARELLI. Univ. of North Carolina At Chapel
Hill.
9:00 DDD12 349.14 Longitudinal changes in brain metabolic
activity after escalation of cocaine self-administration. C.
NICOLAS*; C. TAUBER; F. LEPELLETIER; S. CHALON; P.
BELUJON; L. GALINEAU; M. SOLINAS. Natl. Inst. On Drug
Abuse-Irp, LNEC, INSERM, U1084, UMR INSERM U930,
Univ. Franois Rabelais de Tours.
10:00 DDD13 349.15 Mitochondrial fission in nucleus
accumbens projection neurons subtype promotes cocaine
behavioral plasticity. R. CHANDRA*; M. ENGELN; L.
RIGGS; C. FRANCIS; S. DAS; K. GIRVEN; A. AMGALAN; L.
JENSEN; P. KONKALMATT; A. GANCARZ; S. GOLDEN; G.
TURECKI; S. RUSSO; S. INIGUEZ; D. DIETZ; M. K. LOBO.
Univ. of Maryland, Baltimore, The George Washington Univ.,
Univ. at Buffalo, Mount Sinai Sch. of Med., Douglas Mental
Hlth. Univ. Inst. and McGill Univ., California State Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 EEE1 349.17 Selective ablation of GIRK channels

in dopamine neurons alters behavioral effects of cocaine
in mice. N. M. MCCALL*; L. KOTECKI; S. DOMINGUEZLOPEZ; E. MARRON FERNANDEZ DE VELASCO; N.
CARLBLOM; A. L. SHARPE; M. J. BECKSTEAD; K.
WICKMAN. Univ. of Minnesota, Univ. of Minnesota, The
Univ. of Texas Hlth. Sci. Ctr. at San Antonio, The Univ. of
Texas Hlth. Sci. Ctr. at San Antonio; Univ. of the Incarnate
Word.
9:00 EEE2 349.18 Signaling kinetics of stimulated dopamine
release in the nucleus accumbens core and shell are
differentially altered following abstinence from cocaine selfadministration in behaving rats. M. SADDORIS*. Univ. of
Colorado, Boulder.
10:00 EEE3 349.19 Role of endocannabinoid and dopamine
signaling in cocaine-induced synaptic AMPAR depotentiation
in the nucleus accumbens. A. E. INGEBRETSON*; M. C.
HEARING; M. ESGUERRA; E. D. HUFFINGTON; M. J.
THOMAS. Univ. of Minnesota Dept. of Neurosci., Univ. of
Minnesota Dept. of Neurosci.
11:00 EEE4 349.20 NMDAR dependent intracellular
responses associated with cocaine conditioned place
preference behavior. S. NYGARD; A. KLAMBATSEN;
B. BALOUCH; V. L. QUINONES-JENAB*; S. JENAB.
Washington Univ. Sch. of Med., Hunter College, CUNY.
8:00 EEE5 349.21 Presynaptic adenosine A2A receptor
inhibition impacts behavioral sensitization to repeated
cocaine but not repeated methamphetamine. N. HAYNES*;
R. K. BACHTELL. Univ. of Colorado.
9:00 EEE6 349.22 Evaluating of the role of nucleus
accumbens nitric oxide and somatostatin release in
cocaine seeking. M. D. SCOFIELD*; J. A. HEINSBROEK;
C. GARCIA-KELLER; A. W. SMITH; C. D. GIPSON; P. W.
KALIVAS. Med. Univ. of South Carolina, Med. Univ. of South
Carolina, Icahn Sch. of Med. an Mount Sinai, Arizona Stat
Univ.
10:00 EEE7 349.23 Cocaine inhibits 6-containing nicotinic
acetylcholine receptor-mediated currents. D. CHEN*; Q. SU;
J. NEISEWANDER; J. WU. NRC 445room, Barrow Neurolog.
Inst., Yunfu Peoples Hosp., Arizona State Univ.
11:00 EEE8 349.24 Dysregulation of serotonergic function
in orbitofrontal cortex during cocaine withdrawal. A. M.
WRIGHT*; A. ZAPATA; A. F. HOFFMAN; C. R. LUPICA. Natl.
Inst. On Drug Abuse.
8:00 EEE9 349.25 The 5-HT1B serotonin receptor
potentiates methylphenidate-induced gene regulation in
the striatum. D. ALTER; J. A. BEVERLEY; H. STEINER*.
Chicago Med. School/RFUMS.
9:00 EEE10 349.26 Dopamine neurotransmission in the
medial dorsal striatum is associated with vulnerability to
cocaine addiction. J. K. SHAW*; R. A. ESPAA. Drexel Univ.
Col. of Med.

10:00 EEE11 349.27 Combining multiple schedules of

reinforcement with glutamate biosensors to examine the
effects of cocaine and food on prelimbic glutamatergic
signaling. S. R. BATTEN*; G. A. GERHARDT; J. S.
BECKMANN. Univ. of Kentucky, Univ. of Kentucky.

Neuroscience 2016|Monday AM|57

Mon. AM

10:00 DDD5 349.07 The impact of cocaine self-administration

on value signals in ventral striatum. A. C. BURTON*; G.
B. BISSONETTE; K. C. HEATLEY; E. M. BLUME; M. L.
DONNELLY; M. R. ROESCH. Univ. of Maryland, Col. Park,
Univ. of Maryland, Col. Park.

11:00 DDD14 349.16 Cocaine effects on dopamine neurons

in mice are reduced by both deletion of GIRK2 channels
specifically in dopamine neurons and with cocaine selfadministration experience. A. M. HAGER*; S. DOMINGUEZ
LOPEZ; K. WICKMAN; M. J. BECKSTEAD. Univ. of Texas
Hlth. Sci. Ctr. At San A, Univ. of Minnesota.

POSTER
350. Cocaine: Brain Circuitry I
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 EEE12 350.01 Resolving the contribution of midline
thalamic nuclei efferents during reinstatement of drugseeking using Gi/o-coupled DREADDs. A. M. WUNSCH*;
L. M. YAGER; C. LE; E. A. DONCKELS; J. F. NEUMAIER;
S. M. FERGUSON. Seattle Childrens Res. Inst., Univ. of
Washington, Univ. of Washington, Univ. of Washington.
9:00 EEE13 350.02 Role of a CRF-mediated dopaminergic
projection from the ventral tegmental area to the prelimbic
cortex in stress-induced cocaine seeking. E. VAN
NEWENHIZEN*; O. VRANJKOVIC; J. M. BLACKTOP; T. M.
KLOEHN; G. S. STINNETT; C. H. GERNDT; K. KETCHESIN;
M. E. NORDNESS; C. R. MUELLER; J. R. MCREYNOLDS;
E. M. DONCHECK; D. A. BAKER; A. F. SEASHOLTZ; J. R.
MANTSCH. Marquette Univ., Univ. of Michigan.
10:00 EEE14 350.03 Glucocorticoid-endocannabinoid
interactions in the prelimbic cortex mediate stresspotentiated reinstatement of cocaine seeking through
increased activation of the cortico-accumbens pathway. J. R.
MCREYNOLDS*; E. M. DONCHECK; O. VRANJKOVIC; E.
N. GRAF; X. LIU; T. STOLLENWERK; P. J. GOTTSHALL; Q.
LIU; C. J. HILLARD; J. R. MANTSCH. Marquette Univ., Med.
Col. of Wisconsin.
11:00 FFF1 350.04 Neurocircuitry and cannabinoid receptor
1 involvement in cocaine-taking and cocaine-seeking
behavior following chronic electric footshock stress-induced
escalation of self-administration in rats. C. P. WOLF*; J.
R. MCREYNOLDS; D. M. STARCK; C. J. HILLARD; J. R.
MANTSCH. Marquette Univ., Med. Col. of Wisconsin.
8:00 FFF2 350.05 Proestrus-level 17-estradiol potentiates
the reinstatement of cocaine seeking. M. C. DEBAKER*;
E. M. DONCHECK; J. J. TUSCHER; L. A. URBANIK;
L. M. BARRON; L. J. SCHUH; G. T. LIDDIARD; E. E.
HERDEMAN; K. M. FRICK; J. R. MANTSCH. Marquette
Univ., Univ. of Wisconsin-Milwaukee.
9:00 FFF3 350.06 Localization and mechanisms underlying
17-estradiol-potentiated reinstatement of cocaineseeking behavior in female rats. E. M. DONCHECK*; J.
J. TUSCHER; L. A. URBANIK; M. C. DEBAKER; L. M.
BARRON; K. M. FRICK; Q. LIU; C. J. HILLARD; J. R.
MANTSCH. Marquette Univ., Univ. of Wisconsin-Milwaukee,
Med. Col. of Wisconsin.
10:00 FFF4 350.07 Transient inactivation of the
paraventricular nucleus of the thalamus differentially affects
cue-induced reinstatement in sign-trackers and goaltrackers. B. N. KUHN*; M. S. KLUMPNER; S. FLAGEL. Mol.
and Behavioral Neurosci. Inst., Univ. of Michigan, Univ. of
Michigan.
11:00 FFF5 350.08 Molecular and region specific effects of
garcinol on cocaine-associated memory reconsolidation.
M. S. MONSEY*; D. M. GERHARD; R. S. DUMAN; J. R.
TAYLOR. Yale Univ. Sch. of Med., Yale Univ., Yale Univ. Sch.
of Med.

9:00 FFF7 350.10 The infralimbic and prelimbic cortices

contribute to the inhibitory control of cocaine-seeking
behavior during a discriminative stimulus task in rats. A. L.
GUTMAN*; V. A. EWALD; C. V. COSME; W. R. WORTH; R.
T. LALUMIERE. Univ. of Iowa, Univ. of Iowa.
10:00 FFF8 350.11 Activation of the infralimbic cortex using
a stable step-function opsin attenuates cocaine seeking
during reinstatement after extinction training. V. A. MULLER
EWALD*; W. R. WORTH; R. T. LALUMIERE. Univ. of Iowa.
11:00 FFF9 350.12 Cocaine self-administration alters
endogenous pituitary adenylate cyclase activating peptide
(PACAP) levels in the bed nucleus of the stria terminalis
(BNST). O. MILES*; E. A. THRAILKILL; A. K. LINDEN; V.
MAY; M. E. BOUTON; S. E. HAMMACK. Univ. of Vermont.
8:00 FFF10 350.13 Orexin/hypocretin and dynorphin
innervation within bed nucleus of stria terminalis:
Neuroanatomy and behavioral pharmacology in models of
mood and addiction. S. J. SIMMONS*; L. MO; F. H. TRAN; T.
A. GENTILE; J. W. MUSCHAMP. Temple University, Sch. of
Med., Temple University, Sch. of Med.
9:00 FFF11 350.14 Serotonin 1B receptors in the Bed
Nucleus of the Stria Terminalis contribute to the negative/
anxiogenic effects of cocaine. A. KLEIN*; S. AKHAVAN; M.
BRITO; D. FLANAGAN; K. LEE; A. S. PATIL; E. M. PURVIS;
A. WEI; L. ZHOU; A. ETTENBERG. UC Santa Barbara.
10:00 FFF12 350.15 Effects of dopamine receptor modulation
in the lateral habenula on operant responding for IV cocaine.
K. SHELTON*; E. M. PURVIS; A. GUILLEN; T. DO; A.
ETTENBERG. Univ. of California, Santa Barbara, Univ. of
California, Santa Barbara.
11:00 FFF13 350.16 The involvement of D2 receptor in
basolateral amygdala in the companions-exerted decreasing
effects on cocaine conditioning. W. TZENG*; L. YU.
NATIONAL CHENG KUNG UNIVERSITY, Inst. of Behavioral
Medicine, Natl. Cheng Kung Univ. Col. of Med.

POSTER
351. Cocaine: Cell Signaling
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 FFF14 351.01 AKAP150 in the nucleus accumbens
shell promotes cocaine reinstatement by facilitating PKA
phosphorylation of GluA1 AMPA receptors. L. A. GUERCIO*;
M. E. WIMMER; H. D. SCHMIDT; C. PIERCE. Univ. of
Pennsylvania, Univ. of Pennsylvania, Univ. of Pennsylvania.
9:00 FFF15 351.02 Neuronal-enriched rna-binding protein
hud and microrna mir-495 oppositely regulate cocaineinduced addiction-related gene expression and place
preference behavior. R. J. OLIVER*, JR; R. M. BASTLE;
J. L. BRIGMAN; A. M. ALLAN; J. L. NEISEWANDER; N. I.
PERRONE-BIZZOZERO. Univ. of New Mexico HSC, Arizona
State Univ.

8:00 FFF6 350.09 Blocking D1 receptors in the

agranular insular cortex reduces cued and cocaine-prime
reinstatement in rats. C. V. COSME*; A. L. GUTMAN; R. T.
LALUMIERE. Univ. of Iowa.

10:00 FFF16 351.03 Discovery of selective serotonin (5-HT)

5-HT2C receptor (5-HT2CR) positive allosteric modulators
as potential pharmacotherapy for cocaine use disorder. J.
ZHOU*; E. A. WOLD; C. WILD; C. MCALLISTER; Y. DING;
N. C. ANASTASIO; R. G. FOX; S. J. STUTZ; M. A. WHITE;
H. CHEN; K. A. CUNNINGHAM. Univ. of Texas Med. Br.,
Univ. of Texas Med. Br., Univ. of Texas Med. Br.

58 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 FFF17 351.04 Cav1.2 expression in dopamine D1receptor containing neurons is required for extinction of
cocaine-associated behaviors. C. E. BURGDORF*; K. C.
SCHIERBERL; A. S. LEE; S. BROOKSHIRE; T. A. VAN
KEMPEN; V. MUDRAGEL; T. A. MILNER; M. J. GLASS; R.
L. HUGANIR; A. M. RAJADHYAKSHA. Weill Cornell Med.
Col., Weill Cornell Med. Col., Johns Hopkins Univ. Sch. of
Med.
8:00 FFF18 351.05 Ventral tegmental area L-type calcium
channels mediate cue-induced cocaine seeking and
dopamine release during early withdrawal. E. J. NUNES*; S.
M. HUGHLEY; K. M. SMALL; A. M. RAJADHYAKSHA; N. A.
ADDY. Yale Univ., Weill Cornell Med. Col.

10:00 FFF20 351.07 Prelimbic cortical firing is decreased

during cocaine self-administration in rats. T. S. DENNIS*; T.
C. JHOU; J. F. MCGINTY. Med. Univ. of South Carolina.
11:00 FFF21 351.08 SRC family kinase inhibition prevents the
suppressive effect of BDNF on cocaine-seeking and BDNF
induced phosphorylation of ERK, GluN2A, and GluN2B. S.
M. BARRY*; J. F. MCGINTY. Med. Univ. of South Carolina.
8:00 FFF22 351.09 Intra-prelimbic inhibition of striatalenriched tyrosine phosphatase prevents relapse to cocaineseeking in rats. B. M. SIEMSEN*; S. M. BARRY; P. L.
LOMBROSO; J. F. MCGINTY. Med. Univ. of South Carolina,
Yale Univ. Sch. of Med.
9:00 FFF23 351.10 Effect of adolescent isolation on drug
responsivity: Alterations in C-fos activation and paired pulse
facilitation. A. FOSNOCHT*; A. U. DEUTSCHMANN; A. S.
ELLIS; L. BRIAND. Temple Univ., Temple Univ.
10:00 FFF24 351.11 Cocaine addiction increases vulnerability
to stress: Role of AMPAR trafficking. A. S. ELLIS*; A. Q.
FOSNOCHT; K. E. LUCERNE; L. A. BRIAND. Temple Univ.
11:00 FFF25 351.12 Intraaccumbal administration of
inhibitory peptide (ZIP) blocks cocaine reinstatement
and restores accumbal LTD. L. A. BRIAND*; A. U.
DEUTSCHMANN; J. D. LENZ. Temple Univ.
8:00 FFF26 351.13 The effects of cocaine self-administration
and extinction on NMDA receptor-mediated currents. M. T.
SEPULVEDA-ORENGO*; K. L. HEALEY; K. J. REISSNER.
Univ. of North Carolina at Chapel Hill Dept. of Psychology.

10:00 GGG6 351.19 Dopaminergic dynamics underlying sexspecific reward processing. E. S. CALIPARI*; B. JUAREZ; C.
MOREL; D. M. WALKER; E. RIBERIO; C. RAMAKRISHNAN;
K. DEISSEROTH; M. HAN; E. J. NESTLER. Mount Sinai
Sch. of Med., Stanford Univ.
11:00 GGG7 351.20 Casein-kinase 2 activity may mediate
camkiia-dependent effects on reconsolidation of a cocaineassociated cue memory. J. J. WEEKS*; M. T. RICH; V.
NAGARAJAN; M. M. TORREGROSSA. Univ. of Pittsburgh.

POSTER
352. Nicotine: Neural Mechanisms of Addiction
Theme G: Motivation and Emotion
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 GGG8 352.01 A corticothalamic inhibitory control
pathway mediates smoking relapse vulnerability. B.
FROELIGER*; S. BELL; P. A. MCCONNELL; M. SWEITZER;
F. J. MCCLERNON. Med. Univ. of South Carolina, Duke
Univ. Med. Ctr.
9:00 GGG9 352.02 Nucleus accumbens BDNF
overexpression alters the behavioral response to nicotine.
S. KIRBY*; K. C. BURGESS; L. A. BEUTTEL; D. J.
PETERSON; C. A. BRADLEY; M. ZHU; M. I. PALMATIER,
PhD; R. W. BROWN. East Tennessee State Univ., East
Tennessee State Univ.
10:00 GGG10 352.03 Does periadolescent nicotine-induced
sensitization to cocaine require activation of microglia
and expression of FosB in the brain of the rat? P. S.
NAGCHOWDHURI; H. L. WILLIAMS; B. A. MCMILLEN*.
East Carolina Univ.
11:00 GGG11 352.04 Dysregulation of ACh-GABA-CRF
neurotransmission in the CeA contributes to nicotine selfadministration in dependent rats. M. KALLUPI*; G. DE
GUGLIELMO; P. SCHWEITZER; R. O. MESSING; O.
GEORGE. Scripps Res. Inst., The Scripps Res. Institute,
Committee on the Neurobio. of Addictive Disorders, Div. of
Pharmacol. and Toxicology, Col. of Pharmacy, The Univ. of
Texas at Austin.

9:00 GGG1 351.14 Augmentation of D-serine reduces

reinstatement to cocaine seeking. K. L. HEALEY*; B. WU;
M. SEPULVEDA-ORENGO; K. J. REISSNER. Univ. of North
Carolina At Chapel Hill.

8:00 GGG12 352.05 Kappa opioid modulation of GABA

transmission in the central amygdala is reversed upon
chronic nicotine exposure. P. SCHWEITZER*; M. KALLUPI;
G. F. KOOB; O. GEORGE. Scripps Res. Inst., Natl. Inst. on
Alcohol Abuse and Alcoholism.

10:00 GGG2 351.15 The potential role of Ras in cocaine and

nicotine self-administration in mice. R. E. BERNARDI*; A.
OLEVSKA; R. HEUMANN; E. SANTOS; R. SPANAGEL.
Central Inst. of Mental Hlth., Ruhr-University, Ctr. de
Investigacin del Cncer-Instituto de Biologa Mol. y Celular
del Cncer.

9:00 GGG13 352.06 Neurochemical profile of CNS neurons

activated by menthol in GAD67-GFP knock in mice. O.
DEHKORDI*; J. E. ROSE; A. JAYAM-TROUTH; R. M.
MILLIS; K. F. MANAYE; M. I. DVILA-GARCA. Howard
Univ., Duke Univ. Med. Ctr., American Univ. of Antigua,
Howard Univ., Howard Univ.

11:00 GGG3 351.16 Cocaine induced neurotoxicity < stimulant

behavior is mediated by ulk1 dependent autophagy. P. P.
GUHA*; P. GUHA. Johns Hopkins Univ.

10:00 GGG14 352.07 The dopamine D1 antagonist SCH23390

and the serotonin 5HT2C agonist lorcaserin potentiate
chronic nicotine infusion induced reduction of nicotine
self-administration in rats. D. DIPALMA; B. WILLETTE;
C. WELLS; S. SLADE; B. J. HALL; A. H. REZVANI; E. D.
LEVIN*. Duke Univ., Duke Univ. Med. Ctr.

8:00 GGG4 351.17 Autophagy mediates cocaine-induced

behavioral effects in mice. M. M. HARRAZ*; P. GUHA; P.
CORTES; S. H. SNYDER. Johns Hopkins Univ., Johns
Hopkins Univ., Johns Hopkins Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|59

Mon. AM

9:00 FFF19 351.06 Cav1.3 activation within the VTA regulates

addictive and depressive-like behaviors. A. MARTINEZRIVERA*; J. HAO; T. F. TROPEA; J. STRIESSNIG; N.
A. ADDY; A. M. RAJADHYAKSHA. Weill Cornell Med.
Col., Weill Cornell Med. Col., Univ. of Innsbruck, Univ. of
Innsbruck, Yale Sch. of Med., Yale Grad. Sch. of Arts and
Sci.

9:00 GGG5 351.18 Metabolomics changes within the

brain mesolimbic dopamine system following cocaine selfadministration. N. RODRIGUEZ-SOSA*; S. SERRANOTORRES; J. R. ROUSSEL; N. E. CHORNA; C. S.
MALDONADO-VLAAR. Univ. of Puerto Rico-Rio Piedras,
Univ. of Puerto Rico-Medical Sci. Campus.

11:00 GGG15 352.08 Nicotine selectively remodels dendrites in

the ventral and dorsolateral striatum. H. C. BERGSTROM*;
D. G. EHLINGER; J. BURKE; R. F. SMITH; C. G.
MCDONALD. Vassar Col., Harvard Med. Sch., George
Mason Univ.
8:00 GGG16 352.09 Imaging CA1-hippocampal ensembles
during nicotine-contextual associations. L. XIA*; S. K.
NYGARD; G. G. SOBCZAK; N. J. HOURGUETTES; M. R.
BRUCHAS. Washington Univ. In St. Louis, Washington Univ.
in St louis, Washington Univ. in St. Louis, Washington Univ.
in St Louis.
9:00 GGG17 352.10 Neural mechanisms of emotion
regulation in cigarette smokers. S. BELL*; C. EICHBERG;
P. A. MCCONNELL; K. GRAY; F. J. MCCLERNON; B.
FROELIGER. Med. Univ. of South Carolina, Med. Univ. of
South Carolina, Duke Univ. Med. Ctr., Med. Univ. of South
Carolina, Med. Univ. of South Carolina.
10:00 GGG18 352.11 Hippocampus goes depression:
Structural and functional correlates of negative mood states
after smoking cessation. M. N. SMOLKA*; F. BHME; C.
BURRASCH; N. B. KROEMER. Technische Univ. Dresden.
11:00 GGG19 352.12 Regulation of metabotropic glutamate
receptor 5 phosphorylation by c-jun n-terminal kinase. S.
SEO*; I. RYU; J. KIM; J. KIM; J. YANG; J. OH; E. CHOE.
Neurosci. Lab. of Addiction Res., Inst. of Fisheries Sci.
8:00 GGG20 352.13 Double jeopardy: Obese smokers show
hypoactivation in inhibitory control brain regions compared
to normal weight counterparts during smoking cue exposure.
A. V. ELY*; K. JAGANNATHAN; N. HAGER; H. PATER; T. R.
FRANKLIN. UCSD, Univ. of Pennsylvania.

9:00 GGG21 352.14 Substance P neurotransmission in the

interpeduncular nucleus contributes to nicotine sensitization.
B. L. EGGAN*; S. E. MCCALLUM. Albany Med. Col., Albany
Med. Col.

10:00 GGG22 352.15 Effects of nicotine withdrawal and

Volinanserin on sleep quality in the rat. J. C. SHAHIN;
J. J. BAUTISTA; J. J. IZYGON; D. M. NGHIEM; M.
M. HENCEROTH; E. S. BURSTEIN; C. P. WARD*;
D. H. MALIN. Univ. of Houston Clear Lake, ACADIA
Pharmaceuticals.
11:00 GGG23 352.16 Disruption of sleep patterns in rats during
continuous nicotine infusion. E. NEYHART*; J. C. SHAHIN;
J. J. BAUTISTA; J. J. IZYGON; D. M. NGHIEM; M. M.
HENCEROTH; D. H. MALIN; C. P. WARD. Univ. of HoustonClear Lake.
8:00 GGG24 352.17 Nicotine administration and withdrawal
alters sleep and EEG patterns in mice. H. L. MATHEWS*;
L. JIMENEZ; S. AHMAD; J. A. STITZEL. Univ. of Colorado
Boulder Dept. of Psychology and Neurosci., Univ. of
Colorado- Boulder, Inst. for Behavioral Genet., Univ. of
Colorado- Boulder.
9:00 GGG25 352.18 Investigating the role of the 7 nicotinic
acetylcholine receptors in nicotine reward. A. JACKSON*; P.
MULDOON; M. DAMAJ. Virginia Commonwealth Univ. Hlth.
Syst.
10:00 GGG26 352.19 The 5HT2a antagonist volinanserin
attenuates spontaneous nicotine withdrawal syndrome in
the rat. D. H. MALIN*; S. GADAM; D. J. MCGHIEY; C. L.
AGUILAR; J. R. CAMPBELL; R. N. HUGHES; L. CASTILLO;
P. GOYARZU; E. S. BURSTEIN; C. A. MADISON. Univ. of
Houston Clear Lake, Univ. of Houston-Clear Lake, Univ. of
Houston-Clear Lake, ACADIA Pharmaceuticals.

60 | Society for Neuroscience

11:00 HHH1 352.20 Molecular histochemistry identifies

peptidomic organization and reorganization along striatal
projection units. A. HISHIMOTO*; H. NOMARU; A. NISHI;
K. YE; J. LIM; J. T. AGUILAN; E. NIEVES; G. KANG; R. H.
ANGELETTI; N. HIROI. Kobe Univ. Grad. Sch. of Med.,
Albert Einstein Col. of Med., Albert Einstein Col. of Med.,
Albert Einstein Col. of Med., Albert Einstein Col. of Med.,
Albert Einstein Col. of Med.
8:00 HHH2 352.21 Chronic nicotine induces
neuroadaptations in striatopallidal D2 pathway mediated by
NR2B containing silent synapses. J. XIA; J. A. BEELER*.
Queens Col. CUNY.
8:00 DP08 352.22 (Dynamic Poster) A conditioned place
preference forward genetic screen in zebrafish identifies a
novel locus affecting nicotine preference in fish and smoking
behavior in humans. C. H. BRENNAN*; A. J. BROCK; M.
O. PARKER; V. KUAN; D. JOLLIFFE; A. SUDWARTS; A. R.
MARTINEAU; R. T. WALTON. Queen Mary Univ. of London,
Queen Mary Univ. of London, Portsmouth Univ., Queen Mary
Univ. of London.
10:00 HHH3 352.23 Examination of the neurochemical
mechanisms that modulate sex differences in nicotine
withdrawal. R. J. FLORES GARCIA*; L. CARCOBA; K.
URIBE; L. E. ODELL. Univ. of Texas at El Paso, Univ. of
Texas at El Paso.
11:00 HHH4 352.24 Light-enhanced startle sensitivity to acute
nicotine withdrawal. R. C. BARNET*; A. C. HENNINGS. Col.
William & Mary.
8:00 HHH5 352.25 HIV-1 proteins influence novelty-seeking
behavior and alter region-specific transcriptional responses
to chronic nicotine treatment in HIV-1Tg rats. Z. YANG*;
T. NESIL; S. L. CHANG; M. D. LI. Zhejiang Univ., Univ. of
Virginia, Seton Hall Univ., Seton Hall Univ.

9:00 HHH6 352.26 Blunted nicotine-induced neural activity in

the habenula-interpeduncular nucleus circuit in response to
chronic nicotine history. H. ZHANG*; M. D. EHLERS. Pfizer,
Inc, Biogen.
10:00 HHH7 352.27 Oxytocin phenocopies the effects of
dopamine receptor antagonism on nicotine motivation. T.
E. GRIEDER*; M. YEE; O. GEORGE; D. VAN DER KOOY.
Univ. Toronto, The Scripps Res. Inst.

POSTER
353. Human Cognition and Memory II
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 HHH8 353.01 Brain reorganization following adaptive
working load cognitive training in multiple sclerosis. L.
BONZANO*; L. PEDULL; M. PARDINI; A. TACCHINO; G.
BRICHETTO; M. BOVE. Univ. Genoa, Multiple Sclerosis
Italian Fndn.
9:00 HHH9 353.02 Predicting variations in cognitive load: A
multimodal approach. M. A. NOLAN*; J. R. WILLIAMSON;
M. D. EDDY; J. M. MORAN; C. J. SMALT; T. PATEL; T.
F. QUATIERI; R. J. MCKINDLES. Massachusetts Inst. of
Technol.- Lincoln La, MIT Lincoln Lab., US Army Natick
Soldier Research, Develop. and Engin. Ctr., Tufts Univ.
10:00 HHH10 353.03 Structural plasticity in healthy elderly
after working memory training. A randomized control-group
trial. N. HUDL*; J. WEICKER; A. VILLRINGER; A. THOENEOTTO. Max Planck Inst. For Human Cognitive and Brain
Sci., Max Net Aging Res. Sch., Univ. of Leipzig, Uni.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 HHH11 353.04 Suppression of brain response to a taskirrelevant visual stimulus emerges in a visual hemifield on
which VSTM task was imposed. A. SAYAMA*; T. URAKAWA;
A. KITAMI; H. AZETAKA; O. ARAKI. Tokyo Univ. of Sci.
8:00 HHH12 353.05 Working memory performance in the
elderly closely relates to oscillations and is predicted by
integrity of the parahippocampal cortex and white matter
tracts. T. K. STEIGER*; N. A. HERWEG; M. M. MENZ; N.
BUNZECK. Univ. of Luebeck, Univ. Med. Ctr. HamburgEppendorf.
9:00 HHH13 353.06 Learning working memory gating policies.
A. BHANDARI*; M. J. FRANK; D. BADRE. Brown Univ.,
Brown Univ.
10:00 HHH14 353.07 Single neuron study of memory for audiovisual episodes in the human brain. E. KRAUSE*; H. TANG;
M. ISON; I. FRIED; G. KREIMAN. Harvard Univ., Harvard
Univ., UCLA.

8:00 HHH16 353.09 Shifting the balance between pattern

separation and completion: Recent memory retrieval
increases peoples subsequent ability to recall associations.
A. PATIL*; F. MIAN; J. LEE; K. DUNCAN. Univ. of Toronto.
9:00 HHH17 353.10 Task representations in the dorsolateral
prefrontal cortex. J. DERAEVE*; E. VASSENA; W.
ALEXANDER. Univ. Gent.
10:00 HHH18 353.11 Working memory capacity determines
maximum chunk sizes. M. V. TSODYKS*; Y. MI. Weizmann
Inst. of Sci.
11:00 HHH19 353.12 Recollection precision is supported by
posterior-medial hippocampal networks: Causal evidence
from non-invasive brain stimulation. A. NILAKANTAN*; D.
BRIDGE; E. GAGNON; J. VOSS. Northwestern Univ.
8:00 HHH20 353.13 Externalizing the internal process of
context reinstatement through closed-loop neurofeedback.
M. T. DEBETTENCOURT*; N. B. TURK-BROWNE; K. A.
NORMAN. Princeton Univ.
9:00 HHH21 353.14 Targeted brain stimulation to modulate
memory in humans. Y. EZZYAT*; J. E. KRAGEL; J. F.
BURKE; D. F. LEVY; L. OSULLIVAN; P. WANDA; M. R.
SPERLING; G. A. WORRELL; M. T. KUCEWICZ; K. A.
DAVIS; T. H. LUCAS; C. S. INMAN; B. C. LEGA; B. C.
JOBST; S. A. SHETH; K. ZAGHLOUL; J. M. STEIN; S. R.
DAS; R. GORNIAK; D. S. RIZZUTO; M. J. KAHANA. Univ.
of Pennsylvania, Univ. of California, San Francisco, Univ. of
Pennsylvania, Thomas Jefferson Univ. Hosp., Mayo Clin.,
Hosp. of the Univ. of Pennsylvania, Emory Univ. Hosp., Univ.
of Texas Southwestern Med. Ctr., Dartmouth-Hitchcock Med.
Ctr., Columbia Univ. Med. Ctr., NIH.
10:00 HHH22 353.15 Pre-stimulus oscillatory activity reveals
a preparatory form of episodic retrieval orientation. M. H.
PRICE; E. N. WRIGHT; J. A. LACKEY; E. A. GRIFFITHS; J.
D. JOHNSON*. Univ. of Missouri, Univ. of Missouri, Univ. of
Surrey, Univ. of Missouri.

8:00 HHH24 353.17 Electrophysiological biomarkers

of successful spatial memory encoding. A. JOHRI*; J.
MILLER; C. NOVICH; J. JACOBS; M. KAHANA. Univ. of
Pennsylvania, Columbia Univ., Univ. of Pennsylvania.
9:00 HHH25 353.18 Identifying biomarkers of spatial
memory with direct brain recordings in the Treasure Hunt
task. J. MILLER*; A. WATROUS; C. NOVICH; S. LEE;
M. SPERLING; A. SHARAN; G. WORRELL; B. BERRY;
B. LEGA; B. JOBST; K. DAVIS; S. SHETH; S. DAS; J.
STEIN; R. GORNIAK; D. RIZZUTO; J. JACOBS. Columbia
Univ., Thomas Jefferson Univ., Mayo Clin., Univ. of Texas,
Southwestern, Geisel Sch. of Med. at Dartmouth, Hosp. of
the Univ. of Pennsylvania, Columbia Univ. Med. Ctr., Univ. of
Pennsylvania.
10:00 HHH26 353.19 Rostral-caudal and hemispheric
differences in human hippocampal oscillations during
episodic memory encoding. J. LIN*; M. KAHANA; D.
RIZZUTO; B. LEGA. Univ. of Texas Southwestern Med. Ctr.,
Univ. of Pennsylvania.
11:00 HHH27 353.20 Architecture of a whole-brain ECoG
memory network reveals asynchronous activity of MTL
during encoding. E. A. SOLOMON*; M. R. SPERLING; G.
A. WORRELL; B. M. BERRY; K. A. DAVIS; C. S. INMAN;
B. C. LEGA; B. C. JOBST; S. A. SHETH; K. ZAGHLOUL;
J. M. STEIN; S. R. DAS; R. GORNIAK; D. S. RIZZUTO; M.
KAHANA. Univ. of Pennsylvania, Thomas Jefferson Univ.,
Mayo Clin., Hosp. of the Univ. of Pennsylvania, Emory
Univ., UT Southwestern Med. Ctr., Dartmouth Giesel Sch.
of Med., Columbia Univ., Natl. Inst. of Neurolog. Disorders
and Stroke, Hosp. of the Univ. of Pennsylvania, Univ. of
Pennsylvania.
8:00 HHH28 353.21 Boundary-related neural oscillations in
the human hippocampal formation. S. LEE*; J. MILLER; A.
WATROUS; M. SPERLING; A. SHARAN; G. WORRELL;
B. BERRY; B. LEGA; B. JOBST; K. DAVIS; R. GROSS; S.
SHETH; S. DAS; J. STEIN; R. GORNIAK; D. RIZZUTO; J.
JACOBS. Ctr. For Mind / Brain Sciences, Univ. of Trento,
Columbia Univ., Thomas Jefferson Univ., Mayo Clin., UT
Southwestern, DartmouthHitchcock Med. Ctr., Hosp. of the
Univ. of Pennsylvania, Emory Univ., Columbia Univ. Med.
Ctr., Univ. of Pennsylvania.
9:00 HHH29 353.22 Direct brain recordings reveal patterns
of and oscillations related to spatial navigation and
memory. U. R. MOHAN*; J. MILLER; A. WATROUS; S. LEE;
M. SPERLING; A. SHARAN; G. WORRELL; B. BERRY; B.
LEGA; B. JOBST; K. DAVIS; R. GROSS; S. SHETH; S. DAS;
J. STEIN; R. GORNIAK; D. RIZZUTO; J. JACOBS. Columbia
Univ., Thomas Jefferson Univ. Hosp., Thomas Jefferson
Univ. Hosp., Mayo Clin., Univ. of Texas-Southwestern,
Dartmouth Univ., Hosp. of the Univ. of Pennsylvania, Emory
Univ., Columbia Univ. Med. Ctr., Univ. of Pennsylvania,
Hosp. of the Univ. of Pennsylvania, Thomas Jefferson Univ.
Hosp., Univ. of Pennsylvania.
10:00 HHH30 353.23 Strategic orienting of retrieval processes
toward simulated memories of different artificial remoteness.
E. K. LEIKER*; E. A. GRIFFITHS; E. N. WRIGHT; J. D.
JOHNSON. Univ. of Missouri, Univ. of Surrey.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|61

Mon. AM

11:00 HHH15 353.08 Relationships between ongoing activity

fluctuation in the medial temporal lobe and subsequent
memory performance. R. KEERATIVITTAYAYUT*; R. AOKI;
M. TAGHIZADEH SARABI; K. NAKAHARA. Kochi Univ. of
Technol.

11:00 HHH23 353.16 Large-scale assessment of the effects

of direct electrical stimulation on brain network activity. M.
J. KAHANA*; Y. EZZYAT; B. C. LEGA; J. W. GERMI; G.
A. WORRELL; M. T. KUCEWICZ; M. R. SPERLING; C.
S. INMAN; P. C. HORAK; K. A. DAVIS; K. ZAGHLOUL; S.
A. SHETH; J. M. STEIN; S. R. DAS; R. GORNIAK; D. S.
RIZZUTO. Univ. Pennsylvania, Univ. of Texas Southwestern,
Mayo Clin., Thomas Jefferson Univ. Hosp., Emory Univ.
Hosp., Dartmouth-Hitchcock Med. Ctr., Hosp. of the Univ. of
Pennsylvania, NIH, Columbia Univ.

11:00 HHH31 353.24 Effects of electrical brain stimulation

location on interictal epileptiform activity. B. C. JOBST*; P.
HORAK; A. ROBBINS; S. MEISENHELTER; M. TESTORF;
A. CONNOLLY; M. SPERLING; A. ASADI-POOYA; G.
WORRELL; B. BERRY; K. DAVIS; B. LEGA; K. ZAGHLOUL;
R. GROSS; J. STEIN. Dartmouth-Hitchcock Med. Ctr.,
Geisel Sch. of Med. at Dartmouth, Thayer Sch. of Engin. at
Dartmouth, Thomas Jefferson Univ. Hosp., Mayo Clin., Hosp.
of the Univ. of Pennsylvania, Univ. of Texas Southwestern,
Natl. Inst. of Neurolog. Disorders and Stroke, Emory Univ.

8:00 HHH32 353.25 Electrocorticographic changes in

hippocampal oscillations during memory tasks and spatial
navigation in ambulatory humans. S. MEISENHELTER*;
M. E. TESTORF; P. C. HORAK; N. R. HASULAK; T. K.
TCHENG; D. S. RIZZUTO; M. J. KAHANA; B. C. JOBST.
Dartmouth Col. Geisel Sch. of Med., NeuroPace, Inc., Univ.
of Pennsylvania.
9:00 HHH33 353.26 Human memory enhancement through
stimulation of middle temporal gyrus. M. T. KUCEWICZ*;
B. M. BERRY; Y. EZZYAT; M. KHADJEVAND; L. MILLER;
V. KREMEN; B. H. BRINKMANN; M. R. SPERLING; B.
C. JOBST; R. E. GROSS; B. LEGA; S. A. SHETH; J. M.
STEIN; S. R. DAS; R. GORNIAK; S. M. STEAD; D. S.
RIZZUTO; M. J. KAHANA; G. A. WORRELL. Mayo Clin.,
Mayo Clin., Univ. of Pennsylvania, Thomas Jefferson Univ.
Hosp., Dartmouth-Hitchcock Med. Ctr., Emory Univ., Univ.
of Texas Southwestern Med. Ctr., Columbia Univ., Univ. of
Pennsylvania Hosp.
10:00 HHH34 353.27 Phase synchronization in the human
medial temporal lobe predicts the precision of spatial
memory encoding: Evidence from direct brain recordings.
A. WATROUS*; J. MILLER; S. LEE; M. SPERLING; R.
GORNIAK; A. SHARAN; G. WORRELL; B. BERRY; B.
JOBST; K. DAVIS; R. GROSS; B. LEGA; J. STEIN; S.
DAS; S. SHETH; D. RIZZUTO; J. JACOBS. Columbia
Univ., Thomas Jefferson Univ. Hosp., May Clin., Dartmouth
Univ., Univ. of Pennsylvania, Emory Univ., Univ. of TexasSouthwestern.
11:00 HHH35 353.28 Core episodic encoding and retrieval
processes revealed by dynamics of neural activity. J. E.
KRAGEL*; Y. EZZYAT; J. F. BURKE; J. LIN; J. M. STEIN; S.
R. DAS; R. J. GORNIAK; R. E. GROSS; K. A. DAVIS; M. R.
SPERLING; B. C. JOBST; S. A. SHETH; K. A. ZAGHLOUL;
G. A. WORRELL; D. S. RIZZUTO; M. J. KAHANA. Univ.
of Pennsylvania, Univ. of California, San Francisco Med.
Ctr., Univ. of Texas Southwestern, Hosp. of the Univ. of
Pennsylvania, Thomas Jefferson Univ. Hosp., Emory Univ.
Hosp., Dartmouth Med. Ctr., Columbia Univ. Med. Ctr., NIH,
Mayo Clin.
8:00 HHH36 353.29 Studying the effects of direct subdural
electrical stimulation in human subjects during a verbal
associative memory task. T. SHEEHAN*; R. YAFFE; J.
WITTIG, Jr; S. INATI; G. WORRELL; M. KUCEWICZ; K.
DAVIS; M. KAHANA, PhD; M. SPERLING; S. A. SHETH;
B. JOBST; B. LEGA; K. ZAGHLOUL. NIH, Mayo Clin., Univ.
of Pennsylvania, Thomas Jefferson Univ. Hosp., Columbia
Univ. Med. Ctr., Dartmouth- Hitchcock Med. Ctr., Univ. of
Texas Southwestern Med. Ctr.
9:00 HHH37 353.30 Another View on Deja vu- a memory
illusion that results from a failure of reality monitoring. P.
WALLISCH*; M. J. GODDARD. New York Univ., New York
Univ.

62 | Society for Neuroscience

POSTER
354. Decision Making: Orbitofrontal, Anterior Cingulate, and
Hippocampal Cortices
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 HHH38 354.01 Orbitofrontal cortex neurons encode
confidence in an auditory decision. P. MASSET*; M.
LAGLER; J. SANDERS; T. KLAUSBERGER; A. KEPECS.
Cold Spring Harbor Lab., Med. Univ. of Vienna.
9:00 HHH39 354.02 Neural signals in the anterior cingulate
cortex during effort-based decision-making. S. E.
MORRISON*. Univ. of Pittsburgh.
10:00 HHH40 354.03 Representations of probabilistic evidence
in the prefrontal cortex during decision making. T. YANG*; Y.
ZHANG; Y. CHEN. Inst. of Neurosci.
11:00 III1
354.04 Decision related activities of anterior
insular and orbitofrontal cortex in a gambling behavior of
rats. H. ISHII*; Y. KAIZU; S. TAKAHASHI; S. OHARA; P. N.
TOBLER; K. TSUTSUI; T. IIJIMA. Div. of Sys. Neurosci.,
Tohoku Univ., Lab. for Social and Neural Systems Res.
8:00 III2
354.05 A circuit model for the interplay between
orbitofrontal cortex and lateral prefrontal cortex in valuebased economic decision-making. M. Y. YIM*; X. CAI; X.
WANG. NYU Shanghai, New York Univ.
9:00 III3
354.06 Properties of value adaptation in
orbitofrontal cortex. K. CONEN*; C. PADOA-SCHIOPPA.
Washington Univ. In St Louis.
10:00 III4
354.07 Rule encoding in orbitofrontal cortex and
striatum. G. LOCONTE*; B. SLEEZER; M. CASTAGNO; B.
HAYDEN. Univ. of Rochester.
11:00 III5
354.08 Comparing neural activity patterns in
striatum and orbitofrontal cortex during set shifting using a
dynamics model. P. BALASUBRAMANI*; B. Y. HAYDEN.
Univ. of Rochester, brain and cognitive sciences, Univ. of
Rochester.
8:00 III6
354.09 Shared economic roles of subgenual
and dorsal anterior cingulate cortices in decision making.
H. AZAB*; B. Y. HAYDEN. Univ. of Rochester, Univ. of
Rochester.
9:00 III7
354.10 Adolescent alcohol use increases risk
preference and alters dopamine receptor expression in OFC.
S. D. CORWIN*; E. JACOBS-BRICHFORD; J. D. ROITMAN.
Univ. of Illinois At Chicago.
10:00 III8
354.11 The role of the orbitofrontal cortex in
incentive learning. E. T. BALTZ; C. M. GREMEL*. Univ. of
California San Diego.
11:00 III9
354.12 A hippocampal-posterior parietal
cortex circuit for memory-based decision making. U.
RUTISHAUSER*; T. AFLALO; N. POURATIAN; C. Y. LIU; A.
N. MAMELAK; R. A. ANDERSEN. Cedars-Sinai Med. Ctr.,
Caltech, Cedars-Sinai Med. Ctr., UCLA, USC.
8:00 III10 354.13 Hippocampal entrains and reconfigures
prefrontal single-unit activity during delay in a navigational
task. M. V. MYROSHNYCHENKO*; C. C. LAPISH. Indiana
Univ.
9:00 III11 354.14 Hippocampal contributions to
neural representations in OFC during decision making.
A. M. WIKENHEISER*; Y. MARRERO-GARCIA; G.
SCHOENBAUM. Natl. Instutite on Drug Abuse, Univ. of
Maryland, Sch. of Med., The Johns Hopkins Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 III12
354.15 Orbitofrontal cortex lesions improve
performance in a go/no-go reversal learning task. M. H.
RAY*; M. CRABTREE; C. PICKENS. Kansas State Univ.,
Kansas State Univ.

11:00 III25
355.04 A critical role of NPAS4 in the medial
prefrontal cortex in context retrieval-mediated memory
enhancement. D. KAPELLER-LIBERMANN*; X. YE; C. M.
ALBERINI. New York Univ.

11:00 III13
354.16 Temporal context and decision-making:
Behavioral and neural mechanisms of choice adaptation
in rhesus macaque. J. ZIMMERMANN*; P. GLIMCHER; K.
LOUIE. New York Univ.

8:00 III26 355.05 Cell type mapping of insulin-like growth

factor 2 mRNA expression in the adult rat brain in basal
conditions and following learning. S. L. SHENG*; C. M.
ALBERINI. New York Univ., New York Univ. Sch. of Med.

8:00 III14 354.17 Navigation and decision in a virtual

foraging task for monkeys. R. AKAISHI*; B. HAYDEN. Brain
& Cognitive Sci.

9:00 III27 355.06 Dissecting prelimbic cortical circuits

and mechanisms in retrieval-mediated fear memory
enhancement. X. YE*; D. KAPELLER-LIBERMANN; A.
TRAVAGLIA; C. M. ALBERINI. New York Univ.

9:00 III15 354.18 Prospective evaluation involves

reactivating neural response patterns associated with
outcome monitoring. Z. WANG*; B. Y. HAYDEN. Univ. of
Rochester.

11:00 III17
354.20 Autocorrelation structure at rest predicts
value correlates of single neurons during decision-making. S.
E. CAVANAGH*; S. W. KENNERLEY; L. T. HUNT. UCL Inst.
of Neurol.
8:00 III18 354.21 Prefrontal coding of strategies to reduce
working memory load. F. CHIANG*; J. D. WALLIS. Univ.
of California Berkeley Dept. of Psychology, Helen Wills
Neurosci. Inst.
9:00 III19 354.22 Biasing decision making through
stimulus-outcome specific microstimulation of orbitofrontal
cortex. E. B. KNUDSEN*; J. D. WALLIS. Univ. of California
Berkeley.
10:00 III20
354.23 Social context influences decision signals
in primate ACC. W. S. ONG*; M. L. PLATT. Duke Univ., Univ.
of Pennsylvania.
11:00 III21
354.24 Token asset effect on monkeys decision
making involving risky gains and losses. Y. YANG*; X.
LI; V. STUPHORN. Johns Hopkins Univ., Johns Hopkins
University, Sch. of Med., Zanvyl Krieger Mind/Brain Inst.

POSTER
355. Animal Cognition: Memory Consolidation and
Reconsolidation
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 III22 355.01 Computational model of a positive
BDNF feedback loop in hippocampal neurons following
inhibitory avoidance training. Y. ZHANG*; P. SMOLEN; C. M.
ALBERINI; J. H. BYRNE. Univ. of Texas at Houston Dept. of
Neurobio. and Anat., New York Univ.
9:00 III23 355.02 Latent, long-lasting memory traces
are stored during the infantile amnesia period in rats. A.
TRAVAGLIA*; R. BISAZ; C. M. ALBERINI. New York Univ.
10:00 III24
355.03 The role of glycogenolysis and astrocyteneuronal coupling in mechanism in memory formation during
development. E. CRUZ*; A. TRAVAGLIA; C. M. ALBERINI.
New York Univ. Ctr. for Neural Sci.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 III29
355.08 De novo transcription conversely
modulates the late consolidation of contextual fear
remote memory in prefrontal cortex and hippocampus. L.
M. PEREIRA*; C. M. CASTRO; J. T. MARQUES; G. S.
PEREIRA. Univ. Federal De Minas Gerais, Univ. Federal de
Minas Gerais, Univ. Federal de Minas Gerais.
8:00 III30 355.09 Contribution of newly born progenitors
generated during the proliferative burst to emotional memory
deficits associated with alcohol dependence in male and
female rats. M. FANNON; J. WILLIAMS; K. MYSORE; R.
MORALES; M. STAPLES; H. CAMERON; C. D. MANDYAM*.
VMRF, TSRI, NIH, UCSD.
9:00 III31 355.10 Hippocampal circadian clock regulates
time-dependent memory retrieval and spine morphology
of CA1 neuron. M. MIYAHARA*; S. HASEGAWA; S. KIDA.
Tokyo Univ. of Agr., JST, CREST.
10:00 III32
355.11 Comparisons and discrimination of fear
and extinction neurons at the molecular and cellular levels.
R. ISHIKAWA*; S. KIDA. Tokyo Univ. of Agr., CREST, JST.
11:00 III33
355.12 Paired and unpaired conditioning during
aging: BDNF, GABA, glutamate and serotonin changes after
memory consolidation. C. E. VASQUEZ*; V. MITCHELL; R.
COSSIO; J. FORNAGUERA; G. BRITTON. INDICASAT AIP,
Univ. of Utah, Univ. de Costa Rica.

8:00 III34 355.13 Using viral translating ribosome affinity

purification to study associative recognition memory
consolidation. J. R. GAUNT*; H. SCOTT; L. MARUCCI; S.
SHEARDOWN; E. C. WARBURTON; J. B. UNEY. Univ. of
Bristol, Univ. of Bristol, Takeda Pharmaceut. Co., Univ. of
Bristol.
9:00 III35 355.14 MTOR-dependent mechanisms in the
persistence of contextual fear memory. P. MACCALLUM;
T. KENNY; K. FALLON; J. J. BLUNDELL*. Mem. Univ. of
Newfoundland, Mem. Univ.
10:00 III36
355.15 Dissociation of contextual fear expression
and hippocampal Arc expression following immediate shock.
J. A. LEAKE*; R. ZINN; L. H. CORBIT; B. VISSEL. Garvan
Inst. of Med. Res., Univ. of Sydney, Univ. of New South
Wales, Univ. of Technol.

Neuroscience 2016|Monday AM|63

Mon. AM

10:00 III16
354.19 The role of the monkey orbitofrontal
cortex during value-based decision-making. T. SETOGAWA*;
T. MIZUHIKI; F. AKIZAWA; R. KUBOKI; B. J. RICHMOND; N.
MATSUMOTO; M. SHIDARA. NIH, Univ. of Tsukuba, Univ. of
Tsukuba, JSPS, AIST.

10:00 III28
355.07 Expression of ribosomal RNA gene
variant 4 is activated by learning and required for memory
consolidation of a spatial learning task in mice. K. D.
ALLEN*; M. J. TROY-REGIER; C. HSIEH; P. TSOKAS;
C. OKEZUE; J. WOLK; A. FENTON; T. C. SACKTOR;
A. I. HERNANDEZ. SUNY Downstate Med. Ctr., SUNY
Downstate Med. Ctr., SUNY Downstate Med. Ctr., New
York Univ., New York Univ., New York Univ., The Robert F.
Furchgott Ctr. for Neural and Behavioral Sci.

11:00 III37
355.16 Lowering Fkbp5 expression in the ventral
hippocampus enhances fear conditioning without affecting
anxiety levels. M. CRIADO MARRERO*; B. LPEZTORRES; A. HERNNDEZ; M. COLN; R. MISLA DAVID; J.
PORTER. Ponce Hlth. Sci. Univ.

8:00 III38 355.17 The role of quinone reductase 2 in

hippocampal dependent learning. K. ROSENBLUM*; V.
SHARMA; M. HLEIHEL, 3498838; E. EDRY; G. NATHANIEL.
Sagol Dept Neuro, Univ. of Haifa, Univ. of Haifa.
9:00 III39 355.18 Effects of transcription inhibition in dorsal
striatum on gene expression and memory consolidation
after moderate and enhanced training. A. C. MEDINA*; E.
ALVARADO-ORTZ; M. I. HERNNDEZ GUITRREZ; S.
GONZLEZ-SALINAS; G. L. QUIRARTE; A. ANTARAMIAN;
R. A. PRADO-ALCAL. Neurobiologia Conductual y
Cognitiva. Inst. de Neurobiologia-UNAM, Unidad de
Proteogenomica. Inst. de Neurobiologia-UNAM.

8:00 III50 355.29 Cell type specific translational profiling

during sleep dependent memory consolidation. T.
KARIHARAN*; S. ATON. Univ. of Michigan.
9:00 III51 355.30 Phosphorylation of eukaryotic translation
initiation factor 4E binding protein 2 (4EBP2) is required to
rescue memory impairments caused by sleep deprivation. J.
C. TUDOR*; C. W. CHUNG; E. SORENSEN; T. ABEL. Univ.
of Pennsylvania.

POSTER
356. Encoding Spatial Memories: Neural Circuits and
Ensembles
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

10:00 III40
355.19 Structural changes in medium spiny
neurons of dorsal and ventral striatum associated with
retrieval of over-reinforced inhibitory avoidance learning.
P. BELLO-MEDINA*; G. FLORES; G. L. QUIRARTE; R. A.
PRADO-ALCALA. Inst. de Neurobiologa-UNAM, Inst. de
fisiologa, Inst. de Neurobiologia-UNAM.

8:00 III52 356.01 Hippocampal sharp-wave ripple

characteristics during delay periods in the rodent
automated search task. K. TAHON*; D. A. JACKSON; W. H.
DRINKENBURG. Janssen Pharmaceuticals, Janssen Res. &
Development, a Div. of Janssen Pharmaceutica NV Beerse,
Belgium.

11:00 III41
355.20 Glucocorticoid receptor phosphorylation
in hippocampal and striatal neurons after inhibitory
avoidance training. D. A. GONZALEZ FRANCO*; A. M.
CRUZ-QUIROZ; R. PEGUEROS-MALDONADO; P. BELLOMEDINA; R. A. PRADO-ALCALA; G. L. QUIRARTE. Inst. de
Neurobiologa UNAM.

9:00 JJJ1 356.02 Experience-dependent enhancement of

sharp wave ripples near visual targets. K. L. HOFFMAN*; T.
K. LEONARD. York Univ., York Univ.

8:00 III42 355.21 Glucocorticoid receptor phosphorylation

in the amygdala and hippocampus after acquisition of
contextual fear conditioning. R. PONCE*; M. CARRANZA;
N. SERAFIN; R. A. PRADO-ALCAL; G. L. QUIRARTE. Inst.
De Neurobiologa, UNAM.
9:00 III43 355.22 Retrieval of a context fear memory
involves sex-specific recruitment of hippocampus and
amygdala. A. A. KEISER*; M. A. DARIAN; L. PAN; D.
TCHESSALOVA; K. M. COLLETTE; N. C. TRONSON. Univ.
of Michigan.
10:00 III44
355.23 Concentration of PKM in the basolateral
amygdala correlates with fear memory strength. M.
BERNABO*; K. NADER. McGill Univ.
11:00 III45
355.24 Gene expression and DNA methylation
dynamics in the mouse amygdala during threat
consolidation. S. SHARMA*; S. MADDOX; L. LIN; Y. LI; P.
JIN; K. RESSLER. Emory Univ. Sch. of Med., Mclean Hosp.,
Emory Univ. Dept. of Human Genet.
8:00 III46 355.25 Repressive histone methylation regulates
mTOR activation in the hippocampus during fear memory
reconsolidation. T. J. JAROME*; R. M. HAUSER; M. C.
RICH; F. D. LUBIN. Univ. of Alabama At Birmingham.
9:00 III47 355.26 Context fear memory formation is
regulated by Neat1 long non-coding RNA mediated histone
lysine methylation changes in the hippocampus. A. A.
BUTLER*; F. D. LUBIN; A. W. CHANG. Univ. of Alabama at
Birmingham.
10:00 III48
355.27 Translational profiling of CA1 projection
neurons after fear learning. A. L. JONES*; L. REIJMERS.
Tufts Univ., Tufts Univ.
11:00 III49
355.28 Cell-type specific gene profiling from
amygdala & cortex during long-term taste aversion memory
formation. D. LEVITAN*; D. B. KATZ; S. B. NELSON.
Brandeis Univ., Brandeis, Brandeis.
64 | Society for Neuroscience

8:00 DP09 356.03 (Dynamic Poster) Single neuron

signatures of the cognitive map in virtually navigating rhesus
monkeys. R. A. GULLI*; G. DOUCET; B. W. CORRIGAN; L.
DUONG; S. WILLIAMS; J. MARTINEZ-TRUJILLO. Western
Univ., McGill Univ., McGill Univ., McGill Univ.
11:00 JJJ2 356.04 Closed-loop interruption of hippocampal
ripples in macaque. O. TALAKOUB*; A. GOMEZ PALACIO
SCHJETNAN; M. R. POPOVIC; T. A. VALIANTE; K. L.
HOFFMAN. Univ. of Toronto, York Univ.
8:00 JJJ3 356.05 Population activity during sharp
wave-ripples depends on structured interactions and
spontaneously generated sequential activity in a network
model of hippocampal area CA3. S. KALI*; A. ECKER;
E. VERTES; I. MIKLOS; T. F. FREUND; A. I. GULYAS.
Hungarian Acad. of Sci., Pazmany Peter Catholic Univ., Univ.
Col. London, Hungarian Acad. of Sci., Hungarian Acad. of
Sci.
9:00 JJJ4 356.06 Hippocampal-prefrontal synchrony in
spatial working memory. A. EDSALL*; A. L. GRIFFIN. Univ.
of Delaware.
10:00 JJJ5
356.07 How dentate gyrus place cells represent
distinct place memories. M. T. VAN DIJK*; A. A. FENTON.
New York Univ. Ctr. For Neural Sci., New York Univ., State
Univ. of New York Downstate Med. Ctr.
11:00 JJJ6 356.08 Mnemonic coding of place cells on the
8-arm maze. H. XU*; J. ONEILL; J. CSICSVARI. IST Austria.
8:00 JJJ7 356.09 The Planar cell polarity pathway
regulates the balance between pattern completion and
pattern separation. B. J. ROBERT*; M. M. MOREAU;
M. CARTA; S. D. CARVALHO; A. QUIEDEVILLE; R.
PEYROUTOU; G. BARTHET; M. GARRET; B. ATCHAMA;
S. FIVRE; L. BRAYDAT-BRUNO; C. GUETTE; C.
RACCA; C. MEDINA; D. J. HENDERSON; A. DESMEDT;
C. MULLE; A. MARIGHETTO; M. MONTCOUQUIOL; N.
SANS. Neurocentre Magendie, CNRS, Inst. Interdisciplinaire
de Neurosciences, CNRS- INCIA, Inst. of Neurosci.Newcastle Univ., Inst. of Genet. Med.- Newcastle Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 JJJ8 356.10 Molecular and synaptic mechanisms of

learning and persistent hippocampal memory for an active
place avoidance. R. M. HARRIS*; H. KAO; A. CHUNG; J.
ALARCON; E. KLANN; H. A. HOFMANN; A. A. FENTON.
The Univ. of Texas At Austin, Marine Biol. Labs., New York
Univ., SUNY Downstate Medicacl Ctr., SUNY Downstate
Medicacl Ctr.
10:00 JJJ9
356.11 Long-term imaging of neural ensembles
in a mouse model of intellectual disability. E. H. SCHUT*; N.
NADIF KASRI; F. P. BATTAGLIA. Radboudumc, Radboud
Univ.
11:00 JJJ10 356.12 Cross-activation of hippocampal place
cell patterns by social subjects. X. MOU*; D. JI. BCM.
8:00 JJJ11 356.13 Role of the hippocampus during
observational learning of a spatial memory task. Y.
FUENTEALBA*; J. VALDS G. Univ. of Chile, Unviersity of
Chile.

10:00 JJJ13 356.15 Comparing the effects of dorsoventral

CA1 lesions and full hippocampal lesions on anterograde
tests of spatial memory in rats. A. OCAMPO*; S. VINCENT;
A. HASHI; M. GRAVES; L. R. SQUIRE; R. E. CLARK.
UCSD, UCSD, VA Med. Ctr., UCSD, UCSD.
11:00 JJJ14 356.16 Internally organized spatial firing of MEC
cells during navigation: If space was time. E. PARK*; S.
KEELEY; A. A. FENTON. New York Univ.
8:00 JJJ15 356.17 Neurophysiological correlates of spatial
navigation optimization in the rodent. T. PELC*; M. LLOFRIU;
N. CAZIN; P. SCLEIDOROVICH CHIODI; P. DOMINEY; A.
WEITZENFELD; J. FELLOUS. Arizona Univ., Univ. of South
Florida, INSERM.
9:00 JJJ16 356.18 Interactions between brain-behavior
state and stimulation frequency determine responses to
fornix stimulation in the macaque hippocampus. A. GMEZ
PALACIO SCHJETNAN*; T. K. LEONARD; O. TALAKOUB;
K. L. HOFFMAN. York Univ.
10:00 JJJ17 356.19 Robust spatial memories encoded
by transient neuronal networks: A topological model. Y.
A. DABAGHIAN*. Jan and Dan Duncan Neurolog. Res.
Institute, Baylor Col. of Med.
11:00 JJJ18 356.20 Long-lasting input-specific place learninginduced changes of the hippocampal circuit measured in the
freely-behaving mouse. A. CHUNG*; A. A. FENTON. New
York Univ.
8:00 JJJ19 356.21 Sharp-wave-ripple disruption after
one session learning erases memory. L. GENZEL*; F.
BATTAGLIA; R. MORRIS. Univ. of Edinburgh, Donders Inst.
9:00 JJJ20 356.22 Mapping time to hippocampus CA1
sequences. A. G. KAMBADUR*; S. PALCHAUDHURI; D.
SINGH; U. S. BHALLA. Natl. Ctr. For Biol. Sci. (NCBS).

10:00 JJJ21 356.23 CA1 hippocampal ensemble neural

activity reveals associative representations in mice learning
a bi-conditional learning task. T. ROGERSON*; J. MAXEY;
P. JERCOG; T. H. KIM; S. EISMANN; B. AHANONU; B.
GREWE; M. SCHNITZER. Stanford Univ., Stanford Univ.,
Stanford Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 JJJ23 356.25 Neural firing correlates of visual scene

memory performance in the subiculum and CA1. S. LEE*; H.
LEE; I. LEE. Dept. of Brain & Cognitive Sci.
9:00 JJJ24 356.26 Place cells in the septohippocampal
nucleus of freely behaving rats. A. G. HOWE*; R. M.
DEGUZMAN; G. J. BLAIR; H. T. BLAIR. UCLA, Univ. at
Albany, UCLA.
10:00 JJJ25 356.27 Intra ripple features are constant, but post
ripple features vary across behavioral state in macaques. A.
T. HUSSIN*; T. K. LEONARD; K. L. HOFFMAN. York Univ.,
York Univ., York Univ., York Univ., York Univ.
11:00 JJJ26 356.28 Control of recollection by competition
between slow and fast in hippocampus CA1. A. A.
FENTON*; B. RADWAN; F. SPARKS; D. DVORAK. New
York Univ.
8:00 JJJ27 356.29 Hippocampal CA1 activity encodes
space (response key) and time (order). T. G. WEYAND*; M.
KETCHUM; P. WINSAUER. Louisiana State Univ. Med. Ctr.,
LSU Hlth. Sci. Ctr.
9:00 JJJ28 356.30 A generic model for the generation of
and replay sequences in the hippocampus. A. AZIZI*; K.
DIBA; S. CHENG. RUB, Univ. of WisconsinMilwaukee.

POSTER
357. Learning and Memory: Role of Hippocampal GABAergic
Inhibition
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 JJJ29 357.01 Distinct lateral septal interneurons
broadcast instructive and permissive hippocampal signals to
calibrate fear responses. A. BESNARD*; T. LANGBERG; D.
CHU; W. FENG; D. SAUR; X. XU; A. SAHAY. Harvard Stem
Cell Inst., Ctr. for Regenerative Med., Dept. of Psychiatry, II.
Medizinische Klinik und Poliklinik, Departments of Neurobio.
and Anat.
9:00 JJJ30 357.02 Optogenetic inhibition of striatal
GABAergic neurons promotes functional recovery after
ischemic stroke in mice. L. JIANG; W. LI; Y. LU; Y. MA; Z.
ZHANG; G. YANG; Y. WANG*. Shanghai Jiao Tong Univ.
10:00 JJJ31 357.03 Modulation of the hippocampal circuit
by oriens lacunosum-moleculare neurons. J. HAAM*; J. L.
YAKEL. NIH/NIEHS.
11:00 JJJ32 357.04 Decreased cholinergic input to
hippocampal CA1 olm interneurons in an appps1
mouse model. M. MITTAG*; L. SCHMID; K. KEPPLER;
J. STEFFEN; M. FUHRMANN. German Ctr. of
Neurodegenerative Dis. (DZNE).
8:00 JJJ33 357.05 Neuroligin-3 in hippocampal parvalbumin
interneurons facilitates contextual fear extinction by
regulating presynaptic Group-III mGluRs. J. S. POLEPALLI*;
T. C. SUDHOF; R. C. MALENKA. Stanford Univ., Stanford
Univ., Stanford Univ.
9:00 JJJ34 357.06 Viral-mediated overexpression of NLGN2
enhances GABAergic synapses in the hippocampus and
alters social behavior and anxiety. M. A. VAN ZANDT*;
J. GUPTA; E. WEISS; S. SHRESTHA; S. MAISEL; J. R.
NAEGELE. Wesleyan.
Neuroscience 2016|Monday AM|65

Mon. AM

9:00 JJJ12 356.14 Do distance cues support memory

retrieval in response discriminations and reversal learning?
S. WRIGHT*; D. M. SKINNER; M. L. INGRAM; G. M.
MARTIN. Grenfell Campus, Mem. Univ. of Newfoundland, St.
Johns Campus, Mem. Univ. of Newfoundland.

11:00 JJJ22 356.24 Circuit architectures for the encoding and

processing of 3D orientation. H. ROUAULT*; A. RUBIN; S.
ROMANI. Janelia Res. Campus, HHMI, Weizmann Inst. of
Sci.

10:00 JJJ35 357.07 Role of hippocampal VIP interneurons in

reward-oriented spatial learning. G. F. TURI*; Z. LIAO; W. LI;
J. D. ZAREMBA; A. GROSMARK; X. LUO; L. TOPOLNIK; A.
LOSONCZY. Columbia Univ., Laval Univ.

8:00 JJJ47 358.05 Intercalated cells of the amygdala in

fear and extinction learning. O. BUKALO*; A. LIMOGES; M.
NONAKA; R. PALMITER; L. ZWEIFEL; A. HOLMES. NIH/
NIAAA, Univ. of Washington, Univ. of Washington.

11:00 JJJ36 357.08 Somatostatin-positive interneurons in

the dentate gyrus provide local- and long-range septal
synaptic inhibition. M. BARTOS*; M. YUAN; T. MEYER. Univ.
Freiburg, Univ. of Freiburg.

9:00 JJJ48 358.06 GABAergic and Adrenergic modulation

of excitatory inputs to the lateral division of the central
amygdala blocks fear conditioning. A. DELANEY*; J.
CRANE; N. HOLMES; F. WESTBROOK. Charles Sturt Univ.,
Univ. of New South Wales.

8:00 JJJ37 357.09 Feed forward inhibition dictates

reactivation of hippocampo-cortical ensembles to maintain
remote memory percision. N. GUO*; M. E. SODEN;
A. BESNARD; L. S. ZWEIFEL; A. SAHAY. Ctr. For
Regenerative Med., Harvard Stem Cell Inst., Dept. of
Psychiatry, Massachusetts Gen. Hospital, Harvard Med.
Sch., Dept. of Pharmacology, Univ. of Washington, Dept. of
Psychiatry and Behavioral Sciences, Univ. of Washington.
9:00 JJJ38 357.10 Network state dependent recruitment
of VIP interneurons in awake mice. R. FRANCAVILLA; V.
VILLETTE; X. LUO; O. CAMIRE; L. TOPOLNIK*. CRCHUQCHUL, Laval Univ.
10:00 JJJ39 357.11 Altered metabolic and synaptic functional
connectivity in the MAM model of neurodevelopmental insult.
K. C. OREILLY*; E. R. LEVY; M. I. PERICA; A. A. FENTON.
New York Univ.
11:00 JJJ40 357.12 Long-lasting input-specific modifications
of excitation and inhibition in the hippocampus following
spatial training measured in the anesthetized rat. E. LEVY*;
K. C. OREILLY; A. A. FENTON. NYU.

8:00 JJJ41 357.13 Genetic deletion of Fgf14 disrupts

inhibitory connections of the brain hippocampal region
in a sex specific manner. T. K. ALSHAMMARI*; M. A.
ALSHAMMARI; M. N. NENOV,; E. HOXHA; F. TEMPIA; F.
LAEZZA. Col. of Pharmacy, King Saud Univ., Univ. of Texas
Med. Br., Univ. of Torino.
9:00 JJJ42 357.14 Role of oxytocin receptor in GABAergic
actions. A. L. GUEDEA*; K. A. CORCORAN; K. NISHIMORI;
J. RADULOVIC. Northwestern Univ., Tohoku UniversityGraduate Sch. of Agr. Sci.

POSTER
358. Learning and Memory: Amygdala Circuits
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 JJJ43 358.01 A competitive inhibitory circuit for
selection of active and passive fear responses. J. P.
FADOK*; S. KRABBE; J. COURTIN; M. MARKOVIC; C.
XU; L. MASSI; P. BOTTA; K. BYLUND; C. MUELLER; P.
TOVOTE; A. LTHI. Friedrich Miescher Inst., Biozentrum.
9:00 JJJ44 358.02 Acquired taste valence encoding in
cortico-amygdala circuits. K. LAVI*; G. JACOBSON; K.
ROSENBLUM; A. LUTHI. FMI, Bar Ilan Univ., Univ. of Haifa.
10:00 JJJ45 358.03 Central amygdala microcircuit
mediating learning and expression of active avoidance. M.
MARKOVIC*; C. XU; S. KRABBE; J. GRUENDEMANN; J.
CUSULIN; A. LUTHI. Friedrich Miescher Inst.

10:00 JJJ49 358.07 Associative learning is gated by GABABGIRK signaling in pyramidal neurons of the basolateral
amygdala. M. E. TIPPS*; E. MARRON FERNANDEZ
DE VELASCO; N. M. MCCALL; K. WICKMAN. Univ. of
Minnesota, Univ. of Minnesota.
11:00 JJJ50 358.08 Interactive modulation of the medial
prefrontal cortex and orbitofrontal cortex on amygdala
neuronal activities. C. CHANG*. Natl. Tsing Hua Univ.
8:00 JJJ51 358.09 Role of the prefrontal-amygdala
synapses in the enhancement of Pavlovian conditioning after
observational fear. W. ITO*; A. MOROZOV. Virginia Tech.
Carilion Res. Inst.
9:00 JJJ52 358.10 Synaptic targeting of double-projecting
ventral hippocampal neurons to the medial prefrontal cortex
and basomedial amygdala. J. CHO*; W. KIM. Univ. of
California.
10:00 JJJ53 358.11 Defensive behavior switching mediated
by top-down inhibition of freezing cells in the centromedial
amygdala. J. JHANG*; J. HAN. Korea Advanced Inst. of Sci.
and Technol.
11:00 JJJ54 358.12 The retrorubral field is necessary for
accurate fear discrimination in Pavlovian conditioning. K. M.
WRIGHT*; M. MCDANNALD. Boston Col.
8:00 JJJ55 358.13 Prevention of fear re-appearance by
blockage of dopamine signaling. N. HITORA-IMAMURA*;
Y. MIURA; C. TESHIROGI; Y. IKEGAYA; N. MATSUKI; H.
NOMURA. Hokkaido Univ., Univ. of Tokyo.
9:00 JJJ56 358.14 Differential effects of D1-mediated
dopamine signaling in the amygdala on fear, safety, reward
cue discrimination learning. K. NG; M. POLLOCK; P.
URBANCZYK; E. WOON; E. GREINER; S. SANGHA*.
Purdue Univ., Purdue Inst. for Integrative Neurosci., Purdue
Univ.
10:00 JJJ57 358.15 Optogenetic manipulation of the
amygdalar pyramidal cells alters fear behavior in foraging
rats. M. KONG*; E. KIM; J. J. KIM. Univ. of Washington,
Univ. of Washington, Univ. of Washington.
11:00 JJJ58 358.16 Basolateral amygdala nucleus responses
to appetitive conditioned stimuli correlate with variations in
conditioned behavior. S. LEE*; A. AMIR; D. B. HEADLEY; D.
HAUFLER; D. PARE. Rutgers Univ.
8:00 JJJ59 358.17 Increasing the GluN2A/GluN2B ratio
within neurons of the mouse basal and lateral amygdala
inhibits the modification of an existing fear memory
trace. R. HOLEHONNUR*; A. J. PHENSY; L. J. KIM; M.
MILIVOJEVIC; D. T. VUONG; D. K. DAISON; S. ALEX; M.
TINER; L. E. JONES; J. E. PLOSKI; S. KROENER. Univ. of
Texas at Dallas.

11:00 JJJ46 358.04 Amygdalar PV-interneurons gate

prefrontal input to control fear ensemble activity. P. DAVIS*;
S. VIOLA; L. REIJMERS. Tufts Univ. Sch. of Med.

9:00 JJJ60 358.18 LTP induction and maintenance at

persistent memory engram. J. OH*; J. KWON; H. KIM; Y.
JEONG; H. CHO; J. HAN. Korea Advanced Inst. of Sci. and
Technol.

66 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 JJJ61 358.19 Multimodal and site-specific plasticity of

amygdala parvalbumin interneurons after fear learning. E.
K. LUCAS*; A. JEGARL; R. L. CLEM. Icahn Sch. of Med.
At Mount Sinai, Cornell Univ., Icahn Sch. of Med. at Mount
Sinai.
11:00 KKK1 358.20 Cortico-amygdalar functional network
underlying contextual fear learning in the absence of
hippocampus. C. A. COELHO*; J. C. K. SOARES; T. L.
FERREIRA; J. R. SATO; M. G. M. OLIVEIRA. Univ. Federal
De Sao Paulo, Univ. Federal do ABC.
8:00 KKK2 358.21 Threat anticipation during encoding
impairs visual object recognition memory and pattern
separation. S. H. BRAREN*; J. E. DUNSMOOR; M. C. W.
KROES; V. P. MURTY; E. A. PHELPS. New York Univ., Univ.
of Pittsburgh.

POSTER

Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 KKK3 359.01 Projections from the nucleus prepositus
hypoglossi to the head direction circuit and an extraocular
motor nucleus are separate but overlapping. M. L.
MEHLMAN*; S. S. WINTER; J. S. TAUBE. Dartmouth Col.
9:00 KKK4 359.02 Contributions of self-generated
movements and vestibular inputs to spatial correlates within
the dorsal tegmental nucleus of Gudden. J. R. DUMONT*;
M. L. MEHLMAN; M. E. SHINDER; J. S. TAUBE. Dartmouth
Col., Dartmouth Col.
10:00 KKK5 359.03 Interthalamic oscillatory coordination
in the head direction cell network. W. N. BUTLER*; J. S.
TAUBE. Dartmouth Col.
11:00 KKK6 359.04 Grid cell representation across a multilevel maze. S. S. WINTER*; M. L. MEHLMAN; J. S. TAUBE.
Dartmouth Col.
8:00 KKK7 359.05 Performance in a spatial reorientation
task is correlated with orientation of grid and head direction
cells. S. WEISS*; G. TELHAMI; X. GOFMAN; D. EILAM; D.
DERDIKMAN. Technion Israel Inst. of Technol., Tel-Aviv
Univ.
9:00 KKK8 359.06 Quantification of head direction drift in rat
pups. G. TOCKER*; E. BORODACH; D. DERDIKMAN. BarIlan Univ., Technion- Israel Inst. of Technol.
10:00 KKK9 359.07 Hippocampal lesions impair place and
direction learning in a water plus maze. D. M. SKINNER*.
359.08 Interactions

11:00 KKK10
between vestibular and
proximal-distal allothetic frames of reference in an objectplace paired associate task. L. M. SANCHEZ; S. M.
THOMPSON; B. J. CLARK*. Univ. of New Mexico.
8:00 KKK11 359.09 Longitudinal assessment of Papez circuit
structural change and spatial disorientation in the TgF344AD transgenic rat model of Alzheimers disease. L. E.
BERKOWITZ*; Y. YANG; S. M. THOMPSON; E. N. DRAKE;
E. A. SNEDDON; L. O. SILLERUD; B. J. CLARK. Univ. of
New Mexico, Univ. of New Mexico.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

10:00 KKK13 359.11 Directional discrimination in an objectplace paired associate memory is impaired after muscimol
inactivation of the anterior thalamus. S. M. THOMPSON*; S.
S. WINTERS; B. J. CLARK. Univ. of New Mexico, Dartmouth
college, Univ. of New Mexico.
11:00 KKK14 359.12 Repetition of place cell fields depends on
the head direction system. E. R. WOOD; B. HARLAND; R.
GRIEVES; R. STENTIFORD; D. BETT; P. A. DUDCHENKO*.
Univ. of Edinburgh, Univ. Stirling.
8:00 KKK15 359.13 Representation of environmental
boundaries within an egocentric reference frame. J. R.
HINMAN*; G. W. CHAPMAN, IV; M. E. HASSELMO. Boston
Univ.
9:00 KKK16 359.14 Involvement of the head direction system
in discrimination of visually ambiguous spaces. D. W.
OVERINGTON*; P. JACOB; K. JEFFERY. UCL.
10:00 KKK17 359.15 A hypothesis for path integration of
orientation via oscillatory inhibition. C. KIRST*; J. GREEN;
G. MAIMON. Rockefeller Univ.
11:00 KKK18 359.16 Learning head directional information by
spike timing-dependent plasticity enhances the boundary
avoidance in neuromorphic navigational model. S. KIM*; J.
KWAG. Korea Univ.
8:00 KKK19 359.17 Gravity tuning in mice head direction
cells. D. ANGELAKI; H. CHAM; M. SHINDER; J. DICKMAN*;
J. LAURENS. Baylor Col. of Med.
9:00 KKK20 359.18 Ring attractor dynamics in the Drosophila
central complex. S. KIM*; H. ROUAULT; J. D. SEELIG; S.
DRUCKMANN; V. JAYARAMAN. Janelia Res. Campus /
HHMI, research center caesar / Max Planck Society.
10:00 KKK21 359.19 How to move a compass needle: Angular
velocity integration in the Drosophila central complex.
D. B. TURNER-EVANS; J. D. SEELIG; S. WEGENER;
H. ROUAULT; S. KIM; R. FRANCONVILLE; C. DAN; H.
HABERKERN; Y. SUN; T. WOLFF; S. DRUCKMANN; V.
JAYARAMAN*. Janelia Res. Campus, HHMI, research center
caesar/Max Planck Society.
11:00 KKK22 359.20 Visual inputs to a neural representation
of heading in Drosophila. D. TURNER-EVANS*; V.
JAYARAMAN; H. HABERKERN. Janelia Res. Campus,
HHMI.
8:00 KKK23 359.21 Landmark-guided navigation in a 2D
virtual reality environment. H. J. HABERKERN*; C. BRUNS;
M. BASNAK; B. AHANONU; M. BOLSTAD; J. COHEN; V.
JAYARAMAN. HHMI Janelia Res. Campus, Univ. of Buenos
Aires, Stanford Univ.
9:00 KKK24 359.22 Exploring the neural circuit basis of visual
learning in Drosophila. C. DAN*; T. WOLFF; Y. ASO; G.
RUBIN; V. JAYARAMAN. Janelia Res. Campus, HHMI.
10:00 KKK25 359.23 Dual-color imaging reveals transformation
of visual representations along an input pathway to the
central complex. Y. SUN*; A. NERN; H. DANA; J. P.
HASSEMAN; G. TSEGAYE; G. HOLT; E. R. SCHREITER; L.
L. LOOGER; K. SVOBODA; M. B. REISER; G. M. RUBIN; D.
S. KIM; V. JAYARAMAN. HHMI Janelia Res. Campus.

Neuroscience 2016|Monday AM|67

Mon. AM

359. Spatial Navigation: Head Direction Cells and Spatial

Orientation

9:00 KKK12 359.10 Impaired retrieval of spatial memory and

response perseveration in a radial arm maze after muscimol
inactivation of the anterodorsal thalamus. R. E. HARVEY*;
S. M. THOMPSON; L. M. SANCHEZ; E. A. SNEDDON; R.
M. YODER; B. J. CLARK. Univ. of New Mexico, indiana
university, purdue university fort wayne.

11:00 KKK26 359.24 Sparse reconstruction of recurrent

networks within the Drosophila central complex. S. ALI*;
R. FRANCONVILLE; S. WEGENER; C. PETERSON; S.
TRAN; A. SHERIDAN; B. QU; E. NIELSON; T. WOLFF; J.
S. LAURITZEN; D. BOCK; V. JAYARAMAN. Janelia Res.
Campus, HHMI.

10:00 KKK38 360.11 Perception of backward visual masking

in a patient with bilateral frontal leucotomy. H. RIEIRO;
S. MARTINEZ-CONDE; J. CHANOVAS; E. GALLEGO; F.
VALLE-INCLN; S. L. MACKNIK*. Univ. of Granada, SUNY
Downstate Med. Ctr. Col. of Med., Univ. of A Corua, SUNY
Downstate Med. Ctr. Col. of Med.

8:00 KKK27 359.25 A functional connectivity atlas of the

fly central complex. R. FRANCONVILLE*; C. BERON; S.
NAMIKI; T. WOLFF; V. JAYARAMAN. Janelia Res. Campus.

11:00 KKK39 360.12 Orienting of endogenous spatial attention

can impact subjective awareness more than objective
performance. M. VERNET*; S. LOKEY; S. JAPEE; L. G.
UNGERLEIDER. NIMH/NIH/DHHS, NIMH/NIH/DHHS.

POSTER
360. Perception and Imagery: Visual Processing
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 KKK28 360.01 Concurrent tracking of global and local
processing using MEG. L. LIU*; H. LUO. Peking Univ.,
Peking Univ.
9:00 KKK29 360.02 A generic mechanism for Gestalt and
high-level stimulus interpretation in the human brain. P.
R. GRASSI*; N. ZARETSKAYA; A. BARTELS. Ctr. For
Integrative Neurosci., Univ. of Tbingen, Max Planck Inst. for
Biol. Cybernetics.
10:00 KKK30 360.03 Externally applied noise influences stateswitching dynamics of binocular rivalry. O. L. VAN DER
GROEN*; N. WENDEROTH. ETH Zrich, Neural Control of
Movement Lab.
11:00 KKK31 360.04 Changes of oscillations during binocular
rivalry reflect neural competition. V. PETRUK*; S. ENGEL; B.
HE; S. HE. Univ. of Minnesota, Univ. of Minnesota, Univ. of
Minnesota.
8:00 KKK32 360.05 Transcranial alternating current
stimulation modulated steady-state visual evoked
potentials and conscious perception in binocular rivalry. M.
KATSURAKAWA*; K. KITAJO. RIKEN, Univ. of Tokyo.
9:00 KKK33 360.06 A population of neurons that signal
interocular conflict signal in human visual cortex. S.
KATYAL*; S. HE; M. JI; B. HE; G. PETERSON; S. A.
ENGEL. Univ. of Minnesota Twin Cities.
10:00 KKK34 360.07 Visual change detection process is
relevant to exogenously-driven perceptual alternation of the
bistable image. T. URAKAWA*; M. BUNYA; O. ARAKI. Dept.
of Applied Physics.
11:00 KKK35 360.08 The relation of oscillatory-phase to visual
perception is dependent on attention and location of stimuli.
T. DONOGHUE*; W. FOX; A. KIM; B. VOYTEK. Univ. of
California San Diego, La Costa Canyon High Sch., Univ. of
California San Diego, Univ. of California San Diego.
8:00 KKK36 360.09 Coupled and oscillations mediate
top-down control on visual perception. R. F. HELFRICH*;
M. HUANG; G. WILSON; R. T. KNIGHT. Univ. of California
Berkeley.
9:00 KKK37 360.10 Saturation of population activity predicts
small phosphene size produced with electrical stimulation of
human visual cortex. W. H. BOSKING*; P. SUN; M. OZKER;
X. PEI; M. S. BEAUCHAMP; D. YOSHOR. Baylor Col. of
Med., Univ. of Texas Hlth. Sci. Ctr.

68 | Society for Neuroscience

8:00 KKK40 360.13 Attention to object form modulates

informational connectivity between dorsal and ventral visual
streams. J. TAYLOR*; M. VAZIRI-PASHKAM; Y. XU. Harvard
Univ., Harvard Univ.
9:00 KKK41 360.14 Neos spoon and Newtons apples:
Motion of rigid and non-rigid deformations as cues to
material properties. L. M. ALLEY*; A. C. SCHMID; K.
DOERSCHNER. Justus-Liebig-Universitt Gieen.
10:00 KKK42 360.15 Investigating the Reversed Letter Effect
for stimuli with and without basic features by means of
event-related brain potentials. L. BECKER*; T. SCHENK.
Technische Univ. Chemnitz, Ludwig-Maximilians-Universitaet
Muenchen.
11:00 KKK43 360.16 Examining the segregation of number,
letter, and word form selectivity in human ventral visual
cortex. D. JANINI*; C. BAKER. NIH.
8:00 KKK44 360.17 Predicting stimulus and response
category in a multisensory simulated real world environment
with fMRI and EEG. J. C. ELLIOTT*; W. WANG; D.
KRNAVEK; A. ASTURIAS; V. BABENKO; A. SHAPIRO; P.
CONNOLLY; S. T. GRAFTON. Univ. of California, Santa
Barbara, Teledyne.
9:00 KKK45 360.18 Differential impact of stimulus format on
representational spaces. B. B. BANKSON*; C. BAKER. NIH.
10:00 KKK46 360.19 Category boundaries and typicality
warp the neural representation space of real-world objects.
M. IORDAN*; M. R. GREENE; D. M. BECK; L. FEI-FEI.
Stanford Univ., Univ. of Illinois.
11:00 KKK47 360.20 You gain some you lose some: Changes
in synesthetic perception overtime. A. S. HOCHMAN*; J.
BUENROSTRO; J. F. AWAD; A. ILNICKI; R. MOSHER; S.
A. DREW. California State University, Northridge, California
State University, Northridge.
8:00 KKK48 360.21 Synesthetic grapheme-color associations
are processed early in time and can guide attention
during visual search. O. F. CHESLEY*; C. GRAULTY; E.
CANSECO-GONZALEZ; M. PITTS. Reed Col.
9:00 KKK49 360.22 Consistently Incorrect: Potential implicit
numerical activation in non-synesthetes. J. F. AWAD*; N.
URENDA; D. LARRANAGA; B. C. HACKNEY; S. A. DREW.
California State University, Northridge, California State
University, Northridge.
10:00 KKK50 360.23 On harnessing eye movements to read
the mind and to alter it. B. R. SHETH*; A. R. TIJIBOY. Univ.
of Houston, Univ. Houston.
11:00 KKK51 360.24 EEG oscillations during visual processing
task are different in expert and non expert subjects. D.
NOURI*; M. JAVIDJAM; A. BONYADINAEINI; R. LASHGARI.
Inst. For Res. In Fundamental Sci., Iran Univ. of Sci. and
Technol. (IUST), Inst. For Res. In Fundamental Sci.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 KKK52 360.25 Human single unit activity during

attentional blink. T. P. REBER*; J. FABER; J. NIEDIEK; J.
BOSTRM; V. COENEN; C. E. ELGER; F. MORMANN.
Dept. of Epileptology, Univ. of Bonn, Dept. of Neurology,
Univ. of Bonn, Stereotaxy and MR based OR Techniques,
Dept. of Neurosurgery, Univ. of Bonn.

10:00 KKK64 361.07 Encoding of auditory-visual associations

by single neurons in the human medial temporal lobe. M. S.
KEHL*; A. RACZ; J. NIEDIEK; T. P. REBER; M. BAUSCH; B.
SAMIMIZAD; J. BOSTRM; C. E. ELGER; F. MORMANN.
Univ. of Bonn Med. Ctr., Dept. of Neurosurgery, Univ. of
Bonn Med. Ctr.

9:00 KKK53 360.26 Probing the causality between neural

activation and perception using electrical stimulation in the
human medial-temporal lobe. S. KNIELING*; T. P. REBER;
J. BOSTROEM; C. E. ELGER; F. MORMANN. Dept. of
Epileptology, Univ. of Bonn, Dept. of Neurosurgery, Univ. of
Bonn.

11:00 KKK65 361.08 Visually and memory-selective single

neurons in the human medial temporal lobe during a spatial
memory task. S. MACKAY*; T. P. REBER; M. BAUSCH; J.
BOSTRM; C. E. ELGER; F. MORMANN. Univ. of Bonn
Med. Ctr., Univ. of Bonn Med. Ctr.

10:00 KKK54 360.27 Neural dynamics of event segmentation:

Evidence from intracranial recording. A. JAFARPOUR*; J. J.
LIN; R. T. KNIGHT. Helen Wills Neurosci. Instutite, Dept. of
Neurol.

8:00 KKK56 360.29 The dorsal and ventral default mode

network respond differentially to the valence and vividness of
imagined events. T. PARTHASARATHI*; J. W. KABLE. Univ.
of Pennsylvania.
9:00 KKK57 360.30 A gaze into the minds eye: Gaze as an
indicator of cortical reinstatement during mental imagery. M.
BONE*; M. ST-LAURENT; C. DANG; D. MCQUIGGAN; J. D.
RYAN; B. R. BUCHSBAUM. Rotman Res. Inst.

POSTER
361. Human Long-Term Memory: Medial Temporal Lobe
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 KKK58 361.01 Explaining the role of the hippocampus
in verbal memory. I. A. CLARK*; E. A. MAGUIRE. Wellcome
Trust Ctr. For Neuroimaging.
9:00 KKK59 361.02 The impact of video game experience on
hippocampal grey matter integrity. G. WEST*; K. KONISHI;
M. DIARRA; J. BENADY-CHORNEY; B. DRISDELLE; L.
DAHMANI; D. SODUMS; F. LEPORE; P. JOLICOEUR; V.
BOHBOT. Univ. of Montreal, Univ. of Montreal, Douglas Res.
Inst.
10:00 KKK60 361.03 Neural dynamics underlying the
acquisition of wikipedia concepts. L. S. SCHURMANN*; S.
THEVES; N. DE HAAS; A. R. BACKUS; C. F. DOELLER.
Donders Institute, Radboud Univ.
11:00 KKK61 361.04 Goal-directed search in natural scenes
improves with explicit, MTL-dependent long term memory. S.
YOO*; R. S. ROSENBAUM; J. K. TSOTSOS; M. FALLAH;
K. HOFFMAN. York Univ., York Univ., Rotman Res. Institute,
Baycrest, York Univ., York Univ., York Univ.
8:00 KKK62 361.05 Action-based prediction for known
and novel associations between real-world objects. N. C.
HINDY*; E. W. AVERY; N. B. TURK-BROWNE. Princeton
Univ.
9:00 KKK63 361.06 Visual responses of single neurons in
the human medial temporal lobe are modulated by context.
M. BAUSCH*; J. NIEDIEK; T. P. REBER; S. MACKAY; J.
BOSTRM; C. E. ELGER; F. MORMANN. Univ. of Bonn
Med. Ctr., Univ. of Bonn Med. Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 KKK67 361.10 Tracking dynamic connectivity shifts

between memory systems during context dependent rule
learning. A. E. CHANG*; A. S. WHITEMAN; C. E. STERN.
Boston Univ.
10:00 KKK68 361.11 The hippocampus and generalization:
Investigating the underlying mechanisms using 7T fMRI.
R. KOSTER*; Y. CHEN; M. CHADWICK; D. BERRON; A.
BANINO; E. DUZEL; D. KUMARAN. Google DeepMind, Inst.
of Cognitive Neurol. and Dementia Res., German Ctr. for
Neurodegenerative Dis., UCL Inst. of Cognitive Neurosci.
11:00 KKK69 361.12 Identification of nucleus reuniens in
humans using probabilistic tractography. T. A. ALLEN*; P. C.
REEDERS; R. P. VERTES; A. T. MATTFELD. Florida Intl.
Univ., Florida Atlantic Univ.
8:00 KKK70 361.13 Sequence memory predicts temporal
reward discounting and both activate medial prefrontal cortex
and medial temporal lobe regions. P. C. REEDERS*; T. A.
ALLEN; A. T. MATTFELD. Florida Intl. Univ.
9:00 LLL1 361.14 Activity of semantically invariant neurons
in the human MTL during LFP ripples during sleep. J.
NIEDIEK*; T. P. REBER; H. GAST; J. BOSTRM; V. A.
COENEN; C. E. ELGER; F. MORMANN. Univ. of Bonn, Univ.
of Bonn, Univ. of Bonn.
10:00 LLL2 361.15 Features in prior nights sleep relates to
changes in memory representations. E. COWAN*; A. LIU;
S. KOTHARE; O. DEVINKSY; L. DAVACHI. Ctr. For Neural
Science/ New York Univ., NYU Langone Sch. of Med.,
Comprehensive Epilepsy Ctr., New York Univ.
11:00 LLL3 361.16 Examining the functions of the
hippocampus using multimodal neuroimaging. N.
KESHAVARZIAN*; K. MCWILLIAMS; J. PETERSEN; J.
WILLIAMS; K. OSIPOWICZ. Drexel Univ., Drexel Univ.
8:00 LLL4 361.17 Mediation of musical expectancies
through hippocampus and amygdala interactions. D.
OMIGIE*; S. SAMSON. Max Planck Inst. For Empirical
Aesthtetics, Univ. of Lille.
9:00 LLL5 361.18 Recall deficits with preserved recognition
memory in limbic encephalitis. M. LAD*; S. MULLALY;
T. KELLY; T. GRIFFITHS. Newcastle Univ., Newcastle
Univ., Royal Victoria Infirmary, Wellcome Trust Ctr. for
Neuroimaging.
10:00 LLL6 361.19 Memory integration in patients with
hippocampal lesions. A. PAJKERT; C. FINKE; Y. SHING;
M. HOFFMANN; W. SOMMER; H. R. HEEKEREN; C. J.
PLONER*. Charit, Univ. of Stirling, Humboldt-Universitt zu
Berlin, Freie Univ. Berlin.
11:00 LLL7 361.20 Trial timing in fMRI designs for pattern
information analyses. M. DE ARAUJO SANCHEZ; A. ADKE;
D. ZEITHAMOVA*. Univ. of Oregon.
Neuroscience 2016|Monday AM|69

Mon. AM

11:00 KKK55 360.28 Representation of real-world event

schemas during narrative perception. C. BALDASSANO*; U.
HASSON; K. A. NORMAN. Princeton Univ.

8:00 KKK66 361.09 Perceptual and conceptual object

information is integrated in perirhinal cortex. C. B. MARTIN*;
L. MAN; D. M. DOUGLAS; R. N. NEWSOME; M. D.
BARENSE. Univ. of Toronto, Rotman Res. Inst.

8:00 LLL8 361.21 Neural representations of concepts and

exemplars: Comparing generalization and recognition. C. R.
BOWMAN*; D. ZEITHAMOVA. Univ. of Oregon.
9:00 LLL9 361.22 Does novelty detection in single neurons
of the human amygdala underlie the word frequency effect in
recognition memory performance? J. KUHN*; J. T. WXTED;
L. R. SQUIRE; P. N. STEINMETZ. UCSD, Nakamoto Brain
Res. Inst.
10:00 LLL10 361.23 Neural substrates of fear-conditioning
induced retroactive and selective memory enhancement. D.
S. YI*; J. E. DUNSMOOR; E. A. PHELPS; L. DAVACHI. New
York Univ., New York Univ.
11:00 LLL11 361.24 Memory, interrupted- Examining multivoxel representations when perception clashes with the
contents of working memory. E. B. ONEIL*; A. C. H. LEE.
Univ. of Toronto, Scarborough, Baycrest Ctr. for Geriatric
Care.
8:00 LLL12 361.25 Ibuprofen, but not paracetamol, enhances
word recall memory in humans. M. S. GALLO*; K. A.
BUCKHAULTS; R. G. OWENS; P. T. ORR. Univ. of Scranton,
Univ. of Scranton.
9:00 LLL13 361.26 Ec cortical thickness predicts cognitive
decline in MCI in the ADNI sample. J. M. ROBERTS*; A.
J. HOLBROOK; N. TUSTISON; J. STONE; D. GILLEN; M.
A. YASSA. Univ. of California Irvine Dept. of Neurobio. and
Behavior, Univ. of California Irvine Dept. of Statistics, Univ. of
Virginia, Univ. of Virginia.
10:00 LLL14 361.27 High-frequency band activity in human
hippocampal CA1 predicts the precision of spatial memory
retrieval. R. F. STEVENSON*; J. ZHENG; S. L. LEAL; A. P.
CHUN; S. VADERA; R. T. KNIGHT; J. J. LIN; M. A. YASSA.
UC Irvine, Johns Hopkins Univ., UC Berkeley.
11:00 LLL15 361.28 Hippocampal-cortical networks for
temporal memory precision. M. E. MONTCHAL*; M. A.
YASSA. UC Irvine.
8:00 LLL16 361.29 Category specific phase encoding for
facial expressions in the orbitofrontal cortex. J. ZHENG*; R.
F. STEVENSON; H. ERKOL; M. A. YASSA; R. T. KNIGHT; J.
J. LIN. Univ. of California, Irvine, Univ. of California, Irvine,
Univ. of California, Irvine, Univ. of California, Irvine, Univ. of
California, Berkeley, Univ. of California, Irvine.

POSTER
362. Cortical Control of Executive Function
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 LLL17 362.01 Individual differences in abstract
rule selection. K. D. JUSTUS; B. A. ANDERSON; S. M.
COURTNEY*. Johns Hopkins Univ., Johns Hopkins Univ.
9:00 LLL18 362.02 Young adults born preterm with very
low birth weight exhibit hyper-reactive cognitive control
processing accompanied by disrupted white matter integrity.
A. OLSEN*; E. DENNIS; K. A. I. EVENSEN; A. BRUBAKK;
L. EIKENES; A. K. HBERG. Norwegian Univ. of Sci. and
Technol., Norwegian Univ. of Sci. and Technol., St. Olavs
Hopital, Trondheim Univ. Hosp., USC, Norwegian Univ. of
Sci. and Technol., Norwegian Univ. of Sci. and Technol.,
Trondheim Municipality, Norwegian Univ. of Sci. and
Technol., St. Olavs Hopital, Trondheim Univ. Hosp.

70 | Society for Neuroscience

10:00 LLL19 362.03 Effects of repetitive transcranial magnetic

stimulation at 1 Hz on right dorsolateral prefrontal cortex on
impulse control, quality of life and disability self-assessment
in patients with borderline personality disorder. E.
MORELOS SANTANA*; J. REYES-LPEZ; K. CERRILLOAVILA; R. ALCAL-LOZANO; E. REYES-ZAMORANO;
E. MIRANDA-TERRES; J. RICARDO-GARCELL; M.
GARCA-ANAYA; J. GONZLEZ-OLVERA. Inst. Nacional
De Psiquiatra Ramn De La Fuen, Univ. Autnoma de
Quertaro, Inst. de Neurobiologa, UNAM.
11:00 LLL20 362.04 Sequence monitoring in the frontal cortex.
T. M. DESROCHERS*; D. BADRE. Brown Univ., Brown
Univ., Brown Univ.
8:00 LLL21 362.05 Medial prefrontal cortex signals prediction
errors across domains of pain and cognitive control. A.
JAHN*; D. NEE; W. ALEXANDER; J. BROWN. Haskins
Labs., Helen Wills Neurosci. Inst., Ghent Univ., Indiana Univ.
9:00 LLL22 362.06 Human single-neuron correlate of error
monitoring in the medial frontal cortex. Z. FU*; A. MAMELAK;
I. ROSS; J. CHUNG; R. ADOLPHS; U. RUTISHAUSER.
Caltech, Cedars-Sinai Med. Ctr., Huntington Mem. Hosp.,
Cedars-Sinai Med. Ctr., Caltech.
10:00 LLL23 362.07 Disentangling the relative timing of
right inferior frontal cortex and anterior insula in response
inhibition with intracranial recordings in humans. E.
BARTOLI*; A. ARON; N. TANDON. Uthealth Sci. Ctr. At
Houston, Univ. of California.
11:00 LLL24 362.08 CLOCK regulation of circadian rhythms in
the human neocortex. M. FONTENOT; G. KONOPKA*. UT
Southwestern, UT Southwestern Med. Ctr.
8:00 LLL25 362.09 A computational neural model of
sequential action in the fronto-parietal network. N. ZARR*; J.
W. BROWN. Indiana Univ.
9:00 LLL26 362.10 Frontal dysfunction in resting state
networks in Multiple Sclerosis. J. GIELEN*; J. VAN
SCHEPENDOM; J. LATON; J. DE MEY; A. VANBINST;
M. CAMBRON; M. DHAESELEER; M. DHOOGHE; G.
NAGELS. Vrije Univ. Brussel, Univ. de Mons, UZ Brussel,
Natl. MS Ctr. Melsbroek.
10:00 LLL27 362.11 Effects of the cholinergic agonist nicotine
on cognitive flexibility and stability are modulated by baseline
prefrontal functions. C. M. THIEL*; S. PUSCHMANN; S.
AHRENS. Univ. of Oldenburg.
11:00 LLL28 362.12 Fronto-parietal regions represent both
abstract goals and goal-relevant feature information. N. M.
LONG*; B. A. KUHL. Univ. of Oregon.
8:00 LLL29 362.13 The impact of poly-victimization and
traumatic stress on psychological and neuropsychological
functioning of undergraduate college students. A. STIVER;
W. M. MEIL*. Indiana Univ. of Pennsylvania Dept. of
Psychology.
9:00 LLL30 362.14 Is punishment impairing cognitive control
in procrastinators?- an fMRI monetary Go/NoGo study.
M. WYPYCH*; J. MICHAOWSKI; D. DRODZIEL; M.
BANIA; M. SZCZEPANIK; A. MARCHEWKA. Nencki Inst. of
Experimenal Biol., Warsaw Univ., Warsaw Univ.
10:00 LLL31 362.15 Complementary physiological and
behavioral data streams enhance analysis of fNIRS data
during a real-world driving task. A. GUNDRAN*; A. M.
PICCIRILLI; J. M. BAKER; J. L. BRUNO; L. K. HARBOTT;
H. HOSSEINI; J. C. GERDES; A. L. REISS. Stanford Univ.,
Stanford Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 LLL32 362.16 Neural, physiological, and behavioral

correlates of visuomotor cognitive load: A functional NIRS
study. H. HOSSEINI*; J. L. BRUNO; J. M. BAKER; A.
GUNDRAN; A. M. PICCIRILLI; L. K. HARBOTT; J. C.
GERDES; A. L. REISS. Stanford Univ., Stanford Univ.
8:00 LLL33 362.17 fNIRS measurement of cortical activation
and functional connectivity during a visuospatial working
memory task. J. BAKER*; J. L. BRUNO; A. GUNDRAN; H.
HOSSEINI; A. L. REISS. Stanford Univ.
9:00 LLL34 362.18 Characterizing brain and behavioral
correlates of steering control during simulated driving. J.
BRUNO*; J. M. BAKER; A. GUNDRAN; L. K. HARBOTT; Z.
STUART; A. PICCIRILLI; S. H. HOSSEINI; J. C. GERDES;
A. REISS. Stanford Univ., Stanford Univ.

POSTER
363. Cortical Mechanisms of Language
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 LLL46 363.01 Intracranial electrophysiology
demonstrates hippocampal activation in verbal fluency tasks.
S. T. WILLIAMS*. Univ. of Pennsylvania.
9:00 LLL47 363.02 Inner speech activates auditory cortex:
An fmri study. K. OKADA*; G. HICKOK. Univ. California,
Irvine.

11:00 LLL36 362.20 Executive system recruitment is specific

to goal-related and intentionally directed mind-wandering:
Direct evidence for the functional role of the frontoparietal
control network in self-generated thought. K. C. FOX*; M. L.
DIXON; M. GIRN; S. SHETH; A. HERRERA-BENNETT; K.
CHRISTOFF. Univ. of British Columbia.

10:00 LLL48 363.03 The role of feature type and semantic

domain in effective connectivity underlying semantic
retrieval. S. F. CAPPA*; E. CATRICALA; E. ZANIN; A.
FALINI; N. CANESSA. IUSS Pavia, Div. of Neuroscience,
San Raffaele Scientific Inst., Vita-Salute Univ. and Div. of
Neuroscience, San Raffaele Scientific Inst.

8:00 LLL37 362.21 Fractionating the frontoparietal network

into distinct anterior and posterior systems based on
stable and dynamic network architecture. M. L. DIXON*; K.
CHRISTOFF. UBC.

11:00 LLL49 363.04 Neural correlates of semantic and

syntactic processing in sign language. A. STROH*; F.
ROESLER; G. DORMAL; N. SKOTARA; B. HAENELFAULHABER; B. ROEDER. Univ. of Hamburg.

9:00 LLL38 362.22 Neurophysiological correlates of

executive function in children and adolescents with attentiondeficit hyperactivity disorder: A preliminary qEEG study. K.
JHUNG*; J. PARK; J. CHOI; J. SONG. Catholic Kwandong
Univ., Yonsei Univ. Col. of Med., Natl. Ctr. for Mental Hlth.,
Natl. Hlth. Insurance Service Ilsan Hosp.

8:00 LLL50 363.05 Earlier than expected: Functional

and structural connectivity of early auditory cortex
influences brocas involvement during speech production.
P. FRIEDRICH*; S. OCKLENBURG; C. FRAENZ; O.
GUNTURKUN; E. GENC. Ruhr-University.

10:00 LLL39 362.23 A method for prediction of performance

errors from single-trial EEG data. H. ORA*; Y. MIYAKE.
Tokyo Inst. of Technol.
11:00 LLL40 362.24 Sustained vs. instantaneous connectivity
differentiates processing speed and fluid intelligence. J. B.
KING*; A. K. MALLIK; L. M. SHAH; J. S. ANDERSON. Univ.
of Utah.
8:00 LLL41 362.25 Who does what? Neural representations
of identity and ownership of ones own and a partners
subtasks. D. PISCHEDDA*; S. SEYED-ALLAEI; K.
GRGEN; J. HAYNES; C. F. REVERBERI. Bernstein Ctr.
for Computat. Neurosci., Univ. of Milano-Bicocca, NeuroMIMilan Ctr. for Neurosci., Bernstein Ctr. for Advanced
Neuroimaging, Charit-Universittsmedizin, Humboldt Univ.
zu Berlin, Charit-Universittsmedizin.
9:00 LLL42 362.26 Neural correlates of role switching: A
functional MRI study. H. KADOTA*; Y. KOKAGE. Kochi Univ.
of Technol.
10:00 LLL43 362.27 Neural correlates of response inhibition
in mild-moderate traumatic brain injury: An fMRI study. K. A.
HOLIDAY*; L. T. EYLER; R. T. KIM; S. SORG; A. M. CLARK;
L. DELANO-WOOD; D. M. SCHIEHSER. SDSU/UCSD Joint
Doctoral Program In Clin. Psych, VA San Diego Healthcare
Syst., Desert Pacific Mental Illness Research, Education,and
Clin. Ctr., Dept. of Psychiatry, Univ. of California San Diego.

9:00 LLL51 363.06 Childrens language exposure predicts

their neural activation during language processing. R. R.
ROMEO*; J. A. LEONARD; S. T. ROBINSON; M. L. ROWE;
A. P. MACKEY; J. D. E. GABRIELI. Harvard Univ., MIT,
McGovern Inst. for Brain Res., Harvard Grad. Sch. of Educ.

10:00 LLL52 363.07 Comprehension-dependent cortical

activation during speech comprehension tasks with multiple
languages: Functional near-infrared spectroscopy (fNIRS)
study. M. LEI; T. MIYOSHI; Y. NIWA; I. DAN; H. SATO*. Ctr.
for Exploratory Research, Hitachi, Ltd., Chuo Univ.
11:00 LLL53 363.08 Fractional anisotropy decreases at
extended segments in the left arcuate fasciculus in people
who stutter. K. YASU*; R. A; K. MORI; N. SAKAI. Natl.
Rehab. Ctr. For Persons With Disabilities.
8:00 LLL54 363.09 The shared mechanism underlying music
and reading. M. YU*; M. XU; X. WANG; J. LIU. Beijing
Normal Univ., Beijing Normal Univ.
9:00 LLL55 363.10 fMRI inter-trial variability as behavioral
predictor in reading. J. SCHEFF*; S. BAILEY; M.
RICHMOND; L. CUTTING. Vanderbilt Univ., Vanderbilt Brain
Inst.
10:00 LLL56 363.11 The visual-linguistic interface:
Anatomically aligned semantic representations of vision and
language. A. G. HUTH; S. F. POPHAM; N. Y. BILENKO; J. L.
GALLANT*. Univ. of California Berkeley.

11:00 LLL44 362.28 Neural substrate of shifting visual-spatial

attention during task-switching. S. IWAKI*; K. RANA; L. M.
VAINA. Natl. Inst. Adv Indust Sci. & Tech., Boston Univ.,
Massachusetts Gen. Hospital, Dept. of Neurology, Harvard
Med. Sch.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|71

Mon. AM

10:00 LLL35 362.19 Brain network connectivity of a world

record contender for simultaneous blindfold chess. M.
JOHNSON*; J. POCHON; N. REGGENTE; J. C. WEBSTER;
J. RISSMAN. UCLA.

8:00 LLL45 362.29 Neural networks associated with

response selection Revealed by a flanker task with averted
eye-gazes serving as response cues. H. LEE*; F. LIN; W.
KUO. Natl. Yang-Ming Univ., Natl. Taiwan Univ.

11:00 LLL57 363.12 Contribution of the motor system to

McGurk effect event-related fMRI and TMS studies.
T. MURAKAMI*; J. FUJIWARA; Y. SAKAMOTO; M.
OKAMOTO; T. MIZUOCHI; T. IWABUCHI; M. MAKUUCHI;
M. ABE; H. KUBO; N. MATSUDA; S. KOBAYASHI; Y.
UGAWA. Fukushima Med. Univ., Natl. Rehabil. Ctr. for
Persons with Disabilities, Tohoku Univ.
8:00 LLL58 363.13 The left dorsal premotor cortex in foreign
visual-word processing for beginner readers. L. LI*; X.
FENG; X. MENG; G. DING. Beijing Normal Univ., Peking
Univ.
9:00 LLL59 363.14 Functional plasticity of sentenceprocessing brain networks: An fMRI study of late American
Sign Language acquisition. L. JOHNSON; Y. YI; S.
MICKELSEN; S. MAZE; L. C. BAXTER; P. M. HOWARD; C.
ROGALSKY*. Arizona State Univ., Barrow Neurolog. Inst.
10:00 LLL60 363.15 Infants sensitivity to visual rhythmictemporal patterning of language: An integrated fNIRS
neuroimaging, thermal infrared imaging, and eye tracking
investigation. A. STONE*; B. MANINI; G. KARTHEISER;
C. LANGDON; A. MERLA; L. PETITTO. Gallaudet Univ.,
Gallaudet Univ., Univ. of Chieti-Pescara, Italy, Univ. of ChietiPescara, Italy.
11:00 LLL61 363.16 Oxytocin modulates semantic integration
in speech comprehension. Z. YE*; A. STOLK; I. TONI; P.
HAGOORT. Chinese Acad. of Sci., Donders Inst. for Brain,
Cognition and Behaviour.
8:00 LLL62 363.17 Development of an assessment tool for
the study of pragmatic language comprehension for use in
neuroimaging studies. A. V. CARRILLO-PEA; G. L. LICEAHAQUET; D. E. VALLES-CAPETILLO; M. GIORDANO*.
Univ. Nacional Autnoma De Mxico, Univ. Nacional
Autnoma De Mxico.
9:00 LLL63 363.18 Language lateralization assessed by
magnetoencephalography imaging using three different
language tasks. E. DE WITTE*; L. HINKLEY; D. MIZUIRI;
C. GARRETT; S. HONMA; H. KIRSCH; J. HOUDE; M.
BERGER; S. NAGARAJAN. UCSF Med. Ctr., UCSF Med.
Ctr., UCSF Med. Ctr., UCSF Med. Ctr., UCSF Med. Ctr.,
UCSF Med. Ctr.
10:00 LLL64 363.19 Noninvasive measurement of languagerelated frontal band activity with magnetoencephalography.
H. HASHIMOTO*; Y. HASEGAWA; T. ARAKI; T.
YANAGISAWA; S. YORIHUJI; M. HIRATA. Osaka Univ.,
Osaka university.
11:00 LLL65 363.20 How can the time length of being
bilingual affect the white matter of the brain? connectometry
approach. M. DOLATSHAHI*; A. ANJOMSHOA; A.
KAMALIAN; F. RAHMANI; N. HOSSEINI; M. AARABI.
Tehran Univ. of Med. Sci. _ Students, Tehran Univ. of Med.
Sciences_Students Scientific Res. Ctr., Basir Eye Hlth. Res.
Ctr.
8:00 LLL66 363.21 Resting-state EEG as joint indicator of
language performance and age-related cognitive decline. C.
BEESE*; L. MEYER; B. VASSILEIOU; A. FRIEDERICI. Max
Planck Inst. Cognitive and Brain Sci.
9:00 LLL67 363.22 The right inferior frontal gyrus supports
processing of nested structures in music. V. K. CHEUNG*;
L. MEYER; A. D. FRIEDERICI; S. KOELSCH. Max Planck
Inst. for Human Cognitive and Brain Sci., Bernstein Ctr. for
Computat. Neurosci., Univ. of Bergen.
10:00 LLL68 363.23 Learning new words in a second
language from spontaneous speech: An N400 study. M.
NOORDENBOS*; M. ERNESTUS. Radboud Univ., Max
Planck Inst. for Psycholinguistics.
72 | Society for Neuroscience

11:00 LLL69 363.24 False belief and complementation: An

electroencephalography study. Y. GUAN*; M. J. FARRAR; A.
KEIL. Univ. of Florida, Univ. of Florida.
8:00 LLL70 363.25 Induced high- oscillations during
speaking distinguish variants of primary progressive aphasia.
L. B. HINKLEY*; M. CAHILL-THOMPSON; Z. MILLER; K.
RANASINGHE; D. MIZUIRI; C. GARRETT; S. HONMA; B.
MILLER; K. VOSSEL; J. HOUDE; M. GORNO-TEMPINI; S.
S. NAGARAJAN. UC San Francisco, Univ. of California, San
Francisco.
9:00 MMM1 363.26 Using the N400 as a neural distance
metric for unsupervised clustering of words. M. VAN VLIET*;
M. M. VAN HULLE; R. SALMELIN. Aalto Univ., KU Leuven.
10:00 MMM2 363.27 Enhancement of high- power in
9-month-old infants with early active acoustic experience
suggests accelerated phonemic mapping. S. C. ORTIZMANTILLA*; T. REALPE-BONILLA; J. DICICCO-BLOOM; A.
A. BENASICH. Rutgers The State Univ. of New Jersey.

11:00 MMM3 363.28 Kohonen networks for unsupervised

identification of unique multimodal spectral-temporal profiles.
K. FORSETH*; N. TANDON. UT Hlth. Sci. Ctr. In Houston.

POSTER
364. Animal Models of Schizophrenia and Pharmacological
Treatments
Theme H: Cognition
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 MMM4 364.01 A novel Muscarinic M4 receptor

modulator PGM039678 inhibits Dopamine D1 receptor
signalling pathways in vivo. T. R. PATEL*; S. BECHAR; S.
STAFFORD; R. FOSBEARY; M. SHEARDOWN; L. WALSH;
J. REEVES; P. RUPRAH; M. BARNES. Takeda Cambridge
Ltd.
9:00 MMM5 364.02 Effects of repeated aripiprazole treatment
on D2High receptors and the Akt-GSK3 signaling pathway in
preadolescent and adult rat. M. L. BECKER*; V. REAL; A. D.
HARDIN; C. A. CRAWFORD; S. A. MCDOUGALL. California
State Univ.
10:00 MMM6 364.03 Targeted deletion of both kynurenine
aminotransferase II and kynurenine 3-monooxygenase
in mice: Implications for studying kynurenine pathway
metabolism. A. POCIVAVSEK*; M. A. R. THOMAS; F.
GIORGINI; R. SCHWARCZ. Univ. of Maryland Sch. of Med.,
Univ. of Leicester.
11:00 MMM7 364.04 Withdrawn.
8:00 MMM8 364.05 Activation of the VPAC2 receptor inhibits
neurite outgrowth and branching of cortical neurons by a
PKA-dependent mechanism. H. HASHIMOTO; Y. AGO*;
A. HAYATA-TAKANO; T. KAWANAI; R. YAMAUCHI; J. A.
WASCHEK. Osaka Univ., Univ. of California.

9:00 MMM9 364.06 Characterization of PGM039678,

a positive allosteric modulator of the muscarinic M4
receptor, in animal models of schizophrenia. E. CAYRE;
D. PARACHOU; B. MOT; B. RION; C. DRIEU LA
ROCHELLE*; M. SHEARDOWN; P. RUPRAH; L. WALSH;
J. REEVES; R. FOSBEARY; M. BARNES; T. PATEL. Biotrial
Pharmacol., Takeda Cambridge Ltd.
10:00 MMM10 364.07 Neonatal phencyclidine (PCP) in the rat
induces psychotomimetic effects in adulthood which can
be inhibited by chronic treatment with antipsychotics. V.
CASTAGN*; A. HERNIER. Porsolt S.A.S.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 MMM11 364.08 Selective M1 potentiation improves PCPinduced deficits in working memory and pattern separation
in rats. E. P. LEBOIS*; D. VOLFSON; D. BUHL; S.
GRIMWOOD; J. EDGERTON. Pfizer, Inc., Pfizer, Inc, Pfizer,
Inc.
8:00 MMM12
364.09 Positive allosteric modulators of the 7
nicotinic acetylcholine receptor reinstate cognitive control
and potentiate glutamate levels in prefrontal cortex. D.
PHENIS*; J. D. SCHUMACHER; V. VALENTINI; J. P.
BRUNO. The Ohio State Univ., Univ. of Cagliari.
9:00 MMM13
364.10 Atypical antipsychotic clozapine reversed
deficit on prepulse inhibition of the acoustic startle reflex
produced by microinjection of DOI into the inferior colliculus
in rats. R. B. SILVA*; R. OLIVEIRA. Univ. Federal de So
Paulo.

11:00 MMM15 364.12 The atypical antipsychotic drug

lurasidone to prevent and reverse the impairment in
novel object recognition in phencyclidine-treated mice. M.
HUANG*; L. RAJAGOPAL; S. KWON; H. Y. MELTZER.
Northwestern Univ. Feinberg Sch. of Med.
8:00 MMM16
364.13 Serotonergic hyperfunction in an NMDAR
hypofunction mouse model of schizophrenia. K. NAKAO*;
S. YAMAGUCHI; K. NAKAZAWA. Univ. of Alabama at
Birmingham, Gifu Univ. Grad. Sch. of Med.
9:00 MMM17
364.14 Antipsychotics and 5-HT2A receptor:
Insights from the 5-HT2A knockout mouse. R. JOSHI*; M. M.
PANICKER. Natl. Ctr. For Biol. Sci.
10:00 MMM18 364.15 Comparison of the discriminative stimulus
properties of the antipsychotics amperozide and amisulpride
in C57BL/6 mice and antagonist activity at dopamine D2
and serotonin 5-HT2 receptors in Xenopus oocytes. T. J.
DONAHUE*; J. YOUNKIN; J. C. KING; D. E. LOGOTHETIS;
J. H. PORTER. Virginia Commonwealth Univ., Viginia
Commonwealth Univ., Virginia Commonwealth Univ.

11:00 MMM19 364.16 Does the antipsychotic-like effect of

acute oxytocin on prepulse inhibition persist with chronic
administration? P. D. SHILLING*; G. MELENDEZ; B.
ROBERTS; J. TRAN; A. AVALOS; A. DAQIAN; A. NARWAN;
B. KIAEI; D. FEIFEL. Univ. California, San Diego.
8:00 MMM20
364.17 Chemogenetic activation of CCK-GABA
neurons: Implications for schizophrenia. P. D. WHISSELL*; I.
KHAN; J. KIM. Univ. of Toronto.
9:00 MMM21
364.18 Amelioration of working memory deficits
induced by prefrontal GABA hypofunction by D1 receptor
agonists and D-govadine. J. MECCIA*; M. AUGER; A. G.
PHILLIPS; S. B. FLORESCO. Univ. of British Columbia,
Univ. of British Columbia.

10:00 MMM22 364.19 Ivermectin, a positive modulator of P2X4

receptors, interacts with D1 receptors in modulation of
prepulse inhibition of acoustic startle reflex. S. KHOJA*; L.
ASATRYAN; M. W. JAKOWEC; D. L. DAVIES. USC, USC,
USC.

11:00 MMM23 364.20 Efficacy of -arrestin biased dopamine

D2 receptor compounds as preclinical treatment for
schizophrenia-like behaviors. W. C. WETSEL*; R. M.
RODRIGUIZ; V. M. POGORELOV; S. PARK; C. M.
SCHMERBERG; M. G. CARON; J. JIN. Duke Univ. Dept. of
Psychiatry and Behavioral Sci., Duke Univ. Med. Ctr., Duke
Univ. Med. Ctr., Icahn Sch. of Med. at Mount Sinai.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 MMM25
364.22 Effects of sodium nitroprusside on
MK-801-induced impairments in the trial-unique, delayed
nonmatching-to-location task. J. HURTUBISE*; W. N.
MARKS; D. A. DAVIES; J. K. CATTON; G. B. BAKER; J. G.
HOWLAND. Univ. of Saskatchewan, Univ. of Alberta.
10:00 MMM26 364.23 Accumbens-prefrontal interactions in
the regulation of multiple transmitter systems: Implications
for cognitive deficits in schizophrenia. V. VALENTINI*; J. D.
SCHUMACHER; D. PHENIS; D. BORTZ; J. P. BRUNO. Univ.
of Cagliari-Dept. Biomed. Sci., Ohio State Univ.
11:00 MMM27 364.24 Investigation of -7 nicotinic receptor
modulation effects on VTA dopamine neuron activity in the
MAM animal model of schizophrenia. G. A. NEVES*; A. A.
GRACE. Univ. of Pittsburgh.
8:00 MMM28
364.25 Risperidone ameliorates behavioral
and morphological changes induced by neonatal ventral
hippocampus lesion in rat. H. TENDILLA*; S. MENESESPRADO; R. A. VZQUEZ-ROQUE; G. FLORES. Inst. De
Fisiologa, Benemrita Univ. Autnoma De Puebla.
9:00 MMM29
364.26 Involvement of prefrontal GABAergic
transmission in schizophrenia-like behaviour induced
by chronic adolescent THC exposure. J. RENARD*;
C. KRAMAR; H. HSZKUDLAREK; L. G. ROSEN; W. J.
RUSHLOW; S. R. LAVIOLETTE. Western Ontario Univ.
10:00 MMM30 364.27 Chronic risperidone administration
attenuates neuronal abnormalities in the basolateral
amygdala induced by an animal model of schizophrenia
in the rat. R. A. VAZQUEZ*, SR; H. TENDILLA-BELTRAN;
S. MENESES-PRADO; G. FLORES. Inst. De Fisiologa
Benemrita Univ. Autnoma De Puebla.
11:00 MMM31 364.28 Repeated ropinirole treatment resulting
in recovery of sensorimotor gating induces FosB in
mouse nucleus accumbens neurons that co-express D1
and D3 dopamine receptors, but not D2 receptors. K. T.
MEYERS; A. M. MAPLE; D. M. WALKER; M. E. CAHILL;
A. L. GALLITANO; E. M. NIKULINA; E. J. NESTLER; R. P.
HAMMER*, Jr. Arizona State Univ., Univ. of Arizona Col. of
Med., Icahn Sch. of Med. at Mount Sinai, Univ. of Arizona
Col. of Med., Univ. of Arizona Col. of Med.
8:00 MMM32
364.29 Gender specific interactions between
the prebiotic B-GOS and the antipsychotic olanzapine: An
analysis of central NMDA receptor subunits and weight gain.
A. KAO*; B. LENNOX; P. W. J. BURNET. Univ. of Oxford.
9:00 MMM33
364.30 Behavioral dissection of the dot-pattern
expectancy task (DPX) in non-human primates. A. L.
DENICOLA*; M. V. CHAFEE. Univ. of Minnesota.

POSTER
365. Anatomical Techniques: Circuit Tracing and Staining
Theme I: Techniques
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

8:00 MMM34
365.01 Quantitative, real-time live-cell analysis
method and reagents for evaluation of cell health in neuronal
cultures. J. N. RAUCH; M. L. BOWE; L. OUPICKA; D. M.
APPLEDORN; D. M. ROCK*. Essen Biosci. Inc, Essen
Biosci. Inc.

Neuroscience 2016|Monday AM|73

Mon. AM

10:00 MMM14 364.11 Pharmacological state-dependent

functional connectivity MRI in conscious nonhuman
primates: Validating a translational model for evaluating
antipsychotics. E. MALTBIE*; K. GOPINATH; D. KEMPF; L.
HOWELL. Emory Univ., Yerkes Natl. Primate Res. Ctr.

8:00 MMM24
364.21 Diencephalic D2 dopamine receptor
expression in a rat model for tardive dyskinesia. S. E.
BACHUS*. Univ. of Maryland Baltimore County.

9:00 MMM35
365.02 A signal amplification system for
fluorescent microscopy. R. LIN*; Q. FENG; Y. SHI; M. LUO.
Natl. Inst. of Biol. Sciences, Beijing.

10:00 MMM36 365.03 Validated Antibody Database: A curated

database of antibodies validated in literature. H. XIE*.
Synatom Res.
11:00 MMM37 365.04 Miniature picosecond diode laser
system for two-photon fluorescence imaging of the mouse
brain. R. D. NIEDERRITER; B. N. OZBAY; G. L. FUTIA;
D. RESTREPO*; E. A. GIBSON; J. T. GOPINATH. Univ.
of Colorado Boulder, Univ. of Colorado Anschutz Med.
Campus, Univ. of Colorado Anschutz Med. Campus, Univ. of
Colorado Boulder.
8:00 MMM38
365.05 Determining the contributions of cell and
myelin densities to diffusion magnetic resonance imaging
(DMRI) parameters in the cortex of squirrel monkey using
quantitative histology. V. JANVE*; K. SCHILLING; Y. GAO;
B. A. LANDMAN; I. STEPNIEWSKA; A. W. ANDERSON.
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.
9:00 MMM39
365.06 A whole-brain imaging platform for
fast identifying molecular phenotype in specific neural
circuit. J. YUAN*; T. JIANG; B. LONG; T. XU; Q. LUO; H.
GONG. HUAZHONG UNIVERSITY OF SCIENCE AND
TENCHNOLOGY.
10:00 MMM40 365.07 Semiautomated quantification of
Toxoplasma- CNS host cell interactions. C. J. POTTER*; O.
A. MENDEZ; T. BELLO; M. VALDEZ; E. G. FERNANDEZ;
T. P. TROUARD; A. A. KOSHY. Univ. of Arizona, Univ. of
Arizona, Univ. of Arizona, Univ. of Arizona.
11:00 MMM41 365.08 Axonal divergence of noradrenergic locus
coeruleus neurons that innervate discrete terminal fields. D.
J. CHANDLER*; N. W. PLUMMER; B. D. WATERHOUSE; P.
JENSEN. Drexel Univ. Col. of Med., Natl. Inst. of Envrn. Hlth.
Sci., Rowan Univ. Sch. of Med.
8:00 MMM42
365.09 Ex vivo retrograde transport in rat
cortex: A model for human cortical connectivity. A.
KSENDZOVSKY*; A. S. TOLPYGO; S. WALBRIDGE; J. S.
DIAMOND; D. D. FERRANTE; A. CUMMINS; J. D. HEISS;
J. KAPUR; P. P. MITRA; K. A. ZAGHLOUL. Natl. Inst. of Hlth.
Office of Intramural, Cold Spring Harbor Lab., NIH, Univ. of
Virginia.
9:00 MMM43
365.10 Adeno-associated virus injection to rat
motor cortex for fluorescent tracing of the corticospinal tract:
Effects of survival time and delivery method. H. PARK*; J. B.
CARMEL. Burke Med. Res. Inst., Weil Cornell Med.

10:00 MMM48 365.15 Room temperature subdissection of

rodent brain possible following heat inactivation. K. SKOLD*;
L. SEGERSTRM; M. BORN; I. NYLANDER. Denator AB,
Addiction & Behavior.

POSTER
366. Transsynaptic Tracing
Theme I: Techniques
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 MMM49
366.01 Wiring transmission in the serotonergic
system. A. BERTERO*; A. BIFONE; M. PASQUALETTI.
Univ. of Pisa, Italian institute of technology.
8:00 DP10 366.02 (Dynamic Poster) High resolution and
high field diffusion MRI in the visual system of primates. J.
R. KORENBERG*; O. ABDULLAH; L. DAI; J. TIPPETS; M.
NAVAS-MORENO; M. BURBACK; A. ANGELUCCI; E. HSU;
S. JOSHI. Univ. of Utah, Univ. of Utah, Univ. of Utah, Univ. of
Utah, Univ. of Utah, Univ. of Utah/Moran Eye Ctr.
10:00 MMM50 366.03 Non-human primate white matter
anatomy: Klingler fiber dissection study. T. DECRAMER*;
J. VAN LOON; P. JANSSEN; T. THEYS. KU Leuven, KU
Leuven.
11:00 MMM51 366.04 High throughput imaging of motor
system connectivity in the mouse brain. S. GOKHALE*; K.
POINSATTE; S. MIRZA; D. M. RAMIREZ; X. KONG; E. J.
PLAUTZ; M. P. GOLDBERG. UT Southwestern Med. Ctr.
8:00 MMM52
366.05 An improved viral method to overcome
viral tropisms for retrograde labelling of neurons. S. LI*; A.
VAUGHAN; A. KEPECS. Cold Spring Harbor Lab.
9:00 MMM53
366.06 Transgenic expression of rabies
glycoprotein in mouse hind limb muscle increases the
efficiency of motor pool infection by SADB19dG rabies
virus. L. GOMEZ PEREZ*; R. W. GRIFFITH; F. J. ALVAREZ.
Emory Univ.

POSTER
367. Staining, Tracing, and Imaging Techniques: Novel
Probes
Theme I: Techniques
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

10:00 MMM44 365.11 Mapping neocortical visual circuits by

labeling neurons with unique hues using HSV-1 vectors
expressing Brainbow. A. I. GELLER*; G. ZHANG; O. CHAO;
H. ZHAO; H. CAO; X. LI. LSUHSC.
11:00 MMM45 365.12 Investigating small intestine
neuromuscular anatomy using optical imaging. M. AHMED*;
Y. BAI; J. GOMES; J. C. RAMELLA-ROMAN; R. JUNG.
Florida Intl. Univ.
8:00 MMM46
365.13 Stereology of the substantia nigra pars
compacta comparing totalnumbers of tyrosine hydroxylase
negative neurons to tyrosine hydroxylasepositive neurons in
3 different mouse models. S. O. AHMAD*; E. SCHLEIF. St.
Louis Univ., St. Louis Univ.

8:00 MMM54
367.01 Development of methods for longitudinal
imaging of DREADDs in vivo. J. L. GOMEZ*; L. A.
RODRIGUEZ; R. ELLIS; M. MICHAELIDES. Natl. Inst. on
Drug Abuse.
9:00 MMM55
367.02 Novel human nerve binding peptides for
fluorescence guided surgery. D. V. HINGORANI*. Univ. of
California San Diego.
10:00 MMM56 367.03 Characterization of a transgenic mouse
expressing fluorophores in neurons, microglia, astrocytes,
and oligodendrocytes. J. GAIRE; H. C. LEE; S. CURRLIN; K.
J. OTTO*. Univ. of Florida, Purdue Univ.

9:00 MMM47
365.14 In vivo MRI overestimates amygdala
damage following ibotenic acid lesions in rhesus monkeys.
B. M. BASILE*; E. C. FIUZAT; C. L. KARASKIEWICZ; E. A.
MURRAY. Natl. Inst. of Mental Health, NIH.

11:00 MMM57 367.04 Fluorogen-activating peptide tagged

neuroligin (FAP-NL), a powerful new tool for high-throughput
synapse identification and connectomics. D. A. KULJIS*;
M. T. MATSUSHITA; T. A. SPIX; C. A. TELMER; M. P.
BRUCHEZ; A. L. BARTH. Carnegie Mellon Univ., Carnegie
Mellon Univ., Carnegie Mellon Univ.

74 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

8:00 MMM58
367.05 Development of a PET probe
targeting P2X7 receptor for imaging neuroinflammation.
M. SHUKURI*; K. KATO; T. KUMAMOTO; N. IHARA; T.
HANAKAWA. Showa Pharmaceut. Univ., Natl. Ctr. of Neurol.
and Psychiatry, Musashino Univ., Univ. of Tokyo.
9:00 MMM59
367.06 High-performance probes for two-photon
phosphorescence lifetime microscopy (2PLM) of oxygen. S.
VINOGRADOV*; T. ESIPOVA; M. BARRETT; B. WEBER.
Univ. of Pennsylvania, Univ. of Pennsylvania, Univ. of Zurich.
10:00 MMM60 367.07 Identification and characterization of
hippocampal neurons that encode novel environments using
a genetically-encoded optical voltage sensor. Y. MA*; P. O.
BAYGUINOV; M. B. JACKSON. Univ. of Wisconsin Madison,
Univ. of Wisconsin Madison.

8:00 MMM62
367.09 Brain cell type mapping by in situ
sequencing. X. QIAN*; T. HAULING; L. MAGNO; A.
MUOZ MANCHADO; P. LNNERBERG; N. SKENE;
M. PACHITARIU; N. KESSARIS; S. LINNARSSON; J.
HJERLING-LEFFLER; K. D. HARRIS; M. NILSSON.
Stockholm Univ., Univ. Col. London, Karolinska Institutet.
9:00 NNN1 367.10 Molecular classification of CA1
interneurons by single-cell and in-situ RNA sequencing.
K. D. HARRIS*; X. QIAN; T. HAULING; L. MAGNO; P.
LONNERBERG; A. MUNOZ MANCHADO; N. SKENE;
M. PACHITARIU; N. KESSARIS; S. LINNARSSON; J.
HJERLING-LEFFLER; M. NILSSON. Univ. Col. London,
SciLifeLab, Karolinska Institutet.
10:00 NNN2 367.11 Mapping brain-wide corticocortical
projections at single-cell resolution by sequencing of
barcoded RNA. L. HUANG*; J. M. KEBSCHULL; A. M.
ZADOR. Cold Spring Harbor Lab.
11:00 NNN3 367.12 High-throughput mapping of single
neuron projections by sequencing of barcoded RNA. J.
M. KEBSCHULL*; L. HUANG; P. GARCIA DA SILVA; A. P.
REID; I. D. PEIKON; D. F. ALBEANU; A. M. ZADOR. Cold
Spring Harbor Lab.

8:00 NNN4 367.13 Cellular analysis of ErbB4 isoforms in

CNS neurons using a next generation in situ hybridization
technology for single exon detection. L. M. ERBEN*; M. HE;
M. XIAO-MING; E. PARK; A. BUONANNO. Section on Mol.
Neurobiology, NICHD, NIH, Univ. of Bonn, Advanced Cell
Diagnostics.
9:00 NNN5 367.14 Vascular neuroanatomy of the short-tailed
fruit bat, Carollia perspicillata. R. ORMAN*; T. RAGAN; R.
KOLLMAR; M. STEWART. SUNY Downstate Med. Ctr.,
Tissue Vision, Inc., SUNY Downstate Med. Ctr.
10:00 NNN6 367.15 Crossing the Styx: An integrative pipeline
translating post mortem findings to in vivo MRI space. N.
JUDD*; A. ALKEMADE; M. KEUKEN; G. DE HOLLANDER;
R. BALESAR; D. SWAAB; B. FORSTMANN. Univ. of
Amsterdam, Univ. of Amsterdam, Netherlands Inst. for
Neurosci.
11:00 NNN7 367.16 Methods for automated neuroanatomical
annotations from zebrafish gene expression data. S.
PAJEVIC*; G. D. MARQUART; K. M. TABOR; D. E. DALLE
NOGARE; T. MUELLER; H. A. BURGESS. NIH, Kansas
State Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

9:00 NNN9 367.18 Estimation of stage-specific progression

in Th17 cell-induced adoptive transfer experimental
autoimmune encephalomyelitis (EAE) using in vivo
fluorescence imaging analysis. S. LEE*; H. CHO; Y. SHIN;
H. SALAPA; M. LEVIN. Univ. of Tennessee.
10:00 NNN10 367.19 Novel method for quantitative
assessment of cortical lesion location and size. J. A.
MASIS*; M. JSCH; D. MANKUS; D. D. COX. Harvard
Univ., Harvard Univ.
11:00 NNN11 367.20 Real-time in vivo electrochemical
measurement of local drug concentrations by using diamond
microelectrode. G. OGATA*; Y. ISHII; K. ASAI; Y. SANO;
F. NIN; T. YOSHIDA; T. HIGUCHI; K. HORI; K. MAEDA;
S. KOMUNE; M. TAKAI; H. KUSUHARA; Y. EINAGA; H.
HIBINO. Niigata Univ. Sch. of Med., Niigata Univ., Keio Univ.,
The Univ. of Tokyo, Kyushu Univ., Yuaikai Oda Hosp., The
Univ. of Tokyo, JST-ACCEL, AMED-CREST, AMED.
8:00 NNN12 367.21 Physiological activity monitoring with
conductive polymer based silk electrode. Y. TAKIZAWA; H.
TAKAHASHI; M. NISIZAWA; K. TORIMITSU*. Tohoku Univ.
9:00 NNN13 367.22 In vivo zinc imaging in mouse brain using
two-photon microscopy. Z. NANNAN; S. DING*. Univ. of
Missouri, Univ. of Missouri.
10:00 NNN14 367.23 Nonlinear regression of in vitro fast scan
cyclic voltammetry data for extraction of neurochemical
biomarkers. H. PARK*; B. S. PAEK; J. K. TREVATHAN; K. A.
LUDWIG; J. L. LUJAN; K. H. LEE. Mayo Clin.
11:00 NNN15 367.24 Development of a micro-immunoelectrode
for rapid detection of -synuclein in vivo. C. M. YUEDE*; H.
LEE; H. M. EDWARDS; M. XIONG; C. LI; J. R. CIRRITO.
Washington Univ., Florida Intl. Univ.
8:00 NNN16 367.25 A new reporter for copper (II) detects
specifically the lysosome compartment in live cells. M.
GIUFFRIDA*; G. TRUSSO; C. SATRIANO; S. ZIMBONE; A.
COPANI; G. TOMASELLI; E. RIZZARELLI. Natl. Council of
Res. (CNR), Univ. of Catania, Univ. of Catania.

POSTER
368. Models of Excitability: Networks and Single Neurons I
Theme I: Techniques
Mon. 8:00 AMSan Diego Convention Center,Halls B-H
8:00 NNN17 368.01 Consequences of sparse activity in the
ento-dentate-CA3 pathway: Investigations using a largescale, biologically realistic, computational model of the
hippocampus. G. J. YU*; T. W. BERGER; D. SONG. USC.
9:00 NNN18 368.02 Simulated effects of acetylcholinesterase
inhibitors on hippocampal cell network activity. A.
MERGENTHAL*; J. C. BOUTEILLER; E. HU; T. W.
BERGER. USC.
10:00 NNN19 368.03 A model of axonal branching for medium
and long range fibers in a multi-scale model of hippocampal
tissue. C. S. BINGHAM*; J. BOUTEILLER; D. SONG; T. W.
BERGER. USC.

Neuroscience 2016|Monday AM|75

Mon. AM

11:00 MMM61 367.08 Functional innervation of hilar mossy cells

revealed using a genetically-encoded hybrid optical voltage
sensor. P. BAYGUINOV*; Y. MA; M. B. JACKSON. Univ. of
Wisconsin, Univ. of Wisconsin, Univ. of Wisconsin.

8:00 NNN8 367.17 Predictive sub-voxel fiber tractography

of the primate limbic system using high-resolution confocal
to diffusion-tensor MRI maps. A. VAN HOEK*; L. DAI;
I. YEUNG; O. ABDULLAH; E. HSU; S. JOSHI; J. R.
KORENBERG. Univ. of Utah, Univ. of Utah, Univ. of Utah,
Univ. of Utah, Univ. of Utah.

11:00 NNN20 368.04 A detailed computational model

of mechanisms underlyingcalcium regulation and
dysregulations in glutamatergic postsynaptic spines. E. Y.
HU*; A. MERGENTHAL; J. C. BOUTEILLER; D. SONG; T.
W. BERGER. USC.
8:00 NNN21 368.05 A closed-loop multi-scale simulation
paradigm for accurate modeling of electrical stimulation in
hippocampus. P. HENDRICKSON*; K. LOIZOS; A. GILBERT;
D. SONG; G. LAZZI; T. W. BERGER. USC, Univ. of Utah.
9:00 NNN22 368.06 Extracellular potentials generated by
axon bundles. T. MCCOLGAN*; P. T. KUOKKANEN; J.
LIU; H. WAGNER; C. E. CARR; R. KEMPTER. HumboldtUniversitt Zu Berlin, Univ. of Maryland, RWTH Aachen.
10:00 NNN23 368.07 Model-based control of spreading
depression by applied electric field in spatially extended
neuron-glia model. S. VAN WERT*; S. J. SCHIFF. The
Pennsylvania State Univ.
11:00 NNN24 368.08 Impact of dendritic morphology on
functional subunits in dendrites. S. HONG*; A. TAKASHIMA;
E. DE SCHUTTER. Okinawa Inst. of Sci. and Technol.
8:00 NNN25 368.09 Explicitly incorporating dendritic spines
of different morphological classes into a multi-compartment
model of a pyramidal neuron. S. E. MOTLEY*; T. HOANGTRONG; J. KOZLOSKI; J. H. MORRISON; R. KERR. Icahn
Sch. of Med. At Mount Sinai, Computat. Biol. Center, IBM
Res. Division, IBM T. J. Watson Res. Ctr., Icahn Sch. of Med.
at Mount Sinai, Univ. of California Davis, IBM Res. Australia.
9:00 NNN26 368.10 Atomistic study of the interaction PPAR-
and PPAR-/ with its agonists: A computational study.
A. MORALES*; F. PREZ-SEVERIANO; A. ZAMORANOCARRILLO. THE NATIONAL INSTITUTE OF NEUROLOGY
AND NEUROSURGERY, ENMH-IPN.

9:00 NNN34 368.18 Tms-induced neuronal activation- a

computational study. H. SEO*; N. SCHAWORONKOW;
J. TRIESCH; S. JUN. Gwangju Inst. of Sci. and Technol.,
Frankfurt Inst. for Advanced Studies.
10:00 NNN35 368.19 Learning with discrete representations
using continuous chaotic. neural populations. S. HAXBY*; E.
PETERSON. Univ. California, San Diego, UCSD.
11:00 NNN36 368.20 Effects of synaptic transmission
probability on functional network structure. M. BUDAK*; M.
R. ZOCHOWSKI. Univ. of Michigan Ann Arbor.
8:00 NNN37 368.21 Dynamics of rate-model networks with
separate excitatory and inhibitory populations. M. STERN*;
L. ABBOTT. Hebrew Univ., Columbia Univ.
9:00 NNN38 368.22 Cortical circuit organized through the
log-STDP leads to an internal representation of sensory
experience during development: A model study. T.
MATSUMURA; T. YUASA; S. KANG*. Yamagata Univ., Lab.
for Neural Circuit Theory, Brain Sci. Institute, RIKEN.

10:00 NNN39 368.23 Quasi cycle induced cross frequency. R.

FARHOUDI*; A. ABBASIAN; M. FOTOUHI. Sharif Univ., Inst.
For Res. In Fundamental Sci., Shrif Univ. of Technol.

11:00 NNN40 368.24 PyPN- a tool for simulating peripheral

nerves. C. H. LUBBA*; Y. LE GUEN; S. JARVIS; N. JONES;
S. SCHULTZ. Imperial Col. London, Imperial Col. London,
Imperial Col. London, Imperial Col. London.

POSTER
369. Computational Tools for Human Data I
Theme I: Techniques
Mon. 8:00 AMSan Diego Convention Center,Halls B-H

368.11 The

10:00 NNN27
substances transportation in the
brain extracellular space can be modulated with External
Stimulation. Z. TENG*; X. GUAN; Q. HE; Y. FU; H. HAN.
Peking Univ. Third Hosp.
11:00 NNN28 368.12 A novel method to create an in vitro
dynamic blood brain barrier model. P. MIRANDA-AZPIAZU;
G. JOSE; S. PANAGIOTOU; S. SAHA*. Univ. of Leeds, Univ.
of Liverpool.
8:00 NNN29 368.13 A mathematical model of ischemic stroke.
M. SARKAR*; C. CONTE; R. LEE; D. H. TERMAN. Ohio
State Univ.
9:00 NNN30 368.14 A bayesian hierarchical model for the
biophysical properties of melanopsin. B. V. EHINGER*;
D. EICKELBECK; K. SPOIDA; S. HERLITZE; P. KNIG.
Osnabrck Univ., Ruhr-University Bochum, Univ. Med. Ctr.
Hamburg Eppendorf.
10:00 NNN31 368.15 Determinants of spontaneous
synchronized network activity in primary neuronal cultures:
A computational approach. D. LONARDONI*; H. AMIN; A.
MACCIONE; T. NIEUS; L. BERDONDINI. Inst. Italiano Di
Tecnologia.

8:00 NNN41 369.01 The capacity of information integration of

band is associated with non-responsiveness. H. KIM*; U.
LEE; V. PHILLIP; B. TARIK; J. LEE; G. MASHOUR. Univ. of
Michigan.
9:00 NNN42 369.02 Reintegration of regional brain functions
during gradual and abrupt brain recoveries after a major
perturbation. U. LEE*; M. KIM; G. MASHOUR. Univ. of
Michigan Med. Sch., Ctr. for Consciousness Sci., Pohang
Univ. of Sci. and Technol., Neurosci. Grad. Program.
10:00 NNN43 369.03 Sparse-tensor framework for
computational analysis of brain connectomes. C. F.
CAIAFA*; F. PESTILLI. Indiana Univ. / CONICET, Indiana
Univ.
11:00 NNN44 369.04 Studying intersubject networks and
standard graph measures during dynamic threat processing.
M. NAJAFI*; L. PESSOA. Univ. of Maryland.
8:00 NNN45 369.05 A quantitative systems pharmacology
platform of brain and serum progranulin (PGRN) to
investigate targets in frontotemporal dementia (FTD). C.
FRIEDRICH*; M. M. PRYOR. www.rosaandco.com.

11:00 NNN32 368.16 Network dynamics in early infantile

epileptic encephalopathies. R. E. ROSCH*; F. MOELLER;
T. BALDEWEG; G. BAIER. Univ. Col. London, Univ. Col.
London, Great Ormond Street Hosp. for Children NHS Fndn.
Trust, Univ. Col. London, Univ. Col. London.

9:00 NNN46 369.06 Developing patient-specific, in-situ

computational models using intraoperative ultrasound.
I. CUBEROVIC*; M. A. SCHIEFER; J. ANDERSON; D.
J. TYLER. Case Western Reserve Univ., Case Western
Reserve Univ., Louis Stokes Cleveland VA Med. Ctr.

8:00 NNN33 368.17 From callosal axonal injury to

neurobehavioral dysfunction: Computational modeling of
cortical network dynamics in mild traumatic brain injury. J.
CUI*; L. NG; V. VOLMAN. L-3 Communications/Applied
Technologies, Inc.

10:00 NNN47 369.07 Fear- driven changes of mind in a

decision-making neural network model. P. A. GONZALEZPARRA*; J. HURTADO-LOPEZ; D. F. RAMIREZ-MORENO.
Univ. Autonoma de Occidente, Univ. Autonoma de
Occidente.

76 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

11:00 NNN48 369.08 A hybrid computational model for

optimizing neuromuscular electrical stimulation of peripheral
nerve fibers. P. D. ARGUELLO*; I. PEREZ; L. TONG; D. S.
WON. California State University, Los Angeles.
8:00 NNN49 369.09 Diagnostic prediction of autism in restingstate functional mri using conditional random forest. B. T.
FAIRES*; C. A. NASAMRAN; A. JAHEDI; C. CHEN; J. FAN;
R. MLLER. San Diego State Univ., San Diego State Univ.,
San Diego State Univ., San Diego State Univ.
9:00 NNN50 369.10 Resting state fMRI connectome
differentiating autism from typical development. A. JAHEDI*;
V. MEENI; A. LINKE; S. NAIR; C. P. CHEN; B. A. BAILEY;
R. MLLER. San Diego State Univ., San Diego State Univ.,
SDSU Brain Imaging Develop. Lab., San Diego State Univ.,
San Diego State Univ.

Mon. AM

10:00 NNN51 369.11 Explicitly linking regional activation and

functional connectivity: Community structure of weighted
networks with continuous annotation. A. MURPHY*; S. GU;
N. F. WYMBS; S. T. GRAFTON; D. S. BASSETT. Univ. of
Pennsylvania, Univ. of Pennsylvania, Univ. of California
Santa Barbara.
11:00 NNN52 369.12 Interrogating temporal functional cortical
connectivity patterns with source level narrowband induced
activity and deep recursive neural networks. Z. HARPER;
C. M. WELZIG*. Med. Col. of Wisconsin, Med. Col. of
Wisconsin.
8:00 OOO1 369.13 Video compression applied to 10-TBsized volumetric brain images: A preliminary study. A. LI*; Y.
CHEN; Y. LI; Q. LUO; H. GONG. Huazhong Univ. of Sci. and
Technol.

9:00 OOO2 369.14 Prediction of EMG trajectory using

stochastic dynamical operators and neural recordings. M.
ABOLFATH-BEYGI*; T. D. SANGER; S. F. GISZTER. USC,
Childrens Hosp. of Los Angeles, Drexel Univ. Col. of Med.
10:00 OOO3 369.15 Hyperalignment improves between
subject classification of fmri brain activity during motor
imagery. S. M. AL-WASITY*; A. VUCKOVIC; S. VOGT; Y.
KOIKE; F. POLLICK. Univ. of Glasgow, Lancaster Univ.,
Tokyo Inst. of Technol., Univ. of Glasgow.
11:00 OOO4 369.16 Sensitivity of the human brain
structural networks to brain atlases, weighting methods,
and tractography parameters. K. WEI*; M. CIESLAK; C.
GREENE; S. T. GRAFTON; J. M. CARLSON. Univ. of
California, Santa Barbara, Univ. of California, Santa Barbara,
Univ. of California, Santa Barbara.
8:00 OOO5 369.17 Symmetric Streamline Normalization: A
simple, accurate, and fast approach to spatially normalize
tractography data. C. A. GREENE*; M. CIESLAK; S.
GRAFTON. UC Santa Barbara, UC Santa Barbara, UC
Santa Barbara.
9:00 OOO6 369.18 Non-invasive skull conductivity estimation
and EEG source localization. Z. AKALIN ACAR*; S.
MAKEIG. Univ. of California San Diego.
10:00 OOO7 369.19 The posterior associative white matter
network between the human temporal and parietal brain
lobes. D. BULLOCK*; H. TAKEMURA; C. CAIAFA; F.
PESTILLI. Indiana Univ.- Bloomington, Ctr. for Information
and Neural Networks (CiNet), [email protected],
Osaka Univ., Inst. Argentino de Radioastronomia CCT La
PlataCONICET, Indiana Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday AM|77

Monday PM
SYMPOSIUM
San Diego Convention Center
371. Mechanisms of Object Organization in the Visual
CortexCME
Mon. 1:30 PM- 4:00 PM6F
Chair: R. VON DER HEYDT
How does the visual cortex organize elementary features
to objects? This symposium will provide a comprehensive
picture of recent findings on object-based coding at low
and intermediate cortical levels (V1-V2-V4), its possible
mechanisms, and its hypothetical role in vision. The session
will also question where the organizing influence comes
from, what its time course is relative to other stages of visual
processing, and how the organizing influence relates to
object individuation, awareness, recognition, and selective
attention.

3:20 372.05 Use of noninvasive spinal stimulation combined

with exoskeleton training to facilitate recovery of locomotor
function. P. GAD. UCLA.
3:55 372.06 Closing Remarks.
SYMPOSIUM
San Diego Convention Center
373. Advances in Noninvasive Brain Stimulation Along the
Space-Time ContinuumCME
Mon. 1:30 PM- 4:00 PM6B
Chair: C. GODDARD
Co-Chair: S. H. LISANBY
Noninvasive brain stimulation (NBS) is a key tool for probing
neural circuit function and is being tested to ameliorate
a host of neurological and psychiatric conditions. Recent
studies suggest that specific spatial and temporal NBS
parameters are critical for achieving effective modulation of
intact neural circuitry. This symposium will highlight several
studies that explore the importance and physiological
relevance of specific spatial or temporal patterns using
different forms of NBS.

1:30 371.01 Introduction.

1:35 371.02 Figuring out objects from background and the
modulation by fixational saccades. H. SLOVIN. Gonda Brain
Res. Ctr.
2:10 371.03 Parallel processing of surfaces and borders in early
visual cortex. A. V. MAIER. Vanderbilt Univ.
2:45 371.04 Border-ownership coding and the emergence of
early object representations in the visual cortex. R. VON
DER HEYDT. The Johns Hopkins Univ.
3:20 371.05 Segmentation and discrimination of partially
occluded shapes: Insights from visual and frontal cortex. A.
K. PASUPATHY. Univ. of Washington.
3:55 371.06 Closing Remarks.
SYMPOSIUM
San Diego Convention Center
372. Facilitation of Recovery of Motor Function
After Paralysis With Noninvasive Spinal Cord
StimulationCME
Mon. 1:30 PM- 4:00 PM6A
Chair: V. EDGERTON
This symposium describes changes of the physiological
state of spinal networks using noninvasive spinal cord
stimulation combined with step training in an exoskeleton.
The speakers will demonstrate recovery of voluntary
movement, posture, and locomotor function in individuals
that have been paralyzed for over one year, a time which
historically has been considered beyond the critical period
for motor recovery. A subject that has received these
interventions will share his experiences.

1:30 373.01 Introduction.

1:35 373.02 Optimizing seizure therapy: Sculpting the temporal

and spatial aspects of therapeutic seizures. S. H. LISANBY.
Natl. Inst. of Mental Hlth.

2:10 373.03 Shaping the TMS waveform for selective

neural recruitment and enhanced neuromodulation. A.
PETERCHEV. Duke Univ.

2:45 373.04 From biophysics to treatment: Rational design of

non-invasive brain stimulation to modulate thalamo-cortical
oscillations. F. FROHLICH. Univ. of North Carolina.

3:20 373.05 Informing clinical transcranial brain stimulation

spatial and temporal parameters by preclinical research in
vivo and in vitro. A. ROTENBERG. Boston Childrens Hosp.
3:55 373.06 Closing Remarks.
MINISYMPOSIUM
San Diego Convention Center
374. Casting a Wide Net: Role of Perineuronal Nets in Neural
PlasticityCME
Mon. 1:30 PM- 4:00 PM29D
Chair: B. A. SORG
Perineuronal nets (PNN) are specialized extracellular
matrices surrounding certain central nervous system (CNS)
neurons that stabilize synapses during development.
Removal of PNNs in adults can restore juvenile-like
plasticity. At this minisymposium, speakers will describe
details of the assembly and specific components of PNNs,
and the role PNNs play in schizophrenia, bipolar disorder,
aging, Alzheimers disease, and in plasticity associated with
memory and drugs of abuse.

1:30 372.01 Introduction.

1:35 372.02 Recovery of voluntary movement and postural

control after paralysis. Y. GERASIMENKO. UCLA.
2:10 372.03 Transcutaneous spinal cord stimulation
for modification of spasticity and motor control. U.
HOFSTOETTER. Med. Univ. of Vienna.

2:45 372.04 Modeling of intensity and spatial distribution of

currents using noninvasive spinal stimulation. J. BURDICK.
Caltech.

78 | Society for Neuroscience

1:30 374.01 Introduction.

1:35 374.02 Targeting perineuronal nets to restore function after

damage, neurodegeneration and ageing. J. W. FAWCETT.
Cambridge Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:55 374.03 The molecular complexity of perineuronal net as a

controller in CNS plasticity. J. KWOK. Univ. of Leeds.
2:15 374.04 Cerebellar perineuronal nets in drug addiction:
Brain tattoos or temporary stickers? M. MIQUEL. Univ.
Jaume I, Avenida Sos Baynat.

MINISYMPOSIUM
San Diego Convention Center
376. Mammalian Nervous System Cell Types: CNS Diversity
Through the Lens of Single-Cell RNA Sequencing (RNAseq)CME
Mon. 1:30 PM- 4:00 PM6E

2:35 374.05 Perineuronal nets in tatters: Current findings in

psychiatric disorders. S. BERRETTA. Harvard Med. Sch.

Chair: B. TASIC
The brain contains a myriad of highly specialized cells,
but comprehension of the gene expression programs that
produce this cell-type diversity is incomplete at best. This
session highlights pioneering work from multiple groups
using single-cell RNA-seq approaches to characterize cells
from the developing and adult CNS in mice and humans.
These studies lay the groundwork for a new taxonomy
of nervous system cells and create new opportunities for
investigating CNS function and development.

2:55 374.06 Chondroitin 6-sulfation regulates perineuronal

net formation and neural plasticity. H. KITAGAWA. Kobe
Pharmaceut. Univ.
3:15 374.07 Perineuronal net contribution to cocaine-induced
plasticity. J. M. BLACKTOP. Washington State Univ.
3:35 374.08 Closing Remarks.
MINISYMPOSIUM
San Diego Convention Center

1:30 376.01 Introduction.

375. Object Encoding, Semantic Representation, and Memory

Formation by Single Neurons in the Human Medial
Temporal LobeCME

1:35 376.02 Cellular diversity of human neocortical germinal

zones. A. POLLEN. Univ. of California, San Francisco.

Mon. 1:30 PM- 4:00 PM28A

This minisymposium will compare and contrast recent results

examining object encoding, semantic representation, and
memory formation by single neurons in the human medial
temporal lobe. Speakers from different single-unit recording
centers across the world will examine the level of sparsity
present in the representations, whether they exclusively
reflect semantic properties of the stimuli, and the role of
these representations in memory encoding, retrieval, and
consolidation.
1:30 375.01 Introduction.
1:35 375.02 Effects of non-semantic stimulus properties on
the responses of medial temporal lobe neurons. P. N.
STEINMETZ. Nakamoto Brain Res. Inst.
1:55 375.03 Sparse coding of emotions and concepts and
volitional control in human single neurons. M. CERF.
Northwestern Univ.
2:15 375.04 Learning of anticipatory responses in single
neurons of the human MTL. L. REDDY. Ctr. Natl. de la
Recherche Scientifique.
2:35 375.05 Stimulus-selective, sparsely coded episodic
memory and non-specific novelty detection in single units of
the human hippocampus. J. T. WIXTED. UCSD.
2:55 375.06 Single-neuron representation of location in human
spatial navigation and memory. J. JACOBS. Columbia Univ.
3:15 375.07 Sparse and not-so-sparse semantic coding in the
human MTL and its role in memory consolidation during
sleep. F. MORMANN. Univ. of Bonn.
3:35 375.08 Closing Remarks.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:15 376.04 A census of cell types across the adult mouse brain
by high-throughout single-cell RNA-seq. E. MACOSKO.
Broad Inst. of MIT and Harvard.
2:35 376.05 Cellular taxonomy of visual thalamus and cortex
by single cell transcriptomics. B. TASIC. Allen Inst. For Brain
Sci.
2:55 376.06 Telencephalic interneurons: A single cell
transcriptome comparison. A. B. MUOZ MANCHADO.
Karolinska Institutet.
3:15 376.07 Electrophysiological, transcriptomic and
morphologic profiling of single neurons using patch-seq. C.
R. CADWELL. Baylor Col. of Med.
3:35 376.08 Closing Remarks.
LECTURE
San Diego Convention Center
377.

ALBERT AND ELLEN GRASS LECTURE- Natural

Products as Probes of the Pain Pathway: From
Physiology to Atomic StructureCME
Mon. 3:15 PM- 4:25 PMBallroom 20
Speaker: D. J. JULIUS, Univ. of California, San Francisco.
The study of somatosensation, nociception, and pain has
undergone a revolution with the application of molecular
genetic, biochemical, and biophysical methods. With these
approaches, investigators have begun to identify molecules,
cells, and circuits that underlie stimulus detection,
perception, and maladaptive processes. Together, these
studies are providing an intellectual and technical foundation
for developing new classes of analgesic agents.

Neuroscience 2016|Monday PM|79

Mon. PM

Chair: F. MORMANN
Co-Chair: P. N. STEINMETZ

1:55 376.03 Reconstructing neurogenesis using singlecell RNA-seq. B. TREUTLEIN. Max-Planck-Institute for
Evolutionary Anthrop.

LECTURE
San Diego Convention Center
378. PRESIDENTIAL SPECIAL LECTURE- Toward Wholebody Connectome in DrosophilaCME
Mon. 5:15 PM- 6:25 PMBallroom 20
Speaker: A. CHIANG, Natl. Tsing Hua University, Taiwan.
Support contributed by: Janssen Research & Development
LLC
Our brains receive information from sensory neurons
about our external environment and internal organs. To
understand how the brain processes information and
initiates motor outputs, scientists are constructing complete
wiring diagrams called connectomes that map all neural
connections in the brain and body. Taking Drosophila
melanogaster as an example, this lecture will address
challenges in building whole-body connectomes and how
that knowledge may help us better understand normal
function and treat disease.

NANOSYMPOSIUM
379. Axon and Dendrite Development and Regeneration
Theme A: Development
Mon. 1:00 PMSan Diego Convention Center,30B
1:00 379.01 Enhancing neuronal activity by melanopsin/GPCR
signaling promotes axon regeneration in the adult CNS. K.
LIU*; C. YANG; X. WANG. HKUST.
1:15 379.02 Vangl2 directs stereotyped turning of peripheral
neuronal processes during development of the mouse
cochlea. M. R. DEANS*; S. R. GHIMIRE. Univ. of Utah, Univ.
of Utah.
1:30 379.03 Sonic Hedgehog is a midline switch for Wnt/planar
cell polarity signaling in commissural axons. K. ONISHI*; Y.
ZOU. Univ. of California San Diego.
1:45 379.04 Netrin1 establishes short-range axon
guidance boundaries in the developing spinal cord. S.
G. VARADARAJAN*; J. H. KONG; K. D. PHAN; C. S.
PANAITOF; J. CARDIN; A. KANIA; B. G. NOVITCH; S. J.
BUTLER. UCLA, Univ. of Nebraska, Inst. de Recherches
Cliniques de Montreal, UCLA.
2:00 379.05 A gradient of Reelin regulates axonal lamination in
the vertebrate visual system. F. DEL BENE*; V. DI DONATO;
T. AUER; K. DUROURE; J. CONCORDET. Inst. Curie- Ctr.
de Recherche, Musum Natl. dHistoire Naturelle.

NANOSYMPOSIUM

2:15 379.06 MAP7 regulates microtubule bundles during

development of axon collateral branches. S. TYMANSKYJ*;
B. YANG; L. MA. Thomas Jefferson Univ.
2:30 379.07 Heterogeneity of the axon initial segment in
interneuron and pyramidal cells of rat visual cortex. F.
HOEFFLIN; A. JACK; J. BUCHER; C. SCHULTZ; P. WAHLE;
M. ENGELHARDT*. Univ. Heidelberg, Med. Fac. Mannheim,
Ruhr-University Bochum, Univ. Heidelberg, Med. Fac.
Mannheim, Univ. Heidelberg, Med. Fac. Mannheim.
2:45 379.08 Hierarchical ordering of molecular controls over
corticospinal motor neuron segmental targeting: Implications
for evolution of motor control. V. V. SAHNI*; S. SHNIDER; D.
JABAUDON; J. SONG; J. MACKLIS. Harvard Univ.

3:15 379.10 Independent and overlapping ankyrin-B- and

2-spectrin-based mechanisms control axonal organelle
transport and development of long axonal tracts. D. N.
LORENZO*; V. BENNETT; A. BADEA. Duke Univ., Howard
Hughes Med. Inst., Duke Univ.
3:30 379.11 EphB2 released via extracellular vesicles, a
contact-independent signaling mechanism in axon guidance.
J. GONG*; R. KRNER; R. KLEIN. Max Planck Insitute of
Neurobio., Max Planck Insitute of Biochem.

NANOSYMPOSIUM
380. Mechanisms and Role of Synaptic Pathology in
Alzheimers Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,24A
1:00 380.01 Copaxone induces macrophage clearance of
amyloid-42 oligomers and preserves synapses in AD
models. M. KORONYO-HAMAOUI*; S. LI; Y. KORONYO; D.
DALEY; E. Y. HAYDEN; J. SHEYN; D. FUCHS; T. TORBATI;
A. RENTSENDORJ; D. B. TEPLOW; K. L. BLACK. CedarsSinai Med. Ctr., Wenzhou Univ., Univ. of California Los
Angeles.
1:15 380.02 ZCCHC17 impairment is a potential disrupter of
neuronal activity in Alzheimers disease. A. F. TEICH*; Z.
TOMLJANOVIC; M. PATEL. Columbia Univ., Columbia Univ.,
Mem. Sloan Kettering Cancer Ctr.
1:30 380.03 Inhibition of mammalian phospholipase D isoform 1
prevents amyloid oligomer driven synaptic dysfunction and
memory deficits in rodents. B. KRISHNAN*; W. ZHANG; G.
TAGLIALATELA. Univ. of Texas Med. Br. At Galveston, Univ.
of Texas Med. Br. At Galveston.
1:45 380.04 NSC-derived exosomes reduce hippocampal
synapses vulnerability to the dysfunctional impact of amyloid
oligomers. M. MICCI*; B. KRISHNAN; W. ZHANG;
E. BISHOP; S. G. KERNIE; C. ANACKER; R. HEN; G.
TAGLIALATELA. UTMB, UTMB, Columbia Univ., Columbia
Univ.
2:00 380.05 The plasticity disrupting activity of A requires
expression of the amyloid precursor protein. Z. WANG*; W.
HONG; A. SERONO; T. WALTER; W. LIU; T. T. OMALLEY;
S. LI; T. YOUNG-PEARSE; D. M. WALSH. Brigham and
Womens Hosp. & Harvard Medcial Sch., Brigham and
Womens Hosp.
2:15 380.06 Microtubule-associated protein is essential for
stress-driven hippocampal pathology. I. SOTIROPOULOS*;
S. LOPES; J. VAZ-SILVA; V. PINTO; C. DALLA; N. KOKRAS;
B. T. BEDENK; M. CZISCH; O. F. X. ALMEIDA; N. SOUSA.
ICVS, Sch. of Hlth. Sciences, Minho Univ., ICVS/3Bs- PT
Government Associate Lab., Dept. of Pharmacology, Med.
Sch. of Athens, Max Planck Inst. of Psychiatry.
2:30 380.07 Optogenetic restoration of disrupted slow
oscillations halts amyloid deposition and restores calcium
homeostasis in an animal model of Alzheimers disease. K.
KASTANENKA*; S. S. HOU; N. SHAKERDGE; R. LOGAN;
D. FENG; S. WEGMANN; J. M. HAWKES; X. CHEN; B. J.
BACSKAI. Massachusetts Gen. Hosp.

3:00 379.09 Developmental regulation of dendritic dynamics

and growth in Drosophila larval visual circuit. C. SHENG*; U.
JAVED; J. YIN; B. QIN; C. LONG; Q. YUAN. NINDS, NIH.

2:45 380.08 Heightened synaptic integrity in elderly with

exceptional memory capacity (SuperAgers). O. MELNDEZFERNNDEZ; L. KUKREJA; S. WEINTRAUB; C. WU*;
E. BIGIO; E. ROGALSKI; M. MESULAM; C. GEULA.
Northwestern Univ., Univ. of California- Irvine Sch. of Medici,
Northwestern Univ.

80 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

NANOSYMPOSIUM
381. Motor Neuron Disease Mechanisms
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,32B

1:00 381.01 Overexpression of the Cdk5 inhibitory peptide

(CIP) in motor neurons delay disease and extend survival
of a mouse model of amyotropic lateral sclerosis. B.
BALACHANDRAN KRISHNAMMA*; S. KESAVAPANY; S.
SKUNTZ; V. SHUKLA; N. AMIN; M. BHASKAR; P. GRANT;
H. PANT. NIH, Singapore University, Singapore, NINDS,
NIH.
1:15 381.02 Preconditioning induced by low doses of L-BMAA
in SOD1-G93A mice modulates the ionic transporter NCX3
leading to a state refractory to ALS. G. PIGNATARO*;
S. ANZILOTTI; G. SIMEONE; A. VINCIGUERRA;
P. BRANCACCIO; P. CEPPARULO; N. GUIDA; L.
ANNUNZIATO. FEDERICO II UNIVERSITY OF NAPLES.
1:30 381.03 Monosynaptic excitatory inputs to spinal
motoneurons are depressed in SOD1-G93A mice, model
of Amyotrophic Lateral Sclerosis (ALS). M. BACZYK; M.
MANUEL; C. MARTINOT; N. DELESTREE; D. ZYTNICKI*.
Paris Descartes Univ.

2:00 381.05 Excitability of adult spinal motor neurons in

the FUS-P525L model of ALS. M. MARTINEZ-SILVA; D.
ZYTNICKI; M. MANUEL*. CNRS / Univ. Paris Descartes.
2:15 381.06 Does it really change? Identifying potential
sources of variability in experimental studies of ALS mouse
models. S. S. DUKKIPATI*; A. CHIHI; R. E. W. FYFFE; S. M.
ELBASIOUNY. Wright State Univ.
2:30 381.07 Loss of tdp-43 contributes to non-coding RNA
mediated toxicity. E. Y. LIU*; J. RUSS; E. LEE. Perelman
Sch. of Med. At Univ. of Pennsylvania.

NANOSYMPOSIUM
382. Neuroinflammation: Neurotoxicity and Protection
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,25A
1:00 382.01 Natural Killer cells target sensory neurons for
degeneration after peripheral nerve injury. A. J. DAVIES*; H.
KIM; J. CHOI; S. BACK; Y. KIM; S. ROH; S. KIM; Y. BAE; H.
NA; A. LATREMOLIERE; M. COSTIGAN; S. OH. Seoul Natl.
Univ., Konyang Univ., Kyungpook Natl. Univ., Korea Univ.,
Harvard Med. Sch.

2:15 382.06 Effects of LPS on expression of mRNA for IL-6,

IL-7, and IL-10 and mRNA for IL-6 and IL-7 receptors in CNS
and spleen. P. SZOT*; A. FRANKLIN; T. PETRU BEUCA;
K. BULLOCK; K. HANSEN; W. BANKS; D. LATTEMANN;
M. RASKIND; E. PESKIND. Puget Sound Hlth. Care Syst.,
Univ. of Washington, Puget Sound Hlth. Care Syst., Univ. of
Washington, Puget Sound Hlth. Care Syst.
2:30 382.07 IL-1, a HAND-relevant proinflammatory cytokine,
increases MMP-13 release and PAR-1 signaling in
astrocytes. K. A. MAGUIRE-ZEISS*; T. YIN; E. WENZEL; K.
CONANT. Georgetown Univ. Med. Ctr., Georgetown Univ.
Med. Ctr.
2:45 382.08 Comparison of the injury, and consequent
inflammatory response, after spinal cord injury in neonates
and mature rats may lead to a novel therapeutic avenue.
T. SUTHERLAND*; A. SAPKOTA; C. GORRIE. Univ. of
Technol. Sydney.
3:00 382.09 Treatment of erythropoietin decreases the cognitive
and memory dysfunction by regulating inflammatory
response in Post-operative cognitive decline. B. KOO*; J.
LEE; E. KAM; S. CHEON; S. KIM; J. KIM; E. KIM. Yonsei
Univ.
3:15 382.10 Linking low dose chronic peripheral LPS
injection to neuroinflammation. S. N. CAMPBELL*; Y. HE;
A. BHATTACHARYA; N. C. DERECKI. Janssen Res. &
Develop.
3:30 382.11 Characterizing the effects of mammary tumor
development on neuroinflammation. W. H. WALKER*; M.
M. GAUDIER-DIAZ; J. C. BORNIGER; A. A. ZALENSKI; N.
ZHANG; A. DEVRIES. The Ohio State Univ.
3:45 382.12 Human monoclonal NMDA receptor autoantibodies are sufficient for encephalitis pathogenesis.
J. KREYE; N. K. WENKE; M. CHAYKA; J. LEUBNER; R.
MURUGAN; N. MAIER; A. G. MEISEL*; H. WARDEMANN;
H. PRSS. Charite Univ. Med. Berlin, Max Planck Inst. for
Infection Biol., Charit Univ. Med. Berlin, Charite Univ. Med.
Berlin, Deutsches Krebsforschungszentrum.
4:00 382.13 Identifying a link between metabolic signaling,
functional changes and inflammation in different brain
regions using a unique SNAP-25 mouse model and western
diet. M. IRFAN*; I. VALLADOID ACEBES; T. DARAIO; P.
STANTON; K. BRISMAR; T. HOKFELT; C. BARK. Karolinska
Institutet, New York Med. Col., Karolinska Institutet.

1:30 382.03 TGF-1 mediates ABCD1 dependent brain

endothelial dysfunction. N. SASIDHARAN; M. C. VISSERS;
J. M. T. SNYDER; Y. GONG; F. EICHLER; P. L. MUSOLINO*.
MGH/Harvard.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|81

NANOSYMPOSIUM

1:15 382.02 Ganciclovir suppresses brain inflammation by

activating the STING dependent type I interferon response.
V. MATHUR*; R. BURAI; R. T. VEST; D. DO; K. N. MISTRY;
H. A. LASHUEL; T. WYSS-CORAY. Stanford Univ., Palo Alto
Veterans Inst. for Res., cole Polytechnique Fdrale de
Lausanne, Stanford Univ.

2:00 382.05 Targeting the alternative pathway of complement

to improve functional recovery after spinal cord injury. A.
NARANG*; C. ATKINSON; N. L. BANIK; M. MEHROTRA;
S. TOMLINSON. Med. Univ. of South Carolina Dept. of
Microbiology and Immunol., Med. Univ. of South Carolina,
Med. Univ. of South Carolina, Ralph H. Johnson Veterans
Affairs Med. Ctr.

Mon. PM

1:45 381.04 Regulation of motoneuron excitability in ALS. S. M.

ELBASIOUNY*; T. GARRETT; K. QUINLAN; C. HECKMAN;
S. DUKKIPATI. Wright State Univ., Wright State Univ.,
Northwestern Univ.

1:45 382.04 The complement receptor C5aR1 drives

NLRP3 inflammasome activation and neuropathology in
experimental models of Parkinsons disease. R. GORDON*;
E. A. BALMACEDA; S. MANTOVANI; K. ZHOU; A. G.
KANTHASAMY; M. A. COOPER; K. SCHRODER; T. M.
WOODRUFF. The Univ. of Queensland, The Univ. of
Queensland, The Univ. of Queensland, Iowa State Univ.

4:15 382.14 Deep space radiation with 56Fe iron has early,
sex-specific effects on CNS in WT and Alzheimer
transgenic mice. B. LIU*; E. FITZPATRICK; K. LE; Q. SHI;
L. TROJANCZYK; M. PARK; S. WANG; A. BELANGER;
S. DUBEY; P. HOLTON; V. REISER; W. TRIGG; P. J.
LORELLO; K. M. OBANION; B. CALDARONE; M. DICARLI;
C. A. LEMERE. Ann Romney Ctr. For Neurologic Diseases,
BWH, Harvard Med. Sch., Univ. of Rochester Med. Ctr.,
Dept. of Radiology, BWH, GE Healthcare, GE Healthcare,
NBL, Harvard NeuroDiscovery Ctr. and Dept Neurology,
BWH.

NANOSYMPOSIUM
383. Brain and Spinal Cord Injury
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,33C
1:00 383.01 Terminal axonal sprouting is augmented in partially
injured motor nerves of BACE1 KO mice. C. TALLON*; M. H.
FARAH. Johns Hopkins Univ. SOM.
1:15 383.02 Establishment of the safety evaluation of
integration-free human iPS cell-derived neural stem/
progenitor cells as a source of cell therapy for spinal cord
injury. T. IIDA*; A. IWANAMI; J. KOHYAMA; N. NAGOSHI; M.
MATSUMOTO; H. OKANO; M. NAKAMURA. Dept of Orthop,
Sch. of Med, Keio Univ., Dept of Physiology, Sch. of Med,
Keio Univ.
1:30 383.03 Hyaluronic acid hydrogels for spinal cord
regeneration. C. WALTHERS*; J. LIANG; A. EHSANIPOUR;
S. SEIDLITS. UCLA.
1:45 383.04 Matrine facilitates axonal growth and improves
motor function in spinal cord injury in acute and chronic
phases. N. TANABE*; T. KUBOYAMA; C. TOHDA. Inst. of
Natural Med., Univ. of Toyama.
2:00 383.05 HDAC3 inhibition ameliorates spinal cord injury by
modulation of innate immune response. T. KUBOYAMA*;
Y. HUANG; J. WONG; A. KOEMETER-COX; M. MARTINI;
R. H. FRIEDEL; H. ZOU. Instit of Natural Medicine, Univ. of
Toyama, Fishberg Dept. of Neuroscience, Friedman Brain
Institute, Icahn Sch. of Med. at Mount Sinai, Tisch MS Res.
Ctr. of New York, Dept. of Neurosurgery, Friedman Brain
Institute, Icahn Sch. of Med. at Mount Sinai.

NANOSYMPOSIUM

2:15 383.06 The Neuro-Spinal Scaffold promotes tissue

remodeling, axonal sprouting, and Schwann cell myelination
following acute spinal cord contusion injury in rats. S. W.
MOORE*; R. T. LAYER; A. B. KUTIKOV; P. PODELL; A. A.
AIMETTI; T. R. ULICH; J. D. GUEST. InVivo Therapeut.,
Miller Sch. of Med.
2:30 383.07 Extracellular neuroleukin improves hindlimb motor
dysfunction of spinal cord injury. Y. TANIE*; N. TANABE; T.
KUBOYAMA; C. TOHDA. Inst. of Natural Medicine, Univ. of
Toyam.

2:45 383.08 T2*weighted MRI provides a novel assessment

of spinal cord white matter that correlates more precisely
with clinical features of degenerative cervical myelopathy
than DTI or MT. A. R. MARTIN*; B. DE LEENER; J. COHENADAD; D. W. CADOTTE; S. KALSI-RYAN; S. F. LANGE;
A. CRAWLEY; D. J. MIKULIS; H. GINSBERG; M. G.
FEHLINGS. Univ. of Toronto, Polytechnique Montreal, Univ.
of Toronto.

3:00 383.09 Increased TNF/TNFR1 signaling on macrophages

in the injured peripheral nerve of BACE1 KO mice. J. A.
FISSEL*; M. FARAH. Johns Hopkins Univ. Sch. of Med.,
Johns Hopkins Univ. Sch. of Med.
3:15 383.10 Neuregulin-1 promotes an anti-inflammatory
response associated with reduced glial scarring and
improved neurological recovery following spinal cord injury.
A. ALIZADEH*; S. M. DYCK; H. KATARIA; D. NGUYEN;
T. SANTHOSH; S. KARIMI-ABDOLREZAEE. Univ. of
Manitoba.
3:30 383.12 Aging negatively affects axon regeneration in the
mammalian central nervous system. C. G. GEOFFROY*; B.
J. HILTON; M. CHEN; W. TETZLAFF; B. ZHENG. UCSD,
Intl. Collaboration on Repair Discoveries.

3:45 383.11 Targeting GSK-3 signaling to prevent maladaptive

sensory growth and the development of at and below
level spinal cord injury pain. S. K. BAREISS*; M. ROWE;
B. CONNER; A. WONKA; J. YOW; K. L. BREWER. East
Carolina Univ., East Carolina Univ.

NANOSYMPOSIUM
384. Representation of Objects and Numbers across Ventral
and Dorsal Pathways
Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,23A
1:00 384.01 Neural coding of object shape in the macaque
frontal cortex. I. CAPRARA; E. PREMEREUR; M. C.
ROMERO; P. JANSSEN*. KU Leuven.
1:15 384.02 Luminance gradient at object borders
communicates object location to the human oculo-motor
system. M. J. KILPELAINEN*; M. A. GEORGESON. Univ. of
Helsinki, Aston Univ.
1:30 384.03 Differential sensitivity to whole vs. scrambled
objects in ventral and dorsal pathways. E. FREUD*; J. C.
CULHAM; M. BEHRMANN. Carnegie Mellon Univ., Univ. of
Western Ontario.
1:45 384.04 Rediscovering the ventral and dorsal pathways of
visual information processing. Y. XU*; M. VAZIRI PASHKAM.
Harvard Univ.
2:00 384.05 Task context overrules action-related
representational content in the human frontoparietal areas.
S. BRACCI*; N. DANIELS; H. OP DE BEECK. KU Leuven.
2:15 384.06 Real-world size improves recognition of real
objects, not images. J. C. SNOW*. Univ. of Nevada Reno
Dept. of Psychology.
2:30 384.07 Distinct neural signatures for very small and very
large numerosities. M. FORNACIAI; J. PARK*. Univ. of
Massachusetts.
2:45 384.08 A generalized sense of number for perception and
action. D. BURR*; R. ARRIGHI; G. ANOBILE; I. TOGOLI.
Univ. of Florence.
3:00 384.09 Integration of Number across separate dot clusters.
M. J. MORGAN*; M. KRELLNER; J. A. SOLOMON. MaxPlanck Inst., City Univ. London.
3:15 384.10 Coupling of human temporal and parietal neural
activity during numerical processing. A. L. DAITCH*; J.
PARVIZI. Stanford Univ.
3:30 384.11 A network of topographic numerosity maps
throughout human association cortex. B. M. HARVEY*; S. O.
DUMOULIN. Utrecht Univ., Spinoza Ctr. for Neuroimaging.

82 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:45 384.12 Exploring the neuronal population responses in the

human prefrontal cortex during integrated and segmented
arithmetic processing. X. YANG*; A. DAITCH; J. PARVIZI.
Stanford Univ., Lab. of Behavioral and Cognitive Neurosci.
(LBCN).
4:00 384.13 Pharmacological inactivation of intraparietal sulcus
reveals a causal role in ordinal comparison in macaque
monkeys. N. K. DEWIND*; J. PENG; E. M. BRANNON;
M. L. PLATT. Univ. of Pennsylvania, Rutgers, Univ. of
Pennsylvania.

3:45 385.12 Handedness-dependent hemispheric asymmetries

in parietal spatial attention maps. S. L. SHEREMATA*; M. A.
SILVER. Florida Atlantic Univ., Florida Atlantic Univ., Univ. of
California, Univ. of California, Univ. of California.

NANOSYMPOSIUM
386. Physiological and Pathophysiological Mechanisms of
the Blood Brain Barrier
Theme F: Integrative Physiology and Behavior

NANOSYMPOSIUM
385. Spatial Attention and Working Memory
Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,7B
1:00 385.01 The neural basis of dynamic coding in prefrontal
cortex during a spatial working memory task. E. SPAAK*; D.
WASMUHT; T. J. BUSCHMAN; E. K. MILLER; M. STOKES.
Oxford Univ., Princeton Univ., MIT.

1:30 385.03 Neural correlate of visual working memory in the

macaque monkey. M. PARE*; C. LI; J. BARBER. Queens
Univ.
1:45 385.04 Modulation of neuronal activity in macaque area
V4 during spatial working memory and saccade preparation.
D. JONIKAITIS*; T. MOORE. Stanford Univ. Sch. of Med.,
Howard Hughes Med. Inst. and Stanford Univ.
2:00 385.05 Spatial working memory enhances visual cortical
representations. B. NOUDOOST*; Y. MERRIKHI; T. MOORE;
K. CLARK; E. ALBARRAN; M. PARSA. Montana State Univ.,
Inst. for Res. In Fundamental Sci. (IPM), Stanford Univ.,
Montana State Univ.
2:15 385.06 Graded representations of stimulus salience and
attentional priority across visually-responsive cortex. T. C.
SPRAGUE*; S. ITTHIPURIPAT; V. A. VO; J. T. SERENCES.
New York Univ., UC San Diego, UC San Diego.
2:30 385.07 Rhythmic neural activity within the macaque
attention network modulates moment-to-moment sampling of
the visual environment. I. C. FIEBELKORN*; M. A. PINSK; S.
KASTNER. Princeton Univ., Princeton Univ.
2:45 385.08 Neural modulation of visual input at expected
distractor locations. M. STOKES*; Y. BAUER; A. VON
LAUTZ; C. SUMMERFIELD; M. NOONAN. Oxford
Univ., Univ. of Tbingen, Bernstein Ctr. for Computat.
Neuroscience, Univ. of Oxford.

1:15 386.02 Pericyte degeneration causes diffuse white matter

dysfunction as assessed by advanced magnetic resonance
imaging. A. MONTAGNE*; A. M. NIKOLAKOPOULOU;
Z. ZHAO; G. SI; D. LAZIC; M. DAIANU; A. P. SAGARE;
R. E. JACOBS; S. R. BARNES; P. M. THOMPSON; B. V.
ZLOKOVIC. USC, USC, Caltech.

1:30 386.03 Validation of CD98hc as a novel blood brain barrier

target. B. CHIH*; J. J. ZUCHERO; X. CHEN; N. BIEN-LY; D.
BUMBACA; R. K. TONG; X. GAO; S. ZHANG; K. HOYTE;
W. LUK; M. A. HUNTLEY; L. PHU; C. TAN; D. KALLOP;
R. M. WEIMER; Y. LU; D. S. KIRKPATRICK; J. ERNST;
M. S. DENNIS; R. J. WATTS. Genentech Inc, Genentech,
Genentech, Genentech, Genentech, Genentech, Genentech,
Genentech.
1:45 386.04 Regional Heterogeneity of the Blood-Brain Barrier.
M. BLANCHETTE*; N. RUDERISCH; R. DANEMAN. UCSD,
Roche, UCSD.
2:00 386.05 Intranasal delivery of peptidergic corticotropinreleasing factor receptor antagonists is facilitated by cellpenetrating peptides. L. A. TAN*; J. M. VAUGHAN; K. P.
GARIBAY; P. E. SAWCHENKO. Salk Inst. For Biol. Studies.
2:15 386.06 Pericyte ablation leads to disruption of
the neurovascular unit. B. V. ZLOKOVIC*; A. M.
NIKOLAKOPOULOU; Z. ZHAO; K. KISLER; P. KONG; D.
LAZIC; A. P. SAGARE; M. D. SWEENEY; E. J. LAWSON; Y.
YANG; A. GO. Keck Sch. of Med. of the Univ. of Southern
California.
2:30 386.07 Glymphatic function is suppressed in the
experimental autoimmune encephalomyelitis, EAE, model of
multiple sclerosis. I. LUNDGAARD*; S. ONEIL; E. YANG; H.
VINITSKY; M. NEDERGAARD. Univ. of Rochester, Univ. of
Copenhagen.

2:45 386.08 Microfluidics to model the human blood-brain

barrier for studies of barrier function, drug penetration, and
leukocyte-endothelial interactions. B. R. OBERMEIER*;
G. MARSH; A. HUANG; M. KOLLER; K. FISHER; A. C.
COTLEUR; F. SHIMIZU; Y. SANO; T. KANDA; J. DUFFIELD;
R. M. RANSOHOFF. Biogen, Nortis, Inc., Yamaguchi Univ.

3:15 385.10 Visual field maps constrain working memory

precision. C. E. CURTIS*; W. E. MACKEY; X. DING; X.
WANG; J. WINAWER. NYU, NYU, NYU.
3:30 385.11 Spatial attention modulates voxel receptive fields to
boost the fidelity of multi-voxel stimulus representations. V.
A. VO*; T. C. SPRAGUE; J. T. SERENCES. UC San Diego,
New York Univ., UC San Diego.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|83

NANOSYMPOSIUM

3:00 385.09 Preparatory encoding of the location and scope of

human spatial attention. J. SAMAHA*; T. C. SPRAGUE; B.
VOYTEK; A. GAZZALEY; B. R. POSTLE. UW Madison, New
York Univ., UCSD, Univ. of California, San Francisco.

1:00 386.01 Pericyte modulation by functional antibodies

obtained by a novel selection strategy. J. JUST*; K.
DRASBEK; S. LYKKEMARK; C. NIELSEN; P. KRISTENSEN.
Aarhus Univ., Aarhus Univ., Sino-Danish Ctr. for Educ. and
Research, Univ. of Chinese Acad. of Sci., Aarhus Univ.

Mon. PM

1:15 385.02 Noise correlation structure shapes ensemble

coding of working memory in prefrontal cortex. M. LEAVITT*;
F. PIEPER; A. J. SACHS; J. C. MARTINEZ-TRUJILLO.
McGill Univ., Univ. Med. Ctr. Hamburg-Eppendorf, Univ. of
Ottawa, Univ. of Western Ontario.

Mon. 1:00 PMSan Diego Convention Center,1B

NANOSYMPOSIUM
387. Oxytocin and Social Behavior
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,5B
1:00 387.01 The endocrinome of social communication. C.
THEOFANOPOULOU*; C. BOECKX. Univ. De Barcelona,
Univ. de Barcelona, ICREA.
1:15 387.02 Oxytocin gates VTA dopamine neurons to
promote pro-social behaviors. L. W. HUNG*; K. BEIER;
J. S. POLEPALLI; S. NEUNER; M. WRIGHT; G. DOLEN;
K. DEISSEROTH; R. MALENKA. Stanford Univ., Johns
Hopkins Univ., Stanford Univ.
1:30 387.03 Consolation behavior in prairie vole is predicted by
oxytocin receptor density in anterior cingulate cortex. J. P.
BURKETT*; L. KING; E. ANDARI; L. YOUNG. Emory Univ.,
Scripps Res. Inst., Emory Univ.
1:45 387.04 Oxytocin and vasopressin inhibit virgin female
aggression via V1a receptors. T. R. DE JONG*; V. E. M.
OLIVEIRA; I. D. NEUMANN. Univ. of Regensburg, Univ. of
Regensburg.
2:00 387.05 Developmental consequences in offspring following
maternal oxytocin treatment at birth. W. KENKEL*; A.
PERKEYBILE; J. R. YEE; T. LILLARD; C. F. FERRIS; S.
CARTER; J. CONNELLY. Indiana Univ. Bloomington, Univ. of
Virginia, Northeastern Univ.
2:15 387.06 Retinoic acid signaling in the anterior insula: A
fail-safe system for social cognition complementary to the
oxytocin cascade. S. KIM*; M. RANNALS; J. R. MOORE; M.
KONDO; T. CASH-PADGETT; B. MAHER; A. SAWA. Johns
Hopkins Univ., Johns Hopkins Univ., Lieber Inst. for Brain
Develop.
2:30 387.07 Investigating the genetic basis of natural behavior
using topic modeling. S. MADLON-KAY*; M. MONTAGUE;
N. SNYDER-MACKLER; K. WATSON; P. SKENE; J.
HORVATH; L. BRENT; K. HELLER; M. PLATT. Univ. of
Pennsylvania, Univ. of Pennsylvania, Duke Univ., Univ. of
Colorado, Duke Univ., North Carolina Central Univ., North
Carolina Museum of Natural Sci., Univ. of Exeter, Duke
Univ., Univ. of Pennsylvania.

1:45 388.04 Chronic social defeat stress produces profound

alterations in both behavior and in the brain pituitary
adenylate cyclase-activated polypeptide (PACAP)/PAC1
receptor system. M. SEIGLIE*; C. VELZQUEZ-SANCHEZ;
A. FERRAGUD FAUS; P. COTTONE; V. SABINO. Boston
Univ. Sch. of Med.
2:00 388.05 Rewarded approach of threatening spiders
engages areas of the mesolimbic dopamine system. F.
AHS*; J. BJRKSTRAND; M. FREDRIKSON. Uppsala Univ.,
Karolinska Inst.
2:15 388.06 Central amygdala mediates socially transferred
fear. E. A. KNAPSKA*; K. ROKOSZ; A. HAMED; K.
KONDRAKIEWICZ. Nencki Inst. of Exptl. Biol. PAS.
2:30 388.07 Inducing human fear memory extinction during
sleep. J. HE*; J. YUE; J. BAN; P. LI; L. SHI; L. LU. Peking
Univ. Sixth Hosp., Natl. Inst. on Drug Dependence and
Beijing Key laboratory of Drug Dependence, Peking Univ.,
Peking-Tsinghua Ctr. for Life Sci. and PKU-IDG/McGovern
Inst. for Brain Research, Peking Univ.

2:45 388.08 Dampened BOLD activation to life threat fear

in prairie vole fathers. J. R. YEE*; W. M. KENKEL; A.
PERKEYBILE; K. MOORE; P. KULKARNI; S. W. PORGES;
C. CARTER; C. F. FERRIS. Northeastern Univ., Indiana
Univ.
3:00 388.09 The need for neutral speaking controls in
laboratory-induced emotional states. S. GRIMLEY; C. KO;
F. GRACE; L. E. OLSON*. Univ. of Redlands, Univ. of
Redlands, Univ. of Redlands.
3:15 388.10 Behavioral and neurobiological aspects of
cultural attachment. W. YAP*; G. I. CHRISTOPOULOS; B.
CHEON; Y. HONG. Nanyang Business School, Nanyang
Technological Uni, Culture Sci. Institute, Nanyang Business
School, Nanyang Technological Univ., Decision and
Organizational Neurosci. Lab, Nanyang Business School,
Nanyang Technological Univ., Div. of Psychology, Nanyang
Technological Univ., Singapore Inst. for Clin. Sci. (A*Star),
Chinese Univ. of Hong Kong.

NANOSYMPOSIUM
389. The Role of Neuromodulators in Attentional Processing
Theme H: Cognition

NANOSYMPOSIUM
388. Neural Basis of Emotions
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,2

NANOSYMPOSIUM

1:00 388.01 Distinct brain systems mediate social influence and

conditioned cue effects on pain. L. KOBAN*; M. JEPMA; T.
D. WAGER. Univ. of Colorado Boulder.
1:15 388.02 Transgenerational transmission of learned fears via
observational conditioning. J. A. SILVERS*; B. CALLAGHAN;
K. OSULLIVAN; M. VAN TIEGHEM; N. TOTTENHAM.
UCLA, Columbia Univ.

Mon. 1:00 PMSan Diego Convention Center,4

1:00 389.01 Cholinergic, glutamatergic and attention induced
modulation of oscillatory activity in macaque area V1
and frontal eye field. A. THIELE*; J. HERRERO; M.
GIESELMANN; C. BRANDT; M. DASILVA; S. GOTTHARDT.
Newcastle Univ., Newcaslte Univ.
1:15 389.02 Dopamine affects attention-related activity of
neurons in the macaque FEF. A. L. MUELLER*; T. MOORE.
Stanford Univ.
1:30 389.03 Cholinergic compromise on attentional function and
cortical reorganization in aging. B. YEGLA*; S. JOSHI; J. A.
FRANCESCONI; J. C. FORDE; V. PARIKH. Temple Univ.

1:30 388.03 Dissociating hippocampal contributions to anxietylike behaviour in human approach/avoidance conflict. D. R.
BACH*; M. HOFFMANN; C. FINKE; H. HEEKEREN; C. J.
PLONER. Univ. of Zurich, Charite Univ. Med., Free Univ.

1:45 389.04 Dopaminergic contribution to attentional signals

in parietal cortex. J. VAN KEMPEN*; C. BRANDT; M.
A. BELLGROVE; A. THIELE. Newcastle Univ., Univ. of
Southern Denmark, Monash Univ.

84 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 389.05 The contribution of acetylcholine to working

memory circuits in primate prefrontal cortex. V. C. GALVIN*;
Y. YANG; T. C. LIGHTBOURNE; S. YANG; C. PASPALAS; A.
F. T. ARNSTEN; M. WANG. Yale Univ., Pennsylvania State
Univ.

4:00 A8
390.08 Regulation of oligodendrocyte
differentiation by the control of B-cell CLL lymphoma 11B
expression. C. WANG; K. FANG; C. HO; S. TZENG*. Natl.
Cheng Kung Univ., Natl. Cheng Kung Univ., Natl. Cheng
Kung Univ.

2:15 389.06 Muscarinic M1 receptor modulation of abstract rule

representation in primate dorsolateral prefrontal cortex. A.
J. MAJOR*; S. VIJAYRAGHAVAN; S. EVERLING. Western
Univ.

1:00 A9
390.09 Zeb2 recruits Hdac-NuRD to inhibit Notch
and controls Schwann cell differentiation and remyelination.
L. WU*; J. WANG; J. R. CHAN; M. JANKOWSKI; D.
HUYLEBROECK; Q. LU, 45229. CCHMC, UCSF, KU Leuven
Dept. of Develop. & Regeneration.

2:30 389.07 Cholinergic influences on spatial attention

modulation in area MT of primate visual cortex. C.
QUIGLEY*; V. K. VEITH; S. TREUE. German Primate Ctr.
2:45 389.08 Poor attentional control as a trait in sign-tracking
rats: Cortical cholinergic-GABAergic mechanisms. Y. KIM*;
C. R. RIVET; C. LUSTIG; M. SARTER. Univ. of Michigan.
3:00 389.09 Amphetamine-induced improvement in rat 5-choice
continuous performance test (5C-CPT) in poor performers
and irrespective of concurrent haloperidol treatment. J.
W. YOUNG*; M. R. BREIER; N. R. SWERDLOW. UCSD,
UCSD.

POSTER

Theme A: Development
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 A1
390.01 Developmental increase in cortical
myelination and internodal length variability in the mouse
neocortex. E. PAMA*; K. A. EVANS; P. HUMPHREYS; R. T.
KRADTTIR. Univ. of Cambridge.
2:00 A2
390.02 Characterization of an in vivo tool to study
oligodendrocyte metabolic support to neurons. T. PHILIPS*;
B. M. MORRISON; J. D. ROTHSTEIN. Johns Hopkins Univ.,
Johns Hopkins Univ.
3:00 A3
390.03 Vesicular trafficking in Schwann cell
development and myelination. B. ABDELMESIH*; C.
EYERMANN; C. MELENDEZ-VASQUEZ. Hunter Col.
4:00 A4
390.04 Investigating oligodendrocyte axonal
preference in the mammalian central nervous system. A
whole-tissue high-resolution approach. E. M. FLORIDDIA*;
C. BELLARDITA; P. LW; O. KIEHN; G. CASTELOBRANCO. Karolinska Institutet.
1:00 A5
390.05 Preservation of Schwann cell identity
in vitro through bone morphogenetic protein signaling. Y.
CHAN*; Y. P. TSUI; D. K. Y. SHUM. Sch. of Biomedic. Sci.,
Fac. Med., Univ. Hong Kong.

3:00 A7
390.07 Role of neural stem factor sox2 in
postnatal oligodendrocyte development. S. ZHANG*; C.
CREATO; E. HAMMOND; D. PLEASURE; J. XU; L. SONG;
F. GUO. Inst. For Pediatric Regenerative Medicine, Sh,
Departments of Neurology,School of Medicine, Univ. of
California, Davis.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 A12 390.12 Schwann cell population responses to

nerve stimulation. T. W. GOULD*; D. J. HEREDIA; G. W.
HENNIG. Univ. of Nevada Sch. of Med.
1:00 A13 390.13 In vitro modeling of Canavans disease
using human induced pluripotent stem cells. J. SAAL*; J.
FISCHER; V. KAPS; M. MIZHOROVA; M. ECKHARD; J. O.
SASS; M. KARUS; O. BRSTLE. Univ. of Bonn, Univ. of
Bonn, Univ. of Bonn, Bonn Rhein-Sieg Univ. of Applied Sci.
2:00 B1
390.14 Efficient pharmacogenetic ablation of
oligodendrocyte progenitor cells (NG2 glia) in mice. T. D.
MERSON*; B. H. A. CHUANG; T. J. KILPATRICK; Y. L.
XING. Florey Dept of Neurosci. and Mental Hlth., Florey Inst.
of Neurosci. and Mental Hlth., Univ. of Melbourne.
3:00 B2
390.15 Regulatory function of nogo-a in
oligodendrocyte differentiation. M. A. MAIBACH*; F.
MLLER; O. WEINMANN; M. E. SCHWAB. ETH Zrich.
4:00 B3
390.16 MicroRNA control of myelination and
remyelination in the CNS. H. WANG*; Z. MA; Y. DENG; R.
LU. Cincinnati Childrens Hosp.
1:00 B4
390.17 Fyn-Dab1 signaling during
oligodendrocyte differentiation. D. J. OSTERHOUT*; H.
BHATTI; I. I. GENEVA. SUNY Upstate Med. Univ.
2:00 B5
390.18 Acute oligodendrocyte loss and persisting
white matter injury in a third trimester equivalent model
of fetal alcohol spectrum disorder. J. C. NEWVILLE; C. F.
VALENZUELA; L. LI; L. L. JANTZIE; L. A. CUNNINGHAM*.
Univ. of New Mexico Sch. of Med., Univ. of New Mexico Sch.
of Med.
3:00 B6
390.19 Heterogeneity of astrocyte and NG2
cell insertion at the node of Ranvier. P. JUKKOLA*; D. R.
SERWANSKI; A. NISHIYAMA. Univ. of Connecticut.
4:00 B7
390.20 Glycogen synthase kinase 3
inhibition promotes myelination in preterm rabbit pups
with intraventricular hemorrhage. P. DOHARE*; F. HU; P.
BALLABH. New York Med. Col.
1:00 B8
390.21 Association between stress-induced
Ranvier nodes structural abnormalities and reduced
oligodendrocyte activity in major depressive disorder. S.
MIYATA*; S. SHIMIZU; T. TANAKA; M. TOHYAMA. Kindai
Univ/ Res. Ins Trad Asian Med.
2:00 B9
390.22 Protease activated receptor 2 is a
novel regulator of myelin development and repair. I. A.
SCARISBRICK*; M. RADULOVIC; H. YOON. Mayo Clin.,
Mayo Clin.

Neuroscience 2016|Monday PM|85

NANOSYMPOSIUM

2:00 A6
390.06 Human Schwann cell senescence is
not prevented by ectopic expression of human telomerase
reverse transcriptase. N. D. ANDERSEN*; B. KUO; G.
PIERO; K. RAVELO; P. RAI; P. MONJE. Univ. of Miami
Miller Sch. of Med., Univ. of Miami Miller Sch. of Med.

3:00 A11 390.11 Impact of Mtmr2 knockdown in Schwann

cells. J. KIM; R. DOBROWOLSKI; H. A. KIM*. Rutgers Univ.
Newark.

Mon. PM

390. Oligodendrocytes and Schwann Cells: Development,

Neuron-Interaction, and Myelination

2:00 A10 390.10 Ionotropic glutamate receptor-triggered

cell signaling in Schwann cells. W. M. CAMPANA*; K. W.
HENRY; E. MANTUANO; S. GONIAS. Univ. of California San
Diego, UCSD, Univ. of California San Diego, Sapienz Univ.
of Rome.

3:00 B10 390.23 Motor neuron sonic hedgehog regulates

oligodendrocyte proliferation and maturation in the
developing spinal cord. L. STARIKOV*; A. KOTTMANN.
Sophie Davis Sch. of Biomed. Education, CUNY, CUNY
Grad. Ctr.

4:00 B21 391.08 Behavioral effects of an m1 muscarinic

cholinergic receptor agonist in the BTBR mouse model of
autism. M. E. RAGOZZINO*; H. RAMIREZ; J. T. DUNN; W.
S. MESSER, Jr. Univ. of Illinois at Chicago, Univ. of Illinois at
Chicago, Univ. of Toledo.

4:00 B11 390.24 Nogo/RTN4 as an extracellular vesicleassociated ligand. M. M. HOLM*; D. VAN ROSSUM; M.
EGGER; O. WEINMANN; I. K. HERMANN; M. E. SCHWAB.
Brain Res. Inst., EMPA Swiss Federal Labs. for Materials
Sci. and Technol.

1:00 B22 391.09 Atypical behavioral and neural

phenotypes in a non-human primate model of autism
spectrum disorders. K. MIMURA*; C. SATO; K. NAKAGAKI;
I. AOKI; T. MINAMIMOTO; N. ICHINOHE. Natl. Ctr. of
Neurol. and Psychiatry, Natl. Inst. of Radiological Sciences,
QST, Japan Society for the Promotion of Sci.

1:00 B12 390.25 Sox17 suppression of Wnt/-catenin

promotes oligodendrocyte regeneration through HedgehogSmoothened signaling. L. CHEW*; X. MING; B. MCELLIN; V.
GALLO. Childrens Res. Inst.
2:00 B13 390.26 Pain-induced spinal NG2 cell
proliferation: A critical role of -catenin in neurons but not in
NG2 cells. Y. SHI*; S. TANG. Univ. of Texas Med. Br.

POSTER
391. Autism: Models
Theme A: Development
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 B14 391.01 Early behavioral abnormalities and

perinatal alterations of PTEN/AKT pathway in valproic
acid atuism model mice. E. YANG*; S. AHN; K. LEE;
U. MAHMOOD; H. KIM. Seoul Natl. Univ., Dept. of
Pharmacology, Inje Univeirsity Col. of Med., Seoul Natl. Univ.
Bundang Hospital, Seoul Natl. Univ. Col. of Med.
2:00 B15 391.02 MicroRNAs as potential biomarkers in
Autism spectrum disorder. M. NAKATA*; R. KIMURA; K.
TOMIWA; T. AWAYA; T. KATO; Y. FUNABIKI; T. HEIKE; M.
HAGIWARA. Kyoto Univ. Grad. Sch. of Med., Todaiji Med.
and Educational Ctr., Kyoto Univ. Grad. Sch. of Med., Kyoto
Univ. Grad. Sch. of Human and Envrn. Studies.
3:00 B16 391.03 Autism-related protein MeCP2 regulates
FGF13 expression and emotional behaviours. B. YUAN*.
Inst. of Neurosci.
4:00 B17 391.04 Shank2 and Shank3 geneenvironment interactions in autism spectrum disorders.
S. GRABRUCKER*; G. EHRET; T. M. BOECKERS; A. M.
GRABRUCKER. Ulm Univ., Ulm Univ., Ulm Univ., Ulm Univ.
1:00 B18 391.05 A rubber tail task in Ca2+-dependent
activator protein for secretion (CAPS) 2 knockout mice. M.
WADA*; M. IDE; T. ATSUMI; K. YAGISHITA; M. KATAKAI; Y.
SHINODA; T. FURUICHI; K. KANSAKU. Res. Inst. of NRCD,
Res. Inst. of NRCD, Japan Society for the Promotion of Sci.,
Tokyo Univ. of Sci., Tokyo Univ. of Pharm. and Life Sci., The
Univ. of Electro-Communications.
2:00 B19 391.06 The effects of vagus nerve stimulation on
abnormal emotional learning and social anxiety in an animal
model of autism. A. ALVAREZ-DIEPPA*; S. CAVALIER; K.
GRIFFIN; C. MCINTYRE. Univ. of Texas At Dallas.
3:00 B20 391.07 The behavioral expression and genetic
regulation of repetitive and restricted behaviors in mice in
the context of autism spectrum disorder. R. T. MOLENHUIS*;
H. BRUINING; M. J. V. BRANDT; P. E. VAN SOLDT; J. P. H.
BURBACH; F. A. IRAQI; R. MOTT; M. J. H. KAS. Univ. Med.
Ctr. Utrecht, Univ. Med. Ctr. Utrecht, Tel Aviv Univ., Univ. Col.
London.

86 | Society for Neuroscience

2:00 B23 391.10 Neonatal RU-486 exposure; a gender

specific animal model for the low maternal progesterone
hypothesis of autism. H. GARMAN*; J. KASS; S. KWON; R.
MALSKY; C. INFANTINO; P. WHITAKER. Stony Brook Univ.,
Stony Brook Univ., Stony Brook Univ., Stony Brook Univ.
3:00 B24 391.11 Continuous activation of dopaminergic
system improves autism-related behavioral abnormalities
in mice prenatally exposed to valproic acid. S. HASEBE*;
Y. HARA; M. HIGUCHI; Y. AGO; T. NAKAZAWA; H.
HASHIMOTO; T. MATSUDA; K. TAKUMA. Grad. Sch. of
Dent., Osaka Univ., Grad. Sch. of Pharmaceut. Sci., Osaka
Univ., United Grad. Sch. of Child Develop., Osaka Univ.
4:00 B25 391.12 Neonatal treatments with risperidone
partially reverses aberrant striatal compartmentation
and ultrasonic vocalizations in a mouse model of autism
spectrum disorder. H. KUO; F. LIU*. Natl. Yang-Ming Univ.
1:00 B26 391.13 Autism-related behavior in juvenile and
adult mice following perinatal antidepressant exposure. C.
M. BOND; N. S. WOEHRLE*. Wittenberg Univ.
2:00 C1
391.14 Autistic-like behaviors with hyperactivity
in mice lacking kirrel3. T. HISAOKA*; T. KOMORI; H.
GYOBU; T. KITAMURA; Y. MORIKAWA. Dept. of Anat. &
Neurobiology, Wakayama Med. Univ., The Inst. of Med.
Science, The Univ. of Tokyo.
3:00 C2
391.15 Stereological investigation of the rat
thalamic nuclei following developmental hyperserotonemia.
L. HOUGH*; R. FOREMAN; C. GRUBB. Missouri State Univ.

4:00 C3
391.16 Dietary docosahexaenoic acid
alleviates autistic-like behaviors resulting from maternal
immune activation in mice. M. J. WEISER*; B. MUCHA; H.
DENHEYER; D. ATKINSON; N. SCHANZ; E. VASSILIOU; R.
H. BENNO. DSM, William Patterson Univ., Kean Univ.
1:00 C4
391.17 Valproic acid induction of nrf2 in fetal but
not adult brain. J. GIFFORD*; S. NORTON; A. KUSNECOV;
G. C. WAGNER. Rutgers Univ., Rutgers Univ.
2:00 C5
391.18 The effects of fastigial nuclei
inactivation on social behavior in the rat. V. K. BEHNKE*;
M. E. STEVENSON; H. E. HOBSON; J. R. KRUEGER;
V. G. BELTRONE; A. S. NAZARIO; R. A. SWAIN. Univ. of
Wisconsin-Milwaukee.
3:00 C6
391.19 Developmental exposure to the selective
serotonin reuptake inhibitor citalopram alters spatial learning
and memory, anxiety, sociability, and acoustic startle
response in the offspring of Sprague-Dawley rats as adults.
J. NELMS SPROWLES*; J. R. HUFGARD; A. GUTIERREZ;
R. A. BAILEY; S. A. JABLONSKI; M. T. WILLIAMS; C. V.
VORHEES. Cincinnati Childrens Hosp. Med. Ctr., Univ. of
Cincinnati.
4:00 C7
391.20 GABA-B receptor agonist r-baclofen
reverses behavioral deficits in 16p11.2 deletion mice. M.
SCHAFFLER*; T. M. KAZDOBA; J. N. CRAWLEY. UC Davis,
UC Davis MIND Inst.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 C8
391.21 The impact of maternal care on a female
mouse model of Rett syndrome. A. VOGEL CIERNIA*;
M. PRIDE; A. NORONHA; A. CHANG; D. YASUI; J. N.
CRAWLEY; J. M. LASALLE. Univ. of California Davis, Univ.
of California Davis.

3:00 C20 392.03 The effects of dietary supplementation

with n-3 fatty acids on behavioral and neuroinflammatory
phenotype of the Fmr1-knockout mouse. S. O. NOLAN*; S.
L. HODGES; G. D. SMITH; T. JEFFERSON; B. ESCOBAR;
A. J. HOLLEY; J. N. LUGO. Baylor Univ., Baylor Univ.

2:00 C9
391.22 Correction of cognitive and behavioral
deficits in a 16p11.2 CNV mouse model by selective
activation of GABAB receptors with r-baclofen. L. J.
STOPPEL*; A. R. PREZA; A. J. HEYNEN; M. F. BEAR. MIT.

4:00 C21 392.04 Decrease of MMP-9 level in central

amygdala rescues cognitive deficit in mouse model of fragile
X syndrome. A. PUSCIAN*; S. LESKI; M. WINIARSKI; J.
BOROWSKA; M. CHATURVEDI; J. SADOWSKA; H. LIPP;
E. KNAPSKA. Nencki Inst. of Exptl. Biology, PAS, Inst. of
Anatomy, Univ. of Zurich, Sch. of Lab. Medicine, KwazuluNatal Univ. Durban.

3:00 C10

391.23 Withdrawn.

4:00 C11 391.24 Evaluation of the TrkB agonist

7,8-dihydroxyflavone in the BTBR mouse model of autism.
T. M. KAZDOBA*; P. T. LEACH; K. SISON; J. N. CRAWLEY.
Univ. of California Davis, Univ. of California, Davis.
1:00 C12 391.25 Touchscreen visual discrimination
learning and water maze deficits in the Ts65Dn mouse
model of Down syndrome. P. T. LEACH*; T. M. KAZDOBA;
K. SISON; C. M. GALL; G. LYNCH; J. N. CRAWLEY. Biogen,
Univ. of California Davis Sch. of Med., Univ. of California
Irvine Sch. of Med., Univ. of California Irvine Sch. of Med.

2:00 C23 392.06 Chronic administration of metformin

restores behavioral and morphological abnormalities in
the Fragile X Syndrome mouse model. I. GANTOIS*; J.
POPIC; A. KHOUTORSKY; E. FREEMANTLE; A. AGUILARVALLES; R. CAO; V. SHARMA; A. NAGPAL; K. GAMACHE;
C. CHAPAT; T. POOTERS; K. NADER; J. LACAILLE; C.
G. GKOGKAS; N. SONENBERG. McGill Univ., Univ. de
Montreal, McGill Univ., Univ. of Edinburgh.

3:00 C14 391.27 Ketogenic diets improve behaviors

associated with autism spectrum disorder in the EL mouse.
D. N. RUSKIN*; J. A. FORTIN; S. BISNAUTH; S. A.
MASINO. Trinity Col.

3:00 C24 392.07 Lovastatin treatment early in life prevents

development of cognitive deficits in a rat model of Fragile X
Syndrome. A. ASIMINAS*; S. M. TILL; E. K. OSTERWEIL;
M. F. BEAR; S. CHATTARJI; D. J. A. WYLLIE; P. C. KIND; E.
R. WOOD. The Univ. of Edinburgh, The Univ. of Edinburgh,
The Univ. of Edinburgh, MIT, Ctr. for Brain Develop. and
Repair, Natl. Ctr. for Biol. Sci.

4:00 C15 391.28 Ketogenic diet improves decreased

mitochondrial respiration and activities of electron transport
chain complex I and pyruvate dehydrogenase in BTBR
autistic mice. Y. AHN; N. YEE; R. TOBIAS; J. M. RHO*. Univ.
of Calgary, Alberta Childrens Hospital, Univ. of Calgary.

4:00 C25 392.08 Modulation of behavioral inhibition

in attention deficit hyperactivity disorder. J. REN*; A.
PANAMENO; L. M. HIRSHBERG; L. M. OBERMAN. Brown
Univ., Bradley Hosptal, Bradley Hosptal, Brown Univ., The
NeuroDevelopment Ctr.

1:00 C16 391.29 Identification of circuits regulating

socially-directed behavior using DREADD-fMRI. M.
BENEKAREDDY*; T. J. STACHNIAK; M. VON KIENLIN;
B. KUENNECKE; A. GHOSH. Roche Pharma Res. &
Early Development, Roche I, Roche Pharma Res. & Early
Development, Roche Innovation Ctr. Basel, E-Scape Bio.
2:00 C17 391.30 Digging behavior discrimination: A new
test you will dig. H. L. POND; J. ADELMAN; O. MCKISSICK;
M. MANZINI*. The George Washington Univ.

POSTER
392. Behavior in Fragile X Syndrome and Other
Neurodevelopmental Diseases

1:00 C26 392.09 Children with DCD (development

coordination disorder) have a normal rate of learning of
Active Video Games both in a variable and repetitive
learning protocol. B. C. M. SMITS-ENGELSMAN; E.
BONNEY; L. D. JELSMA; G. FERGUSON; J. E. DUYSENS*.
Univ. of Cape Town, Univ. of Ghana, Univ. of Groningen,
Dept of Kinesiology (faber).
2:00 C27 392.10 Consequences of excessive sensory
stimulation during development on addiction, impulsivity and
attention. S. RAVINDER*; S. GADIWALLA; D. CHRISTAKIS;
S. FERGUSON; J. RAMIREZ. Seattle Childrens Res. Inst.
3:00 C28 392.11 Attention training in children with sensory
processing dysfunction. A. AITKEN*; J. A. ANGUERA; A.
D. ANTOVICH; C. E. ROLLE; S. S. DESAI; E. J. MARCO.
UCSF.

Theme A: Development
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 C18 392.01 Delayed and reduced baseline and social
isolation-potentiated ultrasonic vocalization in neonatal
fragile X knockout mice. B. ZUPAN*; S. R. M. DEWIL; L.
MORSE. Vassar Col., Vassar Col.
2:00 C19 392.02 Characterization of the behavioral
phenotype and neuroinflammatory profile of the FMR1 KO
mouse. S. L. HODGES*; S. O. NOLAN; C. REYNOLDS; G.
D. SMITH; A. HOLLEY; T. JEFFERSON; J. HUEBSCHMAN;
M. VOLQUARDSEN; A. PANDIAN; J. N. LUGO. Baylor Univ.,
Baylor Univ., Baylor Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
393. Molecular Mechanisms of Neuronal and Glial Migration
Theme A: Development
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 C29 393.01 C-terminal RELN deletion disrupts an
interaction with VLDLR causing abnormal cerebral cortex
and hippocampus development. S. HA*; P. P. TRIPATHI; R.
F. HEVNER; D. R. BEIER. Seattle Childrens Res. Inst., Univ.
of Washington Med. Sch., Seattle Childrens Res. Inst.

Neuroscience 2016|Monday PM|87

Mon. PM

2:00 C13 391.26 Forebrain loss of active Met tyrosine

kinase disrupts cortical connectivity and GABA signaling.
S. TANG; S. XU; W. ZHU; F. LO; R. S. ERZURUMLU; E.
M. POWELL*. Univ. of Maryland Sch. of Med., Univ. of
Maryland Sch. of Med., Univ. of Maryland Sch. of Med., Univ.
Maryland, Baltimore.

1:00 C22 392.05 Chronic sleep restriction in Fmr1

knockout and WT mice has long term effects on behavior. R.
M. SARE*; A. SONG; M. LEVINE; C. HILDRETH; A. MFON;
C. SHEELER; C. BEEBE SMITH. Natl. Inst. of Mental Hlth.

2:00 C30 393.02 A possible novel mode of action for Dab1

in modulation of neuronal migration of neocortical neurons.
S. KIKKAWA*; T. NAMIKAWA; T. TERASHIMA. Kobe Univ.
Grad. Sch. of Med.

3:00 D8
393.15 Does GPR56 play a role in the
developing GnRH/Olfactory system? F. VILSON*; Y. SHAN;
X. PIAO; S. WRAY. NIH, Bostons Childrens Hospital,
Harvard Med. Sch.

3:00 C31 393.03 Cdk12 regulates neurogenesis and lateborn neuronal migration in the developing cerebral cortex. M.
FANN*; H. CHEN; H. JUAN; Y. WONG; J. TSAI. Natl. YangMing Univ.

4:00 D9
393.16 Distinct roles for the adhesion molecule
Contactin2 in the development and function of neural circuits
in zebrafish. S. GURUNG*; A. CHANDRASEKHAR. Div. of
Biol. Sci.

4:00 C32 393.04 Loss-of-function of the epileptic

encephalopathy-associated TRIO gene impairs the
morphological development of cortical GABAergic
interneurons. F. CHARRON-LIGEZ*; J. LAROUCHE;
F. HANSSON; M. LACHANCE; J. FALARDEAU; E.
ROSSIGNOL. CHU Ste-Justine Res. Ctr., Univ. de Montral,
Univ. de Montral, Univ. de Montral, Univ. de Montral.

1:00 D10 393.17 The spinal muscular atrophy with

pontocerebellar hypoplasia gene vrk1 regulates neuronal
migration through an amyloid- precursor proteindependent mechanism. H. VINOGRAD-BYK*; T. SAPIR;
L. CANTARERO; P. LAZO; S. ZELIGSON; R. ORLY; P.
RENBAUM; E. LEVY-LAHAD. Shaare Zedek Med. Ctr.,
Weizmann Inst. of Sci., Hosp. Universitario de Salamanca.

1:00 C33 393.05 Dopamine D1 receptor activation and

neuronal migration. M. M. MARTIN*; D. M. MCCARTHY;
C. METIN; P. G. BHIDE. Florida State Univ., Ctr. for Brain
Repair at Florida State Univ., Inserm- Inst. du Fer Moulin.

POSTER

2:00 C34 393.06 Polysialic acid synthesis by ST8SIA2

is essential for cortical interneuron development. U. E.
DIEDERICHS*; C. ROSSDAM; T. KRCHER; I. RCKLE;
N. KESSARIS; Y. YANAGAWA; B. WEINHOLD; H.
HILDEBRANDT. Hannover Med. Sch., Univ. Col. London,
Gunma Univ.
3:00 D1
393.07 Dynamin-related protein 1 controls the
migration and neuronal differentiation of subventricular zonederived neural progenitor cells. H. KIM*; M. SHAKER; B.
CHO; H. CHO; H. KIM; J. KIM; W. SUN. Korea Univ., DGIST.
4:00 D2
393.08 Insulin growth factor 1 control of
subventricular zone progenitor migration. M. DUCKER*; B.
HASSAN; F. SZELE. Univ. of Oxford, Univ. of Oxford.
1:00 D3
393.09 In vivo two-photon imaging of cell
migration in embryos reveals a differential effect of ketamine
application. M. YURYEV*; L. ANDRIICHUK; V. JOKINEN; C.
RIVERA. Univ. of Helsinki, Aalto Univ., Inst. de Neurobiologie
de la Mditerrane, Aix-Marseille Univ.
2:00 D4
393.10 Understanding neurovascular endothelial
cell migration using in vitro three dimensional models. M.
BOUTIN; J. SEVETSON; L. KRAMER; D. HOFFMAN-KIM*.
Brown Univ., Brown Univ., Brown Univ., Brown Univ.

394. Adolescent Development: Animal Models II

Theme A: Development
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 D11 394.01 Impact of voluntary exercise during
adolescence on cognitive performance in a touchscreen
operant chamber during adulthood. J. OLEARY*; C.
BROUWERS; N. BROSENS; O. F. OLEARY; J. F. CRYAN;
A. M. SULLIVAN; Y. M. NOLAN. Univ. Col. Cork, Alimentary
Pharmabiotic Ctr.
2:00 D12 394.02 Aripiprazole sensitization: Adolescence to
adulthood in the conditioned avoidance response model and
pcp model. E. D. FREEMAN*; J. LIN, 68526; C. CHOW; C.
DAVIS; M. LI. Univ. of Nebraska-Lincoln, Univ. of NebraskaLincoln.
3:00 D13 394.03 Investigating the paranodal domain
structure of myelinated axons in the medial prefrontal cortex
of adolescent male and female rats. E. TAVARES*; A. SILVAGOTAY; W. M. VARGAS; H. N. RICHARDSON. Univ. of
Massachusetts- Amherst, Univ. of Massachusetts- Amherst.
4:00 D14 394.04 chronic adolescent stress impairs spatial
working memory in adult female rats. R. MORANO*. Univ. of
Cincinnati.

3:00 D5
393.11 The effect of migration in Schwann cell
line using NRG1, NGF, and GDNF as guidance signals. M.
E. DE BELLARD*; B. ORTEGA; T. DUONG; E. KLEIN; J.
KOWALEWSKI; A. MAYORAL. Cal State Univ. Northridge,
Cal State Univ. Northridge.

1:00 D15 394.05 Effect of pubertal delay and social stress

on hippocampal connectivity in adolescent female rhesus
macaques. M. PINCUS*; J. GODFREY; E. FECZKO; E.
EARL; C. KELLY; M. WILSON; D. FAIR; M. SANCHEZ.
Emory Univ., Oregon Hlth. & Sci. Univ., Trinity Col.

1:00 DP01 393.12 (Dynamic Poster) Erratic migration:

A unique migratory behavior of astrocyte progenitors.
H. TABATA*; M. SASAKI; Y. INAGUMA; H. ITO; H.
TAKEBAYASHI; M. EMA; K. IKENAKA; K. NAGATA; K.
NAKAJIMA. Inst. For Dev. Res., Aichi Human Service Cen.,
Dept. of Anatomy, Keio Univ. Sch. of Med., Div. of Neurobiol.
and Anatomy, Grad. Sch. of Med. and Dent. Sciences,
Niigata Univ., Res. Ctr. for Animal Life Science, Shiga Univ.
of Med. Sci., Div. of Neurobiol. and Bioinformatics, Natl. Inst.
for Physiological Sci.

2:00 D16 394.06 Role of CB1 receptor signaling in the

regulation of afferent-evoked plasticity in the prefrontal
cortex in vivo. H. M. MOLLA*; D. R. THOMASES; K. Y.
TSENG. The Chicago Med. Sch. At RFUMS.

1:00 D6
393.13 EphA4 signaling controls neuroblast
migration and astrocyte organization in the rostral migratory
stream. J. C. CONOVER*; K. L. TODD; K. L. BAKER;
M. EASTMAN; F. KOLLING, 4th; C. E. NELSON. Univ.
Connecticut, Univ. of Connecticut, Univ. of Connecticut.
2:00 D7
393.14 Cytoskeletal dynamics during neuronal
migration: Role of actin binding protein drebrin in GnRH
neuronal movement. Y. SHAN*; S. WRAY. NIH.
88 | Society for Neuroscience

3:00 D17 394.07 Neuroimmune signaling in the nucleus

accumbens underlying the adolescent critical period for
drugs of abuse. A. M. KOPEC*; S. C. SWEAT; N. R. AYRE;
S. D. BILBO. Duke Univ.
4:00 D18 394.08 Differential effects of paradoxical sleep
deprivation on adolescent and adult mice. L. TUAN*; L. LEE.
Natl. Taiwan Univ., Natl. Taiwan Univ., Natl. Taiwan Univ.
1:00 D19 394.09 Arginine vasopressin expression
mediates paternal influence on female offspring aggression
in Peromyscus californicus. C. YOHN*; A. LEITHEAD; E. A.
BECKER. St. Josephs Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 D20 394.10 Gonadal steroids at puberty drive

organizational effects on inhibitory neurotransmission in the
mouse frontal cortex. D. PIEKARSKI*; J. R. BOIVIN; A. W.
THOMAS; L. WILBRECHT. Univ. of California, Berkeley,
Univ. of California, San Francisco.
3:00 D21 394.11 Social defeat stress during adolescence
impairs the maturation of GABAergic function in the
adult prefrontal cortex. E. FLORES-BARRERA*; D. R.
THOMASES; A. CABALLERO; J. S. CARTER; K. E. GRANT;
J. A. ROSENKRANZ; K. Y. TSENG. Rosalind Franklin Univ.
of Med. and Sci., DePaul Univ.
4:00 D22 394.12 Hedonic reward consumption is elevated
in male, but not female, adolescent rats. A. T. LIU*; Y. CUI;
N. P. MURPHY; N. T. MAIDMENT; S. B. OSTLUND. UC
Irvine, UCLA.

2:00 D31 396.02 Neuromorphological characterization of

CA1 pyramidal cells in transgenic mice expressing chimeric
NMDAR GluN2 subunits. R. KEITH*; J. M. AZCARATE; T.
C. DUMAS; Z. SAFI; M. F. BADAKHSH; M. J. KEITH; K. S.
ZECHMAN; G. J. LEE. George Mason Univ. Krasnow Inst.,
George Mason Univ., Robinson Secondary Sch., Thomas
Jefferson High Sch. for Sci. and Technol.
3:00 D32 396.03 Exploration of the molecular mechanisms
underlying the effect of L-lactate on long term memory.
E. K. IBRAHIM; O. AL ZAHRANI; H. FIUMELLI; P. J.
MAGISTRETTI*. King Abdullah Univ. for Sci. and Technol.,
Ecole Polytechnique.
4:00 D33 396.04 Optophysiological characterization
of endogenous and recombinant glutamate receptors in
neuroblastoma cells. N. A. ALMUZAINI*; K. S. JONES.
Howard Univ., Howard Univ.

POSTER
395. Invertebrate Neurotransmitters
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

2:00 D24 395.02 Behavioral pharmacology of planaria

(Giardia) as a model for glutamate excitotoxicity. M.
SCRIBNER; B. R. MILLER*. Texas Wesleyan Univ.
3:00 D25 395.03 Requirement of IP3R function and
SOCE in dopaminergic interneurons for Drosophila flight. S.
SADAF*; S. P. SANE; G. HASAN. Natl. Ctr. For Biol. Sci.,
Natl. Ctr. for Biol. Sci., Natl. Ctr. for Biol. Scirnces.
4:00 D26 395.04 A diurnal rhythm in head histamine in
wild-type and white Drosophila. J. BORYCZ*; J. A. BORYCZ;
I. A. MEINERTZHAGEN. Dalhousie Univ., Dalhousie Univ.
1:00 D27 395.05 Temporal profiling of the phosphorylation
of CaMKII at Threonine 286 & Threonine 305 following
classical conditioning. H. WAN*; G. KEMENES. Univ. of
Sussex, Univ. of Sussex.
2:00 D28 395.06 Dynamics of change of pattern of
serotonin-containing neurons in the terminal abdominal
ganglion of a tenebrionid beetle during metamorphic
development. R. C. ELSON*. Point Loma Nazarene Univ.
3:00 D29 395.07 Automated behavioral pharmacology
assay using planaria (Girardia) in a 3-D printed apparatus.
D. POE*; A. CORNWALL; M. TAYLOR; B. MILLER. Univ. of
North Texas Hlth. Sci. Ctr., Texas Wesleyan Univ.

POSTER
396. NMDA Receptors II
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 D30 396.01 Dysfunctional NMDA receptors affect
excitatory transmission causing neurological disease.
L. FEDELE*; R. J. HARVEY; T. G. SMART. Univ. Col. of
London, UCL Sch. of Pharm.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 E1
396.06 Peculiarities of agonist activity of
homocysteine on GluN2A- and GluN2B-containing NMDA
receptors. S. M. ANTONOV*; D. A. SIBAROV; P. A.
ABUSHIK; R. GINIATULLIN. Sechenov Inst. of Evolutionary
Physiol. and Biochem., A. I. Virtanen Inst. for Mol. Sciences,
Univ. of Eastern Finland.
3:00 E2
396.07 Positive modulatory interactions of
NMDA receptor GluN1/2 ligand binding domain attenuate
competitive antagonists activity. D. BLEDSOE; C. TAMER;
I. MESIC; C. MADRY; H. BETZ; B. G. KLEIN*; B. LAUBE;
B. COSTA. Virginia Tech., Technische Univ. Darmstadt,
Univ. Col. London, Max-Planck-Institut fr Medizinische
Forschung, Virginia Tech, Col. of Vet. Med., Edward Via
Virginia Col. of Osteo. Med.
4:00 E3
396.08 Regulation of striatal neuronal NMDAR
trafficking by palmitoylation: Potential role in Huntington
disease. R. KANG*; L. WANG; S. S. SANDERS; K. ZUO;
M. R. HAYDEN; L. A. RAYMOND. Univ. of British Columbia,
Univ. of British Columbia, Univ. of British Columbia.

1:00 E4
396.09 Human anti-GluN1 antibody-mediated
effects on NMDA receptor subtypes. J. A. PANZER*; A.
RATTELLE; D. R. LYNCH. Childrens Hosp. of Philadelphia.
2:00 E5
396.10 Lateral mobility of synaptic NMDA
receptors in hippocampal slices. A. L. MCQUATE*; A.
BARRIA. Univ. of Washington.
3:00 E6
396.11 Characterisation of two NMDA NR2B
subunit (grin2b) antagonists across tests of impulsivity
and attention. G. A. HIGGINS*; L. B. SILENIEKS; C.
MACMILLAN; J. SEVO; F. D. ZEEB; S. THEVARKUNNEL.
Intervivo Solutions Inc, U. Toronto, Vivocore, CAMH.

4:00 E7
396.12 N-Methyl--Aspartate (NMDA) receptor
glycine site agonist shows pronounced subtype-dependent
pharmacological profiles. M. JESSEN*; K. FREDERIKSEN;
H. BRUNER-OSBORNE; P. KILBURN; A. DAMHOLT. H.
Lundbeck A/S, Univ. of Copenhagen, H. Lundbeck A/S.
1:00 E8
396.13 Investigating the impact of NMDA
receptor hypounction on the synaptic integration of
hippocampal neurogliaform cells. R. CHITTAJALLU*; J. C.
WESTER; M. C. CRAIG; E. BARKSDALE; G. AKGUL; S.
HUNT; C. FANG; X. YUAN; D. COLLINS; K. A. PELKEY; C.
J. MCBAIN. NICHD, NIH.

Neuroscience 2016|Monday PM|89

Mon. PM

1:00 D23 395.01 Neuronal signal molecules in developing

and adult Dreissena, an environmental biofouling mollusk. I.
BATTONYAI*; E. E. VORONEZSHKAYA; A. OBUKHOVA; L.
P. NEZLIN; K. ELEKES. MTA Ctr. For Ecolog. Res., Balaton
Limnol. Inst., Inst. of Developmental Biology, Russian Acad.
of Sci.

1:00 D34 396.05 Epilepsy-associated GRIN2A mutationsfunctional analysis and pharmacological rescue of
phenotypic deficits. L. ADDIS*; J. K. VIRDEE; L. R. VIDLER;
D. A. COLLIER; D. K. PAL; D. URSU. Kings Col. London, Eli
Lilly Res. Ctr.

2:00 E9
396.14 Low-dose NMDAR antagonists increase
the excitation/inhibition balance onto CA1 pyramidal cells
causing disinhibition. A. J. WIDMAN*; L. L. MCMAHON.
Univ. of Alabama, Birmingham (UAB).
3:00 E10 396.15 Structure activity relationships and
mechanism of action of NMDA receptor positive allosteric
modulators based upon 2-naphthoic acid. K. SAPKOTA*;
G. FANG; M. W. IRVINE; E. BURNELL; G. CULLEY; D.
CHOPRA; S. DRAVID; G. L. COLLINGRIDGE; D. E. JANE;
D. T. MONAGHAN. Univ. of Nebraska Med. Ctr., Univ. of
Bristol, Creighton Univ., Univ. of Toronto.
4:00 E11 396.16 Protons exert distinct influences on the
translocation of the M3 domains of GluN1 and GluN2A
N-methyl-D-aspartate receptor subunits. N. N. JACKSON*;
S. N. REID; K. S. JONES. Howard Univ., Howard Univ. Col.
of Med.
1:00 E12 396.17 Endogenous expression of SAP97 in PV
interneurons is correlated to decreased NMDAR synaptic
activity. R. C. FERRER FIERRO*; A. BAEZ; L. WOLLMUTH.
Stony Brook Univ., Stony Brook Univ.
2:00 E13 396.18 Presynaptic NMDA receptors rely on
RIM1 to control readily-releasable pool at synapses onto
layer-5 pyramidal neurons. Y. CHOU*; T. ABRAHAMSSON;
S. LI; A. MANCINO; E. NURO; R. P. COSTA; K. A.
BUCHANAN; D. ELGAR; A. V. BLACKMAN; A. T. JONES;
K. MURAI; P. J. SJSTRM. The Res. Inst. of the McGill
Univ. He, Ctr. for Neural Circuits and Behaviour, Univ. Col.
London.
3:00 E14 396.19 Emerging role of GluN2D-containing
NMDARs in modulating synaptic plasticity within the bed
nucleus of the stria terminalis and anxiety/depressive-like
behaviors. G. J. SALIMANDO*; T. A. WILLS; D. G. WINDER.
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ., Vanderbilt
Univ., Vanderbilt Univ., Louisiana State Univ. Hlth. Sci. Ctr.
4:00 E15 396.20 The role of protein phosphatase 1
in regulating NMDA receptor trafficking. A. M. CHIU*; T.
TEDESCHI; A. SANZ-CLEMENTE. Northwestern Univ.,
Northwestern Univ.
1:00 E16 396.21 Physiological differences between the
primary visual cortex and dorsolateral prefrontal cortex in
primate. S. YANG*; M. WANG; M. ALTMAN; L. E. JIN; V.
GALVIN; A. F. T. ARNSTEN; J. A. MAZER. Yale Univ., Yale
Univ.
2:00 E17 396.22 Effects on magnesium block and
potentiation of non-pore lining residues in NMDA receptor
transmembrane domains. M. WILCOX*; S. MESBAHI,
15217; M. KURNIKOVA, 15217; J. W. JOHNSON. Univ. of
Pittsburgh, Carnegie Mellon Univ.
3:00 E18 396.23 Effects of lithium on NMDAR currents and
intracellular calcium responses of rat cortical neurons. D. A.
SIBAROV*; E. E. POGUZHELSKAYA; P. A. ABUSHIK; S. M.
ANTONOV. Iephb RAS.
4:00 E19 396.24 Modulation of NMDA receptors by TRPC6
and its function in synaptic plasticity. H. SHEN*; W. HU.
Nantong Univ., Univ. of California, Davis.

2:00 E21 396.26 Psd95 deficiency alters nmda and ampa

receptor expression and function during development in the
prefrontal cortex. A. COLEY*; W. GAO. Drexel Univ. Col. of
Med., Drexel Univ.

POSTER
397. AMPA Receptors
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 E22 397.01 Novel AMPA receptor modulators with

an enhanced safety profile. J. R. ATACK*; P. BESWICK;
M. HERD; N. UPTON; D. SPANSWICK; R. PORTER;
M. GOSLING; J. LAMBERT; S. E. WARD. Sussex
Drug Discovery Ctr., Dundee Univ., Transpharmation,
Neurosolutions, Rod Porter Consultancy.
2:00 E23 397.02 Pharmacological characterisation of
the clinical AMPA receptor positive allosteric modulator
[N[(2S)5(6fluoro3pyridinyl)2,3dihydro 1Hinden2yl]2propanesulfonamide]. S. WARD*; P. BESWICK; M. H.
HARRIS; N. CALCINAGHI; J. GARTLON; F. GRAZIANI;
L. LACROIX; S. MOK; B. OLIOSI; J. PARDOE; K. STARR.
Univ. of Sussex, GlaxoSmithKline, GlaxoSmithKline.
3:00 E24 397.03 Identification and characterization of the
binding pocket for negative allosteric modulators in AMPA
receptors. C. STENUM-BERG*; C. L. THISTED; S. C.
ABIEGA; A. S. KRISTENSEN. Univ. of Copenhagen.
4:00 E25 397.04 Defective FRRS1l impairs AMPA-receptor
biogenesis and causes severe intellectual disability. J.
SCHWENK; A. BRECHET; S. BOUDKKAZI; R. BUCHERT;
G. ZOLLES; K. SIQUIER-PERNET; W. BILDL; A. SAADI; C.
BOLE-FEYSOT; P. NITSCHKE; N. AL-SANNAA; A. REIS; A.
KULIK; U. SCHULTE; L. COLLEAUX; R. ABOU JAMRA; B.
FAKLER*. Inst. of Physiol., Inst. of Human Genet., INSERM
UMR 1163, Inst. IMAGINE, Dept. de Neurologie, Dharan
Hlth. Ctr., Inst. of Human Genet., Inst. of Human Genet.
1:00 E26 397.05 Identification of a novel protein that
regulates endosome pH, AMPAR trafficking and synaptic
function. A. J. KALLARACKAL*; J. MELLEM; D. M.
MADSEN; V. MARICQ. Univ. of Utah, Univ. of Utah.
2:00 E27 397.06 Mechanisms underlying slow AMPAreceptor mediated current at mossy fiber-unipolar brush
cell synapse. H. LU; T. S. BALMER*; G. E. ROMERO; L. O.
TRUSSELL. Oregon Hlth. and Sci. Univ., Oregon Hlth. and
Sci. Univ., Oregon Hlth. and Sci. Univ.

3:00 E28 397.07 Claudins: An unexpected source for

more tetraspanning proteins acting as transmembrane
AMPA receptor modulatory proteins. S. HAERING; S.
BHATTACHARYA; M. ASLAM; T. STRASDEIT; J. VON
ENGELHARDT; S. F. TRAYNELIS; M. HOLLMANN*.
NIH/NICHD, Emory Univ. Sch. of Med., Deutsches
Krebsforschungszentrum & Deutsches Zentrum fr
Neurodegenerative Erkrankungen, Ruhr Univ. Bochum, Ruhr
Univ. Bochum.

1:00 E20 396.25 NMDA receptor antagonist-induced

neuronal oscillations are augmented in the GluN-2C
knockout mouse; implications for schizophrenia. Z. MAO*;
Y. ZHANG; K. SAPKOTA; H. ALSAAD; S. DRAVID; D.
MONAGHAN. Univ. of Nebraska Med. Ctr., Univ. of
Nebraska Med. Ctr., Univ. of Nebraska Med. Ctr., Creighton
Univ.

4:00 E29 397.08 Secreted amyloid precursor protein-

regulates synthesis of the AMPA receptor subunit GluA1.
M. K. ELDER*; K. PEPPERCORN; S. TOM DIECK; L.
KOCHEN; E. SCHUMAN; W. TATE; C. ABRAHAM; J.
WILLIAMS. Univ. of Otago, Univ. of Otago, Max Planck Inst.
for Brain Res., Univ. of Otago.

90 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 E30 397.09 Extensive phosphorylation of AMPA

receptors in neurons. N. K. HUSSAIN SHULER*; G. H.
DIERING; S. HEO; B. LIU; R. L. HUGANIR. Johns Hopkins
Univ. Sch. of Med.
2:00 E31 397.10 The auxiliary subunit C9orf4 (FRRS1l)
slows AMPAR recovery from desensitization. S. PEARCE*;
M. FARRANT; S. G. CULL-CANDY. Univ. Col. London.
3:00 E32 397.11 Characterization of AMPAR auxiliary
subunit GSG1L expression pattern and function using
transgenic model systems. A. KAMALOVA*; E. ZAIKA; K.
FUTAI; E. DELPIRE; T. NAKAGAWA. Vanderbilt Univ., Univ.
of Massachusetts Med. Sch.
4:00 E33 397.12 Using high throughput screening methods
to identify small molecule modulators that specifically target
the GluA2-auxiliary subunit complex. C. AZUMAYA*; E.
DAYS; P. VINSON; S. STAUFFER; G. SULIKOWSKI; D.
WEAVER; T. NAKAGAWA. Vanderbilt Univ., Vanderbilt Univ.,
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ.

POSTER
398. Ca2+ Channels and Ca2+ Signaling
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 E34 398.01 Decreased palmitoylation of PSD-95
contributes to src mediated NMDA receptor hypoactivity in
schizophrenia. A. BANERJEE*; A. SENGAR; J. KIM; R. RAY;
K. BORGMANN-WINTER; M. SALTER; C. HAHN. Univ.
Pennsylvania, Sick Kids, Univ. of Pennsylvania, Univ. of
Pennsylvania, Univ. of Pennsylvania and Children Hosp. of
Philadelphia, Sick Kids and Univ. of Toronto.

2:00 E35 398.02 State-dependence alone does not

provide a sufficient CNS margin with an orally efficacious
Cav2 selective small molecule. K. S. RATLIFF*; K.
KNOPP; J. SCHKERYANTZ; B. T. PRIEST; M. CLARK;
R. CERNE; M. WAKULCHIK; B. HEINZ; M. WALKER; A.
VANDERGRIFF; X. HUANG; M. J. VALLI; W. J. PORTER;
J. K. REEL; D. LUFFER-ATLAS; T. JONES; R. M. A.
SIMMONS; B. FORSTER; W. GUO; B. ADAMS; L. YANG; J.
S. MCDERMOTT. Neurosci. Discovery, Eli Lilly & Co.
3:00 E36 398.03 L-type voltage gated calcium channels
functionally couple with IKCa channels in CA1 pyramidal
cells to generate the slow afterhyperpolarization. G. SAHU*;
J. MICLAT; H. ASMARA; G. W. ZAMPONI; R. W. TURNER.
Univ. of Calgary.
4:00 E37 398.04 The 5HT2C receptor decreases seizure
susceptibility in the dorsal subiculum by inhibiting CaV3 ion
channels. A. PETERSEN*; C. S. JENSEN; V. CRPEL; M.
FALKERSLEV; J. PERRIER. Copenhagen Univ., INMED.
1:00 E38 398.05 Crosstalk between InsP3R and TRPV4
in Ca2+ microdomains contributes to paclitaxel-induced
neurotoxicity. W. BOEHMERLE*; P. HUEHNCHEN; C.
HARMS; M. ENDRES. Charite Universitaetsmedizin Berlin.
2:00 F1
398.06 Acute estrogen causes a prolonged
alteration of intracellular calcium signaling in basal forebrain
neurons of F344 rats. D. A. MURCHISON*; A. S. FINCHER;
W. H. GRIFFITH. Texas A&M Hlth. Sci. Ctr.
3:00 F2
398.07 Regulation of NMDA receptor
phosphorylation by multiple calcium signaling pathways.
R. V. OMKUMAR*; M. JOHN; M. KUMAR; J. JAMES; M.
MAYADEVI. Rajiv Gandhi Ctr. For Biotech.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 F4
398.09 Suppression of peripheral sympathetic
activity underlies agmatine-mediated hypotension. Y. KIM*;
S. CHUNG. Yonsei Univ. Col. of Med., Brain Korea 21
Project for Med. Science, Yonsei Univ. Col. of Med.
2:00 F5
398.10 Characterization of the P-type voltagegated calcium channel in chick. Q. LI*; B. ELLIOTT; E. F.
STANLEY. Krembil Res. Inst.
3:00 F6
398.11 Examination of the effects of NCLX
knock-out on mitochondrial and cytosolic Ca2+ signaling
in hippocampal neurons. Z. LIN; J. RYSTED; A.
GNANASEKARAN; Y. M. USACHEV*. Univ. of Iowa Dept. of
Pharmacol.
4:00 F7
398.12 Effect of ghrelin and leptin on voltage
gated calcium channels in rin-m5f cells. B. DOMINGUEZ
MANCERA*; A. HERNNDEZ-BELTRN; M. BARRIENTOSMORALES; P. CERVANTES-ACOSTA; A. RODRGUEZANDRADE. Univ. Veracruzana, Dept Fisiologa, Univ.
Veracruzana, Dept Fisiologa, Univ. Veracruzana, Dept
Fisiologa, Univ. Veracruzana, Dept Fisiologa, Inst.
Tecnolgico de Veracruz.
1:00 F8
398.13 Differential translocation in vitro and in
vivo of two closely related Neuronal Calcium Sensor Proteins
Neurocalcin and Hippocalcin. J. ZHANG*; J. VIVIANO; A.
KRISHNAN; P. BELAN; V. VENKATARAMAN. Rowan Univ.
Sch. of Osteo. Med., Rowan Univ. Sch. of Osteo. Med.,
Bogomoletz Inst. of Physiol.

POSTER
399. Dopamine Transporter Regulation
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 F9
399.01 Dopamine transporter amino and carboxy
termini synergistically mediate ack1-dependent endocytosis.
C. G. SWEENEY*; B. P. TREMBLAY; H. E. MELIKIAN. Univ.
of Massachusetts Med. Sch.
2:00 F10 399.02 Using Drosophila melanogaster as
a model to study how regulated dopamine transporter
trafficking impacts psychostimulant associated reward.
R. R. FAGAN*; P. EMERY; H. E. MELIKIAN. Univ. of
Massachusetts Med. Sch., Univ. of Massachusetts Med.
Sch., Univ. of Massachusetts Med. Sch.
3:00 F11 399.03 Role of G protein subunits in
amphetamine-stimulated increase in extracellular dopamine.
S. S. HARRIS*; M. TERMINEL; E. CASTANEDA; J. C.
MAUNA; E. THIELS; G. E. TORRES. Univ. of Florida, Texas
A&M Univ., Univ. of Texas at El Paso, Univ. of Pittsburgh.
4:00 F12 399.04 Presynaptic determinants of dopamine
signaling in vivo elucidated via forward genetic analysis
of swimming induced paralysis (Swip). O. REFAI*; J.
HARDAWAY; C. L. SNARRENBERG; S. ROBINSON; S.
L. HARDIE; P. FREEMAN; R. D. BLAKELY. Florida Atlantic
Univ., Vanderbilt Univ., Fisk Univ., Florida Atlantic Univ.
1:00 F13 399.05 Methamphetamine regulates the firing
activity of dopamine neurons via a calcium-dependent
potassium channel. M. LIN; D. SAMBO; H. KHOSHBOUEI*.
Univ. of Florida.

Neuroscience 2016|Monday PM|91

Mon. PM

Theme B: Neural Excitability, Synapses, and Glia

4:00 F3
398.08 Relationship between ketamine-induced
toxicity and nmda receptor-mediated calcium influx in
developing neurons. C. WANG*; F. LIU; T. A. PATTERSON;
M. G. PAULE; W. SLIKKER, Jr. Natl. Ctr. for Toxicological
Res.

2:00 F14 399.06 The -1 receptor decreases

methamphetamine stimulation of the dopamine transporter
via a calcium-dependent mechanism. D. O. SAMBO*; M.
LIN; H. KHOSHBOUEI. Univ. of Florida.
3:00 F15 399.07 Mechanistic and behavioral
characterization of the dopamine transporter using a novel
allosteric modulator. S. AGGARWAL*; P. MENELL; A.
CHANG; S. KORTAGERE; O. V. MORTENSEN. Drexel
Univ., Drexel Univ. Col. of Med., Drexel Univ. Col. of Med.
4:00 F16 399.08 Kv2.1 and the dopamine transporter
interact in dopaminergic neurons. J. LEBOWITZ*; J. A. PINO
REYES; S. STREIT; D. SAMBO; M. LIN; H. KHOSHBOUEI;
G. E. TORRES. Univ. of Florida, Univ. of Florida, Col. of
Medicine, Heinrich-Heine-Universitt.
1:00 F17 399.09 Altered sensitivity to serotonin transporter
blockade underlies loss of locomotor response to cocaine
in DAT Val559 mice. A. STEWART*; G. L. DAVIS; R.
GOWRISHANKAR; P. J. GRESCH; F. I. CARROLL; M. K.
HAHN; R. D. BLAKELY. Florida Atlantic Univ., Florida Atlantic
Univ., Vanderbilt Univ., Vanderbilt Univ., Res. Triangle Inst.
2:00 F18 399.10 N-terminus phosphorylation in the
Dopamine Transporter mediates G-stimulated dopamine
efflux. J. GARCIA-OLIVARES*; J. A. BORIS; S. G. AMARA.
Natl. Inst. of Mental Hlth.
3:00 F19 399.11 Dopamine transporter interactome when
exposed to psychostimulants. S. INGRAM; T. RANA; J. S.
GOODWIN*. Meharry Med. Col.
4:00 F20 399.12 Aberrant dopamine D2 autoreceptor
regulation of the dopamine transporter in striatal
dopaminergic terminals of mice expressing the ADHDassociated dopamine transporter variant DAT Val559. R.
GOWRISHANKAR*; G. L. DAVIS; A. M. STEWART; J. S.
RIELE; M. K. HAHN; R. D. BLAKELY. Florida Atlantic Univ.,
Florida Atlantic Univ., Vanderbilt Univ., Vanderbilt Univ.
1:00 F21 399.13 Dopamine transporter expression
evaluated in perinatally asphyxiated rats. S. J. LOPEZPEREZ*; J. U. MORA-VENADERO. Univ. of Guadalajara
(CUCBA), Univ. of Guadalajara.
2:00 F22 399.14 Identification of residues involved in the
dopamine transporter-G interaction and dopamine efflux.
J. A. PINO*; M. H. CHENG; F. PULLARA; A. GOPINATH;
K. SAHA; J. LEBOWITZ; H. KHOSHBOUEI; J. GARCIAOLIVARES; S. G. AMARA; I. BAHAR; G. E. TORRES. Univ.
of Florida, Univ. of Pittsburgh, Univ. of Florida, NIH.
3:00 F23 399.15 Changes in motivation, impulsivity,
cognition and DAergic signaling cascades with ADHDassociated DAT Val559 transgenic mouse. G. L. DAVIS*; L.
A. WALKER; R. D. BLAKELY. Florida Atlantic Univ., Florida
Atlantic Univ., Vanderbilt Univ., Vanderbilt Univ.
4:00 F24 399.16 Noncanonical neurotoxicity of hiv-1 tat
on midbrain dopamine neurons. D. MILLER*; S. STREIT;
K. SAHA; S. BUCH; W. STREIT; J. MCLAUGHLIN; H.
KHOSHBOUEI. Univ. of Florida, Heinrich-Heine-Universitt
Dsseldorf, Univ. of Nebraska.
1:00 F25 399.17 Pharmacological chaperones of the
dopamine transporter rescue dopamine transporter
deficiency syndrome mutations in heterologous cells. P.
BEEREPOOT*; V. M. LAM; A. SALAHPOUR. Univ. of
Toronto.

2:00 F26 399.18 Role of the dopamine transporter

and G protein interaction in amphetamine-induced
hyperlocomotion and reward-conditioned behavior in rats.
C. M. EDWARDS*; J. C. MAUNA; C. D. BASSI; R. LUDER;
J. A. PINO; J. GARCIA-OLIVARES; S. G. AMARA; G. E.
TORRES; E. THIELS. Univ. of Pittsburgh, Univ. of Pittsburgh,
Univ. of Pittsburgh, Univ. of Florida, Natl. Inst. of Mental
Hlth., Natl. Institude of Mental Hlth.
3:00 F27 399.19 Psychoactive benzofury
compounds, 5-APB and 6-APB, mimic the effects of
3,4-methylenedioxyamphetamine (MDA) on monoamine
transmission in rats. M. H. BAUMANN*; H. M. WALTERS; J.
S. PARTILLA; B. E. BLOUGH; S. D. BRANDT. IRP, NIDA,
NIH, DHHS, RTI, Liverpool John Moores Univ.

POSTER
400. Visualizing Presynaptic Structure and Function
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 F28 400.01 Structural and synaptic organization
of the adult reeler mouse somatosensory neocortex.
M. PRUME*; A. ROLLENHAGEN; J. LBKE. Res. Ctr.
Jlich Gmbh, Res. Ctr. Jlich Gmbh, Dept. of Psychiatry,
Psychotherapy and Psychosomatics, RWTH Univ. Hosp.
Aachen, JARA Translational Brain Med.
2:00 F29 400.02 Synaptic organization in layer 5 of the
human temporal lobe: A quantitative electron microscopic
analysis. R. YAKOUBI*; A. ROLLENHAGEN; M. VON LEHE;
K. STZLER; J. LBKE. Res. Ctr. Jlich Gmbh, Inst. of
Neurosci. and Med. INM-2, Res. Ctr. Jlich Gmbh, Dept. of
Neurosurg. at the Univ. Hosp., Sch. of Biomed. Sciences,
Univ. of Ulster, Dept. of Psychiatry, Psychotherapy and
Psychosomatics, RWTH/University Hosp. Aachen, JARA
Translational Brain Med.
3:00 F30 400.03 Immunogold labeling of presynaptic
proteins in developing hippocampal neurons. J. TAOCHENG*. NIH.
4:00 F31 400.04 Super resolution microscopy analysis of
neuromuscular junction active zones in adult and aged mice.
Y. BADAWI*; S. MORI; K. SHIGEMOTO; H. NISHIMUNE.
Univ. of Kansas Med. Ctr., Tokyo Metropolitan Inst. of
Gerontology.
1:00 F32 400.05 Structural heterogeneity of presynaptic
active zones underlies variability in synaptic latency
across synapses at the frog neuromuscular junction. A. E.
HOMAN*; R. LAGHAEI; M. DITTRICH; S. D. MERINEY.
Univ. of Pittsburgh, Carnegie Mellon Univ., Carnegie Mellon
Unversity, Univ. of Pittsburgh.
2:00 F33

400.06 Withdrawn.

3:00 F34 400.07 Oriented docking of dense core

vesicles at active zones on the presynaptic membrane
of neuromuscular junctions. J. JUNG*; J. SZULE; K.
STOUDER; U. MCMAHAN. Texas A&M Univ., Texas A&M
Univ.
4:00 F35 400.08 Characterization of a synaptic vesicle
binding site on the CaV channel distal C-terminal. S.
GARDEZI*; Q. LI; A. R. NATH; E. F. STANLEY. Krembil Res.
Inst.
1:00 F36 400.09 RIM-binding proteins are crucial for
clustering calcium channels and synaptic transmission in
ribbon synapse. F. LUO*; C. ACUNA; T. SDHOF. Hhmi/
Stanford Univ., Stanford Univ., HHMI/Stanford Univ.

92 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 F37 400.10 Analysis of vamp7 function at the

Drosophila neuromuscular junction. I. D. SANTIAGO*;
B. MELENDEZ; T. J. LITTLETON; R. JORQUERA. Univ.
Central Del Caribe, Univ. Central del Caribe, MIT, Univ. de
Chile.
3:00 F38 400.11 Dynamics of the Extended
Synaptotagmins in the endoplasmic reticulum of neurons.
C. WHITEUS*; J. WANG; R. YASUDA; P. DE CAMILLI. Yale
Univ., Max Planck Florida Inst. for Neurosci., Yale University,
Howard Hughes Med. Inst.
4:00 F39 400.12 Genetic expression of an active zone
peptide to induce cell-specific synaptic depression and
to screen for vesicle tethering factors. R. J. KITTEL*; N.
SCHOLZ; N. EHMANN; C. STIGLOHER; T. LANGENHAN.
Univ. of Wuerzburg, Univ. of Wuerzburg.
1:00 F40 400.13 Proteomic screening of GABAergic and
glutamatergic neurons isolated by fluorescence activated
sorting. Z. WEI*; X. LI; L. QIN; H. YU; Z. GAO; S. DUAN.
Inst. of Neuroscience, Zhejiang Univ., Nantong Univ.
2:00 F41 400.14 Synaptotagmin1 sorting to synaptic
vesicles is probabilistic. T. A. SCHIKORSKI*; D. CRUZ. Univ.
Central Del Caribe, Univ. Puerto Rico.

4:00 F43 400.16 Signaling pathway controlling

mitochondria-dependent presynaptic calcium clearance and
neurotransmitter release properties at single synapses along
cortical axons. S. KWON*; R. SANDO, III; T. L. LEWIS, Jr; Y.
HIRABAYASHI; A. MAXIMOV; F. POLLEUX. Columbia Univ.,
The Scripps Res. Inst.
1:00 F44 400.17 Quantification of fast presynaptic Ca2+
kinetics using non-stationary single compartment model.
Y. TIMOFEEVA; D. RUSAKOV; K. E. VOLYNSKI*. Dept.
of Computer Sci. and Ctr. for Complexity Science, Univ. of
Warwick, UCL Inst. of Neurol.
2:00 F45 400.18 Presynaptic calcium dynamics
translate bursts of action potential to control the mode of
neurotransmitter release at the mossy fiber to CA3 pyramidal
cell synapse. S. CHAMBERLAND*; A. EVSTRATOVA; K.
TOTH. CRULRG.
3:00 F46 400.19 Hemi-fused structure mediates and
controls fusion and fission in live cells. S. A. VILLARREAL*;
W. ZHAO; E. HAMID; P. J. WEN; E. S. KRYSTOFIAK; H.
CHIANG; B. KACHAR; L. WU. NINDS, NIDCD.
4:00 F47 400.20 Activity-dependent movement of
synapsin between Drosophila motor boutons. A. VASIN*; M.
BYKHOVSKAIA. Wayne State Univ. Sch. of Med.
1:00 F48 400.21 Monitoring vesicle dynamics in gabadepleted hippocampal neurons using vgat-phluorin. L.
BONET*; S. SUPPLISSON. IBENS.
2:00 F49 400.22 In vivo time lapse imaging of axonal
dense core vesicle trafficking in anaesthesized and awake
mice. J. KNABBE*; J. NASSAL; H. HORSTMANN; M.
VERHAGE; T. KUNER. Inst. of Functional Neuroanatomy,
Ctr. for Neurogenomics and Cognitive Res.
3:00 F50 400.23 Dynamics of synaptic vesicle protein
after single vesicle exocytosis at a hippocampal presynaptic
active zone recorded by a novel live-cell imaging method. J.
FUNAHASHI*; H. TANAKA; T. HIRANO. Dept. of Biophys.,
Grad. Sch. of Sci., Kyoto Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
401. Spike-Timing Dependent Plasticity
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 F52 401.01 Spike-timing dependent plasticity in the
long latency stretch reflex following paired stimulation from a
wearable electronic device. K. FOYSAL*; F. DE CARVALHO;
S. BAKER. Newcastle Univ.
2:00 F53 401.02 The role of local excitatory networks
in the lateral amygdala in emotional memory learning. M.
ABATIS*; R. NIU; R. PERIN; H. MARKRAM; H. BITO; R.
STOOP. Dept. of Psychiatry, CHUV, BMI, EPFL, Dept. of
Neurochemistry, Univ. of Tokyo.
3:00 G1
401.03 Postsynaptic calcium dynamics
associated with bidirectional plasticity of NMDA receptormediated transmission. S. LUTZU; K. ALVINA*; P.
CASTILLO. Albert Einstein Col. of Med., Albert Einstein Col.
of Med.
4:00 G2
401.04 Paired transspinal and transcortical
associative stimulation modulates human spinal motor
output. M. KNIKOU*; D. SANTORA; L. DIXON; M. M.
IBRAHIM. City Univ. of New York.
1:00 G3
401.05 Optimal learning with redundant synaptic
connections. N. HIRATANI*; T. FUKAI. RIKEN Brain Sci.
Inst., The Univ. of Tokyo, JST CREST.
2:00 G4
401.06 Anti-Hebbian learning of optimal
homeostatic IPSG amplitude and decay time. J. K. KIM*; C.
D. FIORILLO. Korea Advanced Inst. of Sci. and Technol.
3:00 G5
401.07 Activity-dependent anti-Hebbian
glutamatergic spike-timing dependent plasticity within the
lateral habenula. L. D. LANGLOIS*; F. NUGENT. Uniformed
Services Univ. of the Hlth. Scienc, Uniformed Services Univ.
of the Hlth. Sci.
4:00 G6
401.08 Identification of a functional spike-timingdependent plasticity rule from ensemble hippocampal
spiking activity with generalized multilinear modeling.
B. S. ROBINSON*; D. SONG; R. E. HAMPSON; S. A.
DEADWYLER; T. W. BERGER. USC, Wake Forest Sch. of
Med.
1:00 G7
401.09 Potential roles of intracellular calcium
dynamics regulated by calcium stores for spatial association
of synaptic plasticity. D. FUTAGI; K. KITANO*. Ritsumeikan
Univ.
2:00 G8
401.10 Cholinergic modulation on LTD in rat
hippocampal network. E. SUGISAKI*; Y. FUKUSHIMA; S.
FUJII; N. NAKAJIMA; T. AIHARA. Tamagawa Univ. Grad.
Sch. of Engin., Kawasaki Univ., Yamagata Univ.
3:00 G9
401.11 Developmental profile of spike timingdependent plasticity at CA3-CA1 synapses of mouse
hippocampus. A. RODRIGUEZ-MORENO*; Y. ANDRADETALAVERA; P. DUQUE-FERIA. Univ. Pablo De Olavide.
4:00 G10 401.12 Complex circuits from simple learning
rules. J. OLSON*; G. KREIMAN. Harvard Univ.

Neuroscience 2016|Monday PM|93

Mon. PM

3:00 F42 400.15 Distinct Ca2+ dynamics in glutamatergic

and aminergic synapses determined by intrinsic neuronal
properties independent of synaptic bouton physical
dimensions and GCaMP expression levels. X. XING*; C.
WU. Univ. of Iowa, the Univ. of Iowa.

4:00 F51 400.24 Rapid and spatially-confined PI(4,5)P2

manipulations by optogenetic approaches regulate vesicle
docking and secretion. C. JI*; F. FAN; X. LOU. Univ. of
Wisconsin-Madison.

1:00 G11 401.13 Experience-dependent regulation of

spike-timing dependent plasticity of inhibition in auditory
cortex. E. D. VICKERS*; R. SCHNEGGENBURGER. EPFL,
EPFL.
2:00 G12 401.14 Spike-timing-dependent plasticity for
short-term memory and long-term memory. Y. PARK*; W.
CHOI; S. PAIK. KAIST, Program of Brain and Cognitive
Engineering, KAIST.

POSTER
402. Structural Plasticity I
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 G13 402.01 CD44 adhesion molecule involved in
molecular mechanisms responsible for stabilization of
dendritic spines. A. SKUPIEN*; M. ROSZKOWSKA; G.
WILCZYNSKI; J. DZWONEK. Nencki Inst. of Exptl. Biol.
Polish Ac, Nencki Inst. of Exptl. Biol. Polish Acad. of Sci.
2:00 G14 402.02 CD44, a novel synaptic cell adhesion
molecule regulating structural and functional plasticity of
dendritic spines. J. DZWONEK*; M. ROSZKOWSKA; A.
SKUPIEN; T. WOJTOWICZ; M. KISIEL; B. RUSZCZYCKI; H.
DOLEZYCZEK; J. W. MOZRZYMAS; J. WLODARCZYK; G.
M. WILCZYNSKI. Nencki Inst. of Exptl. Biol., Nencki Inst. of
Exptl. Biol., Wroclaw Med. University, Nencki Inst. of Exptl.
Biol.
3:00 G15 402.03 Dendritic spine changes associated with
long-term synaptic plasticity in nigral dopamine neurons. M.
KIM*; M. PARK. Sungkyunkwan Univ. Sch. of Med.
4:00 G16 402.04 Localization and regulation of nogo
receptor 1 and its partners. A. T. BRODIN*; K. WELLFELT;
G. SMEDFORS; E. ARVIDSSON; L. OLSON; T. E.
KARLSSON. Karolinska Institutet.
1:00 G17 402.05 Structural plasticity of dendritic spines
during long-term synaptic depression. A. THOMAZEAU*; M.
BOSCH; S. ESSAYAN-PEREZ; M. F. BEAR. The Picower
Inst. For Learning and Memory, Inst. for Bioengineering of
Catalonia.
2:00 G18 402.06 Intracerebroventricular administration of
growth hormone induces neural morphological changes in
the CA1 region of the dorsal hippocampus and the prefrontal
cerebral cortex of adult rats. J. OLIVARES HERNANDEZ;
F. A. GARCA-GARCA*; E. JUAREZ AGUILAR. Univ.
Veracruzana, Univ. Veracruzana.
3:00 G19 402.07 Analysis of the specificity of MMP-9
inhibitor on the nectin-3 shedding upon neuronal stimulation.
E. REJMAK-KOZICKA*; M. DZIEMBOWSKA; K. KALITA; L.
KACZMAREK. Nencki Inst. of Exptl. Biol.
4:00 G20 402.08 Exploring the molecular mechanisms
underlying rapid estrogenic modulation of cortical
connectivity. P. RAVAL*; K. J. SELLERS; J. MUKHERJEE; N.
J. BRANDON; D. P. SRIVASTAVA. Kings Col. London, Tufts
Univ. Med. Sch., AstraZeneca Neurosci. IMED.
1:00 G21 402.09 Early postnatal manganese exposure
affects primary motor cortex development in adolescent
mice. C. E. MOYER*; S. A. BEAUDIN; D. R. SMITH; Y. ZUO.
Univ. of California Santa Cruz, Univ. of California Santa
Cruz.

2:00 G22 402.10 Physical exercise prevented the loss

of spines and improved the ability of memory through the
BDNF-TrkB signal pathway. K. CHEN*; C. LAI; M. TAN; L.
HUANG; L. ZHANG; A. LI; W. GAN; K. SO; C. REN. Jinan
Univ., The Univ. of Hong Kong, Jinan Univ., New York Univ.
3:00 G23 402.11 Age-dependent alterations in dendritic
spine dynamics in the somatosensory cortex following
whisker stimulation. R. L. VOGLEWEDE*; A. R. DEWITT;
E. H. TRIMMER; R. MOSTANY. Tulane Univ. Sch. of Med.,
Tulane Univ. Sch. of Med.
4:00 G24 402.12 Parvalbumin-positive interneurons
of the hippocampus show input-dependent structural
plasticity. A. FOGGETTI; T. SCHIFFELHOLZ; P. WULFF*.
Inst. of Physiology, Univ. of Kiel, Dept. of Psychiatry and
Psychotherapy, Univ. of Kiel.
1:00 G25 402.13 Estrogen sensitive G-protein coupled
receptor (GPER1) rapidly regulates dendritic spine turnover
and PSD-95 dynamics. K. SELLERS*; P. RAVAL; I. A.
WATSON; T. DEEB; J. MUKHERJEE; F. ERLI; D. A. GADD;
N. BRANDON; D. P. SRIVASTAVA. Kings Col. London,
Tufts Univ. Med. Sch., Univ. of Milano-Bicocca, AstraZeneca
Neurosci. IMED.
2:00 G26 402.14 Actin dynamics contribute to the storage
of drug-associated memories in both sexes. E. J. YOUNG*;
G. RUMBAUGH; C. A. MILLER. Scripps Res. Inst., Scripps
Res. Inst.
3:00 G27 402.15 PRG-1 regulates synaptic plasticity
via intracellular PP2A/ITGB1-signaling. X. LIU; J. HUAI;
H. ENDLE; L. SCHTER; W. FAN; Y. LI; S. RICHERS; H.
YURUGI; K. RAJALINGAM; H. JI; H. CHENG; B. RISTER;
G. HORTA; J. BAUMGART; H. BERGER; G. LAUBE; U.
SCHMIDT; M. J. SCHMEISSER; T. BCKERS; T. DELLER;
A. VLACHOS; S. TENZER; R. NITSCH*; J. VOGT. Univ.
Med. Ctr. Mainz, Charit, Univ. of Ulm, Goethe Univ.
Frankfurt.
4:00 G28 402.16 Dendritic coordination between excitatory
and inhibitory plasticity. C. WIERENGA; D. KRUIJSSEN; H.
HU*; B. RSZA. Univ. of Utrecht, Two photon Imaging Lab. /
Inst. of Exptl. Med. of the Hungarian Acad. of Sci.
1:00 G29 402.17 Dissection of molecular mechanism of
Aplysia Sec7 protein-induced neurite outgrowth. Y. JUN; J.
LEE; B. KAANG; D. JANG*. Kyungpook Natl. Univ., Hannam
Univ., Seoul Natl. Univ., Kyungpook Natl. Univ.
2:00 G30 402.18 A new optical method for rapidly erasing
hippocampal synaptic memory. A. GOTO*; K. MIYA; T.
MATSUDA; T. NAGAI; Y. HAYASHI. RIKEN Brain Sci.
Inst., Dept. of Mol. Neurobiology, Fac. of Medicine, Univ.
of Tsukuba, The Inst. of Scientific and Industrial Research,
Osaka Univ., Saitama Univ. Brain Sci. Institute, Saitama
Univ., Sch. of Life Science, South China Normal Univ.
3:00 G31 402.19 The formation concept of protected areas
of the human neocortex in focal damage. V. AKULININ*; A.
MYTSIK; S. STEPANOV; V. RASUMOVSKY. Omsk State
Med. Univ.
4:00 G32 402.20 Enhancement of neuronal differentiation
of mice olfactory epithelium stem cells by DNA methylation
inhibition. I. B. FRANCO ESTRADA*; G. R. R. RAMIREZRODRIGUEZ; M. L. G. LAMAS GREGORI. Ctr. of Res. and
Advanced Studies of the Nat, Natl. Inst. of Psychiatry Ramn
de la Fuente Muiz, Mxico., Ctr. of Res. and Advanced
Studies.
1:00 G33 402.21 Spines in parvalbumin-expressing
interneurons undergo structural reorganization depending on
behavioral experience. D. KAUFHOLD*; M. STRBER; M.
BARTOS. Inst. of Physiol.

94 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 G34 402.22 Neural circuit rewiring in the frontal

association cortex of social defeated mice. T. XU*; Y. SHU.
Wuhan Natl. Lab. For Optoelectronics.
3:00 G35 402.23 PGE1 in liposomes containing
antagonized dendritic spine loss and reduction of VEGF
& VEGFR2 in hippocampus of diabetic rats. M. C.
MOSTALLINO*; F. BIGGIO; V. LOCCI; L. BOI; M. L. MANCA;
A. M. FADDA; G. BROTZU; G. BIGGIO. Natl. Res. Council,
CNR, Univ. of Cagliari, BioRicerca.
4:00 G36 402.24 NMDA receptor signaling mechanisms in
activity-dependent spine shrinkage. I. S. STEIN*; K. ZITO.
UC Davis.
1:00 G37 402.25 The RapGEF Gef26 regulates synaptic
development via inhibition of BMP signalling. K. HEO*. Seoul
Natl. Univ.

2:00 G38 402.26 Vortioxetine increases phosphorylation of

GluA1 subunit of AMPA receptor and alters other molecules
associated with neuroplasticity. L. WESTRICH*; J. WALLER;
B. CASE-WHITESIDE; M. GULINELLO; C. SANCHEZ; Y.
LI. Fairleigh Dickinson Univ., Lundbeck Res., Albert Einstein
Col. of Med.

403. Transcription and Translation: Synaptic and Circuit

Plasticity
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 G39 403.01 Phosphorylation status of eIF4B S406 is
a molecular switch in BC RNA-mediated translational control.
T. EOM*; I. A. MUSLIMOV; S. CHUANG; R. K. S. WONG;
H. TIEDGE. SUNY Downstate Med. Ctr., SUNY Downstate
Med. Ctr.
2:00 G40 403.02 Identification of the newly synthesized
protein required for synaptic plasticity in Xenopus laevis. H.
LIU*; W. SHEN; L. SCHIAPARELLI; D. MCCLATCHY; J. R.
YATES, III; H. T. CLINE. The Scripps Res. Inst., The Scripps
Res. Inst., Hangzhou Normal Univ., The Scripps Res. Inst.
3:00 G41 403.03 Role of FMRP bound miRISC at
the crossroads of NMDAR and mGluR signalling. P. M.
KUTE*; N. NEELAGANDAN; S. GOSH DASTIDAR; S.
CHATTERJI; R. MUDDASHETTY. Inst. for Stem Cell Biol
and Regenerative Med., SASTRA Univ., Natl. Ctr. for Biol.
Sci. (NCBS).
4:00 G42 403.04 Communication of pathway-specific
circuit activity to the genome by dendritic translation of
the immediate early gene Npas4. S. BRIGIDI*; P. LIN; B.
L. BLOODGOOD. Univ. of California San Diego, Univ. of
California San Diego.
1:00 G43 403.05 Transcriptome profiling in hippocampal
dendrites. S. FARRIS*; J. M. WARD; M. SAMADI; Y. WANG;
S. M. DUDEK. Natl. Inst. of Envrn. Hlth. Sci.
2:00 G44 403.06 -adrenergic receptors activation in
conditional dendritic RNA transport. I. A. MUSLIMOV*; H.
TIEDGE. SUNY Downstate Med. Ctr., SUNY Downstate
Med. Ctr.
3:00 G45 403.07 The kinesin motor protein KIF5B
regulates RNA trafficking and dendritic spine morphogenesis
in hippocampal neuron. H. CHAN*; J. HUANG; K. LAI. The
Univ. Of Hong Kong, The Univ. Of Hong Kong.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 G47 403.09 Npas4 is necessary for circuit

homeostasis and plasticity in the mouse primary visual
cortex. X. SUN*; S. F. COOKE; M. J. BERNSTEIN; R. W.
KOMOROWSKI; M. F. BEAR; Y. LIN. MIT.
2:00 G48 403.10 Experience-dependent transcriptional
regulation of inhibition in the CA1 microcircuit. A. L.
HARTZELL*; K. M. MARTYNIUK; G. P. HIGERD; B. L.
BLOODGOOD. UCSD, UCSD.
3:00 G49 403.11 Deconstructing the relationship
between neural activity patterns and Npas4-mediated gene
expression. P. LIN*; G. S. BRIGIDI; B. L. BLOODGOOD.
Univ. of California San Diego, Univ. of California San Diego.
4:00 G50 403.12 The role of activity-induced DNA
breaks in synaptic plasticity, learning, and memory. R.
MADABHUSHI*; O. KRITSKIY; F. GAO; T. X. PHAN; S.
YAMAKAWA; T. GILLINGHAM; R. RUEDA; J. D. JAFFE; L.
TSAI. MIT, The Broad Inst. of Harvard and MIT.
1:00 H1
403.13 Adult Notch signaling underlies
the rewarding memory of alcohol in Drosophila. E.
PETRUCCELLI*; M. FEYDER; R. MUSTER; N. LEDRU; K.
R. KAUN. Brown Univ., Brown Univ.
2:00 H2
403.14 Examination of stalled polysomes in
protein-synthesis dependent long-term potentiation in
hippocampal cultures. K. GINZBERG*; M. ANADOLU; T. E.
GRABER; W. SOSSIN. McGill Univ.
1:00 DP02 403.15 (Dynamic Poster) A combinatorial code
of immediate-early genes encodes salient experiences. A.
CITRI*. The Hebrew Univ.
4:00 H3
403.16 Absence of the long non-coding rna
bc1 disrupts spine morphology and experience-dependent
plasticity and learning. V. BRIZ*; L. RESTIVO; E.
PASCIUTO; K. JUCZEWSKI; V. MERCALDO; A. BORRECA;
T. GIRARDI; R. LUCA; N. GUNKO; P. BAATSEN; R.
POORTHUIS; H. MANSEVELDER; G. FISONE; M.
AMMASSARI-TEULE; J. NYS; L. ATCKENS; P. KRIEGER;
R. MEREDITH; C. BAGNI. VIB Ctr. For the Biol. of DiseaseKu Leuven, Hosp. for Sick Children, Inst. di Ricerca a
Carattere Clinico e Scientico Fondazione Santa Lucia, Natl.
Inst. of Alcoholism and Alcohol Abuse, Natl. Inst. of Hlth.,
Karolinska Institutet, Univ. of Rome Tor Vergata, KU Leuven,
VIB Bio Imaging Core, Ctr. for Neurogenomics and Cognitive
Research, VU Univ., KU Leuven, Ruhr-University Bochum,
Univ. of Lausanne.
1:00 H4
403.17 Serum response factor regulates
structural plasticity of dendritic spines during development.
K. KALITA-BYKOWSKA*; A. KRYSIAK; A. SUSKA; S.
LESKI; L. KACZMAREK. Nencki Inst. of Exptl. Biol.

POSTER
404. Synaptic Excitability and Dendritic Integration
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 H5
404.01 Network dynamics of nociceptive
processing in the anterior cingulate cortex. F. KASANETZ;
M. SANTELLO; T. NEVIAN*. Univ. of Bern.
2:00 H6
404.02 Exploring input-output relations of
neurons in vivo. C. J. ROOME; B. KUHN*. OIST Grad. Univ.
Neuroscience 2016|Monday PM|95

Mon. PM

POSTER

4:00 G46 403.08 A transcriptional program underlying

homeostatic scaling. K. SCHAUKOWITCH*; A. L. REESE;
S. KIM; G. KILARU; J. JOO; E. T. KAVALALI; T. KIM. UT
Southwestern Med. Ctr.

3:00 H7
404.03 Glutamate-mediated plateau potentials
studied by simultaneous multi-site dendritic sodium and
calcium imaging. S. D. ANTIC*; K. MIYAZAKI; W. N. ROSS.
UConn Hlth., New York Med. Col.

4:00 H20 404.16 Role of synaptic amplification in spatial

selectivity in a biophysical model of the CA1 microcircuit.
A. D. MILSTEIN*; C. GRIENBERGER; J. C. MAGEE; S.
ROMANI. Hhmi/Janelia Farm.

4:00 H8
404.04 Somatic membrane potential modulates
the propagation of dendritic spikes in CA1 pyramidal
neurons. T. BOCK*; S. A. SIEGELBAUM. Columbia Univ.

POSTER

1:00 H9
404.05 Synaptically activated sodium changes
in dendritic spines of rat hippocampal pyramidal neurons. K.
MIYAZAKI; W. N. ROSS*. New York Med. Col.
2:00 H10 404.06 Dendritic Integration in the basal and
proximal apical oblique dendrites of two distinct layer 5
pyramidal neuron populations. N. C. DEMBROW*; G. S.
NEWKIRK; W. SPAIN. Univ. of Washington Dept. of Physiol.
and Biophysics, VA Epilepsy Ctr. for Excellence, Univ. of
Washington.
3:00 H11 404.07 Dendritic NMDA spikes: From full-blown
to graded boosting supralinearities. What causes the switch?
F. BRANDALISE*; U. GERBER. Univ. of Zurich.
4:00 H12 404.08 Dendritic spikes determine input
selectivity in pyramidal cells. L. GOETZ; M. R. GROEN; A.
ROTH*; M. HAUSSER. Univ. Col. London.
1:00 H13 404.09 Rostro-caudal gradient of the dendritic
integrative properties of layer 5 pyramidal neurons
across the primary visual cortex. L. N. FLETCHER; S. R.
WILLIAMS*. Queensland Brain Inst.
2:00 H14 404.10 Three-dimensional calcium imaging of
mouse hippocampal neuronal ensembles during Sharp
wave-ripple complexes. D. PALFI*; B. CHIOVINI; L. JUDAK;
G. SZALAY; G. JUHSZ; G. KATONA; B. ROZSA. Peter
Pazmany Catholic Univ., IEM HAS.
3:00 H15 404.11 Dendritic morphology of corticospinal
and crossed-corticostriatal neurons in mouse primary
motor cortex. B. A. SUTER*; S. A. NEYMOTIN; G. M.
G. SHEPHERD; W. W. LYTTON. IST Austria / Jonas
Group, SUNY Downstate, Yale University, Sch. of Med.,
Northwestern University, Feinberg Sch. of Med., SUNY
Downstate, Kings County Hosp. Ctr.
4:00 H16 404.12 Schizophrenia as a disorder of cellular
excitability: Insights from computational models of
cortical neurons and cardiac pacemaker cells. T. MKIMARTTUNEN*; G. HALNES; A. DEVOR; G. T. LINES; A. G.
EDWARDS; A. TVEITO; A. WITOELAR; F. BETTELLA; S.
DJUROVIC; Y. WANG; A. M. DALE; G. T. EINEVOLL; O. A.
ANDREASSEN. Univ. of Oslo, Norwegian Univ. of Life Sci.,
UCSD San Diego, Simula Res. Lab., Univ. of Oslo.
1:00 H17 404.13 Down-regulation of TrkB expression
and signaling by the anti-convulsant drug valproic acid. S.
DEDONI*; M. C. OLIANAS; P. ONALI. Univ. of Cagliari, Dept
Biomed. Sci.
2:00 H18 404.14 Inhibition enhances rate and phase
coding of place in hippocampal CA1. C. GRIENBERGER*;
A. D. MILSTEIN; K. C. BITTNER; S. ROMANI; J. C. MAGEE.
Janelia Farm Res. Campus.
3:00 H19 404.15 Synaptic input distribution plays a
role in the dendritic computation of motion direction in
the retina. A. VLASITS*; R. D. MORRIE; A. TRAN-VANMINH; A. BLECKERT; C. F. GAINER; V. DUTELL; D. A.
DIGREGORIO; M. B. FELLER. Univ. of California Berkeley,
Univ. of California Berkeley, Inst. Pasteur, Ctr. Natl. de
la Recherche Scientifique, Univ. of Washington, Univ. of
California Berkeley.

96 | Society for Neuroscience

405. Oscillations and Synchrony: EEG studies

Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 H21 405.01 Inactivation of the hippocampo-septal
GABAergic feedback modulates rhythm. A. DOMONKOS*;
L. NIKITIDOU LEDRI; A. M. BARTH; M. JELITAI; R.
KARLCAI; K. DEISSEROTH; T. F. FREUND; V. VARGA.
Inst. of Exptl. Medicine, Hungarian Acad. of Sci., Stanford
Univ.
2:00 H22 405.02 Microphysiology of the Human
Rhythm. M. HALGREN*; J. R. MADSEN; D. SCHOMER;
O. DEVINSKY; W. K. DOYLE; I. ULBERT; L. EROSS; D.
FABO; E. HALGREN; S. S. CASH. UCSD, Boston Childrens
Hosp. and Harvard Med. Sch., Beth Israel Deaconess Med.
Ctr., New York Univ. Sch. of Med., Comprehensive Epilepsy
Center, New York Univ. Sch. of Med., Inst. of Cognitive
Neurosci. and Psychology, Res. Ctr. for Natural Sciences,
Hungarian Acad. of Sci. and Pter Pzmny Catholic
University, Fac. of Information Technol. and Bionics, Pter
Pzmny Catholic University, Fac. of Information Technol.
and Bionics. Dept. of Functional Neurosurgery, Natl. Inst.
of Clin. Neurosciences., Epilepsy Centrum, Natl. Inst. of
Clin. Neurosciences, Multimodal Imaging Laboratory, Univ.
of California at San Diego, Massachusetts Gen. Hospital,
Harvard Med. Sch.
3:00 H23 405.03 Boosting occipital power by transcranial
alternating current stimulation at the second harmonic. S.
FARA*; J. MCINTOSH; H. CHOI; C. MEHRING. Bernstein
Ctr. Freiburg, Univ. of Freiburg, Imperial Col. London.

4:00 H24 405.04 EEG source localization of human

rhythms under propofol anesthesia. E. P. STEPHEN*; M. S.
HMLINEN; S. KHAN; E. T. PIERCE; P. G. HARRELL;
J. L. WALSH; E. N. BROWN; P. L. PURDON. MIT,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.,
MIT.
1:00 H25 405.05 Differentiating psychotic disorders with
EEG and band frequency and the effects of brief high
frequency repetitive transcranial magnetic stimulation. F. M.
HOWELLS*; J. HSIEH; H. TEMMINGH; D. J. STEIN. Univ. of
Cape Town.
2:00 H26 405.06 Spontaneous cortical oscillation and the
auditory evoked steady state response: A pharmacological
investigation. B. D. HARVEY*; E. MOROZOVA; C. KELLEY;
M. HAJOS. Biogen, Yale Sch. of Med.
3:00 I1
405.07 Age-related changes in EEG during
isoflurane-induced surgical vs. very deep coma anesthesia.
P. J. SOJA*; T. MARIAM; X. DONG; R. TADAVARTY. The
Univ. of British Columbia.
4:00 I2
405.08 Investigations of phase-amplitude
coupling and long-range phase synchronization during
multisensory working memory maintenance- an MEG study.
J. DAUME*; T. GRUBER; A. K. ENGEL; U. FRIESE. Univ.
Med. Ctr. Hamburg-Eppendorf, Osnabrueck Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 I3
405.09 Dopaminergic medication restores
abnormal -band neural synchronies during a working
memory task in patients with restless legs syndrome. K.
CHA*; J. CHOI; P. SEO; B. LEE; K. JUNG; K. KIM. Yonsei
Univ., Yonsei Univ., Dept. of Neurology, Seoul Natl. Univ.
Med. Ctr.
2:00 I4
405.10 High frequency oscillations evoked
by tones in auditory cortex. Y. KAJIKAWA*; C. E.
SCHROEDER. Nathan Kline Inst., Columbia Univ.
3:00 I5
405.11 Abnormal cortical rhythm and network
during rapid-eye movement sleep in patients with rapideye movement sleep behavior disorder. S. HEO*; H. KIM;
B. LEE; S. KU; J. BYUN; J. SUNWOO; K. JUNG; K. KIM.
Yonsei Univ., Seoul Natl. Univ. Hosp., Kyung Hee Univ.
Hosp., Soonchunhyang Univ. Hosp.
4:00 I6
405.12 Stability of timing and connectivity in
functional networks of the human cortex. J. CHAPETON*; S.
K. INATI; K. A. ZAGHLOUL. NIH.
1:00 I7
405.13 EEG connectivity analysis for healthy
adults under anesthesia. J. CHOI*; S. AHN; H. CHO; M.
KWON; S. LEE; S. JANG; B. CHOI; G. NOH; S. JUN.
Gwangju Inst. of Sci. and Technol., Asan Med. Ctr., Asan
Med. Ctr.

3:00 I9
405.15 0.0002 Hz fluctuations in human
intracranial DC recordings. G. PIANTONI*; E. S.
ROSENTHAL; E. HALGREN; S. S. CASH. Massachusetts
Gen. Hosp., Harvard Med. Sch., UCSD.
4:00 I10
405.16 Neural network dynamics during recovery
from isoflurane as revealed by electroencephalogram in
young and old rats. B. F. COUGHLIN*; S. S. CASH; E. Y.
KIMCHI. Massachusetts Gen. Hosp., Massachusetts Gen.
Hosp., Harvard Med. Sch.
1:00 I11
405.17 Characterization of networks for
rule processing in human stereoEEG data using
consensus-based partial coherence. M. TER WAL*; P.
CARDELLICCHIO; G. A. ORBAN; P. H. TIESINGA. Radboud
Univ., Donders Inst., Univ. of Parma.
2:00 I12
405.18 Cross-frequency coupling: The theoretical
framework. G. CISOTTO*. Univ. of Padua.
3:00 J1
405.19 Site-dependent effects of optogenetic
stimulation in thalamic reticular nucleus on cortical states. V.
VISOCKIS*; S. SAKATA; B. MORRIS; J. PRATT. Strathclyde
Univ., Glasgow Univ.

POSTER
406. Epilepsy: Synaptic and Post-Seizure Mechanisms
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 J2
406.01 Contrasting properties of hippocampal
dentate gyrus and CA1 principal cells. S. A. PARK*; D. A.
COULTER. Childrens Hosp. of Philadelphia, Childrens
Hosp. of Philadelphia, Univ. of Pennsylvania.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 J4
406.03 Effects of de novo epilepsy
encephalopathy mutations of KCNQ2 on voltage-dependent
activation of Kv7/KCNQ channels via their interaction with
CaM. E. KIM*; S. WANG; W. PANG; J. CAVARETTA; H.
CHUNG. Univ. of Illinois At Urbana-Champaign, Neurosci.
Program.
4:00 J5
406.04 Low KCC2 expression in reticular
thalamic neurons is sufficient to regulate network activity.
P. M. KLEIN*; M. E. HARPER; H. M. MCKOWN; M. P.
BEENHAKKER. Univ. of Virginia.

1:00 J6
406.05 Cardiac and respiratory consequences
of repeated epileptic seizures in rat. D. PEDERSON; A.
ASHBY-LUMSDEN; P. P. IRAZOQUI; J. G. JEFFERYS*.
Purdue, Univ. of Oxford, Purdue, Univ. of Oxford.
2:00 J7
406.06 Elevated gonadotropin-releasing
hormone neuron firing activity in a female mouse model of
temporal lobe epilepsy. J. LI; V. A. ABEJUELA; J. KIM; J. B.
LAMANO; N. J. KLEIN; M. A. GHANE; D. J. REYNISH; C. A.
CHRISTIAN*. Univ. of Illinois at Urbana-Champaign, Univ.
of Illinois at Urbana-Champaign, Univ. of Illinois at UrbanaChampaign, Univ. of Illinois at Urbana-Champaign.
3:00 J8
406.07 Resting state glutamatergic activity
revealed two independent epileptogenic networks in
mesial temporal lobe epilepsy. J. BANERJEE*; A. DIXIT; V.
VISHWANATHAN; A. SRIVASTAVA; B. RAMANUJAM; M.
TRIPATHI; P. SARAT CHANDRA. Natl. Brain Res. Ctr., All
India Inst. of Med. Sci., All India Inst. of Med. Sci., All India
Inst. of Med. Sci.
4:00 J9
406.08 Modulation of thalamic and cortical GABA
transporter: The potential mechanism for the anti-absence
activity of mGlu5 receptors. R. CELLI; I. SANTOLINI;
V. DAMORE; A. PITTALUGA; R. GRADINI*; G. VAN
LUIJTELAAR; G. BATTAGLIA; V. BRUNO; F. NICOLETTI; R.
T. NGOMBA. I.R.C.C.S. Neuromed, Univ. of Genova, Univ.
Sapienza, Donders Ctr. for Cognition, Radboud Univ., Univ.
of Lincoln.
1:00 J10 406.09 A novel fluorescent probe for monitoring
extracellular pH shifts during neuronal hyperactivity. M.
CHIACCHIARETTA*; S. LATIFI; M. FADDA; M. BRAMINI;
A. FASSIO; F. CESCA; F. BENFENATI. Inst. Italiano Di
Tecnologia, Dept. of Exptl. Medicine, Univ. of Genova.
2:00 J11 406.10 Involvement of toll-like receptor 2 in
inflammatory responses and seizure generation in two
mouse models of temporal lobe epilepsy. Y. HUNG*; Y.
TSENG; Y. WU; Y. LIN. Natl. Yang-Ming Univ., Taipei
Veterans Gen. Hosp., Hsinchu MacKay Mem. Hosp., Taipei
Veterans Gen. Hosp.
3:00 J12 406.11 Role for 5-HT2C receptors in absence
seizures: An electrophysiological and immunohistochemical
study in GAERS and NEC rats. G. DI GIOVANNI*; M.
VENZI; A. CAVACCINI; C. BOMBARDI; V. CRUNELLI. Univ.
of Malta, AstraZeneca Translational Sci. Ctr. at Karolinska
Institutet, Inst. Italiano di Tecnologia, Univ. of Bologna,
Cardiff Univ.
4:00 J13 406.12 Role of Chd2 in cortical development
and function. S. ABBASI*; J. C. FRANKOWSKI; S. LEE;
K. GONZALEZ; S. SMITH; R. F. HUNT. Univ. of California,
Irvine.
1:00 J14 406.13 Neural activity propagation by
endogenous electric field in the hippocampus in vitro. R.
SHIVACHARAN*; D. DURAND. Case Western Reserve Univ.

Neuroscience 2016|Monday PM|97

Mon. PM

2:00 I8
405.14 Inter-brain connectivity during live verbal
interaction. S. AHN*; H. CHO; M. KWON; K. KIM; B. KIM;
W. CHANG; J. CHANG; S. JUN. Gwangju Inst. of Sci. and
Technol., Korea Res. Inst. of Standards and Sci., Univ. of
Sci. and Technol., Inst. for Integrative Medicine, Intl. St.
Marys Hosp. Catholic Kwandong Univ., Brain Res. Institute,
Yonsei Univ. Col. of Med.

2:00 J3
406.02 Impairment of homeostatic synaptic
scaling in epileptic immature brain. H. SUN*; D. TALOS; F. E.
JENSEN. Univ. of Pennsylvania.

2:00 J15 406.14 Emergence of epilepsy in a transgenic

mouse strain that overexpresses brain-derived neurotrophic
factor in the forebrain. C. YEPES; M. LAQUERRE; W.
ZHOU; K. GUTHRIE; C. ISGOR*. Florida Atlantic Univ.
Charles E Schmidt Col. of Med., Florida Atlantic Univ.
Charles E Schmidt Col. of Med.
3:00 J16 406.15 Selective activation of somatostatin
or parvalbumin expressing interneurons triggers GABAmediated LLDs in rat neocortex. A. BOHANNON*; J.
HABLITZ. Univ. of Alabama At Birmingham, Univ. of Alabama
at Birmingham.
4:00 J17 406.16 Defective synaptic vesicle recycling
in epilepsy and developmental delay-associated de novo
mutations of dynamin 1. K. BONNYCASTLE*; D. C.
SOARES; W. W. K. LAM; M. A. COUSIN. Univ. of Edinburgh,
Univ. of Edinburgh.
1:00 J18 406.17 Selective inhibition of inflammatory
cascades following experimental febrile status epilepticus.
M. M. CURRAN*; K. P. PATTERSON; M. SARGIOUS; T. Z.
BARAM. Univ. of California Irvine.
2:00 K1
406.18 The role of gluk2-containing kainate
receptors in acute hypoxic seizures in the neonatal mouse.
S. A. ZANELLI*; P. WAGLEY; D. GROSENBAUGH; J.
KAPUR. Univ. of Virginia, Univ. of Virginia.
3:00 K2
406.19 Different electrographic epileptic
discharge types associated with absence epilepsy are
interrelated in rat association cortex. S. HALL*; M. A.
WHITTINGTON; R. D. TRAUB. Univ. of York, Dept. of
Physical Sci.
4:00 K3
406.20 Collagen VI extracellular matrix protein
modulates short-term plasticity in the hippocampus:
Implications for epileptogenesis. T. RAMOS-MORENO*; A.
CIFRA; L. NIKITIDOU-LEDRI; S. H. CHRISTIANSEN; C.
GTZSCHE; M. CESCON; P. BONALDO; D. P. WOLDBYE;
K. MERAB. Wallenberg Neurosci. Center/Stem Cell Ctr.,
Lund Univ., Univ. of Copenhagen, Univ. of Padova.
1:00 K4
406.21 Structure and function of sprouted mossy
fiber synapses in epilepsy. W. HENDRICKS*; A. L. BENSEN;
G. L. WESTBROOK; E. SCHNELL. Vollum Inst., Oregon
Hlth. and Sci. Univ., Portland VA Med. Ctr.
2:00 K5
406.22 Potential role of -amyloid peptides in
kainic acid-induced toxicity. D. I. OURDEV*; A. KODAM;
M. MAULIK; Y. WANG; M. BANERJEE; S. KAR. Univ. of
Alberta.
3:00 K6
406.23 Regulation of synaptic transmission by
mTORC1 and mTORC2. M. MCCABE*; C. BARROWS; M.
C. WESTON. Univ. of Vermont.

POSTER
407. Epilepsy: Anticonvulsant and Antiepileptic Strategies
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 K7
407.01 Hippocampal hypermetabolism following
kainic acid administration in awake and anesthetized rats:
FDG-PET study. T. BERDYYEVA*; Y. HSIEH; S. YUN; J.
SHELTON; C. DUGOVIC; H. KOLB; A. SZARDENINGS.
Janssen.

3:00 K9
407.03 A temperature-dependent neural mass
model for suppression of epileptic discharges. J. SORIANO*;
T. KUBO; T. INOUE; H. KIDA; T. YAMAKAWA; M. SUZUKI;
K. IKEDA. Nara Inst. of Sci. and Technol., Univ. of the
Philippines- Diliman, Yamaguchi Univ., Kumamoto Univ.
4:00 K10 407.04 Cannabidiol increases inhibitory
transmission and rescues social deficits in a mouse model
of Dravet Syndrome. J. KAPLAN*; W. A. CATTERALL; N.
STELLA; R. E. WESTENBROEK. Univ. of Washington, Univ.
of Washington.
1:00 K11 407.05 Cannabidiol reduces the duration and
severity of thermally evoked seizures in a mouse model of
Dravet Syndrome. R. E. WESTENBROEK*; J. S. KAPLAN;
N. STELLA; W. A. CATTERALL. Univ. Washington, Univ. of
Washington.
2:00 K12 407.06 Anticonvulsant, antiepileptic and
neuroprotective effects of ketamine, valproate and
midazolam polytherapy against soman exposure in rats. L.
A. LUMLEY*; F. ROSSETTI; M. F. STONE; C. R. SCHULTZ;
M. Q. PHAM; J. NIQUET; C. WASTERLAIN. USAMRICD,
Walter Reed Army Inst. of Res., UCLA-West LA VAMC.
3:00 K13 407.07 Retrospective analysis of acute seizure
management of 215 pediatric cases with intravenous
levetiracetam. B. F. KIRMANI*, ESQ; P. LAKIREDDY; M.
DANG; A. SARODE; S. LONG; P. PATEL; O. KHAN. T, Scott
and White Epilepsy Center, Baylor Scott and White Health/
Texas A& M Univ. HSC Coll of Med., Baylor Scott and White
Hlth., Texas A & M Col. of Med., Baylor Univ.

4:00 K14 407.08 Ganaxolone and diazepam administered

IV produce a synergistic anti-epileptic effect in a treatment
refractory model of status epilepticus. M. S. SAPORITO*;
J. A. GRUNER; J. TSAI; A. PATRONEVA. Marinus
Pharmaceuticals, Inc., Melior Discovery, Inc.
1:00 K15 407.09 Using high-throughput screening to
predict novel antiseizure interventions. A. MOUSAVI NIK*; S.
HULSIZER; I. PESSAH. Univ. of California Davis.
2:00 K16 407.10 Title: The MED64-Quad II system
increases throughput for studies of antiepileptic drug targets
with in vitro MEA pharmacology on acute brain slices. S.
YASUOKA; R. ARANT; G. CHENG*. Alpha MED Scientific
Inc., Alpha Med. Scientific Inc./ Automate Scientific Inc.

3:00 K17 407.11 Neuroactive Steroids exhibit synergistic

interactions with barbiturates at the GABAA receptor in vitro
and this impacts on activity in an animal model of seizure.
M. A. ACKLEY*; G. M. BELFORT; R. S. HAMMOND; M. C.
QUIRK; G. MARTINEZ-BOTELLA; F. G. SALITURO; A. J.
ROBICHAUD; J. J. DOHERTY. SAGE Therapeut.
4:00 L1
407.12 Partial activation of TrkB receptors
corrects interneuronal calcium channel dysfunction and
reduces epileptogenic activity in neocortical circuits following
injury. F. GU*; I. PARADA; T. YANG; F. LONGO; D. PRINCE.
Stanford Univ.
1:00 L2
407.13 A critical developmental window for
17-estradiol antiepileptogenic effect in a mouse model
of x-linked infantile spasms. M. SIEHR*; R. LUCERO; J.
LALONDE; J. NOEBELS. Baylor Col. of Med.
2:00 L3
407.14 Valproic acid decreases the absence
seizures in a myelin mutant taiep rat: A new animal model of
epilepsy. M. CORTES*; Y. SILVA; J. R. EGUIBAR. B. Univ.
Autonoma de Puebla.

2:00 K8
407.02 Cannabidiolic acid controls seizure-like
activity and neuronal excitability. M. HOSSEINI ZARE*;
A. ABDULLA; K. AKULLA; J. ZIURKUS. Univ. of Houston,
Ultragenyx Pharmaceut. INC.
98 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 L4
407.15 Acute effects of lacosamide on spasms in
the multiple-hit rat model of infantile spasms. O. SHANDRA*;
W. B. MOWREY; S. L. MOSH; A. S. GALANOPOULOU.
Albert Einstein Col. of Med., Albert Einstein Col. of Med.,
Albert Einstein Col. of Med., Albert Einstein Col. of Med.
4:00 L5
407.16 Transcranial focal electrical stimulation
via concentric ring electrodes in freely moving cats,
antiepileptogenic and postictal effects. A. VALDSCRUZ*; B. VILLASANA-SALAZAR; W. G. BESIO; V. M.
MAGDALENO-MADRIGAL; D. MARTNEZ-VARGAS;
S. ALMAZN-ALVARADO; R. FERNNDEZ-MAS. Inst.
Nacional De Psiquiatra RFM, Inst. Nacional de Psiquiatra
Ramn de la Fuente Muiz, Univ. of Rhode Island.
1:00 L6
407.17 Effects of High- and Low-frequency
stimulation of thalamic reticular nucleus on ptz-induced
seizures in rats. V. M. MAGDALENO-MADRIGAL*; A.
VALDS-CRUZ; D. MARTNEZ-VARGAZ; S. ALMAZNALVARADO; R. FERNNDEZ-MAS. Inst. Nacional De
Psiquiatra Ramn De La Fuente Muiz.

POSTER
408. Epilepsy: Human Studies I
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 L7
408.01 Characteristics and consistency of
seizure offset dynamics in humans. D. N. CRISP*; J.
SCOTT; M. COOK; M. DUEMPELMANN; G. WORRELL;
W. STACEY. Univ. of Michigan, Univ. of Melbourne, Univ. of
Freiburg, Mayo Clin., Univ. of Michigan.
2:00 L8
408.02 Comparing interictal discharges from
intracranial EEG in patients with and without epilepsy. B. N.
LUNDSTROM*; G. WORRELL; M. STEAD. Mayo Clin.
3:00 L9
408.03 Mechanisms of widespread cortical fMRI
increases and decreases in absence seizures. Y. CHEN*;
S. BRAUN; J. GUO; H. BLUMENFELD. Yale Univ. Sch. of
Med., Yale Univ. Sch. of Med., Yale Univ. Sch. of Med.
4:00 L10 408.04 Driving simulation testing of patients
with epilepsy during inpatient video/EEG monitoring. L.
GOBER; Y. SI; G. TOULOUMES; W. CHEN; E. MORSE;
R. GEBRE; A. BAUERSCHMIDT; M. YOUNGBLOOD;
C. CUNNINGHAM; C. EZEANI; Z. KRATOCHVIL; J.
BRONEN; J. THOMSON; K. RIORDAN; L. HIRSCH; H.
BLUMENFELD*. Yale Univ. Sch. of Med., Yale Univ. Sch. of
Med., Yale Univ. Sch. of Med., Yale Univ. Sch. of Med.

1:00 L11 408.05 Frontal lobe seizures and impaired

consciousness: Intracranial EEG markers. R. GEBRE*; M.
DHAKAR; E. GROVER; I. QURAISHI; E. STERNBERG;
I. GEORGE; A. SIVARAJU; J. BONITO; H. ZAVERI; L.
GOBER; S. AHAMMAD; S. GHOSHAL; L. HIRSCH; D. D.
SPENCER; J. L. GERRARD; H. BLUMENFELD. Yale Sch. of
Med., Yale Sch. of Med., Yale Sch. of Med.
2:00 L12 408.06 Synergism of cross-frequency coupling
and phase synchrony in epileptic focus localization: An iEEG
study. T. NNSI*; B. FILE; L. ERSS; L. ENTZ; D. FAB;
I. ULBERT. Natl. Inst. of Clin. Neurosciences, Insitute of
Cognitive Neurosci. and Psychology, RCNS, HAS, Fac. of
Information Technol. and Bionics, Pzmny Pter Catholic
Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 L14 408.08 An algorithmic adjunct to visual

inspection: Using an Empirical Mode Decomposition
based algorithm to detect seizures. K. R. ASHMONT*;
J. KERRIGAN; M. TROESTER; R. JARRAR; S. HELMS
TILLERY; P. ADELSON; B. GREGER. Barrow Neurolog.
Inst. At Phoenix Children, Barrow Neurolog. Inst. At Phoenix
Childrens Hosp., Univ. of Arizona Col. of Med., Creighton
Univ. Sch. of Med., Arizona State Univ.
1:00 M1
408.09 Disruption of resting state networks by
section of the corpus callosum in humans. J. L. ROLAND*;
A. Z. SNYDER; C. D. HACKER; E. C. LEUTHARDT; M. D.
SMYTH. Washington Univ. in St. Louis, Washington Univ. in
St. Louis, Washington Univ. in St. Louis.
2:00 M2
408.10 Association between white matter
changes and cognitive deficits in patients with temporal lobe
epilepsy. R. RODRGUEZ CRUCES*; V. CAMACHO; L.
CONCHA. Natl. Autonomous Univ. of Mexico.

3:00 M3
408.11 A prospective study of the prevalence
of cell-surface neuronal autoantibodies in adult patients
with recent-onset epilepsies of unknown aetiology. T. C.
MOLONEY*; S. R. IRANI; J. ADCOCK; A. SEN; P. WATERS;
A. VINCENT; B. LANG. Royal Col. of Surgeons, Ireland,
Univ. of Oxford.
4:00 M4
408.12 Ictal-like HFOs during interictal periods
can identify the seizure onset zone. W. C. STACEY*; K. R.
MOON; A. O. HERO, III; S. V. GLISKE. Univ. of Michigan,
Univ. of Michigan.
1:00 M5
408.13 Interictal determination of the seizure
onset zone and laterality of patients developing a
cognitive task. J. GONZALEZ-DAMIAN*; P. E. SAUCEDO
ALVARADO; M. MONTES DE OCA; A. L. VELASCO. Univ.
Nacional Autnoma De Mxico, Hosp. Gen. de Mxico.
2:00 M6
408.14 Selective changes in cb1 receptor
functional coupling to g-proteins in patients with temporal
lobe epilepsy. F. CARMONA CRUZ*; M. CUELLARHERRERA; M. ALONSO-VANEGAS; R. CINAR; L. ROCHA.
Ctr. For Res. and Advanced Studies, Epilepsy Clin. of
Hosp. Gen. de Mexico, Natl. Inst. of Neurol. and Neurosurg.
Manuel Velasco Suarez, Natl. Inst. on Alcohol Abuse and
Alcoholism, Natl. Inst. of Hlth.
3:00 M7
408.15 Vagus nerve stimulation activates
inhibitory neuronal network in human cerebral cortex. T.
MATSUO*; K. KAWAI; K. USAMI. NTT Med. Ctr. Tokyo, Jichi
medical university, Natl. Ctr. for Child Hlth. and Develop.

POSTER
409. Oligodendrocytes
Theme B: Neural Excitability, Synapses, and Glia
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 M8
409.01 Loss of primary cilia in the
oligodendrocyte lineage in relation to myelination. A.
SUBEDI; J. L. FUCHS*. Univ. of North Texas.

Neuroscience 2016|Monday PM|99

Mon. PM

Theme B: Neural Excitability, Synapses, and Glia

3:00 L13 408.07 Ripples show increased phase-amplitude

coupling in mesial temporal lobe epilepsy seizure onset
zones. S. A. WEISS*; I. OROSZ; S. MOY; L. WEI; M.
VANT KLOOSTER; R. T. KNIGHT; R. F. HELFRICH; R. M.
HARPER; A. BRAGIN; I. FRIED; J. ENGEL, Jr.; R. STABA.
Thomas Jefferson Univ., Univ. of California Los Angeles,
Univ. of California Los Angeles, Brain Ctr. Rudolf Magnus,
Univ. of California Berkeley.

2:00 M9
409.02 Regulation of oligodendrocyte lineage
cell function by the RXR nuclear receptor. L. DI CANIO*;
A. GUZMN DE LA FUENTE; G. J. WAYNE; R. J. M.
FRANKLIN. Univ. of Cambridge, GSK.

3:00 N4
409.15 A stroke-specific oligodendrocyte
progenitor cell transcriptome reveals novel genes impacting
recovery after white matter stroke. D. J. DITULLIO*; E. G.
SOZMEN; S. T. CARMICHAEL. UCLA.

3:00 M10 409.03 Comparing probes for zinc detection in

developing and mature oligodendrocytes. C. M. ELITT*; K.
PATEL; J. WANG; C. FAHRNI; P. ROSENBERG. Boston
Childrens Hosp., F.M. Kirby Neurobio. Ctr. and Harvard
Med. Sch., Georgia Inst. of Technol.

4:00 N5
409.16 Functional heterogeneity of
oligodendrocyte progenitors in the central nervous system.
S. FRSTER*; A. C. CRAWFORD; R. B. TRIPATHI; W. D.
RICHARDSON; R. J. M. FRANKLIN. Univ. of Cambridge,
Univ. Col. London.

4:00 M11 409.04 Transcription factor regulation by mTOR

during oligodendrocyte differentiation. I. M. ORNELAS*;
S. WAHL; L. KHANDKER; L. E. MCLANE; T. L. WOOD.
Rutgers Univ.

1:00 N6
409.17 Preferential axon-oligodendrocyte
interactions at axon varicosities preceding initial myelin
ensheathment. M. MARTELL*; B. B. DUXBURY; S. W.
STEELE; A. G. TRUDEL; A. J. TREICHEL; J. H. HINES.
Winona State Univ.

1:00 M12 409.05 Regulation of oligodendrocyte progenitors

through AMPA receptor signaling. A. AGARWAL*; L.
CHAKRAVARTI; K. SPARKS; A. MENON; D. E. BERGLES.
Johns Hopkins Univ.
2:00 M13 409.06 In vitro pre-transplant patterning of
forebrain and spinal cord oligodendrocyte fates from human
pluripotent stem cells. T. MAJOR*; A. H. KUROPATNICKA;
S. A. GOLDMAN. Univ. of Copenhagen, Univ. of Rochester
Med. Ctr.
3:00 M14 409.07 Oligodendrocyte precursor cells (OPCs)
dynamics and Kir4.1 profile in ageing brain. I. CHACON
DE LA ROCHA*; A. D. RIVERA; A. M. BUTT. Univ. of
Portsmouth.
4:00 M15 409.08 Identification of a microRNA regulating
the maturation of oligodendroglial precursor cells and
pathologically up-regulated in human multiple sclerosis.
D. LECCA*; D. MARANGON; G. T. COPPOLINO; A.
MENNDEZ MNDEZ; A. FINARDI; G. DALLA COSTA;
R. FURLAN; M. P. ABBRACCHIO. Univ. of Milan, Univ.
Complutense de Madrid, San Raffaele Scientific Inst.
1:00 M16

2:00 N7
409.18 The role of neuronal activity in
myelination, axon targeting and maintenance of specified
cortical projection neuron populations. K. KORRELL*; A.
HOERDER-SUABEDISSEN; Z. MOLNR. Oxford Univ.
3:00 N8
409.19 Proteolipid protein null mice exhibit
altered numbers of oligodendrocytes. E. A. GOULD*;
D. SHEPHERD; D. RESTREPO; W. MACKLIN. Univ. of
Colorado Denver Sch. of Med., Univ. of Colorado Denver.
4:00 N9
409.20 Oligodendrocytes labelling with
Sulforhodamine 101 depends on astrocytic uptake via
the thyroid hormone transporter OATP1c1 (slco1c1). S.
HLSMANN*; L. HAGOS. Georg August Univ. Goettingen,
Univ. Med. Ctr.

POSTER
410. Alzheimers Disease: Treatment in Humans
Theme C: Neurodegenerative Disorders and Injury

409.09 Withdrawn.

2:00 M17 409.10 Fibroblast Growth Factor Receptor 1

in a mouse model of demyelination. K. M. SMITH*; H. M.
TORRES; J. C. COLLETTE. Univ. of Louisiana At Lafayette,
Univ. of Louisiana at Lafayette.
3:00 M18 409.11 Investigating immune system activation
following loss of the Quaking (QKI) RNA binding proteins
using PLP-CreERT. L. DARBELLI*; S. RICHARD. Jewish
Gen. Hospital, McGill Univ.
4:00 N1
409.12 DNA damage-associated loss of cortical
oligodendrocytes in dementia and Alzheimers disease. K.
TSE*; A. CHENG; F. MA; H. CHOW; K. HERRUP. The Hong
Kong Univ. of Sci. and Technol.
1:00 N2
409.13 GPR17-expressing oligodendrocyte
progenitors participate in the reparative response after brain
ischemia and their behaviour is influenced by microgliaderived vesicles. M. FUMAGALLI*; E. BONFANTI; P.
GELOSA; M. LOMBARDI; E. TREMOLI; M. CIMINO; L.
DIMOU; L. SIRONI; C. VERDERIO; M. P. ABBRACCHIO.
Univ. Degli Studi Di Milano, Ctr. Cardiologico Monzino
IRCCS, IRCCS Humanitas, Univ. of Urbino, Physiological
Genomics, Biomed. Center, Ludwig-Maximilians Univ., CNR
Inst. of Neurosci.
2:00 N3
409.14 Glial disruptions in response to
cerebral hypoperfusion in young adult and aged rats. E. T.
CURFMAN; H. C. PARAISO; R. D. SWEAZEY*; F. CHANG;
I. YU. Indiana Univ. Sch. of Medicine-Fort Wayne, Indiana
University-Purdue Univ. Fort Wayne, Indiana Univ. Syst.

100 | Society for Neuroscience

Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 N10 410.01 A dual incretin receptor agonist is

especially potent in reducing insulin resistance in brains
of mild cognitive impairment (MCI) and Alzheimers
disease dementia (ADd) cases. K. TALBOT*; J. KVASIC;
A. STUCKY; S. M. SHAH; K. LEE; K. P. BAKSHI; M.
CHATTOPADHYAY; A. KHAN; P. L. MCCLEAN; C.
HOLSCHER; A. J. SAMOYEDNY; J. Q. TROJANOWSKI;
R. WILSON; D. A. BENNETT; R. D. DIMARCHI; H. WANG.
Cedars-Sinai Med. Ctr., City Univ. of new York Med. Sch.,
Univ. of Ulster, Lancaster Univ., Univ. of Pennsylvania Sch.
of Med., Rush Univ. Med. Ctr., Indiana Univ.
2:00 N11 410.02 Unexpected retinal structure and changes
in people with Downs syndrome, a high risk population for
Alzheimers disease. M. J. WALPERT*; E. M. NORMANDO;
S. H. ZAMAN; F. M. CORDEIRO; A. J. HOLLAND. Univ. of
Cambridge, Univ. Col. London, Univ. of Cambridge.

3:00 N12 410.03 Combination dosing of the novel M1/

M4-selective muscarinic agonist NSX-0527 and peripheral
muscarinic antagonists for the treatment of Alzheimers
disease. S. A. HANSON; J. C. OCKULY; J. D. BECK; M. L.
HENDRICKSON*. NeuroSolis, Inc., BrainXell, Inc.
4:00 N13 410.04 Open label trial of Magnesium
l-Threonate for adults with mild to moderate Alzheimers
disease. N. L. RASGON*; T. WROOLIE; K. WATSON LIN;
A. KRAMER; D. BALZAFIORE. Stanford Univ. Sch. of Med.,
Stanford Univ. Sch. of Med., Palo Alto Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 N14 410.05 SUVN-502, a pure 5-ht6 receptor

antagonist- proof-of-concept study design in moderate
Alzheimers disease patients. R. V. NIROGI*; K.
MUDIGONDA; K. PENTA; G. BHYRAPUNENI; V. BENADE;
N. MUDDANA; V. PALACHARLA; D. AJJALA; V. GOYAL; S.
PANDEY; R. ABRAHAM; R. KAMBHAMPATI; T. BANDYALA;
V. BHATTA; A. SHINDE. Suven Life Sci.
2:00 N15 410.06 In vivo assessment of the locus coeruleus
in young and older adults using neuromelanin-sensitive MRI.
M. BETTS*; A. CARDENAS-BLANCO; M. KANOWSKI; K.
FLIEBACH; S. TEIPEL; F. JESSEN; E. DZEL. German
Ctr. For Neurodegenerative Dis. (DZNE), Inst. of Cognitive
Neurol. and Dementia Res., Dept. of Neurology, Univ. Hosp.
of Magdeburg, German Ctr. For Neurodegenerative Dis.
(DZNE), Dept. of Psychiatry, Univ. Hosp. Bonn, German Ctr.
For Neurodegenerative Dis. (DZNE), Dept. of Psychosomatic
Med., Dept. of Psychiatry.

4:00 N17 410.08 Relative incidence of seizures and

myoclonus in Alzheimers disease, dementia with Lewy
bodies, and frontotemporal dementia. S. DARWISH*; A. J.
BEAGLE; K. G. RANASINGHE; E. KARAGEORGIOU; K. A.
VOSSEL. Univ. of California, San Francisco.
1:00 N18 410.09 Localization of Peroxisome Proliferator
Activated Receptor in frontal cortex of Alzheimers disease
patients. A. FRACASSI*; S. MORENO; G. TAGLIALATELA.
Univ. of Texas Med. Br., Univ. Roma Tre.
2:00 O1
410.10 Predicting co-variation of Alzheimers
disease pathology from brain connectivity. L. DIGMA*; K.
ARNEMANN; A. RAJ; W. JAGUST. Helen Wills Neurosci.
Inst., Weill Med. Col. of Cornell Univ.

3:00 O2
410.11 A P2Y6 receptor pro-drug modulates
cerebrospinal fluid amyloid 1-42 in PS1/APP mice and
in patients with mild Alzheimers disease. J. DONG*; R.
DOYLE; R. SCHREIBER; N. ROULEAUX; K. FLICK; P.
HAYDON. Tufts Univ. Sch. of Med., GliaCure, Inc., Suadeo
Drug Discovery Consulting LLC, Maastricht Univ.
4:00 O3
410.12 The use of human-based methods to
undertake new strategies for Alzheimers disease research
and define pathways of disease. A. LAM*; F. PISTOLLATO;
E. L. OHAYON. Neurolinx Res. Inst., Physicians Committee
for Responsible Med., Inst. for Hlth. and Consumer
Protection (IHCP), European Commission DG Joint Res.
Ctr. (JRC).

POSTER
411.

Alzheimers Disease: Secretases

Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 O4
411.01 - and -secretase processing of amyloid
precursor protein in the human central nervous system.
J. A. DOBROWOLSKA ZAKARIA*; R. J. BATEMAN; R.
J. VASSAR. Northwestern Univ. Feinberg Sch. of Med.,
Washington Univ. in St. Louis.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 O6
411.03 Activity-driven PS1 phosphorylation is
responsible for pathogenic conformational change of the
PS1/-secretase. J. HORLACHER*; M. MAESAKO; O.
BEREZOVSKA. Massachusetts Gen. Hosp.
4:00 O7
411.04 Phosphatase activity during sleep/wake
cycles regulates APP processing and brain ISF amyloid-
levels. C. E. WALLACE; H. M. EDWARDS; J. R. CIRRITO*.
Washington Univ.
1:00 O8
411.05 Retromer and Rab2-dependent trafficking
are involved in PS1 degradation by proteasomes in
endocytic disturbance. N. KIMURA*; N. UEDA; T. TOMITA;
K. YANAGISAWA. Natl. Ctr. For Geriatrics and Gerontology,
The Univ. of Tokyo.
2:00 O9
411.06 Pen-2 plays a critical role in substrate
binding. C. HU*; T. LI; J. XU; M. CUI; X. XU. The Univ. of
Tennessee, Tianjin Med. Univ., Jilin Med. Univ.
3:00 O10 411.07 Mechanism that BACE1 alternates the
cleaving sites of human APP. T. SUZUKI*; A. KIMURA; S.
HATA. Hokkaido Univ.
4:00 O11 411.08 BACE1/BACE2 selectivity, the next
frontier in -secretase inhibition for Alzheimers disease: A
mouse model of depilation-induced pigmentation for in vivo
screening. P. H. WEN*; J. BRADLEY; M. JOHNSON; M.
SOTO; M. BOURBEAU; D. HICKMAN; S. WOOD. Amgen
Inc, Amgen Inc, Amgen Inc, Amgen Inc.
1:00 O12 411.09 Palmitate-enriched diet increases
BACE1 expression and ensuing Amyloid- genesis by
evoking ER stress and subsequent CHOP activation. G. A.
MARWARHA*; J. SCHOMMER; J. LILEK; O. GHRIBI. Univ.
of North Dakota.

2:00 O13 411.10 Loss of BACE1- but not BACE2function in mice results in decreased body weight, protection
against diet-induced obesity and reduced anxiety. T.
W. ROSAHL*; L. A. HYDE; M. CHAMPY; H. MEZIANE;
C. CANASTO-CHIBUQUE1; K. JUHL; Z. LI; B. PETITDEMOULIERE; T. SORG; J. SCOTT; G. J. EIERMANN; J.
N. CUMMING; E. M. PARKER; M. E. KENNEDY. Merck Res.
Labs., Inst. Clinique de la Soris (ICS), Merck Res. Labs.,
Merck Res. Labs.
3:00 O14 411.11 Role of PSEN1 in neuronal
differentiation and Alzheimers disease- modeling human
neurodegeneration in a dish. C. PIRES*; A. POON; B.
SCHMID; T. T. NIELSEN; L. E. HJERMIND; J. NIELSEN;
C. CLAUSEN; P. HYTTEL; B. HOLST; K. FREUDE. Univ. of
Copenhagen, Bioneer A/S, Danish Dementia Res. Center,
Rigshospitalet, Copenhagen Univ. Hosp.
4:00 O15 411.12 Hif1 activates -secretase and increases
production of amyloid- in cells. C. CARROLL*; Y. LI. Mem.
Sloan-Kettering Cancer Ctr.
1:00 O16 411.13 A brain-derived A42 surrogate marker
in peripheral blood. S. TAGAMI*; K. YANAGIDA; T.
TOMONAGA; T. IKEUCHI; M. WARAGAI; M. TAKEDA; M.
IKEDA; M. OKOCHI. Osaka Univ. Grad. Sch. of Med., Lab.
of Proteome Research, Natl. Inst. of Biomed. Innovation,
Dept. of Mol. Genetics, Brain Res. Institute, Niigata Univ.,
Higashi Matsudo Municipal Hosp., Aino Univ.

Neuroscience 2016|Monday PM|101

Mon. PM

3:00 N16 410.07 A translational program of AAV2-BDNF

gene delivery into the entorhinal cortex for Alzheimers
disease: Development of MRI guidance for accurate gene
targeting and distribution in non-human primates. A. H.
NAGAHARA*; B. R. WILSON; I. IVASYK; I. KOVACS; S.
RAWALJI; J. R. BRINGAS; P. J. PIVIROTTO; W. SAN
SEBASTIAN; L. SAMARANCH; K. S. BANKIEWICZ; M. H.
TUSZYNSKI. UC San Diego, UC San Francisco, Veterans
Affairs Med. Ctr.

2:00 O5
411.02 In vivo spectral FRET assay for
monitoring PS1/-secretase conformational changes.
M. MAESAKO*; J. HORLACHER; O. BEREZOVSKA.
Massachusetts Gen. Hosp.

POSTER
412. Synaptic Pathology in Alzheimers Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 O17 412.01 Impaired synaptic transmission in
the CA1 area of hippocampal slices of APPSwDutIowa/
Nos2-/- (CVN) mice. M. V. KOPANITSA; J. PUOLIVLI; O.
KONTKANEN; R. HODGSON*; A. NURMI; P. J. SWEENEY.
Charles River Discovery.
2:00 O18 412.02 GSK-3-mediated phosphorylation
of PICK1 regulates the GluA2-PICK1 interaction. S.
YAGISHITA*; M. MURAYAMA; T. EBIHARA; K. MARUYAMA;
A. TAKASHIMA. Saitama Med. Univ., Lab. for Alzheimers
disease, RIKEN Brain Sci. Inst., Dept. of Aging Neurobiology,
Ctr. for Develop. of Advanced Med. for Dementia, Natl. Ctr.
for Geriatrics and Gerontology.
3:00 P1
412.03 Early manifestation of synaptic failure
in a transgenic model of AD. S. FORNER*; A. G. PRIETO;
A. LIMON-RUIZ; D. KONG-LEE; A. C. MARTINI; C. DA
CUNHA; L. TRUJILLO-ESTRADA; R. AGER; J. C. DAVILA;
A. GUTIERREZ-PEREZ; C. W. COTMAN; D. BAGLIETTOVARGAS; F. M. LAFERLA. Univ. of California Irvine, Univ. of
California, Irvine, Univ. de Mlaga.
4:00 P2
412.04 Early changes in structure and function of
gray matter axons in a mouse model of Alzheimers disease.
D. PEKALA; M. RAASTAD*. Emory Univ. Sch. of Med.
1:00 P3
412.05 Genetic targeting of APP in hippocampus
demonstrates that synapses postsynaptic to neurons
expressing APP are the earliest sites of injury. E. VICARIO
ORRI*; K. CHIANG; S. TYAN; S. LEUTGEB; E. H. KOO.
Univ. of California San Diego.
2:00 P4
412.06 A-induced caspase activation and
synaptic injury from APP C99 fragment is prevented in the
APP D664A mutant that inhibits caspase-mediated cleavage.
G. PARK; B. MIDTHUNE; M. NAVARRO; R. MALINOW; G.
SALVESEN; E. H. KOO*. UCSD, Sanford Burnham Prebys
Med. Discovery Inst.
3:00 P5
412.07 Fingolimod modulates NMDA receptor
properties in rat hippocampal slices. S. ATTIORI ESSIS*; M.
LAURIER-LAURIN; . PPIN; M. CYR; G. MASSICOTTE.
Univ. Du Qubec Trois-Rivires.
4:00 P6
412.08 Melanocortin 4 receptor activation
ameliorates synaptic plasticity impairment in a mouse model
of Alzheimers disease. M. TIAN*; Y. SHEN; F. GONG; A. K.
Y. FU; N. Y. IP. The Hong Kong Univ. of Sci. and Technol.,
The Hong Kong Univ. of Sci. and Technol., The Hong Kong
Univ. of Sci. and Technol.
1:00 P7
412.09 MC4R activation alleviates amyloid-induced synaptic dysfuntion. F. GONG*; Y. SHEN; M.
TIAN; A. K. Y. FU; N. Y. IP. The Hong Kong Univ. of Sci. and
Technol., The Hong Kong Univ. of Sci. and Technol., The
Hong Kong Univ. of Sci. and Technol.
2:00 P8
412.10 Understanding the melanocortin
microcircuit in the mouse hippocampus. Y. SHEN*; M. TIAN;
F. GONG; Y. ZHENG; A. K. FU; N. Y. IP. The Hong Kong
Univ. of Sci. and Technol., The Hong Kong Univ. of Sci. and
Technol., The Hong Kong Univ. of Sci. and Technol.

3:00 P9
412.11 Dysregulation of microRNA188
expression causes cognitive impairments in Alzheimers
disease by inducing synaptic deficit. H. KIM*; K. LEE; K.
AN; O. KWON; S. PARK; J. CHA; M. KIM; Y. LEE; J. KIM; K.
CHO; H. KIM. Seoul Natl. Univ., POSTECH, Univ. of Bristol.
102 | Society for Neuroscience

4:00 P10 412.12 Synaptic alterations consistent with

parvalbumin-expressing interneuron dysfunction in a novel
mouse model of Alzheimers disease. L. CHEN*; T. SAITO;
T. C. SAIDO; I. MODY. UCLA, RIKEN Brain Sci. Inst., UCLA.
1:00 P11 412.13 Synaptic zinc deficiency induces neuronal
hyperexcitability and impairs adult neurogenesis in the
hippocampus of ZnT3KO transgenic mice. E. VOGLER*; X.
WANG; S. MICHALSKI; X. GAO; M. MAHAVONGTRAKUL;
R. BOHANNAN; J. CHEN; J. A. BUSCIGLIO. Univ. of
California, Irvine, Indiana Univ., Indiana Univ. Sch. of Med.,
Univ. of California, Irvine.
2:00 P12 412.14 Abnormal increased basal EEG activity
in the ZnT3KO mouse model of Alzheimers disease. M.
MAHAVONGTRAKUL*; E. VOGLER; J. YAO; A. TRAN; R. F.
STEVENSON; D. TRAN; J. BUSCIGLIO. Univ. of California,
Irvine.
3:00 Q1
412.15 Modified synaptic transmission and
short-term plasticity in Alzheimers disease. N. SINGH*; S.
NADKARNI. Indian Inst. of Sci. Educ. and Res.
4:00 Q2
412.16 Biochemical and functional deficits in
olfactory epithelium and olfactory bulb of 3-5 month old APP/
PS1 mice. M. CHEN*. South China Normal Univ.
1:00 Q3
412.17 Tumor necrosis factor- mediates LTP
impairment in APP/PS1 mice. A. SINGH*; O. D. JONES; W.
C. ABRAHAM. Univ. of Otago.
2:00 Q4
412.18 Stability of synaptic proteins in the frontal
cortex in the preclinical phase of Alzheimers disease. M. A.
ANSARI*; S. W. SCHEFF. Univ. of Kentucky Sanders-Brown
Ctr. on Aging, Univ. of Kentucky Sanders-Brown Ctr. on
Aging.
3:00 Q5
412.19 Formation and repair of DNA doublestrand breaks in neurons: Implications for Alzheimers
disease and related disorders. M. D. EVANS*; D. CHENG;
L. MUCKE. Gladstone Inst. of Neurolog. Dis., Univ. of
California, San Francisco.
4:00 Q6
412.20 The role of Drp1 in AMPAR trafficking
and Alzheimers disease. M. J. HEIMANN*; C. S. BINDA; E.
BRAKSATOR; C. GUO; K. A. WILKINSON; J. M. HENLEY.
Univ. of Bristol, Univ. of Bristol.
1:00 Q7
412.21 Early life stress worsens cognitive
performance, synaptic plasticity and A levels in APP/
PS1 mice. S. L. LESUIS*; B. A. C. E. VAN HOEK; P. J.
LUCASSEN; H. J. KRUGERS. Univ. Van Amsterdam.
2:00 Q8
412.22 Impact of EphA4 ablation on cognitive
function and disease pathology in a mouse model of
Alzheimers disease. L. POPPE; L. RU; Z. CALLAERTSVEGH; R. DHOOGE; R. LEMMENS; W. L. ROBBERECHT*.
KU Leuven- Univ. of Leuven, Dept. of Neurosciences, Exptl.
Neurol. and Leuven Res. Inst. for Neurosci. and Dis. (LIND),
VIB, Vesalius Res. Center, Lab. of Neurobio., KU LeuvenUniv. of Leuven, Fac. of Psychology and Educational
Sciences, Lab. of Biol. Psychology, mINT animal behavior
core facility, KULeuven, Fac. of Psychology, KU LeuvenUniv. of Leuven, Fac. of Psychology and Educational
Sciences, Lab. of Biol. Psychology and Leuven Res. Inst. for
Neurosciene and Dis. (LIND), Univ. Hosp Gasthuisberg.
3:00 Q9
412.23 Combining molecular profiling of
differentially vulnerable synaptic populations with in-vivo
phenotypic assessment identifies regulators of neuronal
stability. M. LLAVERO HURTADO*; H. R. FULLER; S. L.
EATON; G. PENNETTA; J. D. COOPER; T. M. WISHART.
The Univ. of Edinburgh, Keele Univ., The Univ. of Edinburgh,
The Univ. of Edinburgh, Euan MacDonald Ctr. for Motor
Neurone Dis. Research, Univ. of Edinburgh, Kings Col.
London.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 Q10 412.24 SUVN-G3031, a histamine 3 receptor

inverse agonist potentiates the procognitive and
neurochemical effects of donepezil and memantine. R.
MEDAPATI; V. BENADE; S. DARIPELLI; G. AYYANKI;
V. KAMUJU; R. ABRAHAM; P. JAYARAJAN; G.
BHYRAPUNENI; K. BOJJA; A. K. SHINDE*; R. NIROGI.
Suven Life Sci., Suven Life Sci., Suven Life Sci., Suven Life
Sci., Suven Life Sci.
1:00 Q11 412.25 Grx1 over-expression reverses spine loss
in primary cortical neurons derived from Alzheimers disease
transgenic mice. D. DAS*; R. P. KOMMADDI; A. RAY; B. L.
SCHNEIDER; P. AEBISCHER; V. RAVINDRANATH. Indian
Inst. of Sci., Brain Mind Institute, cole Polytechnique
Fdrale de Lausanne.
2:00 Q12 412.26 Activity and levels of calpain 2 but
not calpain 1 is upregulated in synaptosomes early in
the pathogenesis of Alzheimers disease. F. AHMAD*; D.
BENNETT; V. RAVINDRANATH. Indian Inst. of Sci., Rush
Univ. Med. Ctr.
3:00 Q13 412.27 Structural changes in CA1
hippocampal neurons in adolescent Alzheimers disease
transgenic (APPSwe/PSEN1E9) mice. S. KUMAR*; V.
RAVINDRANATH. Indian Inst. of Sci.

1:00 R1
412.29 Changes in the synaptic proteome in
Alzheimers disease indicate a role for ApoE4 in synapse
degeneration. R. J. JACKSON*; M. LLAVERO; A. G.
HERRMANN; C. M. HENSTRIDGE; D. J. LAMONT; T. M.
WISHART; T. L. SPIRES-JONES. Univ. of Edinburgh, Univ.
of Edinburgh, Univ. of Dundee.
2:00 R2
412.30 Processing bodies and oA-induced
synaptic mRNA dysregulation. C. WILLIAMS; S. MARQUEZVILENDRER; M. A. ROOF; S. SHETTY; C. A. MILLER*.
Keck Sch. of Med. of USC, Axogen Inc, USC.

POSTER
413. Disease-Modifying Therapy for Parkinsons Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 R3
413.01 Identification of drug candidates that
block the effects of -synuclein oligomers on membrane
trafficking. C. SILKY; R. YURKO*; K. MOZZONI; C. REHAK;
N. IZZO; G. RISHTON; G. LOOK; H. SAFFERSTEIN;
S. M. CATALANO. Cognition Therapeut. Inc, Cognition
Therapeutics, Inc.
2:00 R4
413.02 Structure of the N-terminal region
of -synuclein determines the rate of fibril growth. D.
D. DHAVALE; C. TSAI; D. P. BAGCHI; L. A. ENGEL; J.
SAREZKY; P. T. KOTZBAUER*. Washington Univ.
3:00 R5
413.03 HA53T--syn accumulation and
associated neurotoxicity is prevented by the inhibition
of mitochondrial fission. S. BIDO*; R. FAN; K. TIEU; E.
BEZARD. Inst. des Maladies Neurodgnratives, Plymouth
Univ.

2:00 R8
413.06 Multimer-PAGE reveals shift from
multimeric to monomeric -synuclein in HEK293 cells
overexpressing A53T mutant -synuclein. B. A. KILLINGER*;
D. YEDLAPUDI; A. MOSZCZYNSKA. Wayne State Univ.
3:00 R9
413.07 A high throughput screening system for
visualizing therapeutic drugs of neurodegenerative diseases.
S. L. WALKER*; D. C. W. CHAN; V. C. T. MOK; W. H. YUNG;
Y. KE. The Chinese Univ. of Hong Kong, The Chinese Univ.
of Hong Kong, The Chinese Univ. of Hong Kong.
4:00 R10 413.08 Novel reagents and assays indicate
a role for NADPH oxidase 2 in Parkinson disease. J. T.
GREENAMYRE*; E. K. HOFFMAN; M. T. KEENEY; J.
MCCOY; P. J. PAGANO; R. DI MAIO. Univ. of Pittsburgh.
1:00 R11 413.09 Inhibition of LRRK2 prevents rotenone
induced reduction of glucocerebrosidase activity. E. N.
ROCHA*; E. HOFFMAN; R. DI MAIO; P. J. BARRETT; J. T.
GREENAMYRE. Univ. of Pittsburgh.
2:00 R12 413.10 Glatiramir acetate (Copaxone) causes
restoration of the nigrostriatal pathway in a progressive
MPTP mouse model of Parkinsons disease. C. K.
MESHUL*; M. J. CHURCHILL. VA Med. Ctr., OHSU.
3:00 R13 413.11 N-acylethanolamine acid amidase
(NAAA) as a therapeutic target for Parkinsons disease.
S. PONTIS*; N. REALINI; F. PALESE; A. ARMIROTTI; M.
LANFRANCO; D. PIOMELLI. Inst. Italiano Di Tecnologia,
Univ. of California, Irvine.
4:00 R14 413.12 The neurorestorative potential of cortical
disinhibition in a progressive mouse model of Parkinsons
disease. R. HOOD*; C. K. MESHULK. Behavioral
Neuroscience, Oregon Hlth. & Sci. U, Portland VA Med. Ctr.
1:00 R15 413.13 Neuroprotective effects of 7 nicotinic
acetylcholine receptor through the Wnt/-catenin signaling
pathway in both in vivo and in vitro models of Parkinsons
disease. H. JUN*; Y. FAN. The First Affiliated Hosp. of
Nanjing Med. Univ., Dept. of Pharmacol. of Nanjing Med.
Univ.
2:00 R16 413.14 Neuroprotective effect of dimethyl
fumarate in mptp-mouse model of Parkinsons disease. E.
ESPOSITO*; F. BIUNDO; G. CASILI; M. CAMPOLO; R.
CRUPI; M. CORDARO; S. CUZZOCREA. Univ. of Messina.
3:00 R17 413.15 Recovery of motor functions in a
Parkinsons disease rat model after releasing dopamine from
titanium dioxide matrix implants. M. GMEZ-CHAVARN*;
P. PADILLA; J. RAMIREZ-SANTOS; G. PRADO-PRONE;
J. GARCA-MACEDO; G. GUTIERREZ-OSPINA. UNAMBiomedical Res. Institutute, UNAM-Medicine Fac., UNAMPhysics Inst.

4:00 S1
413.16 Long-term transgene expression
in rat brain after intranasal administration of hGDNF
DNA nanoparticles and enhancement by focused
ultrasound (FUS). A. E. ALY*; T. SUN; Y. ZHANG; O.
SESENOGLU-LAIRD; L. PADEGIMAS; M. J. COOPER;
N. J. MCDANNOLD; B. L. WASZCZAK. Northeastern
Univ., Harvard Med. Sch. and Brigham & Womens Hosp.,
Copernicus Therapeut.

4:00 R6
413.04 14-3-3s reduce endogenous -synuclein
aggregation and toxicity induced by fibrillary -synuclein.
R. UNDERWOOD; B. WANG; T. A. YACOUBIAN*. Univ. of
Alabama at Birmingham, Univ. Alabama Birmingham.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|103

Mon. PM

4:00 Q14 412.28 Histological evaluation of synaptic

markers in animal models of Alzheimers disease. J.
NEDDENS*; M. ZHAN; E. AUER; B. HUTTER-PAIER. QPS
Austria GmbH, Univ. of Applied Sci.

1:00 R7
413.05 Structural elucidation of -synuclein
oligomers using a library of sequential antibodies. L.
NILSSON*; T. ISLAM; A. OLOFSSON. Dept. of Chem., Dept.
of medical biochemistry and biophysics.

1:00 S2
413.17 Metabolic profiling and lipidomics of a
potential canine model for a juvenile Parkison disease. T.
L. KOZICZ*; T. EMMERZAAL; F. VAZ; G. S. JOHNSON; D.
P. OBRIEN; C. P. BAINES; E. MORAVA. Radboud Univ.
Nijmegen Med. Ctr., Tulane Univ., Academic Med. Ctr., Univ.
of Missouri Col. of Vet. Med., Univ. of Missouri Col. of Vet.
Med., Univ. of Missouri Col. of Vet. Med.
2:00 S3
413.18 Therapeutic repurposing of raloxifene
as an immunomodulatory drug for the treatment of gut
inflammation in a mouse model of Parkinsons disease. A.
POIRIER*; M. CT; M. BOURQUE; M. MORISSETTE;
T. DI PAOLO; D. SOULET. Ctr. De Recherche Du CHU De
Qubec (CHUL), Univ. Laval, Univ. Laval.

3:00 S4
413.19 Tolerability of siRNA-mediated
-synuclein suppression in the adult rhesus substantia
nigra. R. GRONDIN*; Y. AI; P. HUETTL; H. MENG; F.
POMERLEAU; J. E. QUINTERO; P. A. HARDY; M. T. BUTT;
A. SEHGAL; D. A. BUMCROT; D. M. GASH; Z. ZHANG;
G. A. GERHARDT. Univ. of Kentucky Med. Ctr., Shandong
Univ. Sch. of Med., Univ. of Kentucky Med. Ctr., Tox Path
Specialists LLC, Alnylam Pharmaceuticals Inc.
4:00 S5
413.20 The Role of PAN nuclease in Parkinsons
disease. H. PARK*; T. KAM; T. M. DAWSON; V. L.
DAWSON. Inst. For Cell Engineering, Johns Hopkins Univ.,
Inst. For Cell Engineering, Johns Hopkins Univ.
1:00 S6
413.21 The Michael J. Fox Foundations
strategy to generate, characterize, and distribute preclinical
-synuclein research tools for molecular biology. T. N.
MARTINEZ*; P. H. JENSEN; K. C. LUK; L. GOTTLER; M.
CHOU; B. MILLE-BAKER; F. VERKAAR; C. HABER; L.
STEINBRUCK; H. A. LASHUEL; B. FAUVET; X. TONG;
A. L. MORRIS; K. D. DAVE. The Michael J. Fox Fndn.
For Parkinsons Res., Aarhus Univ., Univ. of Pennsylvania
Perelman Sch. of Med., Proteos, Inc, Abcam, Charles
River, PEPperPRINT, PEPperPRINT, Ecole Polytechnique
Fdrale de Lausanne (EPFL), CPC Scientific, Inc.

POSTER
414. Neurodegeneration and Neuroprotection in Parkinsons
Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 S7
414.01 Aldh1a1 is expressed by two
dopamine neuron subtypes with distinct molecular and
neuroanatomical properties. J. POULIN*; C. M. ESTEP;
Q. CUI; B. HELM; C. S. CHAN; D. J. SURMEIER; R.
AWATRAMANI. Northwestern Univ.- Chicago, Northwestern
Univ., Northwestern Univ.
2:00 S8
414.02 Base excision repair variants and
pesticide exposure increase Parkinsons disease risk. L.
H. SANDERS*; K. C. PAUL; E. H. HOWLETT; X. HU; J. M.
BRONSTEIN; B. RITZ; J. GREENAMYRE. Univ. Pittsburgh,
UCLA, Univ. of Pittsburgh, UCLA.

1:00 S11 414.05 Rab8A effects on -synuclein toxicity in a

rat model of Parkinsonism. N. R. MCFARLAND*; H. PARK;
D. RYU; L. POWELL; R. FOELS; M. PARMAR. Univ. of
Florida, Univ. of Florida.
2:00 S12 414.06 Increase of protein levels in sporadic
and experimental Parkinsons disease. Y. CHU*; Y. HE; J. H.
KORDOWER. Rush Univ. Med. Ctr., Rush Univ. Med. Ctr.
3:00 S13 414.07 The effect of N-methylsasolinol on
-synuclein transgenic PD model. Z. CHEN; H. MA*; F. SUN;
Y. DENG. Sch. of Life Science, Beijing Inst. of Technol.
4:00 S14 414.08 The effect of zinc administration
in Atp13a2-deficient mice. N. A. SANTIAGO*; R.
BLACKWOOD; S. HUBBARD; S. S. KARKARE; E. R.
DIRR; G. E. SHULL; E. MASLIAH; B. LIOU; Y. SUN; P.
FERNAGUT; E. BEZARD; B. DEHAY; S. M. FLEMING.
Northeast Ohio Med. Univ., Univ. of Cincinnati, Univ.
of Cincinnati, Univ. of California San Diego, Cincinnati
Childrens Hosp. Med. Ctr., Univ. of Bordeaux.
1:00 T1
414.09 Nuclear translocation of SIRT2 induced
by Cdk5 dependent phosphorylation promotes the
dopaminergic neuron death in Parkinsons disease. J. YAN*;
P. ZHANG; F. HE; F. JIAO; Q. WANG; L. CHEN; Q. ZHANG;
B. TIAN. Huazhong Univ. of Sci. and Technol.
2:00 T2
414.10 Dysregulation of protein phosphatase
2A in dementia with lewy bodies. H. PARK; K. LEE; E.
PARK; S. OH; R. YAN; J. ZHANG; T. BEACH; C. ADLER;
M. VORONKOV; S. BRAITHWAITE; J. STOCK; M. M.
MOURADIAN*. Rutgers-Robert Wood Johnson Med. Sch.,
Banner Sun Hlth. Res. Inst., Mayo Clin., Signum Biosci.,
Princeton Univ.
3:00 T3
414.11 Characterization of n370s gba1-PD ips
cells derived human dopaminergic neurons. S. YUN*; H. KO.
Johns Hopkin Med.
4:00 T4
414.12 Alterations in ganglioside biosynthesis
and content in Parkinsons disease and role in modulating
vulnerability for neurodegeneration. M. VERMA*; S.
JACKSON; T. N. SEYFRIED; H. CHOI; Z. AKGOC; A. LYNN;
J. S. SCHNEIDER. Thomas Jefferson Univ., Thermo Fisher
Scientific, Boston Col.
1:00 T5
414.13 Differentiation of neuroepithelial stem
cells into functional dopaminergic neurons in 3d microfluidic
cell culture. E. LUCUMI MORENO*; S. HACHI; K. HEMMER;
S. J. TRIETSCH; A. S. BAUMURATOV; T. HANKEMEIER; P.
VULTO; J. C. SCHWAMBORN; R. M. T. FLEMING. Univ. of
Luxembourg, Campus Belval, Mimetas, Leiden Univ.
2:00 T6
414.14 Increased Kv2.1 channel expression
contributes to nigrostriatal degeneration in MPTP induced
Parkinsons disease model. R. CHAO; C. CHENG; P.
CHEN*. Natinal Cheng Kung Univ., Natl. Cheng Kung Univ.
3:00 T7
414.15 A possible involvement of TRPM7 in the
6-hydroxy-dopamine model of Parkinsons disease. L. M.
DATI*; H. ULRICH; H. SUN; Z. FENG; L. BRITTO. Univ. of
Sao Paulo, Univ. of Toronto.

3:00 S9
414.03 Multifunctional neuroprotection by
astrocyte-specific DJ-1 expression in the rotenone model of
Parkinsons disease. B. R. DE MIRANDA*; E. A. BURTON;
J. T. GREENAMYRE. Univ. of Pittsburgh.

4:00 T8
414.16 Neuroplasticity induced by acrobatic
exercise in a rat model of Parkinsons disease. R. S.
PIRES*; N. R. SANTIAGO; Q. R. S. G. FERRAREZI; R. O.
JACOB; C. C. REAL; L. R. G. BRITTO. Univ. Cidade De So
Paulo, Univ. of So Paulo.

4:00 S10 414.04 A longitudinal study of PINK1 and PARK7

KO rats. N. W. MILGRAM*; J. A. CASKANETTE; A. VAN
NIEKERK; A. PATRICK; L. B. SILENIEKS; W. LAU; S.
THEVARKUNNEL; J. A. ARAUJO; G. A. HIGGINS. Cancog
Technologies, U. Toronto, Vivocore, Intervivo Solutions Inc.

1:00 T9
414.17 6-hydroxydopamine- and L-DOPAinduced shifts in striatal monoamine transporter function
in L-DOPA-primed, hemi-Parkinsonian rats. M. CONTI*; S.
MEADOWS; J. GOLD; N. PALUMBO; J. HALLMARK; D.
WERNER; C. BISHOP. Binghamton Univ.

104 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 T10 414.18 Neuroprotective role of Osmotin in

-synuclein induced neuropathology via AMPK activated
signaling cascade. M. JO*; M. KHAN; M. SOHAIL; M. KIM.
Neurobio. Lab.
3:00 T11 414.19 Behavioural effects of sodium benzoate,
a cinnamon metabolite, on the 6-hydroxydopamine rat model
of Parkinsons disease. M. K. SHAMMAS*; R. T. KENNEDY.
Univ. of Michigan, Univ. of Michigan.
4:00 T12 414.20 Distribution of -synuclein in dementia
with Lewy bodies brain tissues. T. EVANS; K. COWAN; O.
ANICHTCHIK*. Plymouth Univ.

POSTER
415. Human and Non-Human Primate Therapies in
Parkinsons Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 DP03 415.02 (Dynamic Poster) Effect of Parkinsonism

and deep brain stimulation on neural oscillations and phaseamplitude coupling within the motor cortex, subthalamic
nucleus and globus pallidus. D. ESCOBAR SANABRIA*; L.
A. JOHNSON; J. ZHANG; S. NEBECK; M. D. JOHNSON; G.
F. MOLNAR; K. B. BAKER; J. L. VITEK. Univ. of Minnesota,
Univ. of Minnesota.
3:00 T14 415.03 Neuro-pathophysiology of SMA-M1 single
unit activity during visually guided reach in the progressive
MPTP nonhuman primate model of Parkinsons disease. B.
CAMPBELL*; C. M. HENDRIX; B. J. TITTLE; Y. ADIBI; Z.
M. WEINSTOCK; G. F. MOLNAR; M. D. JOHNSON; K. B.
BAKER; J. L. VITEK. Univ. of Minnesota, Univ. of Minnesota,
Univ. of Minnesota.
4:00 T15 415.04 Improved spatial resolution of local field
potentials with deep brain stimulation arrays in the globus
pallidus and subthalamic nucleus. S. ZHANG*; M. D.
JOHNSON. Univ. of Minnesota.
1:00 T16 415.05 Low frequency modulations in the
Supplementary Motor Area (SMA) and motor cortex (MC) in
the MPTP nonhuman primate (NHP) model of Parkinsons
disease. Y. ADIBI*; C. HENDRIX; B. CAMPBELL; K. BAKER;
J. L. VITEK. Univ. of Minnesota, Univ. of Minnesota.
2:00 T17 415.06 Evolution in the modulation of passive
responses in primary motor cortex during prolonged STN
DBS in the Parkinsonian monkey. J. WANG*; S. NEBECK; L.
A. JOHNSON; J. ZHANG; M. D. JOHNSON; K. B. BAKER;
G. F. MOLNAR; J. L. VITEK. Univ. of Minnesota, Univ. of
Minnesota.
3:00 T18 415.07 Effect of levodopa on neuronal activity in
primary motor cortex in the MPTP non-human primate model
of Parkinsons disease. S. D. NEBECK; L. A. JOHNSON*; J.
ZHANG; D. ESCOBAR; M. D. JOHNSON; G. MOLNAR; K.
B. BAKER; J. L. VITEK. Univ. of Minnesota Dept. of Neurol.,
Univ. of Minnesota Dept. of Biomed. Engin.
4:00 U1
415.08 STriatal-Enriched protein tyrosine
Phosphatase (STEP) inhibitor TC-2153 improves aspects
of cognitive dysfunction in aged Parkinsonian monkeys. J.
S. SCHNEIDER*; C. WILLIAMS; P. LOMBROSO. Thomas
Jefferson Univ., Yale Univ. Sch. of Med.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 U3
415.10 Positron emission tomography imaging of
cardiac neuroprotection induced by peroxisome proliferatoractivated receptor (PPAR) activation. J. SHULTZ*;
H. RESNIKOFF; V. BONDARENKO; J. HOLDEN; T.
BARNHART; P. LAO; B. CHRISTIAN; J. NICKLES; C. F.
MOORE; M. EMBORG. Univ. of Wisconsin- Madison, Univ.
of Wisconsin- Madison, Univ. of Wisconsin- Madison, Univ.
of Wisconsin- Madison.
3:00 U4
415.11 Early development of common
marmoset vocalizations. C. A. JONES*; M. K. DUFFY; S. A.
HOFFMAN; N. J. SCHULTZ-DARKEN; K. M. BRAUN; M.
R. CIUCCI; M. E. EMBORG. Univ. of Wisconsin- Madison,
Univ. of Wisconsin- Madison, Univ. of Wisconsin- Madison,
Wisconsin Natl. Primate Ctr., Univ. of Wisconsin- Madison.
4:00 U5
415.12 Wirelessly programmable module for
custom deep brain stimulation. E. M. LEWIS*; C. KEMERE.
Rice Univ., Rice Univ.

1:00 U6
415.13 Toward an electrophysiologically
defined sweet spot for deep brain stimulation within the
subthalamic nucleus. A. HORN*; W. NEUMANN; K. DEGEN;
G. SCHNEIDER; A. KHN. Charit Univ. Med., Charit
Univ. Med.
2:00 U7
415.14 Three-dimensional definition of two
prominent deep brain stimulation targets based on a
multimodal high-definition MNI template. S. EWERT*;
A. HORN. Charit Univ. Medicine, (berlin, Germany),
Berenson-Allen Ctr. for Noninvasive Brain Stimulation.
3:00 U8
415.15 Basal ganglia disinhibition in Tourette
syndrome. I. BAR-GAD*; M. ISRAELASHVILI. Bar-Ilan Univ.
4:00 U9
415.16 Patient-specific models of local field
potentials recorded from deep brain stimulation electrodes.
N. MALING; S. F. LEMPKA; Z. BLUMENFELD; H. BRONTESTEWART; C. C. MCINTYRE*. Case Western Reserve
Univ., Cleveland Clin., Stanford Univ.
1:00 U10 415.17 Subthalamic nucleus oscillations
as predictor of motor cortical excitability measured
by transcranial magnetic stimulation. K. UDUPA*; A.
GHAHREMANI; J. R. WESSEL; U. SAHA; T. HOQUE; A. R.
ARON; R. CHEN. Krembil Res. Institute, UHN, Krembil Res.
Inst., Krembil Res. Inst., Univ. of Iowa, Univ. of California
San Diego.
2:00 U11 415.18 Modulation of subthalamic oscillations
by movement parameters in Parkinsons disease. R.
LOFREDI*; A. BOCK; W. NEUMANN; J. HBL; S.
SIEGERT; G. SCHNEIDER; J. KRAUSS; A. KHN. Klinik
Fr Neurologie- Charit Campus Virchow-Kli, Medizinische
Hochschule Hannover.
3:00 U12 415.19 Cortico-basal ganglia connectivity in nonhuman primates: Implications for the therapeutic effect of
STN stimulation in PD patients. A. MATIS*; R. N. LEMON; D.
C. ALEXANDER; A. KRASKOV. UCL Inst. of Neurol., Ctr. for
Med. Image Computing.

Neuroscience 2016|Monday PM|105

Mon. PM

1:00 T13 415.01 Stimulation amplitude-dependent

modulation of neuronal activity around chronically implanted
thalamic deep brain stimulation arrays. M. D. JOHNSON*; Y.
XIAO. Univ. of Minnesota.

1:00 U2
415.09 Intracerebral delivery of induced
pluripotent stem cell-derived neurons using real-time
intraoperative MRI. S. C. VERMILYEA*; J. LU; M. E. OLSEN;
Y. TAO; S. GUTHRIE; E. M. FEKETE; M. K. RIEDEL;
K. BRUNNER; C. BOETTCHER; V. BONDARENKO; E.
BRODSKY; W. F. BLOCK; A. ALEXANDER; S. ZHANG;
M. E. EMBORG. Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison, Univ. of
Wisconsin-Madison, Univ. of Wisconsin-Madison.

4:00 U13 415.20 Phosphodiesterase 9 inhibition therapy

for Parkinsons disease. S. M. PAPA*; A. SINGH; G.
MASILAMONI; X. TANG; L. LEVENTHAL. Emory Univ.,
Yerkes Natl. Primate Res. Center, Emory Univ., FORUM
Pharmaceuticals, Inc.
1:00 U14 415.21 Striatal overexpression of FosB leads to
the development of dyskinesias in Parkinsonian non-human
primates without chronic levodopa exposure. A. SINGH*;
L. F. POTTS; M. MARTINEZ; J. M. YOO; E. S. PARK;
J. ZHANG; E. JUNN; M. M. MOURADIAN; S. M. PAPA.
Yerkes Natl. Primate Res. Center, Emory University, Ctr. for
Neurodegenerative and Neuroimmunologic Dis., Emory Univ.
Sch. of Med.
2:00 U15 415.22 Effects of optogenetic activation of
thalamostriatal terminals in monkeys. A. GALVAN*; X. HU; Y.
SMITH; T. WICHMANN. Emory Univ., Emory Univ.
3:00 U16 415.23 Altered functional connectivity associated
with striatal dopamine depletion in Parkinsons disease. A.
SHIMA*; N. SAWAMOTO; R. INANO; H. TABU; T. OKADA;
K. TOGASHI; R. TAKAHASHI. Kyoto Univ. Grad. Sch. of
Med., Kyoto Univ. Grad. Sch. of Med., Kyoto Univ. Grad.
Sch. of Med., Kyoto Univ. Grad. Sch. of Med.
4:00 U17 415.24 Morphological evidence supporting
dopamine D1/D2 receptor heteromers in the striatum of
the long-tailed macaque. Changes following dopaminergic
manipulation. J. L. LANCIEGO*; A. J. RICO; I. G.
DOPESO-REYES; E. MARTINEZ-PINILLA; D. SUCUNZA;
D. PIGNATARO; E. RODA; D. MARIN-RAMOS; J. L.
LABANDEIRA-GARCIA; S. R. GEORGE; R. FRANCO.
FIMA, CIBERNED, Univ. of Santiago de Compostela,
CIBERNED, Campbell Family Mental Hlth. Institute, Ctr.
for Addiction and Mental Health, Univ. of Toronto, Univ. of
Barcelona, CIBERNED.
1:00 U18 415.25 Early loss of extra-striatal dopaminergic
innervation in a progressive MPTP monkey model: A
putative compensatory mechanism? I. TRIGO DAMAS*;
A. VIAN-LAINS; H. IWAMURO; J. BLESA; M. SANCHEZGONZALEZ; C. CAVADA; J. OBESO. CINAC-HM Puerta Del
Sur, Facultad de Medicina, Univ. Autnoma de Madrid, Dept.
of Neurosurgery. Tokyo Metropolitan Neurolog. Hosp.
2:00 V1
415.26 Dopaminergic neurons intrinsic to
the striatum: A potential compensatory mechanism in
Parkinsons disease? J. BLESA*; N. LOPEZ-GONZALEZ
DEL REY; P. GARCIA-ESPARCIA; I. TRIGO-DAMAS; I.
FERRER; C. CAVADA; J. OBESO. HM Hosp. Puerta del Sur,
Res. Ctr. of Neurodegenerative Dis. (CIBERNED), Bellvitge
Biomed. Res. Inst. (IDIBELL), HM Puerta del Sur, Univ.
Autonoma de Madrid.
3:00 V2
415.27 Dopamine and serotonin hyperinnervation
of the globus pallidus in Parkinsonian monkeys. D.
GAGNON*; L. EID; C. WHISSEL; A. BRAUN; T. DI PAOLO;
M. PARENT. CR-IUSMQ, CR-CHUQ.
4:00 V3
415.28 Aerobic exercise can induce dopamine
release in Parkinsons disease: [11C]Raclopride PET study.
M. A. SACHELI*; B. LAKHANI; J. L. NEVA; D. K. MURRAY;
N. VAFAI; J. MCKENZIE; N. NEILSON; K. DINELLE; I. S.
KLYUZHIN; L. A. BOYD; V. SOSSI; A. J. STOESSL. Pacific
Parkinsons Res. Ctr., Dept. of Physical Therapy, Fac. of
Medicine, Djavad Mowafaghian Ctr. for Brain Health, Univ. of
British Columbia, Fac. of Medicine, Univ. of British Columbia,
Dept. of Physics and Astronomy, Univ. of British Columbia.

2:00 V5
415.30 Phase amplitude coupling of
electrocorticogram signals in a progressive model of
primate Parkinsonism. A. DEVERGNAS*; M. CAIOLA;
D. PITTARD; T. WICHMANN. Yerkes Natl. Primate Res.
Ctr., Dept. of Neurology, Emory university, Udall Ctr. of
Excellence in Parkinsons Dis. Reseach, EMory Univ., Dept.
of Mathematical Sci.

POSTER
416. Mitochondria, Alpha-Synuclein, and Inflammation in
Parkinsons Disease
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 V6
416.01 GPx4 protects against oxidative stressinduced deficits in mitochondrial import: Implications for
Parkinsons disease. C. W. BARRETT*; P. J. BARRETT;
A. D. MORTIMER; C. T. CHU; J. T. GREENAMYRE; T. G.
HASTINGS, 15260. Univ. of Pittsburgh.
2:00 V7
416.02 synuclein binds tom20 and impairs
mitochondrial protein import in Parkinsons disease. P.
BARRETT*; R. DIMAIO; E. HOFFMAN; C. BARRETT;
A. ZHARIKOV; C. CHU; E. BURTON; T. HASTINGS; J.
GREENAMYRE. Univ. of Pittsburgh, Univ. of Pittsburgh.
3:00 V8
416.03 Pathogenic -synuclein mediates
Parkinsons disease-related synaptic dysfunction and
cognitive decline. C. GALLARDO*; A. COVELO; B. SINGH;
H. A. MARTELL-MARTINEZ; M. A. BENNEYWORTH; A.
ARAQUE`; M. K. LEE. Univ. of Minnesota Syst., Univ. of
Minnesota, Univ. of Minnesota, Univ. of Minnesota, Univ. of
Minnesota.
4:00 V9
416.04 Assessing the maximum activity of the
caspase 3 and 9 in a exerimental model of Parkinsons
disease induced by mpp+ in rats. M. ISLAS*; M. RUBIOOSORNIO; I. SANTANDER-RODEA; S. ZAMUDIO; C. RIOS;
A. DIAZ-RUIZ. Inst. Politcnico Nacional, Inst. Nacional de
Neurologa y Neurociruga, Manuel Velasco Suarez, Inst.
Nacional de Neurologa y Neurociruga, Manuel Velasco
Suarez.
1:00 V10 416.05 Chronic psychological stress promotes
PINK1/parkin-mediated mitophagy in mouse amygdala. K.
DUAN*; X. LIU; Z. LI. Natl. Inst. of Mental Hlth., Fudan Univ.
2:00 V11 416.06 Paraquat and stress interactions as
pertains to Parkinsons disease motor deficits and comorbid behaviors. K. FARMER*; C. RUDYK; Z. DWYER; J.
MCNEILL; F. WAHBEH; N. PROWSE; S. HAYLEY. Carleton
Univ.
3:00 V12 416.07 GBA1 deficiency plays a role in the
formation of physiological -synuclein tetramer. S. KIM*; S.
YUN; S. LEE; H. KO. Johns Hopkins Univ.
4:00 V13 416.08 Effect of trans fatty acid on synuclein
channels and implications in Parkinsons disease. S.
SRIDHAR*; A. K. BERA. Indian Inst. of Technol. Madras.
1:00 V14 416.09 Self-defense responses against
6-hydroxydopamine-induced nitrosative cell death in C6
glioma cells. H. MOON; C. LEE; G. PARK; J. JANG*.
Kyungpook Natl. Univ., Keimyung University, Sch. of Med.

1:00 V4
415.29 Plastic resting-state networks in
MPTP-treated monkeys. J. A. AUTIO*; N. TANKI; T. OSE;
J. TAKAHASHI; T. HAYASHI. RIKEN, Ctr. For Life Sci.
Technologies, Kyoto University, CiRA.

2:00 V15 416.10 Glial cells and mast cells signaling

pathways in neuroinflammation. K. DURAISWAMY; R.
THANGAVEL; S. ZAHEER; D. A. SANTILLAN; M. K.
SANTILLAN; M. M. THAKKAR*; A. ZAHEER. HSTMV
Hospital/University of Missouri, Univ. of Iowa.

106 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 V16 416.11 Selective Toll-like receptor inhibition

occludes -synuclein-induced pro-inflammatory signaling &
cytokine release. A. M. HABAS*; S. NATALA; J. WONG; W.
WRASIDLO; M. GILL; D. BONHAUS. Neuropore Therapies,
Inc., Neuropore Therapies Inc., Neuropore Therpaies Inc.
4:00 V17 416.12 Glia maturation factor dependent
activation of nod like receptor family pyrin domain containing
3 (NLRP3) inflammasome. H. JAVED; M. M. KHAN; R.
THANGAVEL; K. DURAISAMY; S. ZAHEER; S. IYER; A.
ZAHEER*. Univ. of Iowa, Univ. of Missouri & Truman VA.
1:00 V18 416.13 Effect of chronic systemic inflammation
in the cytokines profile in central nervous system and its
implication in suceptibility to damage by neurotoxin MPTP
in mice. P. UGALDE MUIZ*; A. CHAVARRA KRAUSER.
Hosp. Gen. De Mxico, Hosp. Gen. De Mxico.
2:00 W1
416.14 Differential gene expression profile
between early and late stage disease model of Parkinsons
disease. A. VERMA*; V. RAVINDRANATH. Indian Inst. of
Sci.

4:00 W3
416.16 Dopaminergic degeneration following
viral mediated dysregulation of dopamine: Implications for
Parkinsons disease. M. BUCHER*; C. W. BARRETT; T. G.
HASTINGS. Univ. of Pittsburgh.

POSTER
417. Huntingtons Disease Mechanisms II
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 W4
417.01 Impaired autophagy in Huntingtons
disease impacts on global microRNA-levels through
Argonaute-2 accumulation. K. PIRCS*; R. PETRI; S.
MADSEN; P. L. BRATTS; M. MATUSIAK-BRCKNER; R.
VUONO; N. DGLON; R. A. BARKER; J. JAKOBSSON.
Lund Univ., Univ. of Cambridge, Lausanne Univ. Hosp.
2:00 W5
417.02 Respiration and Ca2+ handling by
striatal mitochondria purified from brains of YAC128
mice, a model of Huntingtons disease. J. HAMILTON*; T.
BRUSTOVETSKY; N. BRUSTOVETSKY. Indiana Univ. Sch.
of Med., Stark Neurosci. Res. Inst.
3:00 W6
417.03 Redox changes and bioenergetic defects
in striatum and cortex of pre-symptomatic and symptomatic
Huntingtons disease mice. A. C. REGO*; C. MARANGA; I.
L. FERREIRA; M. LAO; S. MOTA; L. NAIA; J. SERENO;
A. ABRUNHOSA; M. HAYDEN; M. CASTELO-BRANCO.
Fac. of Med. and CNC, CNC-Center for Neurosci. and
Cell Biology, Univ. of Coimbra, ICNAS Inst. for Nuclear
Sci. Applied to Health, Univ. of Coimbra, IBILI- Inst. for
Biomed. Imaging and Life Sciences, Fac. of Medicine, Univ.
of Coimbra, Ctr. for Mol. Med. and Therapeutics, Child and
Family Res. Institute, Dept. of Med. Genetics, Univ. of British
Columbia.
4:00 W7
417.04 Mutant Huntington disrupts the nuclear
pore complex. J. C. GLATZER*; J. C. GRIMA; K. ZHANG; J.
DAIGLE; Q. PENG; C. GEATER; I. AHMED; C. ROSS; W.
DUAN; L. THOMPSON; S. H. SNYDER; J. D. ROTHSTEIN.
Univ. of Rochester, Johns Hopkins Neurosci., Univ. of
California, Irvine.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 W9
417.06 Cortical mitochondria from R6/2
Huntingtons disease mice have elevated iron and altered
proteomic and functional markers. S. AGRAWAL*; J. H.
FOX. Univ. of Wyoming.
3:00 W10 417.07 Epigenetic and transcriptional
dysregulation in prodromal Huntingtons disease. F.
YILDIRIM*; C. W. NG; J. CABOCHE; D. E. HOUSMAN; E.
FRAENKEL. Charit Med. Sch., MIT, Paris Seine INSERM,
MIT.

4:00 W11 417.08 Aberrant CELF1 expression in

Huntingtons disease brain contributes to alternative splicing
and changes in RNA stability. S. RAMACHANDRAN*; S.
COFFIN; B. L. DAVIDSON. Childrens Hosp. of Philadelphia,
The Childrens Hosp. of Philadelphia.
1:00 W12 417.09 Disease-associated changes in huntingtin
mRNA 3UTR isoform abundance. L. ROMO*; E. PFISTER;
A. ASHAR-PATEL; M. MOORE; N. ARONIN. Umass Med.
Sch., Umass Med. Sch.
2:00 X1
417.10 Recruitment of a transcriptional repressor
to protein aggregates leads to de-repression of a proapoptotic gene activity and contributes to neuronal toxicity in
polyglutamine diseases. Z. S. CHEN; S. PENG; Q. ZHANG;
D. D. RUDNICKI; E. CHAN*. The Chinese Univ. of Hong
Kong, Johns Hopkins Univ. Sch. of Med.
3:00 X2
417.11 The implications of H3K9me3 in
neuronal dysfunction underlying Huntingtons disease. S.
CHANDRASEKARAN*; Y. JIANG; E. LOH; R. H. MYERS; L.
SHEN; S. AKBARIAN. Icahn Sch. of Med. At Mount Sinai,
Icahn Sch. of Med. At Mount Sinai, Boston Univ.
4:00 X3
417.12 Pias1 regulates mutant huntingtin
accumulation and Huntingtons disease-associated
phenotypes in vivo. J. OCHABA*; A. MAS MONTEYS; E.
L. MOROZKO; J. G. OROURKE; J. C. REIDLING; J. S.
STEFFAN; B. L. DAVIDSON; L. M. THOMPSON. Univ.
of California Irvine, The Childrens Hosp. of Philadelphia,
Cedars-Sinai Med. Ctr., Univ. of California Irvine, The Univ.
of Pennsylvania.
1:00 X4
417.13 Structural tissue changes and their effect
on brain diffusion in the R6/2 mouse model of Huntingtons
disease. L. VARGOVA*; I. VORISEK; M. SYKA. Charles
University, 2nd Fac. of Med., Inst. of Exptl. Med.
2:00 X5
417.14 Age-related changes in cortical and
striatal NADPH-diaphorase staining in the Q175 mouse
model of Huntingtons disease. F. E. PADOVAN NETO*; L.
JURKOWSKI; C. MURRAY; A. WEST. Rosalind Franklin
Univ.
3:00 X6
417.15 Mechanisms underlying axonal transport
deficits in Huntingtons disease. M. KANG*; R. GATTO; C.
WEISSMANN; N. MESNARD-HOAGLIN; S. T. BRADY; G.
A. MORFINI. Univ. of Illinois At Chicago, Marine Biol. Lab.,
Univ. of Illinois at Chicago.
4:00 X7
417.16 MID1-RNA interactions: Implications
in Huntingtons disease. J. SCHILLING*; A. DAGANE;
I. ATANASSOV; E. WANKER; S. KRAU. DZNE, Max
Delbrueck Ctr., MPI for Biol. of Aging.

Neuroscience 2016|Monday PM|107

Mon. PM

3:00 W2
416.15 Diamide induces selective and
progressive dopaminergic neurodegeneration, -synuclein
pathology and Parkinsonism in mice: A model of
Parkinsons disease. A. RAY*; A. VERMA; S. KUMAR; V.
RAVINDRANATH. Indian Inst. of Sci.

1:00 W8
417.05 Integrated mitochondrial function in
human muscle biopsies of Huntingtons disease patients
and in different tissues of the HdhQ111 mouse model. K.
S. LINDENBERG*; E. BARTH; T. MERZ; A. GUMPP; A.
WITTING; P. WEYDT; M. ZUEGEL; J. STEINACKER; G.
LANDWEHRMEYER; E. CALZIA. Ulm Univ., Ulm Univ., Ulm
Univ.

1:00 X8
417.17 Yap and mst1 dysfunction: Implications
for transcriptional dysregulation in Huntingtons disease.
A. DIOS*; K. MUELLER; K. GLAJCH; M. HUIZENGA; M.
LAQUAGLIA; K. VAKILI; G. SADRI-VAKILI. Massachusetts
Gen. Hosp., Boston Childrens Hosp.
2:00 X9
417.18 Huntingtin protein interactions evaluated
in systems biology analyses among non-human animal
models of Huntingtons disease (HD) reveals the broad
scope of neuronal functional protein networks potentially
involved in HD. S. PODVIN*; V. HOOK. UCSD, UCSD.
3:00 X10 417.19 Comparative study of HDL2 versus
HD iPSC models. S. AKIMOV*; D. RUDNICKI; M.
ENCARNACION; X. SUN; D. SAREEN; C. A. ROSS; R. L.
MARGOLIS. Johns Hopkins University, Sch. of Med., Johns
Hopkins Univ. Krieger Sch. of Arts and Sci., GHM Inst. of
CNS Regeneration, Jinan Univ., iPSC Core, Regenerative
Med. Institute, Cedars-Sinai Med. Ctr.
4:00 X11 417.20 Uncovering mechanisms of gaba
neuron degeneration using Huntingtons disease ipscs.
L. MA*; H. SAIYIN, 200433; X. WANG; L. GAO; J. LI; S.
ZHANG; L. MA. Fudan Univ., FUDAN UNIVERSITY, FUDAN
UNIVERSITY, WISCONSIN UNIVERSITY.
1:00 X12 417.21 Inhibition of nonmuscle myosinIIB
facilitates polyQ-aggregates and cellular toxicity in primary
neurons and HD- iPSC-derived neurons. Y. LEE; W. JUNG;
H. CHOI; M. JUN; Y. HUH; D. JANG; J. LEE*. HANNAM
Univ., Korea basic science institute, Kyungpook Natl. Univ.,
Hannam Univ.

POSTER
418. Huntingtons Disease Therapeutics
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 X13 418.01 Exacerbated SIRT3 activity alters
mitochondrial function and dynamics in Huntingtons disease
models. L. NAIA*; C. CARMO; A. M. OLIVEIRA; J. VALERO;
C. LOPES; C. R. OLIVEIRA; T. R. ROSENSTOCK; A. C.
REGO. CenterforNeuroscience andCellBiology- CNC,
Fac. of Medicine, Univ. of Coimbra, Inst. for Interdisciplinary
Research, Univ. of Coimbra (IIIUC).
2:00 X14 418.02 Progress towards potent, selective
and brain penetrant Rho kinase inhibitors suitable for a
proof-of-concept study in HD models. G. MCALLISTER;
O. AZIZ; C. LUCKHURST; I. ANGULO-HERRERA; W.
BLACKABY; J. FRANCIS; A. HAUGHAN; H. KEARNEY;
J. LIEBESCHUETZ; S. L. MARTIN; K. MATTHEWS; V.
BEAUMONT; R. CACHOPE; M. MAILLARD; M. ROSE;
I. MUNOZ-SANJUAN; C. DOMINGUEZ*. Charles River,
Charles River, CHDI Mgmt. Inc., CHDI Managment Inc.
3:00 X15 418.03 Potent, selective and brain penetrant
ATM inhibitor suitable for a proof-of-concept study in
HD models. O. LAZARI; P. BRECCIA; J. BATE; K.
MATTHEWS; G. WISHART; H. VATER; S. L. MARTIN;
H. COX; W. BLACKABY; G. MCALLISTER; D. YATES;
D. F. FISCHER*; P. MILIANI DE MARVAL; L. TOLEDOSHERMAN; R. CACHOPE; M. ROSE; I. MUNOZ-SANJUAN;
C. DOMINGUEZ. Charles River, Biofocus, Charles River,
Charles River, CHDI Foundation/Management Inc.

1:00 X17 418.05 Chronic Class IIa HDAC inhibition only

partially replicates the beneficial effects of HDAC4 genetic
reduction in HD models. O. AZIZ; C. A. LUCKHURST;
T. HEIKKINEN; O. KONTKANEN; G. TOMBAUGH; S.
GELMAN; D. YATES; K. MATTHEWS; R. WILLIAMS; P.
BRECCIA; M. LAMERS; R. JARVIS; A. HAUGHAN; D.
FISCHER; G. MCALLISTER; W. BLACKABY; A. GHAVAMI;
G. OSBORNE; D. GOODWIN; G. BATES; I. MUNOZSANJUAN; C. DOMINGUEZ; L. PARK; M. MAILLARD; V.
BEAUMONT*. Charles River, Charles River, Psychogenics
Inc., Psychogenics Inc., Charles River, UCL Inst. of Neurol.,
CHDI Mgmt.
2:00 X18 418.06 Dual therapeutic benefits of selectivehistone deacetylase 3 inhibition in Huntingtons disease
mice. N. SUELVES; L. KIRKHAM-MCCARTHY; R. S.
LAHUE; S. GINES-PADROS*. Med. School, Univ. of
Barcelona, Inst. d Investigacions Biomdiques August Pi i
Sunyer (IDIBAPS), Ctr. de Investigacin Biomdica en Red
sobre Enfermedades Neurodegenerativas (CIBERNED),
Inst. of Neurosciences, Univ. of Barcelona, Ctr. for
Chromosome Biology, Natl. Univ. of Ireland Galway, NCBES
Galway Neurosci. Centre, Natl. Univ. of Ireland Galway.
3:00 Y1
418.07 TRiC subunits enhance BDNF axonal
transport and rescue striatal atrophy in Huntingtons disease.
X. ZHAO; X. CHEN; E. HAN; Y. HU; P. PAIK; Z. DING; J.
OVERMAN; A. LAU; S. SHAHMORADIAN; W. CHIU; L.
THOMPSON; W. C. MOBLEY*; C. WU. UC San Diego, The
Univ. of Texas MD Anderson Cancer Ctr., Univ. of California,
Irvine, Baylor Col. of Med., Univ. of California San Diego
Dept. of Neurosciences.
4:00 Y2
418.08 An efficient antibiotic inducible gene
therapy system for Huntingtons disease neurons. A.
KOMARLA*; P. DENG; A. TORREST; J. APRILE; W. CARY;
J. GUTIERREZ; W. GRUENLOH; G. ANNETT; T. TEMPKIN;
V. WHEELOCK; D. J. SEGAL; J. NOLTA; K. FINK. Univ.
of California, Davis, Univ. of California, Davis, Univ. of
California, Davis.
1:00 Y3
418.09 Behavioral and electrophysiological
improvements following up-regulation of glt1 in the q175
Huntingtons mouse model. K. D. BUNNER*; C. RANGELBARAJAS; B. M. MCCORMICK; S. J. BARTON; G. V.
REBEC. Indiana Univ.
2:00 Y4
418.10 Effect of GLT-1 up-regulation on striatal
local field potential activity and motor performance. C.
RANGEL BARAJAS*; K. D. BUNNER; S. J. BARTON; G. V.
REBEC. Indiana Univ.
3:00 Y5
418.11 Molecular mechanism underlying
defective BDNF secretion from astrocytes expressingmutant
huntingtin. Y. HONG*; T. ZHAO; X. LI; S. LI. Emory Univ.
4:00 Y6
418.12 Immunoprecipitation and flow cytometry
huntingtin lowering biomarkers. A. L. SOUTHWELL*; N. S.
CARON; S. E. P. SMITH; Y. XIE; J. SONG; I. SEONG; B. R.
LEAVITT; M. R. HAYDEN. UBC-CMMT, Seattle Childrens
Res. Inst., KAIST, MGH.
1:00 Y7
418.13 Proteasome activator, PA28, improves
motor coordination and proteasome function in Huntingtons
disease YAC128 mice. J. JANG*; J. JEON; W. KIM; O.
ISACSON; H. SEO. Hanyang Univ., McLean Hospital,
Harvard Med. Sch.

4:00 X16 418.04 Therapeutic and disease-modifying

effects of ganglioside GM1 in mouse models of Huntingtons
disease. M. ALPAUGH*; D. GALLEGUILLOS; L. C.
MORALES; S. LACKEY; P. KAR; B. KERR; K. TODD; S.
SIPIONE. Univ. of Alberta.
108 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 Y8
418.14 Bexarotene activation of PPAR-
ameliorates preclinical trial outcomes in Huntingtons
disease by promoting mitochondria metabolic function and
autophagy. A. S. DICKEY*; D. SANCHEZ; N. LOMAS; K.
R. SAMPAT; A. FLORES; W. FAN; N. ARBEZ; C. A. ROSS;
R. M. EVANS; E. MASLIAH; A. R. LA SPADA. Sanford
Consortium- UCSD, Salk Inst., Johns Hopkins Univ. Sch. of
Med.

3:00 Y9
418.15 Decreased of HSP 70, XIAP, ikb,
it15 genes expression and the CAG repeat expansion
of animals treated with rnai in an experimental model of
Huntingtons disease. R. AVILES REYES*; G. SARMIENTO;
P. PALACIOS; S. ANDRADE. Univ. of Guayquil, Pontifical
Catholic Univ.
4:00 Y10 418.16 Functional brain reorganization after
exercise training in the CAG140 knock-in mouse model of
Huntingtons disease. D. P. HOLSCHNEIDER*; Z. WANG; D.
P. STEFANKO; W. A. TOY; Y. GUO; G. M. PETZINGER; M.
W. JAKOWEC. USC, USC.

2:00 Y12 418.18 Exercise-enhanced neuroplasticity

modifies disease progression in the CAG140 knock-in mouse
model of Huntingtons disease. M. W. JAKOWEC*; D.
STEFANKO; Z. WANG; W. TOY; D. HOLSCHNEIDER; G.
PETZINGER. USC, USC.
3:00 Y13 418.19 L-theanine, a component of green tea
spares striatal neurons from 3-NP induced neurotoxicity:
Role of Nitric Oxide pathway. S. JAMWAL*, JR; P. KUMAR.
ISF Col. of Pharmacy, Moga.
4:00 Y14 418.20 Effect of amyloid precursor protein knockdown in the YAC128 mouse model of Huntingtons disease.
K. L. BERGGREN; S. AGRAWAL; J. A. FOX; R. NELSON; J.
H. FOX*. Univ. of Wyoming, Univ. of Wyoming.
1:00 Y15 418.21 Therapeutic delivery strategies for
the apical domain of CCT1 in Huntingtons disease. J.
OVERMAN*; Z. CROOK; Z. TAN; A. LAU; L. JOACHIMIAK;
E. SONTAG; A. TOMLINSON; J. REIDLING; B. DEVERMAN;
C. GLABE; J. FRYDMAN; D. HOUSMAN; L. THOMPSON.
UC Irvine, Univ. of California, Irvine, MIT, Stanford Univ.,
Caltech.
2:00 Y16 418.22 Effects of PARP-1 inhibition on CREBbinding protein in the striatal neuronal subpopulations of the
R6/2 mouse model of Huntingtons disease. F. R. FUSCO*;
E. PALDINO; A. CARDINALE; I. SAUVE; V. DANGELO; C.
GIAMP. IRCCS Santa Lucia Fndn. Hosp., Univ. of Rome
Tor Vergata, Catholic Univ. of Rome Sacro Cuore.
3:00 Y17 418.23 Pridopidine treatment improves motor
and psychiatric-like phenotypes in the YAC128 mouse model
of Huntington disease. M. GARCIA-MIRALLES*; L. TAN;
M. LIM; A. ORBACH; M. GEVA; M. HAYDEN; M. POULADI.
Translational Lab. In Genet. Med., Translational Lab. in
Genet. Med., Res. and Development, Teva Pharmaceuticals,
Ctr. for Mol. Med. and Therapeutics, Child and Family Res.
Institute, Univ. of British Columbia.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 Z1
418.25 The effects of environmental enrichment
on myelination and oligodendroglia in the YAC128 model
of Huntingtons disease. C. I. RADULESCU*; M. GARCIAMIRALLES; C. FERRARI BARDILE; M. A. POULADI.
A*STAR Singapore.
2:00 Z2
418.26 Association between abnormal
interhemispheric information transfer and corpus callosal
structure in premanifest Huntingtons disease. H. E.
CRAWFORD*; A. MULICK CASSIDY; S. J. TABRIZI; R. I.
SCAHILL. Huntingtons Dis. Res. Centre, UCL, London Sch.
of Hyg. & Tropical Med.
1:00 DP04 418.27 (Dynamic Poster) Dynamic functional
network connectivity differences between prodromal
Huntingtons disease & healthy control subjects. F. A.
ESPINOZA; R. MILLER; E. MENNIGEN; V. M. VERGARA;
J. A. TURNER; M. MISIURA; J. CIAROCHI; H. JOHNSON;
J. D. LONG; J. BOCKHOLT; J. S. PAULSEN; V. CALHOUN*.
The Mind Res. Network, Georgia State Univ., Univ. of Iowa.

POSTER
419. Apoptosis and Mitochondria
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 Z3
419.01 Phosphorylation of respiratory chain
components by mitochondrial c-Src is required for neuronal
viability. M. OGURA*; J. YAMAKI; M. K. HOMMA; Y.
HOMMA. Fukushima Med. Univ. Sch. of Med.
2:00 Z4
419.02 Docosahexaenoic acid (DHA) protects
Schwann cells against palmitic acid-induced lipotoxicity
through P38 but not JNK MAPK. M. DESCORBETH*; M. DE
LEON. Loma Limda Univ., Loma Linda Univ.
3:00 Z5
419.03 Cysteine s-nitrosylation of
neuroprotective protein prohibitin modulates mitochondrial
dynamics in neurons. L. QIAN; Y. QU; G. MANFREDI; C.
IADECOLA; P. ZHOU*. Weill Med. Coll Cornell Univ.
4:00 Z6
419.04 Orexin A attenuates palmitic acid-induced
hypothalamic cell death. C. M. DUFFY*; J. P. NIXON; T.
A. BUTTERICK. Univ. of Minnesota, Minneapolis Veterans
Affairs Hlth. Care Syst., Minnesota Obesity Ctr.
1:00 Z7
419.05 A mitochondrial division inhibitor, Mdivi-1,
inhibits mitochondrial fragmentation and attenuates kainic
acid-induced hippocampal cell death. H. KIM*; J. LEE; K.
PARK; W. KIM; G. ROH. Gyeongsang Natl. Univ. Sch. of
Med., Korea Natl. Inst. of Hlth.
2:00 Z8
419.06 Excessive D-serine mediates cell death in
developing neuron. M. SUZUKI*; J. SASABE; S. AISO. Keio
Univ. Sch. of Med.
3:00 Z9
419.07 The adaptor protein p66shc regulates
metabolism, ros production, and amyloid sensitivity in cns
cells. A. LONE*; R. C. CUMMING. Western Univ., Western
Univ.

Neuroscience 2016|Monday PM|109

Mon. PM

1:00 Y11 418.17 Pharmacological elevation of

2-arachidonoylglycerol brain levels rescues motivational
dysfunction and accumbal correlates in a Q175 mouse
model of Huntingtons disease. H. M. DANTRASSY*; D. P.
COVEY; N. E. ZLEBNIK; H. QADIR; E. COLE; M. A. ANAYA;
I. GILDISH; J. F. CHEER. Univ. of Maryland Sch. of Med.,
Univ. of Maryland Sch. of Med.

4:00 Y18 418.24 Comparison of delivery modalities for in

vivo administration of transcription activator like effectors in
a Huntingtons disease model. P. DENG*; A. E. KOMARLA;
A. M. TORREST; J. A. APRILE; J. GUTIERREZ; G. M.
ANNETT; D. J. SEGAL; J. A. NOLTA; K. D. FINK. UC Davis,
Stem Cell Program and Inst. for Regenerative Cures.

4:00 Z10 419.08 Genetic manipulation of mTORC1

signaling in mouse cerebellar Purkinje cell. H. KASSAI*; Y.
SAKAI; H. NAKAYAMA; T. MAEDA; K. HASHIMOTO; M.
KANO; A. AIBA. Univ. of Tokyo, Hiroshima Univ., Univ. of
Tokyo, Univ. of Tokyo.
1:00 Z11 419.09 Bcl-XL knockout attenuates mitochondrial
respiration and shifts cellular metabolism towards the
pentose phosphate pathway. A. METHNER*; A. PFEIFFER;
J. SCHNEIDER; A. DOLGA; T. VOSS; J. LEWERENZ.
Johannes Gutenberg Univ. Mainz, Johannes Gutenberg
Univ., Univ. of Groningen, Univ. of Ulm.
2:00 Z12 419.10 Investigating the protective effects of
mitochondrially targeted telomerase on neuronal metabolism
and resistance to amyloid-. O. S. SINGH*; R. C.
CUMMING. Western Univ.
3:00 Z13 419.11 Role of motochondrial oxidative stress
and UCP2 in epilepsy experimental model induced by
pilocarpine. M. B. NEJM*; M. MARQUES, 04034032; A.
HAIDAR; F. SCORZA; E. CAVALHEIRO. Federal Univ. of
Sao Paulo, Federal Univ. of Sao Paulo.
4:00 Z14 419.12 Epigenetic regulation of endophilin-B1
promotes neuronal viability in response to disease and
injury. R. S. MORRISON*; D. B. WANG; Y. KINOSHITA; C.
KINOSHITA; R. LEE; S. P. MURPHY; B. L. SOPHER; G. A.
GARDEN. Univ. Washington, Univ. Washington.
1:00 AA1 419.13 Altered molecular processes of malignant
peripheral nerve sheath tumors support the PTP closure
state driving anti-apoptotic tumor progression. D. DANIELS*;
B. C. PRUDNER; B. VAN TINE. Washington Univ. In St.
Louis, Washington Univ. in St. Louis.
2:00 AA2 419.14 Integrating systems biology and
experimental neurology analysis to discover ovary-orientated
protein ociad1 in alzheimer pathogenesis. X. LI*; T. LIU; L.
WANG; Z. YIN; M. D. CYTOKOWISC; A. L. RIVERA; J. J.
MANCUSO; H. ZHAO; S. POWELL; W. XIA; S. T. C. WONG.
Houston Methodist Res. Inst., Houston Methodist Res.
Inst., Houston Methodist Hospital, Weill Cornell Med., Edith
Nourse Rogers Mem. Veterans Hosp., Houston Methodist
Hospital, Weill Cornell Med.
3:00 AA3 419.15 The highly electronegative low-density
lipoprotein l5 impairs the neuritogenesis in ngf-induced pc12
cells. C. LEE*; C. LAI; J. WANG. Hsin Sheng Junior Col.
of Med. Care and Mana, Grad. Inst. of Medicine, Col. of
Medicine,Kaohsiung Med. Univ.
4:00 AA4 419.16 PARP-1-dependent expression of proapoptotic factor bnip3 is mediated by hypoxia inducible
factor-1 in hypoxic neurons. P. LU; S. ATOUI; C. M.
ANDERSON*. Univ. of Manitoba.
1:00 AA5 419.17 Rescue of visual function resulting from
mitochondrial defects. G. CORTOPASSI*; S. DATTA; A. YU.
UC DAVIS, UC Davis.

POSTER
420. Neurochemistry of Injury: Therapeutic Strategies
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 AA6 420.01 Enhancing brain metabolism to restore
functional connectivity and plasticity after TBI. G. KRISHNA*;
Z. YING; L. F. F. ROYES; A. PAYDAR; N. G. HARRIS; F.
GOMEZ-PINILLA. Univ. of California, Federal Univ. of Santa
Maria UFSM, Univ. of California.
110 | Society for Neuroscience

2:00 AA7 420.02 Perivascular macrophages mediate

vascular oxidative stress and neurovascular dysfunction
induced by amyloid- through CD36 and NOX2. L. PARK*;
L. GARCIA-BONILLA; K. UEKAWA; P. ZHOU; R. PITSTICK;
L. YOUNKIN; S. YOUNKIN; G. CARLSON; C. IADECOLA.
Weill Cornell Med. Col., McLaughlin Res. Inst., Mayo Clin.
Jacksonville.
3:00 AA8 420.03 Calpain 5, an overlooked calpain in CNS
injuries. J. W. GEDDES*; V. BONDADA; C. MASHBURN; J.
A. WANG; R. L. HILL; E. D. HALL; D. W. RODGERS. Univ.
Kentucky Med. Ctr.
4:00 AA9 420.04 Omega-3 fatty acids influence the onset
and course of PTSD-like brain and behaviors following mild
traumatic brain injury. A. OBENAUS; I. ALICEA-POLANCO;
E. HADDAD; P. KALYAN-MASIH; J. D. VEGA-TORRES;
E. KINNEY-LANG; M. DE LEON; J. D. FIGUEROA*. Loma
Linda Univ. Sch. of Med., Loma Linda Univ. Sch. of Med.
1:00 AA10 420.05 Interleukin-2 monoclonal
antibody(JES6-1) attenuates cerebral ischemic injury via
modulating T cell activation. Y. ZHOU*; P. LI; L. WANG; W.
YU. Renji Hosp., Renji Hospital, Shanghai Jiaotong Univ.
Sch. of Med.
2:00 AA11 420.06 Acute upregulation of bone
morphogenetic protein 4 regulates endogenous cell
response and glial reactivity following spinal cord injury.
C. HART*; S. M. DYCK; K. T. SANTHOSH; D. MILLER;
S. KARIMI-ABDOLREZAEE. Univ. of Manitoba, Univ. of
Manitoba.

3:00 AA12 420.07 Conserved mechanisms underlying

MultiStem cell therapy across neurological injury and
disease. B. T. LANG*; S. A. BUSCH; R. W. MAYS. Athersys.
4:00 AA13 420.08 N-acetyl-l-cysteine reduces
hypoglycemia-induced hippocampal neuronal death. A.
KHO*; J. KIM; B. CHOI; M. SOHN; S. SUH. Hallym Univ.,
Univ. of Manitoba, Inha Univ.
1:00 AA14 420.09 Effects of an acetylcholinesterase
inhibitor, donepezil, on seizure-induced hippocampal
neuronal death. J. JEONG*; B. CHOI; M. LEE; H. CHOI;
H. SONG; S. SUH. Hallym Univ., Kangdone Sacred Heart
Hospital, Hallym Univ. Med. Ctr., Hallym University, Col. of
Med.
2:00 AA15 420.10 Protocatechuic acid reduces traumatic
brain injury-induced neuronal death. S. LEE*; B. CHOI; S.
SUH. Col. of Med.
3:00 AA16 420.11 Protective effects of potocatechuic acid
on seizure-induced neuronal death. S. LEE*; B. CHOI; M.
LEE; H. CHOI; H. SONG; M. SOHN; S. SUH. Hallym Univ.,
Kangdone Sacred Heart Hospital, Hallym Univ. Med. Ctr.,
Hallym University, Col. of Med., Inha Univ.
4:00 AA17 420.12 Sphingosine 1-phosphate receptor
1 regulates retinal ganglion cell survival and axonal
regeneration after optic nerve trauma. V. E. PERNET*; D.
DALKARA; S. JOLY. Ctr. De Recherche Chuq/Universit
Laval, Inserm UMR S968, Inst. de la vision- Sorbonne
universits, UPMC universit Paris 6, UMR S968-CNRS,
UMR 7210.
1:00 AA18 420.13 Sirt1 regulates NG2 expressing
progenitor proliferation after white matter injury. B.
JABLONSKA*; M. GIERDALSKI; T. HAWLEY; M. CARTON;
A. LICHAUCO; J. CABRERA-LUQUE; T. YUEN; D.
ROWITCH; V. GALLO. Childrens Natl. Med. Ctr., Childrens
Natl. Med. Ctr., George Washington Univ., Univ. of California,
Univ. of California.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 BB1 420.14 MMP inhibitor SB3CT reduces

accumulation of chloride in injured neurons. V. I. DZHALA*;
J. GLYKYS; K. STALEY. Massachusetts Gen. Hosp.
3:00 BB2 420.15 An integral membrane phospholipid
phosphate phosphatase, PLPPR1, overcomes chondroitin
sulfate inhibition and promotes plasticity. C. AGBAEGBU*; H.
KATAGIRI; H. GELLER; P. YU. NIH\NHLBI, Jinan Univ.
4:00 BB3 420.16 Brain trauma disrupts peripheral
metabolism and fructose potentiates these effects. Z. YING*;
L. F. F. ROYES; G. KRISHNA; F. GOMEZ-PINILLA. UCLA,
Univ. Federal de Santa Maria, UCLA, UCLA.

1:00 BB4 420.17 Validation of lysophosphatidic acid as a

target for patients with traumatic brain injury. J. WOJCIAK;
N. SABBADINI; A. J. MORRIS; C. MORGANTI-KOSSMANN;
A. PBAY; D. DEUTSCHMAN; R. A. SABBADINI*. Lpath,
Inc., San Diego State Univ., Lexington Veterans Affairs Med.
Ctr., Monash Univ., Univ. of Melbourne.
2:00 BB5 420.18 Injury-induced alterations in amygdala
e/i balance: Synaptic mechanisms. H. METHENY*; C.
PALMER; A. COHEN. Childrens Hosp. of Philadelphia, Univ.
of Pennsylvania.

4:00 BB7 420.20 Effects of traumatic brain injury and

branched chain amino acid dietary therapy on spatial
episodic-like memory. A. S. COHEN*; H. METHENY; G.
XIONG; R. PATERNO. Childrens Hosp Philadelphia, Univ. of
Pennsylvania, Childrens Hosp Philadelphia.
1:00 BB8 420.21 Hyperglycemia increases basal and
swelling-induced ROS production in C6 cells. A. K.
EDUAFO; N. A. SEITZ; G. LI; C. A. WAKER; J. E. OLSON*.
Wright State Univ., Wright State Univ. Boonshoft Sch. Med.
2:00 BB9 420.22 Zinc chelation and Klf9 suppression
additively promote long distance axon regeneration after
optic nerve injury. E. F. TRAKHTENBERG*; Y. LI; Q.
FENG; J. TSO; P. A. ROSENBERG; J. L. GOLDBERG; L.
I. BENOWITZ. Boston Childrens Hospital, Harvard Med.
Sch., Boston Childrens Hospital, Harvard Med. Sch., Boston
Childrens Hospital, Harvard Med. Sch., Stanford Univ.,
Boston Childrens Hospital, Harvard Med. Sch.

3:00 BB14 420.27 Apathy following traumatic brain injury

increases with damage to the dopamine system. P. O.
JENKINS*; N. BOURKE; S. DE SIMONI; D. J. SHARP.
Imperial Col., Imperial Col.
4:00 BB15 420.28 Age-dependent effects of haptoglobin
deletion in neurobehavioral and anatomical outcomes
following traumatic brain injury. A. V. GLUSHAKOV*; R. A.
ARIAS; E. TOLOSANO; S. DORE. Univ. of Florida Col. of
Med., Univ. of Florida, Univ. of Florida, Univ. of Torino, Univ.
of Florida.
1:00 BB16 420.29 Myelin plasticity supports recovery of
nerve conduction velocity after experimental traumatic brain
injury. R. C. ARMSTRONG*; C. M. MARION; N. P. CRAMER;
K. L. RADOMSKI; F. YU; Z. GALDZICKI. Uniformed Services
Univ. of the Hlth. Scienc.
2:00 BB17 420.30 New therapeutic treatment for traumatic
brain injury: Targeting p75ntr as an immune-modulator after
traumatic brain injury. S. LEE*; A. LIN; J. SACRAMENTO;
N. SINGHAL; M. CASTEL; B. CANOLLE; S. DELBARYGOSSART; B. FERZAZ; F. BONO-COLOMBIE; J. C.
BRESNAHAN; M. S. BEATTIE. UCSF, UCSF, Sanofi,
Evotec.

POSTER
421. Excitotoxicity and Calcium
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 BB18 421.01 Identification of targetable steps to
modulate nNOS/NOS1AP(CAPON)-dependent signalling
mechanisms. L. LI*; M. JAAKKOLA; L. T. T. AN; L. L. ELO;
M. J. COURTNEY. Univ. of Eastern Finland, Neuronal
Signalling Lab,Turku Ctr. for Biotechnology, Univ. of Turku
and Abo Akademi Univ., Computat. Biomedicine Lab, Turku
Ctr. for Biotechnology, Univ. of Turku and Abo Akademi Univ.

3:00 BB10 420.23 Adaptaquin is an inhibitor of oxygensensing prolyl-hydroxylases that abrogates ATF4-dependent
death and improves outcomes from brain injury. S. S.
KARUPPAGOUNDER*; I. ALIM; M. W. BOURASSA; C. C.
THINNES; T. YEH; I. GAZARYAN; J. ZHONG; S. CHO; J. W.
CAVE; C. J. SCHOFIELD; E. SHOHAMI; F. COLBOURNE;
G. COPPOLA; R. R. RATAN. Burke/Cornell Med. Res. Inst.,
Univ. of Oxford, The Hebrew University, Univ. of Alberta,
Univ. of California at Los Angeles.

2:00 CC1 421.02 Endogenous extracellular zinc is

neuroprotective against glutamate excitotoxicity mediated
via NMDA receptors. R. F. KRALL*; K. HARTNETT; T.
TZOUNOPOULOS; E. AIZENMAN. Univ. of Pittsburgh, Univ.
of Pittsburgh, Univ. of Pittsburgh.

4:00 BB11 420.24 The mGluR2/3 receptor antagonist

BCI-838 reverses anxiety-related behavioral traits in a rat
model of blast-related mTBI. G. PEREZ-GARCIA*; R. DE
GASPERI; M. GAMA SOSA; M. LASHOF-SULLIVAN; S.
AHLERS; G. ELDER; S. GANDY. Icahn Sch. of Med. At
Mount Sinai, Icahn Sch. of Med. at Mount Sinai, Veterans
Affairs Med. Ctr., Naval Med. Res. Ctr., Icahn Sch. of Med. at
Mount Sinai, Icahn Sch. of Med. at Mount Sinai.

4:00 CC3 421.04 Nicotinic receptors neuroprotect rat

hypoglossal motoneurons from excitotoxicity evoked by
glutamate uptake block. S. CORSINI; M. TORTORA; A.
NISTRI*. SISSA.

1:00 BB12 420.25 Changes in the pathology of head injury

in mice with differing brain DHA levels. A. DESAI*; H. CHEN;
K. KEVALA; H. KIM. Natl. Inst. On Alcohol Abuse and
Alcoholism, Natl. Inst. on Alcohol Abuse and Alcoholism,
Natl. Inst. of Hlth.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 CC2 421.03 Zn2+ triggered mitochondrial dysfunction

depends upon entry via the mitochondrial Ca2+ uniporter.
S. G. JI*; J. H. WEISS. Univ. of California, Irvine, Univ. of
California, Irvine.

1:00 CC4 421.05 General anesthetics regulate autophagy

and cell survival via modulating inositol 1,4,5 trisphosphate
receptor. G. LIANG; G. REN; Y. ZHOU; D. J. JOSEPH*;
B. YANG; S. INAN; M. YANG; A. KING; H. WEI. Dept. of
Anesthesiol. and Critical Care, Perelman Sch. of Medicine,
Univ. of Pennsylvania, Childrens Hosp. of Philadelphia.

Neuroscience 2016|Monday PM|111

Mon. PM

3:00 BB6 420.19 Increased dentate gyrus net synaptic

efficacy is not due to altered hilar evoked GABAergic
transmission following mild traumatic brain injury. K. A.
FOLWEILER*; H. METHENY; B. JOHNSON; A. COHEN.
Univ. of Pennsylvania, Childrens Hosp. of Philadelphia.

2:00 BB13 420.26 Inhibition of cysteine proteases,

especially cathepsin B, improves behavioral deficits,
pathology and biomarkers in traumatic brain injury
and trauma-related animal models. G. R. HOOK*; S.
JACOBSEN; K. GRABSTEIN; M. KINDY; V. HOOK. ALSP,
Inc., AstraZeneca Neurosci., Univ. of Washington, Univ. of
South Florida, UCSD.

2:00 CC5 421.06 Trpc3 ion channel mediated calcium

loading in mouse purkinje neurons. J. PARMAR*; A. J.
CRAIG; M. KLUGMANN; G. VON JONQUIERES; L.
BIRNBAUMER; A. J. MOORHOUSE; J. M. POWER; G. D.
HOUSLEY. UNSW Australia, UNSW Australia, Pontifical
Catholic Univ. of Argentina (UCA), UNSW Australia.

3:00 CC6 421.07 Control of excitotoxic injury by

mitochondrial glutamate oxidation. A. S. DIVAKARUNI;
M. WALLACE; A. Y. ANDREYEV; I. J. REYNOLDS; C.
M. METALLO; A. N. MURPHY*. UCSD, UCSD, Teva
Pharmaceuticals, UCSD.

4:00 CC7 421.08 Combined high throughput screening and

high content analysis approaches to neuronal physiology/
pathology monitoring provide powerful tools for drug
discovery. P. KITCHENER*; L. PAULHAC; F. SIMON.
Fluofarma.
1:00 CC8 421.09 Structural disassembly of ATP synthase
and its role in mitochondrial permeability transition during
glutamate induced neuronal death. N. MNATSAKANYAN*;
H. PARK; J. WU; P. MIRANDA; E. A. JONAS. Yale Univ.
2:00 CC9 421.10 Iron overload-induced calcum
signals modulates mitochondrial fragmentation in mouse
hippocampal neuron cells. D. LEE*; H. LEE; D. LEE.
Kyungpook Natl. Univ., Biomed. Res. Institute, Chung-Ang
Univ. Col. of Med.
3:00 CC10 421.11 Intracellular calcium ([Ca2+]i) regulating
proteins as targets for chemotherapy in neuroblastoma.
D. BUSSELBERG*; J. E. MCCALLUM; E. VARGHESE; N.
GOPINATH; S. VARGHESE; A. FLOREA. Weill Cornell Med.
Col. In Qatar, Univ. Dsseldorf.
4:00 CC11 421.12 Characterization of crossresistance of cisplatin resistant neuroblastoma cells to
other chemotherapeutic agents. A. M. FLOREA*; G.
REIFENBERGER; D. BUSSELBERG. Heinrich Heine Univ.
Dsseldorf, Uniklinikum, Heinrich-Heine Univ. Dusseldorf,
Weill Cornell Med. in Qatar.

POSTER
422. Neuroprotective Mechanisms: Natural Products
Theme C: Neurodegenerative Disorders and Injury

4:00 DD4 422.04 Characterisation of dorsolateral

prefrontal cortex microstructure following sodium azide
induced Alzheimers disease in rats: Kolaviron therapeutic
mechanisms. O. J. OLAJIDE*; O. B. AKINOLA; S. R. PRICE;
B. U. ENAIBE. Univ. of Ilorin, Univ. Col. London.
1:00 DD5 422.05 The neuroprotective effects and possible
mechanism of action of a methanol extract from Asparagus
cochinchinensis: In vitro and in vivo studies. A. JALSRAI*;
T. NUMAKAWA; H. KUNUGI; D. DIETERICH; A. BECKER.
Ctr. of Traditional Med., Natl. Inst. of Neuroscience, Natl. Ctr.
of Neurol. and Psychiatry, Tokyo, Inst. of Pharmacol. and
Toxicology.
2:00 DD6 422.06 Curcumin inhibits the activation
and translocation of NF-kB in rat hippocampus after
experimental exposure to ozone. S. D. NERY-FLORES*;
M. L. MENDOZA-MAGAA; M. A. RAMREZ-HERRERA;
J. J. RAMREZ-VZQUEZ; M. M. J. ROMERO-PRADO; A.
A. RAMREZ-MENDOZA; L. HERNNDEZ-HERNNDEZ.
Univ. De Guadalajara.
3:00 DD7 422.07 Mitochondrial targets of nobiletin and
dieckol in the regulation of neuronal cell survival and death.
J. LEE; S. EUN*; J. WU; K. AMARSANAA; S. JEON; S.
JUNG. Cheju Natl. Univ. Coll Med.
4:00 DD8 422.08 Neuroprotective role of Thymoquinone
in hippocampal cultures. S. M. SHAIKH*; M. S. RAO;
S. SMITHA. Dr. D.Y. PATIL BIOTECHNOLOGY &
BIOINFORMATICS INST, Fac. of Medicine, Kuwait Univ.
1:00 DD9 422.09 Comparison of the neuroprotective
effects of phenolic acid metabolites of berry anthocyanins
in cerebellar granule neurons. E. IGNOWSKI*; A. WINTER;
M. BRENNER; M. SNODGRASS; D. LINSEMAN. Univ. of
Denver.
2:00 DD10 422.10 Curcumin is able to reverse the inhibition
of neurotransmitter release by amyloid oligomers at
choroidal synapses in the embryonic avian eye. J. QUINN;
O. ANDERSON; M. RAJSOMBATH; D. GRAY*. Simmons
Col., Simmons Col., Simmons Col., Simmons Col.

POSTER
423. Neurotoxic Agents
Theme C: Neurodegenerative Disorders and Injury

Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 DD1 422.01 Cyto-protective and-toxic effects of
Cordyceps militaris and cordycepin on rat CNS neurons and
PC12 cells. K. TABATA; S. ITO; J. SONODA; K. TAKAKURA;
K. NAGAI; M. SHIOZAKI; M. SHIBATA; M. KOIKE; Y.
UCHIYAMA; T. GOTOW*. Cell Biol., Col. Nutr., Koshien
Univ., Cell. Biochem., Col. Nutr., Koshien Univ., Osaka Univ.,
Grad. Sch. of Med., Kagoshima Univ., Grad. Sch. of Med.,
Juntendo Univ., Grad. Sch. of Med., Juntendo Univ., Grad.
Sch. of Med.
2:00 DD2 422.02 Korean red ginseng and ginsenosideRb1/-Rg1 alleviate experimental autoimmune
encephalomyelitis by suppressing Th1 and Th17 cells and
upregulating regulatory T cells. M. LEE*; M. JANG; J. CHOI;
D. KIM; I. CHO. Kyung Hee Uni., Col. of Korean Medicine,
Kyung Hee Univ., Barrow Neurolog. Institute, St Josephs
Hosp. and Med. Ctr.
3:00 DD3 422.03 Involvement of activation of the Nrf2/
HO-1 signaling pathway in protection against amyloid 25-35induced neurotoxicity by sulfuretin. S. KWON*; S. LEE; C.
JANG. Sungkyunkwan Univ., Sungkyunkwan Univ.

112 | Society for Neuroscience

Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 DD11 423.01 Ceramide contributes to cognitive
impairment and palmitate induced apoptosis in hippocampal
cell culture. C. WANG*; T. A. BUTTERICK; V. MAVANJI; C.
M. DUFFY; M. R. LITTLE; E. E. NOBLE; J. P. NIXON; C.
J. BILLINGTON; C. M. KOTZ. Minneapolis VA Hlth. Care
Syst., Univ. of Minnesota, Minnesota Obesity Ctr., Univ. of
Minnesota, Univ. of Minnesota, Univ. of Minnesota.
2:00 DD12 423.02 Understanding the effects of TDP43
C-terminal fragments. Y. T. KASU*; C. S. BROWER. Texas
Womans Univ.
3:00 DD13 423.03 Chronic iron overload and deficiency in
adult male c57b6 mice. D. G. PETERS*; J. R. CONNOR; Q.
X. YANG; M. D. MEADOWCROFT. The Pennsylvania State
Univ.- Col. of Med., The Pennsylvania State Univ.- Col. of
Med., The Pennsylvania State Univ.- Col. of Med.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 DD14 423.04 Early exposure to general anesthesia

impairs the presynaptic machine for neurotransmitter
release. N. LUNARDI*; H. P. OSURU; A. OKLOPCIC; P.
DIANA; C. DEFREITAS; V. JEVTOVIC-TODOROVIC. Univ.
of Virginia Hlth. Syst., Univ. of Colorado, Denver, Univ. of
Virginia, Universita degli Studi di Padova.
1:00 DD15 423.05 Inhaled anesthetic sevoflurane-induced
up-regulation of pro-apoptosis proteins in infant monkey
brains. Q. GU*; F. LIU; S. SARKAR; S. LIU; J. KANUNGO;
C. WANG; W. SLIKKER, Jr.; M. G. PAULE. FDA Natl. Ctr. for
Toxicological Res.
2:00 DD16 423.06 Levetiracetam mitigates doxorubicininduced DNA and synaptic damage in neurons. J. F.
MORUNO MANCHON*; Y. DABAGHIAN; N. UZOR; S. R.
KESLER; J. S. WEFEL; A. S. TSVETKOV. Univ. of Texas
Med. Sch., The Jan and Dan Duncan Neurolog. Res.
Institute, Baylor Col. of Medecine, Rice Univ., The Univ. of
Texas Grad. Sch. of Biomed. Sci., M.D. Anderson Cancer
Ctr.

3:00 EE8 423.15 The effect of arsenic exposure on

behavior in rats of various age groups and on pups
development. T. BIKASHVILI*; T. LORDKIPANIDZE; N.
GOGICHAISHVILI; N. POCHKHIDZE. I.Beritashvili Ctr. of
Exptl. Biomedicine, Ilia State Univ.
4:00 EE9 423.16 -N-Methylamino-L-alanine interferes
with metabolic pathways related to neurotransmission in
human SH-SY5Y neuroblastoma cells as determined by
metabolic profiling. L. ERSSON*; M. K. R. ENGSKOG;
J. HAGLF; T. ARVIDSSON; C. PETTERSSON; E.
BRITTEBO. Uppsala Univ., Uppsala Univ., Med. Product
Agency, Uppsala Univ.
1:00 EE10 423.17 Depressive-like behavior in adult rats
chronically exposed to a glyphosate-based herbicide:
Involvement of glutamatergic excitotoxicity and oxidative
stress. D. CATTANI*; P. A. DE OLIVEIRA; R. D. S.
PREDIGER; E. B. PARISOTTO; D. WILHELM FILHO; A. Z.
PACHECO DE SOUZA. Federal Univ. of Santa Catarina,
Federal Univ. of Santa Catarina.

2:00 EE11 423.18 Assessing drug neurotoxicity and

functional mode of action using high-throughput MEA
recording from human iPSC neurons combined with
multivariate spike train analysis. K. JGELT*; A. STEDER;
O. H. U. SCHROEDER; B. M. BADER. NeuroProof GmbH.

4:00 EE1 423.08 Bortezomib induced apoptosis of

adult neural stem cells and post-chemotherapy cognitive
impairment in mice. P. HUEHNCHEN*; W. BOEHMERLE; M.
ENDRES. Charite Universitaetsmedizin Berlin, Berlin Inst. of
Hlth., Cluster of Excellence NeuroCure, Ctr. for Stroke Res.
Berlin, German Ctr. for Neurodegenerative Dis.

3:00 EE12 423.19 A rat model of nerve agent exposure

applicable to the pediatric population: The anticonvulsant
efficacies of atropine and GluK1 antagonists. J. P. APLAND*;
S. L. MILLER; V. ARONIADOU-ANDERJASKA; T. H.
FIGUEIREDO; E. M. PRAGER; C. P. ALMEIDA-SUHETT;
M. F. M. BRAGA. USAMRICD, USUHS, USUHS, USUHS,
USUHS.

1:00 EE2 423.09 Effect of lead on the expression of

metallothionein-3 in the brain of young rats. A. RAHMAN*; K.
KHAN. Kuwait Univ., Fac. of Medicine, Kuwait Univ.
2:00 EE3 423.10 Abnormal visual function in a mouse
model of hemochromatosis with retinal iron loading. E.
A. MILWARD*; A. SHAHANDEH; D. M. JOHNSTONE; A.
BRANDLI. The Univ. of Newcastle, Univ. of Sydney, Univ. of
Melbourne.
3:00 EE4 423.11 The effect of an organophosphorus agent
on human neuroblastoma cell line SK-N-SH. Y. YAMADA*;
K. YAMADA; H. SHIRAISHI; A. NAMERA; Y. ARIMA; M.
NAGAO. Fac. of Engineering, Kindai.Univ., Daiyukai.First
Hosp. Dept. of Gynecol. and Obstet., Inst. of Biomed. and
Hlth. Sciences.
4:00 EE5 423.12 Propofol affects neurodegeneration and
neurogenesis by regulation of autophagy via its effects on
intracellular calcium homeostasis. H. QIAO; Y. LI; Z. XU;
W. LI; Z. FU; G. LIANG; H. WEI*. The Eye Ear Nose and
Throat Hosp. of Fudan Univ., Univ. Pennsylvania, Provincial
Hosp. Affiliated to Shandong Univ., First Maternity and Infant
Hospital, Tongji Univ. Sch. of Med.
1:00 EE6 423.13 Aspartame causes dose dependent
hippocampal injury in adult male mice. P. U. NWOHA*; A. Y.
ONAOLAPO. Obafemi Awolowo Univ., Ladoke Akintola Univ.
of Technol.
2:00 EE7 423.14 The effects of silica nanoparticles on
affective and cognitive behaviors, and on synapse in vivo
and in vitro. R. YOU*; S. S. Y. CHENG; C. H. L. HUNG; Y. S.
HO; R. C. C. CHANG. Lab. of Neurodeg. Dis., Sch. Biomed.
Sci., HKU, Inst. of Chinese Med. Sciences, Univ. of Macau,
Sch. of Nursing, Fac. of Hlth. and Social Sciences, The Hong
Kong Polytechnic Univ., Res. Ctr. of Heart, Brain, Hormone
and Healthy Aging, LKS Fac. of Medicine, HKU, State Key
Lab. of Brain and Cognitive Sciences, HKU.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 EE13 423.20 Pupillary light response in guinea

pigs and swine exposed to organophosphate agents.
E. D. CLARKSON; M. C. MOFFETT*; J. E. MORGAN;
K. H. SMITH; S. M. SCHULZ; J. K. CHANDLER; C. L.
ROUSAYNE; C. KOLANKO. USAMRICD, Eyemarker
Systems, Inc.
1:00 EE14 423.21 Investigation of the resistance to
glutamate-induced excitoxicity in mouse motor neuronlike NSC-34 cells on graphene oxide films. G. SENGUL*;
S. TASDEMIR; P. CORUK; B. KAYHAN; A. SENDEMIR
URKMEZ. Ege Univ. Sch. Med., Ege University, Fac. of
Engin., Ege University, Inst. of Hlth. Sci., Ege University,
Fac. of Engin. and Ege University, Grad. Sch. of Natural and
Applied Sci.
2:00 EE15 423.22 Inhibition of necroptosis by treatment
with necrostatin-1 or RIP1 siRNA potentiates taxol-induced
neuronal death via the activation of ERKs in mouse cortical
cultures. J. KIM*; S. HWANG. Chonnam Natl Univ. Med.
Sch.
3:00 EE16 423.23 Sex differences in oxaliplatin induced
neuropathic pain behaviors. L. CHEN*; M. SHEN. Natl.
Cheng Kung Univ., Natl. Cheng Kung Univ.
4:00 EE17 423.24 The neurocognitive effects of vanadium in
young male rats. M. F. DE BUTTE*. West Texas A&M Univ.
1:00 EE18 423.25 Impact of aflatoxin B1 on hypothalamic
neuropeptides regulating feeding behavior. F. TREBAK*; A.
ALAOUI; D. ALEXANDRE; S. ELOUEZZANI; Y. ANOUAR;
N. CHARTREL; R. MAGOUL. DC2N Inserm U982 Rouen
Univ., Lab. of Neuroendocrinology & Nutritional and climatic
Environment, Univ. Sidi Mohamed Ben Abdellah, Fac. of Sci.
DM.

Neuroscience 2016|Monday PM|113

Mon. PM

3:00 DD17 423.07 Mitochondrial complex 1 mutation

causes anesthetic-induced mortality in fruit flies. M.
PEROUANSKY*; C. LOEWEN; Z. OLUFS; B. GANETZKY.
Univ. of Wisconsin Madison Dept. of Anesthesiol., Univ.
Wisconsin Madison, Univ. of Wisconsin, Univ. of Wisconsin.

2:00 FF1 423.26 Parkin dependent mitophagy rescues

retinal ganglion cell from ethambutol induced apoptosis. B.
LEE*; H. JUN; J. KIM; J. KIM. Seoul Natl. Univ., Seoul Natl.
Univ. Hosp.
3:00 FF2 423.27 Additive deficits on egocentric and
allocentric learning induced after developmental manganese
overexposure combined with 6-hydroxydopamine striatal
lesions. R. A. BAILEY*; A. GUTIERREZ; J. R. HUFGARD;
T. L. KYSER; A. M. HEMMERLE; K. B. SEROOGY; C. V.
VORHEES; M. T. WILLIAMS. Cincinnati Childrens Hosp.
Med. Ctr., Univ. of Cincinnati, Univ. of Cincinnati Col. of Med.
4:00 FF3 423.28 Effects of testosterone on cell death and
cognitive deficits following postnatal exposure to isoflurane.
J. SASAKI RUSSELL*; J. LEONG; M. ROTMAN; J. CHAN;
J. SALL. Univ. of California, San Francisco.
1:00 FF4 423.29 Resting State fMRI of Gulf War Illness
patients reveals abnormal connectivity within and between
different brain function networks consistent with the multisymptom illness. K. GOPINATH*; V. KRISHNAMURTHY;
L. KRISHNAMURTHY; B. THAPA-CHETRY; L. OUYANG;
A. GOYAL; P. GANDHI; Y. FANG; R. BRIGGS; R. HALEY.
Emory Univ., Univ. of Texas Southwestern Med. Ctr., Univ. of
Florida.
2:00 FF5 423.30 Neurodevelopmental effects of
organophosphate pesticide exposure. E. A. FRADINGER*;
B. AHN; G. X. GARCIA; H. R. SCHMIDT; H. GARCIA; O.
MAC; D. B. BOURGAIZE. Whittier Col.

POSTER
424. Neuroprotection in Models of Immune Mediated
Demyelination
Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 FF6 424.01 Noggin inhibits bmp signaling
in oligodendrocyte progenitor cells to repress
transdifferentiation into astrocytes. H. STRASBURGER*; L.
KIRBY; J. SCHOTT. Johns Hopkins Hosp., Johns Hopkins
Neuroimmunology.
2:00 FF7 424.02 Neuroprotective effect of melatonin
in experimental optic neuritis in rats. M. L. ARANDA*; M.
F. GONZALEZ FLEITAS; M. I. KELLER SARMIENTO;
M. S. CHIANELLI; P. H. SANDE; D. DORFMAN; R. E.
ROSENSTEIN. CEFyBO- CONICET.
3:00 FF8 424.03 Serum factors as predictors of
interferon- (IFN-)-induced depression. A. BORSINI*; P.
ZUNSZAIN; C. PARIANTE; S. THURET. Kings Col. London.
4:00 FF9 424.04 Pivotal role of the macrophage
colony stimulating factor (CSF1) in experimental allergic
encephalomyelitis. N. BORJINI*; M. FERNANDEZ; L.
GIARDINO; L. CALZ. Chiesi Farmaceutici SpA, Univ. of
Bologna, IRET Fndn., Univ. of Bologna, Univ. of Bologna.
1:00 FF10 424.05 Persistent cytokine production induced
in the cerebral meninges in a rat model of MS gives rise
to chronic cortical pathology. R. REYNOLDS*; R. JAMES;
E. BROWNE; L. FUENTES; N. MAZARAKIS. Imperial Col.
London.
2:00 FF11 424.06 Beneficial effects of nimodipine in EAE.
A. SCHAMPEL*; S. KUERTEN. Univ. of Wuerzburg, Univ. of
Wuerzburg.

114 | Society for Neuroscience

3:00 FF12 424.07 Altered functional Connectivity of striatal

subregions in patients with multiple sclerosis. F. CUI*; L.
ZHOU; K. JORGENSON; Z. WANG; Y. YU; Y. GAO; J.
KONG. Massachusetts Gen. Hospital/Harvard Med. Sch.,
Dongzhimen Hosp.

4:00 FF13 424.08 The effect of ONO-2952, a novel

translocator protein 18 kDa antagonist, in a mouse model of
multiple sclerosis. M. ISHISAKA; T. KOMIYA; T. KITAJIMA;
A. KISHI*; S. KATSUMATA. ONO Pharmaceut. Co., Ltd.
1:00 FF14 424.09 Local administration of TH2 cells into
the CNS ameliorates the inhibitory effects of IFNg on
remyelination. L. A. KIRBY*; M. SMITH; J. SCHOTT; P.
CALABRESI. Johns Hopkins.
2:00 FF15 424.10 Astrocyte remodeling precedes
extracellular matrix modifications in the glial lamina of mice
with glaucomatous optic neuropathy. R. A. FISCHER*;
H. L. MALLARO; E. S. BUYS; R. M. SAPPINGTON.
Vanderbilt Univ., Vanderbilt Univ., Vanderbilt Univ. Med.
Ctr., Massachusetts Gen. Hosp. and Harvard Med. Sch.,
Massachusetts Gen. Hosp. and Harvard Med. Sch.,
Massachusetts Gen. Hosp. and Harvard Med. Sch.,
Massachusetts Gen. Hosp. and Harvard Med. Sch.
3:00 FF16 424.11 Cuprizone treatment, toxic demyelination,
and the blood-brain barrier. J. SHELESTAK*; R. CUKELJ; N.
SINGHAL; J. MCDONOUGH; E. FREEMAN; R. CLEMENTS.
Kent State Univ., Kent State Univ.
4:00 FF17 424.12 Increased expression of specific
NKG2D ligand in a mouse model of multiple sclerosis.
L. LEGROUX*; S. VERSTRAETEN; G. DEBLOIS; A.
MOHEBIANY; D. BEAUSEIGLE; N. ARBOUR. CRCHUM,
Univ. De Montral.
1:00 FF18 424.13 Increased gabaergic inhibition through
5-subunit containing GABAars contributes to impaired
hippocampal synaptic plasticity in eae. L. G. KAMMEL*;
W. WEI; R. VOSKUHL; T. ODELL. David Geffen Sch. of
Medicine, UCLA, David Geffen Sch. of Medicine, UCLA,
David Geffen Sch. of Medicine, UCLA.
2:00 GG1 424.14 Molecular MRI reveals pselectin protein
as a predictive marker in experimental autoimmune
encephalomyelitis. R. M. MACREZ*; A. QUESNAULT; A.
QUESNAULT. GIP Cyceron Inserm U919, INSERM U919.
3:00 GG2 424.15 Estrogen receptor (ER) on CD11c+
cells is required for ER-ligand mediated neuroprotection
during experimental autoimmune encephalomyelitis. R.
KIM*; N. ITOH; A. HOFFMAN; R. KOVASH; R. VOSKUHL.
UCLA, UCLA, UCLA.
4:00 GG3 424.16 Oligodendrocyte lineage tracing in a
multiple sclerosis mouse modela cuprizone-fed mouse
transferred with myelin-reactive th17 cells. J. JIN*; M.
SMITH; D. HEO; M. POUDEL; D. TOSI; E. BAXI; D.
BERGLES; P. A. CALABRESI. Johns Hopkins Univ. Sch. of
Med.
1:00 GG4 424.17 Role of RhoA in T cell adhesion and
migration in an experimental model of multiple sclerosis. A.
MANRESA ARRAUT*; H. HASSELDAM; F. F. JOHANSEN.
Biotech Res. & Innovation Ctr.
2:00 GG5 424.18 Strain differences in sensitivity to
cuprizone induced demyelination. Q. YU*; R. HUI; Y.
HUANG; A. KUSNECOV; C. F. DREYFUS; R. ZHOU.
Rutgers, Rutgers, Rutgers.
3:00 GG6 424.19 Interferon -stimulated human dendritic
cells produce promyelinating exosomes and replicate rodent
studies. K. M. PUSIC*; L. WON; A. D. PUSIC; R. P. KRAIG.
Univ. of Chicago, Univ. of Chicago.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 GG7 424.20 Anti-neuroinflammatory effect of VB037 in

experimental autoimmune encephalomyelitis model. H. LI*;
Y. LO; K. CHANG. Chang-Gung Mem. Hosp.
1:00 GG8 424.21 AdipoR agonist, AdipoRon, decreases
lipid accumulation and ameliorates the functions of myelinladen macrophages. X. SUN*; Q. ZHOU; H. XIANG; A. LI;
C. QIN; X. CHEN; Y. REN. Jinan Univ., Inst. of Inflammation
and Diseases, the First Affiliated Hosp. of Wenzhou Med.
Univ., Dept. of Biomed. Sciences, Florida State Univ. Col. of
Med.
2:00 GG9 424.22 Interactions between stress-induced
modifications of intestinal inflammation and the occurrence
of EAE relapses. A. FOURNIER*; M. NEUNLIST; D. VIVIEN;
R. MACREZ; F. DOCAGNE. INSERM U919, INSERM U913.
3:00 GG10 424.23 Opposite functions of microglial and
monocyte/macrophagial TNFR2 in EAE pathogenesis: The
good versus the bad. H. GAO*; M. DANZI; C. S. CHOI; M.
TAHERIAN; C. DALBY-HANSEN; D. G. ELLMAN; P. M.
MADSEN; J. L. BIXBY; V. P. LEMMON; K. L. LAMBERTSEN;
R. BRAMBILLA. Univ. of Miami, Columbia Univ., Univ. of
Southern Denmark.

1:00 GG12 424.25 Therapeutic estrogen receptor

(ER) ligands modulate peripheral cytokines and may be
responsible for remyelination in a mouse model of multiple
sclerosis. H. KARIM*; J. HASSELMANN; N. YASUI; J.
KATZENELLENBOGEN; S. TIWARI-WOODRUFF. Univ. of
California, Riverside, Univ. of Illinois.
2:00 GG13 424.26 The contribution of dysfunctional hnRNP
A1 and anti-hnRNP A1 antibodies to MS pathogenesis. H.
SALAPA*; S. LEE; Y. SHIN; M. C. LEVIN. Univ. of Tennessee
Hlth. Sci. Ctr.

3:00 GG14 424.27 Temporal changes in the glial response

mechanism in the Cuprizone/Rapamycin model of Multiple
Sclerosis. M. MADDIE*; D. CHMURA; S. LUNN; H.
BATTAPADY; S. MEDICETTY; B. TRAPP. Renovo Neural,
Cleveland Clin. Fndn.
4:00 HH1 424.28 Ketone body esters as a therapeutic
strategy for canavan disease. A. P. APPU*; P. ARUN; J.
R. MOFFETT; J. K. KRISHNAN; A. M. NAMBOODIRI.
Uniformed Services Univ. of Hlth. Sci.
1:00 HH2 424.29 Neuronal antigen specific T cells
modulate CNS inflammation during autoimmunity. A.
RAYASAM*; M. HSU; M. DALLMANN; J. KIJAK; N. ZINDL;
M. SANDOR; Z. FABRY. Univ. of Wisconsin- Madison, Univ.
of Wisconsin-Madison, Univ. of Wisconsin-Madison.
2:00 HH3 424.30 Erythropoietin upregulates brain
hemoglobin expression and levels of H3K4me3. N. K.
SINGHAL*; K. ALKHAYER; J. SHELESTEK; R. CLEMENTS;
E. FREEMAN; J. MCDONOUGH. Kent State Univ.
3:00 HH4 424.31 Intrathecal delivery of primary progressive
MS cerebrospinal fluid induces behavioral deficits and spinal
cord pathology in mice. J. K. WONG*; M. ALAHIRI; S. S.
SADIQ. Tisch MS Res. Ctr. of New York.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

425. Stroke Recovery Activity-Dependent Mechanisms

Theme C: Neurodegenerative Disorders and Injury
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 HH5 425.01 Differences in audio and visual working
memory during computerized cognitive rehabilitation in
chronic stroke survivors. E. M. WALLACK*; L. P. KELLY;
A. J. DEVASAHAYAM; T. CHATTERJEE; M. B. DOWNER;
J. MCCARTHY; G. A. ESKES; B. ABRAHA; S. M. M.
HASAN; A. R. CHAVES; H. D. WISEMAN; J. DAWE; M.
PLOUGHMAN. Mem. Univ., Dalhousie Univ.
2:00 HH6 425.02 Maximal exercise does not increase
brain derived neurotropic factor (BDNF) in chronic stroke
survivors: Association with resting energy metabolism and
peak oxidative capacity. L. P. KELLY*; A. J. DEVASAHAYAM;
E. M. WALLACK; B. ABRAHA; J. MCCARTHY; M.
B. DOWNER; S. M. M. HASAN; F. A. BASSET; M.
PLOUGHMAN. Mem. Univ.
3:00 HH7 425.03 Can circulating BDNF levels discriminate
high from low impairment in chronic stroke survivors?
B. ABRAHA*; E. M. WALLACK; L. P. KELLY; A. J.
DEVASAHAYAM; T. CHATTERJEE; S. GRANTER-BUTTON;
J. MCCARTHY; M. PLOUGHMAN. Mem. Univ.
4:00 HH8 425.04 Is BDNF response to maximal exercise
associated with performance in cognitive rehabilitation
training in chronic stroke survivors? H. D. WISEMAN*; M. B.
DOWNER; B. ABRAHA; E. M. WALLACK; T. CHATTERJEE;
L. P. KELLY; A. J. DEVASAHAYAM; A. R. CHAVES; J.
MCCARTHY; M. PLOUGHMAN. Mem. Univ.
1:00 HH9 425.05 Anti-inflammatory activity of adiponectin
function on BBB after intracerebral hemorrhage. X. YANG*;
H. JANG; Y. KIM; I. CHOI; S. LEE; B. YOON. The Seoul
Natl. Univ. Hosp., Seoul Natl. Univ., Seoul Natl. Univ., Seoul
Natl. Univ.
2:00 HH10 425.06 Activity-dependent regulation of
neurogenesis after stroke. H. LIANG*; S. T. CARMICHAEL,
90066. Univ. of California Los Angeles Dept. of Neurol.,
UCLA.
3:00 HH11 425.07 Customary exercise prevents the
poststroke memory dysfunction by constitutive elevation of
hippocampal BDNF. N. HIMI*; N. OKABE; E. NAKAMURAMARUYAMA; H. TAKAHASHI; T. KOGA; K. NARITA; O.
MIYAMOTO. Kawasaki Med. Sch., Kawasaki Univ. of Med.
Welfare.
4:00 HH12 425.08 Kinect-based upper extremity training
is effective for individuals with stroke: Outcomes and
participants perspective. W. LIAO*; S. MCCOMBE WALLER;
R. FELDMAN; J. WHITALL. Univ. of Maryland Baltimore,
Univ. of Southampton.
1:00 HH13 425.09 Stroke induced brain morphological
changes and the influence of physical exercise. S. GULL; S.
SCHMIDT; K. HERRMANN; C. FRAHM; J. REICHENBACH;
C. GASER; O. W. WITTE*. Friedrich Schiller Univ. Jena,
Friedrich Schiller Univ. Jena, Friedrich Schiller Univ. Jena,
Friedrich Schiller Univ. Jena, Friedrich Schiller Univ. Jena.
2:00 HH14 425.10 Short bouts of exercise before ischemic
stroke ameliorate behavioral and histological outcomes
by enhancing angiogenesis. S. PIANTA*; H. NGUYEN; S.
MASHKOURI; D. AUM; X. KAYA; N. TAJIRI; S. ACOSTA; J.
LEE; C. V. BORLONGAN. Univ. of South Florida Col. of Med.

Neuroscience 2016|Monday PM|115

Mon. PM

4:00 GG11 424.24 Mitoxantrone prevents disease relapse in

a rat model of multiple sclerosis. E. ANDRIAMBELOSON*;
J. BINDLER; C. NEVEU; L. BOURGOIN; L. GORJ; B.
HUYARD; N. KADOUCI; F. LAUGA; E. POIRAUD; S.
WAGNER. NEUROFIT.

POSTER

3:00 HH15 425.11 Effects of repetitive passive ankle stretch

applied with a pneumatic robot on soleus h-reflex excitability.
S. NOBLE*; G. E. P. PEARCEY; C. QUARTLY; P. E. ZEHR.
Univ. of Victoria, Rehabil. Neurosci. Lab., Intl. Collaboration
On Repair Discoveries, Vancouver Island Hlth. Authority,
Univ. of Victoria.
4:00 HH16 425.12 Dysfunctional Notch 3 signaling inhibits
the mediation of beneficial effects of physical activity and
enriched environment on adult neurogenesis in a transgenic
CADASIL mouse model. C. KLEIN*; S. SCHREYER; F. E.
KOHRS; P. EL HAMOURY; A. PFEFFER; T. MUNDER; F.
EHRET; G. KEMPERMANN; B. STEINER. Charit Neurol.,
Ctr. for Regenerative Therapies Dresden.
1:00 HH17 425.13 Post stroke bimanual performance relates
to corpus callosum properties. A. M. AURIAT*; J. LAU; J. K.
FERRIS; J. L. NEVA; L. A. BOYD. Univ. of British Columbia,
Univ. of British Columbia.
2:00 II1
425.14 Robot-assisted mechanical therapy
protects against stroke-induced skeletal muscle injury. C. L.
RINK*; M. BALCH; H. HARRIS; S. GNYAWALI; C. K. SEN;
S. KHANNA. The Ohio State Univ. Wexner Med. Ctr.

1:00 II7
426.05 Synergistic interaction of morphine plus
clonidine in cisplatin-induced neuropathic pain in rat. A.
ZUIGA*; J. REYES-GARCA; F. FLORES-MURRIETA; H.
ROCHA-GONZLEZ. INER, Escuela Superior de Medicina
IPN.
2:00 II8
426.06 The therapeutic effect of Rho kinase
inhibitor Y-27632 on protection from chemotherapy-induced
peripheral neuropathy in a tumor-bearing mouse model. Y.
ZHU*; G. A. HOWARD, IV; K. PITTMAN; C. BOYKIN; K.
VERBANAC; Q. LU. Brody Sch. Of Med., Brody Sch. Of
Med.
3:00 II9
426.07 The role of TLR4 signaling pathway
in oxaliplatin-induced peripheral neuropathy in rat. P. M.
DOUGHERTY*; A. ILLIAS; Y. LI; H. ZHANG; K. YU; J. F.
VELASQUEZ; J. P. CATA. Univ. of Texas MD Anderson
Cancer Ctr., MD Anderson, MD Anderson.org.
4:00 II10 426.08 Neuroprotectin D1 protects the
chemotherapy-induced neuropathy by modulating the
function of macrophages. S. BANG*; Z. XU; R. JI. Pain Res.
Div. ,Department of Anesthesiol. and Neurobiology, Duke
Univ.

3:00 II2
425.15 Delayed administration of citalopram
is associated with long-lasting motor improvements and
promotes brain remodelling in an experimental model of
stroke. S. CHEN; L. BENNET; A. L. MCGREGOR*. Univ. of
Auckland, Univ. of Auckland, Univ. of Otago.

1:00 II11 426.09 Contribution of voltage-gated sodium

channel 1.7 in rat in paclitaxel induced peripheral pain. Y. LI*;
D. D. EDWARDS; R. M. CASSIDY; D. S. HARRISON; A. K.
KOSTURAKIS; H. ZHANG; P. M. DOUGHERTY. The Univ. of
Texas MD Anderson Cancer Ctr., Philadelphia Col. of Osteo.
Med., The Univ. of Texas Hlth. Sci. Ctr., Duke Univ. Sch. of
Med., The Univ. of Texas Hlth. Sci. Ctr.

POSTER

2:00 II12 426.10 Paclitaxel application leads to longterm changes of presynaptic TRPV1 receptors function in
spinal cord dorsal horn. P. ADAMEK*; J. PALECEK. Inst. of
Physiology, Czech Acad. of Sci., Fac. of Science, Charles
Univ.

426. Peripheral Neuropathy: Mechanisms and Interventions

Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 II3
426.01 Long-term recovery from chemotherapyinduced neuropathy following paclitaxel, ixabepilone,
eribulin and vinorelbine in mice. K. M. WOZNIAK*; Y. WU;
Y. LIU; R. WEINBERG; V. CAROZZI; G. FUMAGALLI; P.
ALBERTI; B. COOK; S. BENBOW; B. A. LITTLEFIELD; K.
NOMOTO; L. WILSON; M. A. JORDAN; S. FEINSTEIN; S.
ECKLEY; C. DEJARDINS; G. CAVALETTI; J. MANKOWSKI;
M. POLYDEFKIS; B. S. SLUSHER. Johns Hopkins Sch. of
Med., Johns Hopkins Med. Sch. of Med., Johns Hopkins
Med. Sch. of Med., Johns Hopkins Med. Sch. of Med., Univ.
of Milano-Bicoca, Univ. of California, Santa Barbara, Univ.
of California, Santa Barbara, Eisai Res. Insitute, Eisai Inc,
Univ. of California, Santa Barbara, Eisai Res. Insitute, Johns
Hopkins Med. Sch. of Med.

2:00 II4
426.02 PGN-503, a herpes simplex virus based
vector expressing neurotrophin-3 for the prevention and
treatment of chemotherapy induced peripheral neuropathy.
J. R. GOSS*; D. KRISKY; K. BOUCH; M. OMALLEY; S.
COGHLAN; J. WECHUCK. Periphagen Inc.

3:00 II5
426.03 Prevention of oxaliplatin-induced
neurotoxicity involving decrease in peripheral blood flow by
oral administration of Goshajinkigan. T. KONO; Y. OMIYA*;
H. SEKINE; M. YAMAMOTO; K. MIYANO; Y. KASE; Y.
UEZONO. Hokkaido Univ., Sapporo Higashi Tokushukai
Hosp., Tsumura & Co., Natl. Cancer Ctr. Res. Inst.

4:00 II6
426.04 TRPM8-mediated response to cold
in human DRG neurons and its modulation by the
chemotherapy agent oxaliplatin. A. GHETTI*; J. ZHANG; Y.
MIRON; J. STRETTON; K. MORRISON; P. MURDOCK; K.
PAGE; P. MILLER. Anabios Corp., Asterand Biosci.

116 | Society for Neuroscience

3:00 II13 426.11 HKP-16 ameliorates chemotherapyinduced neuropathic pain in rats by oral administration. H.
KIM*; S. HWANG; S. ABDI. MD Anderson Cancer Ctr.
4:00 II14 426.12 Pentoxifylline decreases inflammatory
cytokines in the dorsal root ganglia in chemotherapy-induced
neuropathic pain in rats. S. H. KIM*; H. KIM; S. ABDI. The
Univ. of Texas MD Anderson Cancer Ctr.
1:00 II15 426.13 The Neuronal calcium sensor-1
knockout mouse model and its utility in better understanding
chemotherapy-induced neuropathic pain. E. M. EDWARDS;
A. FERRAR; D. GIUVELIS; K. LINDROS; I. M. BERGQUIST;
O. PONGS; E. KAFTAN; B. EHRLICH; E. J. BILSKY*.
Univ. of New England, 2Institut fr Physiologie, Univ. des
Saarlandes, Yale Univ., Univ. of New England.
2:00 II16 426.14 Oxaliplatin impairs mechano-sensory
encoding by slowly adapting cutaneous afferents. J. A.
VINCENT; P. NARDELLI; T. C. COPE*. Wright State Univ.,
Georgia Inst. of Technol.
3:00 II17 426.15 Fy-504, a potent and selective nav1.8
antagonist, blocked chemotherapy-induced peripheral
neuropathy (CIPN). P. CHO*. Physiol. Lab.
4:00 JJ1 426.16 The role of fscns1 in peripheral nerve
regeneration. T. OMURA*; D. XU; T. BANNO; A. OKAMOTO;
K. OMURA; Y. MATSUYAMA. Hamamatsu Univ. Sch. of
Med., Sakuradai Hosp.
1:00 JJ2 426.17 Axonal dysfunction in rab7-associated
cmt2b peripheral sensory neuropathy. C. WU*; X. CHEN;
X. ZHAO; W. YANG; C. JOLIVALT; L. BAO. UCSD Sch. of
Med., Univ. of California San Diego, Inst. of Biochem. and
Cell Biol.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 JJ3 426.18 Oral administration of Compound A,

which presents anti-inflammatory properties, ameliorates
diabetic neuropathy. F. H. P. MACEDO*; R. D. AIRES; R. C.
M. FERREIRA; D. P. D. MACHADO; T. R. L. ROMERO; J.
H. LEAL-CARDOSO; J. S. CRUZ. Univ. Federal de Minas
Gerais, Univ. Federal de Minas Gerais, Univ. Federal de
Minas Gerais, Univ. Estadual do Cear.
3:00 JJ4 426.19 Exosomes derived from schwann cells
ameliorates periheral neuropathy in type II diabetic mice. A.
SZALAD*; L. WANG; M. CHOPP; X. LU; L. JIA; M. LU; Y.
ZHANG; R. ZHANG; X. LIU; Z. ZHANG. Henry Ford Hosp.,
Henry Ford Hosp.
4:00 JJ5 426.20 Sensory weighting in elderly people and
neuropathy patients. C. F. MAURER*. Neurozentrum.

1:00 JJ6 426.21 Human iPSC-derived neurons to address

peripheral concerns: Applications beyond neurotoxicity
assessment. G. LUERMAN; D. HESS; B. MURPHY*; A.
EHLICH; H. BOHLEN. Axiogenesis, Axiogenesis AG.

POSTER
427. Spinal Cord Processing: Pharmacology
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 JJ7 427.01 Latent pain sensitization is masked
by spinal and , but not , opioid receptor analgesia in
male and female mice. L. CUSTODIO-PATSEY*; R. R.
DONAHUE; W. FU; B. K. TAYLOR. Univ. of Kentucky.
2:00 JJ8 427.02 Agrins may inhibit diabetic neuropathic
pain. J. CUI*; D. ERASSO; S. ABDI. MD ANDERSON
CANCER CENTER, Univ. of Miami, MD Anderson Cancer
Ctr.
3:00 JJ9 427.03 Lack of effect of diazepam on the
presynaptic depolarization of primary afferents in the
undernourished rat. M. G. CARREON*; C. VELZQUEZDELGADO; B. SEGURA-ALEGRA; S. QUIROZGONZLEZ; I. JIMENEZ-ESTRADA. CINVESTAV-IPN,
Natl. Autonomous Univ. of Mexico, Univ. Estatal del Valle de
Ecatepec.

1:00 JJ15 427.09 Lidocaine metabolite,

monoethylglycinexylidide, affects synaptic transmission in rat
spinal dorsal horn. K. FURUTANI*; Y. KAMIYA; T. KOHNO;
H. BABA. Niigata university.
2:00 JJ16 427.10 Molecular and electrophysiological
characterization of neuropeptide Y Y1 receptor-expressing
neurons in the substantia gelatinosa of the spinal cord. G. P.
SINHA*; W. FU; K. C. HALMOS; B. N. SMITH; S. DOOLEN;
B. K. TAYLOR. Univ. of Kentucky, Univ. of Kentucky.
3:00 JJ17 427.11 Underlying mechanisms of
acetaminophen in the spinal dorsal horn neurons. N.
OHASHI; M. SASAKI; M. OHASHI; Y. KAMIYA; H. BABA*;
T. KOHNO. Niigata Univ. Grad. Sch. of Med. and Dent. Sci.,
Uonuma institute of community medicine, Niigata Univ, Sch.
Med.
4:00 KK1 427.12 Effect of voltage gated sodium channel
toxins as therapeutic agents for chronic pain. N. R.
MUNASINGHE; J. DEUIS; V. HERZIG; Z. DEKAN; W. L.
IMLACH*; R. LEWIS; G. KING; P. ALEWOOD; J. KLINT;
I. VETTER; M. J. CHRISTIE. Univ. of Sydney, Univ. of
Queensland, The Univ. of Sydney.
1:00 KK2 427.13 Peripheral nerve injury increases
stimulation-induced neuropeptide Y release as measured
by Y1 receptor internalization in the rat dorsal horn. B.
K. TAYLOR*; W. FU; W. CHEN; J. G. MARVIZON. Univ.
of Kentucky, UC Los Angeles, VA Greater Los Angeles
Healthcare Syst.

2:00 KK3 427.14 Inhibition of bone resorption does not

contribute to the analgesic effects of Src antagonism in an
animal model of cancer-induced bone pain. V. HURST*;
D. LAMBERT; I. HOLEN; K. J. ESCOTT; D. ANDREW.
The Univ. of Sheffield, The Univ. of Sheffield, The Univ. of
Sheffield, Astrazeneca.
3:00 KK4 427.15 Sex differences in pioglitazone
analgesia for painful diabetic neuropathy. D. E. LAIRD*;
R. R. DONAHUE; R. B. GRIGGS; B. K. TAYLOR. Univ. of
Kentucky.

4:00 JJ10 427.04 Calcium-permeable AMPA receptor

signaling in dorsal horn contributes to latent pain
sensitization after inflammation. R. R. DONAHUE; G. P.
SINHA; J. A. MORON; B. K. TAYLOR; S. DOOLEN*. Univ. of
Kentucky, Washington Univ., Univ. of Kentucky.

4:00 KK5 427.16 Small molecule inhibitors of PSD95nNOS protein-protein interactions suppress formalin-evoked
Fos protein expression and nociceptive behavior in rats. L.
M. CAREY*, IV; P. KULKARNI; G. A. THAKUR; Y. Y. LAI; A.
G. HOHMANN. Indiana Univ., Northeastern Univ.

1:00 JJ11 427.05 Effects of botulinum toxin on histaminedependent and histamine-independent pruritus. T.
L. YAKSH*; M. J. MARINO; S. PAUL; Z. WANG; N.
MASCARENHAS; A. DINARDO; R. RAMACHANDRAN.
Univ. of California San Diego, UCSD.

1:00 KK6 427.17 Contribution of presynaptic HCN

channels to excitatory inputs of spinal substantia gelatinosa
neurons. T. LIU*; S. PENG; D. ZHANG; X. HU; L. LI; C.
XIE. The First Affiliated Hosp. of Nanchang Univ., the First
Affiliated Hosp. of Nanchang Univ.

2:00 JJ12 427.06 New botulinum conjugates targeting

NK1 and opiate receptor expressing neurons for the control
of chronic pain. S. M. GERANTON; M. MAIARU; A. S.
MANGIONE; C. TASSORELLI; E. FERRARI; C. LEESE; B.
DAVLETOV; S. P. HUNT*. Univ. Col. London, C. Mondino
Natl. Neurolog. Inst., Univ. of Lincoln, Univ. of Sheffield.

2:00 KK7 427.18 Spinal -1 receptor mediates

dephosphorylation of astrocytic aromatase leading to
nociceptive effect in mice formalin model. M. LEE; H. CHOI;
A. J. BEITZ; J. LEE*. Seoul Natl. Univ., Univ. of Minnesota.

3:00 JJ13 427.07 Inhibition of transient receptor potential

vanilloid type 1 (TRPV1) receptor by 2-adrenergic
receptors in dorsal root ganglia neurons. M. PUOPOLO*; S.
CHAKRABORTY; Y. LU; M. REBECCHI. Stony Brook Med.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 KK8 427.19 Ifenprodil and agmatine inhibit C-fibermediated EPSCs in spinal cord slices from Nav1.8-ChR2
mice. J. J. WAATAJA; P. A. SGULA; G. L. WILCOX;
C. A. FAIRBANKS*. Univ. Minnesota, McGill Univ., Univ.
Minnesota.

Neuroscience 2016|Monday PM|117

Mon. PM

Theme D: Sensory Systems

4:00 JJ14 427.08 Tonic inhibition of spinal PKA- and Epacmediated latent pain sensitization by neuropeptide Y. W.
FU*; N. YE; J. ZHOU; B. K. TAYLOR. Univ. of Kentucky,
Univ. of Texas Med. Br.

POSTER
428. Pain: Thalamic and Cortical Processing
Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 KK9 428.01 Repetitive motor cortex stimulation for the
relief of neuropathic pain after nerve injury in rats. M. CHA*;
B. LEE. Yonsei Univ. Col. of Med.
2:00 KK10 428.02 Contribution of ascending serotonin
facilitation to neuronal hyperactivity in the anterior cingulate
cortex underlying the maintenance of neuropathic pain. C.
BIAN; R. HU; M. LI; J. LIU; J. YANG; W. GUO; S. ZOU; K.
REN; R. DUBNER; F. WEI*. Univ. of Maryland Baltimore,
Tongji Hospital, Huazhong Univ. of Sci. and Technol., Jinling
hospital, Nanjing Univ. Sch. of Med.
3:00 KK11 428.03 Chronic pain disrupts the affective
response to acute pain through altered neural activities in the
anterior cingulate cortex (ACC). J. WANG*; Q. ZHANG; A.
TONG; T. MANDERS; A. GARG; R. YANG; Z. CHEN. New
York Univ. Sch. of Med., New York Univ. Sch. of Med.
4:00 KK12 428.04 Reticular thalamic neuronal activity
changes by formalin induced nociception of awake behaving
mice. Y. HUH*; J. CHO. Korea Inst. of Sci. and Technol.
1:00 KK13 428.05 Lateralized effects of neuropeptide S
(NPS) on amygdala output neurons in an arthritis pain rat
model. G. JI*; V. NEUGEBAUER. Texas Tech. Univ. Hlth.
Sci. Ctr., Texas Tech. Univ. Hlth. Sci. Ctr.
2:00 KK14 428.06 Affective components of chronic pain
reflect circuit-specific changes in the anterior cingulate
cortex. K. S. MEDA*; T. PATEL; J. M. BRAZ; A. I. BASBAUM;
V. S. SOHAL. UCSF, UCSF.
3:00 KK15 428.07 Characterizing the sensitivity of laserevoked EEG potentials to stimulus intensity using signal
detection analysis. B. BECK*; G. IANNETTI; P. HAGGARD.
Univ. Col. London, Univ. Col. London.

4:00 KK16 428.08 Neural signatures of pain in animal

models. C. Y. SAAB*; B. LEBLANC. Brown/RIH.
1:00 KK17 428.09 Anterior cingulate cortex (ACC)
representation of aversive pain intensity. Q. ZHANG*; A.
TONG; T. MANDERS; A. GARG; R. YANG; L. URIEN; Z.
CHEN; J. WANG. New York Univ., New York Univ.
2:00 KK18 428.10 Dorsal and ventral parts of the thalamic
nucleus submedius provide two independent inputs to
different areas of the rat orbitofrontal cortex: A single neurontracing study using virus vectors. E. KURAMOTO*; H. IWAI;
A. YAMANAKA; S. OHNO; R. SENDO; K. KOYANAGI; S.
TOYODOME; T. FURUTA; H. HIOKI; T. GOTO. Kagoshima
Univ., Kagoshima Univ., Kagoshima Univ., Kyoto Univ.
3:00 LL1 428.11 Dishabituation of central nervous system
to tonic pain following chiropractic care- a standardized low
resolution brain electromagnetic tomography (sLORETA)
based study. M. NAVID*; D. LELIC; I. NIAZI; K. HOLT; E. B.
MARK; A. M. DREWES; H. HAAVIK. Aalborg Univ. Hosp.,
Aalborg Univ., New Zealand Col. of Chiropractic, Auckland
Univ. of Technol., Aalborg Univ.
4:00 LL2 428.12 Effects of chronic pain on the cortical
circuitry implicated in pain and endogenous analgesia. J.
CHERIYAN*; P. L. SHEETS. Indiana Univ. Scool of Med.,
Univ. of Notre Dame.

2:00 LL4 428.14 Brain-network mechanisms underlying

the analgesic effect of electrical stimulation of periaqueductal
gray. N. WANG*; Y. SU; J. WANG; F. LUO. Inst. of
Psychology, Chinese Acad. of Sciences; Key Lab. of Mental
H, Dept. of Applied Psychology, Wenzhou Med. Univ.
3:00 LL5 428.15 Prefrontal cortical feedforward inhibition
of amygdala output neurons in arthritic and neuropathic pain
rat models. V. NEUGEBAUER*; T. KIRITOSHI. Texas Tech.
Univ. Hlth. Sci. Ctr., Texas Tech. Univ. Hlth. Sci. Ctr.
4:00 LL6 428.16 Monomethyl fumarate (MMF) inhibits
pain behaviors of arthritic rats: Involvement of the
amygdala. H. KIM*; J. M. THOMPSON; V. GANAPATHY;
V. NEUGEBAUER. Texas Tech. Univ. Hlth. Sci. Ctr., Texas
Tech. Univ. Hlth. Sci. Ctr., Texas Tech. Univ. Hlth. Sci. Ctr.
1:00 LL7 428.17 Vesicular Gamma-aminobutyric Acid
transporter (VGAT) expression in the ventral posterior
thalamus can modulate hypersensitivity following varicella
zoster virus (VZV) infection of rat whisker pad. M.
UMORIN*; C. STINSON; M. DENG; M. RAO; M. YEE; L.
L. BELLINGER; P. KINCHINGTON; P. R. KRAMER. Texas
A&M Univ. Baylor Col. of Dent., Wuhan Univ. Sch. and Hosp.
of Stomatology, Univ. of Pittsburgh.
2:00 LL8 428.18 Lateralized feedforward inhibition of
amygdala output neurons in an arthritis pain rat model. T.
KIRITOSHI*; V. NEUGEBAUER. Texas Tech. Univ. Hlth. Sci.
Ctr., Texas Tech. Univ. Hlth. Sci. Ctr.
3:00 MM1 428.19 Hyperexcitability of somatosensory
cortical neurons in CK1d migraine mutant mice. P. S.
SURYAVANSHI*; P. A. SAWANT-POKAM; K. C. BRENNAN.
Univ. of Utah, Univ. of Utah.
4:00 MM2 428.20 5-HT2CR blockade in the amygdala
conveys analgesic efficacy to SSRIs in a neuropathic
pain rat model. T. T. DANG*; G. JI; T. A. GREEN; V.
NEUGEBAUER. Texas Tech. Univ. Hlth. Sci. Ctr., The Univ.
of Texas Med. Br., Texas Tech. Univ. Hlth. Sci. Ctr.
1:00 MM3 428.21 SK channel-mediated electrophysiological
and behavioral effects of riluzole in the amygdala in
a neuropathic pain rat model. J. M. THOMPSON*; V.
YAKHNITSA; G. JI; V. NEUGEBAUER. Texas Tech. Univ.
Hlth. Sci. Ctr., Texas Tech. Univ. Hlth. Sci. Ctr.
2:00 MM4 428.22 Neuronal encoding of modality and
intensity of somatosensory stimuli in the mouse S1 cortex.
Y. KIM*; C. KIM; H. YOON; S. KIM; S. KIM. Seoul Natl. Univ.
Col. of Med., Kyunghee Univ. Col. of Korean medicine.
3:00 MM5 428.23 Short-term effect of transcranial direct
current stimulation (tdcs) in healthy subjects: Somatosensory
and pain threshold. M. HUNG*. China Med. Univ. Hosp.,
China Med. Univ. Hosp.

POSTER
429. Somatosensation: Thalamocortical Processes
Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 MM6 429.01 The neurochemistry of thalamic reticular
cells and its relationship with cell physiology and synaptic
connectivity. R. MARTINEZ-GARCIA; B. VOELCKER; S. L.
PATRICK; B. W. CONNORS; S. J. CRUIKSHANK*. Brown
Univ.

1:00 LL3 428.13 SK channel function in CRF-containing

amygdala neurons in a neuropathic pain rat model. V. A.
YAKHNITSA*; T. KIRITOSHI; V. NEUGEBAUER. Texas
Tech. Univ. Hlth. Sci. Ctr., Texas Tech. Univ. Hlth. Sci. Ctr.
118 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 MM7 429.02 Infrabarrels: Ensembles of structurally

and functionally distinct neurons in layer 6a of mouse
somatosensory cortex. S. R. CRANDALL*; S. L. PATRICK;
S. J. CRUIKSHANK; B. W. CONNORS. Brown Univ.
3:00 MM8 429.03 Contextual modulation of spatial
coding during active sensation. E. LYALL*; S. R. PLUTA;
E. RYAPOLOVA-WEBB; G. I. TELIAN; D. E. TAYLOR; H.
ADESNIK. Univ. of California Berkeley, Univ. of California
Berkeley, Univ. of California Berkeley.
4:00 MM9 429.04 Mapping cortical mesoscopic networks
linked to the firing of single cortical and sub-cortical neurons.
D. XIAO*; M. P. VANNI; C. MITELUT; A. CHAN; Y. XIE; A.
CHEN; N. SWINDALE; T. H. MURPHY. Kinsmen Lab, Dept.
of Psychiatry, Capital Med. Univ., Dept. of Ophthalmology
and Visual Sci.
1:00 MM10 429.05 Modeling the vibrotactile responses
of excitatory and inhibitory neurons in the hindpaw
representation of rat SI cortex. B. VARDAR*; B. GL.
Bogazici Univ.
2:00 MM11 429.06 Pom thalamocortical input drives
layer-specific response transformations. N. AUDETTE*; J.
URBAN-CIECKO; M. MATSUSHITA; A. L. BARTH. Carnegie
Mellon Univ., Carnegie Mellon Univ.

4:00 NN1 429.08 Understanding optogenetic stimulation

strategies: A study of opsin-neuron models and their spiking
behaviors. A. WILLATS*. Georgia Inst. of Technol. & Emory
Univ.
1:00 NN2 429.09 Closed loop optogenetic control of neural
circuits in vivo: Developing design principles for controlling
patterns of neural firing rate. M. F. BOLUS*; A. A. WILLATS;
C. J. WHITMIRE; Z. COSTELLO; M. B. EGERSTEDT; C. J.
ROZELL; G. B. STANLEY. Georgia Inst. of Technol. & Emory
Univ., Georgia Inst. of Technol. & Emory Univ., Georgia Inst.
of Technol.
2:00 NN3 429.10 Intracortical network effects preserve
thalamocortical input efficacy in a cortex without layers.
J. GUY*; A. SACHKOVA; M. MCK; M. WITTE; R. J.
WAGENER; J. F. STAIGER. Univ. Med. Ctr., Univ. of
Geneva.
3:00 NN4 429.11 Neural dynamics of single units and local
field potentials in mouse barrel cortex underlying detection at
perceptual threshold. H. SHIN*; S. R. JONES; C. I. MOORE.
Brown Univ.
4:00 NN5 429.12 Human rhythm modulation with
perception and attention reflects the density of rhythmic
transients across trials. S. R. JONES*; S. TSUTSUI; R. LAW;
H. SHIN; C. I. MOORE. Brown Univ., Brown Univ.
1:00 NN6 429.13 Mechanisms of sensory inhibition induced
by neocortical rhythms. R. LAW*; S. TSUTSUI; S. R.
JONES. Brown Univ., Brown Univ.

430. Second-Order Processing of Olfactory Inputs

Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 NN7 430.01 Developing a bio-electronic nose by
interfacing to the early olfactory system. E. SHOR; T.
BOZZA; D. RINBERG*. New York Univ., Northwestern
Univesity.
2:00 NN8 430.02 Onset latency analysis of odor-evoked
calcium response in the juxtaglomerular cells of mouse
olfactory bulb. R. HOMMA*; X. LV; S. ZENG; S. NAGAYAMA.
Univ. of Texas Med. Sch. at Houston, Huazhong Univ. of Sci.
and Technol., Huazhong Univ. of Sci. and Technol.
3:00 NN9 430.03 Control of mitral/tufted cell output
by selective inhibition among olfactory bulb glomeruli.
M. WACHOWIAK*; T. BOZZA; K. R. HANSEN; M. N.
ECONOMO. Univ. of Utah, Northwestern Univ., Univ. of
Utah.
4:00 NN10 430.04 Structural basis for cholinergic
regulation of neural circuits in the mouse olfactory bulb. M.
HAMAMOTO; E. KIYOKAGE; K. TOIDA*. Kawasaki Med.
Sch.
1:00 NN11 430.05 Dynamics of neuronal ensembles
in the main olfactory bulb. S. WADDLE; E. LYMAN; K.
PADMANABHAN*. Univ. of Delaware, Univ. of Rochester.
2:00 NN12 430.06 Increased olfactory bulb BDNF does not
enhance the normal survival of new granule cells and does
not prevent deprivation-induced cell death. K. M. GUTHRIE*;
R. BERGER; B. MCDOLE. Florida Atlantic Univ., Florida
Atlantic Univ.
3:00 NN13 430.07 Dynamic regulation of mitral cell spike
synchronization and phase-locking by external tufted cells in
a glomerular network model. C. RAPP*; F. FROHLICH; T. A.
CLELAND; G. LI. Univ. of North Carolina At Chapel Hill, Univ.
of North Carolina At Chapel Hill, Cornell Univ.

4:00 NN14 430.08 Reconstruction of neuronal activity and

connectivity patterns in the zebrafish olfactory bulb. A. A.
WANNER*; C. GENOUD; R. W. FRIEDRICH. Friedrich
Miescher Inst. For Biol. Res.
1:00 OO1 430.09 Mechanisms and functions of the offset
response in insect olfaction. S. HANEY*; D. SAHA; B.
RAMAN; M. BAZHENOV. UCSD, Washington Univ., Univ. of
California.
2:00 OO2 430.10 Modulatory convergence of serotonin and
dopamine in an olfactory network. K. M. LIZBINSKI*; A. M.
DACKS. West Virginia Univ.
3:00 OO3 430.11 Integration of olfactory and
mechanosensory stimuli in the projection neurons of
antennal lobe in the moth Manduca sexta. H. LEI*; J. KIM; J.
G. HILDEBRAND. Univ. Arizona, Univ. of Arizona.
4:00 OO4 430.12 The connectivity of the serotonergic
input to the olfactory system of Drosophila. K. COATES*;
A. AUDA; C. MICHAEL; S. MICHAELS; T. SIZEMORE; A.
MAJOT; A. DACKS. West Virginia Univ.
1:00 OO5 430.13 The role of connectivity patterns in
a computational model of Drosophila antennal lobe. R.
HAYNES*; M. SAMAVAT; D. LULI; S. CROOK. Arizona State
Univ., Arizona State Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|119

Mon. PM

3:00 MM12 429.07 Corticothalamic neurons target fastspiking and somatostatin containing interneurons with
different short-term dynamics. A. AGMON*; H. HU. West
Virginia Univ. Sch. of Med., West Virginia Univ. Sch. of Med.

POSTER

2:00 OO6 430.14 Serotonergic modulation of inhibitory

input to lateral horn modifies olfactory attraction in
Drosophila. A. H. AUDA*; K. COATES; T. SIZEMORE; A.
DACKS. West Virginia Univ.
3:00 OO7 430.15 Disorder and compressive sensing
in the olfactory system. K. KRISHNAMURTHY*;
A. HERMUNDSTAD; T. MORA; A. WALCZAK; V.
BALASUBRAMANIAN. Univ. of Pennsylvania, Univ. of
Pennsylvania, Janelia Res. Campus, Ecole normale
suprieure, Ecole normale suprieure.
4:00 OO8 430.16 Odor-evoked responses in both olfactory
bulb and brain stem in a perfused preparation of the rat
olfactory system. F. PEREZ DE LOS COBOS PALLARES;
D. FARMER; D. STANIC; M. LUKAS; M. DUTSCHMANN;
V. EGGER*. Regensburg Univ., Ludwig-Maximilian Univ.,
Florey Inst. of Neurosci. and Mental Hlth.

3:00 PP5 430.27 Possible roles for dopamine and

vasoactive intestinal polypeptide in the circadian rhythms of
the mammalian olfactory bulb. K. S. KORSHUNOV*; L. J.
BLAKEMORE; P. Q. TROMBLEY. Florida State Univ., Florida
State Univ.
4:00 PP6 430.28 Functional mapping of circuits mediating
inhibition of olfactory bulb interneurons. A. SANZ DEZ*; N.
BENITO; D. DE SAINT JAN. INCI CNRS.
1:00 PP7 430.29 Reconstructing odor identity from
olfactory bulb sequences using patterned optogenetics. J.
V. GILL*; J. M. KAPPEL; E. CHONG; G. SERRANO; D.
RINBERG. New York Univ., New York Univ. Langone Med.
Ctr., New York Langone Med. Ctr.

1:00 OO9 430.17 Assaying the spatial and temporal

structure of olfactory bulb inhibition using paired recordings.
H. A. ARNSON*; B. W. STROWBRIDGE. Case Western
Reserve Univ. Sch. of Med.

2:00 PP8 430.30 Physiological and molecular phenotyping

of glomerular layer interneurons in the mouse olfactory bulb.
O. R. BRAUBACH*; T. TOMBAZ; T. GEILLER; R. HOMMA;
T. BOZZA; L. B. COHEN; Y. CHOI. Korea Inst. of Sci. and
Technol. (KIST), Yale Univ. Sch. of Med., Kavli Inst. for
Systems Neurosci., Univ. of Texas Med. Sch. at Houston,
Northwestern Univ.

2:00 OO10 430.18 Mimicking natural stimulation patterns

to the olfactory bulb. C. E. VAAGA*; G. L. WESTBROOK.
Oregon Hlth. and Sci. Univ.

POSTER

3:00 OO11 430.19 BDNF augmentation in vivo increases

spine density in adult-born olfactory granule cells. B.
MCDOLE*; C. ISGOR; K. GUTHRIE. Florida Atlantic Univ.,
Florida Atlantic Univ.

431. Auditory Processing and Perception in Non-Humans

4:00 OO12 430.20 The role of olfactory bulb adult

neurogenesis in olfactory representation and behavior. W.
L. LI*; I. IMAYOSHI; T. KOMIYAMA. Univ. of California San
Diego, Kyoto Univ., Japan Sci. and Technol. Agency, Univ. of
California San Diego.

1:00 PP9 431.01 Independent attentional modulation of

compound auditory feature integration and segregation.
K. N. OCONNOR*; A. J. PRABHU; J. S. JOHNSON; M. L.
SUTTER. UC Davis.

1:00 OO13 430.21 Synaptic distribution of individually

labeled mitral cells in the external plexiform layer of the
mouse olfactory bulb. T. MATSUNO; E. KIYOKAGE*; K.
TOIDA. Kawasaki Med. Sch.
2:00 OO14 430.22 Targeting dense reconstructions of
an olfactory bulb circuit with X-ray and serial block-face
electron microscopy. C. BOSCH PIOL*; K. L. BRIGGMAN;
M. HELMSTAEDTER; T. W. MARGRIE; A. T. SCHAEFER.
The Francis Crick Inst., NINDS, Max Plank Inst. for Brain
Res., UCL, Sainsbury Wellcome Ctr. for Neural Circuits and
Behaviour.

Theme D: Sensory Systems

Mon. 1:00 PMSan Diego Convention Center,Halls B-H

2:00 PP10 431.02 Prefrontal and sensory correlates of

auditory spatial attention in the macaque. C. R. CAMALIER*;
A. BROWN; J. JACOBS; M. MISHKIN; B. B. AVERBECK.
NIH.
3:00 PP11 431.03 Sensory coding properties predict
selective attention effects on single units in primary auditory
cortex. Z. P. SCHWARTZ; S. V. DAVID*. Oregon Hlth. & Sci.
Univ.
4:00 PP12 431.04 A gradient frequency neural network
model of auditory scene analysis. J. C. KIM*; E. W. LARGE.
Univ. of Connecticut.

3:00 PP1 430.23 Control of the granule cell-short axon cell

local circuit in the olfactory bulb by direct feedforward and
feedback axonal inputs. F. R. POUILLE*; N. E. SCHOPPA.
Univ. of Colorado, AMC.

1:00 PP13 431.05 Reward cues direct auditory attention

and modulate fMRI activations in monkey auditory cortex.
P. WIKMAN; T. RINNE; C. I. PETKOV*. Univ. of Helsinki,
Newcastle Univ.

4:00 PP2 430.24 A model of experience-dependent odor

construction in the olfactory bulb. A. BORTHAKUR*; T. A.
CLELAND. Cornell Univ.

2:00 PP14 431.06 Using deep networks to generate

naturalistic stimuli reveals shared higher-level perceptual
space among wild-caught starlings. M. THIELK*; T.
SHARPEE; T. GENTNER. UCSD, Salk Inst.

1:00 PP3 430.25 Electrical stimulation of the locus

coeruleus enhances signal to noise ratio in the olfactory bulb
of anesthetized rats. L. C. MANELLA*; N. PETERSEN; C.
LINSTER. Cornell Univ.
2:00 PP4 430.26 Middle tufted cell drive the mitral cell
spatiotemporal firing patterns through glomerular and
granule cell microcircuits. F. CAVARRETTA*; M. MIGLIORE;
M. L. HINES; K. M. IGARASHI; G. M. SHEPHERD. Yale
University-School of Med., Univ. of Milan, Natl. Res. Council,
Univ. of California.

120 | Society for Neuroscience

3:00 PP15 431.07 Primate BOLD data demonstrating

fundamental bases for auditory figure-ground analysis. P.
DHEERENDRA*; F. BALEZEAU; S. KUMAR; A. BLAMIRE;
A. THIELE; T. D. GRIFFITHS. Newcastle Univ., Univ. Col. of
London.
4:00 PP16 431.08 Dynamics of cortical activity during
behavioral engagement and auditory perception. I.
CARCEA*; M. N. INSANALLY; R. C. FROEMKE. NYU Med.
Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 QQ1 431.09 Inactivation of primate dorsolateral

prefrontal cortex during auditory working memory. L. M.
ROMANSKI*; B. PLAKKE; T. LINCOLN; A. POREMBA; J.
BIGELOW. Univ. of Rochester Sch. of Med. and Dent., Univ.
of Iowa, Univ. of California, San Francisco.

2:00 QQ14 431.22 Contribution of correlated neural activity

in the auditory cortex to the cocktail-party problem. F.
RODRIGUEZ-CAMPOS; T. BANNO; Y. E. COHEN*; S.
BENNUR. Univ. of Pennsylvania, Univ. of Pennsylvania
Dept. of Otorhinolaryngology.

2:00 QQ2 431.10 The impact of parvalbumin deficiency

on auditory function in aging mice. J. BURIANOVA*; R.
TURECEK; B. SCHWALLER; J. SYKA. Inst. of Exptl.
Medicine, CAS, Univ. of Fribourg.

POSTER

3:00 QQ3 431.11 DREADD-mediated silencing of

projections from basolateral amygdala to nucleus
accumbens disrupts pre-pulse inhibition in rats. B. L.
AGUILAR*; E. WICKER; L. MALKOVA; P. A. FORCELLI.
Georgetown Univ., Georgetown Univ., Georgetown Univ.
4:00 QQ4 431.12 Attenuated responses to self-generated
sounds in auditory cortex. B. RUMMELL; J. KLEE; T.
SIGURDSSON*. Goethe Univ. Frankfurt.

2:00 QQ6 431.14 Higher age-related decline in behavior

discrimination of amplitude modulation frequencies
compared to auditory evoked potentials. J. LAI*; E. L.
BARTLETT. Purdue Univ., Purdue Univ.
3:00 QQ7 431.15 Parallel processing by cortical inhibition
in auditory cortex enables flexible behavior and learning.
K. KUCHIBHOTLA*; J. V. GILL; G. W. LINDSAY; E.
PAPADOYANNIS; T. A. H. STEN; R. E. FIELD; K. D.
MILLER; R. C. FROEMKE. New York Univ. Sch. of Med.,
Columbia Unviersity, NYU Sch. of Med.
4:00 QQ8 431.16 Acoustic environmental enrichment
prolonged natural lifespan of mice. Y. YAMASHITA*; N.
KAWAI; O. UENO; T. OOHASHI; M. HONDA. Natl. Inst. of
Neuroscience, Natl. Ctr. of Neurol. and Psychiatry, Fndn. for
Advancement of Intl. Sci.
1:00 QQ9 431.17 Shared mechanisms of mismatch
activity in common marmosets and macaque monkeys. M.
KOMATSU*; N. FUJII. RIKEN Brain Sci. Inst.
2:00 QQ10 431.18 Task-related plasticity in the inferior
colliculus of the marmoset monkey. S. J. SLEE*; S. V.
DAVID. Oregon Hlth. and Sci. Univ.
3:00 QQ11 431.19 Contribution of population activity in
the auditory cortex to the cocktail-party problem. K. L.
CHRISTISON-LAGAY*; S. BENNUR; Y. COHEN. Perelman
Sch. of Med. At the Univ. of Pennsylvania, Univ. of
Pennsylvania.

Theme D: Sensory Systems

Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 QQ15 432.01 Decoding the white matter geometrical
structure by encoding connectomes in multidimensional
spaces. F. PESTILLI*; C. F. CAIAFA. Indiana Univ., Indiana
Univ. / CONICET.
2:00 QQ16 432.02 Towards a standard cortical observer
model in human V1-V3. C. OLSSON, 10003; N. C.
BENSON; J. WINAWER*. New York Univ., New York Univ.
3:00 QQ17 432.03 A fully computable model of bottom-up
and top-down processing in high-level visual cortex. K. N.
KAY*; J. D. YEATMAN. Univ. of Minnesota, Twin Cities, Univ.
of Washington.
4:00 QQ18 432.04 Preserved information in multivoxel
patterns despite significant decrease in mean signals
following surgical removal of human inferior occipital cortex.
K. S. WEINER*; J. JONAS; L. MAILLARD; G. HOSSU; S.
COLNAT-COULBOIS; K. GRILL-SPECTOR; B. ROSSION.
Stanford Univ., Univ. Hosp. of Nancy, Univ. Hosp. of Nancy,
Univ. of Louvain.
1:00 QQ19 432.05 Population receptive field attraction by
spatial attention varies across cortical depth in human V1.
B. P. KLEIN*; A. FRACASSO; S. O. DUMOULIN. Helmholtz
Inst., Spinoza Ctr. for Neuroimaging, Univ. Med. Ctr.
2:00 QQ20 432.06 Neural variability is an individual trait. A.
ARAZI*; G. GONEN- YAACOVI; I. DINSTEIN. Ben Gurion
Univ., Ben Gurion Univ.
3:00 RR1 432.07 Contextual modulation in human visual
cortex: Orientation tuning of surround suppression varies
with the spatial extent of the surround. S. WARDLE*; K.
SEYMOUR. Macquarie Univ., ARC Ctr. of Excellence in
Cognition and its Disorders.
4:00 RR2 432.08 The phase of ongoing oscillations
predicts eye movements and visually evoked responses in
striate cortex during visual search. N. N. THIGPEN*. Univ. of
Florida.
1:00 RR3 432.09 V1 & V2 receive high-level scene
information via cortical feedback. A. T. MORGAN*; L. S.
PETRO; L. MUCKLI. Univ. of Glasgow.

4:00 QQ12 431.20 The role of auditory thalamo-striatal and

cortico-striatal neurons in amplitude modulation frequency
discrimination. N. D. PONVERT*; S. JARAMILLO. Univ. of
Oregon.

2:00 RR4 432.10 Array coils for ultra-high resolution

columnar imaging in visual cortex. A. BECKETT*; A. T.
VU; S. SCHILLACK; D. A. FEINBERG. Univ. of California,
Advanced MRI Technologies, Virtumed.

1:00 QQ13 431.21 Behavior-dependent gating and

extraction of task-relevant auditory signals in ferret
frontal cortex. J. LAWLOR BLONDEL*; B. ENGLITZ; A.
MEYER; U. GRSKA; S. SHAMMA; Y. BOUBENEC. Ecole
Normale Superieure, Lab. des Systmes Perceptifs, CNRS
UMR 8248, Dept. of Neurophysiology, Donders Ctr. for
Neuroscience, Radboud Univ. Nijmegen, Gatsby Computat.
Neurosci. Unit, Sainsbury Wellcome Ctr.

3:00 RR5 432.11 Luminance modulates the contrast

response in human visual cortex. L. VINKE*; S. LING.
Boston Univ., Boston Univ., Boston Univ., Radboud Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 RR6 432.12 Cortical depth dependent 7T BOLD

responses to parametrically varied luminance contrast. I.
MARQUARDT*; M. SCHNEIDER; O. GULBAN; D. IVANOV;
K. ULUDAG. Dept. of Cognitive Neurosci.

Neuroscience 2016|Monday PM|121

Mon. PM

1:00 QQ5 431.13 Behavioral uncertainty in tone-in-noise

and speech-in-noise detection tasks reflected in neuronal
responses in ferret auditory and frontal cortices. J. B.
FRITZ*; C. BIMBARD; D. D. DUQUE; D. DELGUEDA; S.
V. DAVID; S. A. SHAMMA. Inst. For Systems Res., Ecole
Normale Superieure, Univ. of Maryland, Oregon Hlth. Sci.
Univ.

432. Human Visual Cortex

POSTER
433. Rodent Visual Cortex
Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 RR7 433.01 Extra-classical receptive field effects on
visual processing in the awake rodent. F. LUONGO*; L. LIU;
D. TSAO. Caltech.
2:00 RR8 433.02 Binocular integration in mouse using
stereoscopic cues to guide behavior. V. CHOI*; S. JOO; J.
M. SAMONDS; A. C. HUK; N. J. PRIEBE. Univ. of Texas at
Austin, Univ. of Texas at Austin.

3:00 RR21 433.15 Neuromodulatory axon activity in

the visual cortex. R. S. LARSEN*; J. ZHUANG; D.
OLLERENSHAW; T. DAIGLE; J. WATERS. Allen Inst. For
Brain Sci.
4:00 RR22 433.16 Robust electro-physiological type
identification using co-clustering analysis of clustering
tree. C. LEE*; N. GOUWENS; K. LEPAGE; V. MENON; T.
BAKKEN; S. SUNKIN; A. ARKHIPOV; M. HAWRYLYCZ.
Allen Inst. For Brain Sci., Allen Inst. for Brain Sci., Allen Inst.
for Brain Sci.
1:00 SS1 433.17 A modern approach to labelling and
visualizing the central visual pathway. J. L. BALSOR*; K. M.
MURPHY. McMaster Univ.

3:00 RR9 433.03 Locomotion enhances information

represented in mouse visual cortex both by increasing firing
rates and decreasing correlations. M. C. DADARLAT*; M. P.
STRYKER. Univ. of California, San Francisco.

2:00 SS2 433.18 Interneurons derived from the caudal

ganglionic eminence are preferentially connected to callosal
projecting pyramidal cells in deep cortical layers. J. C.
WESTER*; C. J. MCBAIN. NIH, NIH.

4:00 RR10 433.04 Thalamocortical and intracortical

contributions to binocular matching of orientation preference
in mouse visual cortex. Y. GU*; J. CANG. Northwestern Univ.

3:00 SS3 433.19 Learning changes the selectivity and

interactions of GABAergic interneuron classes in visual
cortex. J. POORT*; A. G. KHAN; A. BLOT; S. B. HOFER; T.
D. MRSIC-FLOGEL. Univ. Col. London, Biozentrum.

1:00 RR11 433.05 Basal forebrain projections to different rat

visual cortical areas. F. HUPP-GOURGUES; K. JEGOUIC;
S. BOUHABEL; E. H. VAUCHER*. Univ. of Montreal.
2:00 RR12 433.06 The entropy of neural ensemble
firing patterns in mouse primary visual cortex correlates
with behavioural performance. M. TOLKIEHN*; A.
BERDITCHEVSKAIA; S. R. SCHULTZ. Imperial Col.
London.
3:00 RR13 433.07 Sculpting the dynamics of neuronal
networks in the mouse cortex with optogenetic tools. T.
TSUBOTA; D. LYAMZIN; A. BENUCCI*. RIKEN Brain Sci.
Inst.
4:00 RR14 433.08 Morphologically-defined cell types in
mouse primary visual cortex. S. A. SORENSEN*; T. DESTA;
A. HENRY; R. DALLEY; D. SANDMAN; N. THATRA; G.
WILLIAMS; J. BERG; X. LIU; K. GODFREY; D. FENG; N.
GOUWENS; C. LEE; Z. ZHOU; H. PENG; Y. WANG; A.
BERNARD; L. NG; J. HARRIS; H. ZENG. Allen Inst.
1:00 RR15 433.09 Behavioral state modulates 3-5 Hz
membrane potential oscillations in mouse visual cortex. M.
EINSTEIN*; P. POLACK; P. GOLSHANI. UCLA, Rutgers
Univ., UCLA.
2:00 RR16 433.10 Invariant and abstract perceptual
representations in mouse decision-making. R. AOKI*;
D. LYAMZIN; M. ABDOLRAHMANI; M. J. MORAIS; A.
BENUCCI. RIKEN Brain Sci. Inst.
3:00 RR17 433.11 Identification of neuronal ensembles from
primary visual cortex in vivo using probabilistic graphical
models. S. HAN*; L. CARRILLO-REID; E. TARALOVA; T.
JEBARA; R. YUSTE. Columbia Univ., Columbia Univ.
4:00 RR18 433.12 Cholinergic modulation of an inhibitory
microcircuit changes dendritic integration after the
visual critical period. C. E. YAEGER*; K. L. KWAN; J. T.
TRACHTENBERG. UCLA.
1:00 RR19 433.13 PV interneurons in visual cortex control
contrast sensitivity and spatial integration of pyramidal cells.
M. FIORINI*; S. ERISKEN; A. VAICELIUNAITE; O. JURJUT;
S. KATZNER; L. BUSSE. Univ. of Tuebingen, Intl. Max
Planck Res. Sch., LMU Munich.

4:00 SS4 433.20 How does behavioral relevance affect

neural responses in mouse primary visual cortex and
thalamus? A. WAL*; A. VAICELIUNAITE; P. GEORGIEVA; L.
BUSSE; S. KATZNER. Univ. of Tuebingen, Intl. Max Planck
Res. Sch., LMU Munich.
1:00 SS5 433.21 Generation of biophysically-detailed
models that reflect diverse intrinsic properties of cortical
neuron types. N. W. GOUWENS*; J. BERG; T. DESTA;
D. FENG; T. FLISS; K. GODFREY; T. JARSKY; C. LEE;
S. SORENSEN; S. SUNKIN; Z. ZHOU; A. BERNARD;
C. DANG; L. NG; H. PENG; J. PHILLIPS; H. ZENG; M.
HAWRYLYCZ; C. KOCH; A. ARKHIPOV. Allen Inst. For Brain
Sci.
2:00 SS6 433.22 Circuit models with multiple types of
inhibitory neurons based on a brain-wide map of cell density.
G. R. YANG*; L. C. GARCIA DEL MOLINO; Y. KIM; P.
OSTEN; X. WANG. New York Univ., Cold Spring Harbor
Lab., Penn State Univ., NYU-ECNU Joint Inst. of Brain and
Cognitive Sci.
3:00 SS7 433.23 Cortical microcircuit endowed with
three interneuron subtypes exhibits a repertoire of multiple
dynamical regimes. L. GARCIA DEL MOLINO*; G. R. YANG;
X. WANG. New York Univ.
4:00 SS8 433.24 Stimulus-specific response enhancement
in mouse primary visual cortex depends on locomotion.
M. KANEKO*; Y. FU; M. P. STRYKER. Univ. of California,
Singapore Bioimaging Consortium, Agency for Sci. Technol.
and Res.

POSTER
434. Striate Cortex Plasticity I
Theme D: Sensory Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 SS9 434.01 Role of CREB, SRF and MEF2 in ocular
dominance plasticity. N. S. PULIMOOD*; A. E. MEDINA.
Univ. of Maryland Baltimore.

2:00 RR20 433.14 2-photon imaging of task-dependent

cortical population dynamics during a visual discrimination.
J. B. WEKSELBLATT*; R. D. DI RICCO; C. M. NIELL. Univ.
of Oregon.
122 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 SS10 434.02 Orientation tuning curves and selectivity

in V1: Influence of the past stimulus. F. ETINDELE SOSSO*;
V. BHARMAURIA; L. BACHATENE; S. CATTAN; A.
OUELHAZI; N. CHANAURIA; S. MOLOTCHNIKOFF. Univ. of
Montreal.

3:00 SS23 434.15 The recovery of ocular dominance and

visual acuity in murine amblyopia are limited by NgR1 in
distinct components of the visual circuitry. C. STEPHANY*;
H. M. DORTON; A. W. MCGEE. Childrens Hosp. of Los
Angeles, USC.

3:00 SS11 434.03 The role of Neuregulin1/ErbB4 signaling

in transplant-induced cortical plasticity. X. ZHENG*; T.
IKRAR; X. XU; S. P. GANDHI. Univ. of California, Irvine,
Univ. of California, Irvine, Univ. of California, Irvine.

4:00 SS24 434.16 Reprograming of neuronal ensembles in

primary visual cortex with two-photon optogenetics in vivo.
L. CARRILLO-REID*; W. YANG; D. PETERKA; R. YUSTE.
Columbia Univ., Columbia Univ.

4:00 SS12 434.04 Cholinergic enhancement accelerates

recovery of vision after optic nerve damage. M. CHAMOUN*;
E. SERGEEVA; P. HENRICH-NOACK; S. JIA; L.
GRIGARTZIK; J. MA; Q. YOU; F. HUPP-GOURGUES;
B. A. SABEL; E. VAUCHER. Univ. De Montreal, Otto-vonGuericke Univ.

1:00 SS25 434.17 Rem2 is required for normal critical

period ocular dominance plasticity of the visual cortex. S. E.
RICHARDS*; A. R. MOORE; K. KENNY; S. PARADIS; S. D.
VAN HOOSER. Brandeis Univ.

1:00 SS13 434.05 Brain-wide analysis of parvalbumin,

somatostatin and vasointestinal peptide levels in cortical
interneurons of sighted and enucleated mice using a newly
developed imaging tool. M. LARAMEE*; S. VREYSEN; L.
ARCKENS. KU Leuven.

3:00 SS15 434.07 Short-term deprivation of the amblyopic

eye, combined with physical exercise, promotes long-term
visual recovery in adult anisometropic patients. C. LUNGHI*;
A. SALE; A. LEPRI; A. SFRAMELI; A. DENDRAMIS; D.
LISI; M. LEPRI; M. C. MORRONE. Univ. of Pisa, Natl. Res.
Council, Univ. of Pisa, Univ. of Pisa.
4:00 SS16 434.08 Intriguing! Auditory stimulus shifts
orientation selectivity of visual neurons in cat V1. N.
CHANAURIA*; V. BHARMAURIA; L. BACHATENE;
S. CATTAN; F. A. ETINDELE-SOSSO; J. ROUAT; S.
MOLOTCHNIKOFF. Univ. of Montreal, Univ. of Sherbrooke.
1:00 SS17 434.09 Evidence for an intact retinotopic
organization of early visual cortex but impaired extrastriate
processing in sight recovery individuals. S. SOURAV*;
D. BOTTARI; R. BALACHANDAR; R. KEKUNNAYA; B.
RDER. Univ. of Hamburg, LV Prasad Eye Inst.
2:00 SS18 434.10 Increasing Arc prolongs the critical period
for juvenile plasticity in primary visual cortex. T. KIM*; E. D.
PASTUZYN; K. R. JENKS; H. OKUNO; J. ICHIDA; H. BITO;
M. F. BEAR; J. D. SHEPHERD. MIT, Univ. of Utah, Kyoto
Univ., Univ. of Tokyo, MIT.
3:00 SS19 434.11 Cortico-fugal output from visual cortex
promotes plasticity of innate motor behavior. B. LIU*; A.
HUBERMAN; M. SCANZIANI. UCSD, UCSD/HHMI.

3:00 TT1 434.19 Dichoptic perceptual training in juvenile

amblyopes with or without patching history. J. ZHANG*; X.
LIU; C. YU. Peking Univ., Tengzhou Central Peoples Hosp.

POSTER
435. Cortical Planning and Execution: EEG
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 TT2 435.01 EEG/fNIRS as biomarkers for neural
activation in humans during motor tasks. T. H. CRUZ*; T.
BULEA; T. S. MOULTON; A. C. DE CAMPOS; A. SHARMA;
T. HUPPERT; D. DAMIANO. NICHD/NIH, NIH, Northwestern
Univ. Feinberg Sch. of Med., Univ. Federal de Sao Carlos,
Univ. of Pittsburgh.
2:00 TT3 435.02 EEG signals related to movement-related
cortical potential by direction-cue and go-cue. A. FUNASE*;
S. TAKAGI; I. TAKUMI. Nagoya Inst. of Technol., RIKEN.
3:00 TT4 435.03 Children with cerebral palsy have
uncharacteristic cortical oscillations during a visuomotor
target matching task. M. J. KURZ*; A. L. PROSKOVEC; J.
E. GEHRINGER; E. HEINRICHS-GRAHAM; T. W. WILSON.
Univ. of Nebraska Med. Ctr., Univ. of Nebraska Med. Ctr.
4:00 TT5 435.04 Orthogonalising parameters of predictive
coding within a visuomotor adaptation task. C. E. PALMER*;
S. ONDOBAKA; J. M. KILNER. Inst. of Neurology, Univ. Col.
London, Wellcome Trust Ctr. for Neuroimaging.

4:00 SS20 434.12 High-dimensional structure of inhibitory

population activity in visual cortex. C. STRINGER*; M.
PACHITARIU; M. DIPOPPA; M. OKUN; M. CARANDINI; K.
HARRIS. Univ. Col. London, Univ. Col. London.

1:00 TT6 435.05 Directionally tuned signals in human EEG

during step-tracking wrist movement. H. KAMBARA*; H.
TANAKA; M. MIYAKOSHI; N. YOSHIMURA; Y. KOIKE; S.
MAKEIG. Tokyo Inst. Technol., Japan Advanced Inst. of Sci.
and Technol., Univsersity of California, San Diego, Tokyo
Insittue of Technol.

1:00 SS21 434.13 Visual cortical activity during a virtual

foraging task in mice. A. RESULAJ*; S. R. OLSEN; M.
SCANZIANI. Univ. of California San Francisco, Allen Inst. for
Brain Sci.

2:00 TT7 435.06 Dynamics of directional tuning and

reference frames in humans: A high-density EEG study. H.
TANAKA*; M. MIYAKOSHI; S. MAKEIG. Japan Advanced
Inst. of Sci. and Technol., UCSD.

2:00 SS22 434.14 Recordings from 10,000 neurons reveal

high dimensionality in cortical activity. M. PACHITARIU*; C.
STRINGER; S. SCHRODER; M. CARANDINI; K. HARRIS.
Univ. Col. London.

3:00 TT8 435.07 Altered sensorimotor cortical oscillations

in individuals with multiple sclerosis suggests a faulty
internal model. D. J. ARPIN*; E. HEINRICHS-GRAHAM;
J. E. GEHRINGER; T. W. WILSON; M. J. KURZ. Univ. of
Nebraska Med. Ctr., Univ. of Nebraska Med. Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|123

Mon. PM

2:00 SS14 434.06 Cortical representation of a myopic

peripapillary crescent: Evidence against fill-in of retinal
lesions. D. L. ADAMS*; J. R. ECONOMIDES; J. C.
HORTON. UCSF.

2:00 SS26 434.18 A surprising transient period of synaptic

imbalance exists in the rat visual cortex during postnatal
development. H. ZHANG; M. T. WONG-RILEY*. Med. Col. of
Wisconsin, Med. Col. of Wisconsin.

4:00 TT9 435.08 Neuromechanical changes associated

with learning an isometric ankle plantarflexion target
matching task. J. GEHRINGER*; D. J. ARPIN; E.
HEINRICHS-GRAHAM; T. W. WILSON; M. KURZ. Univ. of
Nebraska Med. Ctr., Univ. of Nebraska Med. Ctr.

1:00 TT10 435.09 Improving source localization

of movement-related potentials with tri-polar
electroencephalography. C. TOOLE*; P. STEELE; J.
DICECCO; W. BESIO. Univ. of Rhode Island, CREmedical,
Univ. of Rhode Island, Naval Undersea Warfare Ctr.
2:00 TT11 435.10 Dynamic phase-amplitude coupling in the
EEG during gait adaptation. J. WAGNER*; R. MARTINEZ
CANCINO; C. NEUPER; G. MUELLER-PUTZ; S. MAKEIG.
Graz Univ. of Technol., Univ. of California San Diego, Univ. of
Graz.

POSTER
436. Cortical Planning and Execution: Human Physiology
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 TT12 436.01 Changes associated with motor learning
of TMS-evoked EEG responses. H. SEKIGUCHI*; S.
TAKEUCHI; M. MIYAZAKI; K. YAMANAKA. Jobu Univ.,
Shizuoka Univ., Showa Womens Univ.
2:00 TT13 436.02 Independent preparation of what and
whenin the cortico-spinal pathway. N. HAGURA*; Y. GOTO;
M. MATSUMURA. CiNet, Kyoto Univ.
3:00 TT14 436.03 The gradient level of inhibition in
response preparation. L. LABRUNA*; C. TISCHLER; D.
LEVITIN; M. J. DABIT; I. GREENHOUSE; F. LEBON; R. B.
IVRY. UC Berkeley, McGill Univ., Univ. Bourgogne Franche
Comt.
4:00 UU1 436.04 Examining the influence of dorsolateral
prefrontal cortex activity on ipsilateral primary motor cortex
excitability with dual-site TMS. M. J. BROWN*; M. VESIA; C.
GUNRAJ; R. CHEN. Univ. Hlth. Network.
1:00 UU2 436.05 Cortical processes to predict timing of gait
initiation through visual information. K. TAKEDA*; Y. NISHI;
H. MANI; N. HASEGAWA; T. ISHIGAKI; Y. TAKAMURA; M.
OSUMI; S. NOBUSAKO; H. MAEJIMA; S. MORIOKA; T.
ASAKA. Hokkaido Univ., Kio Univ., Hokkaido Univ., Kio Univ.
2:00 UU3 436.06 Gaze pattern differences inform hand
posture to object shape during reach-to-grasp. A. YOUSEFI*;
S. BILALOGLU; J. R. RIZZO; Y. LU; P. RAGHAVAN.
New York Univ. Sch. of Med., Steinhardt Sch. of Culture,
Education, and Human Develop.

3:00 UU4 436.07 Determination of treatment algorithms

for patient subgroups for post-stroke hand function
rehabilitation. P. RAGHAVAN*; Y. LU; C. BAYONA; S.
BILALOGLU; A. YOUSEFI; A. TANG; V. ALURU; A.
RANGAN. New York Univ. Langone Med. Ctr., New York
Univ. Sch. of Med., New York Univ., New York Univ. Med.
Ctr.
4:00 UU5 436.08 Plasticity in cortical control
signals to muscles in pianists with overuse injury with
peripheral behavioral intervention. S. BILALOGLU*; S.
CHAKRABARTY; Y. LU; A. YOUSEFI; P. RAGHAVAN. New
York Univ. Sch. of Med., Univ. of Leeds, Steinhardt Sch. of
Culture, Education, and Human Develop., Steinhardt Sch. of
Culture, Education, and Human Develop.

124 | Society for Neuroscience

1:00 UU6 436.09 Selective and global inhibition of

interneuron circuits in human motor cortex during
movement preparation. R. HANNAH*; S. TREMBLAY; J. C.
ROTHWELL. UCL Inst. of Neurol.
2:00 UU7 436.10 Differential effects of rTMS on
motor cortex excitability, interhemispheric inhibition and
performance in elderly people. M. WISCHNEWSKI; G. M.
KOWALSKI; J. FREEMAN; S. R. BELAGAJE; G. HOBBS; C.
M. BUETEFISCH*. Emory Univ., West Virginia Univ.
3:00 UU8 436.11 Anticipatory corticospinal control of
motoneurons during self-unloading of wrist muscles:
Comparison with usual unloading. L. ZHANG*; A.
FELDMAN. Dept. of Neuroscience, Univ. of Montreal.
4:00 UU9 436.12 Cortical coherence during movement. A.
OKEEFFE*; N. POURATIAN. UCLA Hlth. Syst.
1:00 UU10 436.13 A comparison of widespread motor
inhibition during movement preparation and stopping. I.
GREENHOUSE*; L. CAO; R. B. IVRY. Univ. of California
Berkeley.
2:00 UU11 436.14 Abnormal interhemispheric interactions
are present in the chronic but not in the acute or subacute
post-stroke periods. J. XU*; M. BRANSCHEIDT; H.
SCHAMBRA; G. LIUZZI; L. STEINER; N. KIM; T. KITAGO;
A. LUFT; J. W. KRAKAUER; P. A. CELNIK. Johns Hopkins
Univ., Univ. of Zurich, Johns Hopkins Univ., Columbia Univ.
3:00 UU12 436.15 Somatotopic specificity of motor cortex
plasticity in response to visuo-proprioceptive realignment. J.
L. MIRDAMADI*; A. K. LYNCH; Y. LIU; H. J. BLOCK. Indiana
Univ., Indiana Univ.
4:00 UU13 436.16 Investigating the temporal aspects
of action observation: Evidence from soccer players.
M. BOVE*; L. PEDULL; E. GERVASONI; A. BISIO; M.
BIGGIO; L. AVANZINO. Univ. of Genoa.
1:00 UU14 436.17 The competitive effect of alternative
movements with different probabilities on EEG during
preparation period. A. FUJIKAWA*; Y. MATSUMOTO; T.
URAKAWA; O. ARAKI. Tokyo Univ. of Sci.
2:00 VV1 436.18 Electroencephalography based analysis
of hemispheric activation asymmetry for goal- and non
goal-oriented movements with virtual mirror feedback. M.
ROHAFZA*; M. YAROSSI; E. TUNIK; S. ADAMOVICH.
New Jersey Inst. of Technol., Rutgers Biomed. Hlth. Sci.,
Northeastern Univ.
3:00 VV2 436.19 The influence of cerebellar transcranial
direct current stimulation on motor skill acquisition
and learning in a throwing task. B. J. POSTON*; L. L.
ALBUQUERQUE; A. K. JACKSON; K. M. FISCHER; M. A.
GUADAGNOLI; Z. A. RILEY. Univ. of Nevada Las Vegas,
Indiana-University-Purdue Univ. Indianapolis.
4:00 VV3 436.20 Diverse patterns of movement related
potentials after EEG BMI intervention in severe chronic
stroke patients. O. YILMAZ*; D. BROETZ; W. CHO; E.
GARCIA COSSIO; G. LIBERATI; F. BRASIL; M. ROCHA
CURADO; N. BIRBAUMER; A. RAMOS MURGUIALDAY.
Bahcesehir Univ., Univ. of Tuebingen, Inst. of Neuroscience,
Univ. catholique de Louvain, Ospedale San-Camillo,
Neurotechnology Laboratory, TECNALIA Hlth.
1:00 VV4 436.21 Minimizing the required number of
surface EEG electrodes with focused positioning. M. B.
BAYRAM*; H. ARGUNSAH BAYRAM. Acibadem Univ.,
Kessler Fndn.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 VV5 436.22 Visual perception threshold is

inversely correlated with moment-to-moment changes in
corticomuscular coherence during tonic isometric voluntary
ankle dorsiflexion in humans. R. MATSUYA*; J. USHIYAMA;
S. KASUGA; J. USHIBA. Keio Univ. Grad. Sch. of Sci. and
Technol., Keio Univ., Keio Univ. school of Med., Keio Univ.
3:00 VV6 436.23 The mirror neuron system discriminates
action exemplar: A human fMRI study. S. FERRI*; A.
PLATONOV; G. A. ORBAN. Univ. of Parma.

POSTER
437. Cortical Planning and Execution: MRI
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 VV7 437.01 Neural correlates of performance time on
a tool-use task in chimpanzees. L. D. REYES*; S. BIANCHI;
W. D. HOPKINS; C. C. SHERWOOD. George Washington
Univ., Icahn Sch. of Med. at Mount Sinai, Georgia State
Univ., Yerkes Natl. Primate Res. Ctr., George Washington
Univ.

2:00 VV16 437.10 A general framework for quantitatively

assessing neurocomputational models with functional
neuroimaging data. A. DALIRI*; J. A. TOURVILLE; A. NIETOCASTANON; F. H. GUENTHER. Boston Univ., Boston Univ.
3:00 VV17 437.11 Functional neuroimaging of position
matching at the elbow. J. M. KENZIE*; S. E. FINDLATER; D.
J. PITTMAN; B. G. GOODYEAR; S. P. DUKELOW. The Univ.
of Calgary, The Univ. of Calgary.
4:00 VV18 437.12 Temporal evolution of visual and
motor direction selectivity in human cortex during target
representation, motor planning, and reach execution. D.
C. CAPPADOCIA*; S. MONACO; Y. CHEN; G. BLOHM; J.
CRAWFORD. York Univ., Univ. of Trento, Queens Univ.
1:00 VV19 437.13 Mirror symmetric movement encoding
in the human motor system. S. HAAR*; O. DONCHIN; I.
DINSTEIN. Ben Gurion Univ., Ben Gurion Univ., Ben Gurion
Univ.
2:00 VV20 437.14 The correlations of brain activations
during self- and stimuli-triggered movements with
personality traits. K. OMATA*; S. ITO; H. OKADA; Y. OUCHI.
Hamamatsu Univ. Sch. of Med., Hamamatsu Medicai
Imaging Center, Hamamatsu Med. Photonics Fndn.
3:00 VV21 437.15 Cortical activation associated with
automatic control of pelvic floor muscles in women. M.
S. YANI*; J. GORDON; S. P. ECKEL; D. J. KIRAGES; S.
ASAVASOPON; J. J. KUTCH. USC, USC, Loma Linda Univ.

3:00 VV9 437.03 Functional motor cortical connectivity

in twins and non-related individuals. J. E. JOSEPH*; P.
CHRISTOVA; A. GEORGOPOULOS. Univ. of Minnesota.

4:00 VV22 437.16 Neural correlates of multisensory action

predictions investigated with a custom-made passive
movement device. B. VAN KEMENADE*; E. ARIKAN;
K. PODRANSKI; O. STEINSTRTER; B. STRAUBE; T.
KIRCHER. Philipps-University Marburg.

4:00 VV10 437.04 Motor network dynamics when

coordinating bimanual actions. S. VISWANATHAN*; R.
ABDOLLAHI; B. A. WANG; S. DAUN; G. R. FINK; C.
GREFKES. Univ. Hosp. of Cologne, Res. Ctr. Juelich, Univ.
of Cologne.
1:00 VV11 437.05 Increased locomotor demand is
associated with decreased cortical power. J. R. LUKOS*;
J. C. BRADFORD; D. P. FERRIS. Space and Naval Warfare
Systems Center, Pacific, U.S. Army Res. Lab., Univ. of
Michigan.
2:00 VV12 437.06 Degree of right-handedness mediates
inter-hemispheric connectivity of the human motor cortex
during inter-hemispheric transfer: fMRI evidence. P. PATEL*;
M. BELLANI; K. RAMASESHAN; G. RAMBALDELLI; C.
MARZI; P. BRAMBILLA; V. DIWADKAR. Wayne State Univ.,
Azienda Ospedaliera Universitaria Integrata Verona, Wayne
State Univ. Sch. of Med., Univ. degli Studi di Verona, Univ. of
Verona, Univ. of Milan, Wayne State Univ. Sch. of Med.

3:00 VV13 437.07 Distribution of interhemispheric structural

connections between motor regions on the corpus callosum
in older adults. J. C. STEWART*; J. BAIRD; G. PATHAK; S.
C. CRAMER. Univ. of South Carolina, Univ. of California,
Irvine.
4:00 VV14 437.08 Cortical and network reorganization after
bilateral forearm transplantation: A longitudinal case study.
C. R. HERNANDEZ-CASTILLO*; J. DIEDRICHSEN; E.
AGUILAR-CASTANEDA; M. IGLESIAS. Consejo Nacional
De Ciencia Y Tecnologa- Ctedra, Western Univ., Inst.
Nacional de Neurologia y Neurocirugia, Inst. Nacional de
Ciencias Medicas y Nutricion.
1:00 VV15 437.09 Intrinsic functional organization
of the human motor cortex. P. S. CHRISTOVA*; A. P.
GEORGOPOULOS. Univ. Minnesota.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 DP05 437.17 (Dynamic Poster) Neural and behavioral

evaluation of face and hand video stimuli. E. KILROY*; L.
HARRISON; S. GIMBEL; S. CERMAK; L. AZIZ-ZADEH.
USC.
2:00 VV23 437.18 Continuous decoding of movement
from fMRI in a goal-directed manual tracking task. D. A.
BARANY*; S. VISWANATHAN; S. T. GRAFTON. UC Santa
Barbara, Univ. Hosp. of Cologne.
3:00 VV24 437.19 Functional MRI activity patterns in the
action observation network for chronic stroke patients. P.
HEYDARI*; S. LIEW; H. DAMASIO; C. WINSTEIN; L. AZIZZADEH. USC, USC.

POSTER
438. Neuroprosthetics: Electrodes and Tissue
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 VV25 438.01 Neural dust: A wireless, mm-scale device
platform for interfacing with the nervous system in vivo. R.
NEELY*; D. SEO; K. SHEN; U. SINGHAL; E. ALON; J. M.
RABAEY; J. M. CARMENA; M. M. MAHARBIZ. UC Berkeley,
UC Berkeley, UCB/UCSF Joint program.

2:00 VV26 438.02 Reducing power consumption of dbs

device using platinum-iridium coating. A. PETROSSIANS*.
USC.
3:00 WW1 438.03 Soft, mechanically brain-like composite
materials improve the long-term, electrical characteristics of
the neural interface. A. SRIDHARAN*; V. VOZIYANOV; J.
MUTHUSWAMY. Arizona State Univ.

Neuroscience 2016|Monday PM|125

Mon. PM

2:00 VV8 437.02 Task-dependent changes in -band

power during preparation for sensory-motor action. Y.
MATSUMOTO*; A. FUJIKAWA; T. URAKAWA; O. ARAKI.
Tokyo Univ. of Sci.

4:00 WW2 438.04 The influence of different impedance

values in neuronal recording: A correlational study in
marmoset. B. B. GARCIA*; J. H. SATO; M. F. P. ARAJO;
H. S. G. PEREIRA. Santos Dumont Inst., State Univ. of Rio
Grande do Norte, Anita Garibaldi Ctr. for Hlth. Educ. and
Res.

3:00 WW13 438.15 Multicolor genetically-encoded calciumsensitive bioluminescent reporters of neural activity for brainmachine interfaces. M. A. PENDER*; K. LIN; A. BARES; E.
DING; M. G. KAPLITT; C. B. SCHAFFER; N. NISHIMURA.
Cornell Univ., Brain and Spine Center, Weill Cornell Med.
Col.

1:00 WW3 438.05 Functional evaluation of a superoxide

dismutase mimic coating for chronically implanted neural
electrodes. X. S. ZHENG*; X. T. CUI. Univ. of Pittsburgh.

4:00 WW14 438.16 Plasticity in the excitability of neurons

surrounding implanted neuroprostheses. J. W. SALATINO*;
D. R. MONCREASE; E. K. PURCELL. Michigan State Univ.,
Michigan State Univ., Michigan State Univ., Michigan State
Univ.

2:00 WW4 438.06 Neural and vascular morphological

changes after chronic electrode implantation. Y. GAO*; M.
YE; D. KIM; A. LOZZI; A. BORETSKY; C. G. WELLE; D. X.
HAMMER. US Food and Drug Admin., Univ. of Colorado
Denver.
3:00 WW5 438.07 Evaluation of neural cell adhesion
molecule L1 coating for improved chronic recordings.
P. CODY*; N. SNYDER; J. DU; R. TIEN; J. WILLIAMS;
S. SUWAY; J. ORELLANA; Y. INOUE; T. KOZAI; C.
LEGENAUR; A. SCHWARTZ; X. CUI. Univ. of Pittsburgh,
Interphase Materials, Shenzhen Inst. of Advanced
Technology, Chinese Acad. of Sci., Univ. of Pittsburgh, Univ.
of Pittsburgh, Carnegie Mellon Univ., Univ. of Pittsburgh,
Univ. of Pittsburgh.
4:00 WW6 438.08 Dexamethasone retrodialysis attenuates
microglial response to implanted probes in vivo. T. D.
KOZAI*; A. S. JAQUINS-GERSTL; A. L. VAZQUEZ; A. C.
MICHAEL; X. CUI. Univ. of Pittsburgh, Univ. of Pittsburgh,
Univ. of Pittsburgh, Univ. of Pittsburgh Brain Inst., Univ. of
Pittsburgh, Univ. of Pittsburgh.
1:00 WW7 438.09 Elucidating the role of macrophage
lineage in the FBR to chronically implanted microelectrode
arrays. B. VELAGAPUDI*; M. B. CHRISTENSEN; P. A.
TRESCO. The Univ. of Utah.
2:00 WW8 438.10 Extracellular matrix coatings minimize the
FBR to high density microelectrode arrays. M. POLEI*; P. A.
TRESCO. Univ. of Utah.
3:00 WW9 438.11 Experimental study of invasive braincomputer interface for rodents using carbon nano-tube
coated micro-electrodes. S. JAFARIZADEH*; V. AZIMIRAD;
P. SHAHABI; J. MAHMOUDI; T. DEHGHAN HELAN. Qazvin
Branch, Islamic Azad University, Qazvin, Ir, Univ. of Tabriz,
Tabriz Univ. of Med. Sci., Univ. of Tabriz.
4:00 WW10 438.12 How to get PEDOT on your neural
electrodes: Reliable, functionalized and homogenously
coated. L. ASPLUND*; C. BOEHLER; F. OBERUEBER; S.
HEIZMANN; C. KLEBER; R. HASSARATI; A. SCHOPF. Univ.
of Freiburg.

1:00 WW11 438.13 Signal quality changes and histological

tissue reactions during long-term micro-electrocorticographic
recordings. C. A. GKOGKIDIS*; X. WANG; M.
GIERTHMUEHLEN; S. DOOSTKAM; M. SCHUETTLER; J.
RICKERT; J. HABERSTROH; T. STIEGLITZ; W. BURGARD;
T. BALL. Med. Center, Univ. of Freiburg, Fac. of Engineering,
Univ. Freiburg, Med. Center, Univ. of Freiburg, Cortec GmbH,
Med. Center, Univ. of Freiburg, Fac. of Engineering, Univ.
Freiburg.

1:00 WW15 438.17 Chronic recording and stimulation of

rodent peripheral nerves using implanted microelectrode
arrays. S. VASUDEVAN*; K. PATEL; R. SHARMA; R.
CALDWELL; L. RIETH; C. WELLE. U.S. Food and Drug
Admin., Univ. of Maryland, Univ. of Utah, Univ. of Utah, Univ.
of Colorado.

POSTER
439. Neuroprosthetics: Human Microelectrode-Based Control
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 WW16 439.01 Native upper limb movement encoding by
intracortical recordings in human sensorimotor cortex. D. A.
ROYSTON*; S. T. FOLDES; J. E. DOWNEY; J. WEISS; S. N.
FLESHER; E. TYLER-KABARA; M. BONINGER; R. GAUNT;
J. L. COLLINGER. Univ. of Pittsburgh, Univ. of Pittsburgh,
Barrow Neurolog. Inst. at Phoenix Childrens Hosp., Univ.
of Pittsburgh, VA Pittsburgh Healthcare Syst., Univ. of
Pittsburgh, Univ. of Pittsburgh.
2:00 WW17 439.02 Encoding of intended grasp force in
primary motor cortex during brain-computer interface
controlled robotic arm use. J. E. DOWNEY*; J. WEISS; A.
B. SCHWARTZ; R. GAUNT; J. L. COLLINGER. Univ. of
Pittsburgh, Univ. of Pittsburgh, Univ. of Pittsburgh.
3:00 WW18 439.03 Bimanual representations in
electrophysiology recordings from human posterior parietal
cortex. S. KELLIS*; Y. NI; C. KLAES; T. AFLALO; B. LEE;
K. PEJSA; K. SHANFIELD; S. HAYES-JACKSON; B.
PHILLIPS; M. AISEN; C. HECK; C. LIU; R. ANDERSEN.
Caltech, Caltech, Keck Hosp. of USC, Rancho Los Amigos
Natl. Rehabil. Ctr.

4:00 WW19 439.04 Detection of phonemes, short words

and phrases from single units and 12-20 Hz frequency
band data during overt and covert speech recorded
chronically from a speaking human. P. R. KENNEDY*; C. R.
GAMBRELL, 30096; N. SHIH. Neural Signals Inc, Neural
Signals Inc.
1:00 WW20 439.05 Towards a multi-state click decoder in
intracortical brain computer interfaces. J. G. CIANCIBELLO*;
M. VILELA; T. HOSMAN; J. SAAB; D. LESENFANTS; D.
M. BRANDMAN; B. FRANCO; L. R. HOCHBERG; J. D.
SIMERAL. Brown Univ., Brown Univ., VA Med. Ctr., Brown
Univ., Massachusetts Gen. Hosp., Harvard Med. Sch.

2:00 WW12 438.14 In vivo 2-photon imaging of neural

implants: Surface modification with L1CAM camouflages
devices from microglial encapsulation. J. R. ELES*; T. D. Y.
KOZAI; N. R. SNYDER; C. F. LAGENAUR; A. VAZQUEZ; X.
T. CUI. Univ. of Pittsburgh.

126 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 WW21 439.06 Reducing electrical artifacts in

microelectrode brain recordings during functional electrical
stimulation. D. YOUNG*; W. D. MEMBERG; B. MURPHY;
B. WALTER; J. SWEET; J. MILLER; L. R. HOCHBERG; R.
F. KIRSCH; A. B. AJIBOYE. Case Western Reserve Univ.,
FES Ctr. of Excellence, Rehab. R&D Service, Louis Stokes
Cleveland Dept. of VA Med. Ctr., Neurol., UH Case Med.
Ctr., Neurol., CWRU Sch. of Med., Neurosurg., UH Case
Med. Ctr., Neurolog. Surgery, CWRU Sch. of Med., Sch. of
Engin., Brown Univ., Neurol., Massachusetts Gen. Hosp.,
Neurol., Harvard Med. Sch., Inst. For Brain Sci., Brown Univ.

1:00 XX6 439.13 Evaluating force representation in motor

cortex of intracortical BCI users with chronic tetraplegia.
A. RASTOGI*; B. A. MURPHY, 44106; F. R. WILLETT; W.
D. MEMBERG; B. L. WALTER, 44106; J. P. MILLER; J. A.
SWEET; C. E. VARGAS-IRWIN; L. R. HOCHBERG; R. F.
KIRSCH; A. B. AJIBOYE. Case Western Reserve Univ., Univ.
Hosp. Case Med. Ctr., Case Western Reserve Univ. Sch. of
Med., Univ. Hosp. Case Med. Ctr., Case Western Reserve
Univ. Sch. of Med., Brown Univ., Brown Univ., Brown Univ.,
Massachusetts Gen. Hosp., Harvard Med. Sch., Louis
Stokes Cleveland Dept. of VA Med. Ctr.

3:00 WW22 439.07 Idle state detection from motor cortical

activity in a person with tetraplegia using an intracortical
brain-computer interface. D. LESENFANTS*; J. SAAB; T.
HOSMAN; M. VILELA; B. JAROSIEWICZ; B. FRANCO;
S. S. CASH; E. N. ESKANDAR; J. D. SIMERAL; J. P.
DONOGHUE; L. R. HOCHBERG. Brown Univ., Dept.
of VA Med. Ctr., Brown Univ., Brown Univ., Brown
Univ., Massachusetts Gen. Hosp., Harvard Med. Sch.,
Massachusetts Gen. Hosp., Wyss Ctr.

2:00 XX7 439.14 Decoding articulation by neuronal spike

frequency and power spectrum recorded from human face
motor cortex. K. IBAYASHI*; T. MATSUO; N. KUNII; Y.
ISHISHITA; S. SHIMADA; K. KAWAI; N. SAITO. Univ. of
Tokyo, Grad. Sch. of Med., NTT Med. Ctr. Tokyo, Univ. of
Tokyo, Jichi Med. Univ.

1:00 XX2 439.09 Using direction-independent, movement

magnitude information from motor cortex to enhance
intracortical brain-computer interface performance. F.
WILLETT*; B. MURPHY; W. D. MEMBERG; C. H. BLABE;
J. SAAB; B. JAROSIEWICZ; C. PANDARINATH; B.
WALTER; J. SWEET; J. MILLER; J. M. HENDERSON;
K. V. SHENOY; J. D. SIMERAL; L. R. HOCHBERG; R. F.
KIRSCH; A. B. AJIBOYE. Case Western Reserve Univ.,
Louis Stokes Cleveland Dept. of VA Med. Ctr., Stanford
Univ., Brown Univ., Dept. of VA Med. Ctr., Brown Univ.,
Brown Univ., Stanford Univ., UH Case Med. Ctr., CWRU
Sch. of Med., UH Case Med. Ctr., CWRU Sch. of Med.,
Stanford Univ., Stanford Univ., Stanford Univ., Stanford Univ.,
Massachusetts Gen. Hosp., Harvard Med. Sch.
2:00 XX3 439.10 Closed loop intracortical brain computer
interface cursor control in people using a continuously
updating Gaussian process decoder. D. BRANDMAN*;
M. C. BURKHART; T. HOSMAN; J. SAAB; A. A. SARMA;
D. J. MILSTEIN; C. VARGAS-IRWIN; B. FRANCO; J. P.
DONOGHUE; M. T. HARRISON; L. R. HOCHBERG. Brown
Univ., Brown Univ., Brown Univ., Brown Univ., Dept. of VA
Med. Ctr., Brown Univ., Brown Univ., Massachusetts Gen.
Hosp.
3:00 XX4 439.11 Overcoming contextual differences in
motor cortical neural firing patterns when controlling multiple
end effector devices using an intracortical brain-computer
interface (iBCI). V. CHAVAKULA*; S. E. FASOLI; D. M.
BRANDMAN; J. SAAB; T. HOSMAN; B. FRANCO; J. D.
SIMERAL; J. P. DONOGHUE; L. R. HOCHBERG. Brown
Univ., Brigham and Womens Hosp., Harvard Med. Sch.,
Dept. of VA Med. Ctr., Brown Univ., Brown Univ., MGH
Inst. of Hlth. Professionals, Brown Univ., Brown Univ.,
Massachusetts Gen. Hosp., Wyss Ctr., Brown Univ., Harvard
Med. Sch.
4:00 XX5 439.12 Retrospectively supervised pointand-click decoder calibration during practical use of an
intracortical brain-computer interface. B. JAROSIEWICZ*;
A. A. SARMA; J. SAAB; B. FRANCO; L. R. HOCHBERG.
Brown Univ., Dept. of VA Med. Ctr., Brown Univ., Brown
Univ., Massachusetts Gen. Hosp., Harvard Med. Sch.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 XX9 439.16 Closed-loop control of a sensorized

virtual prosthetic hand by a human subject after amputation.
D. T. KLUGER*; D. M. PAGE; S. M. WENDELKEN; T. S.
DAVIS; D. T. HUTCHINSON; C. DUNCAN; D. J. WARREN;
G. A. CLARK. Univ. of Utah.
1:00 XX10 439.17 Decoding hand level prosthetic control
signals from regenerative peripheral nerve interfaces in
human subjects. P. VU*; Z. T. IRWIN; I. C. SANDO; P. T.
HENNING; M. G. URBANCHEK; P. S. CEDERNA; C. A.
CHESTEK. Univ. of Michigan, Univ. of Michigan, Univ. of
Michigan.

POSTER
440. Posture: Muscle Activity, Exercise, and Biomechanics
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 XX11 440.01 Intersegmental coordination of bipedally

standing rat. Y. SATO*; T. FUNATO; D. YANAGIHARA;
Y. SATO; S. FUJIKI; S. AOI; K. TSUCHIYA. The Univ. of
Electro-Communications, The Univ. of Tokyo, Teikyo Heisei
Univ., Kyoto Univ.
2:00 XX12 440.02 Effects of visual feedback training using
center of gravity along with center of pressure for static
postural balance. H. MANI*; K. TAKEDA; N. HASEGAWA;
Y. SATO; S. TANAKA; Y. SUDA; H. MAEJIMA; T. ASAKA.
Hokkaido Univ., Hokkaido Univ.
3:00 XX13 440.03 Task performance during a modified
Srensen test in subjects with and without chronic low back
pain. J. S. THOMAS*; R. D. KAYA; R. L. PUTHOFF; M. E.
APPLEGATE; S. T. LEITKAM; D. W. RUSS. Ohio Univ.
4:00 XX14 440.04 A new biomechanical interpretation of
the ankle and hip strategies in balance control during human
standing. S. SASAGAWA*; A. IMURA; K. NAKAZAWA.
Dept. of Human Sciences, Kanagawa Univ., Dept. of Human
Sciences, Kanagawa Univ., Dept. of Life Sciences, Grad.
Sch. of Arts and Sciences, The Univ. of Tokyo.

Neuroscience 2016|Monday PM|127

Mon. PM

4:00 XX1 439.08 Adaptive threshold for point-and-click

applications using intracortical brain computer interface.
M. VILELA*; J. CIANCIBELLO; T. HOSMAN; J. SAAB;
D. LESENFANTS; B. FRANCO; B. JAROSIEWICZ; J.
SIMERAL; L. R. HOCHBERG. Brown Univ., Dept of VA Med.
Ctr., Brown Univ., Massachusetts Gen. Hosp., Brown Univ.,
Harvard Med. Sch.

3:00 XX8 439.15 Learning mechanisms in the

posterior parietal cortex: A brain-machine interface
study with a tetraplegic human. S. SAKELLARIDI*; V.
N. CHRISTOPOULOS; T. AFLALO; K. W. PEJSA; E.
R. ROSARIO; D. OUELLETTE; N. POURATIAN; R. A.
ANDERSEN. Caltech, Caltech, Casa Colina Hosp. Ctr., Univ.
of California Los Angeles.

1:00 XX15 440.05 Use of the Cleveland Clinic-Postural

Stability Index to characterize postural instability in
Parkinsons disease. S. J. OZINGA*; M. M. KOOP; S. M.
LINDER; T. DEY; J. L. ALBERTS. Cleveland Clin.
2:00 XX16 440.06 Development of a directional intervention
protocol based-evidence for individuals with chronic low back
pain. A. F. CARVALHO*; A. H. NOWOTNY; M. R. OLIVEIRA;
L. A. STURION; N. A. SHIRABE; C. E. CARVALHO; F. K. S.
BERALDO; F. K. S. BERALDO; L. C. L. CARVALHO; A. W.
GIL; R. A. DA SILVA JR. Univ. Norte Do Paran- UNOPAR,
Univ. Norte Do Paran- UNOPAR.
3:00 XX17 440.07 Neuromuscular pattern of trunk
during one-leg balance stance in individuals with and
without chronic low back pain. R. A. DA SILVA JR*; A. F.
CARVALHO; A. H. NOWOTNY; M. R. OLIVEIRA; L. A.
STURION; N. SHIRABE; P. E. DE SOUZA; R. S. DA SILVA;
K. P. FERNANDES; E. R. VIEIRA. Univ. Norte Do Paran
(UNOPAR), Univ. Norte do Paran (UNOPAR), Florida Intl.
Univ. (FIU).
4:00 XX18 440.08 A novel characterization of human
balance control during standing with visual sensory
deprivation. W. BOEHM*; K. NICHOLS; K. GRUBEN. Univ.
of Wisconsin Madison.
1:00 XX19 440.09 12 weeks of balance and mobility training
with or without simultaneous cognitive training improves
reaction time but does not improve posture in healthy
older adults. D. A. JEHU*; N. PAQUET; Y. LAJOIE. Univ. of
Ottawa, Univ. of Ottawa.
2:00 XX20 440.10 Different leaning effects of dynamic
postural control by visual or auditory feedback training.
N. HASEGAWA*; M. SAKUMA; S. TANAKA; Y. SATO; K.
TAKEDA; H. MANI; H. MAEJIMA; T. ASAKA. Hokkaido Univ.,
Sapporo Yamanoue Hosp., Natl. Hosp. Organization East
Saitama Natl. Hosp., Hokkaido Univ.
3:00 XX21 440.11 The effect of mental fatigue on postural
stability. A. MORRIS*; A. CHRISTIE. Univ. of Oregon.
4:00 XX22 440.12 Standing postural control while stepping
over randomly moving virtual obstacles. H. IDA*; S.
MOHAPATRA; A. S. ARUIN. Jobu Univ., Univ. of Montana,
Univ. of Illinois at Chicago.
1:00 YY1 440.13 Intermittent muscle activities occur
according to joint state during human quiet standing. H.
TANABE*; K. FUJII; M. KOUZAKI. The Univ. of Tokyo,
Nagoya Univ., Japan Society for the Promotion of Sci., Kyoto
Univ.
2:00 YY2 440.14 Learning postural control with continuous
visual feedback in healthy young adults and chronic stroke
survivors. L. PELLEGRINO*; P. GIANNONI; L. MARINELLI;
M. CASADIO. Univ. of Genoa, Univ. of Genoa, Univ. of
Genoa.
3:00 YY3 440.15 Increased postural threat influences
the conscious perception of voluntary leaning. T. W.
CLEWORTH*; T. INGLIS; M. G. CARPENTER. Univ. of
British Columbia, Intl. Collaboration On Repair Discoveries,
Djavad Mowafaghian Ctr. for Brain Hlth.

4:00 YY4 440.16 Postural control as a function of sloped

support surfaces. A. DUTT-MAZUMDER*. Med. Univ. of
South Carolina.

2:00 YY6 440.18 Smartphone-based assessment of

changes in postural stability in neurological patients after
a therapeutic exercise intervention. B. L. TRACY*; A. A.
SCHMID; D. M. MILLER; K. E. TIMROTH; B. E. HOLLAND;
L. R. JANKOWSKI; M. F. FRITZ. Colorado State Univ.,
Colorado State Univ., Colorado State Univ.

POSTER
441. Motor Neuron-Muscle Interface
Theme E: Motor Systems
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 YY7 441.01 Neuronal-specific cargo-delivery platform
for post-botulism therapies. V. PATEL*; M. PIRES-ALVES; A.
M. PATEL; M. HO; J. J. MCARDLE; B. A. WILSON. Rutgers
Univ., Univ. of Illinois.

2:00 YY8 441.02 Botulinum neurotoxin type A-cleaved

SNAP25 is confined to primary motor neurons and
expressed on the plasma membrane following intramuscular
toxin injection. R. S. BROIDE*; J. FRANCIS; B. B. CAI.
Allergan PLC.
3:00 YY9 441.03 Pharmacological modulators of
presynaptic calcium concentration reverse botulinum
neurotoxin-induced silencing of synapses in vitro and delay
paralysis in ex vivo muscle preparations. A. B. BRADFORD*;
P. H. BESKE; J. B. MACHAMER; T. M. RUSSO; P. M.
MCNUTT. US Army Med. Res. Inst. of Chem. Def.
4:00 YY10 441.04 3,4-DAP reverses botulinum-induced
muscle paralysis by increasing neurotransmitter release
probability at unintoxicated release sites. J. MACHAMER*; A.
BRADFORD; T. RUSSO; P. MCNUTT. US Army Med. Res.
Inst. of Chem. Def.
1:00 YY11 441.05 Conditioning at the neuromuscular
junction: Elucidating the eliciting conditions. M. M. STRAIN*;
J. D. TURTLE; Y. HUANG; J. W. GRAU. Texas A&M Univ.
Dept. of Psychology.
2:00 YY12 441.06 Ighmbp2 deficiency corresponds to
protein translation changes and leads to differentiation
defects in motoneurons. V. SURREY*; M. MORADI;
B. DOMBERT; H. VYAS; C. WINKLER; U. FISCHER;
S. JABLONKA. Univ. Hosp. Wuerzburg, Natl. Univ. of
Singapore, Univ. Wuerzburg.
3:00 YY13 441.07 Effects of tamoxifen on single muscle
fiber function and protein expression after spinal cord injury.
I. K. SALGADO VILLANUEVA; A. E. RODRIGUEZ; A. I.
TORRADO; M. E. SANTIAGO; W. R. FRONTERA; J. D.
MIRANDA*. Univ. Puerto Rico Sch. Med., Vanderbilt Univ.
Sch. of Medicine.
4:00 YY14 441.08 Association of small ankyrin 1 with
sarcolipin. A. LABUZA*; P. F. DESMOND; J. MURIEL; M.
L. MARKWARDT; M. A. RIZZO; R. J. BLOCH. Univ. of
Maryland Baltimore.
1:00 ZZ1 441.09 Oxidative stress and reduced gsh:gssg
ratio in ryr1-related myopathies. M. S. RAZAQYAR*; J.
WITHERSPOON; J. ELLIOTT; I. ARVESON; K. MEILLEUR.
NINR.

1:00 YY5 440.17 Influence of task-related and personrelated variables on the impaired anticipatory postural
adjustments of people with low back pain: Insight into
heterogeneous results across studies. J. V. JACOBS*; J.
R. HITT; S. M. HENRY. Liberty Mutual Res. Inst. for Safety,
Univ. of Vermont, Univ. of Vermont Med. Ctr.

2:00 ZZ2 441.10 Functional analysis of Nav1.4 mutation in

a case presenting with Schwartz-Jampel features, myotonic
discharges, and herculean development. X. XIONG; D. H.
FELDMAN; T. L. KLASSEN; C. G. SANCHEZ ACOSTA;
L. PLAZA-BENHUMEA; R. MASELLI; C. LOSSIN*. UC
Davis, Sch. of Med., Univ. of British Columbia, Neurologa
Pediatrica, Hosp. Gen. de Mexico, UC Davis- Sch. of Med.

128 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 ZZ3 441.11 Chronic inflammatory demyelinating

polyneuropathy weakness is associated with reduced muscle
mass and motor unit loss. K. GILMORE*; K. KIMPINSKI;
T. DOHERTY; C. RICE. The Univ. of Western Ontario, The
Univ. of Western Ontario, The Univ. of Western Ontario, The
Univ. of Western Ontario, London.
4:00 ZZ4 441.12 Biophysical and structural properties
that contribute to the special biomechanics of the octopus
arm. L. ZULLO*; F. MAIOLE; S. M. FOSSATI; N. NESHER;
B. HOCHNER. Inst. Italiano Di Tecnologia, NSYN, Univ. of
Genova and Inst. Italiano di Tecnologia, NSYN, Inst. Italiano
di Tecnologia, The Ruppin Academic Ctr., The Hebrew Univ.
1:00 ZZ5 441.13 Light-activation of channelrhodopsin-2
expressed in chick embryo hindlimb muscle mimics neural
activation of muscle. J. R. WHITAKER*; S. FROMHERZ;
P. R. PATRYLO; A. A. SHARP. Southern Illinois Univ.
Carbondale, Saginaw Valley State Univ., Southern Illinois
Univ. Sch. of Med.
2:00 ZZ6 441.14 Development of a separation method of
neural component from spastic resistance. K. TAKEDA*; S.
MIZUNO; H. MAEDA; K. OHNO; A. ORAND; G. TANINO; H.
MIYASAKA; S. SONODA. Nanakuri Inst, Fujita Hlth. Univ.,
Dept. of Rehabil. Med. II, Sch. of Medicine, Fujita Hlth. Univ.

4:00 ZZ8 441.16 A three-dimensionally engineered

spinal cord-skeletal muscle bioactuator. C. S. LIU*; C.
CVETKOVIC; G. NASERI KOUZEHGARANI; R. BASHIR;
M. U. GILLETTE. Univ. of Illinois, Univ. of Illinois, Univ. of
Illinois.
1:00 ZZ9 441.17 The effect of an 8 week CrossFit type
exercise program on inflammatory injury and balance. G. S.
BAINS*; E. LOHMAN; L. BERK; N. DAHER; R. CHETTIAR;
O. AMBODE; B. MIRANDA; R. SINGH; F. NUGENT. Loma
Linda Univ., Southern Utah Univ.

2:00 ZZ10 441.18 Intermittent leg cycling sprints induce

fatigue-related suppression of human soleus Hoffmann
reflexes. G. E. PEARCEY*; S. NOBLE; B. MUNRO; J. L.
BISHOP; E. ZEHR. Univ. of Victoria, Univ. of Victoria, Nike
Sport Res. Lab.
3:00 ZZ11 441.19 Bladder and urethral function in
female rabbit: A model of damage. R. LOPEZ JUAREZ*;
R. ZEMPOALTECA; D. CORONA-QUINTANILLA; F.
CASTELN; M. MARTNEZ-GMEZ. Univ. Autonoma De
Tlaxcala, Univ. Autnoma de Tlaxcala, Univ. Autnoma de
Tlaxcala, Univ. Nacional Autnoma Mxico, UNAM.
4:00 ZZ12 441.20 Identifying the function of tyramine in the
mouse uterus. M. AGRE; B. OBAYOMI; L. TOWNLEY; D. P.
BALUCH*. Arizona State Univ.
1:00 ZZ13 441.21 New measurement system of human arm
stiffness for clinical evaluation. T. YUKAKO*; K. IGARASHI;
S. KATSURA; F. NAKAI; C. YAMADA; Y. ITAGUCHI; H.
YOSHIZAWA; K. FUKUZAWA. Keio Univ., Waseda Univ.,
Japan Society for the Promotion of Sci., Tokyo Womens
Med. Univ.

442. Neuroethology of Sensory and Motor Systems:

Vertebrates
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 ZZ14 442.01 Rat whiskers are used in airflow sensing.
Y. S. YU*; M. M. GRAFF; C. S. BRESEE; Y. B. MAN; M. J.
Z. HARTMANN. Northwestern Univ. Dept. of Mechanical
Engin., Northwestern Univ. Interdepartmental Neurosci.
Program, Northwestern Univ. Dept. of Biomed. Engin.
2:00 AAA1 442.02 The three-dimensional morphology of
vibrissal follicles and muscles: Implications for motor control.
C. S. BRESEE*; J. L. ALADEFA; L. A. HUET; H. BELLI; M.
J. Z. HARTMANN. Northwestern Univ., Northwestern Univ.,
Northwestern Univ., Northwestern Univ.
3:00 AAA2 442.03 The effect of social stress on the
dopaminergic pathway of the escape circuit in zebrafish. K.
CLEMENTS*; T. MILLER; E. JI; F. ISSA. East Carolina Univ.,
UCLA.
4:00 AAA3 442.04 Social status-dependent molecular
regulation of dopaminergic pathways in the brain of zebrafish
(danio rerio). T. H. MILLER*; K. CLEMENTS; E. JI; F. ISSA.
East Carolina Univ., Univ. of California, East Carolina Univ.
1:00 AAA4 442.05 Trade-offs between speed and
variability in responses to looming visual stimuli. K. D.
BHATTACHARYYA*; D. L. MCLEAN; M. A. MACIVER.
Northwestern Univ., Northwestern Univ.
2:00 AAA5 442.06 The visual system of the northern
elephant seal. E. C. TURNER*; E. K. SAWYER; J. H. KAAS.
Vanderbilt Univ.
3:00 AAA6 442.07 Predation behavior is based on
background thermoregulation in a pit-viper Gloydius
brevicaudus. Q. CHEN*; Y. TANG. Chengdu Inst. of Biology,
Chinese Acad. of Sci., Chengdu Inst. of Biology, Chinese
Acad. of Sci.
4:00 AAA7 442.08 A three-dimensional stereotaxic mri brain
atlas of house crows (corvus splendens). S. SEN*; S. PAUL;
P. RAGHUNATHAN; S. S. KUMARAN; S. IYENGAR. Natl.
Brain Res. Ctr., All India Inst. of Med. Sci.
1:00 AAA8 442.09 Regressive evolution of the hagfish visual
system: Blind but hopeful monsters. W. T. ALLISON*. Univ.
of Alberta.
2:00 AAA9 442.10 Modulation of locomotor behaviors by a
dopaminergic population in the zebrafish hypothalamus. J.
P. BARRIOS*; A. D. MCPHERSON; S. ANJEWIERDEN; J.
B. NEWTON; S. J. LUKS-MORGAN; R. I. DORSKY; A. D.
DOUGLASS. Univ. of Utah, Univ. of California San Diego,
Univ. of Utah.
3:00 AAA10 442.11 Lesions of the telencephalon and the
application of a dopamine D1 receptor antagonist result
in similar modifications of the acoustic startle response in
goldfish. A. N. OPALKA*; N. FISCHER; R. F. WALDECK.
The Univ. of Scranton, The Univ. of Scranton.
4:00 AAA11 442.12 From drug discovery to neural
mechanisms of nicotine-induced motor behavior in zebrafish.
H. SCHNEIDER*. Depauw Univ.
1:00 AAA12 442.13 Processing of sensory input by pyramidal
neurons in the electrosensory lateral line lobe of the weakly
electric fish Apteronotus albifrons. D. MARTINEZ*; M.
CHACRON. McGill Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|129

Mon. PM

3:00 ZZ7 441.15 Wireless innervation of neurons

using electromagnetic fields in craw. B. KUTER*; E. C.
GUSTAFSON; E. P. WIERTELAK, 55105. Macalester Col.,
Univ. of Minnesota, Macalester Col.

POSTER

2:00 AAA13 442.14 Dance complexity related to the volume

of a sensorimotor region in manakins. W. HELMHOUT*;
G. PANO; W. R. LINDSAY; L. B. DAY. Univ. of Mississippi,
Goteborg Univ.
3:00 AAA14 442.15 Olfactory navigation in realistic odor
landscapes: Modeling and simulation of odor localization
and path-following strategies in mice. J. HENGENIUS*; N.
URBAN; B. ERMENTROUT. Univ. of Pittsburgh, Univ. of
Pittsburgh, Univ. of Pittsburgh.

POSTER
443. Genetic Approaches in Songbirds
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 AAA15 443.01 Bidirectional manipulation of mTOR
signaling reveals complicated contribution to sensory
learning. S. AHMADIANTEHRANI*; S. E. LONDON. Univ. of
Chicago, Univ. of Chicago.
2:00 AAA16 443.02 An efficient and flexible gene
manipulation strategy in zebra finch brain. S. E. LONDON*;
S. AHMADIANTEHRANI. Univ. of Chicago, Univ. of Chicago,
Univ. of Chicago.
3:00 AAA17 443.03 Epigenetics of learning in zebra finch.
D. CONDLIFFE*; J. GEORGE; C. BARTON; A. LEITAO;
M. GAHR; P. HURD; D. CLAYTON. Queen Mary Univ. of
London, Max Planck Inst.
4:00 AAA18 443.04 CREB-mediated interplay of genes and
environment in the postnatal song learning in songbirds. K.
ABE*; D. WATANABE. Kyoto Univ.
1:00 AAA19 443.05 A role for SLIT1 in regulating singing
behavior in adult male zebra finches. M. CHAKRABORTY*;
I. H. LEE; E. KOUNTOURIS; L. CHEN; R. NEVE; J.
CHABOUT; G. L. GEDMAN; H. CHOE; E. D. JARVIS.
Howard Hughes Med. Inst., Duke Univ. Med. Ctr., MIT.
2:00 AAA20 443.06 A comprehensive profiling of differential
gene expression specializations in the song system of a
vocal learning songbird, Taeniopygia guttata. G. GEDMAN*;
A. PFENNING; J. AUDET; J. PALPENT; E. D. JARVIS. Duke
Univ., Carnegie Mellon Univ., McGill Univ., Howard Hughes
Med. Inst.
3:00 AAA21 443.07 Transcriptome profiling of the vocal nuclei
in zebra finches (T. guttata) reveals molecular specializations
of neural circuits for the production of learned song. S.
FRIEDRICH*; P. V. LOVELL; C. V. MELLO. Oregon Hlth. &
Sci. Univ.
4:00 AAA22 443.08 Comparative transcriptomics of vocal
nuclei of Annas hummingbirds and zebra finches reveal
convergent and group-specific molecular features of vocal
learning circuits in hummingbirds and songbirds. P. V.
LOVELL*; M. WIRTHLIN; C. V. MELLO. Oregon Hlth. and
Sci. Univ. Sch. of Med.
1:00 AAA23 443.09 Identification of candidate gene regulatory
sequence elements associated with the emergence of vocal
learning in songbirds. M. WIRTHLIN*; P. V. LOVELL; C. V.
MELLO. Oregon Hlth. & Sci. Univ.
2:00 AAA24 443.10 An update and new applications of the
zebra finch expression brain atlas (www.zebrafinchatlas.org).
C. V. MELLO*; P. V. LOVELL. Oregon Hlth. and Sci. Univ.
Sch. of Med.

130 | Society for Neuroscience

3:00 AAA25 443.11 Egg laying male has androgynous song

system. J. A. HOWELL*; N. WEBB; R. PEREZ; A. HRIBAR;
L. DAY. Univ. of Mississippi.
4:00 AAA26 443.12 Expression of lipoprotein receptorrelated proteins (LRPs) in brain of zebra finches: Possible
links to VSVg-pseudotyped viral infectivity. T. VELHO*; P. V.
LOVELL; M. WIRTHLIN; C. LOIS; C. V. MELLO. CALTECH,
Federal Univ. of Rio Grande do Norte, Oregon Hlth. and Sci.
Univ.
1:00 BBB1 443.13 Robust male-specific expression of the
UTS2B gene emerges early in the development of a zebra
finch forebrain vocal control nucleus. Z. W. BELL*; J. M.
GEORGE; D. F. CLAYTON. Queen Mary, Univ. of London.
2:00 BBB2 443.14 Reelin signaling in the basal ganglia:
Striatal, pallidal, or both? E. FRALEY*; P. E. PHELPS; S. A.
WHITE. UCLA, UCLA.
3:00 BBB3 443.15 FoxP2 overexpression coupled with
auditory deprivation in adult zebra finches disrupts molecular
microcircuitry in a song-dedicated basal ganglia nucleus. N.
F. DAY*; Z. D. BURKETT; A. T. HILLIARD; X. XIAO; S. A.
WHITE. Univ. of California Los Angeles, Stanford Univ.
4:00 BBB4 443.16 FoxP2 isoform-specific overexpression
in juvenile zebra finches alters transcriptional networks
underlying learned vocalization. Z. D. BURKETT*; N. F. DAY;
A. T. HILLIARD; J. B. HESTON; X. XIAO; S. A. WHITE. Univ.
of California Los Angeles, Univ. of California Los Angeles,
Stanford Univ., Univ. of California Los Angeles.
1:00 BBB5 443.17 Attenuated expression of contactin
associated protein-like 2 in a primary motor nucleus of
the song system impairs vocal imitation. S. A. WHITE*; Q.
CHEN; Y. MAI; M. C. CONDRO; S. C. PANAITOF. Univ.
of California Los Angeles, Univ. of California, Univ. of
Nebraska.
2:00 BBB6 443.18 Accumulation of singing experience
regulates the critical period of vocal plasticity during birdsong
active learning. S. HAYASE*; M. KOBAYASHI; E. OHGUSHI;
K. WADA. Hokkaido Univ.

POSTER
444. Social Communication in Non-Avian Models
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 BBB7 444.01 Vocal combinatorial behavior in rats.
T. RIEDE*; C. HERNANDEZ; M. SABIN; H. BORGARD.
Midwestern Univ.
2:00 BBB8 444.02 Male mice emit ultrasonic vocalizations
during agonistic interactions. D. T. SANGIAMO; M. R.
WARREN; X. ZHONG; J. P. NEUNUEBEL*. Univ. of
Delaware.
3:00 BBB9 444.03 Sex differences in the acoustic structure
of mouse ultrasonic vocalizations. M. S. SPURRIER; E.
ROTH*; M. R. WARREN; J. P. NEUNUEBEL. Univ. of
Delaware, Univ. of Delaware.
4:00 BBB10 444.04 Direct quantification of a social
communication deficit in a mouse model of autism. M. R.
WARREN*; J. P. NEUNUEBEL. Univ. of Delaware.
1:00 BBB11 444.05 Dopaminergic mechanisms of vocal
communication in prairie voles. M. L. GUSTISON*; N.
NEVREZ; M. SEHRSWEENEY; M. WYBRECHT; I. K.
WOHL; E. E. WRIGHT; B. J. ARAGONA. Univ. of Michigan,
Univ. of Michigan.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 BBB12 444.06 Temporal dynamics of locus coeruleus

activity during courtship in male mice. D. ECKMEIER; S. D.
SHEA*. Cold Spring Harbor Lab.
3:00 BBB13 444.07 Alterations in USV and cortical structure
in KOR-1 KO mice. B. VILJETIC; M. ANSONOFF; S.
WIJERANTE; M. PINTAR; M. RASIN; J. E. PINTAR*.
Rutgers Robert Wood Johnson Med. Sch., Rutgers Robert
Wood Johnson Med. Sch.
4:00 BBB14 444.08 Movement and electric analysis of freely
swimming pulse type weakly electric fish. R. D. PINTO*; A.
C. FREIRES DE OLIVEIRA; R. T. GUARIENTO; L. O. B.
ALMEIDA; I. H. Z. DE STEFANI; M. R. GONALVES. Inst.
Fisica De Sao Carlos- Univ. Sao Paulo.
1:00 BBB15 444.09 Dynamics of electrical behavior of
Gymnotus carapo electric fish during dominance contest.
R. TUMA GUARIENTO*; T. S. MOSQUEIRO; P. MATIAS; V.
CESARINO; L. O. B. ALMEIDA; R. D. PINTO. Univ. of Sao
Paulo- Sao Carlos Inst. of, Univ. of California, Univ. of Sao
Paulo- Sao Carlos Inst. of Physics.

1:00 DP06 444.11 (Dynamic Poster) Specification of

male versus female acoustic communication behaviors in
Drosophila virilis. C. A. BAKER*; X. GUAN; M. MURTHY.
Princeton Univ.
4:00 BBB17 444.12 A circuit screen for song production
neurons in Drosophila melanogaster. A. HAMMONS*; D.
PACHECO; M. MURTHY. Princeton Univ., Princeton Univ.
1:00 BBB18 444.13 Characterizing neural activity in the song
motor circuit of Drosophila. D. A. PACHECO PINEDO*; M.
MURTHY. Princeton Univ.
2:00 BBB19 444.14 Social consequences of interruptions
during marmoset conversations. C. TOARMINO*; C. T.
MILLER. Univ. of California San Diego, UCSD.
3:00 BBB20 444.15 Primate frontal cortex neurons predict
the outcome of natural conversations. V. JOVANOVIC*;
S. NUMMELA; L. DE LA MOTHE; C. T. MILLER. UCSD,
Tennessee State Univ.
4:00 BBB21 444.16 Asymmetry in vocal communication
in marmosets- influence of social context and gender
differences. J. SHARMA*; R. LANDMAN; J. HYMAN; L.
BRATTAIN; K. JOHNSON; T. QUATIERI; K. SRINIVASAN; A.
WISLER; G. FENG; M. SUR; R. DESIMONE. MIT and MGH,
Broad Inst. and McGovern Inst., McGovern Inst. of Brain
Res., MIT, McGovern Inst. of Brain Res. and Broad Inst.,
Picower Inst. for Learning and Memory and Simons Ctr. for
Social Brain.
1:00 BBB22 444.17 A framework for studying the neuronal
basis of interactive social behavior. K. HAROUSH*; Z.
WILLIAMS. Harvard Med. Sch., Harvard Med. Sch.
2:00 BBB23 444.18 Understanding language genetics:
Establishing bats as a mammalian model of vocal learning.
P. RODENAS-CUADRADO; J. MENGEDE; M. YARTSEV;
U. FIRZLAFF; S. VERNES*. Max Planck Inst. For
Psycholinguistics, Helen Wills Neurosci. Inst., Lehrstuhl fr
Zoologie, Donders Ctr. for Cognitive Neuroimaging.
3:00 BBB24 444.19 Changes in EEG approximate entropy
reflect auditory processing and functional complexity in frogs.
G. FANG*; Y. LIU; Y. TANG. Chengdu Inst. of Biology, CAS.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
445. Neuroimmunology: Regulating Systems
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 BBB26 445.01 Innate lymphoid cells: Novel mediators of
gut-brain immune regulation? N. C. DERECKI*; G. ALEMANMUENCH; P. SOROOSH; H. BANIE; J. KARRAS; L.
CHANG; M. HESSE; T. LOVENBERG; A. BHATTACHARYA.
Janssen Res. and Develop., Janssen Res. and Develop.
2:00 CCC1 445.02 Cholinergic signalling in forebrain
regulates peripheral inflammation. V. A. PAVLOV*; K. R.
LEHNER; H. A. SILVERMAN; M. ADDORISIO; T. TSAAVA;
M. OCHANI; W. HANES; P. S. OLOFSSON; S. S. CHAVAN;
N. M. NATHANSON; Y. AL-ABED; V. F. PRADO; M. A.
M. PRADO; K. J. TRACEY. The Feinstein Inst. For Med.
Res., Hofstra Northwell Sch. of Med. at Hofstra Univ., The
Feinstein Inst. for Med. Res., Univ. of Washington, The
Feinstein Inst. for Med. Res., Robarts Res. Institute, The
Univ. of Western Ontario.
3:00 CCC2 445.03 Antibody efflux from cerebrospinal fluid to
systemic circulation. J. NESTOR*; C. KOWAL; B. VOLPE; B.
DIAMOND. Feinstein Inst. For Med. Res.
4:00 CCC3 445.04 The involvement of the brains choroid
plexus in stress response. A. KERTSER*; K. BARUCH; M.
SCHWARTZ. Weizmann Inst. of Sci.
1:00 CCC4 445.05 Investigating neuroimmune function
throughout pregnancy and the postpartum period. M. L.
SHERER*; C. K. POSILLICO; J. M. SCHWARZ. Univ. of
Delaware, Univ. of Delaware.
2:00 CCC5 445.06 Three-dimensional mapping of neuralimmune interactions in the spleen of nave mice. E.
HAMMOND; I. BRUST-MASCHER; E. N. MILLER; C.
REARDON*. UC Davis.
3:00 CCC6 445.07 Increased oxytocin immunoreactivity
in male and female germ-free Swiss-Webster mice. N. V.
PETERS*; M. J. PAUL; B. CHASSAING; J. DUNN; A. T.
GEWIRTZ; G. J. DE VRIES. Georgia State Univ., Univ. at
Buffalo, Georgia State Univ.
4:00 CCC7 445.08 Interleukin 18 reduces food intake
modulating excitatory synaptic transmission in bed nucleus
of the stria terminalis. F. BERTON*; W. FRANCESCONI; M.
SANCHEZ-ALVAREZ; S. ALBONI; C. BENATTI; S. MORI; W.
NGUYEN; E. ZORRILLA; G. MORONCINI; F. TASCEDDA;
B. CONTI. The Scripps Res. Inst., The Scripps Res. Inst.,
Univ. of Modena and Reggio Emilia, The Scripps Res. Inst.,
Universita Politecnica delle Marche.
1:00 CCC8 445.09 Vagus nerve stimulation decreases
activation of select CD4+ T cell populations and NK cells in
mice. J. ESTELIUS*; K. CHEMIN; E. LE MATRE; J. LAMPA.
Karolinska Institutet, Karolinska Univ. Hosp.
2:00 CCC9 445.10 Delayed contribution of hematopoieticallyderived central nervous system macrophages in mixed
chimeric mice utilizing the myeloablative compound
Busulfan. M. I. ROCHA; K. B. PRUNER; J. M. KURTZ; T. D.
WILLIAMS*. Emmanuel Col.

Neuroscience 2016|Monday PM|131

Mon. PM

2:00 BBB16 444.10 Non-invasive inference of neuronal

refractory time in pulse type weakly electric fish
communication. A. S. RIOS*; R. T. GUARIENTO; L. O. B.
ALMEIDA; I. H. Z. DE STEFANI; R. D. PINTO. Univ. of Sao
Paulo.

4:00 BBB25 444.20 Call initiation in African clawed frogs. A.

YAMAGUCHI*. Univ. of Utah.

3:00 CCC10 445.11 Molecular mechanisms of csf

hypersecretion in intraventricular hemorrhage-associated
hydrocephalus. J. K. KARIMY*; D. B. KURLAND; B.
CARUSILLO; J. ZHANG; V. GERZANICH; J. SIMARD; K. T.
KAHLE. Univ. of Maryland Baltimore, Yale, Univ. of Dundee.
4:00 CCC11 445.12 Immune regulation and mesenchymal
stromal cell-produced pain relief: 2. role of NFB signaling
and regulatory T cells. W. GUO*; S. IMAI; S. ZOU; F. WEI; R.
DUBNER; K. REN. Univ. of Maryland, Kyoto Univ. Hosp.
1:00 CCC12 445.13 Airway nociceptors: Allergen sensing
and reflex responses. S. TALBOT*; S. L. FOSTER; M.
A. PASCAL; R. B. CHANG; A. PARRIN; B. DOYLE;
N. Y. LAI; C. LAEDERMANN; R. E. ABDULNOUR; A.
LATREMOLIERE; L. BROWNE; S. D. LIBERLES; B. P.
BEAN; B. D. LEVY; C. J. WOOLF. Childrens Hosp. Boston.,
Harvard Med. Sch., Brigham and Womens Hosp., Harvard
Med. Sch.
2:00 CCC13 445.14 Murine cervical vagus nerve activity:
Methodology of recording and analysis. H. A. SILVERMAN*;
B. E. STEINBERG; T. TSAAVA; A. STIEGLER; E. A.
BATTINELLI; J. NEWMAN; A. CARAVACA; S. ROBBIATI; P.
T. HUERTA; S. S. CHAVAN; K. J. TRACEY. Feinstein Inst.
at Northwell Hlth., Hofstra Northwell Sch. of Med. at Hofstra
Univ., Dept. of Anesthesia Univ. of Toronto, Circulatory
Technology, Inc., Karolinska Instituetet, Lab. of Immune and
Neural Networks, Feinstein Inst. at Northwell Hlth.
3:00 CCC14 445.15 Investigating the effects of inflammation
and minocycline on central glutamate receptors and the
metabolome. S. CHAN*; F. PROBERT; D. C. ANTHONY;
P. W. J. BURNET. Univ. of Oxford, Univ. of Oxford, Univ. of
Oxford.
4:00 CCC15 445.16 Immune regulation and mesenchymal
stromal cell-produced pain relief: 1. promotion of antiinflammatory phenotype. S. IMAI; W. GUO; S. ZOU; F. WEI;
R. DUBNER; K. REN*. Univ. of Maryland Sch. of Dent.,
Kyoto Univ. Hosp.
1:00 CCC16 445.17 Neuronal regulatory RNAs and
neuropsychiatric lupus. A. IACOANGELI*; I. MUSLIMOV;
H. TIEDGE. SUNY Downstate Med. Ctr., SUNY Downstate
Med. Ctr.
2:00 CCC17 445.18 Age-associated circadian dysregulation
in rats may sensitize neuroinflammatory responses. L. K.
FONKEN*; M. M. KITT; A. D. GAUDET; R. M. BARRIENTOS;
L. R. WATKINS; S. F. MAIER. Univ. of Colorado.
3:00 CCC18 445.19 Involvement of hypothalamic CCL2/CCR2
chemokine system in the stimulatory effects of maternal
exposure to low-dose ethanol on embryonic development
of orexigenic peptide neurons in rats. S. F. LEIBOWITZ*; G.
CHANG; O. KARATAYEV. Rockefeller Univ.
4:00 CCC19 445.20 Nicotine mediated immunosuppression
is compromised in lipopolysaccharide activated splenocytes
from microsomal prostaglandin E synthase1 knockout
mice. P. REVATHIKUMAR*; U. KARMAKAR; E. LE MATRE;
M. KOROTKOVA; P. JAKOBSSON; J. LAMPA. Dept. of
Medicine, Karolinska Institutet.
1:00 CCC20 445.21 Estradiol enhances microglial reactivity
in the ventromedial hypothalamus of pubertal female mice.
A. VELEZ*; S. FOUNTAIN; J. D. BLAUSTEIN. Univ. of
Massachusetts, Amherst, Univ. of Massachusetts, Med. Sch.

132 | Society for Neuroscience

POSTER
446. Neuroimmunology: Behavioral Effects
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 CCC21 446.01 Interleukin-13 receptor 1 contributes to
loss of dopaminergic neurons in a model of chronic stress.
S. MORI*; S. SUGAMA; W. NGUYEN; G. MORONCINI; Y.
KAKINUMA; P. MAHER; B. CONTI. The Scripps Res. Inst.,
Nippon Med. Sch., Universita Politecnica delle Marche, Salk
Inst. for Biol. Studies.
2:00 CCC22 446.02 Altered experience-dependent
interleukin-1 signaling in juvenile rats exposed to ethanol
as neonates. M. J. GOODFELLOW*; D. H. LINDQUIST. Ohio
State Univ. Dept. of Psychology.
3:00 CCC23 446.03 Chronic cocaine self-administration
alters cognitive flexibility in male HIV transgenic rats. S. E.
HEMBY*; S. MCINTOSH. Fred Wilson Sch. of Pharmacy/
High Point Univ., Fred Wilson Sch. of Pharmacy/High Point
Universi.
4:00 CCC24 446.04 Sex differences in the effects of dietary
emulsifiers on physiology and behavior in mice. M. K.
HOLDER*; B. CHASSAING; N. V. PETERS; J. WHYLINGS;
A. T. GEWIRTZ; G. J. DE VRIES. Georgia State Univ.,
Georgia State Univ., Georgia State Univ.
1:00 CCC25 446.05 The role of TRAIL in cancer-related
fatigue following radiation therapy. S. D. DETERAWADLEIGH*; L. R. FENG; L. N. SALIGAN. NIH, NIH.
2:00 CCC26 446.06 Neuroimmune modulation of
hippocampal synaptic signaling, neural circuit activity, and
memory retrieval. T. E. WHITE; J. CZERNIAWSKI; G.
LEWANDOWSKI; J. F. GUZOWSKI*. Univ. of California,
Univ. of California, Irvine, Univ. of California Irvine Dept. of
Neurobio. and Behavior.
3:00 DDD1 446.07 Low grade colitis sensitizes sickness
response to lipopolysaccharide in BALB/c mice. J.
KONSMAN*; L. CHASKIEL; R. DANTZER. CNRS UMR
5287 INCIA / Univ. Bordeaux, CNRS UMR 5226, CNRS
UMR5226, MD Anderson Cancer Ctr.
4:00 DDD2 446.08 Behavioral and physiological sexdifferences following cardiac arrest/ cardiopulmonary
resuscitation. M. M. GAUDIER-DIAZ*; A. H. HAINES; W. H.
WALKER, II; N. ZHANG; R. J. NELSON; A. DEVRIES. The
Ohio State Univ.
1:00 DDD3 446.09 Environmental mold exposure alters the
relationships between microglial morphology and behavior.
K. PAGE*; C. MCDERMOTT; S. UVAYDOV; D. ALEBDY; R.
PANG; C. F. HARDING; C. L. PYTTE. Grad. Center, CUNY,
Queens College, CUNY, Hunter College, CUNY, Hunter
College, CUNY, Hunter College, CUNY.
2:00 DDD4 446.10 Effect of neonatal immune activation on
the developing immune system and learning in juveniles.
B. OSBORNE*; S. SOLOMOTIS; J. M. SCHWARZ. Univ. of
Delaware.
3:00 DDD5 446.11 The effects of doxycycline and mold
exposure on neurogenesis and contextual memory. N. C.
ABREU*; A. EL-RAZI; I. VORONINA; K. PAGE; A. LOPEZ;
S. UVAYDOV; C. F. HARDING; C. L. PYTTE. Queens
College, City Univ. of New York, Hunter College, City Univ.
of New York, Hunter College, City Univ. of New York, Grad.
Center, City Univ. of New York, Hunter College, City Univ. of
New York.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 DDD6 446.12 Blockage of central interleukin 6

trans-signaling prevents predator stress in the mouse. I.
GONZALEZ-NATERAS; F. MONTERO-AMEZCUA; R.
CUEVAS-OLGUIN; E. ESQUIVEL-RENDON; J. VARGASMIRELES; C. GONZALEZ-DEL CARPIO; S. ROSE-JOHN;
M. ATZORI*. Univ. Autonoma de San Luis Potosi, Christian
Albrechts Univ., Univ. Autnoma de San Luis Potos.
1:00 DDD7 446.13 Psychomotor activation levels in mice are
regulated by vasoactive intestinal peptide produced by bone
marrow derived blood cells. R. PANJWANI*; C. R. GIVER; J.
P. SCHRODER; J. FELGER; D. G. STEIN; E. K. WALLER.
Emory Univ. Col. of Arts and Sci., Emory Univ. Sch. of Med.,
Emory Univ. Sch. of Med., Emory Univ. Sch. of Med., Emory
Univ. Sch. of Med.

POSTER
447. Autonomic Control: Cardiovascular Regulation II
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 EEE4 447.01 Robust continuous estimation of cardiac
output and systolic time intervals using a moving ensemble
method. M. CIESLAK*; W. S. RYAN; W. MEIRING; V.
BABENKO; H. ERRO; Z. M. RATHBUN; J. BLASCOVICH,
PhD.; S. T. GRAFTON. UCSB, Univ. of California, Santa
Barbara, Univ. of California, Santa Barbara, Univ. of
California, Santa Barbara.
2:00 EEE5 447.02 The NeuroCorrelates of steady state
blood pressure and heart rate in healthy humans. L.
BARNDEN*; R. BURNET; P. DEL FANTE; R. KWIATEK; B.
CROUCH; Z. SHAN. Griffith Univ., Royal Adelaide Hosp.,
Healthfirst Network, Lyell McEwin Hosp., Royal Adelaide
Hosp.

3:00 DDD9 446.15 Astrocyte modulation of stress-enhanced

fear learning, an animal model of post-traumatic stress
disorder. M. E. JONES*; L. B. COOPER; E. B. KELLY; J. E.
PANICCIA; C. L. LEBONVILLE; D. T. LYSLE. Univ. of North
Carolina At Chapel Hill, Univ. of North Carolina at Chapel
Hill.

3:00 EEE6 447.03 Protective effects of training status on

autonomic modulation and blood pressure during acute
exercise in normotensive adults and elderly. A. S. ZAGO*;
G. F. M. MARTINS; L. P. BARBOSA; L. L. CESAR; A. M.
JACOMINI; R. F. SILVA; S. L. AMARAL. Univ. Estadual
Paulista.

4:00 DDD10 446.16 Sustained peripheral inflammation

triggers anandamide hydrolysis to promote anxiety. H. A.
VECCHIARELLI*; M. MORENA; M. STICHT; C. M. KEENAN;
W. HO; K. A. SHARKEY; M. N. HILL. Univ. of Calgary, Univ.
of Calgary.
1:00 DDD11 446.17 Genipin attenuates LPS-induced
persistent changes of emotional behaviors and neural
activation in the hypothalamic paraventricular nucleus and
the central amygdala nucleus. T. YABE*; Y. HIRAKI; S.
NISHIDA; R. ARAKI. Setsunan Univ.
2:00 DDD12 446.18 A history of juvenile malaria predisposes
mice towards anxiety-like responses, neuroinflammation,
and decreased neurogenesis in response to adultonset stress. S. K. GUHA*; I. SARKAR; S. SHAH; M.
PATGAONKAR; S. SHARMA; S. PATHAK; V. A. VAIDYA.
Tata Inst. of Fundamental Res.
3:00 DDD13 446.19 CX3CR1-expressing monocytes alter
learning and learning-dependent dendritic spine plasticity
during viral immune activation. J. M. GARRE*; H. MOURASILVA; J. J. LAFAILLE; G. YANG. New York Univ., New York
Univ.
4:00 DDD14 446.20 Toxoplasma gondii infection and blunted
response to stimulant drug administration. R. MCFARLAND*;
M. V. PLETNIKOV; R. H. YOLKEN. Johns Hopkins Univ.,
Johns Hopkins Univ., Johns Hopkins Univ.

1:00 EEE1 446.21 Vium Digital Vivarium enables

automated drug efficacy assessment in animal models of
multiple sclerosis. L. SCHAEVITZ*; D. FORD; M. LIM. Vium.
TM

2:00 EEE2 446.22 Early life depletion of microglia programs

lifelong mood-related behavior and brain development. L. H.
NELSON*; S. WARDEN; K. M. LENZ. Ohio State Univ., The
Ohio State Univ., The Ohio State Univ.
3:00 EEE3 446.23 Attenuation of TLR4 signalling
prevents behavioural alterations induced by a short
alcohol binge during adolescence. J. W. JACOBSEN*; F.
BUISMAN-PILJIMAN; D. BARRATT; S. MUSTAFA; M. R.
HUTCHINSON. Univ. of Adelaide, Univ. of Adelaide.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 EEE7 447.04 Cognitive and mood deficits and

associations between symptoms and disease severity in
early-diagnosed, treatment-nave obstructive sleep apnea.
L. EHLERT; B. ROY; D. KANG; M. WOO; R. AYSOLA;
R. KUMAR*. Univ. of California at Los Angeles, Univ. of
California at Los Angeles, Univ. of California at Los Angeles,
Univ. of California at Los Angeles, Univ. of California at
Los Angeles, Univ. of California at Los Angeles, Univ. of
California at Los Angeles.
1:00 EEE8 447.05 Sympathetic blockade markedly prolongs
EEG coherence and delays the onset of cardiac arrest after
asphyxia. F. TIAN*; T. LIU; G. XU; D. LI; T. GHAZI; T. SHICK;
A. SAJJAD; M. WANG; P. FARREHI; J. BORJIGIN. Univ. of
Michigan, Veterans Admin. Ann Arbor Healthcare Syst.
2:00 EEE9 447.06 Alteration of cardiac autonomic function
in patients with newly diagnosed epilepsy. R. K. GOIT*.
Nepalgunj Med. Col.
3:00 EEE10 447.07 Sex and hormonal status influence
the redistribution of the AMPA GluA1 receptor subunit in
estrogen receptor containing paraventricular hypothalamic
neurons following slow-pressor angiotensin II hypertension.
A. C. OVALLES*; J. MARQUES-LOPES; T. A. VAN
KEMPEN; M. J. GLASS; C. IADECOLA; E. M. WATERS; T.
A. MILNER. Weill Cornell Med., The Rockefeller Univ.
4:00 EEE11 447.08 Renalase expression and regulation in
PC12 cells. C. R. WILLIAMSON*; S. KHURANA; T. C. TAI.
Laurentian Univ., Northern Ontario Sch. of Med., Laurentian
Univ., Laurentian Univ.
1:00 EEE12 447.09 Chronic inhibition of catalase attenuates
the overexpression of AT1 receptor and proinflammatory
cytokine mRNA in the hypothalamus of hypertensive rats.
M. R. LAUAR*; D. S. A. COLOMBARI; L. A. DE LUCA JR.;
P. M. DE PAULA; E. COLOMBARI; C. A. F. ANDRADE; J. V.
MENANI. Dept Physiol. and Pathol., UNESP.
2:00 EEE13 447.10 Pharmacological evidence that NaHS
inhibits the vasopressor responses induced by stimulation
of the preganglionic sympathetic outflow in pithed rats.
A. SACHEZ-LOPEZ*; S. HUERTA-DE LA CRUZ; E. J.
GUTIRREZ-LARA; J. H. BELTRAN-ORNELAS; D.
CENTURIN. Cinvestav-Coapa.
Neuroscience 2016|Monday PM|133

Mon. PM

2:00 DDD8 446.14 Targeted deletion of P2X7 ion channels

prevent Mycobacterium bovis, BCG induced depressive
like behaviors in mice. J. C. OCONNOR*; L. REDUS;
N. DERECKI; A. BHATTACHARYA. UTHSCSA, Audie L.
Murphy VA Hosp., Janssen Res. & Development, LLC.

3:00 EEE14 447.11 Intraneural interrogation of vagus

nerve activity. A. KANNEGANTI; A. S. DESHMUKH; M. I.
ROMERO-ORTEGA*. Univ. of Texas at Dallas.
4:00 FFF1 447.12 Combined administration of insulin
and leptin significantly increased Fos production in the
arcuate nucleus and renal sympathetic nerve activity.
H. HABEEBALLAH; N. ALSUHAYMI; M. STEBBING; T.
JENKINS; E. A. BADOER*. RMIT Univ.
1:00 FFF2 447.13 Cardiovascular control by neurons of
the rostral ventrolateral medulla in conscious rats. I. C.
WENKER*; C. ABE; R. L. STORNETTA; P. G. GUYENET.
Univ. of Virginia, Gifu Univ.
2:00 FFF3 447.14 Ventrolateral medullary pathways
mediate cardiovascular responses to activation of the ventral
tegmental area. J. CIRIELLO*. Univ. Western Ontario.
3:00 FFF4 447.15 Ketamine and amphetamines inhibit
neurogenic nitrergic vasodilation of porcine isolated basilar
arteries. M. CHEN; S. LAI; P. KUNG; Y. LIN; H. YANG; P.
CHEN; T. J. LEE*. Buddhist Tzu Chi Gen. Hosp., Tzu Chi
Univ. of Sci. and Technol., Inst. of Pharmacol. and toxicology,
Tzu Chi Univ., Southern Illinois Univ. Med. Sch., Tzu Chi
Univ.
4:00 FFF5 447.16 Assessing fear memory by modelling
conditioned bradycardia and respiratory responses. G.
CASTEGNETTI*; A. TZOVARA; M. STAIB; P. C. PAULUS;
N. HOFER; D. R. BACH. Univ. of Zurich, TU Dresden, Univ.
Col. London.

POSTER
448. Gastrointestinal: Reproductive Regulation
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 FFF6 448.01 Chronic stress is associated with
augmented urinary bladder neuronal sprouting. B. M.
MCDONNELL*; A. KULLMANN; A. WOLF-JOHNSON; A.
KANAI; L. RODRIGUEZ; L. BIRDER. Univ. of Pittsburgh,
Inst. of Urology, Univ. of Southern California.
2:00 FFF7 448.02 Electrical stimulation to increase colonic
activity. D. J. BOURBEAU*; K. AAMOTH; K. GUSTAFSON.
DVA, MetroHealth Med. Syst., Cleveland FES Ctr., Case
Western Reserve Univ.
3:00 FFF8 448.03 Identifying brain networks controlling
micturition and continence in mouse. A. M. VERSTEGEN*; L.
GUO; J. C. MATHAI; V. VANDERHORST; M. L. ZEIDEL; J.
C. GEERLING. Beth Israel Deaconess Med. Center; Harvard
Medi, Beth Israel Deaconess Med. Center; Harvard Med.
Sch., Beth Israel Deaconess Med. Center; Harvard Med.
Sch.
4:00 FFF9 448.04 Impact of decentralization on cholinergic
transmission and neuronal excitability in mouse major pelvic
ganglia. C. W. KYI*; D. J. SCHULZ. Univ. of Missouri, Univ.
of Missouri.

2:00 FFF11 448.06 Anxiogenic effect of probiotics, prebiotics

and synbiotics on healthy juvenile rats. J. A. BRAVO*; C.
BARRERA-BUGUEO; J. ESCOBAR-LUNA; O. REALINI;
R. SOTOMAYOR-ZRATE; M. GOTTELAND; M. JULIOPIEPER. Pontificia Univ. Catolica de Valparaiso, Univ. de
Valparaso, Univ. de Chile.
3:00 FFF12 448.07 Differential effects of SSRIs on rat
intestinal permeability and innate immune response markers.
M. JULIO-PIEPER*; J. EYZAGUIRRE-VELASQUEZ; C.
GONZALEZ-ARANCIBIA; L. OLAVARRIA-RAMIREZ; J.
ESCOBAR-LUNA; C. BARRERA-BUGUEO; J. A. BRAVO.
PONTIFICIA UNIVERSIDAD CATOLICA DE VALPARAISO.
4:00 FFF13 448.08 Cisplatin causes up regulation of orexin
R-1 receptor and serotonin in nodose ganglion of the least
shrew (Cryptotis parva). M. S. AL-TIKRITI*; W. KHAMAS; S.
CHEBOLU; N. DARMANI. Western Univ. of Hlth. Sci.
1:00 FFF14 448.09 Progressive lower urinary tract
dysfunction in mice with alkaline ceramidase 3 deficiency.
J. SCHRANDT*; W. F. COLLINS, III; C. MAO. Stony Brook
Univ., Stony Brook Univ., Stony Brook Univ.
2:00 FFF15 448.10 Acute intermittent hypoxia-induced longterm facilitation of micturition-related external oblique muscle
activity. M. CATEGE; N. P. PHAGU; I. C. SOLOMON; W. F.
COLLINS*, III. Stony Brook Univ., Stony Brook Univ.
3:00 FFF16 448.11 Histomorphometry of postganglionic and
sensory neurons of the vagina of nulliparous and pregnant
rats. N. MIRTO-AGUILAR; N. XELHUANTZI; J. PALACIOS;
M. JUAREZ*; Y. CRUZ. Univ. Veracruzana, Univ. Autonoma
Tlaxcala, Univ. Autonoma Tlaxcala, Univ. Autonoma
Tlaxcala, Univ. Autonoma Tlaxcala.
4:00 FFF17 448.12 Modulation of blood glucose by the dorsal
vagal complex. C. R. BOYCHUK*; J. A. BOYCHUK; K. C.
HALMOS-SMITH; B. N. SMITH. Univ. of Kentucky.

1:00 FFF18 448.13 Spinal cord stimulation may improve the

voiding function in rodent with dopaminergic brain lesion
injury. J. YEH; J. MAO; H. H. CHANG*. USC.
2:00 FFF19 448.14 Uncontrolled diabetic hyperglycemia is
resolved by vertical sleeve gastrectomy in a murine model
of type 1 diabetes. K. HALMOS*; C. R. BOYCHUK; B. N.
SMITH. Univ. of Kentucky.
3:00 FFF20 448.15 Sensory urethral innervation in male
rats. R. JUAREZ MENDIETA*; I. JIMENEZ; Y. CRUZ. Univ.
Autonoma De Tlaxcala, Inst. Politcnico Nacional.
4:00 FFF21 448.16 Development of skull-mounted port for
bladder infusion during cystometry in unanesthetized, freelymoving rats. J. S. CARP*; J. R. WOLPAW. Natl. Ctr. For
Adaptive Neurotechnologies.
1:00 FFF22 448.17 Effect of parasympathetic or sympathetic
denervation on intestinal epithelial stem cell proliferation.
E. A. DAVIS*; M. C. WASHINGTON; H. PHILLIPS; A.
I. SAYEGH; M. J. DAILEY. Univ. of Illinois at UrbanaChampaign, Tuskegee Univ., Univ. of Illinois at UrbanaChampaign.

1:00 FFF10 448.05 Sensory innervation of the pancreatic

islet. M. MAKHMUTOVA*; R. RODRIGUE-DIAZ; J. ALMACA;
J. WEITZ; E. BERNAL-MIZRACHI; A. CAICEDO. Univ. of
Miami.

2:00 FFF23 448.18 Network dynamics underlying the

encoding of visceral sensorimotor information. A.
MANOHAR*; A. CURTIS; S. ZDERIC; R. VALENTINO.
Childrens Hosp. of Philadelphia, Childrens Hosp. of
Philadelphia.

134 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
449. Gastrointestinal: Urinary and Renal Regulation
Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 FFF24 449.01 Reflexive inhibition of bladder function

via saphenous nerve stimulation in anesthetized rats. Z.
MOAZZAM*; P. B. YOO. Univ. of Toronto.
2:00 FFF25 449.02 Unilateral denervation of the genitourinary
tract induces signs of sexual, urinary dysfunction and
infertility in male rats. J. ARELLANO; F. CASTELN; J.
CUATECONTZI; Y. CRUZ*. Univ. Veracruzana, Univ.
Autonoma Tlaxcala.
3:00 FFF26 449.03 Modulation of urine glucose by renal
nerves stimulation in rat. A. A. JIMAN*; A. G. LEWIS; K. H.
CHHABRA; P. S. CEDERNA; R. J. SEELEY; M. J. LOW; T.
M. BRUNS. Univ. of Michigan, Univ. of Michigan, Univ. of
Michigan, Univ. of Michigan.

4:00 GGG1 449.04 Prostaglandin E2 installation as an

overactive bladder model in cats. C. L. LANGDALE*; J.
A. HOKANSON; A. SRIDHAR; W. M. GRILL. Duke Univ.,
GlaxoSmithKline, Duke Univ., Duke Univ., Duke Univ.

2:00 GGG3 449.06 Autonomic control of bladder function is

regulated by TREK-1, a two-pore domain potassium channel.
R. H. PINEDA*; R. B. MEACHAM; A. P. MALYKHINA. Univ.
of Colorado Sch. of Med.
3:00 GGG4 449.07 OAB ithout an overactive bladder:
Insights from an acute prostaglandin E2 rat model. J. A.
HOKANSON*; C. LANGDALE; A. SRIDHAR; W. GRILL.
Duke Univ. Dept. of Biomed. Engin., GlaxoSmithKline.

3:00 GGG12 449.15 Evaluating sexual arousal in a female

rat model with tibial nerve stimulation. L. ZIMMERMAN*; I.
C. RICE; M. B. BERGER; T. M. BRUNS. Univ. of Michigan,
Univ. of Michigan, Univ. of Michigan Hlth. Syst.
4:00 GGG13 449.16 High-salt intake decreases intestinal
Na+/K+-ATPase activity in normotensive rats but not in
hypertensive Dahl salt-sensitive rats. M. TANDAI-HIRUMA*;
T. KEMURIYAMA; Y. NISHIDA. Natl. Def Med. Col.
1:00 GGG14 449.17 Estrus-cycle dependent variations
regulate sensitivity of rat urinary bladder urothelial cells. A. S.
WOLF-JOHNSTON*; F. A. KULLMANN; L. A. BIRDER. Univ.
Pittsburgh.
2:00 GGG15 449.18 A novel method to non-invasively
determine the post-void residual in continuous serial
cystometrograms. Z. C. DANZIGER*; W. M. GRILL. Duke
Univ.
3:00 GGG16 449.19 Kalman filter decoding of bladder
pressure from dorsal root ganglia activity. A. OUYANG*; S.
E. ROSS; T. M. BRUNS. Univ. of Michigan.
4:00 GGG17 449.20 Central inhibition of initiation of
swallowing by systemic administration of diazepam and
baclofen in anaesthetized rats. T. TSUJIMURA*; S. SAKAI; T.
SUZUKI; K. TSUJI; J. MAGARA; B. J. CANNING; M. INOUE.
Niigata Univ. Grad. Sch. of Med. and Dent. Sci., Johns
Hopkins Asthma and Allergy Ctr.
1:00 GGG18 449.21 Intratesticular administration of
p-chloroanfetamine (PCA) alters sperm quality. J. A.
DIAZ-RAMOS; C. A. DON-LOPEZ; A. L. RODRGUEZGUTIERREZ; M. FLORES-FLORES; R. DOMINGUEZ*;
M. E. AYALA-ESCOBAR; A. ARAGON-MARTINEZ. FES
Zaragoza UNAM, Inst. Tecnologico del Altiplano de Tlaxcala.

4:00 GGG5 449.08 GABA, glycine and opioid

neurotransmitter mechanisms underlying sacral
neuromodulation of bladder overactivity in cats. X. JIANG*;
U. BANSAL; T. FULLER; J. BANDARI; B. SHEN; Z. ZHANG;
J. WANG; J. ROPPOLO; W. DE GROAT; C. TAI. Univ. of
Pittsburgh, Qilu Hosp. of Shandong Univ.

2:00 GGG19 449.22 Plasticity in trpv4 expression and

function in micturition reflex pathways during postnatal rat
development. B. M. GIRARD*; S. MALLEY; M. VIZZARD.
Univ. of Vermont Dept. of Neurolog. Sci.

1:00 GGG6 449.09 Chronic monitoring and stimulation of the

lower urinary tract during sedated and awake testing. S. E.
ROSS*; A. OUYANG; A. KHURRAM; A. A. A. JIMAN; Z. J.
SPERRY; C. J. STEPHEN; T. M. BRUNS. Univ. of Michigan.

POSTER

2:00 GGG7 449.10 Transient receptor potential vanilloid

4 channels modulate Ca2+ signals in interstitial cells of
Cajal at urothelial-lamina propria junction of rat pups. M. A.
VIZZARD*; M. T. NELSON; T. J. HEPPNER. Univ. Vermont
Col. Med., Univ. Vermont Col. Med.
3:00 GGG8 449.11 Connectome and putative function of
MET-positive neurons in the vagal motor complex. A. K.
KAMITAKAHARA*; H. WU; P. LEVITT. Childrens Hosp. Los
Angeles, USC.
4:00 GGG9 449.12 Detection of nausea in rats using
the monitoring of facial expression. K. YAMAMOTO*; S.
TATSUTANI; T. ISHIDA. Osaka Univ.

450. Sleep Behavior in Humans and Non-Human Primates

Theme F: Integrative Physiology and Behavior
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 GGG20 450.01 Polysomnographic characterization
of nocturnal sleep in Cynomolgus macaques. A.
V. GOONAWARDENA*; M. DI ZAMBOTTI; A. R.
WILLOUGHBY; C. GLAVIS-BLOOM; I. M. COLRAIN; T. L.
WALLACE; T. S. KILDUFF. SRI Intl., SRI Intl.
2:00 GGG21 450.02 Statistical source separation of
rhythmic LFP patterns during sharp wave ripples in the
macaque hippocampus. J. F. RAMIREZ-VILLEGAS*; N. K.
LOGOTHETIS; M. BESSERVE. Max Planck Inst. For Biol.
Cybernetics, Eberhard-Karls Univ. of Tbingen, The Univ. of
Manchester, Max Planck Inst. for Intelligent Systems.

1:00 GGG10 449.13 Pudendal nerve stimulation elicits

oscillations in vaginal blood flow. I. C. RICE*; L. L.
ZIMMERMAN; S. E. ROSS; M. B. BERGER; T. M. BRUNS.
Univ. of Michigan, Univ. of Michigan, Univ. of Michigan Hlth.
Syst.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|135

Mon. PM

1:00 GGG2 449.05 Wireless monitoring and optogenetic

modulation of bladder function. A. D. MICKLE*; J. YOON;
S. M. WONG; S. PARK; K. N. NOH; K. MEACHAM; J.
ROGERS; R. W. GEREAU, IV. Washington Univ., Univ. of
Illinois at Urbana-Champain.

2:00 GGG11 449.14 EMG analysis of external urethral

sphincter in awake spinal cord injured rats during
urodynamic assessment. M. P. SCHNEIDER*; A. K.
ENGMANN; T. M. KESSLER; M. E. SCHWAB. Univ. of
Zrich.

3:00 GGG22 450.03 The expression of dreams: Emotional

facial expressions during REM sleep associated to
dream mentation in depressed and healthy women. A.
P. RIVERA*; I. RAMREZ SALADO; E. LPEZ RUIZ; J.
GONZLEZ OLVERA; F. AYALA GUERRERO; J. PIA;
A. SILVA CABALLERO; B. REYES ARANGUREN; D.
CASTRO NIETO; A. JIMNEZ ANGUIANO. Inst. Nacional
De Psiquiatria Ramon De La Fuente, Univ. Autnoma
Metropolitana, Inst. Nacional De Psiquiatria Ramon De La
Fuente.
4:00 GGG23 450.04 Sleep amount is a potential biomarker for
predicting behavioral responses in a mouse model of PTSD.
C. L. GRAY*; L. PINCKNEY; E. N. OLIVER; K. N. PAUL; J.
C. EHLEN. Morehouse Sch. of Med.
1:00 GGG24 450.05 Sleep deprivation after trauma imparts
resilience to post-traumatic stress disorder (PTSD). J.
DEAN*; J. DELORME; G. POE; Y. ARIAS-DELPHI. Univ.
of Michigan Dept. of Mol. and Integrative Physiol., Univ. of
Michigan, Univ. of Michigan, Univ. of Puerto Rico Ponce.
2:00 GGG25 450.06 Brief body-mind training improves sleep
quality. Y. TANG*; X. DING; R. TANG. Texas Tech. Univ.,
Dalian Nationalities Univ., Washington Univ. in St. Louis.

3:00 GGG26 450.07 Intensive practice during the day induces

task-specific performance errors: The differential effects of
nap and quiet rest. A. B. NELSON*; M. T. CHAN; J. LIN;
P. PANDAY; J. BORKOWSKI; H. CHEN; M. GADALLA; B.
O. THOMSON; G. TONONI; C. CIRELLI; M. F. GHILARDI.
CUNY Med. Sch., CUNY Med. Sch., UW Madison.
4:00 HHH1 450.08 Insufficient sleep time is associated with
low thyroid stimulating hormone levels in a sample of young
mexican population. B. PREZ; R. SAUDO-TORRES; A.
PAVN-ROSADO; S. ABURTO; R. AYALA-MORENO; M. A.
MELGAREJO*. Univ. Veracruzana, Univ. La Salle.
1:00 HHH2 450.09 Aberrant brain functional network integrity
in adolescents with insomnia. M. PARK*; S. PARK; B. PARK;
B. KIM. Dept. of Psychiatry, Seoul St. Marys Hospi, Dept.
of Psychiatry, Seoul Natl. Hosp., Dept. of Statistics, Hankuk
Univ. of Foreign Studies Seoul, Dept. of Psychiatry and
Behavioral Science, Seoul Natl. Univ. Col. of Med.
2:00 HHH3 450.10 Investigation of sleep quality and
executive functioning in Hong Kong adolescents. J. Y. HO*;
Y. T. CHAN; A. K. C. SUEN; E. Y. Y. LAU; R. L. T. LEE; P. H.
LEE; R. C. C. CHANG. The Hong Kong Polytechnic Univ.,
Po Leung Kuk Laws Fndn. Col., The Hong Kong Inst. of
Educ., The Univ. of Hong Kong.
3:00 HHH4 450.11 Measures of cognition and sleep
in infants, using dEEG: Frontal sleep spindle spectral
frequency is negatively correlated with cognition in
3.5-month-old infants. S. PETERS*; A. A. BENASICH.
Rutgers Univ.- Newark.
4:00 HHH5 450.12 No entrainment of endogenous brain
rhythms to 1Hz sinusoidal tACS in human intracranial EEG.
B. LAFON; L. C. PARRA*; D. FRIEDMAN; S. HENIN; L.
MELLONI; G. BUZSAKI; O. DEVINSKY; A. LIU. City Col.
of New York, City Col. of New York, New York Univ. Sch. of
Med., NYU Comprehensive Epilepsy Ctr., NYU Neurosci.
Inst.

2:00 HHH7 450.14 Spectral analysis of EEG activity during

weekend recovery sleep. S. J. MORTON*; C. M. DEPNER;
E. L. MELANSON; J. R. GUZZETTI; K. P. WRIGHT, Jr.
Univ. of Colorado Boulder, Univ. of Colorado Boulder, Univ.
of Colorado Anschutz Med. Campus, Univ. of Colorado
Anschutz Med. Campus.
3:00 HHH8 450.15 Interaction of menstrual cycle and heart
rate variability on sleep dependent memory consolidation.
N. SATTARI*; L. WHITEHURST; M. NAJI; E. MCDEVITT; S.
MEDNICK. UCR.
4:00 HHH9 450.16 Neural correlates of sleep-dependent
consolidation of visual perceptual learning: An ERP study. M.
AHMADI*; E. A. MCDEVITT; M. A. SILVER; S. C. MEDNICK.
Univ. of California Riverside, Univ. of California Berkeley.
1:00 HHH10 450.17 Coupling of heart inter-beat intervals and
slow oscillations during sleep. M. NAJI*; G. P. KRISHNAN;
M. BAZHENOV; S. C. MEDNICK. UC San Diego, UC
Riverside.
2:00 HHH11 450.18 The impact of psychostimulants and
hypnotics on cognitive performance in neurotypical adults. L.
N. WHITEHURST*; L. BATELLI; S. AGOSTA; S. MEDNICK.
Univ. of California, Riverside, Italian Inst. of Technol.
3:00 HHH12 450.19 Modulating acetylcholine during sleep
consolidation of episodic memory and perceptual learning. E.
A. MCDEVITT*; M. AHMADI; M. A. SILVER; S. C. MEDNICK.
Sleep and Cognition Lab., Univ. of California, Helen Wills
Neurosci. Inst., Sch. of Optometry, Vision Sci. Grad. Group.
4:00 HHH13 450.20 Medial prefrontal white matter changes
associate with sleep quality in patients with Chronic Fatigue
Syndrome. Z. SHAN*; R. KWIATEK; R. BURNET; P. DEL
FANTE; D. R. STAINES; S. M. MARSHALL-GRADISNIK;
L. R. BARNDEN. Griffith Univ., Lyell McEwin Hosp., Royal
Adelaide Hosp., Healthfirst Network.
1:00 HHH14 450.21 Sleep apnea symptoms and depression
in young adults. R. WILLIAMSMORRIS*; F. BARRIENTOS;
T. REYNOSO. Southern Adventist Univ., Southern Adventist
Univ., Southern Adventist Univ.
2:00 HHH15 450.22 Altered regional cortical thickness in
children with obstructive sleep apnea syndrome. R. A. MA*;
L. KHEIRANDISH-GOZAL; M. F. PHILBY; R. KUMAR; D.
GOZAL; P. M. MACEY. UCLA, The Univ. of Chicago, The
Univ. of Chicago, UCLA, David Geffen Sch. of Med. at Univ.
of California Los Angeles.
3:00 HHH16 450.23 Nucleus accumbens regional volume
changes in newly-diagnosed obstructive sleep apnea
patients vary by sex. J. PRASAD*; J. A. OGREN; R.
KUMAR; R. AVSOLA; F. L. YAN-GO; M. A. WOO; M.
THOMAS; R. M. HARPER; P. M. MACEY. Univ. of California
Los Angeles, UCLA, UCLA, UCLA, UCLA, UCLA, UCLA,
UCLA, UCLA, UCLA.
4:00 HHH17 450.24 Obstructive sleep apnea is accompanied
by altered neurochemical levels in the midbrain and
hypothalamus. P. M. MACEY*; M. K. SARMA; R.
NAGARAJAN; J. A. OGREN; R. AYSOLA; R. M. HARPER;
M. A. THOMAS. Univ. of California at Los Angeles, UCLA,
UCLA, UCLA, UCLA.

1:00 HHH6 450.13 Prevalence of sleep disorders in a

mexican children population. S. ABURTO*; E. VENTURAARIZMENDI; B. PREZ; E. AGUILAR; R. MENDOZAAMARO; A. NAVARRETE-MUNGUA; M. MELGAREJO.
Univ. Veracruzana.

1:00 HHH18 450.25 Wake high-density EEG spatiospectral

signatures of insomnia. E. J. VAN SOMEREN*; M.
COLOMBO; Y. WEI; J. RAMAUTAR. Netherlands Inst. For
Neurosci., Netherlands Inst. For Neurosci.

136 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 HHH19 450.26 Somnivore, a user-friendly platform

for automated sleep scoring of animal and human
polysomnography data. G. ALLOCCA*; L. A. JOHNSTON; D.
R. FREESTONE; A. L. GUNDLACH. The Univ. of Melbourne,
The Univ. of Melbourne.

1:00 HHH30 451.09 Neural correlates of decision making

in the aversive-reward conflict task. A. AFZAL*; S.
ZOROWITZ; K. K. ELLARD; A. S. WIDGE; A. GILMOUR;
D. DOUGHERTY; E. ESKANDAR; T. DECKERSBACH.
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.

3:00 HHH20 450.27 Coordination of cortical and thalamic

activity during non-REM human sleep. R. A. MAKMCCULLY*; M. ROLLAND; A. SARGSYAN; J. TREES; P.
CHAUVEL; H. BASTUJI; M. REY; E. HALGREN. UCSD
MMIL, UCSD, UCSD, Aix-Marseille Univ., INSERM, Inst.
de Neurosciences des Systmes UMR 1106, Assistance
Publique-Hpitaux de Marseille, Timone Hosp., Lyon
Neurosci. Res. Center, INSERM, U1028; CNRS, UMR5292,
Univ. Claude Bernard, Lyon 1, Service de Neurologie
Fonctionnelle et dpileptologie, Hpital Neurologique,
Hospices Civils de Lyon, APHM, Timone Hosp.

2:00 HHH31 451.10 Rewarding stimulation of the medial

prefrontal cortex activates extensive brain regions: An
optogenetics-fMRI study. Y. HU*; A. TALISHINSKY; H. LU; S.
IKEMOTO; Y. YANG. Natl. Inst. on Drug Abuse.

4:00 HHH21 450.28 Repeating circular waves enable

strengthening of large-scale neural assemblies during sleep
spindles in human cortex. L. E. MULLER*; G. PIANTONI;
D. KOLLER; S. S. CASH; E. HALGREN; T. J. SEJNOWSKI.
Salk Inst., Massachusetts Gen. Hosp. (MGH), UCSD.

POSTER

Theme G: Motivation and Emotion

Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 HHH22 451.01 The influence of intra-dorsolateral
striatum injection of an NMDA receptor agonist or antagonist
on extinction of response learning in the plus-maze. J.
GOODMAN*; R. RESSLER; M. G. PACKARD. Texas A&M
Univ.

3:00 HHH32 451.11 Functional states of hippocampal and

prefrontal circuits characterizing the acquisition of an operant
conditioning tasks and related and unrelated behaviors in
alert behaving rats. A. GRUART*. Pablo de Olavide Univ.
4:00 HHH33 451.12 Methylphenidate shifts healthy volunteers
towards a reward-sensitive strategy during learning-based
decision-making. K. M. HARLE*; C. HYSEK; S. ZHANG; A.
YU; M. PAULUS. UCSD, UCSD, UCSD.
1:00 HHH34 451.13 The effects of chemogenetic inactivation
of the medial prefrontal cortex during Pavlovian appetitive
conditioning. S. E. KEEFER*; G. D. PETROVICH. Boston
Col.
2:00 HHH35 451.14 DREADD inactivation of medial prefrontal
cortex neurons disrupts renewal of Pavlovian conditioned
responding to food cues in male rats. L. C. ANDERSON*; G.
D. PETROVICH. Boston Col.
3:00 HHH36 451.15 The effect of intermittent versus
continuous training on the incentive salience of a Pavlovian
alcohol cue. F. R. VILLARUEL*; S. HEFFERNAN; M.
CHAHINE; N. CHAUDHRI. Concordia Univ.
4:00 HHH37 451.16 Simple paradigm for investigating the
learning of cost-benefit associations in monkeys. T. VANDE
CASTEELE; J. ARSENAULT; W. VANDUFFEL*. K.U.
Leuven, Mass. Gen. Hosp., Harvard Med. Sch.

2:00 HHH23 451.02 Effectiveness of extinction protocols

depends on the memory system engaged during acquisition.
R. RESSLER*; J. GOODMAN; M. PACKARD. Texas A&M.

1:00 HHH38 451.17 Lateral habenula plays a role in the

process by which no association between two events is
learned. D. KIM*; B. CHOI; J. HAN. Konkuk Univ.

3:00 HHH24 451.03 Selective effects of dorsal and ventral

medial prefrontal cortex inactivation during instrumental
reward seeking. J. P. CABALLERO*; D. E. MOORMAN. Univ.
of Massachusetts Amherst, Univ. of Massachusetts Amherst.

2:00 HHH39 451.18 Nicotine enhances Pavlovian conditioned

responding in male and female rats. S. J. STRINGFIELD*; A.
C. MADAYAG; J. XU; C. A. BOETTIGER; D. L. ROBINSON.
Univ. of North Carolina, Univ. of North Carolina, Univ. of
North Carolina.

4:00 HHH25 451.04 When and where learning is taking place?

Multisynaptic changes in strength during different behaviors
related to the acquisition of an operant conditioning task by
behaving rats. J. DELGADO-GARCIA*. Pablo Olavide Univ.
1:00 HHH26 451.05 Early exposure to a high-fat diet
negatively impacts learning and memory in female rats and
is ameliorated by enriched environments. A. K. SUTER*;
S. HUSSAIN; N. RAMIREZ; C. DAWSON; S. MOMI; S.
VILLARREAL; L. FINK; A. HUSSAIN; M. CHAUDHRY; I. C.
SUMAYA. California State Univ. Bakersfield.
2:00 HHH27 451.06 The effect of extinction on the specific
and general forms of the Pavlovian-instrumental transfer
(PIT) effect. D. E. ALARCON*; A. R. DELAMATER. Brooklyn
Col.- CUNY.
3:00 HHH28 451.07 Model of dopamine neurons processing
temporal difference errors. D. R. SCHUWEILER*; P. A.
GARRIS. Illinois State Univ.
4:00 HHH29 451.08 Altered metabolism but no change in
working memory in rats subjected to a high-fat/high-sucrose
diet. H. M. MURPHY*; C. H. WIDEMAN. John Carroll Univ.,
John Carroll Univ.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
452. Fear and Aversive Learning and Memory: Acquisition
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 HHH40 452.01 Characterization of rapid reacquisition
of contextual fear behavior following post-extinction
reconditioning in C57BL/6J mice and Long Evans rats. A.
WILLIAMS*; K. M. LATTAL, 97210. Oregon Hlth. & Sci.
Univ., Oregon Hlth. & Sci. Univ.
2:00 III1
452.02 and low band mediates tone fear
conditioning under urethane anesthetized rats. E. F.
OLIVEIRA*; M. B. REYES. CMCC/UFABC, Univ. Federal do
ABC.
3:00 III2
452.03 Basal ganglia output controls active
avoidance behavior. S. HORMIGO; G. VEGA-FLORES; M.
A. CASTRO-ALAMANCOS*. Drexel Univ. Col. of Med.

Neuroscience 2016|Monday PM|137

Mon. PM

451. Appetitive and Incentive Learning and Memory:

Conditioning I

4:00 III3
452.04 Personality traits contribute to voluntary
pain-related avoidance behavior. Y. NISHI*; M. OSUMI;
S. NOBUSAKO; K. TAKEDA; S. MORIOKA. Kio Univ.,
Hokkaido Univ.

2:00 III17 452.18 Fear conditioning of social stimuli at

proximal and distant locations in an immersive virtual reality
environment. G. KASTRATI*; J. ROSN; S. HULTBERG; F.
AHS. Uppsala Univ.

1:00 III4
452.05 Sub-second fear discrimination in rats:
Adult impairment in adolescent heavy alcohol drinkers. M. A.
MCDANNALD*; K. M. WRIGHT; A. DILEO. Boston Col.

3:00 III18 452.19 Remote but not recent pre-exposure

increases generalization of fear learning in humans. B. D.
YETTON*; D. J. CAI; S. C. MEDNICK. Univ. Of California,
Riverside, Univ. Of California, Los Angeles, Univ. Of
California, Riverside.

2:00 III5
452.06 Optogenetic analysis of prefrontal
contributions to contextual fear memories. A. ASOK*; D.
V. GAGLIARDOTTO; A. M. HUGHES; J. SCHULKIN; J. B.
ROSEN. Columbia Univ., Univ. of Delaware, Georgetown
Univ.
3:00 III6
452.07 The use of synthetic TMT as a
psychological stressor in a rodent model of PTSD. B. C.
MOUZON*; M. ALGAMAL; J. OJO; F. CRAWFORD. The
Roskamp Inst.
4:00 III7
452.08 Female rats acquire and recall a
conditioned safety signal more rapidly than males. A. R.
FOILB*; J. BALS; M. SARLITTO; J. P. CHRISTIANSON.
Boston Col.
1:00 III8
452.09 Inactivation of the obitofrontal cortex
impairs fear discrimination. M. C. SARLITTO; A. R. FOILB; J.
P. CHRISTIANSON*. Boston Col.
2:00 III9
452.10 Brain-wide patterns of fos expression
during fear learning correlate with emotional state rather than
specific sensory stimuli. J. CHO*; S. RENDALL; J. GRAY.
Harvard Med. Sch., Harvard Med. Sch., Harvard Med. Sch.
3:00 III10 452.11 Diffuse traumatic brain injury enhances
fear learning and dynamically alters processing within the
auditory fear circuit. A. N. HOFFMAN*; J. LAM; Y. CAI; D.
A. HOVDA; C. C. GIZA; M. S. FANSELOW. UCLA, UCLA,
UCLA, UCLA, UCLA, UCLA.

4:00 III19 452.20 Role of the Neuropeptide Y Y1 receptor

antagonist, BIBP 3226 on NPY induced resilience in socially
defeated Syrian hamsters. K. KENNIEL*; T. LACEY; R.
KINGSTON; C. M. MARKHAM. Spelman Col., Morehouse
Col., Spelman Col., Morehouse Col.
1:00 III20 452.21 The effects of exercise on resilience to
social defeat stress in syrian hamsters. C. M. MARKHAM*;
R. KINGSTON; J. BEST; M. EDWARDS. Morehouse Col.,
Spelman Col., Morehouse Col.
2:00 III21 452.22 Fear conditioning increases GABA
release from cerebellar stellate cells. C. DUBOIS*; S. LIU.
LSUHSC.
3:00 III22 452.23 Sex-specific modulation of trace fear
acquisition by pituitary adenylate cyclase activatingpolypeptide signaling in the medial prefrontal cortex. A. J.
KIRRY*; M. R. HERBST; S. E. POIRIER; R. C. TWINING; M.
R. GILMARTIN. Marquette Univ.
4:00 III23 452.24 Neural dynamics of fear conditioning.
S. YIN*; Y. LIU; A. KEIL; M. DING. Univ. of Florida, Univ. of
California, Davis, Univ. of Florida.

1:00 III24 452.25 Virtual burrow assay for measuring

aversion to conditioned stimuli. C. E. SCHOONOVER*; A. J.
P. FINK; R. AXEL. Columbia Univ.

4:00 III11 452.12 Lesions of the ventromedial prefrontal

cortex reduce stress enhanced fear learning in a stimulus
specific manner. Z. T. PENNINGTON*; A. S. ANDERSON; M.
S. FANSELOW. UCLA, UCLA.

2:00 III25 452.26 Parametric characterization of a novel

one way active avoidance learning on a treadmill using head
fixed mice. H. JIE*; T. GEILLER; S. ROYER; J. CHOI. Korea
Univ., Korea Inst. of Sci. and Technol., Korea Univ.

1:00 III12 452.13 Genetically encoding an in vivo tag

of synaptic plasticity associated with memory. D. B.
WEATHERILL*; R. TANNA; K. C. MARTIN; S. CHATTARJI;
M. S. FANSELOW. UCLA, UCLA, UCLA, Natl. Ctr. For Biol.
Sci.

3:00 III26 452.27 Behavioral correlates of neuronal

allocation in auditory fear conditioning. J. L. STRAIGHT*; C.
MCINTYRE. Univ. of Texas At Dallas.

2:00 III13 452.14 Incubation of Pavlovian fear responding:

Behavioral and neural correlates of recent and remote
memory using between- and within-subject designs. N.
ODYNOCKI*; P. R. ZAMBETTI; A. M. POULOS. Univ. At
Albany State Univ. of New York.
3:00 III14 452.15 Neural tract tracing-based modeling
of contextual fear circuits across development in rats.
A. J. SANTARELLI*; K. N. NEGISHI; A. M. KHAN; A. M.
POULOS. The State Univ. of New York At Albany, Univ. of
Texas at El Paso.
4:00 III15 452.16 Mapping time- dependent contextual
processing and immediate early gene expression in
hippocampal and extra- hippocampal regions in C57Bl/6J
mice. L. M. COLON*; T. WINSTON; A. POULOS. Univ. At
Albany State Univ. of New York.
1:00 III16 452.17 Hemodynamic changes in frontoparietal
networks predict electrocortical population activity in visual
cortex during aversive conditioning. N. M. PETRO*; L. F.
GRUSS; S. YIN; H. HUANG; V. MISKOVIC; M. DING; A.
KEIL. Univ. of Florida, Univ. of Florida, Univ. of Florida, State
Univ. of New York at Binghamton.

138 | Society for Neuroscience

4:00 III27 452.28 The role of acid sensing ion channel 1A

in Pavlovian reward learning. A. GHOBBEH*; S. ALAM; R. J.
TAUGHER; R. FAN; R. T. LALUMIERE; J. A. WEMMIE. The
Univ. of Iowa, The Univ. of Iowa.

POSTER
453. Motivation Neurocircuitry: Thalamus and Hypothalamus
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 III28 453.01 Lateral habenular-projecting
hypothalamic neurons regulate food preference in rats. R. M.
OCONNOR*; P. J. KENNY. Icahn Sch. of Medicine, Mount
Sinai.
2:00 III29 453.02 Lateral habenula orexin receptor-2
signaling controls aggression reward. M. FLANIGAN*; H.
ALEYASIN; A. TAKAHASHI; E. S. CALIPARI; C. MENARD;
M. PFAU; S. J. RUSSO. Icahn Sch. of Med. At Mount Sinai,
Univ. of Tsukuba.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 III30 453.03 Neuroanatomical and electrophysiological

studies of Gad2-expressing neurons in the lateral habenula.
A. W. WALKER*; L. A. QUINA; G. R. MORTON; Y. A. HSU;
A. WEI; E. E. TURNER. Seattle Childrens Res. Inst.
4:00 III31 453.04 Hypothalamic and midbrain peptidergicaminergic pathways modulate intrinsic GABAergic signaling
in the lateral habenula: A study using in vivo juxtacellular
labelling, retrograde tracing, IHC and confocal microscopy.
L. ZHANG*; V. S. HERNANDEZ; L. E. EIDEN. Natl.
Autonomous Univ. of Mexico, NIMH-IRP, NIH.
1:00 III32 453.05 Stimulation-induced Fos-like
immunoreactivity following electrolytic lesions of the dorsal
diencephalic conduction system. M. FAKHOURY*; D.
VOYER; D. LVESQUE; P. ROMPR. Univ. of Montreal.
2:00 III33 453.06 A hypothalamic circuit controlling
aggressive motivation and action. A. L. FALKNER*; R.
TREMBLAY; I. SCHMITT; B. RUDY; M. HALASSA; D. LIN.
NYU Sch. of Med., NYU Sch. of Med.

4:00 III35 453.08 Initial chemoarchitectural analysis of the

infralimbic, prelimbic, and anterior cingulate areas of cerebral
cortex in the adult male rat: Novel maps within a canonical
atlas space. K. NEGISHI*; S. N. RODARTE; O. KOLENC; A.
M. KHAN. UNIVERSITY OF TEXAS AT EL PASO, Univ. of
Texas at El Paso.
1:00 III36 453.09 Using multi-scale, mixed media methods
to visualize and map electrophysiologically identified
glucose-sensing neurons within canonical brain atlas space.
E. PERU*; A. M. SANTIAGO; V. H. ROUTH; A. M. KHAN.
Univ. of Texas At Univ., Rutgers New Jersey Med. Sch., Univ.
of Texas at El Paso.
2:00 III37 453.10 Further elaboration of forebrain
and midbrain neuronal populations projecting to the
ventral tegmental area, with an emphasis on the lateral
hypothalamic area. E. M. WALKER*; B. DE HARO; J.
SCHUELER; R. H. THOMPSON; A. M. KHAN. Univ. of Texas
El Paso, Univ. of Texas El Paso, Univ. of Texas El Paso,
Univ. of Texas El Paso, USC, Univ. of Texas El Paso.
3:00 III38 453.11 Further elaboration of arcuate
hypothalamic nucleus circuitry based on retrograde studies
in the adult male rat. A. MARTINEZ*; B. E. PINALES; A. M.
KHAN. Univ. of Texas At El Paso.
4:00 III39 453.12 Migration, spatial alignment, and
registration of multi-scale neuroscientific datasets related to
the control of motivated behaviors within canonically defined
maps of the lateral hypothalamic area. A. E. HERNANDEZ*;
A. M. KHAN. Univ. of Texas At El Paso, Univ. of Texas At El
Paso.
1:00 III40 453.13 High spatial resolution mapping of AgoutiRelated Peptide-immunoreactive axons to a canonical rat
brain atlas. B. E. PINALES*; J. D. HAHN; A. M. KHAN. Univ.
of Texas At El Paso, USC, Univ. of Texas at El Paso.
2:00 III41 453.14 Involvement of lateral hypothalamus
orexin circuits in cocaine demand. C. PANTAZIS*; E. M.
MCGLINCHEY; G. ASTON-JONES. Rutgers Univ., Med.
Univ. of South Carolina.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 III43 453.16 Intermittent access to cocaine increases

demand for cocaine in an orexin/hypocretin-dependent
manner. M. H. JAMES*; C. M. STOPPER; N. E. KOLL; B. A.
ZIMMER; G. ASTON-JONES. Brain Hlth. Inst.
1:00 III44 453.17 Attenuating noradrenergic or serotonergic
signaling in hippocampus during initial abstinence from
cocaine persistently decreases later relapse to cocaine
seeking in a sex-dependent manner. A. S. KOHTZ*; G.
ASTON-JONES. Brain Hlth. Inst.
2:00 III45 453.18 The role of oxytocin neuron activity in
drug-seeking during initial abstinence from cocaine selfadministration. B. LIN*; A. KOHTZ; M. SMITH; G. ASTONJONES. Rutgers Univ., Rutgers Univ., Med. Univ. of South
Carolina.
3:00 III46 453.19 A critical role for melanopsin in light
deprivation-induced depression. H. E. BOWREY*; M. H.
JAMES; G. ASTON-JONES. Rutgers Univ.
4:00 III47 453.20 Collateralization of projections from
neurons in the PVT to the nucleus accumbens, bed nucleus
of the stria terminalis, and central nucleus of the amygdala.
X. DONG*; S. LI; G. J. KIROUAC. Univ. of Manitoba, Univ. of
Manitoba.
1:00 III48 453.21 Differential activity in the circuitry of
the paraventricular nucleus of the thalamus following
presentation of an incentive vs. a reward-predictive
stimulus. J. L. HAIGHT*; Z. L. FULLER; K. M. FRASER; S.
B. FLAGEL. Univ. of Michigan, Univ. of Michigan, Univ. of
Michigan, Univ. of Michigan.
2:00 III49 453.22 Lateral hypothalamus glutamatergic
projections to VTA mediate escape responses and aversion
in mice. M. F. BARBANO*; H. WANG; M. MORALES. Johns
Hopkins Univ., Natl. Inst. on Drug Abuse.
3:00 III50 453.23 Comparison of stimulations of the
lateral preoptic area and ventral pallidum using measures
of reward, anxiety and ingestion. R. A. REICHARD*; K. P.
PARSLEY; S. SUBRAMANIAN; D. S. ZAHM. St. Louis Univ.
Med. Sch.
4:00 III51 453.24 Chemogenetic activation of the lateral
hypothalamus reverses early life stress-induced anhedonia.
E. J. CAMPBELL*; C. D. ADAMS; C. S. MITCHELL; D. M.
HODGSON; C. V. DAYAS. Univ. of Newcastle.

POSTER
454. Neurocircuitry of Emotion: Brain Stimulation and
Synchronization
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 DP07 454.01 (Dynamic Poster) A multi-modality
visualization tool. N. PELED*; O. FELSENSTEIN; R.
LAPLANTE; T. SITNIKOVA; S. ZOROWITZ; A. AFZAL; A.
GILMOUR; K. K. ELLARD; D. L. VALLEJO; A. C. PAULK;
K. FARNES; T. DECKERSBACH; S. STUFFLEBEAM;
M. HAMALAINEN; A. S. WIDGE; S. S. CASH; D. D.
DOUGHERTY; E. N. ESKANDAR. MGH/HST Martinos Ctr.
For Biomed. Imaging, Harvard, Bar-Ilan university, Mass
Gen. Hosp., Mass Gen. Hosp., Mass Gen. Hosp.
Neuroscience 2016|Monday PM|139

Mon. PM

3:00 III34 453.07 Elaboration of hypothalamic

chemoarchitecture of the adult male rat: A high spatial
resolution mapping study of melanin-concentrating hormone,
hypocretin/orexin, and calbindin immunoreactivities
in multiple subjects. C. DARCY*; A. MARTINEZ; L. F.
ARANDA; H. F. L. CERVANTES; L. E. CHACON; R. P.
CORDERO; V. FERNANDEZ; G. A. GARCIA; S. HOLGUIN;
A. JAQUEZ; T. G. MIRAMONTES; B. MONTAO; P. C.
MUOZ; I. R. VALENZUELA; J. S. YU; A. M. KHAN. Univ.
Texas El Paso, Univ. of Texas at El Paso.

3:00 III42 453.15 Methylphenidate reverses attention

deficits induced by chemogenetic stimulation of the locus
coeruleus in rats performing a 2-alternative forced-choice
task. M. A. PRESKER*, JR; E. M. VAZEY; J. ZHANG; A.
SNYDER; G. ASTON-JONES. Rutgers- The State Univ. of
New Jersey, Univ. of Massachusetts.

2:00 III52 454.02 Representations of aversive risk and

decision conflict in the human subthalamic nucleus and
globus pallidus internus. T. HERRINGTON*; S. PATEL;
K. KANOFF; S. TSAI; S. ZOROWITZ; T. SITNIKOVA; K.
ELLARD; T. DECKERSBACH; A. WIDGE; D. DOUGHERTY;
E. ESKANDAR. Massachusetts Gen. Hosp. Dept. of Neurol.,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.
3:00 JJJ1 454.03 Bayesian state-space modeling of
reversal learning in fmri. S. ZOROWITZ*; A. AFZAL;
T. DECKERSBACH; K. K. ELLARD; A. L. GILMOUR;
D. D. DOUGHERTY; E. N. ESKANDAR; A. S. WIDGE.
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp.
4:00 JJJ2 454.04 Neural stimulation induces changes in
behavior and neural responsiveness in the Emotion Conflict
Resolution (ECR) task. A. C. PAULK; D. I. VALLEJOLOPEZ; A. DOMINGUEZ; N. NOSSENSON; N. PELED;
A. YOUSEFI; K. K. ELLARD; S. ZOROWITZ; A. AFZAL; B.
CROCKER; I. BASU; T. SITNIKOVA; T. DECKERSBACH;
D. D. DOUGHERTY; E. N. ESKANDAR; S. S. CASH; A. S.
WIDGE*. Massachusetts Gen. Hosp., Massachusetts Gen.
Hosp., Massachusetts Gen. Hosp., Massachusetts Gen.
Hosp.
1:00 JJJ3 454.05 A biophysical model of electrical
stimulation evoked responses in cortical and subcortical
brain regions of the human and non human primate. I.
BASU*; A. C. PAULK; K. FARNES; M. M. ROBERTSON; B.
CROCKER; D. I. VALLEJO-LOPEZ; D. D. DOUGHERTY; S.
S. CASH; E. N. ESKANDAR; M. KRAMER; A. S. WIDGE.
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., Boston Univ.
2:00 JJJ4 454.06 Functional inference distinguishes
task and stimulation states across cortical and
subcortical networks. N. R. PROVENZA*; K. FARNES; N.
NOSSENSON; M. M. ROBERTSON; D. VALLEJO-LOPEZ;
A. C. PAULK; N. PELED; M. W. MCCONLEY; S. H. CHIN;
P. D. PARKS, II; D. DOUGHERTY; S. S. CASH; E. N.
ESKANDAR; A. S. WIDGE; D. A. BORTON. Brown Univ.,
Draper, Massachusetts Gen. Hosp., Massachusetts Gen.
Hosp., MGH/HST Martinos Ctr. for Biomed. Imaging, Boston
Univ., Massachusetts Gen. Hosp., Brown Univ.
3:00 JJJ5 454.07 An exploration of stimulation effects
in the non-human primate brain. M. M. ROBERTSON; A.
C. PAULK; I. BASU; J. CHENG; C. MARTINEZ-RUBIO;
J. EICHENLAUB*; D. DOUGHERTY; S. S. CASH; A. S.
WIDGE; E. N. ESKANDAR. Massachusetts Gen. Hosp.,
Johns Hopkins Hosp., Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.
4:00 JJJ6 454.08 Characterizing stimulation-evoked
synchrony in brain networks. A. YOUSEFI*; A. C. PAULK; I.
BASU; B. NAZARI; K. B. FARNES; M. M. ROBERTSON; B.
CROCKER; S. S. CASH; D. D. DOUGHERTY; A. S. WIDGE;
E. N. ESKANDAR; U. T. EDEN. MGH, Isfahan Univ. of
Technol., MGH, MGH, Boston Univ.

2:00 JJJ8 454.10 Oscillatory synchronization enables

dynamic information processing to resolve reward
seeking vs. risk avoidance conflict. T. A. SITNIKOVA*; S.
ZOROWITZ; A. AFZAL; A. L. GILMOUR; K. K. ELLARD;
T. M. HERRINGTON; S. PATEL; A. C. PAULK; M.
HAMALAINEN; S. STUFFLEBEAM; A. S. WIDGE; D. D.
DOUGHERTY; E. N. ESKANDAR; T. DECKERSBACH.
Massachusetts Gen. Hosp. & Harvard Med. Sch.,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp. &
Harvard Med. Sch.
3:00 JJJ9 454.11 Behavioral and neurophysiological
dynamics during resolution of cognitive or emotional conflict.
K. B. FARNES; A. C. PAULK*; D. VALLEJO-LOPEZ; M.
M. ROBERTSON; N. NOSSENSON; N. PELED; K. K.
ELLARD; S. ZOROWITZ; A. AFZAL; T. SITNIKOVA; T.
DECKERSBACH; D. DOUGHERTY; E. N. ESKANDAR;
A. S. WIDGE; S. S. CASH. Massachusetts Gen. Hosp.,
Massachusetts Gen. Hosp., Massachusetts Gen. Hosp.,
MGH/HST Martinos Ctr. for Biomed. Imaging, Massachusetts
Gen. Hosp., MGH/HST Martinos Ctr. for Biomed. Imaging.
4:00 JJJ10 454.12 The control of firing patterns of midbrain
periaqueductal gray neurons in vivo. H. H. SUBRAMANIAN*;
P. A. SILBURN. The Univ. of Queensland.
1:00 JJJ11 454.13 Optogenetic stimulation of the excitatory
parabrachial projections to central amygdala induces
anxiety- and depression-like behaviors in rats. Y. CAI; Z. Z.
PAN*. UT-MD Anderson Cancer Ctr.
2:00 JJJ12 454.14 Pathway-specific optogenetic
manipulations to induce long-lasting changes in anxietyrelated behavior. A. C. FELIX-ORTIZ*; G. G. CALHOON;
A. BURGOS-ROBLES; P. NAMBURI; K. ANANDALINGAM;
N. D. BHAGAT; K. M. TYE. Picower Inst. for Learning and
Memory, MIT, Harvard-MIT Hlth. Sci. and Technol. Program,
Northeastern Univ.
3:00 JJJ13 454.15 Negative over positive: Unidirectional
inhibitory interaction among amygdala projection neurons. G.
G. CALHOON*; A. BEYELER; P. NAMBURI; G. GLOBER; K.
M. TYE. MIT.
4:00 JJJ14 454.16 A cortico-amygdala circuit encodes
observational fear learning. S. A. ALLSOP*; A. C. FELIXORTIZ; R. WICHMANN; A. VIENNE; A. BEYELER; E. H.
NIEH; D. BA; A. C. SMITH; A. EDMONDS; A. MAGZOUB; E.
BROWN; K. M. TYE. M.I.T., M.I.T., Harvard Univ.
1:00 JJJ15 454.17 Transcranial alternating current
stimulation reduced negative emotions and functional
integration of anterior cingulate cortex. K. ONODA*; T.
KAWAGOE; H. ZHENG; S. YAMAGUCHI. Shimane Univ.
2:00 JJJ16 454.18 The neural basis of the human affective
startle modulation- evidence from two independent
studies using parallel EMG-fMRI. M. KUHN*; J. WENDT;
R. SJOUWERMAN; M. MLLER; C. BCHEL; T. B.
LONSDORF. Univ. Med. Ctr. Hamburg-Eppendorf, Univ. of
Greifswald.

1:00 JJJ7 454.09 Multimodal exploration of decisionmaking in the human subthalamic nucleus. S. R. PATEL*;
T. HERRINGTON; S. SHETH; M. MIAN; S. BOURNE; S.
ZOROWITZ; A. AFZAL; T. DECKERSBACH; A. WIDGE; D.
DOUGHERTY; E. ESKANDAR. Massachusetts Gen. Hosp.

140 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

POSTER
455. Circuitry and Substrates of Fear
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 JJJ17 455.01 noradrenergic blockade in the
basolateral amygdala, but not the medial prefrontal cortex,
rescues the immediate extinction deficit. T. F. GIUSTINO*;
J. R. SEEMANN; G. M. ACCA; T. D. GOODE; P. J.
FITZGERALD; S. MAREN. Inst. For Neurosci., Texas A&M
Inst. for Neurosci.
2:00 JJJ18 455.02 Single neurons in the medial prefrontal
cortex of freely moving rats signal fear renewal. P. J.
FITZGERALD*; T. F. GIUSTINO; S. MAREN. Texas A&M
Univ.
3:00 JJJ19 455.03 Opposing inhibition in prelimbic prefrontal
neurons impairs active avoidance. M. M. DIEHL*; G. J.
QUIRK. Univ. of Puerto Rico, Sch. of Med.
4:00 JJJ20 455.04 Hippocampal-prefrontal projection
mediates contextual fear memory retrieval. J. JIN*; T.
GOODE; Q. WANG; S. MAREN. Texas A&M Univ., Dept. of
Biology, Texas A&M Univ.

2:00 JJJ22 455.06 Nucleus reuniens mediates the encoding

of extinction memories. K. R. RAMANATHAN*; J. JIN; S.
MAREN. Texas A&M Univ., Texas A&M Univ., Texas A&M
Univ.
3:00 JJJ23 455.07 TRPV1 receptors modulate aversive
responses and social behavior in rodentes. A. B. TERZIAN*;
L. RESSTEL. Univ. of So Paulo.
4:00 JJJ24 455.08 TRPV1 receptor of the ventral portion of
medial prefrontal cortex modulates conditioned emotional
response: Involvement of local glutamatergic and nitrergic
system. D. L. ULIANA*; L. S. ANTERO; S. F. LISBOA; L. B.
M. RESSTEL. Sch. of Med. of Ribeiro Preto- USP.
1:00 JJJ25 455.09 The expression of contextual fear
conditioning involves ACh release and activation of M1M3 muscarinic receptors/NO/cGMP pathway in the dorsal
hippocampus of rats. L. ANTERO*; D. L. ULIANA; L. B.
RESSTEL. Ribeiro Preto Med. Sch.- USP.

3:00 JJJ31 455.15 Social buffering during fear

memory extinction involves medial prefrontal cortex. T.
GORKIEWICZ*; K. ROKOSZ; K. MEYZA; E. KNAPSKA.
Nencki Inst.
4:00 JJJ32 455.16 Role of dopaminergic D2 receptors of
globus pallidus in anxiety response in rat. G. AVILA; E.
CHUC-MEZA; O. PICAZO; M. GARCIA-RAMIREZ*. ENCBIPN, ENCB-IPN, ESM-IPN, ENCB-IPN.
1:00 JJJ33 455.17 Histamine in the basolateral amygdala
promotes inhibitory avoidance learning independently of
hippocampus. F. BENETTI*; C. R. G. FURINI, Furini, CR;
J. C. MISKYW, Miskyw, JC; I. IZQUIERDO; E. BALDI;
G. PROVENSI; C. BUCHERELLI; M. B. PASSANI; P.
BLANDINA. Univ. Federal Do Rio Grande Do Sul, Pontifical
Catholic Univ. of Rio Grande do Sul, Pontifical Catholic Univ.
of Rio Grande do Sul, Univ. di Firenze.
2:00 JJJ34 455.18 Cortical drive to the extended amygdala
modulates stress-induced behavior in mice. K. S. GIRVEN*;
D. SPARTA. Univ. of Maryland, Baltimore.
3:00 JJJ35 455.19 Neuronal correlates for neuroendocrine
adaptation to repeated stress. S. MATOVIC*; E. W. SALTER;
X. WANG; W. INOUE. Robarts Res. Inst., Robarts Res. Inst.
4:00 JJJ36 455.20 C-Fos activation mapping of the bed
nucleus of the stria terminalis in response to multimodal
stress-inducing stimuli. X. LIN*; K. SAMI; M. LI; F. BERTON;
W. FRANCESCONI; X. XU. Univ. of California Irvine, The
Scripps Res. Inst.
1:00 JJJ37 455.21 Distinct neural projections from the
anteroventral bed nuclei of the stria terminalis modulate
the endocrine and behavioral stress responses. S. B.
JOHNSON*; R. M. ANDERSON; E. B. EMMONS; S. A.
ROMIG-MARTIN; N. S. NARAYANAN; R. T. LALUMIERE; J.
J. RADLEY. Univ. of Iowa, Univ. of Iowa.
2:00 JJJ38 455.22 Topographic gene expression analysis
of the nucleus accumbens shell and ventral tegmental
area yields novel therapeutic target possibilities for anxiety,
depression, and drug addiction. E. J. CROFTON*; Y.
ZHANG; S. KOSHY; T. A. GREEN. Univ. of Texas Med. Br.
3:00 JJJ39 455.23 Modulation of the endocannabinoid
system within the nucleus accumbens shell elicits
anxiolytic-like effects in rats. T. PARDO*; N. YUSIF; C. S.
MALDONADO. Univ. of Puerto Rico- Rio Piedras Campus.

2:00 JJJ26 455.10 Subcortical projection-specific control of

innate anxiety and learned fear by the ventral hippocampus.
J. C. JIMENEZ*; A. GOLDBERG; G. ORDEK; V. M. LUNA;
K. SU; S. PENA; L. ZWEIFEL; R. HEN; M. KHEIRBEK.
Columbia Univ., Univ. of California, San Francisco, Columbia
Univ., Univ. of Washington.

4:00 JJJ40 455.24 The anxiolytic effect of elevated

2-Arachidonoylglycerol signalling in the basolateral
amygdala is mitigated by heightened levels of emotional
arousal. K. LEITL*; M. MORENA; H. VECCHIARELLI;
M. GRAY; P. CAMPOLONGO; M. HILL. Univ. of Calgary,
Sapienza.

3:00 JJJ27 455.11 Differential role of the hippocampal &

basolateral amygdalar endocannabinoid neurotransmission
in the modulation of fear memory retrieval in rats. B.
RUBINO; M. CARLUCCI; E. SANTI; P. RATANO; P.
CAMPOLONGO*. Sapienza Univ. of Rome.

1:00 JJJ41 455.25 ASIC1a in ASIC4-positive neurons is

important for innate fear and anxiety phenotypes. Y. CHIEN*;
S. LIN; C. CHEN. Academia Sinica/Institute of Biomed. Sci.,
Inst. of Biomed. Sciences, Academia Sinica, Taiwan Mouse
Clinic, Natl. Comprehensive Mouse Phenotyping and Drug
Testing Center, Academia Sinica.

4:00 JJJ28 455.12 Effects of intra-amygdaloid injection of the

D1 antagonist SCH23390 on the fear/anxiety induced by the
exposure to a living cat in rats. E. N. LEVARIO RAMREZ*;
M. CRESPO RAMREZ; M. PREZ DE LA MORA. UNAM.

2:00 JJJ42 455.26 Circuit-specific plasticity of inhibitory

synapses on VTA dopamine neurons. K. BARCOMB*; A. M.
POLTER; A. C. TSUDA; J. A. KAUER. Brown Univ.

1:00 JJJ29 455.13 A central amygdala to BNST circuit that

regulates anxiety. S. AHRENS*; B. LI. Cold Spring Harbor
Lab.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|141

Mon. PM

1:00 JJJ21 455.05 Reversible inactivation of the bed

nucleus of the stria terminalis disrupts the expression of fear
to unpredictable threats. T. D. GOODE*; G. M. ACCA; S.
MAREN. Texas A&M Univ.

2:00 JJJ30 455.14 Netrin-G1 regulates fear and anxiety in

dissociable neural circuits. Q. ZHANG*; S. ITOHARA. Riken.

POSTER
456. Post-Traumatic Stress Disorder: Models
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 JJJ43 456.01 Sex-specific phenotypes in a rat model
of post-traumatic stress disorder (PTSD). A. POOLEY*; A.
J. ROBISON; M. S. MAZEI-ROBISON; A. L. EAGLE; S. M.
BREEDLOVE; C. L. JORDAN. Michigan State Univ.
2:00 JJJ44 456.02 Vagus nerve stimulation reverses
extinction impairments and alters PTSD symptoms in the
SPS animal model. L. J. NOBLE*; I. J. GONZALEZ; V. B.
MERUVA; A. K. HUTCHINSON; T. DAM; S. K. THOMAS; E.
MEYERS; M. P. KILGARD; C. K. MCINTYRE. Univ. of Texas
At Dallas.
3:00 JJJ45 456.03 A preclinical mouse model of traumatic
memory storage- implications for PTSD. S. SILLIVAN*; N.
JOSEPH; C. MILLER. The Scripps Res. Institute-Florida.
4:00 JJJ46 456.04 PTSD-like behavioral profile of mice
with full 5-HT2C receptor editing: Response to paroxetine
treatment. M. RGUE; C. POILBOUT; L. LANFUMEY*;
R. MONGEAU. INSERM 894 Ctr. of Psychiatry and
Neurosciences, Univ. Paris Descartes.
1:00 JJJ47 456.05 Alternations in fear behavior following
acute stress in adrenalectomized rats: Involvement of
kynurenic acid and implications for PTSD. D. J. BUCCI*;
N. E. DEANGELI; K. S. HERRINGTON; H. WU; R.
SCHWARCZ. Dartmouth Col., Maryland Psych Res. Ctr.
2:00 JJJ48 456.06 Influence of estrous stage on the
behavioral response of female rats to a predator-based
psychosocial stress model of PTSD. E. D. EISENMANN*; R.
M. ROSE; M. E. FRY; B. L. JOHNSON; M. R. HUNTLEY; M.
E. HEIKKILA; B. A. KOHLS; P. R. ZOLADZ. Ohio Northern
Univ.
3:00 JJJ49 456.07 Clonidine prevents the anxiogenic,
but not cardiovascular, consequences of a predatorbased psychosocial stress model of PTSD. M. E. FRY*;
E. D. EISENMANN; R. M. ROSE; B. L. JOHNSON; M.
R. HUNTLEY; M. E. HEIKKILA; K. L. ROBINSON; B. R.
RORABAUGH; P. R. ZOLADZ. Ohio Northern Univ., Ohio
Northern Univ.
4:00 JJJ50 456.08 Decreased voluntary ethanol
consumption in a predator-based psychosocial stress
model of PTSD. R. M. ROSE*; E. D. EISENMANN; B. L.
JOHNSON; M. E. FRY; M. E. HEIKKILA; M. R. HUNTLEY; P.
R. ZOLADZ. Ohio Northern Univ.
1:00 JJJ51 456.09 Adolescent trauma results in distinct
behavioral covariates and neural activation patterns in
habenula associated brain regions. G. I. ELMER*; J. R.
SCHANK; J. MITCHELL; R. DAMAZDIC; C. L. MAYO; D.
BRADY; A. PINCUS; C. KING; M. HEILIG; J. D. TAPOCIK.
Maryland Psychiatric Res. Ctr., NIAAA, NIH, Colby.

2:00 JJJ52 456.10 Susceptibility to traumatic stress

predicts elevations in cocaine self-administration and the
dopaminergic response to cocaine. Z. D. BRODNIK*; M.
CLARK; K. KORNSEY; R. A. ESPAA, 19129. Drexel Univ.,
Drexel Univ. Col. of Med.
3:00 JJJ53 456.11 Awake resting-state fMRI in a posttraumatic stress disorder rat model. P. D. PEREZ*;
D. DOPFEL; L. ANTINORI; J. RUDDY; N. ZHANG.
Pennsylvania State Univ.

142 | Society for Neuroscience

4:00 JJJ54 456.12 Do opiate and hypothalamus-pituitaryadrenal gland systems affect fear, depression, and
movement behaviors for posttraumatic stress disorder
in rats? C. CHIU*; A. C. W. HUANG. Fo Guang Univ.,
Psychology, Fo Guang Univ.
1:00 JJJ55 456.13 Oxytocin attenuates stress-induced
reinstatement of alcohol seeking in mice with a history of
trauma. C. KING*; W. C. GRIFFIN; J. F. MCGINTY; H. C.
BECKER. Med. Univ. of South Carolina.
2:00 JJJ56 456.14 Effects of acute immobilization stress on
brain network functional connectivity and its use as a PTSD
model. D. DOPFEL*; N. ZHANG. Pennsylvania State Univ.,
Pennsylvania State Univ.
3:00 JJJ57 456.15 Role of 2-adrenergic receptors in
modulating post-traumatic stress disorder-like behaviors in
a novel fearful DxH congenic recombinant inbred mouse
strain with a DBA/2J background. R. WICKRAMASEKARA;
Y. FARHAT; S. AKKOSEOGLU; D. M. YILMAZER-HANKE*.
Creighton Univ.
4:00 JJJ58 456.16 Single prolonged stress-induced
deficits in fear extinction recall are affected by exposure to
functional modulators of astrocytic glutamate transport. T. S.
COTRONE; B. S. JORTNER*; M. F. EHRICH; B. G. KLEIN.
Virginia Tech, Col. of Vet. Med., VA-MD Regional Col. Vet
Med.
1:00 JJJ59 456.17 Animal models of post traumatic stress
disorder: Behavioral characterization and pharmacological
validation. I. MORGANSTERN*; Q. CHANG; A. CHOO; L.
THIEDE; K. HOMA; E. SABATH; W. ALVINS; J. SUTPHEN;
M. LANG; S. DAVIS; T. HANANIA. Psychogenics.
2:00 JJJ60 456.18 Acetylcholinesterase (AChE)
heterozygous mice present with a postraumatic stress
disorder-like phenotype. K. SMITH*; R. M. RODRIGUIZ;
J. S. COLVIN; M. W. PEASE; N. NGUYEN; C. KIM; J. J.
WILKINS; D. E. WILLIAMSON; W. C. WETSEL. UT Hlth. Sci.
Ctr. San Antonio, Duke Univ., Duke Univ., Duke Univ., Duke
Univ.
3:00 JJJ61 456.19 Acute nicotine enhances spontaneous
recovery of contextual fear and changes c-fos early
gene expression in infralimbic cortex, hippocampus, and
amygdala. J. TUMOLO*; B. GARRETT; M. G. KUTLU; E.
HOLLIDAY; T. J. GOULD. Temple Univ., Temple Univ.
4:00 KKK1 456.20 mGluR5 mediates both resilience
to traumatic stress and relapse to cocaine seeking. J.
SHALLCROSS*; L. KNACKSTEDT; M. SCHWENDT. Univ. of
Florida.
1:00 KKK2 456.21 Effects of single prolonged stress, a
PTSD model, on adult hippocampal neurogenesis and
extinction-retention. E. RODRIGUEZ*; I. LIBERZON. Univ. of
Michigan, Univ. of Michigan.
2:00 KKK3 456.22 Exploring novelty-seeking behaviours
and amphetamine sensitization in rats exposed to single
prolonged stress. K. THIRUMAL*; P. KENT; C. CAYER; J.
JAMES; H. ANISMAN; Z. MERALI. Carleton Univ., Royal
Ottawa Inst. of Mental Hlth. Res., Carleton Univ.
3:00 KKK4 456.23 Post-stress glucose eliminates PTSDlike symptoms following traumatic stress in rats: Temporal
constraints. N. SMITH*; M. A. CONOSCENTI; T. R. MINOR.
UCLA.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

4:00 KKK5 456.24 IGFBP2 induces resilience to stress

in rats via a novel non-IGF1 or AMPA receptor dependent
mechanism. J. S. BURGDORF*; E. M. COLECHIO; N.
GHOREISHI-HAACK; A. L. GROSS; X. ZHANG; P. L.
STANTON; R. L. KROES; J. R. MOSKAL. Northwestern
Univ., Aptinyx Inc., New York Med. Col., New York Med. Col.
1:00 KKK6 456.25 The role of Akt signaling in persistent
fear expression in a rodent model of post traumatic stress
disorder. D. K. KNOX*; T. DEPIETRO; J. STAIB; M.
CHAMNESS; E. MOULTON. Univ. of Delaware.
2:00 KKK7 456.26 Effects of glucose on learned
helplessness behavior with a novel control condition. N.
C. CHRISTIE*; M. A. CONOSCENTI; T. R. MINOR. UCLA,
UCLA.
3:00 KKK8 456.27 Establishing a modified model of PTSD
in adolescent rats. A. L. GARRISON*; E. N. WALSH; J. M.
SMITH; T. E. KOELTZOW. Bradley Univ.
4:00 KKK9 456.28 Combined single prolonged stress
(SPS) and CO2 inhalation as a novel model of comorbid
post-traumatic stress disorder (PTSD) and panic disorder
associated behaviors in mice. K. M. MCMURRAY*; J. D.
SCHURDAK; L. L. VOLLMER; R. SAH. Univ. of CincinnatiReading Campus, Univ. of Cincinnati, Cincinnati VA.

POSTER
457. Amphetamines: Behavioral Studies
Theme G: Motivation and Emotion
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 KKK11 457.01 Relationship between methamphetamine
use, reinforcement and seeking in mice with high genotypedependent methamphetamine intake. S. SHABANI*; E. I.
MOJICA; L. HELLMUTH; S. HOULTON; T. J. PHILLIPS.
Minot State Univ., Methamphetamine Abuse Res. Center,
Oregon Hlth. & Sci. Univ., Veterans Affairs Portland Hlth.
Care Syst.
2:00 KKK12 457.02 Context-independent effects of footshock
on drug-seeking. C. PIZZIMENTI*; T. NAVIS; K. M. LATTAL.
Oregon Hlth. and Sci. Univ., Oregon Hlth. & Sci. Univ.
3:00 KKK13 457.03 Examination of sex dependent neural
substrates correlated with meth triggered reinstatement in
rats. S. T. PITTENGER*; S. CHOU; S. T. BARRETT; O. D.
LOH; R. A. BEVINS. Univ. of Nebraska-Lincoln, Univ. of
Nebraska Med. Ctr.

4:00 KKK14 457.04 Cue-induced relapse to

methamphetamine seeking in compulsive methamphetamine
takers and abstinent rats. I. N. KRASNOVA*; N. TERRY; M.
MCCOY; B. LADENHEIM; J. CADET. NIDA, NIH, DHHS.
1:00 KKK15 457.05 Effects of Ro5-4864 on
methamphetamine self-administration in male and female
rats. G. F. GUERIN*; S. M. HAROLD; S. R. PORTER; C.
D. SCHMOUTZ; G. LI; J. M. COOK; N. E. GOEDERS.
LSUHSC-S, Univ. of Wisconsin-Milwaukee.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 KKK17 457.07 Effects of oxytocin following traumatic

stress on methamphetamine seeking in female rats. C. E.
ONEILL*; R. J. NEWSOM; J. F. MCGINTY. Med. Univ. of
South Carolina.
4:00 KKK18 457.08 Rearing condition alters the ability
of ceftriaxone to attenuate cue and amphetamine
reinstatement. E. J. GARCIA*; D. L. ARNDT; M. E. CAIN.
Kansas State Univ.

1:00 KKK19 457.09 Self-administration of psychstimulants

via vapor inhalation in rats. M. A. TAFFE*; J. D. NGUYEN;
S. A. VANDEWATER; M. COLE. The Scripps Res. Inst., The
Scripps Res. Inst., La Jolla Alcohol Research, Inc.
2:00 KKK20 457.10 Sufficiency of dopamine receptor
stimulation in the reinstatement of methamphetamine
seeking. T. A. LARSON; M. C. WINKLER; R. K. BACHTELL*.
Univ. of Colorado, Univ. of Colorado.
3:00 KKK21 457.11 The 5-HT1B receptor agonists, CP 94,253
and zolmitriptan, attenuate the reinforcing and motivational
effects of methamphetamine. R. GARCIA*; A. R. COTTER;
K. LESLIE; K. ENNIS; T. BENSON; M. F. OLIVE; J. L.
NEISEWANDER. Arizona State Univ., Arizona State Univ.,
Arizona State Univ.
4:00 KKK22 457.12 Rewarding effects of a methamphetamine
and morphine speedball as assessed by ultrasonic
vocalizations in rats. T. T. TOWNER*; A. ROCHA; K. A.
TRUJILLO. California State Univ. San Marcos.
1:00 KKK23 457.13 Complex behavioral interactions between
dissociative drugs and methamphetamine. A. ESCOBEDO*;
K. A. TRUJILLO. California State Univ. San Marcos.
2:00 KKK24 457.14 Altered effort expenditure and intact
reward sensitivity for non-drug rewards in protracted
drug withdrawal. A. B. THOMPSON*; J. GERSON; A.
STOLYAROVA; A. BUGARIN; Z. GUTTMAN; J. JENTSCH;
A. IZQUIERDO. UCLA, Binghamton Univ.
3:00 KKK25 457.15 Recovery effects on behavior
and development during abstinence after chronic
methylphenidate treatment. D. FRICKE*; A.
VIJAYASHANTHAR; C. F. LOWINGER; L. B. JERMYN; L.
S. ROBISON; M. HADJIARGYROU; D. E. KOMATSU; P. K.
THANOS. Univ. At Buffalo, Stony Brook Univ., New York Inst.
of Technol., Stony Brook Univ.
4:00 KKK26 457.16 Separating the agony from ecstasy:
Prosocial effects and neurotoxicity of R(-)-3,4methylenedioxymethamphetamine in mice. D. W. CURRY*;
L. L. HOWELL. Emory Univ., Emory Univ.
1:00 KKK27 457.17 Effect of 1 receptor antagonist PD
144418 on methamphetamine self administration in rats. M.
TAPIA*; J. LEE; G. GEREAU; D. MILLER; M. WILL. Univ. of
Missouri.
2:00 KKK28 457.18 The effects of enriched environment on
the response to methamphetamine in adolescent and adult
mice. A. M. DAHLY; E. P. BAKER; E. C. MAGNUSON; J. H.
WEISS*; J. A. SIEGEL*. The Univ. of St. Thomas.

Neuroscience 2016|Monday PM|143

Mon. PM

1:00 KKK10 456.29 Chronic PTSD-like effects (after 6

months) in a mouse model of comorbid traumatic stress and
repetitive mTBI. M. ALGAMAL*; J. O. OJO; M. OWENS; M.
MULLAN; D. DIAMOND; F. CRAWFORD. Roskamp Inst.,
The Open Univ., James A. Haley Veterans Hosp., Univ. of
South Florida.

2:00 KKK16 457.06 Differential effects of ratio requirement on

reinforcing efficacy of synthetic cathinone analogs of MDMA.
S. B. DOLAN*; M. GATCH. Univ. of North Texas Hlth. Sci.
Ctr.

3:00 KKK29 457.19 Systemic administration of the GABAA

receptor antagonist bicuculline prevents the effects of the
administration of the 5-HT1A receptor agonist 8-OH-DPAT
on the discriminative signal of amphetamine in a conditioned
taste aversion procedure. F. MIRANDA-HERRERA*; A.
SANDOVAL-SNCHEZ; L. N. CEDILLO; J. C. JIMENEZ;
A. I. BARRIENTOS-NORIEGA; R. I. RUIZ-GARCIA. Univ.
Nacional Autonoma De Mexico.

4:00 KKK30 457.20 Apomorphine induced post-trial increases

or decreases in dopaminergic activation can reverse or
enhance catalepsy conditioning induced by haloperidol. M.
P. CARRERA*; R. J. CAREY; F. R. C. DIAS; L. R. OLIVEIRA;
B. G. SANTOS; J. L. L. SILVA. State Univ. of North
Fluminense, SUNY Upstate Med. Univ.

POSTER
458. Attention and Frontal Cortex
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 KKK31 458.01 Attentional effects on network dynamics
in local field potentials of primate lateral prefrontal cortex. M.
ABBASS*; L. DUONG; A. SACHS; J. MARTINEZ-TRUJILLO.
Univ. of Western Ontario, The Ottawa Hosp.
2:00 KKK32 458.02 Partially-segregated neuronal populations
in the lateral prefrontal cortex encode attended and
memorized visual features. D. MENDOZA-HALLIDAY*; J.
MARTINEZ-TRUJILLO. MIT, Western Univ.
3:00 KKK33 458.03 Chemogenetic inhibition of prefrontal
projection neurons and attentional capacities in forebrain
trkA-suppressed rats. V. V. PARIKH*; M. G. KUTLU; S.
JOSHI; B. YEGLA. Temple Univ.
4:00 KKK34 458.04 Real-time tagging of visual, saccadic,
spatial memory and attention prefrontal representations. S.
BEN HAMED*; C. WARDAK; E. ASTRAND. Inst. des Sci.
Cognitives Marc Jeannerod, Inst. des Sci. Cognitives Marc
Jeannerod, Mlardalen Univ.
1:00 KKK35 458.05 Reward strengthens the representation
of task-relevant information in the prefrontal cortex during
learning. B. MASSI*; C. H. DONAHUE; D. LEE. Yale Univ.,
UCSF.
2:00 KKK36 458.06 Micro- and macro-circuit components of a
putative attention filter. M. G. WHITE*; M. PANICKER; B. M.
ROBERTS; B. N. MATHUR. Univ. of Maryland, Sch. of Med.
3:00 KKK37 458.07 Prefrontal neurons fulfill criteria for
solving the credit assignment problem. W. F. ASAAD*; J.
PERGE; E. N. ESKANDAR. Brown Univ., Brown Univ.,
Massachusetts Gen. Hosp. / Harvard Med. Sch.
4:00 KKK38 458.08 Distractor suppression and distractor
interference in the light of direct real-time access to the
covert attentional spotlight from the frontal eye fields. F.
DI BELLO*; S. BEN HADJ HASSEN; E. ASTRAND; S.
BEN HAMED. Inst. Des Sci. Cognitives Marc Jeannerod,
Mlardalens Univ.
1:00 KKK39 458.09 Mapping connections of prefrontal cortex
using electrical microstimulation and fMRI in the macaque.
R. XU*; N. P. BICHOT; P. K. WEIGAND; A. TAKAHASHI; R.
DESIMONE. MIT.
2:00 KKK40 458.10 Effects of attention on neural activity
of orbitofrontal cortex. Y. XIE*; C. NIE; T. YANG. Inst. of
Neurosci.

144 | Society for Neuroscience

3:00 KKK41 458.11 Neuronal modulations in prefrontal cortex

are associated with multiple components of visuospatial
attention. T. Z. LUO*; J. H. R. MAUNSELL. The Univ. of
Chicago.
4:00 KKK42 458.12 Circuit mechanisms of prefrontal
contribution to visual behavior. R. HUDA*; G. PHO; L.
GUNTER; I. WICKERSHAM; M. SUR. Picower Inst. for
Learning and Memory, MIT, MIT.
1:00 KKK43 458.13 Comparison of the contribution from
superior colliculus and frontal eye field to covert spatial
attention. A. BOLLIMUNTA*; A. R. BOGADHI; R. J.
KRAUZLIS. Natl. Eye Inst.
2:00 KKK44 458.14 Prefrontal inter- and intra-hemispheric
neuronal noise correlations depend on the ongoing behavior.
S. BEN HADJHASSEN*; E. ASTRAND; C. WARDAK; S.
BEN HAMED. Inst. Des Sci. Cognitives Marc Jeannerod.
3:00 KKK45 458.15 Neural network properties are
dynamically modulated by attention in primate lateral
prefrontal cortex. L. DUONG*; M. ABASS; A. SACHS; J.
MARTINEZ-TRUJILLO. Robarts Res. Inst., Western Univ.,
The Ottawa Hosp., Robarts Res. Inst.
4:00 KKK46 458.16 Responses of frontal eye field neurons in
a visual foraging task. K. MIRPOUR*; Z. BOLANDNAZAR; J.
W. BISLEY. UCLA, UCLA, UCLA.
1:00 KKK47 458.17 Animal model of spatial neglect in
macaque monkeys. K. TSUJIMOTO*; M. SAWADA; M.
FUKUNAGA; M. YOSHIDA. Natl. Inst. For Physiological Sci.,
SOKENDA,Graduate Univ. for Advanced studies, Natl. Inst.
For Physiological Sci.

POSTER
459. Attention in Visual Cortical Areas
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 KKK48 459.01 Methylphenidate enhances early stage
sensory signal processing within the rat during performance
of a visual signal detection task. R. L. NAVARRA*; B. D.
CLARK; B. D. WATERHOUSE. Drexel Univ. Col. of Med.,
Drexel Univ. Col. of Med., Rowan Univ. Sch. of Med.
2:00 KKK49 459.02 Indvidual rats choose alternate, suboptimal strategies in a (flawed) signal detection task. An
observational study, with a moral. B. D. CLARK*; J. S.
SHUMSKY; B. D. WATERHOUSE. Drexel Univ. Col. of Med.,
Rowan Univ. Sch. of Med.
3:00 KKK50 459.03 Population encoding of attentional states
in the absence of visual stimulation. A. C. SNYDER*; B.
M. YU.; M. A. SMITH. Univ. of Pittsburgh, Carnegie Mellon
Univ., Ctr. for the Neural Basis of Cognition, Carnegie Mellon
Univ., Univ. of Pittsburgh, Fox Ctr. for Vision Restoration.
4:00 KKK51 459.04 Neuronal correlates of attentional
selectivity in area V4 is independent of motivational context.
S. GHOSH*; J. H. R. MAUNSELL. Univ. of Chicago.
1:00 KKK52 459.05 Dual-task interference in macaque early
visual cortex. J. POSSEL*; M. W. SELF; P. R. ROELFSEMA.
Netherlands Inst. For Neurosci., Ctr. for Neurogenomics and
Cognitive Res., Academic Med. Ctr.
2:00 KKK53 459.06 Spatial summation sub-compartments in
the orientation column. X. SONG*; M. LI; T. XU; D. W. HU; A.
W. ROE; C. Y. LI. Zhejiang Univ. Interdisciplinary Inst. of, The
Col. of Mechatronics and Automation, Univ. of Electronic Sci.
and Technol. of China.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 KKK54 459.07 Communication between the pulvinar and

the layers of Area V4 during selective visual attention. R.
LY*; S. KASTNER. Princeton Univ., Princeton Univ.
4:00 KKK55 459.08 The attentional bias for novelty fluctuates
across time. D. VATTEROTT*; J. GOTTLIEB. Columbia Univ.
1:00 KKK56 459.09 Superior colliculus inactivation with
functional imaging reveals novel nodes in the control of
spatial attention. A. R. BOGADHI*; A. BOLLIMUNTA; D. A.
LEOPOLD; R. J. KRAUZLIS. Natl. Eye Inst., Natl. Inst. of
Mental Hlth.
2:00 KKK57 459.10 How configural is the configural
superiority effect? a neuroimaging investigation of
configurality in visual cortex. O. M. FOX; A. HAREL*; K. B.
BENNETT. Wright State Univ.

POSTER
460. Executive Function: Models of Disorders
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

2:00 KKK59 460.02 Altered markers of synaptic development

and learning and memory deficits in the cereblon knockout
mouse model of intellectual disability. D. K. FISCHER; C. C.
BAVLEY; A. M. RAJADHYAKSHA*. Joan and Sanford I Weill
Med. Col. of Cornell Univ.
3:00 KKK60 460.03 Loss of MeCP2 in cholinergic neurons
causes part of RTT-like phenotypes via the 7 receptor
in hippocampus. Y. ZHANG*; S. CAO; P. SUN; H. HE;
C. YANG; X. CHEN; C. SHEN; X. WANG; Z. CHEN; D.
K. BERG; S. DUAN; X. LI. Zhejiang Univ. Sch. of Med.,
Neurobio. Section, Div. of Biol. Sci. and Ctr. for Neural
Circuits and Behavior, Univ. of California, San Diego.
4:00 KKK61 460.04 Effect of the -1 receptor selective
compound LS-1-137 on the DOI-induced head twitch
response in mice. R. R. LUEDTKE*, Ph.D.; M. MALIK; C.
RANGEL-BARAJAS; R. H. MACH. Univ. North Texas Hlth.
Sci. Cter, Univ. of North Texas Hlth. Sci. Ctr., Indiana Univ.
Bloomington, Univ. of Pennsylvania Sch. of Med.
1:00 KKK62 460.05 Male-specific deficits in natural reward
learning in a mouse model of 16p11.2 hemideletion. N. M.
GRISSOM*; S. MCKEE; H. SCHOCH; N. BOWMAN; R.
HAVEKES; W. OBRIEN; E. MAHRT; K. COMMONS; C.
PORTFORS; T. NICKL-JOCKSCHAT; T. REYES; T. ABEL.
Univ. of Pennsylvania, Univ. of Cincinnati, Univ. of California
Irvine, Univ. of Groningen, Washington State Univ., Boston
Childrens Hosp., Aachen Univ.

1:00 KKK66 460.09 Modeling exposure therapy in rats: Fear

extinction-induced infralimbic activity underlies reversal of
chronic stress-induced shift towards passive coping. D. A.
MORILAK*; E. FUCICH; M. SAUNDERS. Univ. of Texas
Hlth. Sci. Ctr. at San Antonio.
2:00 KKK67 460.10 Alter neuronal ensembles in a neuronal
overproduction mouse model of autism. W. FANG*; R.
YUSTE. Columbia Univ.

3:00 KKK68 460.11 Methamphetamine rescues latency of

reward collection in TAT transgenic mice while not affecting
probabilistic learning, motivation, or exploratory behavior
compared to controls. M. B. MILIENNE-PETIOT*; D. S.
DEBEN; J. W. YOUNG; A. MINASSIAN; T. TMARC. UCSD,
Utrecht Univ., UCSD.
4:00 KKK69 460.12 Pavlovian and dopaminergic influences
on the development and escalation of compulsive checking
behaviour in rats: Implications for models of obsessive
compulsive disorder (OCD). D. M. EAGLE*; C. SCHEPISI;
S. CHUGH; S. DESAI; S. HAN; T. HUANG; J. LEE; C.
SOBALA; W. YE; T. W. ROBBINS. Univ. Cambridge, Univ.
Bristol.
1:00 KKK70 460.13 Cortico-striatal regions of the rat and
checking-like behaviour: Dissociable effects of lesions to
the orbitofrontal cortex, medial prefrontal cortex, nucleus
accumbens core and dorsal striatum in an operant observing
response task. L. DANGELO*; D. M. EAGLE; C. M.
COMAN; T. W. ROBBINS. Univ. of Cambridge, Behavioural
and Clin. Neurosci. Inst., Univ. Paris-Saclay.
2:00 LLL1 460.14 Effects of cola nitida acetone extract on
brain sodium-potassium adenosine triphosphatase activity,
spatial memory in healthy and streptozotocine induced
diabetic female wistar rats. A. O. IMAMFULANI*; K. O.
SANUSI; B. V. OWOYELE. Univ. of Ilorin.
3:00 LLL2 460.15 Behavioral and physiological effects
of excitatory DREADD expression in the rat medial
prefrontal cortex: Lack of evidence for neuronal activation
with clozapine-N-oxide. K. ISHIWARI*; A. M. GEORGE;
C. D. MARTIN; K. A. HAUSKNECHT; R. SHEN; S. HAJDAHMANE; J. B. RICHARDS. Univ. at Buffalo, Univ. at
Buffalo.
4:00 LLL3 460.16 Timing and temporal discounting in
a model of aging-related parkinsonism. M. BUHUSI*; A.
MANJUNATH; A. R. MATTHEWS; K. OLSEN; J. CARLSON;
J. YANG; C. V. BUHUSI. Utah State Univ., Utah State Univ.,
Med. Univ. of South Carolina.

2:00 KKK63 460.06 Cortical GluN2B contribution to reversal

learning in Prenatal Alcohol Exposure. K. L. MARQUARDT*;
J. CAVANAGH; K. CALDWELL; J. BRIGMAN. Univ. of New
Mexico, Univ. of New Mexico, UNM Hlth. Sci. Ctr.
3:00 KKK64 460.07 Alcohol induced mGluR2 deficit in the
prefrontal cortex leads to behavioral inflexibility in rats.
S. PFARR*; M. L. KLEE; M. W. MEINHARDT; N. MEIER;
O. VON BOHLEN UND HALBACH; M. SCHNEIDER;
R. L. BELL; K. SCHNIG; W. H. SOMMER. Central
Inst. of Mental Hlth., Inst. fr Anatomie und Zellbiologie,
Universittsmedizin, Indiana Univ. Sch. of Med., Central Inst.
of Mental Hlth.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Neuroscience 2016|Monday PM|145

Mon. PM

1:00 KKK58 460.01 The role of cacna1c in cognitive

functioning. Z. R. DARUWALLA*; D. FISCHER; A.
RAJADHYAKSHA. Pediatric Neurology, Weill Cornell Med.
Col.

4:00 KKK65 460.08 Modeling exposure therapy in rats: Fear

extinction-induced infralimbic protein synthesis underlies
reversal of chronic stress-induced cognitive inflexibility. E.
A. FUCICH*; D. PAREDES; D. A. MORILAK. Univ. of Texas
Hlth. Sci. Ctr., Univ. of Texas Hlth. Sci. Ctr. at San Antonio.

POSTER

POSTER

461. Adult Hippocampal Neurogenesis: Consequences of

Altering Neuronal Production

462. Learning and Memory: Gamma and Theta Rhythms

Theme H: Cognition

Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 LLL4 461.01 Increased hippocampal neurogenesis
is associated with worse contextual memory. J. JORDAN*;
S. SCHWARTZ; I. VORONINA; K. LIN; C. HARDING; C.
PYTTE; A. WINTER. Grad. Center, The City Univ. of New
York, Queens College, The City Univ. of New York, Hunter
College, The City Univ. of New York, Hunter College, The
City Univ. of New York, Grad. Center, The City Univ. of New
York, Paul D Schreiber High Sch.
2:00 LLL5 461.02 Depletion of adult neurogenesis
compromises hippocampal feedback inhibition. C. L.
HOLLANDS*; S. KERNIE; O. LAZAROV. The Univ. of Illinois
at Chicago, Columbia Univ.
3:00 LLL6 461.03 Analysis of gender and strain differences
in basal hippocampal neurogenesis in adult rats. A. M.
FORMICA; F. E. GRIFFEY; A. R. DIXON; D. M. HAYES*.
Radford Univ.
4:00 LLL7 461.04 Lentiviral overexpression of interleukin1 in the hippocampus induces neurogenesis-associated
cognitive deficits in touchscreen learning paradigms. C. M.
HUESTON*; J. F. CRYAN; Y. M. NOLAN. Univ. Col. Cork.
1:00 LLL8 461.05 Exercise-induced changes in NGF
are critical for the rescue of spatial working memory and
septohippocampal functioning. J. M. HALL*; F. GOMEZPINILLA; L. Z. YING; L. M. SAVAGE. Binghamton Univ.,
UCLA.
2:00 LLL9 461.06 Seizures originating in different brain
regions have differential effects on fear memory and
the functional integration of seizure-generated granule
neurons. N. NOGOVITSYN*; J. J. BOTTERILL; H. J.
CARUNCHO; L. E. KALYNCHUK. Univ. of Saskatchewan,
Univ. of Saskatchewan, Univ. of Saskatchewan, Univ. of
Saskatchewan.
3:00 LLL10 461.07 Could changes in hippocampal neuron
cytoarchitecture explain the depressive behavior of CB1
knockout mice? H. A. BRUSCO*; D. SORIANO; F. CONDE;
L. CALTANA. IBCN (UBA-CONICET) Facultad De Medicina
UBA.
4:00 LLL11 461.08 Imaging the functional integration of
adult-born hippocampal granule cells into the dentate
gyrus network. S. N. TUNCDEMIR*; G. TURI; G. ORDEK;
A. LOSONCZY; R. HEN, 10016. RFMH Columbia Univ.,
Columbia Univ., Columbia Univ.
1:00 LLL12 461.09 The role of adult neurogenesis in visuospatial learning and memory is dependent on stress during
training and sex. T. P. OLEARY*; D. ESPINUEVA; D. R. M.
SEIB; J. S. SNYDER. Univ. of British Columbia.
2:00 LLL13 461.10 Inhibition of adult neurogenesis impairs
learning of spatiotemporal regularities. R. YU*; J. ZHAO; J.
S. SNYDER. The Univ. of British Columbia.
3:00 LLL14 461.11 The effects of amygdala kindling on
hippocampal neurogenesis and pattern separation. J. K.
CARR*; H. LEHMANN; N. M. FOURNIER. Trent Univ.

Mon. 1:00 PMSan Diego Convention Center,Halls B-H

1:00 LLL15 462.01 Modulation of glutamatergic neurons
in the medial septum in the freely moving mouse.
J. ROBINSON*; F. MANSEAU; S. WILLIAMS. Inst.
Universitaire En Sant Mentale Douglas, McGill Univ.
2:00 LLL16 462.02 Calcium imaging of medial septal neurons
in freely-behaving mice. J. BOTT*; S. WILLIAMS. Dept of
Pyschiatry, McGill University, Douglas Ins.
3:00 LLL17 462.03 Spatial reference memory impairments
are associated with abolished CA1 - cross-frequency
coupling in freely behaving J20 APP mice. G. ETTER*; S.
WILLIAMS. Douglas Mental Hlth. Inst., McGill Univ.
4:00 LLL18 462.04 Deep Brain Stimulation to improve
memory function in an animal model of Alzheimer Disease.
E. VICO VARELA*; S. WILLIAMS. McGill Univ.-Douglas
Mental Hlth. Uni. Inst.
1:00 LLL19 462.05 Altered prefronto-hippocampal neural
network dynamics in a murine model of Down syndrome
during memory processing. M. ALEMANY; T. GENER; M.
PUIG*. IMIM-Hospital del Mar Med. Res. Inst.
2:00 LLL20 462.06 Serotonin 5-HT1A and 5-HT2A receptors
and antipsychotics modulate and rhythms and prefrontohippocampal connectivity in behaving mice. T. A. GENER*;
M. ALEMANY; M. PUIG. IMIM-Hospital Del Mar Med. Res.
Inst.

3:00 LLL21 462.07 Quantitative EEG as a tool for monitoring

efficacy of putative cognitive enhancers: Preclinical
investigation. S. DARIPELLI*; V. BENADE; G. AYYANKI; V.
KAMUJU; G. BHYRAPUNENI; R. NIROGI. Suven Life Sci.
Ltd.
4:00 LLL22 462.08 Impairments in spatial memory
representations in freely moving 3xTg mice. A. J. MABLY*;
D. T. JONES; B. J. GEREKE; L. L. COLGIN. Univ. of Texas
at Austin.
1:00 LLL23 462.09 Experience-dependent trends in the CA1
cross spectrum revealed by a generalized additive mixed
model. B. J. GEREKE*; A. J. MABLY; L. L. COLGIN. The
Univ. of Texas at Austin, Univ. of Texas at Austin.
2:00 LLL24 462.10 The correlation between frequency
and running speed in the dentate gyrus and CA2 of freely
behaving rats. C. ZHENG*; Y. HSIAO; L. L. COLGIN. Univ. of
Texas At Austin, Univ. of Texas At Austin.
3:00 LLL25 462.11 Social investigation of conspecifics and
robots: Oscillatory neural dynamics. E. J. LEONARDIS*;
S. HEATH; J. WILES; A. A. CHIBA; L. K. QUINN. UC San
Diego, Univ. of Queensland.
4:00 LLL26 462.12 Transformation of independent oscillatory
inputs into temporally precise rate codes. D. A. NITZ*; D.
TINGLEY; A. ALEXANDER; L. QUINN; A. CHIBA. Univ. of
California San Diego, New York Univ., UCSD.
1:00 LLL27 462.13 Small conduction delays induce global
synchrony in sparsely but strongly connected inhibitory
networks. C. C. CANAVIER*; R. A. TIKIDJI-HAMBURYAN.
Louisiana State Univ. Hlth. Sci. Ctr., George Washington
Univ.
2:00 LLL28 462.14 Mechanisms of spike timing in a detailed
computer model of a medial entorhinal cortical stellate cell.
M. J. BEZAIRE*; M. E. HASSELMO. Boston Univ.

146 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 LLL29 462.15 State dependence of directional

interactions between basal forebrain and visual cortex in
and band local field potentials. A. KLAASSEN*; J. NAIR; J.
POIROT; A. VYSSOTSKI; B. RASCH; G. RAINER. Univ. of
Fribourg, Univ. of Zurich.
4:00 LLL30 462.16 Decoding recalled color imagery
using ECoG signals in the macaque inferior temporal and
prefrontal cortices. H. TANIGAWA*; K. MAJIMA; R. TAKEI;
K. KAWASAKI; H. SAWAHATA; K. NAKAHARA; A. IIJIMA; T.
SUZUKI; Y. KAMITANI; I. HASEGAWA. Niigata Univ., Kyoto
University, Grad. Sch. of Informatics, Niigata University,
Grad. Sch. of Sci. and Technol., Niigata University,
Grad. Sch. of Med. and Dent. Sci., Toyohashi Univ. of
Technol., Kochi Univ. of Technology, Res. Ctr. for Brain
Communication, Ctr. for Information and Neural Networks,
Natl. Inst. of Information and Communications Technol.
1:00 LLL31 462.17 Fimbria fornix stimulation parameters
determine oscillations coupling of the prefrontal cortex and
hippocampus. V. LUO*; M. L. SHAPIRO. Icahn Sch. of Med.
At Mount Sinai.

3:00 LLL33 462.19 Hippocampal across its areal axis:

Predicting, preparing or manipulating future locomotor
speed? L. L. LONG*; I. H. STEVENSON; M. A. ESCABI; J. J.
CHROBAK. Univ. of Connecticut, Univ. of Connecticut, Univ.
of Connecticut.
4:00 LLL34 462.20 Diffusion-mapped delay coordinates
characterize attractor clustering in hippocampal network
dynamics during spatial navigation. D. G. MCHAIL*; T.
BERRY; J. R. CRESSMAN; T. C. DUMAS. George Mason
Univ., George Mason Univ., George Mason Univ., George
Mason Univ.

2:00 LLL40 463.06 Hippocampal viscoelasticity mediates

the benefits of aerobic fitness on memory in healthy
young adults. H. SCHWARB*; C. L. JOHNSON; A. M.
DAUGHERTY; C. H. HILLMAN; A. F. KRAMER; N. J.
COHEN; A. K. BARBEY. Univ. of Illinois, Univ. of Delaware.
3:00 LLL41 463.07 Functional MRI of language and memory
lateralisation for presurgical evaluation of paediatric epilepsy.
S. M. BUCK*; T. BALDEWEG; D. W. CARMICHAEL; R.
ELWARD; F. VARGHA-KHADEM. Inst. of Child Hlth., Inst. of
Child Hlth., Inst. of Child Hlth.
4:00 LLL42 463.08 KIBRA polymorphism and hippocampusassociated integrity in middle age: A multi-modal
neuroimaging investigation. L. E. KORTHAUER*; N. T.
NOWAK; H. SCHERKENBACH; E. A. AWE; M. FRAHMAND;
I. DRISCOLL. Univ. of Wisconsin-Milwaukee, Winona State
Univ.
1:00 LLL43 463.09 Using eye movements to dissociate
memory performance in normal and pathological aging. J. K.
BLUJUS*; C. M. KAIVER; E. I. GRACIAN; K. J. JENNETTE;
D. E. HANNULA; I. DRISCOLL. Univ. of Wisconsin
Milwaukee.
2:00 LLL44 463.10 Healthy ageing and memory
consolidation. A. WEARN*; S. DILLON; H. K. ISOTALUS; D.
TSIVOS; M. J. KNIGHT; B. MCCANN; R. A. KAUPPINEN; E.
J. COULTHARD. Univ. of Bristol.

POSTER
464. Social Behaviors and Pharmacology
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

POSTER
463. Medial Temporal Lobe: Normal and Pathological Memory
Through the Lifespan
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 LLL35 463.01 Memory-guided drawing training
increases Granger causal influences from the perirhinal
cortex to V1 in the blind. L. CACCIAMANI*; L. T. LIKOVA.
Smith-Kettlewell Eye Res. Inst.
2:00 LLL36 463.02 Aerobic fitness and hippocampal subfield
volume in young adults. M. F. DUNNE*; R. K. NAUER; K.
SCHON. Boston Univ. Sch. of Med., Boston Univ., Boston
Univ.
3:00 LLL37 463.03 The influence of adolescent hippocampal
volume and functional connectivity on memory performance:
A cross-sectional investigation from the Dev-CoG project.
D. E. WARREN*; A. RANGEL; J. M. STEPHEN; V. D.
CALHOUN; Y. WANG; T. W. WILSON. Univ. of Nebraska
Med. Ctr., Creighton Univ., The Mind Res. Network, Tulane
Univ.
4:00 LLL38 463.04 3T hippocampal metabolites reflect verbal
memory decline in aging. S. NIKOLOVA; S. STARK; C. E.
STARK*. Univ. of California, Irvine, Univ. of California Irvine.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 LLL45 464.01 Does the social cognition enhancing

effect of acute oxytocin persist with chronic administration?
D. FEIFEL*; P. D. SHILLING; G. MELENDEZ; J. TRAN; B.
ROBERTS; A. AVALOS; W. THUY-UYEN; A. SRIVASTAVA;
P. KISHORE; I. DAMANI. UCSD.
2:00 LLL46 464.02 Facial responses to experienced and
observed affective touch. L. M. MAYO*; I. MORRISON; J.
LIND; H. OLAUSSON; M. HEILIG. Linkping Univ.
1:00 DP08 464.03 (Dynamic Poster) Intermediate
neurodynamic representations: A pathway towards
quantitative measurements of teamwork. R. STEVENS*; T.
L. GALLOWAY; A. WILLEMSEN-DUNLAP. IMMEX/UCLA,
JUMP Simulation and Educ. Ctr.
4:00 LLL47 464.04 Preventive effect of suvorexant on night
time falls in patients with cognitive impairment. S. YAKOU; T.
SHIMAZU*; K. TAKAHASHI. Saitama Neuropsychiatric Inst.,
2-33-28, Saitama Neuropsychiatrc Inst., Saitama Med. Univ.
1:00 LLL48 464.05 Exploring the potential of oxytocin for
enhancing interpersonal motor resonance upon direct
eye gaze: A transcranial magnetic stimulation study. J.
PRINSEN*; S. BRAMS; K. ALAERTS. KU Leuven.
2:00 LLL49 464.06 Hedonic responses to touch from
strangers depend on the perceived attractiveness of
the caresser. G. NOVEMBRE*; R. ETZI; I. MORRISON.
Linkoeping Univ., Univ. of Milan-Bicocca.

Neuroscience 2016|Monday PM|147

Mon. PM

2:00 LLL32 462.18 Learning stages in a rule switching task

affects - couplings in rat hippocampus. T. NAKAZONO*;
S. TAKAHASHI; Y. SAKURAI. Grad. Sch. of Brain Science,
Doshisha Univers, Kyoto Univ., Grad. Sch. of Brain Science,
Doshisha Univers.

1:00 LLL39 463.05 A longitudinal lifespan study of diffusivity

changes in limbic tracts and decline of episodic memory
in normal aging. Z. SONG*; D. C. PARK. Univ. of Texas at
Dallas.

3:00 LLL50 464.07 Associative learning of what is yours and

mine. P. L. LOCKWOOD*; M. WITTMANN; M. APPS; G.
HUMPHREYS; M. RUSHWORTH. Univ. of Oxford.
4:00 LLL51 464.08 Oxytocin biases men but not women
to restore social connections with individuals who socially
exclude them. X. XU*; S. YAO; L. XU; Y. GENG; W. ZHAO;
X. MA; J. KOU; R. LUO; K. KENDRICK. UESTC.
1:00 LLL52 464.09 Is it me moving this? Embodiment
over the virtual body is improved by active control. V.
BRUGADA-RAMENTOL*; I. CLEMENS; . ROMN; G. G
DE POLAVIEJA. Fundaao Champalimaud, Champalimaud
Res.
2:00 LLL53 464.10 Oxytocin increases tolerance of infidelity
in males but decreases it in females. L. XU*; R. LUO; X.
ZHENG; X. XU; Z. GAO; K. KENDRICK. UESTC.
3:00 LLL54 464.11 Sensory and metacognitive processing
is modulated by the mere inferred presence of another
individual. S. EREIRA*; Z. KURTH-NELSON; S. FLEMING;
R. DOLAN. Univ. Col. London, Univ. Col. London.
4:00 LLL55 464.12 How social coordination emerges
and changes among multiple heterogeneous agents: An
experimental human firefly study. M. ZHANG*; J. A. S.
KELSO; E. TOGNOLI. Florida Atlantic Univ., Ulster Univ.
1:00 LLL56 464.13 Oxytocin transiently and selectively
facilitates acceptance of social advice from others but
without increasing their trustworthiness. R. LUO*; L. XU;
W. ZHAO; X. MA; X. XU; J. KOU; Z. GAO; B. BECKER; K.
KENDRICK. UESTC.
2:00 LLL57 464.14 Oxytocin facilitates emotional empathy
for individuals expressing negative emotions in males and
females. Y. GENG*; W. ZHAO; F. ZHOU; B. BECKER; K.
KENDRICK. UESTC.
3:00 LLL58 464.15 Behavioral and molecular individuality in
zebrafish is controlled by a YY1/HDAC1/p300 pathway. A. C.
ROMAN*; J. VICENTE-PAGE; G. GARCIA DE POLAVIEJA.
Fundaao Champalimaud, Fundaao Champalimaud.
4:00 LLL59 464.16 Using development in zebrafish larvae to
extract the rules of collective behavior. R. C. HINZ*; G. DE
POLAVIEJA. Champalimaud Fndn.
1:00 LLL60 464.17 Optimal group size in collective decision
making. J. VICENTE-PAGE*; C. IOANNOU; A. PEREZESCUDERO; G. DE POLAVIEJA. Fundaao Champalimaud,
Sch. of Biol. Sciences, Univ. of Bristol, MIT.
2:00 LLL61 464.18 Early life social isolation in larval
zebrafish alters behavior in social and non-social contexts. A.
H. GRONEBERG*; J. C. MARQUES; M. B. ORGER; G. G.
DE POLAVIEJA. Champalimaud Res., Champalimaud Res.
1:00 DP09 464.19 (Dynamic Poster) The role of the
serotonin 2A receptor system in self and other initiated
social interaction in LSD-induced states. K. H. PRELLER*;
L. SCHILBACH; T. POKORNY; J. FLEMMING; R.
KRAEHENMANN; P. STMPFLI; M. LIECHTI; E. SEIFRITZ;
F. X. VOLLENWEIDER. Psychiatric Univ. Hosp. Zrich, Max
Planck Inst. of Psychiatry, Univ. of Zurich, Univ. Hosp. Basel.
4:00 LLL62 464.20 Negative gender-related information
reduces social cognition in breast cancer patients. A.
N. SOKOLOV*; M. A. PAVLOVA; S. Y. BRUCKER; D.
WALLWIENER; E. SIMOES. Eberhard Karls Univ. Hosp.
Tbingen, Eberhard Karls Univ. of Tuebingen, Eberhard
Karls Univ. Hosp. Tbingen.

148 | Society for Neuroscience

1:00 LLL63 464.21 Long-term treatment with

methylphenidate for mental fatigue and pain after traumatic
brain injury. L. 0. RONNBACK*; B. JOHANSSON. Inst. of
Neurosci. and Physiol., Inst. Neurosci and Physiol.
2:00 LLL64 464.22 Can everyone see the target? Crosscultural differences in bottom-up and top-down attention:
A computational modelling study. E. MAVRITSAKI*; P.
RENTZELAS. Birmingham City Univ., Birmingham City Univ.

POSTER
465. Neural Processes and Disorders of Social Cognition
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 LLL65 465.01 Emergence of distinct dynamical states
in the brain network for self-other processing. Y. CHEN*; T.
HUANG. Natl. Taiwan Univ., Natl. Taiwan Univ.
2:00 LLL66 465.02 Brain networks associated with
neuroticism, social networks, and loneliness in Traumatic
Brain Injury. J. N. BEADLE*; A. RIGON; M. VOSS; M. DUFF.
Univ. of Nebraska at Omaha, Univ. of Iowa, Univ. of Iowa,
Univ. of Iowa.
3:00 LLL67 465.03 Perceived social isolation is associated
with altered functional connectivity in neural networks
associated with tonic alertness and executive control. E.
LAYDEN*; J. T. CACIOPPO; S. CACIOPPO; S. F. CAPPA;
A. DODICH; A. FALINI; N. CANESSA. The Univ. of Chicago,
The Univ. of Chicago, Inst. Universitario di Studi Superiori,
San Raffaele Scientific Inst.
4:00 LLL68 465.04 All Together Now: The neural basis
of social development associated with music training. M.
SACHS*; B. ILARI; J. KAPLAN; H. DAMASIO; A. DAMASIO;
A. HABIBI. Brain and Creativity Inst., USC.
1:00 LLL69 465.05 Social Disorganisation links autism
and schizophrenia spectrum disorders through excitationinhibition neurotransmitter imbalance. T. C. FORD*; R.
NIBBS; D. P. CREWTHER. Swinburne Univ. of Technol.,
Swinburne Univ. of Technol.
2:00 LLL70 465.06 Psychotherapists show significant
differences in perspective taking, emotional regulation and
brain network connectivity. V. E. OLALDE*; S. ALCAUTER,
76230; F. BARRIOS, 76230; R. MERCADILLO; S.
FEDERICA; E. PASAYE. UNAM, Inst. De Neurobiologa,
Univ. Autonoma de Mexico, Univ. Autnoma Metropolitana
Unidad Iztapalapa.
3:00 MMM1 465.07 Shared cortical alterations in
anorexia nervosa and autism spectrum disorder. M.
BJORNSDOTTER*; M. DAVIDOVIC; L. KARJALAINEN; G.
STARCK; H. OLAUSSON; E. WENTZ. Univ. of Gothenburg,
Linkping Univ., Univ. of Gothenburg, Sahlgrenska Univ.
Hosp.
4:00 MMM2 465.08 Divergent facial scanning patterns
in behavioural-variant frontotemporal dementia and
semantic dementia. R. HUTCHINGS*; R. PALERMO; J.
BRUGGEMANN; J. R. HODGES; O. PIGUET; F. KUMFOR.
Neurosci. Res. Australia, Univ. of New South Wales, ARC
Ctr. of Excellence in Cognition and its Disorders, Univ. of
Western Australia.
1:00 MMM3 465.09 Neural and computational processes
underlying dynamic changes in self-esteem. G. WILL*; R.
B. RUTLEDGE; M. MOUTOUSSIS; R. J. DOLAN. Univ. Col.
London, Max Planck Univ. Col. London Ctr. for Computat.
Psychiatry and Ageing Res.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 MMM4 465.10 A neural correlate of math anxiety in the

ventromedial prefrontal cortex. K. CHOE*; A. MATTARELLAMICKE; M. G. BERMAN; S. L. BEILOCK. Univ. of Chicago,
Stanford Univ.
3:00 MMM5 465.11 When cultures mix: Neurobehavioral
responses to the visual mixing of cultural symbols. G.
CHRISTOPOULOS*; W. YAP; B. CHEON; Y. HONG.
Nanyang Business Sch., Nanyang Technological Univ.,
Nanyang Technological Univ., Chinese Univ. of Hong Kong.
4:00 MMM6 465.12 Excessive association between negative
intentionality and immorality is diminished in autism
spectrum disorder. K. IIJIMA*; Y. YOMOGIDA; K. ASADA;
K. ABE; A. SUGIURA; S. KUMAGAYA; K. MATSUMOTO.
Brain Sci. Institute, Tamagawa Univ., Japan Society for
the Promotion of Sci., Res. Ctr. for Advanced Sci. and
Technology, The Univ. of Tokyo, Dept. of Life Sciences,
GSAS, Univ. of Tokyo, Tokyo, Japan.
1:00 MMM7 465.13 Neural responses to moral violations do
not support a division between individualizing and binding
categories. E. HANNA*; V. IYENGAR; S. CLIFFORD; F. DE
BRIGARD; R. CABEZA; W. SINNOTT-ARMSTRONG. Duke
Univ., Univ. of Houston.

3:00 MMM9 465.15 Over-entrainment to the partners eyeblinks during eye contact in autistic spectrum disorders. T.
KOIKE*; H. K. TAKAHASHI; E. NAKAGAWA; S. OKAZAKI;
H. C. TANABE; H. KOSAKA; H. OKAZAWA; N. SADATO.
Natl. Inst. for Physiological Sci., Nagoya Univ., Univ. of
Fukui.
4:00 MMM10
465.16 Connectivity between auditory and
visual cortices mediates the impact of argument strength on
the efficacy of anti-smoking videos among low-sensationseeking smokers. Z. SHI*; V. FAIRCHILD; A. WANG;
C. ARONOWITZ; J. N. CAPPELLA; D. ROMER; D. D.
LANGLEBEN. Univ. of Pennsylvania, Univ. of Pennsylvania,
Univ. of Pennsylvania.

1:00 MMM11
465.17 Affective bias is sensitive to acute
electrical stimulation of two limbic regions: Subcallosal
cingulate white matter and amygdala. K. C. ROWE*; H. S.
MAYBERG; C. K. KOVACH; C. S. INMAN; A. L. CROWELL;
R. E. GROSS; D. L. DRANE; J. T. WILLIE. Emory Univ. Sch.
of Med., Emory Univ., Univ. of Iowa, Emory Univ., Emory
Univ.

POSTER
466. Schizophrenia: Biochemistry and Neuropathology
Theme H: Cognition
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 MMM12
466.01 Neural complexity as a potential
translational biomarker for psychosis. A. YANG*; B. HAGER;
R. BRADY; B. CLEMENTZ; G. PEARLSON; J. SWEENEY;
C. TAMMINGA; M. KESHAVAN. Beth Israel Deaconess Med.
Ctr., Div. of Publ. Psychiatry, Departments of Psychology and
Neuroscience, Bio-Imaging Res. Center, Univ. of Georgia,
Athens. USA, Departments of Psychiatry and Neuroscience,
Yale Univ. Sch. of Med., Dept. of Psychiatry and Behavioral
Neuroscience, Univ. of Cincinnati Sch. of Med., Dept. of
Psychiatry, Univ. of Texas Southwestern Med. Ctr.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 MMM14
466.03 Proteomic signatures associated with
cognitive deficits in schizophrenia. J. LAVOIE*; C. NA; L.
SHAFFER; R. WARD; D. SCHRETLEN; K. ISHIZUKA; A.
PANDEY; A. SAWA. Johns Hopkins Univ. Sch. of Med.

4:00 MMM15
466.04 Abnormal trajectory of intracortical
myelination in schizophrenia implicates white matter in
disease pathophysiology and the therapeutic mechanism of
action of antipsychotics. T. A. TISHLER*; G. BARTZOKIS;
P. H. LU; E. P. RAVEN; M. KHANOYAN; C. KIRKPATRICK;
M. PYLE; P. VILLABLANCA; L. L. ALTSHULER; J. MINTZ;
J. VENTURA; L. CASAUS; K. L. SUBOTNIK; K. H.
NUECHTERLEIN; B. M. ELLINGSON. UCLA, Georgetown
Univ., Univ. of Texas Hlth. Sci. Ctr.
1:00 MMM16
466.05 Causal relationship between the
antioxidant glutathione, kynurenic acid and glutamate in
rat prefrontal cortex. H. WU*; R. SCHWARCZ. Maryland
Psychiatric Res. Ctr.
2:00 MMM17
466.06 Characterization of cellular localization
of OTX2 in human prefrontal cortex and its alterations
in schizophrenia. K. M. ATHANAS*; M. I. ARDELT; S.
BERRETTA; W. T. WOO. McLean Hosp., McLean Hosp.,
Harvard Med. Sch., Beth Israel Deaconess Med. Ctr.,
Harvard Univ.
3:00 MMM18
466.07 Glutamatergic signaling is disrupted in
the PSD of the amygdala and the nucleus accumbens in
schizophrenia. J. CESARE; A. BANERJEE; S. WILLARD;
N. BOWMAN; C. HAHN; K. BORGMANN-WINTER*. Univ.
of Pennsylvania, Univ. Pennsylvania, Childrens Hosp. of
Philadelphia.
4:00 MMM19
466.08 Emerging roles of Disrupted-InSchizophrenia 1 in microglia. F. OGAWA*; A. NOMURA; K.
MATSUZAKI; S. MIYAKE. Juntendo Univ. Sch. of Med.

1:00 MMM20
466.09 Changed cortical BQCA modulation of
[3H]NMS binding in schizophrenia. B. DEAN*; S. HOPPER;
J. CONN; E. SCARR. Mol. Psychiatry Lab., Vanderbilt Univ.
Sch. of Med.
2:00 MMM21
466.10 Neurons expressing parvalbumin in
the thalamic reticular nucleus and their potential role in
the pathophysiology of schizophrenia. S. A. BUKHARI*; H.
PANTAZOPOULOS; S. BERRETTA. McLean Hosp., Harvard
Med. Sch., Harvard Med. Sch.
3:00 MMM22
466.11 Modeling heterochromatin: Method for
determining epigenetic effects of antipsychotics at immune
promoters. B. M. FEINER*; J. K. MELBOURNE; K. A.
CHASE; R. P. SHARMA. UIC Psychiatry, Univ. of California.
4:00 MMM23
466.12 Inhibition of the schizophrenia associated
microRNA miR-137 disrupts neuregulin-induced protein
synthesis. K. THOMAS*; B. ANDERSON; N. SHAH; Q. GU;
G. J. BASSELL. Emory Univ., Emory Univ.
1:00 MMM24
466.13 Activated pSTAT1 levels as a
biologically relevant immune signal in schizophrenia. J. K.
MELBOURNE*; B. FEINER; C. ROSEN; K. A. CHASE; R.
P. SHARMA. Univ. of Illinois At Chicago, Univ. of California,
Jesse Brown Veterans Affairs Med. Ctr.
2:00 MMM25
466.14 Effects of selective attention on activity
in auditory steady-state response (ASSR): An EEG study.
A. TOYOMAKI*; A. MIYAZAKI; N. HASHIMOTO; I. KUSUMI.
Hokkaido univ, Hokkaido Univ.
Neuroscience 2016|Monday PM|149

Mon. PM

2:00 MMM8 465.14 A neuroimaging account of accountability

in allocentric decision making. S. FITZGERALD*; G.
CHRISTOPOULOS. Nanyang Business Sch., Culture Sci.
Inst., Decision and Organizational Neruoscience Lab.,
Nanyang Business Sch.

2:00 MMM13
466.02 Perineuronal net-associated extracellular
matrix clusters in the normal human amygdala: Relevance
to SZ. K. T. PILOBELLO*; H. PANTAZOPOULOS; S.
BERRETTA; R. MCCULLUMSMITH; S. ODONOVAN; R.
KOENE; P. W. TILLBERG; E. S. BOYDEN. McLean Hosp.,
McLean Hosp., Univ. of Cincinnati, MIT.

3:00 MMM26
466.15 The acute and chronic effects of ketamine
on cross-frequency couplings and alterations in locomotive
speed in the rat hippocampus: Implications for translational
models of schizophrenia. T. I. MICHAELS*; L. L. LONG; I.
H. STEVENSON; J. J. CHROBAK; C. A. CHEN. Univ. of
Connecticut.

POSTER

4:00 MMM27
466.16 Over-expression of CNRIP in the ventral
hippocampus of rodents produces a schizophrenia-like
phenotype. A. M. BOLEY*; S. M. PEREZ; J. J. DONEGAN;
D. D. AGUILAR; A. GIUFFRIDA; D. J. LODGE. UTHSCSA,
UTHSCSA.

1:00 MMM37
467.01 Systematizing the construction of
connectomes using an interactive Excel-based platform
to facilitate data entry and collation. J. D. HAHN*; L. W.
SWANSON. USC.

1:00 MMM28
466.17 Links between auditory hallucination
and regional functional dysconnectivity in schizophrenia.
D. K. SHUKLA*; J. CHIAPPELLI; P. KOCHUNOV; L. M.
ROWLAND; L. HONG. Univ. of Maryland.
2:00 MMM29
466.18 Three-dimensional analysis of dendritic
spines and mitochondria in dentate gyrus granule
cells in Schnurri-2 knockout mice, an animal model for
schizophrenia. A. NAKAO*; K. TAKAO; K. OHIRA; N.
MIYAZAKI; K. MURATA; T. MIYAKAWA. Fujita Hlth. Univ.,
Natl. Inst. for Physiological Sci., Univ. of Toyama, Mukogawa
Womens Univ., Natl. Inst. for Physiological Sci.

3:00 MMM30
466.19 Dysbindin regulates mitochondrial fission
in hippocampal excitatory neurons through the DynaminLike-Protein DLP1. J. ZHAO*; Z. LI. NIMH/NIH.
4:00 MMM31
466.20 GSK3 modulates NR2A subunit
expression by regulating -catenin abundance in the
prefrontal cortex. S. MONACO*; W. GAO, 19107. Drexel
Univ. Col. of Med., Drexel Univ.
1:00 MMM32
466.21 Dysregulation of schizophreniaassociated genes by elevation of microRNA biogenesis
machinery. M. GEAGHAN*; M. CAIRNS; A. BRICHTA.
Univ. of Newcastle, Australia, Hunter Med. Res. Inst.,
Schizophrenia Res. Institue.
2:00 MMM33
466.22 dopamine D3 receptor blockade rescues
hyperdopamine activity-induced deficit in novel object
recognition memory. P. CHANG*; J. CHEN. Chang-Gung
University/ Grad. Insititute of Biomed. Sci.
3:00 MMM34
466.23 Parkinsonism predicts personality
traits related to genetic risk and treatment outcomes
in schizophrenia. J. MOLINA*; M. CALVO; M. BALDA;
G. GUERRERO; E. PADILLA; C. CLONINGER; G. DE
ERAUSQUIN. UCSD, Fundacin de Lucha contra los
Trastornos Neurolgicos y Psiquitricos en Minoras,
Morsani Col. of Medicine, Univ. of South Florida,
Departments of Psychiatry and Genetics, Washington Univ.
Sch. of Med., Div. of Neurosciences and Dept. of Psychiatry
and Neurology, UTRGV Sch. of Med.
4:00 MMM35
466.24 Delusions of influence correlate with
reduced temporal binding in patients with schizophrenia. M.
J. ROTH; M. J. BUEHNER; K. HESSE; D. WILDGRUBER;
H. WONG; A. LINDNER*. Hertie Inst., Intl. Max Planck Res.
Sch. for Cognitive and Systems Neurosci., Cardiff Univ.,
Univ. of Tuebingen, Werner Reichardt Ctr. for Integrative
Neurosci.
1:00 MMM36
466.25 Decreased lactate dehydrogenase activity
and abnormal expression of lactate shuttle transporters in
schizophrenia. C. R. SULLIVAN*; K. CLICK; R. KOENE;
A. RAMSEY; C. MIELNIK; R. MCCULLUMSMITH. Univ. of
Cincinnati, Univ. of Cincinnati, Univ. of Toronto.

150 | Society for Neuroscience

467. Bioinformatics
Theme I: Techniques
Mon. 1:00 PMSan Diego Convention Center,Halls B-H

2:00 MMM38
467.02 What does this gene do: Data
presentation in Mouse Genome Informatics for the scientific
community including neuroscientists. L. NI*; &. ON BEHALF
OF MOUSE GENOME INFORMATICS GROUP. The
Jackson Lab.
3:00 MMM39
467.03 Three dimensional digital template atlas
of the macaque brain. C. REVELEY; A. GRUSLYS; F. YE;
J. SAMAHA; D. GLEN; B. RUSS; Z. SAAD; A. SETH; D. A.
LEOPOLD; K. S. SALEEM*. Sackler Ctr. for Consciousness
Science, Univ. of Sussex, Univ. of Cambridge, Natl. Inst. of
Mental Health, Natl. Inst. of Neurolog. Disorders and Stroke,
and Natl. Eye Institute, Natl. Inst. of Hlth., Natl. Inst. of
Mental Hlth. (NIMH/NIH), Natl. Inst. of Mental Hlth. (NIMH/
NIH), Natl. Inst. of Mental Health, Natl. Inst. of Neurolog.
Disorders and Stroke, and Natl. Eye Institute, Natl. Inst. of
Health; Natl. Inst. of Mental Hlth. (NIMH/NIH).
4:00 MMM40
467.04 Neuroimaging phenome-wide association
study of mathematical disability. S. YARED*; C. GONZALEZZACARIAS; F. SEPEHRBAND; L. ZHAO; K. LYNCH; I.
MACPHEE; S. SALUJA; A. W. TOGA; K. A. CLARK. USC,
USC.
1:00 MMM41
467.05 Optimal trajectories for brain state
transitions. S. GU*; R. F. BETZEL; M. CIESLAK; S. T.
GRAFTON; F. PASQUALETTI; D. S. BASSETT. Univ. of
Pennsylvania, Univ. of Pennsylvania, The Univ. of California,
Santa Barbara, The Univ. of California, Riverside.
2:00 MMM42
467.06 A bioinformatic pipeline for the
discovery of translational targets relevant to cocaine
abuse. R. J. ELLIS*; J. L. GOMEZ; L. A. RODRIGUEZ; M.
MICHAELIDES. Natl. Inst. On Drug Abuse.
3:00 MMM43
467.07 Finding neuronal cre-expressing mutant
mice using www.creportal.org. H. ONDA*; S. A. MURRAY; M.
KNOWLTON; C. L. SMITH; J. T. EPPIG. The Jackson Lab.,
The Jackson Lab.
4:00 MMM44
467.08 An inter-region model of the mouse brain
mesoscale connectome. N. S. GRADDIS*; K. D. HARRIS;
N. CAIN; J. D. WHITESELL; K. E. HIROKAWA; E. T. SHEABROWN; J. A. HARRIS; S. MIHALAS. Allen Inst. For Brain
Sci., Univ. of Washington.
1:00 MMM45
467.09 Keeping track of your data with tools
for comprehensive data organization. C. J. KELLNER; A.
STOEWER; M. SONNTAG; A. KOUTSOU; A. SOBOLEV; J.
BENDA; T. WACHTLER*; J. GREWE. Ludwig-MaximiliansUniv Munich, Eberhard Karls Univ.
2:00 MMM46
467.10 Inferring driver transcription factors from
RNA-Seq data. M. DANZI*; J. L. BIXBY; V. P. LEMMON; S.
WUCHTY. Univ. of Miami, Univ. of Miami, Univ. of Miami.
3:00 MMM47
467.11 Structural analysis of membrane myelin
zero and mannose binding proteins from neurons, that
modulate immune response against Mycobacterium leprae
infection. M. CORREDOR*; V. CARDONA; A. MUOZGOMEZ. Univ. of Antioquia, Univ. of Antioquia, Biol. Inst.,
Univ. of Antioquia.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

1:00 MMM48
467.13 Bigneuron data analysis for massivescale, automated neuron reconstructions. X. LIU*; Z. ZHOU;
T. GILLETTE; G. ASCOLI; M. HAWRYLYCZ; S. HILL; C.
KOCH; E. MEIJERING; H. PENG. Allen Inst. For Brain
Sci., George Mason Univ., Ecole polytechnique fdrale de
Lausanne (EPFL), Erasmus Univ. Med. Ctr.
2:00 MMM49
467.14 Bioinformatic analysis of phenotypic data
of ASD rodent models. W. PEREANU*; M. A. ESTEVEZ; I.
DAS; S. B. BASU. Mindspec, Mindspec.
3:00 MMM50
467.15 Comparison of single cell and pooled
cell expression data from mouse and human brain. O.
MANCARCI*; L. TOKER; P. PAVLIDIS. Univ. of British
Columbia.
4:00 MMM51
467.16 SciCrunch: A cooperative and
collaborative data, information and resource discovery
portal for scientific communities. J. S. GRETHE*; A. E.
BANDROWSKI; M. CHIU; T. H. GILLESPIE; J. GO; Y. LI;
I. B. OZYURT; L. MARENCO; P. L. MILLER; R. WANG; G.
M. SHEPHERD; M. E. MARTONE. Univ. of California San
Diego, Yale Univ. Sch. of Med.
1:00 MMM52
467.17 Mouse Phenome Database: A curated
and integrated resource for studying sex differences and
sex x genotype interactions. M. BOGUE*; S. C. GRUBB; V.
PHILIP; E. J. CHESLER. The Jackson Lab.

POSTER
468. Optical Methods: Probe Development and Applications
Theme I: Techniques
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 MMM53
468.01 Sparse, strong and large area targeting of
genetically encoded voltage indicators. S. ANTIC; C. SONG;
T. KNOPFEL*. UConn Hlth., Imperial Col. London.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 MMM54
468.02 Engineering and characterization of
genetically encoded red and far-red voltage indicators for
imaging neuronal activity. M. KANNAN*; G. VASAN; A.
YANG; V. A. PIERIBONE. The John B Pierce Lab., Yale Univ.
3:00 MMM55
468.03 Genetically encodable hybrid optical
voltage sensing with high temporal resolution in neurons
using a novel quencher. M. PABST*; T. ALICH; B.
SZALONTAI; P. TRAN; G. C. FAAS; I. MODY. Univ. of Bonn
Med. Ctr., The David Geffen Sch. of Med. at UCLA.
4:00 MMM56
468.04 Characterization of the neural activity
integrator CaMPARI for all-optical functional connectivity
mapping in acute brain slices. T. A. ZOLNIK*; E.
SCHREITER; F. JOHENNING; L. LOOGER; M. LARKUM;
R. SACHDEV. Charit Universittsmedizin, Janelia Res.
Campus, Humboldt Univ.
1:00 MMM57
468.05 Development of fast-GCaMP indicators
for neuronal spike counting. M. C. APPLEGATE*;
N. A. REBOLA; K. A. COUCHMAN; M. KISLIN; D.
BAKSHINSKAYA; L. A. LYNCH; D. A. DIGREGORIO; S. S.
WANG. Princeton Univ., Princeton Univ., Inst. Pasteur, Ctr.
Natl. de la Recherche Scientifique 3157, Princeton Univ.
2:00 MMM58
468.06 Two-photon in vivo imaging of
neuronal membrane potential with VoltageFluor. M.
VANDENBERGHE*; H. UHLIROVA; M. THUNEMANN;
K. KILIC; C. R. WOODFORD; P. TIAN; P. A. SAISAN; C.
G. L. FERRI; M. YANG; M. ABASHIN; Q. CHENG; K. L.
WELDY; Y. FAINMAN; G. T. EINEVOLL; S. DJUROVIC; O.
A. ANDREASSEN; A. M. DALE; E. W. MILLER; R. Y. TSIEN;
A. DEVOR. UCSD, Univ. of Olso, Brno Univ. of Technol.,
UCSD, UCSD, John Carroll Univ., UCSD, Norwegian Univ. of
Life Sci., Univ. of Olso, Univ. of Olso, KG Jebsen centre for
Psychosis Research, Univ. of Bergen, UC Berkeley, UCSD,
UCSD, Harvard Med. Sch.
3:00 MMM59
468.07 Stabilizing proteins with a novel chemical
technique to preserve function in unphysiological conditions.
M. G. MCCUE*; Y. PARK; H. CHOI; R. CHEN; J. YOON; W.
TRIEU; K. CHUNG. MIT, MIT, Broad Inst. of Harvard Univ.

4:00 MMM60
468.08 Simple, scalable proteomic imaging for
high-dimensional profiling of intact systems. J. SWANEY*;
E. MURRAY; J. H. CHO; D. GOODWIN; T. KU; S. KIM; H.
CHOI; Y. PARK; J. PARK; A. HUBBERT; M. MCCUE; S.
VASSALLO; N. BAKH; M. P. FROSCH; V. J. WEDEEDN; H.
SEUNG; K. CHUNG. MIT, MIT, MIT, Simons Ctr. for Data
Analysis, MIT, MIT, C.S. Kubik Lab. of Neuropathology,
Massachusetts Gen. Hosp. and Harvard Med. Sch.,
Princeton Univ.
1:00 MMM61
468.09 Rapid and scalable molecular
phenotyping of intact biological systems using eTANGO.
J. H. CHO*; K. CHUNG. MIT, MIT, MIT, MIT, Broad Inst. of
Harvard Univ. and Massachusetts Inst. of Technol.
2:00 MMM62
468.10 Integrated imaging of the magnified
three-dimensional proteome library of intact systems. T. KU*;
J. SWANEY; J. PARK; A. ALBANESE; E. MURRAY; J. H.
CHO; Y. PARK; V. MANGENA; J. CHEN; K. CHUNG. MIT,
MIT, MIT, Yonsei Univ. Col. of Med., MIT, MIT, MIT, Broad
Inst. of Harvard Univ. and MIT.
3:00 NNN1 468.11 Cell-MAP for super-resolution proteomic
imaging of cultured cells. A. ALBANESE*; J. SWANEY; T.
KU; J. PARK; K. CHUNG. MIT, MIT, MIT, MIT, MIT.
4:00 NNN2 468.12 A photoconvertible genetically
encoded glutamate indicator for neuronal imaging. S.
PAPADOPOULOS; J. DONG; J. LAMBERT; K. ZITO; L.
TIAN*. Univ. of California, Davis, Univ. of California, Davis.

Neuroscience 2016|Monday PM|151

Mon. PM

1:00 DP10 467.12 (Dynamic Poster) BigNeuron algorithm

porting and bench testing for automatic, massive-scale
neuron reconstruction. Z. ZHOU*; X. LIU; A. RAMANATHAN;
H. CHEN; Y. LI; M. PRABHAT; K. BOUCHARD; L. GU;
L. CHENG; Z. WAN; J. YANG; N. ZHONG; L. QU; J.
YANG; S. LIU; W. CAI; H. ZHOU; S. ZENG; C. WANG; A.
SIRONI; P. GOWACKI; P. FUA; M. RADOJEVIC; D. JIN;
T. ZHAO; J. ZHOU; Z. ZHENG; P. HONG; T. ZENG; R. LI;
S. JI; H. IKENO; Y. CHING; T. LIU; E. BAS; B. ROYSAM;
S. SORENSEN; A. NERN; G. TOURASSI; J. WELLS; R.
KANZAKI; K. ITO; J. KIM; G. JEFFERIS; Y. WANG; E.
RUBEL; P. T. GONZALEZ-BELLIDO; R. WONG; B. YE;
H. ZENG; E. LEIN; H. CLINE; A. CHIANG; G. M. RUBIN;
S. HILL; M. HAWRYLYCZ; A. JONES; C. KOCH; E.
MEIJERING; G. A. ASCOLI; H. PENG. Allen Inst. For Brain
Sci., Oak Ridge Natl. Lab., Univ. of Georgia, Lawrence
Berkeley Natl. Lab., Bioinformatics institute, A*STAR,
Beijing Univ. of Technol., Maebashi Inst. of Technol., Anhui
Univ., Northeastern Univ., The Univ. of Sydney, Huazhong
Univ. of Sci. & Technology, Natl. Taiwan Univ. of Sci. and
Technol., cole Polytechnique Fdrale de Lausanne
(EPFL), Erasmus Univ. Med. Ctr. Rotterdam, Pennsylvania
State Univ., Janelia Res. Campus, Northern Illinois Univ.,
Brandeis Univ., Washington State Univ., Univ. of Hyogo, Natl.
Chiao Tung Univ., Univ. of Houston, Univ. of Tokyo, Korea
Inst. of Sci. and Technol., MRC Lab. of Mol. Biol., Univ. of
Washington, Florida State Univ., Univ. of Cambridge, Univ.
of Michigan, The Scripps Res. Inst., Natl. Tsing Hua Univ.,
Blue Brain Project, EPFL, Krasnow Inst. for Advanced Study,
George Mason University.

1:00 NNN3 468.13 A novel optical probe, FFN270, enables

in vivo multiphoton imaging of presynaptic noradrenergic
synapses in mouse sensory cortex. S. CLARK*; M.
DUNN; A. HENKE; Y. KOVALYOVA; R. KARPOWICZ; K.
KEMPADOO; D. SULZER; D. SAMES. Columbia Univ.,
Columbia Univ., Columbia Univ.
2:00 NNN4 468.14 Anatomical and functional
characterization of wake-promoting dopamine neurons
in the dorsal raphe nucleus. J. CHO*; J. TREWEEK; M.
ALTERMATT; A. GREENBAUM; V. GRADINARU. Caltech,
Caltech.
3:00 NNN5 468.15 Progression of Parkinsons-like pathology
following inoculation of -synuclein preformed fibrils in
the gut. C. CHALLIS*; T. R. SAMPSON; B. YOO; S. K.
MAZMANIAN; L. A. VOLPICELLI-DALEY; V. GRADINARU.
Caltech, Univ. of Alabama at Birmingham.
4:00 NNN6 468.16 Engineering novel adeno-associated
viruses for enhanced transduction and target specificity
across the CNS by adopting high-throughput in vivo and
in silico methods. T. DOBREVA*; D. BROWN; S. KUMAR;
Y. LUO; R. HURT; B. E. DEVERMAN; V. GRADINARU.
Caltech.
1:00 NNN7 468.17 Long-term tracking and automated image
analysis reveals that the upside-down jellyfish has a sleeplike state. C. N. BEDBROOK; R. D. NATH; M. J. ABRAMS;
J. S. BOIS; L. A. GOENTORO; P. W. STERNBERG; V.
GRADINARU*. CALTECH, CALTECH.
2:00 NNN8 468.18 Optical and viral vector strategies for
mapping the structure and function of the cardiac autonomic
nervous system. P. S. RAJENDRAN*; R. C. CHALLIS;
K. Y. CHAN; B. E. DEVERMAN; A. GREENBAUM; K.
SHIVKUMAR; V. GRADINARU. Univ. of California- Los
Angeles, Caltech.
3:00 NNN9 468.19 Tissue clearing of bones for enhanced
optical and molecular access to osseous neuro-immune
environments using PACT-deCAL. A. GREENBAUM*;
K. CHAN; T. DOBREVA; D. BROWN; D. H. BALANI; C.
CHALLIS; A. LIGNELL; L. CAI; H. M. KRONENBERG; V.
GRADINARU. Caltech, Massachusetts Gen. Hosp. and
Harvard Med. Sch., Caltech.
4:00 NNN10 468.20 Retinal characterization of the Thy1GCaMP3 mouse after optic nerve transection. S. N.
BLANDFORD*; S. R. FARRELL; M. L. HOOPER; B. C.
CHAUHAN; W. H. BALDRIDGE. Dalhousie Univ., Dalhousie
Univ., Nova Scotia Hlth. Authority, Dalhousie Univ.

1:00 NNN11 468.21 Recording neuronal networks with BeRST

1, a photostable far red/near-infrared voltage sensitive dye.
A. WALKER*; Y. HUANG; E. W. MILLER. UC Berkeley, UC
Berkeley.
2:00 NNN12 468.22 High-speed recording of neural activity in
awake mice and flies using a fluorescent voltage indicator.
Y. GONG*; C. HUANG, 94305; J. MARSHALL; J. LI; B.
GREWE; Y. ZHANG; S. EISMANN; M. SCHNITZER. Duke
Univ., Stanford Univ.
3:00 NNN13 468.23 Subcellular localization of algal lightsensitive anion channelrhodopsin ACR2 and cation
channelrhodopsin ChR2 in mammalian neurons. E. M.
RODARTE; F. RIVERA-MILIAN; R. JANZ*. Univ. of Texas
Hlth. Sci. Ctr. Houston, UT-Houston Med. Schl.
4:00 NNN14 468.24 Cell-type specific optical recording of
membrane voltage dynamics in freely moving mice. J. D.
MARSHALL*; J. LI; Y. GONG; F. ST PIERRE; M. Z. LIN; M.
J. SCHNITZER. Stanford Univ., Stanford Univ.

152 | Society for Neuroscience

1:00 NNN15 468.25 Automated functional, mesoscopic,

cortical imaging, self-initiated by gcamp6 transgenic mice in
their home-cage. J. LEDUE*; F. BOLANOS; M. VANNI; G.
SILASI; J. BOYD; D. HAUPT; T. H. MURPHY. Univ. of British
Columbia.

POSTER
469. Electrode Arrays I
Theme I: Techniques
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 NNN16 469.01 Neuronal activity depending on zinc
concentration on multi-electrode array. H. JEONG*; S.
HWANG; S. JUN. Ewha Womans Univ., Ewha Womans
Univ.
2:00 NNN17 469.02 From lab-to-marketplace:
Commercialization of a stretchable microelectrode array. O.
GRAUDEJUS*; R. PONCE WONG; S. AHUJA; S. WAGNER;
B. MORRISON, III. BMSEED Llc/Arizona State Univ.,
BMSEED Llc, Columbia Univ., Princeton Univ.
3:00 NNN18 469.03 Immobilization induces a sleep-like state
in C. elegans. D. L. GONZALES*; K. N. BADHIWALA; J. T.
ROBINSON. Rice Univ., Rice Univ., Rice Univ., Baylor Col. of
Med.
4:00 NNN19 469.04 A novel electrodiffusive scheme for
modeling ion dynamics in neural tissue. A. V. SOLBR*;
A. MALTHE-SRENSSEN; G. T. EINEVOLL; G. HALNES.
Univ. of Oslo, Norwegian Univ. Life Sci.
1:00 NNN20 469.05 Local versus global effects of isoflurane
anesthesia on visual processing in the fly brain. D. COHEN*;
O. H. ZALUCKI; B. VAN SWINDEREN; N. TSUCHIYA.
Monash, Queensland Brain Inst.
2:00 NNN21 469.06 Cognitive and symptom correlates of
EEG time-frequency domain decomposition during a flanker
task in subjects with PTSD. G. MAY*; H. WAHBEH; S.
NELSON. VA VISN 17 Ctr. of Excellence, Univ. of Texas at
Dallas, Texas A & M Univ., Oregon Hlth. & Sci. Univ., Baylor
Univ.
3:00 NNN22 469.07 Biophysical modeling of single-neuron
contributions to EEG and ECoG signals. S. NAESS*; T.
V. NESS; G. HALNES; E. HALGREN; A. M. DALE; G. T.
EINEVOLL. Univ. of Oslo, Norwegian Univ. of Life Sci.,
UCSD.
4:00 NNN23 469.08 A library of human electrocorticographic
data and analyses. K. J. MILLER*; J. OJEMANN. Stanford,
Univ. of Washington.
1:00 NNN24 469.09 Highdensity optoelectrical neural
probe based on silicon nitride photonics for single neuron
recording and stimulation. L. HOFFMAN*; S. LIBBRECHT;
M. WELKENHUYSEN; A. ANDREI; V. BAEKELANDT;
S. HAESLER; D. BRAEKEN. IMEC, NERF, KULeuven,
[email protected].
2:00 NNN25 469.10 Spatial correlation in a 400 micron
pitch electrocorticography grid. N. ROGERS*; J. HERMIZ;
E. KAESTNER; M. GANJI; B. S. CARTER; S. S. CASH;
D. BARBA; S. DAYEH; E. HALGREN; V. GILJA. Univ. of
California San Diego, Univ. of California San Diego, Univ. of
California San Diego, Massachusetts Gen. Hospital, Harvard
Med. Sch.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

3:00 NNN26 469.11 Ear-EEG as a novel technology for

wearable brain wave monitoring. C. GRAVERSEN*; E. B.
PETERSEN; A. FAVRE-FELIX; L. FIEDLER; J. OBLESER; T.
LUNNER. Oticon Eriksholm Res. Ctr., Linkbing Univ., Tech.
Univ. of Denmark, Univ. of Lbeck.

3:00 NNN38 469.23 A long-term feasibility study for neural

recording with carbon-fiber based microelectrode array. Y.
LEE*; Y. LIM; S. HWANG; S. JUN. Ewha Womans Univ.,
Korea Inst. of Sci. and Technol., Ewha Womans University,
Seodaemun-Gu.

4:00 NNN27 469.12 An attention model of binocular rivalry. H.

LI*; J. RANKIN; J. RINZEL; M. CARRASCO; D. J. HEEGER.
New York Univ., New York Univ., New York Univ., New York
Univ.

4:00 NNN39 469.24 Persistence of dysfunctional auditory

information processing following pharmacotherapy in Internet
gaming disorder: An event-related potential study. M. PARK*;
Y. KIM; J. LEE; D. KIM; J. CHOI. SMG-SNU Boramae Med.
Ctr., Seoul St. Marys Hosp., Seoul Natl. Univ. Col. of Med.

1:00 NNN28 469.13 A new 3D in-vitro model for studying

human sensory neurons. E. GRAS LAVIGNE*; N.
PY; D. BUTTIGIEG; L. LHOMME; F. MAGDINIER; R.
STEINSCHNEIDER. Neuronexperts, Equipe Epigntique,
Chromatine & Maladies Lab. INSERM UMR S_910.
2:00 NNN29 469.14 Tunnel culture systems on microelectrode
arrays to measure electrical conduction in a controllednetwork system. S. GEISSLER*; A. HIERLEMANN. ETH
Zurich.

4:00 NNN31 469.16 Validation of high density flexible ECoG

arrays: Monkey somatosensory evoked potential analysis.
T. KAIJU*; K. DOI; M. YOKOTA; K. WATANABE; M. INOUE;
H. ANDO; K. TAKAHASHI; F. YOSHIDA; M. HIRATA; T.
SUZUKI. Osaka Univ., Ctr. for Information and Neural
Networks (CiNet), Univ. of Chicago, Osaka Univ.
1:00 NNN32 469.17 Potential of optogenetic neuromodulation
and ecog electrodes for bi-directional brain machine
interface. F. YOSHIDA*; T. ARAKI; S. YOSHIMOTO; T.
UEMURA; T. KAIJU; T. SUZUKI; T. SEKITANI; M. HIRATA.
Osaka Univ. Med. Sch., Osaka Univ., Osaka Univ., Ctr. for
Information and Neural Networks, Natl. Inst. of Information
and Communications Technol., Osaka Univ.
2:00 NNN33 469.18 Measurement and characterization of
low frequency extracellular potential from cultured neuronal
networks. S. JOO; Y. NAM*. KAIST.
3:00 NNN34 469.19 Assessing very high density
intraoperative ECoG grids using a 7x8 grid with 400 um
pitch. J. HERMIZ*; N. ROGERS; E. KAESTNER; M.
GANJI; B. CARTER; S. CASH; D. BARBA; S. DAYEH; E.
HALGREN; V. GILJA. UCSD, MGH, Harvard Med. Sch.
4:00 NNN35 469.20 A 512-channels, whole array readout,
CMOS implantable probe for acute recordings in the
brain. M. MALERBA*; G. ANGOTZI; G. MANDELBAUM;
B. SABATINI; L. BERDONDINI. Italian Inst. of Technol.,
Harvard Med. Sch.
1:00 NNN36 469.21 Validating silicon polytrodes with
paired juxtacellular recordings. J. P. NETO*; G. LOPES; J.
FRAZO; J. NOGUEIRA; P. LACERDA; E. FORTUNATO; P.
BAIO; A. AARTS; S. MUSA; A. ANDREI; P. BARQUINHA;
A. KAMPFF. Sainsbury Wellcome Ctr., Champalimaud
Neurosci. Programme, Champalimaud Ctr. for the Unknown,
CENIMAT I3N, Atlas Neuroengineering, IMEC.
2:00 NNN37 469.22 Cognitive responses recorded during
neurosurgery using microarray pedot:pss electrodes. E.
KAESTNER*; J. HERMIZ; N. ROGERS; M. GANJI; R.
CARTER; S. CASH; D. BARBA; S. DAYEH; V. GILJA;
E. HALGREN. Univ. of California San Diego, UCSD,
Massachutsetts Gen. Hosp.

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

2:00 NNN41 469.26 Low intensity low frequency ultrasound

neuromodulation in cultured rat hippocampal neuron. S.
HWANG*; H. JEONG; S. KIM; Y. LEE; T. KIM; S. JUN. Ewha
Womans Univ., Kyung Hee Univ., Ewha Womans Univ.
3:00 NNN42 469.27 In vivo testing of the neural sewing
machine: A method for inserting fine, flexible neural
probes. T. L. HANSON*; C. DIAZ-BOTIA; S. JUNG; M.
M. MAHARBIZ; P. N. SABES. UCSF, Univ. of California,
Berkeley, Univ. of California, Berkeley.
4:00 NNN43 469.28 Opto-EEG constructs mesoscopic and
stimulant-dependent functional connectome in mice. S.
LEE*; E. HWANG; D. LEE; W. JUNG; J. CHOI. KIST, KIST,
Inst. of Basic science, POSTECH.
1:00 NNN44 469.29 Withdrawn.
2:00 NNN45 469.30 Mapping and modeling EEG signals
before and after a craniotomy procedure. D. ISSAR*; A.
SNYDER; M. SMITH. Univ. of Pittsburgh, Carnegie Mellon
Univ., Univ. of Pittsburgh.

POSTER
470. Computational Tools for Circuit Mapping
Theme I: Techniques
Mon. 1:00 PMSan Diego Convention Center,Halls B-H
1:00 NNN46 470.01 Computational infrastructure to enable
whole-brain mesoscale circuit mapping for Marmoset. M.
LIN*; Y. S. TAKAHASHI; K. WEBER; K. HOSSAIN; B. HUO;
A. S. TOLPYGO2; D. D. FERRANTE; S. BAI; M. G. ROSA;
H. OKANO; P. P. MITRA. Riken, Japan, Cold Spring Harbor
Lab., Monash Univ., Keio Univ. Sch. of Med.
2:00 NNN47 470.02 Computational topology algorithms for
skeletonizing whole mouse brain tracer-injection data using
discrete Morse theory. D. D. FERRANTE*; S. WANG; Y.
WANG; P. P. MITRA. Cold Spring Harbor Labs., Ohio State
Univ.
3:00 NNN48 470.03 Automated segmentation of Nissl-stained
somata from whole-brain histological image data. A. SINGH*;
T. PARAG; D. FERRANTE; P. MITRA. IIT Madras, HHMI
Janelia Res. Campus, Cold Spring Harbor Lab.
4:00 NNN49 470.04 Automated detection of GFP labelled
nuclei in whole-brain light-microscopic data sets for mouse
with high precision and recall. S. DAS*; V. V. GOPAL; G.
PAHARIYA; D. D. FERRANTE; P. P. MITRA. Indian Inst. of
Technol. Madras, Cold Spring Harbor Lab.

Neuroscience 2016|Monday PM|153

Mon. PM

3:00 NNN30 469.15 Laser and oxygen plasma treated carbon

fiber electrode array for the detection of electrophysiological
and dopaminergic activity. P. R. PATEL*; P. POPOV; A.
MOHEBI; D. G. D. EGERT; A. A. HAMID; K. NAJAFI; J.
D. BERKE; B. J. ARAGONA; C. A. CHESTEK. Univ. of
Michigan, Univ. of Michigan, Univ. of Michigan.

1:00 NNN40 469.25 Trial for drug-induced epileptogenic

phenotype classification in primary rodent neurons and
human induced pluripotent stem cell-derived neurons. N.
MIYAMOTO*; T. KADOWAKI; K. SAWADA. EISAI Co., Ltd.,
Eisai Co., Ltd.

1:00 NNN50 470.05 Methods from computational topology for

comparing neuronal shapes. Y. WANG*; Y. LI; G. A. ASCOLI;
P. P. MITRA. The Ohio State Univ., George Mason Univ.,
Cold Spring Harbor Lab.
2:00 NNN51 470.06 A comprehensive data set for whole-brain
mesoscale connectivity mapping in mouse using injections
of a viral anterograde tracer (AAV) on a brain-wide grid. A. S.
TOLPYGO*; D. D. FERRANTE; F. MECHLER; S. SAVOIA;
N. FRANCIOTTI; P. P. MITRA. Cold Spring Harbor Lab.
3:00 NNN52 470.07 A novel method for extracting brain
connectivity information from neuroscience text articles. A.
NAIDU; J. JAYAKUMAR*; S. CHAKRABORTI; A. SHARMA;
P. SREENIVASA KUMAR; D. DEODHARE; P. P. MITRA.
Indian Insitute of Technology-Madras, Ctr. for Artificial
Intelligence & Robotics (CAIR), DRDO, Cold Spring Harbor
Labs.
4:00 OOO1 470.08 Precision mapping of structural
connectomes in individual brains. B. MCPHERSON*; C.
CAIAFA; A. AVENA-KOENIGSBERGER; J. CONTRERAS;
L. SHEN; Y. WU; J. GONI; A. SAYKIN; O. SPORNS; F.
PESTILLI. Indiana Univ. Bloomington, Indiana Univ. Purdue
Univ. Indianapolis, Indiana Univ. Purdue Univ. Indianapolis.
1:00 OOO2 470.09 New methods for obtaining sparse brain
connectivity networks. G. RANGARAJAN*; S. MODY. Indian
Inst. of Sci., Indian Inst. of Sci.
2:00 OOO3 470.10 Path ensembles and a tradeoff between
communication efficiency and resilience in the human
connectome. A. I. AVENA KOENIGSBERGER*; B. MISIC;
R. X. D. HAWKINS; A. GRIFFA; P. HAGMANN; J. GOI; O.
SPORNS. Indiana Univ., Indiana Univ., Stanford Univ., Ecole
Polytechnique Federale de Lausanne, Purdue Univ.
3:00 OOO4 470.11 Modeling of large-scale functional
brain networks based on structural connectivity from DTI:
Comparison with EEG derived phase coupling networks and
evaluation of alternative methods along the modeling path.
M. BNSTRUP*; H. FINGER; B. CHENG; A. MESS; C.
HILGETAG; G. THOMALLA; C. GERLOFF; P. KNIG. Univ.
Med. Ctr. Hamburg-Eppendorf, Univ. of Osnabrck, Univ.
Med. Ctr. Hamburg-Eppendorf.
4:00 OOO5 470.12 Synthetic connectomics: Analyzing
evolved neural networks for simple reaching with a tool. Y.
CHOE*; Q. LI; J. YOO. Texas A&M Univ.

1:00 OOO6 470.13 N2A: A language and software tool for

large-scale modeling. F. ROTHGANGER*. Sandia Natl.
Labs.

1:00 OOO10 470.17 Development of Functional Connectome

DB within SenseLab to incorporate and mine functional
connectomics data. L. MARENCO*; R. WANG; R. A.
MCDOUGAL; T. M. MORSE; N. T. CARNEVALE; P. L.
MILLER; G. M. SHEPHERD. Yale Univ. Sch. of Med., Yale
Univ. Sch. of Med., VA Connecticut Healthcare Syst., Yale
Univ. Sch. of Med.
2:00 OOO11 470.18 Neural decoding of motor responses
with Bayesian graphical models. B. BARIBAULT*; J.
VANDEKERCKHOVE. Univ. of California, Irvine.
3:00 OOO12 470.19 Towards optimal information storage
in hierarchical neural circuits. A. ALEMI*. Ecole Normale
Suprieure.
4:00 OOO13 470.20 Replicating neurophysiological data with
spiking neural networks utilizing an evolutionary framework.
E. ROUNDS*; A. ALEXANDER; E. SCOTT; K. DE JONG;
D. NITZ; J. KRICHMAR. Univ. of California, Irvine, UCSD,
George Mason Univ.
1:00 OOO14 470.21 Multiscale interactions predict stress
in adult zebrafish (Danio rerio). K. M. KHAN*; E. M.
CARAMILLO; A. D. COLLIER; J. K. DOYON; J. D. CLARK;
T. SURBER; A. HAJNAL; D. J. ECHEVARRIA. Univ. of
Southern Mississippi.
2:00 OOO15 470.22 Future-proof digital representation of
neuronal morphologies. B. TORBEN-NIELSEN*; E. BAS;
W. CHEN; H. CUNTZ; J. KIM; Y. KUBOTA; A. M. MOORE;
C. SHIH; G. TAVOSANIS; H. PENG; G. A. ASCOLI; E. DE
SCHUTTER. Univ. of Hertfordshire, Howard Hughes Med.
Inst., Okinawa Inst. of Sci. and Technol., Ernst Strngmann
Inst. (ESI) for Neurosci. in Cooperation with Max Planck
Society, Frankfurt Inst. for Advanced Studies, Korea Inst. of
Sci. & Technol. (KIST), Div. of Cerebral Circuitry, Natl. Inst.
for Physiological Sci., RIKEN Brain Sci. Inst., Tunghai Univ.,
Deutsches Zentrum fr Neurodegenerative Erkrankungen
e. V. (DZNE) in der Helmholtz-Gemeinschaft German Ctr.
for Neurodegenerative Dis. (DZNE) within the Helmholtz
Assn. c/o Life & Med. Sci. (LiMeS), Allen Inst. for Brain Sci.,
Krasnow Inst. for Advanced Study, George Mason Univ.
3:00 OOO16 470.23 Generating and predicting long-range
neural connectivity using the reverse geometric principle.
P. H. TIESINGA*; M. BAKKER; R. BAKKER. Radboud
Univ. Nijmegen, Radboud Univ. Nijmegen, Radboud Univ.
Nijmegen.

2:00 OOO7 470.14 Identifying interactions in neural

circuit simulations and other data using non-linear
multi-dimensional hidden-state models. L. G. GIBB*;
A. FRIEDMAN; J. F. SLOCUM; D. TYULMANKOV; A.
ALTSHULER; S. RUANGWISES; Q. SHI; S. E. TORO
ARANA; D. W. BECK; J. E. C. SHOLES; A. M. GRAYBIEL.
MIT, Harvard Univ., Boston Univ.
3:00 OOO8 470.15 Non-linear multi-dimensional hidden state
models for the analysis of neural circuits. A. FRIEDMAN*;
J. F. SLOCUM; D. TYULMANKOV; L. G. GIBB; A.
ALTSHULER; S. RUANGWISES; Q. SHI; S. E. TORO
ARANA; D. W. BECK; J. E. C. SHOLES; A. M. GRAYBIEL.
MIT, Harvard Univ., Boston Univ.
4:00 OOO9 470.16 What do neurons do? A similarity
matching perspective. C. PEHLEVAN*; D. B. CHKLOVSKII.
Simons Fndn.

154 | Society for Neuroscience

Indicated a real or perceived conflict of interest, see page 155 for details.
Indicates a high school or undergraduate student presenter.
* Indicates abstracts submitting author

Conflict of Interest Statements

The following presenters, signified by a dot () in the program, indicated a real or perceived conflict of interest.
Presenters listed without a dot in the program had no financial relationships to disclose.
PRESENTATION
NUMBER STATEMENT

274
274.02
275.04

275.05

279.06
282.06
282.07

282.14
283.09

284.06

I. Gozes: E. Ownership Interest (stock, stock options,

royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Coronis Partners.
I. Gozes: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Coronis Partners.
S. G. Waxman: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Pfizer, Convergence
Pharmaceuticals.
C.L. Sommer: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; PI for RCT on Neridronic
acid in CRPS, Grnenthal; Research grant from Kedrion
for research on inflammatory neuropathies. D. Fees for
Non-CME Services Received Directly from Commercial
Interest or their Agents (e.g., speakers bureaus); Speaker
for Baxalta, Genzyme, Grifols. F. Consulting Fees (e.g.,
advisory boards); Consulting for Baxalta, Genzyme, Air
Liquide, CSL Behring, Pfizer.
J.P. Culver: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Cephalogics.
S. OShea: F. Consulting Fees (e.g., advisory boards);
Genetech.
D. Paquet: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Patent filed. D. Kwart:
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Patent filed. M. Tessier-Lavigne:
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Patent filed.
W. Murphy: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); StemPharm.
N.B. Fedorov: A. Employment/Salary (full or part-time);
Charles River. Y.A. Kuryshev: A. Employment/Salary (full
or part-time); Charles River. J. Fisher: A. Employment/
Salary (full or part-time); Charles River. A. Wright: A.
Employment/Salary (full or part-time); Charles River. C.
Wu: A. Employment/Salary (full or part-time); Charles River.
L.C. Armstrong: A. Employment/Salary (full or part-time);
Charles River. C. Mathes: A. Employment/Salary (full or
part-time); Charles River. M. Ackley: A. Employment/Salary
(full or part-time); Ssage Therapeutics.
S. Minami: A. Employment/Salary (full or part-time);
Alkahest, Inc.. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Alkahest, Inc.S. Rege:
A. Employment/Salary (full or part-time); Alkahest, Inc.. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Alkahest, Inc.H. Hackbart: A.
Employment/Salary (full or part-time); Alkahest, Inc.. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Alkahest, Inc.S.P. Braithwaite:
A. Employment/Salary (full or part-time); Alkahest, Inc.. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Alkahest, Inc..

155 | Society for Neuroscience

PRESENTATION
NUMBER STATEMENT

284.07

285.04

285.08

287.01

287.03

G.E. Stutzmann: E. Ownership Interest (stock, stock

options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); NeuroLucent,
Inc.
E.M. Sigurdsson: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); H Lundbeck
A/S.
J. Ahlfors: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); New World
Laboratories Inc.A.C. LeBlanc: C. Other Research
Support (receipt of drugs, supplies, equipment or other inkind support); NEW WORLD LABORATORIES INC..
I. Garitaonandia: A. Employment/Salary (full or parttime); International Stem Cell Corporation. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); International Stem Cell Corporation. R. Gonzalez:
A. Employment/Salary (full or part-time); International
Stem Cell Corporation. E. Ownership Interest (stock,
stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
International Stem Cell Corporation. M. Poustovoitov:
A. Employment/Salary (full or part-time); International
Stem Cell Corporation. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); International
Stem Cell Corporation. T. Abramihina: A. Employment/
Salary (full or part-time); International Stem Cell
Corporation. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); International Stem Cell
Corporation. A. Noskov: A. Employment/Salary (full or parttime); International Stem Cell Corporation. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified
mutual funds); International Stem Cell Corporation. T.
Christiansen-Weber: A. Employment/Salary (full or parttime); International Stem Cell Corporation. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); International Stem Cell Corporation. G. Sherman:
A. Employment/Salary (full or part-time); International
Stem Cell Corporation. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); International
Stem Cell Corporation. A. Semechkin: A. Employment/
Salary (full or part-time); International Stem Cell
Corporation. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); International Stem
Cell Corporation. D. Redmond: F. Consulting Fees (e.g.,
advisory boards); International Stem Cell Corporation. R.A.
Kern: A. Employment/Salary (full or part-time); International
Stem Cell Corporation. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); International
Stem Cell Corporation.
W. Li: A. Employment/Salary (full or part-time); Neural
Plasticity and Repair Unit, Wallenberg Neuroscience
Center, Department of Experimental Medical Science,
Lund University, 221 84 Lund, Sweden. E. Englund: A.
Employment/Salary (full or part-time); Lund University. H.
Widner: A. Employment/Salary (full or part-time); Lund
University. B. Mattsson: A. Employment/Salary (full or parttime); Lund University. D. van Westen: A. Employment/
Salary (full or part-time); Lund University. J. Ltt: A.
Employment/Salary (full or part-time); lund University. S.
Rehncrona: A. Employment/Salary (full or part-time); Lund
University. A. Bjrklund: A. Employment/Salary (full or

PRESENTATION
NUMBER STATEMENT

287.08

287.09

288.07
289.07

part-time); lund University. O. Lindvall: A. Employment/

Salary (full or part-time); Lund University. J. Li: A.
Employment/Salary (full or part-time); Lund University.
R. Di Maio: A. Employment/Salary (full or part-time);
University of Pittsburgh. C. Other Research Support
(receipt of drugs, supplies, equipment or other in-kind
support); Ri.MED Foundation.
J. Chaufty: A. Employment/Salary (full or part-time);
Berg, LLC. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Berg, LLC.
S. Phat: A. Employment/Salary (full or part-time);
Berg, LLC. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Berg, LLC.
J. Ranjan: A. Employment/Salary (full or part-time);
Berg, LLC. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Berg, LLC. K. Ha:
A. Employment/Salary (full or part-time); Berg, LLC. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Berg, LLC. S. Akella: A.
Employment/Salary (full or part-time); Berg, LLC. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Berg, LLC. R. Degaonkar:
A. Employment/Salary (full or part-time); Berg, LLC. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Berg, LLC. C. Barlow:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant and
pending and current grants). If you are a PI for a drug study,
report that research relationship even if those funds come
to an institution; Berg, LLC. K. Thapa: A. Employment/
Salary (full or part-time); Berg, LLC. E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
Berg, LLC. M. Kiebish: A. Employment/Salary (full or
part-time); Berg, LLC. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Berg, LLC. S.
Gesta: A. Employment/Salary (full or part-time); Berg, LLC.
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Berg, LLC. B. Schuele: B.
Contracted Research/Research Grant (principal investigator
for a drug study, collaborator or consultant and pending
and current grants). If you are a PI for a drug study, report
that research relationship even if those funds come to an
institution; Berg, LLC. V.K. Vishnudas: A. Employment/
Salary (full or part-time); Berg, LLC. E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
Berg, LLC. N.R. Narain: A. Employment/Salary (full or
part-time); Berg, LLC. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); Berg,
LLC. R. Sarangarajan: A. Employment/Salary (full or
part-time); Berg, LLC. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Berg, LLC. P.
Narain: A. Employment/Salary (full or part-time); Berg. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Berg. J. Langston: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution; Berg,
LLC.
J.G. Ojemann: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Therma Neuroscience.
C.F. Ross: A. Employment/Salary (full or part-time);
University of Chicago. F. Arce-McShane: A. Employment/

156 | Society for Neuroscience

PRESENTATION
NUMBER STATEMENT

290.02

290.03

290.06

290.07

291.01
291.10
292.01
294.01

Salary (full or part-time); University of Chicago. N.

Hatsopoulos: A. Employment/Salary (full or part-time);
University of Chicago. B. Sessle: A. Employment/
Salary (full or part-time); University of Toronto. Y. Lanka:
A. Employment/Salary (full or part-time); University of
Chicago.
E. Perez Guzman: A. Employment/Salary (full or parttime); National Institutes of Health (NIH). R. Anglin: A.
Employment/Salary (full or part-time); National Institutes
of Health (NIH). M. Amer: A. Employment/Salary (full or
part-time); Boris family foundation grant. M. Bailey: A.
Employment/Salary (full or part-time); National Institutes of
Health (NIH). S.M. Collins: A. Employment/Salary (full or
part-time); National Institutes of Health (NIH). M. Surette:
A. Employment/Salary (full or part-time); National Institutes
of Health (NIH). P. Bercik: A. Employment/Salary (full or
part-time); National Institutes of Health (NIH).
M.T. Bailey: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Research Contract with
Mead Johnson Pediatric Nutrition.
A.E. Hoban: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Science Foundation
Ireland. R. Stilling: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Science Foundation
Ireland. F. Shanahan: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Science Foundation
Ireland. T.G. Dinan: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Science Foundation
Ireland. J.F. Cryan: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Science Foundation
Ireland. G. Clarke: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Science Foundation
Ireland.
J.A. Foster: A. Employment/Salary (full or part-time);
University Health Network, McMaster University.
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a
drug study, report that research relationship even if those
funds come to an institution; Ontario Brain Institute. S.L.
Thompson: A. Employment/Salary (full or part-time);
Ontario Graduate Scholarship.
H. Okano: F. Consulting Fees (e.g., advisory boards);
SanBio Co. Ltd..
Y. Yamazaki: Other; Rikaenalysis. H. Okano: F. Consulting
Fees (e.g., advisory boards); San Bio, Inc., Daiichi Sankyo
Co., Ltd.A. Iriki: Other; Rikaenalysis.
M.A. Patwary: A. Employment/Salary (full or part-time);
Intel Corporation. T.L. Willke: A. Employment/Salary (full or
part-time); Intel Corporation.
P. Dhar: A. Employment/Salary (full or part-time); AIIMS.
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a

PRESENTATION
NUMBER STATEMENT

297.04

301.11

302.04

304.06

304.09
305.01

305.14

306.09
306.26
307.09

308.01
308.16

drug study, report that research relationship even if those

funds come to an institution; AIIMS, ICMR. P. Kumar: A.
Employment/Salary (full or part-time); AIIMS. P. Kaushal:
A. Employment/Salary (full or part-time); AIIMS.
A.E. Anderson: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Baylor College of
Medicine.
L. Danober: A. Employment/Salary (full or part-time);
Laboratoire Servier. T. Schaer: A. Employment/Salary (full
or part-time); HiQScreen. K. Kambarat: A. Employment/
Salary (full or part-time); HiQScreen. F. Marger: A.
Employment/Salary (full or part-time); HiQScreen.
S. Bretin: A. Employment/Salary (full or part-time);
Laboratoire Servier. D. Bertrand: A. Employment/Salary
(full or part-time); HiQScreen.
R. Matsumoto: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; KAKENHI 26282218,
15H01664, 15H05874. Other; Endowed department by
UCB, GSK, NihonKoden, Otsuka. T. Kunieda: Other;
Otsuka Pharmaceutical. A. Ikeda: B. Contracted Research/
Research Grant (principal investigator for a drug study,
collaborator or consultant and pending and current grants).
If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
KAKENHI 26282218, 15H01664, 15H05874. Other;
Endowed department by UCB, GSK, NihonKoden, Otsuka.
S. Miyamoto: Other; Otsuka Pharmaceutical.
A. Pantovic: Other; The study was supported by the
Ministry of Science and Technological Development of the
Republic of Serbia (grant number 173053 and 41025).
Ljubica Harhaji-Trajkovic is a recipient of the UNESCO
LORE. A. Pantovic: Other; The study was supported by
the Ministry of Science and Technological Development of
the Republic of Serbia (grant number 173053 and 41025).
Ljubica Harhaji-Trajkovic is a recipient of the UNESCO
LORE.
N. Stella: A. Employment/Salary (full or part-time); Stella
Therapeutics.
K. Harada: A. Employment/Salary (full or part-time); Cyfuse
Biomedical K.K.D. Song: A. Employment/Salary (full or
part-time); Cyfuse Biomedical K.K.N. Kita: A. Employment/
Salary (full or part-time); Cyfuse Biomedical K.K..
A.P. Nicholas: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Cynapus, Michael J Fox
Foundation, Adamas. F. Consulting Fees (e.g., advisory
boards); UCB, US WorldMeds, Ipsen, Acadia, Lundbeck.
I. Zarco de Coronado: A. Employment/Salary (full or parttime); A. S. Mosso-Mendoza: Other; voluntary.
C. Messier: A. Employment/Salary (full or part-time);
University of Ottawa.
K. Krajnak: F. Consulting Fees (e.g., advisory boards);
Celladon. F. Wang: A. Employment/Salary (full or parttime); Purdue University. R. Dahl: E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
Neurodon, CEO.
A. Pascual-Leone: F. Consulting Fees (e.g., advisory
boards); Nexstim, Neuronix, Starlab Neuroscience,
Neuroelectrics, Axilum Robotics, Magstim, Neosync.
H. Borghys: A. Employment/Salary (full or part-time);
Janssen R&D. P. Buijnsters: A. Employment/Salary (full or
part-time); Janssen R&D. D. Dhuyvetter: A. Employment/
Salary (full or part-time); Janssen R&D. M. Somers: A.

PRESENTATION
NUMBER STATEMENT

309.04

309.07
309.09

309.12

310.08

310.17
310.18
310.27
311.08

311.17

312.03

312.20
313.17

Employment/Salary (full or part-time); Janssen R&D. R.

Vreeken: A. Employment/Salary (full or part-time); Janssen
R&D.
D. Brocker: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Equity holder in Deep
Brain Innovations, LLC. Inventor on licensed patents.W.
Grill: E. Ownership Interest (stock, stock options, royalty,
receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Equity holder in Deep
Brain Innovations, LLC. Inventor on licensed patents..
M.F. Ghilardi: F. Consulting Fees (e.g., advisory boards);
New York University.
J. Vesper: F. Consulting Fees (e.g., advisory boards);
Medtronic Inc, Boston Scientific, St. Jude Medical. A.
Schnitzler: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Theva Pharma. D. Fees
for Non-CME Services Received Directly from Commercial
Interest or their Agents (e.g., speakers bureaus); Medtronic
Inc, Boston Scientific, St. Jude Medical, UCB, MEDA
Pharma, TEVA Pharma, GlaxoSmithKline. F. Consulting
Fees (e.g., advisory boards); Medtronic Inc, Boston
Scientific, St. Jude Medical.
T.A. Jerde: F. Consulting Fees (e.g., advisory boards);
Medtronic. N. Reinking: A. Employment/Salary (full or parttime); Medtronic. M. Kelly: A. Employment/Salary (full or
part-time); Medtronic. T. Billstrom: A. Employment/Salary
(full or part-time); Medtronic. L. Lentz: A. Employment/
Salary (full or part-time); Medtronic. R.S. Raike: A.
Employment/Salary (full or part-time); Medtronic.
V. Anantharam: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); PK Biosciences
Corp. Ames, IA. A.G. Kanthasamy: E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds); PK
Biosciences Corp. Ames, IA.
S. Kikuta: A. Employment/Salary (full or part-time); JSPS.
P. Halje: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Neurolixis Inc
(receipt of drugs).
G. Petzinger: F. Consulting Fees (e.g., advisory boards);
US World Meds.
K. Seki: B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; Intramural Research Grant (23-9) for
Neurological and Psychiatric Disorders from the National
Center of Neurology and Psychiatry, Health Labour
Sciences Research Grant for Research on Development of
N.
J.W. Mink: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Abeona Therapeutics,
Inc.. F. Consulting Fees (e.g., advisory boards); Medtronic,
Inc., Biomarin, Inc..
R.P. Bowser: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Iron Horse Diagnostics,
Inc.. F. Consulting Fees (e.g., advisory boards); Above &
Beyond, LLC..
Y. Xu: A. Employment/Salary (full or part-time); Michigan
State University.
D. Bhatia: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Department
of Science and Technology, Government of India.

Neuroscience 2016|Monday Conflict of Interest Statements|157

PRESENTATION
NUMBER STATEMENT

315.12

317.06

317.09

318.13
319.05

319.06

320.12

320.18
320.20

321.08

321.10
321.14
322.11

324.08

B.A. Hooker: A. Employment/Salary (full or part-time);

AbbVie. R. Rajagovindan: A. Employment/Salary (full
or part-time); AbbVie. M.J. Voorbach: A. Employment/
Salary (full or part-time); AbbVie. C.H. Schroeder: A.
Employment/Salary (full or part-time); AbbVie. J.D. Beaver:
A. Employment/Salary (full or part-time); AbbVie.
F. Kamme: A. Employment/Salary (full or part-time);
Ionis Pharmaceuticals. B. Powers: A. Employment/
Salary (full or part-time); Ionis Pharmaceuticals. C.
Mazur: A. Employment/Salary (full or part-time);
Ionis Pharmaceuticals. D.A. Wolf: A. Employment/
Salary (full or part-time); Biogen Inc.J.M. Sullivan: A.
Employment/Salary (full or part-time); inviCRO LLC. D.A.
Norris: A. Employment/Salary (full or part-time); Ionis
Pharmaceuticals. A. Verma: A. Employment/Salary (full or
part-time); Biogen Inc.E. Swayze: A. Employment/Salary
(full or part-time); Ionis Pharmaceuticals.
B.T. Staahl: A. Employment/Salary (full or part-time);
University of California, Berkeley. M. Benekareddy: A.
Employment/Salary (full or part-time); Roche Pharma
Research and Early Development, Basel, Switzerland.C.
Coulon-Bainier: A. Employment/Salary (full or parttime); Roche Pharma Research and Early Development,
Basel, Switzerland.A. Ghosh: A. Employment/Salary
(full or part-time); E-Scape Bio, San Francisco, California,
USA.J.A. Doudna: A. Employment/Salary (full or parttime); University of California, Berkeley, California, USA.,
Innovative Genomics Initiative, University of California,
Berkeley, California, USA.., Howard Hughes Medical
Institute, University of California, Berkeley, California, USA.,
Physical Biosciences Division, Lawrence Berkeley National
Laboratory, Berkeley, California, USA., Department of
Chemistry, University of California, Berkeley, California,
USA..
U. Joshi: A. Employment/Salary (full or part-time);
Roskamp Institute.
M. Ito: B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a
drug study, report that research relationship even if those
funds come to an institution; SENSHIN Medical Research
Foundation, Japan Society for the Promotion of Science.
J. Hinman: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; NIH 2015 K08 NS.
B. Lang: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); inventors of the
intellectual property covering ISP. J. Silver: E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); inventors of the intellectual property covering ISP.
S.D. Miller: A. Employment/Salary (full or part-time); Head
of Scientific Advisory Board, Cour Pharmaceuticals.
A. Brown: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Names on patents
related to Sox9 inhibition.
M.P. Hefferan: A. Employment/Salary (full or part-time);
Neuralstem Inc. K. Johe: A. Employment/Salary (full or
part-time); Neuralstem Inc. T.G. Hazel: A. Employment/
Salary (full or part-time); Neuralstem Inc.
L. Ramos-Languren: A. Employment/Salary (full or parttime); Maestra en Ciencias Farmacuticas.
J.S. Meabon: A. Employment/Salary (full or part-time);
Neurogenix Pharmaceuticals.
J. Spiess: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Cortrop Ins., Encinitas,
CA.
J. Kim: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or

158 | Society for Neuroscience

PRESENTATION
NUMBER STATEMENT

325.05

327.05

330.04

331.13

331.25
332.14
334.15

335.13
335.21
342.24

consultant and pending and current grants). If you are a

PI for a drug study, report that research relationship even
if those funds come to an institution; Basic Research
Program(2015R1D1A1A01059014). J. Hyun: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
Research Grant; Mid-career Researcher Program (R-201501266), Basic Research Program (R-2015-01133).
N. Tahirova: A. Employment/Salary (full or part-time);
Full-time student at Columbia University. E. Poivet:
A. Employment/Salary (full or part-time); NYU medical
center. L. Xu: A. Employment/Salary (full or part-time);
Full time student at Columbia University. S. Firestein: A.
Employment/Salary (full or part-time); Full time professor at
Columbia University.
V. Adenis: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Neurelec/
Oticon Medical. P. Stahl: A. Employment/Salary (full
or part-time); Neurelec / Oticon Medical. D. Gnasia: A.
Employment/Salary (full or part-time); Neurelec / Oticon
Medical.
H. Lau: A. Employment/Salary (full or part-time); University
of California, Los Angeles. M.A. Basso: A. Employment/
Salary (full or part-time); University of California, Los
Angeles.
S.S. McAfee: A. Employment/Salary (full or part-time);
University of Tennessee Health Science Center. Y. Liu:
A. Employment/Salary (full or part-time); UniVersity
of Tennessee Health Science Center. D.H. Heck: A.
Employment/Salary (full or part-time); University of
Tennessee Health Science Center.
R.H. Gifford: Other; Dr. Gifford is a member of the
Audiology Advisory Board for Advanced Bionics and
Cochlear Americas.
G.N. Olivier: A. Employment/Salary (full or part-time);
Rehab Without Walls.
S. Zanos: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are
a PI for a drug study, report that research relationship
even if those funds come to an institution; Cyberonics/
Livanova. S. Moorjani: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are
a PI for a drug study, report that research relationship
even if those funds come to an institution; Cyberonics/
Livanova. S. Sabesan: A. Employment/Salary (full or
part-time); Cyberonics/Livanova. E.E. Fetz: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
Cyberonics/Livanova.
W. Cusack: A. Employment/Salary (full or part-time); St.
Jude Medical.
D. Phillips: A. Employment/Salary (full or part-time);
University Of Oregon. A. Karduna: A. Employment/Salary
(full or part-time); University of Oregon.
L.E. Guerriero: C. Other Research Support (receipt of
drugs, supplies, equipment or other in-kind support); Signal
Solutions. C. Wang: C. Other Research Support (receipt
of drugs, supplies, equipment or other in-kind support);
Signal Solutions. T.C. Brooks: C. Other Research
Support (receipt of drugs, supplies, equipment or other
in-kind support); Signal Solutions. S. Sunderam: C. Other
Research Support (receipt of drugs, supplies, equipment
or other in-kind support); Signal Solutions. B.F. OHara:
C. Other Research Support (receipt of drugs, supplies,
equipment or other in-kind support); Signal Solutions. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Signal Solutions.

PRESENTATION
NUMBER STATEMENT

342.25

343.07
343.11
343.17
344.06

345.01

347.06
347.09

347.18

349.27
352.14

352.15

C. Wang: C. Other Research Support (receipt of drugs,

supplies, equipment or other in-kind support); Signal
Solution Inc.T.C. Brooks: C. Other Research Support
(receipt of drugs, supplies, equipment or other in-kind
support); Signal Solution Inc.L.E. Guerriero: C. Other
Research Support (receipt of drugs, supplies, equipment
or other in-kind support); Signal Solution Inc.A.A. Ajwad:
C. Other Research Support (receipt of drugs, supplies,
equipment or other in-kind support); Signal Solution
Inc.S. Sunderam: C. Other Research Support (receipt
of drugs, supplies, equipment or other in-kind support);
Signal Solution Inc.A.W. Seifert: C. Other Research
Support (receipt of drugs, supplies, equipment or other
in-kind support); Signal Solution Inc.B.F. OHara: C. Other
Research Support (receipt of drugs, supplies, equipment or
other in-kind support); Signal Solution Inc.. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); Signal Solution Inc..
O.O. Sunday: A. Employment/Salary (full or part-time);
Full. L.D. Ior: A. Employment/Salary (full or part-time); Full.
A. Ozur: Other; CIHR MOP-136969, CIHR MOP-136967,
NSERC 298475.
M.C. Hoener: A. Employment/Salary (full or part-time); F.
Hoffmann-LaRoche, Ltd..
E. Shokri-Kojori: A. Employment/Salary (full or part-time);
National Institutes of Health. D. Tomasi: A. Employment/
Salary (full or part-time); National Institutes of Health. N.
Volkow: A. Employment/Salary (full or part-time); National
Institutes of Health.
D.A. Lewis: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; investigator-initiated
research support from Pfizer, and in 2012-2014 served as a
consultant in the areas of target identification and validation
and new compound development to Autifony, Bristol-Myer.
M.E. Sloan: A. Employment/Salary (full or part-time);
National Institute on Alcohol Abuse and Alcoholism,
Bethesda, MD, United States.
C.E. McGonigle: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are
a PI for a drug study, report that research relationship
even if those funds come to an institution; NIAAA R15
AA022506. J.E. Grisel: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even if
those funds come to an institution; NIAAA R15 AA022506.
A. Agarwal: A. Employment/Salary (full or part-time);
Signal Solutions LLC. K. Donohue: A. Employment/Salary
(full or part-time); Signal Solutions LLC. B.F. OHara: E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Signal Solutions LLC.
G.A. Gerhardt: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Greg A. Gerhardt.
B.L. Eggan: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Pfizer. S.E.
McCallum: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Pfizer.
E.S. Burstein: A. Employment/Salary (full or part-time);
ACADIA Pharmaceuticals. C.P. Ward: C. Other Research
Support (receipt of drugs, supplies, equipment or other
in-kind support); ACADIA Pharmaceuticals. D.H. Malin:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; ACADIA Pharmaceuticals.

PRESENTATION
NUMBER STATEMENT

352.26
353.25

355.13

355.17
356.01

356.23

357.13

363.07

363.28
364.01

364.06

364.08

H. Zhang: A. Employment/Salary (full or part-time); Pfizer

Inc. M.D. Ehlers: A. Employment/Salary (full or part-time);
Pfizer, Inc.
S. Meisenhelter: C. Other Research Support (receipt
of drugs, supplies, equipment or other in-kind support);
NeuroPace, Inc.N.R. Hasulak: A. Employment/Salary
(full or part-time); NeuroPace, Inc.T.K. Tcheng: A.
Employment/Salary (full or part-time); NeuroPace, Inc.B.C.
Jobst: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); NeuroPace,
Inc..
J.R. Gaunt: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Takeda
Pharmaceutical Company. S. Sheardown: A. Employment/
Salary (full or part-time); Takeda Pharmaceutical Company.
K. Rosenblum: C. Other Research Support (receipt of
drugs, supplies, equipment or other in-kind support); Dr.
Jean Boutin, Laboratoires Servier, France.
K. Tahon: A. Employment/Salary (full or part-time);
Department of Neuroscience, Janssen Research &
Development, a Division of Janssen Pharmaceutica
NV Beerse, Belgium.D.A. Jackson: A. Employment/
Salary (full or part-time); Janssen Pharmaceuticals. W.H.
Drinkenburg: A. Employment/Salary (full or part-time);
Janssen Pharmaceuticals.
M. Schnitzer: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Inscopix. F. Consulting
Fees (e.g., advisory boards); Inscopix.
T.K. Alshammari: A. Employment/Salary (full or part-time);
Department of Pharmacology and Toxicology , College
of Pharmacy, King Saud University , Riyadh , Kingdom of
Saudi Arabia.
M. Lei: A. Employment/Salary (full or part-time); Hitachi,
Ltd.T. Miyoshi: A. Employment/Salary (full or part-time);
Hitachi, Ltd.Y. Niwa: A. Employment/Salary (full or parttime); Hitachi, Ltd.H. Sato: A. Employment/Salary (full or
part-time); Hitachi, Ltd..
N. Tandon: A. Employment/Salary (full or part-time);
Memorial Hermann Hospital.
T.R. Patel: A. Employment/Salary (full or part-time);
Takeda Cambridge Ltd.S. Bechar: A. Employment/Salary
(full or part-time); Takeda Cambridge ltd. S. Stafford: A.
Employment/Salary (full or part-time); Takeda Cambridge
Ltd. R. Fosbeary: A. Employment/Salary (full or part-time);
Takeda Cambridge Ltd. L. Walsh: A. Employment/Salary
(full or part-time); Takeda Cambridge Ltd. J. Reeves: A.
Employment/Salary (full or part-time); Takeda Cambridge
Ltd. P. Ruprah: A. Employment/Salary (full or part-time);
Takeda Cambrdige Ltd. M. Barnes: A. Employment/Salary
(full or part-time); Takeda Cambridge Ltd..
E. Cayre: A. Employment/Salary (full or part-time); Biotrial
Pharmacology. D. Parachou: A. Employment/Salary (full or
part-time); Biotrial Pharmacology. B. Mot: A. Employment/
Salary (full or part-time); Biotrial Pharmacology. B.
Rion: A. Employment/Salary (full or part-time); Biotrial
Pharmacology. C. Drieu La Rochelle: A. Employment/
Salary (full or part-time); Biotrial Pharmacology. M.
Sheardown: A. Employment/Salary (full or part-time);
Takeda Cambridge Ltd.P. Ruprah: A. Employment/Salary
(full or part-time); Takeda Cambridge Ltd.L. Walsh: A.
Employment/Salary (full or part-time); Takeda Cambridge
Ltd.J. Reeves: A. Employment/Salary (full or part-time);
Takeda Cambridge Ltd.R. Fosbeary: A. Employment/
Salary (full or part-time); Takeda Cambridge Ltd.M.
Barnes: A. Employment/Salary (full or part-time); Takeda
Cambridge Ltd.T. Patel: A. Employment/Salary (full or
part-time); Takeda Cambridge Ltd..
E.P. Lebois: A. Employment/Salary (full or part-time);
Pfizer, Inc.D. Volfson: A. Employment/Salary (full or parttime); Pfizer, Inc. D. Buhl: A. Employment/Salary (full or
part-time); Pfizer, Inc. S. Grimwood: A. Employment/Salary
(full or part-time); Pfizer, Inc.J. Edgerton: A. Employment/
Salary (full or part-time); Pfizer, Inc.

Neuroscience 2016|Monday Conflict of Interest Statements|159

PRESENTATION
NUMBER STATEMENT

364.12

364.16

364.19

364.20

365.01

365.03
365.11
365.15
367.13

H.Y. Meltzer: B. Contracted Research/Research Grant

(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Research grant. F.
Consulting Fees (e.g., advisory boards); Consulting fees.
D. Feifel: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); DF is a named inventor
on a patent application for the therapeutic use of oxytocin,
filed on his behalf by UCSD..
L. Asatryan: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Liana Asatryan is on
a patent for the use of IVM for treatment of alcohol use
disorders. D.L. Davies: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Daryl L. Davies
is an inventor on a patent for the use of IVM for treatment
of alcohol use disorders.
W.C. Wetsel: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Rugen, Research study.
M.G. Caron: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Acadia Pharmaceutical
-- own stock. F. Consulting Fees (e.g., advisory
boards); Omeros Corporation; Lundbeck, Consultant;
Psychopharmacology Advisory Board.
J.N. Rauch: A. Employment/Salary (full or part-time);
Essen BioScience. M.L. Bowe: A. Employment/Salary
(full or part-time); Essen BioScience. L. Oupicka: A.
Employment/Salary (full or part-time); Essen BioScience.
D.M. Appledorn: A. Employment/Salary (full or part-time);
Essen BioScience. D.M. Rock: A. Employment/Salary (full
or part-time); Essen BioScience.
H. Xie: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Synatom Research.
A.I. Geller: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Alkermes Inc..
K. Skold: A. Employment/Salary (full or part-time); Head
of Research. M. Born: A. Employment/Salary (full or parttime); Head of Development.
L.M. Erben: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Probes
were provided by ACD. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); ACD holds the
patent. M. He: A. Employment/Salary (full or part-time);
Employed by ACD. C. Other Research Support (receipt
of drugs, supplies, equipment or other in-kind support);
Probes were provided in kind by ACD. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified
mutual funds); ACD hold the patent. M. Xiao-Ming: A.
Employment/Salary (full or part-time); Employed by ACD.
C. Other Research Support (receipt of drugs, supplies,
equipment or other in-kind support); Probes were provided
in kind by ACD. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); ACD holds the patent.
E. Park: A. Employment/Salary (full or part-time); employed
by ACD. C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Probes were
provided in kind by ACD. E. Ownership Interest (stock,
stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
ACD holds the patent. A. Buonanno: C. Other Research
Support (receipt of drugs, supplies, equipment or other
in-kind support); Probes were provided in kind by ACD. E.

160 | Society for Neuroscience

PRESENTATION
NUMBER STATEMENT

368.23
368.24

369.14

372

372.02
372.04

372.05

373

373.02

373.03

373.04

Ownership Interest (stock, stock options, royalty, receipt

of intellectual property rights/patent holder, excluding
diversified mutual funds); ACD holds the patent.
R. Farhoudi: A. Employment/Salary (full or part-time);
Sharif unversity.
C.H. Lubba: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; GSK.
M. Abolfath-Beygi: A. Employment/Salary (full or parttime); University of Southern California. T.D. Sanger:
A. Employment/Salary (full or part-time); University of
Southern California. S.F. Giszter: A. Employment/Salary
(full or part-time); Drexel University College of Medicine.
V. Edgerton: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroRecovery
Technologies.
Y. Gerasimenko: F. Consulting Fees (e.g., advisory
boards); NeuroRecovery Technologies.
J. Burdick: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroRecovery
Technologies.
P. Gad: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroRecovery
Technologies.
C. Goddard: A. Employment/Salary (full or part-time); Tal
Medical, Inc (full time employment). E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds); Tal
Medical, stock options.
S.H. Lisanby: A. Employment/Salary (full or part-time);
National Institute of Mental Health. C. Other Research
Support (receipt of drugs, supplies, equipment or other
in-kind support); Equipment support from Magstim and
MagVenture. D. Fees for Non-CME Services Received
Directly from Commercial Interest or their Agents (e.g.,
speakers bureaus); none. E. Ownership Interest (stock,
stock options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); Coinventor on TMS technology, no royalties. F. Consulting
Fees (e.g., advisory boards); none.
A. Peterchev: A. Employment/Salary (full or part-time);
none. C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); MagVenture
(TMS equipment loan unrelated to this presentation),
Tal Medical (TMS equipment loan unrelated to this
presentation).. D. Fees for Non-CME Services Received
Directly from Commercial Interest or their Agents (e.g.,
speakers bureaus); Rogue Research (travel support
related to cTMS technology discussed in this presentation),
Tal Medical (travel support unrelated to this presentation)..
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Rogue Research (royalty related
to cTMS technology discussed in this presentation);
Magstim (support for patent application filings).. F.
Consulting Fees (e.g., advisory boards); None..
F. Frohlich: A. Employment/Salary (full or part-time);
University of North Carolina at Chapel Hill (full-time).
C. Other Research Support (receipt of drugs, supplies,
equipment or other in-kind support); Travel support from
Tal Medical.. D. Fees for Non-CME Services Received
Directly from Commercial Interest or their Agents (e.g.,
speakers bureaus); None. E. Ownership Interest (stock,
stock options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); UNC
has filed several provisional patents on the non-invasive
brain stimulation research in the Frohlich Lab., None of
it is licensed and Dr. Frohlich does not financially benefit
from these filings at this point. Flavio Frohlich is the

PRESENTATION
NUMBER STATEMENT

373.05

374.02
377

381.01

382.14

383.06

383.08

majority owner of Pulvinar Neuro, a brain stimulation start

up company.. F. Consulting Fees (e.g., advisory boards);
StrataSolar. Other; The clinical studies performed in the
Frohlich Lab have received a label of conflict of interest with
administrative considerations, since they allow for the use
of a brain stimulation device developed in the Frohlich Lab
which is covered by provisional patent filings from UNC..
A. Rotenberg: A. Employment/Salary (full or part-time);
Boston Childrens Hospital, Harvard Medical School (full
time). B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; Sage Pharceuticals (contracted
research, unrelated to proposed topic). C. Other Research
Support (receipt of drugs, supplies, equipment or other
in-kind support); Biscayne Pharmaceuticals: In-kind
support (drugs, supplies). D. Fees for Non-CME Services
Received Directly from Commercial Interest or their Agents
(e.g., speakers bureaus); None. E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
Neuromotion Inc.: co-founder, advisor, equity, NeuroRex
Inc.: Medical advisory board, equity. F. Consulting Fees
(e.g., advisory boards); as above consulting fees waived.
Other; None of the above-mentioned relationships conflict
with the planned presentation..
J.W. Fawcett: F. Consulting Fees (e.g., advisory boards);
Acorda Therapeutics.
D.J. Julius: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Patent royalty from
Univ. of California. F. Consulting Fees (e.g., advisory
boards); Scientific Advisory Bd member for Genentech, Inc.
and Hydra, Inc..
B. Balachandran Krishnamma: A. Employment/Salary
(full or part-time); NIH. S. skuntz: A. Employment/Salary
(full or part-time); NIH. N. Amin: A. Employment/Salary (full
or part-time); NIH. M. Bhaskar: A. Employment/Salary (full
or part-time); NIH. P. Grant: A. Employment/Salary (full or
part-time); NIH. H. Pant: A. Employment/Salary (full or parttime); NIH.
B. Liu: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Receipt
of GE180 TSPO ligand cassettes from General Electric.
V. Reiser: A. Employment/Salary (full or part-time); GE
Healthcare. W. Trigg: A. Employment/Salary (full or parttime); GE Healthcare.
S.W. Moore: A. Employment/Salary (full or part-time);
InVivo Therapeutics. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); InVivo
Therapeutics. R.T. Layer: A. Employment/Salary (full or
part-time); InVivo Therapeutics. E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
InVivo Therapeutics. A.B. Kutikov: A. Employment/Salary
(full or part-time); InVivo Therapeutics. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); InVivo Therapeutics. P. Podell: A. Employment/
Salary (full or part-time); InVivo Therapeutics. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); InVivo Therapeutics. A.A. Aimetti: A. Employment/
Salary (full or part-time); InVivo Therapeutics. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); InVivo Therapeutics. T.R. Ulich: A. Employment/
Salary (full or part-time); InVivo Therapeutics. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); InVivo Therapeutics. J.D. Guest: F. Consulting
Fees (e.g., advisory boards); InVivo Therapeutics.
A.R. Martin: A. Employment/Salary (full or part-time);
Ministry of Health Clinician Investigator Program.

PRESENTATION
NUMBER STATEMENT

383.11

386.03

386.08

388.08

391.01

391.16
391.29

395.01
396.05

B. Conner: B. Contracted Research/Research Grant

(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; East Carolina University
Undergraduate Research and Creative Activities Award.
B. Chih: A. Employment/Salary (full or part-time);
Genentech Inc. J.J. Zuchero: A. Employment/Salary (full
or part-time); Genentech. X. Chen: A. Employment/Salary
(full or part-time); Genentech. N. Bien-Ly: A. Employment/
Salary (full or part-time); Genentech. D. Bumbaca:
A. Employment/Salary (full or part-time); Genentech.
R.K. Tong: A. Employment/Salary (full or part-time);
Genentech. X. Gao: A. Employment/Salary (full or parttime); Genentech. S. Zhang: A. Employment/Salary (full or
part-time); Genentech. K. Hoyte: A. Employment/Salary
(full or part-time); Genentech. W. Luk: A. Employment/
Salary (full or part-time); Genentech. M.A. Huntley: A.
Employment/Salary (full or part-time); Genentech. L. Phu:
A. Employment/Salary (full or part-time); Genentech. C.
Tan: A. Employment/Salary (full or part-time); Genentech.
D. Kallop: A. Employment/Salary (full or part-time);
Genentech. R.M. Weimer: A. Employment/Salary (full
or part-time); Genentech. Y. Lu: A. Employment/Salary
(full or part-time); Genentech. D.S. Kirkpatrick: A.
Employment/Salary (full or part-time); Genentech. J. Ernst:
A. Employment/Salary (full or part-time); Genentech.
M.S. Dennis: A. Employment/Salary (full or part-time);
Genentech. R.J. Watts: A. Employment/Salary (full or parttime); Genentech.
B.R. Obermeier: A. Employment/Salary (full or part-time);
Biogen. G. Marsh: A. Employment/Salary (full or part-time);
Biogen. A. Huang: A. Employment/Salary (full or part-time);
Biogen. M. Koller: A. Employment/Salary (full or part-time);
Nortis, Inc.K. Fisher: A. Employment/Salary (full or parttime); Nortis, Inc.A.C. Cotleur: A. Employment/Salary (full
or part-time); Biogen. F. Shimizu: A. Employment/Salary
(full or part-time); Biogen. J. Duffield: A. Employment/
Salary (full or part-time); Biogen. R.M. Ransohoff: A.
Employment/Salary (full or part-time); Biogen.
P. Kulkarni: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Animal Imaging
Research. C.F. Ferris: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Animal Imaging
Research, Ekam Solutions.
E. Yang: A. Employment/Salary (full or part-time); BK 21
plus. H. Kim: Other; he Korea Healthcare Technolog y R&D
Project (HI3C1451) of Ministry for Health,, Science and
Technology (NRF-2011-0021866).
M.J. Weiser: A. Employment/Salary (full or part-time);
DSM.
M. Benekareddy: A. Employment/Salary (full or part-time);
F. Hoffman-La Roche. T.J. Stachniak: A. Employment/
Salary (full or part-time); F. Hoffman-La Roche. M. von
Kienlin: A. Employment/Salary (full or part-time); F.
Hoffman-La Roche. B. Kuennecke: A. Employment/Salary
(full or part-time); F. Hoffman-La Roche. A. Ghosh: A.
Employment/Salary (full or part-time); E-Scape Bio.
I. Battonyai: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); OTKA
GRANT No. 111990; RFBR GRANT No. 12-04-01510.
L. Addis: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Contractor for Eli
LIlly. J.K. Virdee: A. Employment/Salary (full or part-time);
Contractor for Eli Lilly. L.R. Vidler: A. Employment/Salary
(full or part-time); Employed by Eli Lilly. D.A. Collier: A.
Employment/Salary (full or part-time); Employed by Eli
Lilly. D.K. Pal: F. Consulting Fees (e.g., advisory boards);
Amplexa Genetics. D. Ursu: A. Employment/Salary (full or
part-time); Employee of Eli Lilly.

Neuroscience 2016|Monday Conflict of Interest Statements|161

PRESENTATION
NUMBER STATEMENT

396.09

396.12

397.01

397.07

398.02

402.26

405.04

406.05
407.01

D.R. Lynch: E. Ownership Interest (stock, stock options,

royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); patent for testing antiNMDAR antibodies with royalties paid to Eurimmune.
M. Jessen: A. Employment/Salary (full or part-time); H.
Lundbeck A/S. K. Frederiksen: A. Employment/Salary (full
or part-time); H. Lundbeck A/S. P. Kilburn: A. Employment/
Salary (full or part-time); H. Lundbeck A/S. A. Damholt: A.
Employment/Salary (full or part-time); H. Lundbeck A/S.
M. Gosling: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Enterprise
Therapeutics.
S. Haering: Other; Department of Biochemistry I - Receptor
Biochemistry, Ruhr University Bochum, Bochum, 44780,
Germany. T. Strasdeit: Other; RUB Research SchoolPlus,
Ruhr University Bochum, 44780 Bochum, Germany,
Graduate School of Chemistry and Biochemistry, Ruhr
University Bochum, 44780 Bochum, Germany.
K.S. Ratliff: A. Employment/Salary (full or part-time); Eli
Lilly & Co.K. Knopp: A. Employment/Salary (full or parttime); Eli Lilly & Co.J. Schkeryantz: A. Employment/
Salary (full or part-time); Eli Lilly & Co.B.T. Priest: A.
Employment/Salary (full or part-time); Eli Lilly & Co.M.
Clark: A. Employment/Salary (full or part-time); Eli Lilly &
Co.R. Cerne: A. Employment/Salary (full or part-time); Eli
Lilly & Co.M. Wakulchik: A. Employment/Salary (full or
part-time); Eli Lilly & Co.B. Heinz: A. Employment/Salary
(full or part-time); Eli Lilly & Co.M. Walker: A. Employment/
Salary (full or part-time); Eli Lilly & Co.A. Vandergriff:
A. Employment/Salary (full or part-time); Eli Lilly & Co.X.
Huang: A. Employment/Salary (full or part-time); Eli Lilly
& Co.M.J. Valli: A. Employment/Salary (full or part-time);
Eli Lilly & Co.W.J. Porter: A. Employment/Salary (full
or part-time); Eli Lilly & Co.J.K. Reel: A. Employment/
Salary (full or part-time); Eli Lilly & Co.D. Luffer-Atlas:
A. Employment/Salary (full or part-time); Eli Lilly & Co.T.
Jones: A. Employment/Salary (full or part-time); Eli Lilly &
Co.R.M.A. Simmons: A. Employment/Salary (full or parttime); Eli Lilly & Co.B. Forster: A. Employment/Salary (full
or part-time); Eli Lilly & Co.W. Guo: A. Employment/Salary
(full or part-time); Eli Lilly & Co.B. Adams: A. Employment/
Salary (full or part-time); Eli Lilly & Co.L. Yang: A.
Employment/Salary (full or part-time); Eli Lilly & Co.J.S.
McDermott: A. Employment/Salary (full or part-time); Eli
Lilly & Co..
L. Westrich: A. Employment/Salary (full or part-time);
Lundbeck Research (part-time). J. Waller: A. Employment/
Salary (full or part-time); Lundbeck Research (full-time). B.
Case-Whiteside: A. Employment/Salary (full or part-time);
Lundbeck Research (part-time). M. Gulinello: F. Consulting
Fees (e.g., advisory boards); Lundbeck Research. C.
Sanchez: A. Employment/Salary (full or part-time);
Lundbeck Research (full-time). Y. Li: A. Employment/Salary
(full or part-time); Lundbeck Research (full-time).
E.N. Brown: F. Consulting Fees (e.g., advisory boards);
Masimo. P.L. Purdon: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Dr. Purdon is an
inventor on patents pending on anesthetic brain monitoring
that have been licensed by Massachusetts General
Hospital to Masimo Corporation.. F. Consulting Fees (e.g.,
advisory boards); Masimo Corporation.
P.P. Irazoqui: Other; co-founder Bionode LLC.
T. Berdyyeva: A. Employment/Salary (full or part-time);
Janssen LLC. C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); Janssen
LLC. Y. Hsieh: A. Employment/Salary (full or part-time);
Janssen. S. Yun: A. Employment/Salary (full or part-time);
Janssen LLC. J. Shelton: A. Employment/Salary (full or
part-time); Janssen LLC. C. Dugovic: A. Employment/
Salary (full or part-time); Janssen. H. Kolb: A. Employment/
Salary (full or part-time); Janssen. A. Szardenings: A.
Employment/Salary (full or part-time); Janssen.

162 | Society for Neuroscience

PRESENTATION
NUMBER STATEMENT

407.08

407.11

408.05
408.11

409.02

410.01
410.03

410.05

M.S. Saporito: A. Employment/Salary (full or part-time);

Marinus Pharmaceuticals, Inc.J.A. Gruner: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
Melior Discovery, Inc.J. Tsai: A. Employment/Salary (full
or part-time); Marinus Pharmaceuticals, Inc.A. Patroneva:
A. Employment/Salary (full or part-time); Marinus
Pharmaceuticals, Inc..
M.A. Ackley: A. Employment/Salary (full or part-time);
SAGE Therapeutics. G.M. Belfort: A. Employment/Salary
(full or part-time); SAGE Therapeutics. R.S. Hammond: A.
Employment/Salary (full or part-time); SAGE Therapeutics.
M.C. Quirk: A. Employment/Salary (full or part-time); SAGE
Therapeutics. G. Martinez-Botella: A. Employment/Salary
(full or part-time); SAGE Therapeutics. F.G. Salituro: A.
Employment/Salary (full or part-time); SAGE Therapeutics.
A.J. Robichaud: A. Employment/Salary (full or part-time);
SAGE Therapeutics. J.J. Doherty: A. Employment/Salary
(full or part-time); SAGE Therapeutics.
J.L. Gerrard: F. Consulting Fees (e.g., advisory boards);
Medtronic.
S.R. Irani: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Royalty for antibody
assays. P. Waters: D. Fees for Non-CME Services
Received Directly from Commercial Interest or their Agents
(e.g., speakers bureaus); Received speaker honoraria from
Biogen Idec and Euroimmun AG, Royalties for antibody
assays. A. Vincent: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); AV receives
royalties and payments for antibody assays and AV is the
named inventor on patent application WO/2010/046716
WO/2010/046716 entitled Neurological Autoimmune
Disorders.B. Lang: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Royalties for
antibody assays.
L. Di Canio: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; GSK. G.J. Wayne: A.
Employment/Salary (full or part-time); GSK.
R.D. DiMarchi: A. Employment/Salary (full or part-time);
Consultant for Novo Nordisk U.S.A..
S.A. Hanson: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroSolis, Inc.J.C.
Ockuly: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroSolis, Inc.J.D.
Beck: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroSolis, Inc.M.L.
Hendrickson: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); NeuroSolis, Inc..
R.V. Nirogi: A. Employment/Salary (full or part-time);
Suven Life Sciences Ltd. K. Mudigonda: A. Employment/
Salary (full or part-time); Suven Life Sciences Ltd. K.
Penta: A. Employment/Salary (full or part-time); Suven Life
Sciences Ltd. G. Bhyrapuneni: A. Employment/Salary
(full or part-time); Suven Life Sciences Ltd. V. Benade:
A. Employment/Salary (full or part-time); Suven Life
Sciences Ltd. N. Muddana: A. Employment/Salary (full
or part-time); Suven Life Sciences Ltd. V. Palacharla: A.
Employment/Salary (full or part-time); Suven Life Sciences
Ltd. D. Ajjala: A. Employment/Salary (full or part-time);
Suven Life Sciences Ltd. V. Goyal: A. Employment/Salary
(full or part-time); Suven Life Sciences Ltd. S. Pandey:
A. Employment/Salary (full or part-time); Suven Life
Sciences Ltd. R. Abraham: A. Employment/Salary (full or
part-time); Suven Life Sciences Ltd. R. Kambhampati: A.

PRESENTATION
NUMBER STATEMENT

410.11

411.01

411.10

412.11
412.24

413.01

Employment/Salary (full or part-time); Suven Life Sciences

Ltd. T. Bandyala: A. Employment/Salary (full or part-time);
Suven Life Sciences Ltd. V. Bhatta: A. Employment/Salary
(full or part-time); Suven Life Sciences Ltd. A. Shinde: A.
Employment/Salary (full or part-time); Suven Life Sciences
Ltd.
J. Dong: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; The study is supported
by GliaCure, Inc. and The Alzheimers Drug Discovery
Foundation. R. Schreiber: A. Employment/Salary (full
or part-time); Suadeo Drug Discovery Consulting LLC.
P. Haydon: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; GliaCure, Inc.
J.A. Dobrowolska Zakaria: C. Other Research Support
(receipt of drugs, supplies, equipment or other in-kind
support); Antibody support from Merck & Co.. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); Patent publication #20110294138. R.J. Bateman:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a
drug study, report that research relationship even if those
funds come to an institution; Director, Dominantly Inherited
Alzheimers Network Trials Unit (DIAN-TU). E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); Patent publications #20110294138, 20130115716,
20140302520. Other; co-founder, C2N Diagnostics.
T.W. Rosahl: A. Employment/Salary (full or part-time);
Merck Research Laboratories. L.A. Hyde: A. Employment/
Salary (full or part-time); Merck Research Laboratories.
C. Canasto-Chibuque1: A. Employment/Salary (full or
part-time); Merck Research Laboratories. K. Juhl: A.
Employment/Salary (full or part-time); Merck Research
Laboratories. Z. Li: A. Employment/Salary (full or
part-time); Merck Research Laboratories. J. Scott: A.
Employment/Salary (full or part-time); Merck Research
Laboratories. G.J. Eiermann: A. Employment/Salary (full or
part-time); Merck Research Laboratories. J.N. Cumming:
A. Employment/Salary (full or part-time); Merck Research
Laboratories. E.M. Parker: A. Employment/Salary (full or
part-time); Merck Research Laboratories. M.E. Kennedy:
A. Employment/Salary (full or part-time); Merck Research
Laboratories.
H. Kim: A. Employment/Salary (full or part-time); BK21
PLUS, SNU.
R. Medapati: A. Employment/Salary (full or part-time);
Suven Life Sciences. V. Benade: A. Employment/Salary
(full or part-time); Suven Life Sciences. S. Daripelli: A.
Employment/Salary (full or part-time); Suven Life Sciences.
G. Ayyanki: A. Employment/Salary (full or part-time);
Suven Life Sciences. V. Kamuju: A. Employment/Salary
(full or part-time); Suven Life Sciences. R. Abraham: A.
Employment/Salary (full or part-time); Suven Life Sciences.
P. Jayarajan: A. Employment/Salary (full or part-time);
Suven Life Sciences. G. Bhyrapuneni: A. Employment/
Salary (full or part-time); Suven Life Sciences. K. Bojja: A.
Employment/Salary (full or part-time); Suven Life Sciences.
A.K. Shinde: A. Employment/Salary (full or part-time);
Suven Life Sciences. R. Nirogi: A. Employment/Salary (full
or part-time); Suven Life Sciences.
C. Silky: A. Employment/Salary (full or part-time); Salary.
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Stock. R. Yurko: A. Employment/
Salary (full or part-time); CogRx. K. Mozzoni: A.
Employment/Salary (full or part-time); Salary. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual

PRESENTATION
NUMBER STATEMENT

413.04
413.16

413.19

415.09

415.13

417.08

418.15

funds); Stock. C. Rehak: A. Employment/Salary (full or

part-time); Salary. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); Stock.
N. Izzo: A. Employment/Salary (full or part-time); Salary. G.
Rishton: A. Employment/Salary (full or part-time); Salary.
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Stock. G. Look: A. Employment/
Salary (full or part-time); Cognition Therapeutics Inc. H.
Safferstein: A. Employment/Salary (full or part-time);
Salary. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Stock. S.M. Catalano:
A. Employment/Salary (full or part-time); Salary. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Stock.
T.A. Yacoubian: Other; Talene Yacoubian declares that
she has a US Patent #7,919,262 on the use of 14-3-3s in
neurodegeneration..
O. Sesenoglu-Laird: A. Employment/Salary (full or
part-time); Copernicus Therapeutics, Inc. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); Copernicus Therapeutics, Inc. L. Padegimas:
A. Employment/Salary (full or part-time); Copernicus
Therapeutics, Inc. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Copernicus
Therapeutics, Inc. M.J. Cooper: A. Employment/Salary (full
or part-time); Copernicus Therapeutics, Inc. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified mutual
funds); Copernicus Therapeutics, Inc.
R. Grondin: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Financial support
for this study was provided to the University of Kentucky
by Alnylam Pharmaceuticals Inc. (Cambridge, MA) with
funding received from the Michael J. Fox Foundation for
Parkinsons Res. C. Other Research Support (receipt of
drugs, supplies, equipment or other in-kind support); The
hardware and software associated with the delivery system
was provided by Medtronic Inc. (Minneapolis, MN).A.
Sehgal: A. Employment/Salary (full or part-time); Dr.
Sehgal is a current employee of Alnylam Pharmaceuticals.
D.A. Bumcrot: A. Employment/Salary (full or part-time); Dr.
Bumcrot was an employee of Alnylam Pharmaceuticals at
the time the work was completed..
W.F. Block: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); inseRT MRI. A.
Alexander: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); inseRT MRI.
W. Neumann: C. Other Research Support (receipt of
drugs, supplies, equipment or other in-kind support);
Medtronic. G. Schneider: C. Other Research Support
(receipt of drugs, supplies, equipment or other in-kind
support); Medtronic, St. Jude Medical, Boston Scientific.
A. Khn: C. Other Research Support (receipt of drugs,
supplies, equipment or other in-kind support); St. Jude
Medical, Medtronic, Ipsen Pharma, Boston Scientific.
B.L. Davidson: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Co-founder
Spark Therapeutics.
R. Aviles Reyes: A. Employment/Salary (full or part-time);
University of Guayaquil. B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a

Neuroscience 2016|Monday Conflict of Interest Statements|163

PRESENTATION
NUMBER STATEMENT

420.07

420.17

420.26

421.07

421.08

422.04

423.18

424.08

PI for a drug study, report that research relationship even

if those funds come to an institution; Pontifical Catholic
University, Quito Ecuador.
B.T. Lang: A. Employment/Salary (full or part-time);
Athersys. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Athersys.
S.A. Busch: A. Employment/Salary (full or part-time);
Athesys. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Athersys. R.W. Mays:
A. Employment/Salary (full or part-time); Athersys. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Athersys.
J. Wojciak: A. Employment/Salary (full or part-time); Lpath,
Inc.R.A. Sabbadini: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Lpath, Inc.. F.
Consulting Fees (e.g., advisory boards); Lpath, Inc.. Other;
Inventor.
G.R. Hook: A. Employment/Salary (full or part-time);
American Life Science Pharmaceuticals. E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified
mutual funds); American Life Science Pharmaceuticals.
S. Jacobsen: A. Employment/Salary (full or part-time);
AstraZeneca. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); American Life
Science Pharmaceuticals. K. Grabstein: E. Ownership
Interest (stock, stock options, royalty, receipt of intellectual
property rights/patent holder, excluding diversified
mutual funds); American Life Science Pharmaceuticals.
V. Hook: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); American Life Science
Pharmaceuticals.
A.S. Divakaruni: F. Consulting Fees (e.g., advisory
boards); Seahorse Bioscience. A.N. Murphy: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
Teva Pharmaceuticals. C. Other Research Support (receipt
of drugs, supplies, equipment or other in-kind support);
Seahorse Bioscience.
P. Kitchener: A. Employment/Salary (full or part-time);
Fluofarma. L. Paulhac: A. Employment/Salary (full or parttime); Fluofarma. F. Simon: A. Employment/Salary (full or
part-time); Fluofarma.
O.J. Olajide: A. Employment/Salary (full or part-time);
University of Ilorin. B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even if
those funds come to an institution; International Society for
Neurochemistry.
K. Jgelt: A. Employment/Salary (full or part-time);
NeuroProof GmbH. A. Steder: A. Employment/Salary (full
or part-time); NeuroProof GmbH. O.H.U. Schroeder: E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); NeuroProof GmbH. B.M. Bader:
A. Employment/Salary (full or part-time); NeuroProof
GmbH.
M. Ishisaka: A. Employment/Salary (full or part-time); ONO
Pharmaceutical Co., LTD.T. Komiya: A. Employment/
Salary (full or part-time); ONO Pharmaceutical Co., LTD.T.
Kitajima: A. Employment/Salary (full or part-time); ONO
Pharmaceutical Co., LTD.A. Kishi: A. Employment/Salary
(full or part-time); ONO Pharmaceutical Co., LTD.S.
Katsumata: A. Employment/Salary (full or part-time); ONO
Pharmaceutical Co., LTD..

164 | Society for Neuroscience

424.27

426.01

426.02

426.03

426.04

426.21

M. Maddie: A. Employment/Salary (full or part-time);

Renovo Neural. D. Chmura: A. Employment/Salary (full
or part-time); Renovo Neural. S. Lunn: A. Employment/
Salary (full or part-time); Renovo Neural. H. Battapady:
A. Employment/Salary (full or part-time); Renovo Neural.
S. Medicetty: A. Employment/Salary (full or part-time);
Renovo Neural. B. Trapp: A. Employment/Salary (full or
part-time); Cleveland Clinic Foundation. F. Consulting Fees
(e.g., advisory boards); Renovo Neural.
B.A. Littlefield: A. Employment/Salary (full or part-time);
Eisai Inc. K. Nomoto: A. Employment/Salary (full or parttime); Eisai Inc. S. Eckley: A. Employment/Salary (full or
part-time); Eisai Inc.C. DeJardins: A. Employment/Salary
(full or part-time); Eisai Inc. B.S. Slusher: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution; Eisai
Inc.
J.R. Goss: A. Employment/Salary (full or part-time);
Periphagen. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Periphagen. D. Krisky:
A. Employment/Salary (full or part-time); Periphagen. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Periphagen. K. Bouch: A.
Employment/Salary (full or part-time); Periphagen. M.
OMalley: A. Employment/Salary (full or part-time);
Periphagen. S. Coghlan: A. Employment/Salary (full or
part-time); Periphagen. J. Wechuck: A. Employment/
Salary (full or part-time); Periphagen. E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
Periphagen.
T. Kono: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Tsumura&Co.Y. Omiya:
A. Employment/Salary (full or part-time); Tsumura&Co.H.
Sekine: A. Employment/Salary (full or part-time);
Tsumura&Co.M. Yamamoto: A. Employment/Salary (full
or part-time); Tsumura&Co.K. Miyano: B. Contracted
Research/Research Grant (principal investigator for a
drug study, collaborator or consultant and pending and
current grants). If you are a PI for a drug study, report
that research relationship even if those funds come to an
institution; Tsumura&Co.Y. Kase: A. Employment/Salary
(full or part-time); Tsumura&Co.Y. Uezono: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
Tsumura&Co..
A. Ghetti: A. Employment/Salary (full or part-time);
AnaBios Corporation, Asterand. J. Zhang: A. Employment/
Salary (full or part-time); AnaBios Corp.Y. Miron: A.
Employment/Salary (full or part-time); AnaBios Corp.J.
Stretton: A. Employment/Salary (full or part-time);
Asterand Biosciences. K. Morrison: A. Employment/Salary
(full or part-time); Asterand Biosciences. P. Murdock:
A. Employment/Salary (full or part-time); Asterand
Biosciences. K. Page: A. Employment/Salary (full or parttime); Asterand Biosciences. P. Miller: A. Employment/
Salary (full or part-time); AnaBios Corp..
G. Luerman: A. Employment/Salary (full or part-time);
Axiogenesis AG. D. Hess: A. Employment/Salary (full or
part-time); Axiogenesis AG. B. Murphy: A. Employment/
Salary (full or part-time); Axiogenesis AG. A. Ehlich: A.
Employment/Salary (full or part-time); Axiogenesis AG.
H. Bohlen: A. Employment/Salary (full or part-time);
Axiogenesis AG. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Axiogenesis
AG.

PRESENTATION
NUMBER STATEMENT

427.14
427.17

427.18

428.08

430.07

430.08

432.10

435.09

436.07
437.07
438.02

438.13
439.04

440.01

K.J. Escott: A. Employment/Salary (full or part-time);

employee of Astrazeneca.
T. Liu: A. Employment/Salary (full or part-time); fulltime. B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a
drug study, report that research relationship even if those
funds come to an institution; the National Natural Science
Foundation of China.
J. Lee: B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a
drug study, report that research relationship even if
those funds come to an institution; This research was
supported by the National Research Foundation (NRF)
Grant 2014R1A2A2A01007695 funded by the Korean
Government (MSIP).
C.Y. Saab: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Research grant from
Asahi Kasei Pharma and Boston Scientific. B. LeBlanc:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; Research grants from Asahi Kasei
Pharma & Boston Scientific.
F. Frohlich: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are
a PI for a drug study, report that research relationship
even if those funds come to an institution; Funding from
Tal Medical. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Majority stock holder
of Pulvinar Neuro, LLC. F. Consulting Fees (e.g., advisory
boards); Strata Solar.
A.A. Wanner: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); European
patent application EP14736451, US patent application
US14897514, ariadne-service gmbh.
A. Beckett: A. Employment/Salary (full or part-time);
Advanced MRI Technologies. A.T. Vu: A. Employment/
Salary (full or part-time); Advanced MRI Technologies.
S. Schillack: A. Employment/Salary (full or part-time);
Virtumed LLC. D.A. Feinberg: A. Employment/Salary (full
or part-time); Advanced MRI Technologies.
P. Steele: A. Employment/Salary (full or part-time);
CREmedical. W. Besio: E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); CREmedical.
P. Raghavan: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Patent holder.
S.C. Cramer: F. Consulting Fees (e.g., advisory boards);
Roche, MicroTransponder, Dart Neuroscience, RAND
coporation, personalRN.
A. Petrossians: A. Employment/Salary (full or part-time);
Platinum Group Coatings. E. Ownership Interest (stock,
stock options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); Platinum
Group Coatings.
M. Schuettler: A. Employment/Salary (full or part-time);
Cortec GmbH. J. Rickert: A. Employment/Salary (full or
part-time); Cortec GmbH.
P.R. Kennedy: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); 98% of Neural Signals
Inc..
T. Funato: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or

PRESENTATION
NUMBER STATEMENT

440.05

440.16
440.17
441.02

441.18

446.14

446.16
446.21

448.13

449.01

449.04

consultant and pending and current grants). If you are a PI

for a drug study, report that research relationship even if
those funds come to an institution; JSPS. D. Yanagihara:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; JSPS. S. Fujiki: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
JSPS. S. Aoi: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; JSPS.
J.L. Alberts: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Intellectual property is
in place related to the methods described in this abstract..
A. Dutt-Mazumder: A. Employment/Salary (full or parttime); Medical University of South Carolina.
J.V. Jacobs: A. Employment/Salary (full or part-time);
Liberty Mutual Insurance.
R.S. Broide: A. Employment/Salary (full or part-time);
Allergan PLC. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Allergan PLC. J.
Francis: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Allergan PLC. B.B. Cai:
A. Employment/Salary (full or part-time); Allergan PLC.
B. Munro: A. Employment/Salary (full or part-time); NIKE
Inc.J.L. Bishop: A. Employment/Salary (full or part-time);
NIKE Inc.E. Zehr: F. Consulting Fees (e.g., advisory
boards); NIKE Inc..
J.C. OConnor: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Janssen Research &
Development, LLC.N. Derecki: A. Employment/Salary (full
or part-time); Janssen Research & Development, LLC.A.
Bhattacharya: A. Employment/Salary (full or part-time);
Janssen Research & Development, LLC..
M.N. Hill: F. Consulting Fees (e.g., advisory boards);
Matthew Hill is a scientific consultant for Pfizer..
L. Schaevitz: A. Employment/Salary (full or part-time);
Vium. D. Ford: A. Employment/Salary (full or part-time);
Vium. M. Lim: A. Employment/Salary (full or part-time);
Vium.
J. Yeh: A. Employment/Salary (full or part-time); Institute
of Urology, University of Southern California. J. Mao:
A. Employment/Salary (full or part-time); Institute of
Urology, University of Southern California. H.H. Chang: A.
Employment/Salary (full or part-time); Institute of Urology,
University of Southern California. B. Contracted Research/
Research Grant (principal investigator for a drug study,
collaborator or consultant and pending and current grants).
If you are a PI for a drug study, report that research
relationship even if those funds come to an institution; NIH
grant (R01DK106181).
P.B. Yoo: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Patent file has been
submitted.
C.L. Langdale: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; GlaxoSmithKline.
J.A. Hokanson: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or

Neuroscience 2016|Monday Conflict of Interest Statements|165

PRESENTATION
NUMBER STATEMENT

449.10

450.07
450.14

451.10
452.25
456.10

456.24

consultant and pending and current grants). If you are a

PI for a drug study, report that research relationship even
if those funds come to an institution; GlaxoSmithKline.
A. Sridhar: A. Employment/Salary (full or part-time);
GlaxoSmithKline. W.M. Grill: B. Contracted Research/
Research Grant (principal investigator for a drug study,
collaborator or consultant and pending and current grants).
If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
GlaxoSmithKline.
M.A. Vizzard: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; NIH DK051369, NIH
DK060481, NIH DK053832. M.T. Nelson: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
DK053832, HL121706, HL095488.
M.F. Ghilardi: F. Consulting Fees (e.g., advisory boards);
The Fresco Institute @ NYU.
K.P. Wright: A. Employment/Salary (full or part-time);
American College of Chest Physicians, The Obesity
Society, Obesity Medicine Association. B. Contracted
Research/Research Grant (principal investigator for a
drug study, collaborator or consultant and pending and
current grants). If you are a PI for a drug study, report
that research relationship even if those funds come to
an institution; National Institute of Health, Office of Naval
Research, Torvec Inc.. E. Ownership Interest (stock, stock
options, royalty, receipt of intellectual property rights/patent
holder, excluding diversified mutual funds); Torvec Inc.. F.
Consulting Fees (e.g., advisory boards); Torvec Inc..
Y. Hu: A. Employment/Salary (full or part-time); This
research was supported [in part] by the Intramural
Research Program of the NIH, NIDA.
C.E. Schoonover: A. Employment/Salary (full or part-time);
Columbia University.
Z.D. Brodnik: A. Employment/Salary (full or part-time);
Drexel University College of Medicine. R.A. Espaa: A.
Employment/Salary (full or part-time); Drexel University
College of Medicine.
J.S. Burgdorf: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Aptinyx. F. Consulting
Fees (e.g., advisory boards); Aptinyx. E.M. Colechio:
A. Employment/Salary (full or part-time); Aptinyx Inc.. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Aptinyx Inc.N. Ghoreishi-Haack:
A. Employment/Salary (full or part-time); Aptinyx Inc.. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Aptinyx Inc.A.L. Gross: A.
Employment/Salary (full or part-time); Aptinyx Inc.. E.
Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Aptinyx Inc.X. Zhang: C. Other
Research Support (receipt of drugs, supplies, equipment
or other in-kind support); Aptinyx Inc.P.L. Stanton:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; Aptinyx Inc.. E. Ownership Interest
(stock, stock options, royalty, receipt of intellectual property
rights/patent holder, excluding diversified mutual funds);
Aptinyx Inc.. F. Consulting Fees (e.g., advisory boards);
Aptinyx Inc.R.L. Kroes: A. Employment/Salary (full or
part-time); Aptinyx Inc.. E. Ownership Interest (stock,
stock options, royalty, receipt of intellectual property rights/
patent holder, excluding diversified mutual funds); Aptinyx
Inc.J.R. Moskal: A. Employment/Salary (full or part-time);

166 | Society for Neuroscience

PRESENTATION
NUMBER STATEMENT

457.04
457.09

457.20

460.08

460.09

460.11

Aptinyx Inc.. E. Ownership Interest (stock, stock options,

royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Aptinyx Inc..
I.N. Krasnova: A. Employment/Salary (full or part-time);
National Institutes of Health.
M.A. Taffe: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; R44DA041967. C. Other
Research Support (receipt of drugs, supplies, equipment or
other in-kind support); La Jolla Alcohol Research, Inc. S.A.
Vandewater: F. Consulting Fees (e.g., advisory boards);
La Jolla Alcohol Research, Inc. M. Cole: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
R44DA041967. E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); La Jolla Alcohol
Research, Inc.
M.P. Carrera: A. Employment/Salary (full or part-time);
Universidade Estadual do North Fluminense. B. Contracted
Research/Research Grant (principal investigator for a
drug study, collaborator or consultant and pending and
current grants). If you are a PI for a drug study, report
that research relationship even if those funds come to an
institution; CNPq and FAPERJ. F.R.C. Dias: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
FAPERJ. L.R. Oliveira: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; UENF/PIBIC. B.G.
Santos: B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; CAPES. J.L.L. Silva: B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
UENF/PIBIC.
D.A. Morilak: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; H Lundbeck A/S.
F. Consulting Fees (e.g., advisory boards); Lundbeck
Research, USA.
D.A. Morilak: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; H Lundbeck A/S.
F. Consulting Fees (e.g., advisory boards); Lundbeck
Research, USA.
M.B. Milienne-Petiot: A. Employment/Salary (full or parttime); UCSD. B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; TMARC. J.W. Young: A.
Employment/Salary (full or part-time); UCSD. B. Contracted
Research/Research Grant (principal investigator for a drug
study, collaborator or consultant and pending and current
grants). If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
TMARC. A. Minassian: A. Employment/Salary (full or parttime); UCSD. B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or

PRESENTATION
NUMBER STATEMENT

462.07

464.01

465.17

466.04

466.09

466.19
467.11
468.08

consultant and pending and current grants). If you are a PI

for a drug study, report that research relationship even if
those funds come to an institution; TMARC.
S. Daripelli: A. Employment/Salary (full or part-time);
Suven Life Sciences LTD., Hyderabad, India. V. Benade:
A. Employment/Salary (full or part-time); Suven Life
Sciences LTD., Hyderabad, India. G. Ayyanki: A.
Employment/Salary (full or part-time); Suven Life Sciences
LTD., Hyderabad, India. V. Kamuju: A. Employment/Salary
(full or part-time); Suven Life Sciences LTD., Hyderabad,
India. G. Bhyrapuneni: A. Employment/Salary (full or
part-time); Suven Life Sciences LTD., Hyderabad, India. R.
Nirogi: A. Employment/Salary (full or part-time); Suven Life
Sciences LTD., Hyderabad, India.
D. Feifel: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); DF is a named inventor
on a patent application for the therapeutic use of oxytocin,
filed on his behalf by UCSD.
H.S. Mayberg: E. Ownership Interest (stock, stock options,
royalty, receipt of intellectual property rights/patent holder,
excluding diversified mutual funds); Dr. Mayberg has
licensed intellectual property to St. Jude Medical Inc. to
develop DBS for the treatment of severe depression (US
2005/0033379A1)..
T.A. Tishler: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are
a PI for a drug study, report that research relationship
even if those funds come to an institution; Janssen
Scientific Affairs, LLC. G. Bartzokis: B. Contracted
Research/Research Grant (principal investigator for a
drug study, collaborator or consultant and pending and
current grants). If you are a PI for a drug study, report
that research relationship even if those funds come to an
institution; Janssen Scientific Affairs, LLC. K.L. Subotnik:
B. Contracted Research/Research Grant (principal
investigator for a drug study, collaborator or consultant
and pending and current grants). If you are a PI for a drug
study, report that research relationship even if those funds
come to an institution; Janssen Scientific Affairs, LLC.
K.H. Nuechterlein: B. Contracted Research/Research
Grant (principal investigator for a drug study, collaborator
or consultant and pending and current grants). If you are a
PI for a drug study, report that research relationship even
if those funds come to an institution; Janssen Scientific
Affairs, LLC. B.M. Ellingson: B. Contracted Research/
Research Grant (principal investigator for a drug study,
collaborator or consultant and pending and current grants).
If you are a PI for a drug study, report that research
relationship even if those funds come to an institution;
Janssen Scientific Affairs, LLC.
J. Conn: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are a PI
for a drug study, report that research relationship even if
those funds come to an institution; Research funding from
Bristol Myers-Squibb, Johnson and Johnson, AstraZeneca.
E. Ownership Interest (stock, stock options, royalty, receipt
of intellectual property rights/patent holder, excluding
diversified mutual funds); Patents that protect different
classes of M1 PAMs. F. Consulting Fees (e.g., advisory
boards); Consultant Pfizer.
J. Zhao: A. Employment/Salary (full or part-time); NIMH/
NIH.
M. Corredor: A. Employment/Salary (full or part-time);
University of Antioquia, Biology Institute, GEBIOMIC Group.
M.P. Frosch: B. Contracted Research/Research Grant
(principal investigator for a drug study, collaborator or
consultant and pending and current grants). If you are
a PI for a drug study, report that research relationship
even if those funds come to an institution; Massachusetts
Alzheimer Disease Research Center.

PRESENTATION
NUMBER STATEMENT

468.21
469.11

470.13

A. Walker: A. Employment/Salary (full or part-time); UC

Berkeley. Y. Huang: A. Employment/Salary (full or parttime); UC Berkeley.
C. Graversen: A. Employment/Salary (full or part-time);
Eriksholm Research Centre - part of Oticon. E.B. Petersen:
A. Employment/Salary (full or part-time); Eriksholm
Research Centre - part of Oticon. A. Favre-Felix: A.
Employment/Salary (full or part-time); Eriksholm Research
Centre - part of Oticon. T. Lunner: A. Employment/Salary
(full or part-time); Eriksholm Research Centre - part of
Oticon.
F. Rothganger: A. Employment/Salary (full or part-time);
Sandia National Laboratories.

Neuroscience 2016|Monday Conflict of Interest Statements|167

Hotel Floor Plans

MANCHESTER GR AND HYAT T
1 Market Pl
San Diego, CA 92101

MARRIOT T MARQUIS SAN DIEGO MARINA

333 W Harbor Dr
San Diego, CA 92101

FIRST FLOOR
(Ground Level)

SECOND FLOOR
(Lobby Level)

SOUTH TOWER

LE VEL 3

Second Floor

South Tower

Bayside
1st Floor
Laguna
Leucadia
Oceanside
Point Loma
Santa Rosa
Solana
Vista
3rd Floor
Balboa
Cardiff
Carlsbad
Del Mar
Encinitas
Marina Ballroom DG
Miramar
Mission Hills
Palomar
4th Floor
Catalina
Coronado
Dana Point
La Costa
La Jolla
La Mesa
Malibu
Newport Beach

NORTH TOWER
Lobby Level
Presidio 12
Rancho Santa Fe 13
Marriott Ballroom 113
San Diego Ballrooms AC
Torrey Pines 13
1st Floor
Temecula

LE VEL 4
South Tower

HILTON SAN DIEGO BAYFRONT

and Escalators

1 Park Blvd
San Diego, CA 92101

AQUA LE VEL

COBALT LE VEL

INDIGO LE VEL

SAPPHIRE LE VEL

SAN DIEGO CONVENTION CENTER

111 W Harbor Dr
San Diego, CA 92101

UPPER LE VEL

MEZ Z ANINE LE VEL

Exhibits and Poster Sessions

SAN DIEGO CONVENTION CENTER
Meeting Dates: November 1216
Exhibit Dates: November 1316
Note: Entrances will open at noon on Saturday and at 7 a.m. Sunday through Wednesday for poster presenter
setup only. Poster sessions are open for all attendees at 1 p.m. on Saturday and 8 a.m. Sunday through Wednesday.
Pending fire marshal approval. Floor plans subject to change. For current floor plan, visit SfN.org/exhibits.

Hilton Bayfront

KEY
Publishers Row
SfN Booth
Nonprofits/ U.S.
Government Agencies

Express Badge
Pick-Up

Sustaining Associate Members

Womens Restroom

Abstract Locator

Mens Restroom

Concession Area

Entrance

Shuttle
Information

Info
Booth

Exhibitor
Service
Center

Express
Badge
Pick-Up

SAN DIEGO CONVENTION CENTER

Gaslamp Quarter
Coat &
Bag
Check

Coat &
Bag
Check

Restaurants
Reservations

KEY
Publishers Row
SfN Booth
Nonprofits/ U.S.
Government Agencies

Sustaining Associate Members

Womens Restroom

Abstract Locator

Mens Restroom

Concession Area

Entrance

Info
Booth

Express
Badge
Pick-Up

Program
& Exhibit
Guide
Pick-Up

Marriott Marquis
and Marina

SEE YOU IN
WASHINGTON, DC
NOVEMBER 1115

SfN.org